<SEC-DOCUMENT>0001493152-16-008381.txt : 20160330
<SEC-HEADER>0001493152-16-008381.hdr.sgml : 20160330
<ACCEPTANCE-DATETIME>20160330121137
ACCESSION NUMBER:		0001493152-16-008381
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		101
CONFORMED PERIOD OF REPORT:	20151231
FILED AS OF DATE:		20160330
DATE AS OF CHANGE:		20160330

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Synergy CHC Corp.
		CENTRAL INDEX KEY:			0001562733
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				990379440
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-55098
		FILM NUMBER:		161537902

	BUSINESS ADDRESS:	
		STREET 1:		865 SPRING STREET
		CITY:			WESTBROOK
		STATE:			ME
		ZIP:			04092
		BUSINESS PHONE:		615-939-9004

	MAIL ADDRESS:	
		STREET 1:		865 SPRING STREET
		CITY:			WESTBROOK
		STATE:			ME
		ZIP:			04092

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Synergy Strips Corp.
		DATE OF NAME CHANGE:	20140429

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Oro Capital Corporation, Inc.
		DATE OF NAME CHANGE:	20121121
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>form10-k.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"> <FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Washington,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>FORM
10-K</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ANNUAL
REPORT PURSUANT TO SECTION 13 OR 15(d)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OF
THE SECURITIES EXCHANGE ACT OF 1934</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the fiscal year ended December 31, 2015</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commission
file number: 333-185103</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 90; width: 259"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B><U>Synergy
CHC Corp.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 49%; text-align: center; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Nevada</B></FONT></td>
    <TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td>
    <TD STYLE="width: 49%; text-align: center; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>99-0379440</B></FONT></td></tr>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
                                         or other jurisdiction of</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">incorporation
        or organization)</FONT></P></td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
                                         Employer</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
        No.)</FONT></P></td></tr>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td></tr>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">865
    Spring Street Westbrook, ME</FONT></td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">04092</FONT></td></tr>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of principal executive offices)</FONT></td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Zip
    Code)</FONT></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&rsquo;s
telephone number, including area code: 615-939-9004</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:<B> None</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(g) of the Act:<B> Common Stock, par value $0.00001 per share</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes [&nbsp;&nbsp;]
No [X]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is not required to file reports pursuant to Section 13 or 15 (d) of the Act. Yes [&nbsp;&nbsp;]
No [X]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive
Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such
shorter period that the registrant was required to submit and post such files). Yes [X] No [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not
be contained, to the best of registrant&rsquo;s knowledge, in definitive proxy or information statements incorporated by reference
in Part III of this Form 10-K or any amendment to this Form 10-K. [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller
reporting company. See the definitions of &ldquo;large accelerated filer,&rdquo; &ldquo;accelerated filer&rdquo; and &ldquo;smaller
reporting company&rdquo; in Rule 12b-2 of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 66pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 66%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large
    accelerated filer [&nbsp;&nbsp;]</FONT></td>
    <TD STYLE="width: 34%; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated
    filer [&nbsp;&nbsp;]</FONT></td></tr>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-accelerated
    filer [&nbsp;&nbsp;] (Do not check if a smaller reporting company)</FONT></td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller
    reporting company [X]</FONT></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes [&nbsp;&nbsp;] No [X]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate market value of the registrant&rsquo;s common stock held by non-affiliates as of June 30, 2015 was approximately $18.9
million based upon the closing price of the common stock as quoted by the Over-the-Counter Bulletin Board (the &ldquo;OTC Bulletin
Board&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 28, 2016, there were 81,692,954 shares of the registrant&rsquo;s common stock, par value $0.00001 per share, outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Table
of Contents</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD COLSPAN="4" STYLE="text-decoration: none; font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="#a_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PART
    I</FONT></A></td></tr>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"></td></tr>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="width: 0.7in; font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    1.</FONT></td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-decoration: none; text-align: justify"><A HREF="#a_002"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BUSINESS</FONT></A></td>
    <TD STYLE="width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.5in; text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT></td></tr>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    1A.</FONT></td>
    <TD STYLE="text-decoration: none; font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="#a_003"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RISK
    FACTORS</FONT></A></td>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></td></tr>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    1B.</FONT></td>
    <TD STYLE="text-decoration: none; font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="#a_004"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">UNRESOLVED
    STAFF COMMENTS</FONT></A></td>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</FONT></td></tr>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    2.</FONT></td>
    <TD STYLE="text-decoration: none; font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="#a_005"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROPERTIES</FONT></A></td>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</FONT></td></tr>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    3.</FONT></td>
    <TD STYLE="text-decoration: none; font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="#a_006"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LEGAL
    PROCEEDINGS</FONT></A></td>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</FONT></td></tr>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    4.</FONT></td>
    <TD STYLE="text-decoration: none; font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="#a_007"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MINE
    SAFETY DISCLOSURES</FONT></A></td>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</FONT></td></tr>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td></tr>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD COLSPAN="4" STYLE="text-decoration: none; font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="#a_008"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PART
    II</FONT></A></td></tr>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td></tr>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    5.</FONT></td>
    <TD STYLE="text-decoration: none; font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="#a_009"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MARKET
    FOR REGISTRANT&rsquo;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</FONT></A></td>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</FONT></td></tr>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    6.</FONT></td>
    <TD STYLE="text-decoration: none; font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="#a_010"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SELECTED
    FINANCIAL DATA</FONT></A></td>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</FONT></td></tr>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    7.</FONT></td>
    <TD STYLE="text-decoration: none; font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="#a_011"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MANAGEMENT&rsquo;S
    DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</FONT></A></td>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</FONT></td></tr>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    7A.</FONT></td>
    <TD STYLE="text-decoration: none; font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="#a_012"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">QUANTITATIVE
    AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</FONT></A></td>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></td></tr>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    8.</FONT></td>
    <TD STYLE="text-decoration: none; font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="#a_013"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONSOLIDATED
    FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</FONT></A></td>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></td></tr>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    9.</FONT></td>
    <TD STYLE="text-decoration: none; font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="#a_014"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CHANGES
    IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</FONT></A></td>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></td></tr>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    9A.</FONT></td>
    <TD STYLE="text-decoration: none; font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="#a_015"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONTROLS
    AND PROCEDURES</FONT></A></td>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13</FONT></td></tr>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    9B.</FONT></td>
    <TD STYLE="text-decoration: none; font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="#a_016"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">OTHER
    INFORMATION</FONT></A></td>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14</FONT></td></tr>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td></tr>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD COLSPAN="4" STYLE="text-decoration: none; font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="#a_017"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PART
    III</FONT></A></td></tr>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td></tr>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    10.</FONT></td>
    <TD STYLE="text-decoration: none; font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="#a_018"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DIRECTORS,
    EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</FONT></A></td>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></td></tr>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    11.</FONT></td>
    <TD STYLE="text-decoration: none; font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="#a_019"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXECUTIVE
    COMPENSATION</FONT></A></td>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</FONT></td></tr>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    12.</FONT></td>
    <TD STYLE="text-decoration: none; font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="#a_020"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECURITY
    OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</FONT></A></td>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20</FONT></td></tr>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    13.</FONT></td>
    <TD STYLE="text-decoration: none; font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="#a_021"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CERTAIN
    RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</FONT></A></td>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21</FONT></td></tr>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    14.</FONT></td>
    <TD STYLE="text-decoration: none; font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="#a_022"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRINCIPAL
    ACCOUNTANT FEES AND SERVICES</FONT></A></td>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22</FONT></td></tr>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td></tr>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD COLSPAN="4" STYLE="text-decoration: none; font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="#a_023"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PART
    IV</FONT></A></td></tr>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td></tr>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM
    15.</FONT></td>
    <TD STYLE="text-decoration: none; font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="#a_024"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXHIBITS
    AND CONSOLIDATED FINANCIAL STATEMENT SCHEDULES</FONT></A></td>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">23</FONT></td></tr>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td></tr>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="text-decoration: none; font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><A HREF="#a_025"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SIGNATURES</FONT></A></td>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">26</FONT></td></tr>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td></tr>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EXHIBIT
    INDEX</FONT></td>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CAUTIONARY
NOTE REGARDING FORWARD-LOOKING STATEMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Information
contained in this annual report contains &ldquo;forward-looking statements&rdquo; as defined by the Private Securities Litigation
Reform Act of 1995. These forward-looking statements are contained principally in the sections titled &ldquo;Management&rsquo;s
Discussion and Analysis of Financial Condition and Results of Operations&rdquo; and &ldquo;Business,&rdquo; and are generally
identifiable by use of the words &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;should,&rdquo; &ldquo;expect,&rdquo; &ldquo;anticipate,&rdquo;
&ldquo;estimate,&rdquo; &ldquo;believe,&rdquo; &ldquo;intend&rdquo; or &ldquo;project&rdquo; or the negative of these words or
other variations on these words or comparable terminology. As used herein, &ldquo;we,&rdquo; &ldquo;us,&rdquo; &ldquo;our&rdquo;
and the &ldquo;Company&rdquo; refers to Synergy CHC Corp. and its wholly owned subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
forward-looking statements herein represent our expectations, beliefs, plans, intentions or strategies concerning future events,
including, but not limited to: our future financial performance; the continuation of historical trends; the sufficiency of our
cash balances for future needs; our future operations; our sales and revenue levels and gross margins, costs and expenses; the
relative cost of our operation as compared to our competitors; new product introduction, entry and expansion into new markets
and utilization of new sales channels and sales agents; improvements in, and the relative quality of, our technologies and the
ability of our competitors to copy such technologies; our competitive technological advantages over our competitors; brand image,
customer loyalty and expanding our customer base; the sufficiency of our resources in funding our operations; and our liquidity
and capital needs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
forward-looking statements are based on our current expectations and beliefs concerning future developments, and there can be
no assurance that any projections or other expectations included in any forward-looking statements will come to pass. Moreover,
our forward-looking statements are subject to various known and unknown risks, uncertainties and other factors that may cause
our actual results, performance or achievements to be materially different from future results, performance or achievements expressed
or implied by any forward-looking statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as required by applicable laws, we undertake no obligation to update publicly any forward-looking statements for any reason, even
if new information becomes available or other events occur in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><A NAME="a_001"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PART
I</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><A NAME="a_002"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ITEM
1. BUSINESS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 13.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Overview</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 13.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 13.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a consumer health care company that is in the process of building a portfolio of best-in-class consumer product brands. Our
strategy is to grow both organically and by further acquisition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 13.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 13.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Corporate
History</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 13.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 13.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
were organized as a corporation under the laws of the State of Nevada on December 29, 2010 under the name &ldquo;Oro Capital Corporation&rdquo;.
On April 7, 2014, an Agreement and Plan of Merger (the &ldquo;Merger Agreement&rdquo;) was entered into by and among us, Synergy
Merger Sub, Inc., a Delaware corporation and our wholly owned subsidiary formed for the purpose of the transactions under the
Merger Agreement (&ldquo;Merger Sub&rdquo;), and Synergy Strips Corp., a Delaware corporation incorporated on January 24, 2012
(&ldquo;SSC&rdquo;). The Merger Agreement provided for the merger of Merger Sub with and into SSC (the &ldquo;Merger&rdquo;),
with SSC surviving the merger as our wholly owned subsidiary. On April 17, 2014, we issued a share dividend to our shareholders
in order to effect a 30-for-1 forward stock split. The Merger was consummated on April 21, 2014. On April 21, 2014, we changed
our fiscal year end from July 31 to December 31. On April 28, 2014, we changed the name of the Company from &ldquo;Oro Capital
Corporation&rdquo; to &ldquo;Synergy Strips Corp.&rdquo; On August 5, 2015, we changed the name to &ldquo;Synergy CHC Corp.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 13.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 13.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2015
Fiscal Year Developments</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 13.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 13.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2015, we were active in our acquisition strategy. Our objective is to focus on three verticals: Nutraceuticals, Cosmeceuticals
and Over the Counter (OTC). The following products were acquired during 2015 in each vertical:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 13.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 32%; text-align: center; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Nutraceuticals</B></FONT></td>
    <TD STYLE="width: 2%; text-align: center; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td>
    <TD STYLE="width: 32%; text-align: center; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cosmeceuticals</B></FONT></td>
    <TD STYLE="width: 2%; text-align: center; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td>
    <TD STYLE="width: 32%; text-align: center; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Over
    the Counter</B></FONT></td></tr>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><IMG SRC="image_002.jpg" ALT="" STYLE="height: 80; width: 96"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><IMG SRC="image_003.jpg" ALT="" STYLE="height: 80; width: 122"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><IMG SRC="image_005.jpg" ALT="" STYLE="height: 80; width: 90"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td></tr>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><IMG SRC="image_006.jpg" ALT="" STYLE="height: 60; width: 180"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><IMG SRC="image_007.jpg" ALT="" STYLE="height: 60; width: 159"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 13.2pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description
of the Business</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOCUSfactor
is sold at America&rsquo;s leading retailers such as Costco, Sam&rsquo;s Club, BJ&rsquo;s, Walmart, Walgreens and The Vitamin
Shoppe. FOCUSfactor is a brain-health nutritional supplement that includes a proprietary blend of brain supporting vitamins, minerals,
antioxidants and other nutrients. In December 2012, the United States Patent and Trademark Office issued US Patent 8,329,227 covering
FOCUSfactor&rsquo;s proprietary formulation &ldquo;for enhanced mental function.&rdquo; The issuance of the patent marked one
of the few times a patent has been issued for a nationally branded nutritional supplement. FOCUSfactor is clinically tested with
results demonstrating improvements in focus, concentration and memory in healthy adults.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Flat
Tummy Tea is a uniquely formulated two-step herbal detox tea that works to naturally help speed metabolism, boost energy and reduce
bloating. Flat Tummy Tea is sold exclusively online at www.flattummytea.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hand
MD is the world&rsquo;s first anti-aging skincare line formulated specifically for the hands. Hand MD is sold exclusively online
at www.buyhandmd.com.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neuragen
is a topical product that works directly at the site of pain as opposed to oral products. Neuragen reduces the spontaneous firing
of damaged peripheral nerves. By calming these nerves, Neuragen is clinically shown to reduce shooting and burning pains quickly
and without side effects. Neuragen is sold at Walgreens and through various distribution channels.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">UrgentRx
is a line of fast-acting, portable OTC medications that prove &lsquo;right now relief&rsquo; for today&rsquo;s busy, on the go
consumer. UrgentRx fast powders are innovative, fast acting flavored powdered medications in patented credit card sized packets.
They can be taken without water, providing immediate relief for a wide variety of every day ailments such as allergy attacks,
headaches, aches and pains, heartburn and upset stomach. UrgentRx can be found at convenience stores and drugstores across the
United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Products</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Current
Products</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><IMG SRC="image_008.jpg" ALT="" STYLE="height: 400; width: 638"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Development
and Commercialization Strategy</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to expand on the current retail strategies and build out a strong online sales model.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Research
and Development</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently outsource our research and development to a third parties experienced in the development of such technologies, which
third party is led by a group of experienced scientists.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Manufacturing</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently outsource the manufacturing of our products to third parties who have the necessary equipment and technology to provide
mass quantities as required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Commercialization</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are highly dependent on two retailers for the sale of our FOCUSfactor product: Costco Wholesale Corporation and Sam&rsquo;s West,
Inc./Walmart (a/k/a Sam&rsquo;s Club). We intend to diversify our sales network and generate revenue by selling our consumer-ready
products to retailers across North America, which retailers may then sell to end consumers through retail distribution channels.
We also sell direct to wholesalers and distributors at a reduced cost to grow our revenue base quickly and to penetrate the market
more effectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Intellectual
Property</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
success depends in part upon our ability to protect our core technology and intellectual property. To establish and protect our
proprietary rights, we will rely on a combination of patents, patent applications, trademarks, copyrights, trade secrets, including
know-how, license agreements, confidentiality procedures, non-disclosure agreements with third parties, employee disclosure and
invention assignment agreements, and other contractual rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2012, the United States Patent and Trademark Office issued U.S. Patent 8,329,227 covering FOCUSfactor&rsquo;s proprietary
formulation &ldquo;for enhanced mental function.&rdquo; The issuance of the patent marked one of the few times a patent has been
issued for a nationally branded nutritional supplement. The issuance of the patent for FOCUSfactor came after a 2011 clinical
study report which showed that FOCUSfactor improved memory, concentration and focus in healthy adults participating in the study.
The clinical study of FOCUSfactor was sponsored by Factor Nutrition Labs, the owner of the Focus Factor Business at the time,
and was conducted by Cognitive Research Corporation, a full-service contract research organization that specializes in the effects
of nutritional supplements and pharmaceutical products on human cognition. The study was conducted in compliance with all applicable
country requirements for the conduct of clinical studies, including those outlined by the International Conference on Harmonization,
Consolidated Guidelines on Good Clinical Practices, and the Food and Drug Administration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2013, the United States Patent and Trademark Office issued U.S. Patent 8,376,140 covering UrgentRx&rsquo;s portable powder
delivery system and method.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Distribution
and Marketing</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
plan to focus on selling to retailers and distributors who currently are active in the consumer product space to expedite the
penetration of market acceptance of the product. We are currently conducting research with focus groups to find out what the best
approach for marketing efforts is and how to do so on the most cost-effective manner. We also plan to develop an online sales
channel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Markets</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
sell our products in mostly American retail locations along with other developed countries with similar retail landscapes to North
America. Knight has distribution rights to sell our products in Canada and certain other territories.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Competition</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
there are many competing products on the market, in all our current product categories, FOCUSfactor is the only product in its
category with both a patent and clinical study to support its claims. These competitors include a wide range of products, from
targeted brain-enhancement supplements to indirect competitors such as energy drinks that claim to improve concentration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Government
Regulation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
products that we sell, and those that we are developing for future sale, may be subject to U.S. Food and Drug Administration (&ldquo;FDA&rdquo;)
approval for packaging compliance. With respect to the products we currently sell, our regulator counsel has reviewed all of our
products and we are compliant with the current rules. Since the current products sold are considered nutraceuticals, cosmeceuticals
and over the counter products, minimal regulations are placed on the product with the exception of the appropriate labeling and
warnings on the packaging.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will rely on legal and operational compliance programs, as well as local counsel, to guide its businesses in complying
with applicable laws and regulations of the jurisdictions in which it does business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company does not anticipate, at this time, that the cost of compliance with U.S. and foreign laws will have a material financial
impact on its operations, business or financial condition. There are however no guarantees that new regulatory and tariff legislation
may not have a material negative effect on its business in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Employees</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 18, 2016, we had 28 full-time employees and no part-time employees. We intend to grow our employee base in response to
the demands and requirements of the business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><A NAME="a_003"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ITEM
1A. RISK FACTORS.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a &ldquo;smaller reporting company,&rdquo; as defined by Item 10 of Regulation S-K, we are not required to provide this information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><A NAME="a_004"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ITEM
1B. UNRESOLVED STAFF COMMENTS.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
Applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><A NAME="a_005"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ITEM
2. PROPERTIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table describes our principal properties leased as of March 18, 2016:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Purpose</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Location</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Square
    Footage</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 38%; font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Technology
    Center (1)</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 36%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">Halifax, NS</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 20%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6,800</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Main Office (2)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">Westbrook, ME</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,510</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Subsidiary Head
    Office (3)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">Denver, CO</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,995</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Subsidiary Head
    Office (4)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cottesloe, WA, Australia</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,370</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
Monthly rental payments are $5,500 per month through December 2016</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27.5pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Monthly rental payments are $4,290 per month on a month to month basis</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27.5pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Monthly rental payments are $8,923 per month less a $3,010 per month sublease through March 2017</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27.5pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
Monthly rental payments are $5,500 AUD per month (approximately $4,200 USD) through November 2016.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><A NAME="a_006"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ITEM
3. LEGAL PROCEEDINGS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are not a party to any legal proceedings and we are not aware of any claims or actions pending or threatened against us. In the
future, we might from time to time become involved in litigation relating to claims arising from our ordinary course of business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><A NAME="a_007"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ITEM
4. MINE SAFETY DISCLOSURES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
Applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><A NAME="a_008"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PART
II</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><A NAME="a_009"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ITEM
5. MARKET FOR REGISTRANT&rsquo;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Only
a sporadic and limited market exists for our securities. There is no assurance that a regular trading market will develop, or
if one develops, that it will be sustained. Therefore, a shareholder in all likelihood will be unable to resell his, her or its
securities in our Company. Furthermore, it is unlikely that a lending institution will accept our securities as pledged collateral
for loans unless a regular trading market develops. Our securities are traded on the OTCQB operated by OTCMarkets.com under the
symbol &ldquo;SNYR&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 60%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Quarter
    Ended</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">High</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Low</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 72%; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">12/31/15</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.74</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.46</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">9/30/15</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.70</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.40</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">6/30/15</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.00</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.35</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">3/31/15</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.43</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.30</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">12/31/14</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.55</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.31</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">9/30/14</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.60</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.31</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">6/30/14</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.00</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.30</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">3/31/14</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.33</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.33</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shareholders</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 28, 2016, we had 42 shareholders of record of our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dividend
Policy</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not declared any cash dividends. We do not intend to pay dividends in the foreseeable future, but rather to reinvest earnings,
if any, in our business operations. The payment of cash dividends in the future, if any, will be at the discretion of our board
of directors and will depend upon such factors as earnings levels, capital requirements, our overall financial condition and any
other factors our board deems relevant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Equity
Compensation Plans</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information required by Item 5 of Form 10-K regarding equity compensation plans is incorporated herein by reference to &ldquo;Item
11. Executive Compensation&rdquo; in this report.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><A NAME="a_010"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ITEM
6. SELECTED FINANCIAL DATA.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a &ldquo;smaller reporting company,&rdquo; as defined by Item 10 of Regulation S-K, we are not required to provide this information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><A NAME="a_011"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ITEM
7. MANAGEMENT&rsquo;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
following discussion is an overview of the important factors that management focuses on in evaluating our business; financial
condition and operating performance should be read in conjunction with the financial statements included in this Annual Report
on Form 10-K. This discussion contains forward-looking statements that involve risks and uncertainties. Actual results could differ
materially from those anticipated in these forward-looking statements as a result of any number of factors, including those set
forth in the Company&rsquo;s reports filed with the SEC on Form 10-K, 10-Q and 8-K as well as in this Annual Report on Form 10-K.
Given the uncertainties that surround such statements, you are cautioned not to place undue reliance on such forward-looking statements.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Overview</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is in the business of marketing and distributing consumer branded products through various distribution channels primarily
in the health and wellness industry. The Company&rsquo;s strategy is to grow both organically and by future acquisition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management&rsquo;s discussion and analysis of our financial condition and results of operations are only based on our current
business and should be read in conjunction with our audited Consolidated Financial Statements and accompanying notes thereto included
elsewhere in this Annual Report Form 10-K. Key factors affecting our results of operations include revenues, cost of revenues,
operating expenses and income and taxation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Non-GAAP
Financial Measures</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
currently focus on Adjusted EBITDA to evaluate our business relationships and our resulting operating performance and financial
position. Adjusted EBITDA is defined as EBITDA (net income plus interest expense, income tax expense, depreciation and amortization),
further adjusted to exclude certain non-cash expenses and other adjustments as set forth below. We present Adjusted EBITDA because
we consider it an important measure of our performance and it is a meaningful financial metric in assessing our operating performance
from period to period by excluding certain items that we believe are not representative of our core business, such as certain
non-cash items and other adjustments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that Adjusted EBITDA, viewed in addition to, and not in lieu of, our reported results in accordance with accounting principles
generally accepted in the United States (&ldquo;U.S. GAAP&rdquo;), provides useful information to investors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31, 2015</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="width: 76%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Net
    loss</B></FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 20%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,536,548</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Interest income</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,460</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Interest expense</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">958,740</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Taxes</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">389,945</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Depreciation</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,513</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="padding-bottom: 1.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amortization</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,260,654</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EBITDA</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">72,844</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Loss on change
    in fair value of derivative liability</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,028,921</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stock-based compensation</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">551,714</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>One-time expenses
    for acquisitions</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">216,119</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Loss on foreign
    currency translation and transaction</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">46,860</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Write off of
    obsolete inventory</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,451</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF">
    <TD STYLE="padding-bottom: 1.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjusted
    EBITDA</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,940,909</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">EBITDA
and Adjusted EBITDA are considered non-GAAP financial measures. EBITDA represents earnings before interest, taxes, depreciation
and amortization. Adjusted EBITDA represents EBITDA, further adjusted to exclude the impact of higher-than-normal revenue change
order activity and certain expenses and transactions that we believe are not representative of our core operating results, including
loss on change in fair value of derivative liability; stock-based compensation; one-time expenses for acquisitions; loss on foreign
currency translation and transaction; and the write off of obsolete inventory. The Company&rsquo;s definitions of EBITDA and adjusted
EBITDA might not be comparable to similarly titled measures reported by other companies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Results
of Operations for the Years Ended December 31, 2015 and December 31, 2014</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2015, we completed five acquisitions, with at least one in each of the three targeted verticals of Nutraceuticals, Cosmeceuticals
and Over the Counter (OTC). Our objective is to grow all three verticals to provide a balanced and synergistic portfolio that
drives consumer demand via multiple channels.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Revenue</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2015, we had revenues of $13,456,377 from sales of our products, as compared to revenue of $9,158
for the year ended December 31, 2014. This is primarily due to the acquisitions we completed during 2015.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Cost
of Revenue</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2015, our cost of revenue was $5,308,130. Our cost of revenue for the year ended December 31, 2014,
was $5,616. This increase is also due to the acquisitions we completed during 2015.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Operating
Expenses</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling
and Marketing Expenses</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2015, our selling and marketing expenses were $3,685,727 as compared to $0 for the year ended December
31, 2014, which is primarily due to marketing our various products in multiple media channels including print, television and
online.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
and Administrative Expenses</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2015, our general and administrative expenses were $3,368,495. For the year ended December 31, 2014,
our operating expenses were $961,636, which was primarily due to promoting the Synergy brand throughout North America and loss
from the Merger transaction. The increase in 2015 is primarily due to the acquisitions completed during 2015 and having general
costs now to run and manage each brand.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
and Amortization Expenses</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2015 our depreciation and amortization expenses were $608,002 as compared to $0 for the year ended
December 31, 2014. The increase in 2015 is due to the acquisitions completed during 2015.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Other
Income and Expenses</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2015 we had other (income) and expense items of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 86%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Interest income</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,460</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Interest expense</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">958,740</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Remeasurement gain on translation
    of foreign subsidiary</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(7,740</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Loss on change in fair value of derivative
    liability</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,028,921</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Amortization of debt discount</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,499,640</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Amortization of debt issuance cost</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">154,525</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">7,632,626</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2014 we had interest expense of $1,998. The increase in interest expense in 2015 was due to the issuance
of loans for the purpose of acquisitions of various companies&rsquo; during 2015. We also issued warrants along with the loans
and paid debt issuance cost in 2015 which lead to the amortization of debt discount and debt issuance cost during 2015. We issued
warrants with a reset provision in 2015 which lead to the calculation of warrant derivative liability and hence we recorded a
loss on change in fair value of derivative liability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Income
tax expense</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2015 we incurred income tax expense of $389,945 primarily related to our subsidiary, NomadChoice Pty
Limited (NomadChoice), located in Australia and which we acquired in 2015.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Net
Loss</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">For
the year ended December 31, 2015, our net loss was $7,536,548. This was primarily due to non-operating expenses such as amortization
of debt discounts and the change in the fair value of derivative liabilities. For the year ended December 31, 2014 our net loss
was $960,092. This was primarily due to increased spending on developing the Synergy brand and securing penetration in the U.S.
market and loss from the Merger transaction.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Liquidity
and Capital Resources</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Overview</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
of December 31, 2015, we had $3,640,893 cash on hand and a $6,165,812 working capital deficit. The deficit is largely due to the
future liability we&rsquo;ve accrued for in relation to an earn-out payment of $2,551,500 in which payments are due based solely
on future earnings and a derivative liability for stock warrants outstanding of $3,096,179. In addition, we also have restricted
cash of $607,084 which is comprised of $510,605 for the earn-out payment held in escrow account, $46,479 for a rolling reserve
with Paypal and $50,000 for credit card collateral.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Going
Concern</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s consolidated financial statements are prepared using U.S. GAAP applicable to a going concern, which contemplates
the realization of assets and liquidation of liabilities in the normal course of business. The Company had an accumulated deficit
at December 31, 2015 of $8,569,841. The Company had a working capital deficit of $6,165,812 as of December 31, 2015. Due to acquisitions
during 2015 of revenue producing products, the Company believes it has established an ongoing source of revenue that is sufficient
to cover its operating costs. The ability of the Company to continue as a going concern is dependent on the Company obtaining
adequate capital to fund operating losses until it establishes a revenue stream and becomes profitable. If the Company is unable
to obtain adequate capital it could be forced to cease development of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to continue as a going concern and to develop a reliable source of revenues, and achieve a profitable level of operations
the Company will need, among other things, additional capital resources. Management&rsquo;s plans to continue as a going concern
include raising additional capital through borrowing and/or sales of equity and debt securities. However, management cannot provide
any assurances that the Company will be successful in accomplishing any of its plans.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described
in the preceding paragraph and eventually secure other sources of financing and attain profitable operations. The accompanying
consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue
as a going concern. In their report accompanying our audited financial statements, our independent registered public accounting
firm expressed substantial doubt as to our ability to continue as a going concern.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Year
Ended December 31, 2015 and 2014</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Net
Cash Used in Operating Activities</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">For
the year ended December 31, 2015, we used net cash of $644,316 in operating activities, as compared to $489,175 used in operating
activities for the year ended December 31, 2014. The decrease was primarily attributable to a change in the business due to acquisitions
during 2015.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
$644,316 consists of our net loss of $7,536,548 reduced by:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 86%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Amortization of debt
    issuance cost</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">154,525</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Depreciation and amortization</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">608,002</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stock based compensation</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">551,714</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Amortization of debt discount</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,499,640</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Foreign currency transaction loss</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">54,600</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fair value of derivative loss</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,028,921</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Remeasurement gain on translation
    of foreign subsidiary</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(7,740</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Bad debt allowance</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">50,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Increase in accounts receivable</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,317,050</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Increase in inventory</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(19,632</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Increase in prepaid expenses</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(194,889</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Increase in accounts payable and
    accrued expenses</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">484,141</FONT></P>


</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Net
Cash Used in Investing Activities</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2015, we used net cash of $4,399,856 in investing activities, as compared to $0 used in investing
activities for the year ended December 31, 2014. The increase was primarily attributable to the acquisitions during 2015.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 86%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Payments for acquisition
    of fixed assets</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(7,833</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Restricted cash</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(607,084</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Payments for acquisition of Focus
    Factor assets</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(4,500,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Payments for acquisition of Neuragen
    assets</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(250,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Payments for acquisition of NomadChoice
    Pty Ltd</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2,918,200</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash acquired in acquisitions</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,883,261</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Net
Cash Provided by Financing Activities</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2015, financing activities provided $8,684,727, as compared to $486,283 provided by financing activities
for the year ended December 31, 2014. The increase was primarily attributable to proceeds from notes payable issued in connection
with the acquisitions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 86%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Advances from related
    party</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">16,077</FONT></TD><TD STYLE="width: 1%; text-align: left"></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Proceeds from notes payable</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">11,500,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Repayment of notes payable</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,150,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Payment of debt issuance costs</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(533,377</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Payment of dividends on subsidiary</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,173,975</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Proceeds from exercise of warrants</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Proceeds from issuance of common
    stock</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">26,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Key
2016 Initiatives</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2016, we have plans for organic growth within our current product lines by developing and launching new products. We have new
marketing campaigns in process and intend to expand our online presence for each product. While we intend to grow further through
additional acquisitions, we feel it is important to also develop our existing products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Contractual
Obligations and Off-Balance Sheet Arrangements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Contractual
Obligations</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Off-Balance
Sheet Arrangements</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Inflation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
effect of inflation on the Company&rsquo;s operating results was not significant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Summary
of Significant Accounting Policies</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect
the reported amount of assets and liabilities, the disclosure of contingent assets and liabilities and the reported amounts of
revenue and expenses during the reported periods. The more critical accounting estimates include estimates related to revenue
recognition and accounts receivable allowances. We also have other key accounting policies, which involve the use of estimates,
judgments and assumptions that are significant to understanding our results, which are described in Note 2 to our audited consolidated
financial statements appearing elsewhere in this report.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Recent
Accounting Pronouncements</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note
2 to our audited consolidated financial statements appearing elsewhere in this report includes Recent Accounting Pronouncements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><A NAME="a_012"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ITEM
7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a &ldquo;smaller reporting company,&rdquo; as defined by Item 10 of Regulation S-K, we are not required to provide this information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><A NAME="a_013"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ITEM
8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information required by this Item is set forth in the consolidated financial statements and notes thereto beginning at page F-1
of this Form 10-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FINANCIAL
STATEMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Synergy
CHC Corp.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(formerly
Synergy Strips Corp.)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-decoration: none; text-align: justify"><A HREF="#a_026"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reports
    of Independent Registered Public Accounting Firm</FONT></A></td>
    <TD STYLE="width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.6in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</FONT></td></tr>
<TR STYLE="background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-decoration: none; font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="#a_027"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated
    Balance Sheets</FONT></A></td>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-2</FONT></td></tr>
<TR STYLE="background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-decoration: none; font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="#a_028"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated
    Statements of Operations</FONT></A></td>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-3</FONT></td></tr>
<TR STYLE="background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-decoration: none; font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="#a_029"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated
    Statement of Changes in Stockholders&rsquo; Equity (Deficit)</FONT></A></td>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-4</FONT></td></tr>
<TR STYLE="background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-decoration: none; font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="#a_030"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated
    Statements of Cash Flows</FONT></A></td>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-5
    - F-6</FONT></td></tr>
<TR STYLE="background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-decoration: none; font: 10pt Times New Roman, Times, Serif; text-align: justify"><A HREF="#a_031"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
    to the Consolidated Financial Statements</FONT></A></td>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-7</FONT></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><A NAME="a_026"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Report
of Independent Registered Public Accounting Firm</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the Board of Directors and shareholders</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Synergy
CHC Corp.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(formerly
Synergy Strips Corp.)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have audited the accompanying consolidated balance sheets of Synergy CHC Corp. (formerly Synergy Strips Corp.) (the &ldquo;Company&rdquo;)
as of December 31, 2015 and 2014, and the related consolidated statements of operations, stockholders&rsquo; equity (deficit)
and cash flows for each of the two years in the period ended December 31, 2015. These consolidated financial statements are the
responsibility of the Company&rsquo;s management. Our responsibility is to express an opinion on these consolidated financial
statements based on our audits.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are
free of material misstatement. We were not engaged to perform an audit of the Company&rsquo;s internal control over financial
reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures
that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company&rsquo;s
internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test
basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and
significant estimates made by management, and evaluating the overall financial statement presentation. We believe that our audits
provide a reasonable basis for our opinion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position
of Synergy CHC Corp. (formerly Synergy Strips Corp.) at December 31, 2015 and 2014, and the results of its operations and its
cash flows for each of the two years in the period ended December 31, 2015, in conformity with accounting principles generally
accepted in the United States of America.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern.
As discussed in Note 2 to the consolidated financial statements, the Company suffered a net loss and has a net working capital
deficiency, which raises substantial doubt about its ability to continue as a going concern. Management&rsquo;s plans regarding
those matters are also described in Note 2. The consolidated financial statements do not include any adjustments that might result
from the outcome of this uncertainty.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif; text-align: justify; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    RBSM LLP</I></FONT></td>
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td></tr>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RBSM
    LLP</FONT></td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td></tr>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    30, 2016</FONT></td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td></tr>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td></tr>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
    York, New York</FONT></td>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Synergy
CHC Corp.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(formerly
Synergy Strip Corp.)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><A NAME="a_027"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated
Balance Sheets</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2015</FONT></TD><TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2014</FONT></TD><TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Assets</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Current Assets</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash and cash equivalents</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,640,893</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">338</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Restricted cash</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">607,084</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accounts Receivable</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,979,857</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,898</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Note receivable from related party</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">16,077</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prepaid expenses</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">422,434</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">10,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Inventory</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">686,655</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">26,064</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total Current Assets</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">9,336,923</FONT></P>


</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">55,376</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fixed assets, net</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,017</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Goodwill</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">11,496,402</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Intangible assets, net</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,915,262</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Debt issuance cost, net</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">378,852</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total Assets</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">27,139,456</FONT></P>


</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">55,376</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Liabilities and
    Stockholders&rsquo; Equity (Deficit)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Current Liabilities:</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accounts payable and accrued liabilities</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,032,102</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">74,642</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Provision for income taxes payable</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">910,894</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Earn out payment</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,551,500</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Current portion of long-term debt, net
    of debt discount, related party</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,162,060</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">100,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Current portion of long-term debt</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">750,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6,400</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Warrant derivative liability</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,096,179</FONT></P>


</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total Current Liabilities</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">15,502,735</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">181,042</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Long-term Liabilities:</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Note payable</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">750,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Royalty payable</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">258,897</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Notes payable, net of debt discount,
    related parties</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,208,111</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total long-term liabilities</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6,217,008</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total Liabilities</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">21,719,743</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">181,042</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Commitments and contingencies</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stockholders&rsquo;
    Equity (Deficit):</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Common stock, $0.00001 par value; 300,000,000
    and 75,000,000 shares authorized, respectively; 81,692,954 and 62,100,000, shares issued and outstanding, respectively</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">817</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">621</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Common stock to be issued</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">68,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">40,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Additional paid in capital</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">13,920,735</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">867,004</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accumulated deficit</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">(8,569,841</FONT></P>


</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,033,291</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total stockholders&rsquo; equity (deficit)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,419,713</FONT></P>


</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(125,666</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total Liabilities
    and Stockholders&rsquo; Equity (Deficit)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">27,139,456</FONT></P>


</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">55,376</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Synergy
CHC Corp.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(formerly
Synergy Strips Corp.)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><A NAME="a_028"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated
Statements of Operations</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
                                         the year</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ended</B></FONT></P></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
                                         the year</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ended</B></FONT></P></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2015</FONT></TD><TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2014</FONT></TD><TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Revenue</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">13,456,377</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">9,158</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cost of Sales</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,308,130</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,616</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Gross Profit</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8,148,247</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,542</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Operating expenses</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Selling and marketing</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,685,727</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">General and administrative</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,368,495</FONT></P>


</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">961,636</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Depreciation and amortization</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">608,002</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total operating expenses</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">7,662,224</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">961,636</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><P STYLE="margin: 0"></P>


</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Income (loss) from
    operations</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">486,023</FONT></P>


</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(958,094</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other (income) expenses</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Interest income</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,460</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Interest expense</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">958,740</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Remeasurement gain on translation of
    foreign subsidiary</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(7,740</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Loss on change in fair value of derivative
    liability</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,028,921</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Amortization of debt discount</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,499,640</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Amortization of debt issuance cost</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">154,525</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Imputed and other interest expense</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,998</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total other expenses</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">7,632,626</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,998</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net loss before income
    taxes</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(7,146,603</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(960,092</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Income tax expense</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">389,945</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    loss after tax</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">(7,536,548</FONT></P>


</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(960,092</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net loss per share
    - basic and diluted</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(0.11</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(0.01</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted average
    common shares - basic and diluted</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">68,852,305</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">97,165,479</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Synergy
CHC Corp.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(formerly
Synergy Strips Corp.)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><A NAME="a_029"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated
Statement of Stockholders&rsquo; Equity (Deficit)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Common stock</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Additional Paid in</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Common Stock</FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif">to be</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accumulated </FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    Stockholders&rsquo;</FONT></TD><TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shares</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Amount</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Capital</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">issued</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Deficit
    &nbsp; <B>&nbsp;</B></FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Equity</FONT></TD><TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Balance
    as of December 31, 2013</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 6%; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">180,000,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 6%; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,800</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 6%; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">58,578</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 6%; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 6%; border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(73,199</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="width: 2%; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 6%; border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(12,821</FONT></TD><TD STYLE="width: 1%; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cancellation of Oro Corporation shares</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(135,900,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,359</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,359</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Common stock issued to Synergy shareholders</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">16,000,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">160</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">24,840</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">25,000</FONT></TD><TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Common stock issued for cash</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,000,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">20</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">499,980</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">500,000</FONT></TD><TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fair value of vested stock options</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">282,247</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">282,247</FONT></TD><TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Common stock to be issued for services</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">40,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">40,000</FONT></TD><TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net loss</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(960,092</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(960,092</FONT></TD><TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Balance as of December
    31, 2014</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">62,100,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">621</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">867,004</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">40,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,033,291</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>(125,666</B></FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>)</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Common stock issued for cash</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">40,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">25,999</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">26,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Common stock issued as part of the Contribution
    Agreement with Hand MD</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,142,857</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">21</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,499,978</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,500,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Common stock issued for acquisitions
    of Breakthrough Products, Inc.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,000,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;3
                                         0 &nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,549,970</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,550,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Common stock issued for acquisitions
    of NomadChoice Pty Ltd.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,571,428</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">36</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,749,964</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,750,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Common stock issued to settle accounts
    payable</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">292,857</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">204,997</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">205,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Common stock issued for conversion of
    notes payable</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">400,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">99,996</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">100,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Common stock issued for exercise of
    warrants</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">10,145,812</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">101</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(99</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fair value of warrants issued along
    with notes payable</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,968,801</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,968,801</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fair value of vested stock options</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">523,714</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">523,714</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fair value of warrants issued to Breakthrough
    Products, Inc. as part of acquisition</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">430,411</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">430,411</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Common stock to be issued for services</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">28,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">28,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net loss</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(7,536,548</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(7,536,548</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Balance
    as of December 31, 2015</B></FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>81,692,954</B></FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>$</B></FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>817</B></FONT></TD><TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>$</B></FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>13,920,735</B></FONT></TD><TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>$</B></FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>68,000</B></FONT></TD><TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>$</B></FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>(</B></FONT><P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">8,569,839</FONT></P>


</TD><TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>)</B></FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>$</B></FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,419,713</FONT></TD><TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Synergy
CHC Corp.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(formerly
Synergy Strips Corp.)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><A NAME="a_030"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated
Statements of Cash Flows</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
                                         the year</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Ended</B></FONT></P></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
                                         the year</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ended</B></FONT></P></TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2015</FONT></TD><TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2014</FONT></TD><TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash Flows from
    Operating Activities</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 60%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net loss</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(7,536,548</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(960,092</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Adjustments to reconcile net loss
    to net cash used in operating activities:</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Amortization of debt issuance cost</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">154,525</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Depreciation and amortization</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">608,002</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stock based compensation expense</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">551,714</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">322,247</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Loss on acquisition</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">109,040</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Amortization of debt discount</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,499,640</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Foreign currency transaction loss</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">54,600</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fair value of derivative loss</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,028,921</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Remeasurement gain on translation
    of foreign subsidiary</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(7,740</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Bad debts</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">50,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Changes in operating assets and liabilities:</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accounts receivable</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,317,050</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2,898</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Inventory</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(19,632</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(26,064</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prepaid expense</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(194,889</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">10,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accounts payable and accrued liabilities</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">484,141</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">58,591</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net cash used in operating activities</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(644,316</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(489,175</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash Flows from
    Investing Activities</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Payments for acquisition of fixed
    assets</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(7,833</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Restricted cash</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(607,084</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Payments for acquisition of Focus
    Factor</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(4,500,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Payments for acquisition transaction
    with Knight Therapeutics Inc.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(250,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Payments for acquisition of NomadChoice
    Pty Ltd</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2,918,200</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash acquired in acquisitions</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,883,261</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net cash used in investing activities</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(4,399,856</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash Flows from
    Financing Activities</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">(Repayments to) advances from related
    party notes</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">16,077</FONT></P>


</TD><TD STYLE="text-align: left"></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(16,077</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Proceeds from notes payable</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">11,500,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">100,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Repayment of notes payable</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,150,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(97,640</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Payment of debt issuance cost</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(533,377</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dividends paid</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,173,975</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Proceeds from exercise of warrants</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Proceeds from issuance of common
    stock</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">26,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">500,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net cash provided by financing activities</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">8,684,727</FONT></P>


</TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">486,283</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net increase (decrease) in cash and
    cash equivalents</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,640,554</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2,892</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash and Cash Equivalents, beginning
    of period</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">338</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,230</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash
    and Cash Equivalents, end of period</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,640,893</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">338</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Supplemental Disclosure of Cash Flow
    Information:</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash paid during the period for:</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Interest</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">806,740</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,667</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Income taxes</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,688</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Supplemental Disclosure of Non-cash
    Investing and Financing Activities:</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Common stock
    issued for conversion of notes payable</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">100,000</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Beneficial conversion
    feature on warrants issued concurrent with debt</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,968,801</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Derivative liability
    at inception</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,067,258</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Assumption of
    liabilities as part of asset purchase agreement with Factor Nutrition Labs, LLC</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,912,827</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Assumption of
    liabilities as part of acquisition transaction with Knight Therapeutics Inc.</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">969,532</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Note issued as
    part of asset purchase agreement with Factor Nutrition Labs, LLC</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,500,000</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Common stock
    issued as part of contribution agreement with Hand MD</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,500,000</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Common stock
    issued for the acquisition of Breakthrough Products, Inc.</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,550,000</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Common stock
    issued for the acquisition of NomadChoice Pty Ltd.</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,750,000</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fair value of
    warrants issued as part of acquisition of Breakthrough Products, Inc.</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">430,411</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net liabilities
    taken over as part of acquisition of Breakthrough Products, Inc.</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">422,749</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net assets taken
    over as part of acquisition of NomadChoice Pty Ltd.</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">70,801</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Common stock
    issued to settle payables</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">205,000</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cancellation
    of common stock as part of purchase transaction</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,359</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Financing for
    prepaid insurance</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">20,000</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Assumption of
    liabilities as part of acquisition transaction</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">84,040</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Issuance of shares as part of acquisition
    transaction</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">25,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these consolidated financial statements</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SYNERGY
CHC CORP.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(FORMERLY
SYNERGY STRIPS CORP.)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><A NAME="a_031"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
1 &ndash; Nature of the Business</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Synergy
CHC Corp. (&ldquo;Synergy&rdquo;, &ldquo;we&rdquo;, &ldquo;us&rdquo;, &ldquo;our&rdquo; or the &ldquo;Company&rdquo;) (formerly
Synergy Strips Corp.) was incorporated on December 29, 2010 in Nevada under the name &ldquo;Oro Capital Corporation.&rdquo; On
April 21, 2014, the Company changed its fiscal year end from July 31 to December 31. On April 28, 2014, the Company changed its
name to &ldquo;Synergy Strips Corp.&rdquo;. On August 5, 2015, the Company changed its name to &ldquo;Synergy CHC Corp.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is a consumer health care company that is in the process of building a portfolio of best-in-class consumer product brands.
Synergy&rsquo;s strategy is to grow its portfolio both organically and by further acquisition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Synergy
is the sole owner of three subsidiaries: Neuragen Corp., Breakthrough Products, Inc. and NomadChoice Pty Ltd. and the results
have been consolidated in these statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
2 &ndash; Summary of Significant Accounting Policies</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Basis
of Presentation</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany
balances and transactions have been eliminated in consolidation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Use
of Estimates</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities, and disclosure of contingent liabilities at the date of the financial
statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.
At December 31, 2015 and 2014 significant estimates included in these estimates are assumptions about collection of accounts receivable,
useful life of fixed and intangible assets, goodwill and assumptions used in Black-Scholes-Merton, or BSM, valuation methods,
such as expected volatility, stock based compensation, risk-free interest rate, and expected dividend rate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Cash
and Cash Equivalents</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all cash on hand and in banks, including accounts in book overdraft positions, certificates of deposit and other
highly-liquid investments with maturities of three months or less, when purchased, to be cash and cash equivalents. As of December
31, 2015 the Company had no cash equivalents. The Company maintains its cash and cash equivalents in banks insured by the Federal
Deposit Insurance Corporation (FDIC) in accounts that at times may be in excess of the federally insured limit of $250,000 per
bank. The Company minimizes this risk by placing its cash deposits with major financial institutions. At December 31, 2015, the
uninsured balance amounted to $3,453,290.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Capitalization
of Fixed Assets</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company capitalizes expenditures related to property and equipment, subject to a minimum rule, that have a useful life greater
than one year for: (1) assets purchased; (2) existing assets that are replaced, improved or the useful lives have been extended;
or (3) all land, regardless of cost. Acquisitions of new assets, additions, replacements and improvements (other than land) costing
less than the minimum rule in addition to maintenance and repair costs, including any planned major maintenance activities, are
expensed as incurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Revenue
Recognition</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognizes revenue in accordance with the Financial Accounting Standards Board&rsquo;s (&ldquo;FASB&rdquo;), Accounting
Standards Codification (&ldquo;ASC&rdquo;) 605, Revenue Recognition (&ldquo;ASC 605&rdquo;). ASC 605 requires that four basic
criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred
and/or service has been performed; (3) the selling price is fixed and determinable; and (4) collectability is reasonably assured.
The Company believes that these criteria are satisfied upon shipment from its fulfillment centers. Certain of our distributors
may also perform a separate function as a co-packer on our behalf. In such cases, ownership of and title to our products that
are co-packed on our behalf by those co-packers who are also distributors, passes to such distributors when we are notified by
them that they have taken transfer or possession of the relevant portion of our finished goods. Freight billed to customers is
presented as revenues, and the related freight costs are presented as cost of goods sold. Cancelled orders are refunded if not
already dispatched, refunds are only paid if stock is damaged in transit, discounts are only offered with specific promotions
and orders will be refilled if lost in transit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Accounts
receivable</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
receivable are generally unsecured. The Company establishes an allowance for doubtful accounts receivable based on the age of
outstanding invoices and management&rsquo;s evaluation of collectability. Accounts are written off after all reasonable collection
efforts have been exhausted and management concludes that likelihood of collection is remote. Any future recoveries are applied
against the allowance for doubtful accounts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Advertising
Expense</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company expenses marketing, promotions and advertising costs as incurred. Such costs are included in general and administrative
expense in the accompanying consolidated statements of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Research
and Development</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Costs
incurred in connection with the development of new products and processing methods are charged to general and administrative expenses
as incurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Income
Taxes</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company utilizes FASBASC 740, &ldquo;Income Taxes,&rdquo; which requires the recognition of deferred tax assets and liabilities
for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this
method, deferred tax assets and liabilities are determined based on the difference between the tax basis of assets and liabilities
and their financial reporting amounts based on enacted tax laws and statutory tax rates applicable to the periods in which the
differences are expected to affect taxable income. A valuation allowance is recorded when it is &ldquo;more likely-than-not&rdquo;
that a deferred tax asset will not be realized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company generated a deferred tax asset through net operating loss carry-forward. However, a valuation allowance of 100% has been
established due to the uncertainty of the Company&rsquo;s realization of the net operating loss carry forward prior to its expiration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NomadChoice
Pty Ltd, the Company&rsquo;s wholly-owned subsidiary is subject to income taxes in the jurisdictions in which it operates. Significant
judgment is required in determining the provision for income tax. There are many transactions and calculations undertaken during
the ordinary course of business for which the ultimate tax determination is uncertain. The company recognizes liabilities for
anticipated tax audit issues based on the Company&rsquo;s current understanding of the tax law. Where the final tax outcome of
these matters is different from the carrying amounts, such differences will impact the current and deferred tax provisions in
the period in which such determination is made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Net
Earnings (Loss) Per Common Share</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company computes earnings per share under ASC subtopic 260-10, Earnings Per Share. Basic earnings (loss) per share is computed
by dividing the net income (loss) attributable to the common stockholders (the numerator) by the weighted average number of shares
of common stock outstanding (the denominator) during the reporting periods. Diluted loss per share is computed by increasing the
denominator by the weighted average number of additional shares that could have been outstanding from securities convertible into
common stock (using the &ldquo;treasury stock&rdquo; method), unless their effect on net loss per share is anti-dilutive. As of
December 31, 2015, options to purchase 5,000,000 shares of common stock and warrants to purchase 9,132,002 shares of common stock
were outstanding these potential shares were excluded from the shares used to calculate diluted earnings per share as their inclusion
would reduce net loss per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Going
Concern</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s consolidated financial statements are prepared using U.S. GAAP applicable to a going concern, which contemplates
the realization of assets and liquidation of liabilities in the normal course of business. The Company had an accumulated deficit
at December 31, 2015 of $8,569,841. The Company had a working capital deficit of $6,165,812 as of December 31, 2015. Due to acquisitions
during 2015 of revenue-producing products, the Company believes it has established an ongoing source of revenue that is sufficient
to cover its operating costs. The ability of the Company to continue as a going concern is dependent on the Company obtaining
adequate capital to fund operating losses until it establishes a revenue stream and becomes profitable. If the Company is unable
to obtain adequate capital it could be forced to cease development of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to continue as a going concern and to develop a reliable source of revenues, and achieve a profitable level of operations
the Company will need, among other things, additional capital resources. Management&rsquo;s plans to continue as a going concern
include raising additional capital through borrowing and/or sales of equity and debt securities. However, management cannot provide
any assurances that the Company will be successful in accomplishing any of its plans.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 34.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 34.1pt"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 34.1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described
in the preceding paragraph and eventually secure other sources of financing and attain profitable operations. The accompanying
consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue
as a going concern.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Fair
Value Measurements</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company measures and discloses the fair value of assets and liabilities required to be carried at fair value in accordance with
ASC 820, Fair Value Measurements and Disclosures. ASC 820 defines fair value, establishes a framework for measuring fair value,
and enhances fair value measurement disclosure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
825 defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly
transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities
required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it
would transact and considers assumptions that market participants would use when pricing the asset or liability, such as inherent
risk, transfer restrictions, and risk of nonperformance. ASC 825 establishes a fair value hierarchy that requires an entity to
maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 825 establishes
three levels of inputs that may be used to measure fair value:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1 - Quoted prices for identical assets or liabilities in active markets to which we have access at the measurement date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2 - Inputs other than quoted prices within Level 1 that are observable for the asset or liability, either directly or indirectly.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3 - Unobservable inputs for the asset or liability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
determination of where assets and liabilities fall within this hierarchy is based upon the lowest level of input that is significant
to the fair value measurement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2015, the Company has determined that there were no assets or liabilities measured at fair value except for the
warrant derivative liability which is valued using Level 3 estimates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Inventory</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory
consists of raw materials, components and finished goods. The Company&rsquo;s inventory is stated at the lower of cost (FIFO cost
basis) or market. Finished goods include the cost of labor to assemble the items.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Stock-Based
Compensation</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company adopted the provisions of ASC 718. We estimate the fair value of stock options using a binomial model, consistent with
the provisions of ASC 718 and SEC Staff Accounting Bulletin No. 107, Share-Based Payment. Option-pricing models require the input
of highly subjective assumptions, including the price volatility of the underlying stock. We determined that the use of implied
volatility is expected to be more reflective of market conditions and, therefore, could reasonably be expected to be a better
indicator of our expected volatility than historical volatility. The expected term assumption used in calculating the estimated
fair value of our stock-based compensation awards using the Black-Scholes-Merton (BSM) model is based on detailed historical data
about employees&rsquo; exercise behavior, vesting schedules, and death and disability probabilities. In addition, we are required
to estimate the expected forfeiture rate and only recognize expense for those shares expected to vest. We estimate the forfeiture
rate based on historical experience of our stock-based awards that are granted, exercised and cancelled. We believe the resulting
BSM calculation provides a more refined estimate of the fair value of our employee stock options.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Long-lived
Assets</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-lived
assets include equipment and intangible assets other than those with indefinite lives. We assess the carrying value of our long-lived
asset groups when indicators of impairment exist and recognize an impairment loss when the carrying amount of a long-lived asset
is not recoverable when compared to undiscounted cash flows expected to result from the use and eventual disposition of the asset.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicators
of impairment include significant underperformance relative to historical or projected future operating results, significant changes
in our use of the assets or in our business strategy, loss of or changes in customer relationships and significant negative industry
or economic trends. When indications of impairment arise for a particular asset or group of assets, we assess the future recoverability
of the carrying value of the asset (or asset group) based on an undiscounted cash flow analysis. If carrying value exceeds projected,
net, undiscounted cash flows, an additional analysis is performed to determine the fair value of the asset (or asset group), typically
a discounted cash flow analysis, and an impairment charge is recorded for the excess of carrying value over fair value. As of
December 31, 2015, our qualitative analysis of long-lived assets did not indicate any impairment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Goodwill</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
asset purchase is accounted for under the purchase method of accounting. Under that method, assets and liabilities of the business
acquired are recorded at their estimated fair values as of the date of the acquisition, with any excess of the cost of the acquisition
over the estimated fair value of the net tangible and intangible assets acquired recorded as goodwill. As of December 31, 2015
our qualitative analysis of goodwill did not indicate any impairment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><U>Foreign
Currency Translation</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
functional currency of each of the Company&rsquo;s foreign subsidiaries is the U.S. Dollar. The Company&rsquo;s subsidiary maintains
its record using local currency (Australian Dollar). All monetary assets and liabilities of foreign subsidiaries were translated
into U.S. Dollars at fiscal year-end exchange rates, non-monetary assets and liabilities of foreign subsidiaries were translated
into U.S. Dollars at transaction day exchange rates. Income and expense items related to non-monetary items were translated at
exchange rates prevailing during the transaction date and other incomes and expenses were translated using average exchange rate
for the period. The resulting translation adjustments, net of income taxes, were recorded in statements of operations as Remeasurement
gain or loss on translation of foreign subsidiary.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><U>Concentrations
of Credit Risk</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In
the normal course of business, the Company provided credit terms to its customers; however, collateral was not required. Accordingly,
the Company performed credit evaluations of its customers and maintained allowances for possible losses which, when realized,
were within the range of management&rsquo;s expectations. From time to time, a higher concentration of credit risk existed on
outstanding accounts receivable for a select number of customers due to individual buying patterns.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Warehousing
costs</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warehouse
costs include all third party warehouse rent fees and any additional costs relating to assembly or special pack-outs of the Company
products are charged to general and administrative expenses as incurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Product
display costs</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
displays manufactured and purchased by the Company are for placement of product in retail stores. This also includes all costs
for display execution and setup and retail services are charged to general and administrative expenses as incurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Warrant
Derivative Liabilities</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
815 generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments
and account for them as free standing derivative financial instruments. These three criteria include circumstances in which (a)
the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic
characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument
and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with
changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative
instrument would be considered a derivative instrument subject to the requirements of ASC 815. ASC 815 also provides an exception
to this rule when the host instrument is deemed to be conventional, as described.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
Black-Scholes-Merton option-pricing model, with dilution effects, was utilized to estimate the fair value of the Warrant Derivative
Liabilities as of November 12, 2015 and December 31, 2015. This model is subject to the significant assumptions discussed below
and requires the following key inputs with respect to the Company and/or instrument:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Input</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">November
    12, 2015</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2015</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stock Price</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 20%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.46</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 20%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.69</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercise Price</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.49</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.49</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Expected Life (in years)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">9.75</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stock Volatility</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">157.56</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">152.07</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Risk-Free Rate</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.32</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.27</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dividend Rate</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding Shares of Common Stock</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,547,243</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,547,243</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Cost
of Sales</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
of sales includes the purchase cost of products sold and all costs associated with getting the products into the retail stores
including buying and transportation costs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Debt
Issuance Costs</U></FONT><BR>
<BR>
</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debt
issuance costs consist primarily of arrangement fees, professional fees and legal fees. These costs are capitalized and are being
amortized to interest expense over the term of the related debt facilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Impairment
of Long-Lived Assets</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
facts and circumstances indicate that the carrying values of long-lived assets, including fixed assets, may be impaired, an evaluation
of recoverability is performed by comparing the carrying value of the assets to projected future cash flows in addition to other
quantitative and qualitative analyses. Upon indication that the carrying value of such assets may not be recoverable, the Company
recognizes an impairment loss as a charge against current operations. Long-lived assets to be disposed of are reported at the
lower of the carrying amount or fair value, less estimated costs to sell. The Company makes judgments related to the expected
useful lives of long-lived assets and its ability to realize undiscounted cash flows in excess of the carrying amounts of such
assets which are affected by factors such as the ongoing maintenance and improvements of the assets, changes in economic conditions
and changes in operating performance. As the Company assesses the ongoing expected cash flows and carrying amounts of its long-lived
assets, these factors could cause the Company to realize a material impairment charge.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Shipping
Costs</U></FONT><BR>
<BR>
</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shipping
and handling costs billed to customers are recorded in sales. Shipping costs incurred by the company are recorded in selling and
marketing expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Related
parties</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parties
are considered to be related to the Company if the parties that, directly or indirectly, through one or more intermediaries, control,
are controlled by, or are under common control with the Company. Related parties also include principal owners of the Company,
its management, members of the immediate families of principal owners of the Company and its management and other parties with
which the Company may deal if one party controls or can significantly influence the management or operating policies of the other
to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. The All transactions
with related parties shall be recorded at fair value of the goods or services exchanged. Property purchased from a related party
is recorded at the cost to the related party and any payment to or on behalf of the related party in excess of the cost is reflected
as a distribution to the related party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Segment
Reporting</U></FONT><BR>
<BR>
</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Segment
identification and selection is consistent with the management structure used by the Company&rsquo;s chief operating decision
maker to evaluate performance and make decisions regarding resource allocation, as well as the materiality of financial results
consistent with that structure. Based on the Company&rsquo;s management structure and method of internal reporting, the Company
has one operating segment. The Company&rsquo;s chief operating decision maker does not review operating results on a disaggregated
basis; rather, the chief operating decision maker reviews operating results on an aggregate basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Recent
Accounting Pronouncements</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASU
2015-03</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
April 2015, the FASB issued Accounting Standards Update (&ldquo;ASU&rdquo;) No. 2015-03, Interest - Imputation of Interest (Subtopic
835-30): Simplifying the Presentation of Debt Issuance Costs. The amendments in this ASU require that debt issuance costs related
to a recognized debt liability be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability,
consistent with debt discounts. The recognition and measurement guidance for debt issuance costs are not affected by the amendments
in this ASU. The amendments are effective for financial statements issued for fiscal years, and interim periods within those fiscal
years, beginning after December 15, 2015. The amendments are to be applied on a retrospective basis, wherein the balance sheet
of each individual period presented is adjusted to reflect the period-specific effects of applying the new guidance. The Company
is evaluating the possible effect of this guidance on its financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASU
2015-02</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2015, the FASB issued ASU No. 2015-02, Consolidation (Topic 810): Amendments to the Consolidation Analysis, which is
intended to improve targeted areas of consolidation guidance for legal entities such as limited partnerships, limited liability
corporations, and securitization structures (collateralized debt obligations, collateralized loan obligations, and mortgage-backed
security transactions). The ASU focuses on the consolidation evaluation for reporting organizations that are required to evaluate
whether they should consolidate certain legal entities. In addition to reducing the number of consolidation models from four to
two, the new standard simplifies the FASB Accounting Standards Codification and improves current U.S. GAAP by placing more emphasis
on risk of loss when determining a controlling financial interest, reducing the frequency of the application of related-party
guidance when determining a controlling financial interest in a variable interest entity (&ldquo;VIE&rdquo;), and changing consolidation
conclusions for companies in several industries that typically make use of limited partnerships or VIEs. The ASU will be effective
for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. Early adoption is permitted,
including adoption in an interim period. We do not expect the adoption of ASU 2015-02 to have a material effect on our financial
position, results of operations or cash flows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASU
2015-01</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2015, the FASB issued ASU No. 2015-01, &ldquo;Income Statement - Extraordinary and Unusual Items (Subtopic 225-20): Simplifying
Income Statement Presentation by Eliminating the Concept of Extraordinary Items.&rdquo; This ASU eliminates from U.S. GAAP the
concept of extraordinary items. ASU 2015-01 is effective for fiscal years, and interim periods within those fiscal years, beginning
after December 15, 2015. A reporting entity may apply the amendments prospectively. We do not expect the adoption of ASU 2015-01
to have a material effect on our financial position, results of operations or cash flows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASU
2014-17</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2014, the FASB issued ASU No. 2014-17, &ldquo;Business Combinations (Topic 805): Pushdown Accounting.&rdquo; This ASU
provides an acquired entity with an option to apply pushdown accounting in its separate financial statements upon occurrence of
an event in which an acquirer obtains control of the acquired entity. An acquired entity may elect the option to apply pushdown
accounting in the reporting period in which the change-in-control event occurs. If pushdown accounting is applied to an individual
change-in-control event, that election is irrevocable. ASU 2014-17 was effective on November 18, 2014. The adoption of ASU 2014-17
did not have any effect on our financial position, results of operations or cash flows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASU
2014-16</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2014, the FASB issued ASU 2014-16, &ldquo;Derivatives and Hedging (Topic 815).&rdquo; ASU 2014-16 addresses whether the
host contract in a hybrid financial instrument issued in the form of a share should be accounted for as debt or equity. ASU 2014-16
is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. We do not currently
have issued, nor are we investors in, hybrid financial instruments. Accordingly, we do not expect the adoption of ASU 2014-16
to have any effect on our financial position, results of operations or cash flows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASU
2014-15</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2014, the FASB issued ASU No. 2014-15, &ldquo;Presentation of Financial Statements - Going Concern (Subtopic 205-40)&rdquo;.
ASU 2014-15 provides guidance related to management&rsquo;s responsibility to evaluate whether there is substantial doubt about
an entity&rsquo;s ability to continue as a going concern and to provide related footnote disclosure. ASU 2014-15 is effective
for annual periods ending after December 15, 2016, and for interim and annual periods thereafter. Early application is permitted.
We do not expect the adoption of ASU 2014-15 to have a material effect on our financial position, results of operations or cash
flows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASU
2014-12</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2014, the FASB issued ASU No. 2014-12, &ldquo;Compensation &ndash; Stock Compensation (Topic 718): Accounting for Share-Based
Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period.&rdquo;
This ASU requires that a performance target that affects vesting and that could be achieved after the requisite service period
be treated as a performance condition. ASU 2014-12 is effective for fiscal years, and interim periods within those fiscal years,
beginning after December 15, 2015. We do not expect the adoption of ASU 2014-12 to have a material effect on our financial position,
results of operations or cash flows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASU
2014-09</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
May 2014, the FASB issued ASU No. 2014-09, &ldquo;Revenue from Contracts with Customers (Topic 606).&rdquo; ASU 2014-09 affects
any entity using U.S. GAAP that either enters into contracts with customers to transfer goods or services or enters into contracts
for the transfer of nonfinancial assets unless those contracts are within the scope of other standards (e.g., insurance contracts
or lease contracts). ASU 2014-09 is effective for fiscal years, and interim periods within those fiscal years, beginning after
December 15, 2016. We are still evaluating the effect of the adoption of ASU 2014-09. In August 2015, the FASB issued ASU 2015-14,
which defers the effective date of ASU 2014-09 by one year for all entities and permits early adoption on a limited basis. ASU
2014-09 will be effective for the Company in the first quarter of 2018, and early adoption permitted in the first quarter of 2017.
The Company does not believe the adoption of this ASU will have a material impact on its consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASU
2014-08</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
April 2014, the FASB issued ASU No. 2014-08, &ldquo;Presentation of Financial Statements (Topic 205) and Property, Plant, and
Equipment (Topic 360) and Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity.&rdquo; ASU
2014-08 amends the definition for what types of asset disposals are to be considered discontinued operations, as well as amending
the required disclosures for discontinued operations and assets held for sale. ASU 2014-08 is effective for fiscal years, and
interim periods within those fiscal years, beginning on or after December 15, 2014. The adoption of ASU 2014-08 did not have any
effect on our financial position, results of operations or cash flows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were various updates recently issued, most of which represented technical corrections to the accounting literature or application
to specific industries and are not expected to a have a material impact on the Company&rsquo;s condensed financial position, results
of operations or cash flows.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Change
in Fiscal Year End</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 21, 2014, the Company&rsquo;s board of directors approved a change to the Company&rsquo;s fiscal year end from July 31 to
December 31 of each year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
3 &ndash; Acquisitions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Asset
Purchase Agreement with Factor Nutrition Labs, LLC:</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 22, 2015 (the &ldquo;Closing Date&rdquo;), the Company entered into an Asset Purchase Agreement (the &ldquo;Purchase Agreement&rdquo;)
with Factor Nutrition Labs, LLC, a Delaware limited liability company (the &ldquo;Seller&rdquo;), Vita Partners, LLC, RPR Partners,
LLC, and Thor Associates, Inc. (each a &ldquo;Principal Owner&rdquo;). Pursuant to the Purchase Agreement, the Company purchased
all of the assets of the Seller&rsquo;s line of business and products called FOCUS Factor (the product plus the business related
to the product is collectively referred to as the &ldquo;Focus Factor Business&rdquo;) and assumed the accounts payable and contractual
obligations of the Focus Factor Business for an aggregate purchase price of $6.0 million, with $4.5 million paid on the Closing
Date, and $750,000 to be paid on or before January 20, 2016 and an additional $750,000 to be paid on or before January 20, 2017.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Distribution
Agreement</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 22, 2015, the Company and Knight entered into a Distribution, License and Supply Agreement (the &ldquo;Distribution Agreement&rdquo;),
pursuant to which the Company granted to Knight an exclusive license to commercialize FOCUSFactor, FOCUSFactor Kids and Synergy
Strip and all improvements thereto (together the &ldquo;Licensed Products&rdquo;) and appointed Knight as the exclusive distributor
to offer to sell and sell the Licensed Products in Canada, and, at Knight&rsquo;s election, one or more of Israel, Russia, and
Sub-Saharan Africa. The Distribution Agreement provides that Knight may sublicense its rights or use sub-distributors under the
Distribution Agreement on terms consistent with the terms of the Distribution Agreement. During the term of the Distribution Agreement,
Knight agrees to obtain from the Company all its requirements for the Licensed Products and the Company agrees to supply the Licensed
Products at its adjusted production cost plus a designated percentage and any applicable taxes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of a long term inability by the Company to supply Knight with the Licensed Products, Knight is entitled to require,
among other remedies, the Company to grant a Knight-designated third party a non-exclusive license to use all relevant intellectual
property to manufacture and supply Knight with the Licensed Products for commercialization in the Territory. The term of the Distribution
Agreement runs until 15 years from the date of the first commercial sale of a Licensed Product in Canada, and the Distribution
Agreement will automatically renew for successive 15-year periods unless either party provides the other with written notice of
its intention not to renew (a &ldquo;Non-Renewal Notice&rdquo;). The Company agrees that in the event it issues a Non-Renewal
Notice, the Company will pay to Knight a non-renewal fee equal to the net sales of the Licensed Products achieved by Knight in
the Territory during the eight calendar quarters preceding the date of such notice, plus all applicable taxes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Distribution
Option Agreement</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Loan Agreement, the Company entered into a Product Distribution Option Agreement, dated January 22, 2015 (the
&ldquo;Option Agreement&rdquo;), pursuant to which the Company granted Knight the exclusive right to negotiate the exclusive distribution
rights of any one or more of the Company&rsquo;s products, including products from the Focus Factor Business, for the territories
of Canada, Russia, Sub-Saharan Africa and Israel (the &ldquo;Option&rdquo;), pursuant to designated parameters. The Option Agreement
is effective upon the date of the Option Agreement, will run until January 31, 2045, and will automatically renew thereafter for
successive five-year periods unless either party provides a notice of termination prior to the Option Agreement&rsquo;s expiration.
If Knight does not exercise the option then the Company is free to contract for distribution with other parties, but only on terms
no less favorable than those offered by Knight pursuant to the Option Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 3, 2015, we entered into an Amendment to First Amendment Agreement (the &ldquo;Second Amendment Agreement&rdquo;) with
Knight pursuant to which we agreed to grant distribution rights to Knight for Breakthrough&rsquo;s products. To satisfy this obligation,
on December 3, 2015, we also entered into an Amendment and Confirmation Agreement (the &ldquo;Confirmation Agreement&rdquo;) with
Knight, Nomad and Breakthrough to amend the Distribution, License and Supply Agreement dated January 22, 2015 (the &ldquo;Distribution
Agreement&rdquo;) between us and Knight to grant to Knight an exclusive license to commercialize any and all Nomad and Breakthrough
products and appoint Knight as the exclusive distributor to offer and sell those products in Canada, Israel, Romania, Russia and
each of the countries within Sub-Saharan Africa, which is the new &ldquo;Territory&rdquo; under the Distribution Agreement, as
amended. Pursuant to the Second Amendment Agreement, Nomad will buy all Flat Tummy Tea products within the Territory for direct
to consumer sales exclusively from Knight and/or its affiliates at cost of goods plus 60% of gross sales.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has accounted for this transaction under the acquisition method of accounting. Under the acquisition method of accounting,
the total acquisition consideration price is allocated to the assets acquired and liabilities assumed based on their preliminary
estimated fair values based on the management&rsquo;s estimates as of the date of the acquisition. The Company expects to retain
the services of independent valuation firm to determine the fair value of these identifiable intangible assets. Once determined,
the Company will reallocate the purchase price of the acquisition based on the results of the independent evaluation if they are
materially different from the allocations as recorded on January 22, 2015. The Company expects the purchase price allocations
for the acquisition of Focus Factor Business to be completed by the filing of first quarter 2016 statements. The preliminary allocation
of the purchase price to the assets acquired and liabilities assumed based on the estimated fair values is as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-decoration: underline"><FONT STYLE="font-family: Times New Roman, Times, Serif">Assets</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 78%; text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accounts
    Receivable</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 18%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,733,167</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Inventory</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">67,113</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Intellectual Property</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,000,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Non-compete provision</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">50,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Non-solicitation
    provision</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">50,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Intangible assets-Customer
    relationships</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,941,030</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Goodwill</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,071,517</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-decoration: underline"><FONT STYLE="font-family: Times New Roman, Times, Serif">Liabilities</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accounts Payable</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(971,381</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accrued
    Expenses</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">(941,446</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">6,000,000</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Customer relationships, the non-compete and the non-solicitation provisions will be amortized over their estimated useful lives
of 5 years. During the year ended December 31, 2015, the Company charged to operations amortization expense of $384,720.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purchase price allocated to the acquisition of the assets of Factor Nutrition Labs, LLC is made up as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Amount</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 84%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash payment made on January
    22, 2015</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,500,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash payment to be made on January 20,
    2016</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">750,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash payment
    to be made on January 20, 2017</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">750,000</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6,000,000</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pro
forma Results of Operations. The historical operating results of the Focus Factor Business prior to its acquisition date have
not been included in the Company&rsquo;s historical consolidated operating results. Pro forma results of operations data (unaudited)
for the years ended December 31, 2014 and 2013, as if the acquisition had occurred on January 1, 2013, are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31,</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2014</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2013</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Revenue</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,695,295</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">10,629,171</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net (loss) income</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(183,471</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">932,209</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pro
forma revenue amount above does not include adjustment/reductions relating to certain discounts, coupons and placement fees and
is presented gross.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amounts of revenue and net income of the FOCUS Factor Business since the acquisition date included in the consolidated statement
of operations for the year ended December 31, 2015 are approximately $10,482,367 and $1,216,928, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Asset
Purchase Agreement with Knight Therapeutics Inc.:</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 26, 2015 (the &ldquo;Closing Date&rdquo;), Neuragen Corp., a Delaware corporation (&ldquo;Neuragen&rdquo;) and our wholly
owned subsidiary, entered into an Asset Purchase Agreement (the &ldquo;Purchase Agreement&rdquo;) with Knight Therapeutics Inc.,
a Canadian corporation (&ldquo;Knight Canada&rdquo;). Pursuant to the Purchase Agreement, Neuragen purchased the U.S. rights related
to an innovative OTC product that helps relieve pain caused by diabetic nerve damage (the &ldquo;Purchased Assets&rdquo;) for
an aggregate purchase price of $1.2 million, with (i) $250,000 paid on the Closing Date, (ii) $250,000 to be paid on or before
June 30, 2016, (iii) $700,000 to be paid in quarterly installments (beginning with the quarter ending September 30, 2015) equal
to the greater of $12,500 or 5% of U.S. net sales, and (iv) 2% of U.S. net sales of Neuragen for 60 months thereafter. The payment
of such amounts is secured by a security interest in certain assets, undertakings and property (&ldquo;Collateral&rdquo;) pursuant
to the Security Agreement, which will be released upon receipt of total payments of $1.2 million (collectively, &ldquo;Total Consideration&rdquo;).
The Company has recorded present value of future payments of $515,854 as of December 31, 2015. The Company has recorded interest
expense of $37,372 for the year ended December 31, 2015.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Security
Agreement</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
the Closing Date, Neuragen entered into a Security Agreement with Knight Canada, pursuant to which Neuragen granted a lien and
security interest to Knight Canada in Collateral in connection with the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Security Agreement was made to secure the payment of all indebtedness, obligations and liabilities of Neuragen of the Purchase
Agreement, including all expenses and charges, legal or otherwise, suffered or incurred by Knight Canada in collecting or enforcing
such indebtedness of the Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Security Agreement includes customary events of default, including but not limited to: payment defaults; Neuragen becoming insolvent
or entering into bankruptcy; or if any contemplated security ceases to be a valid and perfected first-priority security interest
that is not remedied within fifteen business days by Neuragen. Upon the occurrence of an event of default and during the continuation
thereof, the principal amount of the outstanding Total Consideration will bear a default interest rate of an additional 10% per
annum.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
acquisition was treated as an acquisition of assets as the transaction involved the acquisition of a brand and a license agreement.
The Company expects to retain the services of independent valuation firm to determine the fair value of these identifiable intangible
assets. Once determined, the Company will reallocate the purchase price of the acquisition based on the results of the independent
evaluation if they are materially different from the allocations as recorded on June 26, 2015. The Company expects the purchase
price allocations for the asset acquisition to be completed by the filing of second quarter 2016 statements. The preliminary allocation
of the purchase price to the assets acquired and liabilities assumed based on the estimated fair values is as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-decoration: underline"><FONT STYLE="font-family: Times New Roman, Times, Serif">Assets</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 84%; text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accounts
    Receivable</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">58,054</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Inventory</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">204,925</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Intangible property</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">100,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">License agreement</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">606,553</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-decoration: underline"><FONT STYLE="font-family: Times New Roman, Times, Serif">Liabilities</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accounts Payable</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(51,795</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accrued
    Expenses</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">(148,520</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">769,217</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
intangible property and license agreement will be amortized over their estimated useful lives of 5 years. During the year ended
December 31, 2015, the Company charged to operations amortization expense of $70,655.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Contribution
Agreement with Hand MD Corp.:</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 18, 2015 (the &ldquo;Closing Date&rdquo;), we entered into a Contribution Agreement with Hand MD Corp., a Delaware corporation,
whereby we contributed to Hand MD Corp. 2,142,857 shares of our common stock in exchange for 50% of Hand MD Corp.&rsquo;s outstanding
capital securities valued at $0.70 per share. Simultaneously, Hand MD, LLC, a California limited liability company, entered into
a Contribution Agreement with Hand MD Corp., the principal owners of Hand MD, LLC, and us whereby Hand MD LLC contributed to Hand
MD Corp. all of its right, title and interest in its intellectual property associated with skincare, nail care and nail polish
products (the &ldquo;Hand MD Business&rdquo;) in exchange for the other 50% of Hand MD Corp.&rsquo;s outstanding capital securities.
In the Contribution Agreement among Hand MD Corp., Hand MD, LLC, the principal owners of Hand MD, LLC and us, Hand MD, LLC and
its principal owners agreed to not compete or solicit customers or employees for five years. As part of the transaction, we also
purchased from Hand MD Corp. all inventory related to the Hand MD Business for approximately $106,000. The Company has recorded
50% of the present value of future royalty payments of $258,897 as of December 31, 2015.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also entered into a license agreement with Hand MD Corp. on August 18, 2015, whereby we acquired the exclusive worldwide license
to commercialize Hand MD Corp. skincare products and all improvements thereto. The license runs in perpetuity unless earlier terminated.
We will pay Hand MD Corp. a royalty of 5% of the net sales price of product sold, transferred or otherwise disposed of by us,
as well as 5% of any amount we receive from sublicensees, subject to a minimum royalty of $250,000 in the second year of the license
and $500,000 in the third year of the license, after which the minimum royalty terminates. We are solely responsible for any regulatory
and intellectual property filings, including those necessary to maintain regulatory approvals for the licensed products. Either
we or Hand MD Corp. can terminate the agreement in the event of bankruptcy or insolvency of the other party, or the uncured material
breach of the agreement by the other party. Upon termination we would be entitled to sell any inventory of licensed product in
the normal course of business and consistent with sales of licensed product during the term of the agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Contribution Agreements and the License Agreement contain customary representations and warranties and covenants by the respective
parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also entered into a Consulting Agreement on August 18, 2015, with Kara Harshbarger, the co-founder of Hand MD, LLC, pursuant to
which she will provide marketing and sales related services. We will pay Ms. Harshbarger $10,000 a month for one year unless the
Consulting Agreement is terminated earlier by either party. If we terminate the Consulting Agreement without cause, we will be
obligated to pay the remaining term of the Agreement. Ms. Harshbarger agreed not to compete with us in the United States in any
marketing or sales of skincare, nail polish and nail care products during the term of the Consulting Agreement and for 12 months
after its termination. Ms. Harshbarger also agreed not to solicit customers or employees for the same period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
acquisition was treated as an acquisition of assets as the transaction involved the acquisition of a brand and a license agreement.
The Company expects to retain the services of independent valuation firm to determine the fair value of these identifiable intangible
assets. Once determined, the Company will reallocate the purchase price of the acquisition based on the results of the independent
evaluation if they are materially different from the allocations as recorded on August 18, 2015. The Company expects the purchase
price allocations for the asset acquisition to be completed during 2016. The preliminary allocation of the purchase price to the
assets acquired and liabilities assumed based on the estimated fair values is as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-decoration: underline"><FONT STYLE="font-family: Times New Roman, Times, Serif">Assets</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 84%; text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Intangible
    property</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">100,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">License agreement</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,670,675</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-decoration: underline"><FONT STYLE="font-family: Times New Roman, Times, Serif">Liabilities</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Royalty payable</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(258,897</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Others</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(11,778</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,500,000</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
intangible property and license agreement will be amortized over their estimated useful lives of 5 years. During the year ended
December 31, 2015, the Company charged to operations amortization expense of $118,045.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Stock
Purchase Agreement with Breakthrough Products, Inc.:</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 12, 2015 (the &ldquo;UrgentRx Closing Date&rdquo;), we entered into a Stock Purchase Agreement (the &ldquo;UrgentRx SPA&rdquo;)
with Breakthrough Products, Inc., a Delaware corporation (the &ldquo;Company&rdquo;), URX ACQUISITION TRUST, a Delaware statutory
trust, (the &ldquo;Trust&rdquo;), Jordan Eisenberg, the chief executive officer and a shareholder of the Company (&ldquo;Eisenberg&rdquo;),
and the other shareholders of the Company (Eisenberg and such other shareholders collectively referred to as the &ldquo;UrgentRx
Sellers&rdquo;) for the purchase of all the issued and outstanding capital stock of the Company for 6,000,000 shares of our common
stock (&ldquo;UrgentRx Equity Consideration&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the UrgentRx Equity Consideration, we have agreed to pay a royalty to the Trust, for the benefit of the UrgentRx Sellers,
equal to 5% of gross sales of the UrgentRx (as defined below) following the first $5,000,000 in gross sales by the UrgentRx Products,
on a quarterly basis for a period of seven years from the UrgentRx Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is engaged in the business of developing and selling medications for headache, heart burn, allergy attack, ache and pain,
and upset stomach in the form of powders (&ldquo;UrgentRx&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the UrgentRx Closing Date, we discovered certain liabilities and obligations of Breakthrough that required an adjustment to the
UrgentRx Equity Consideration and the royalty payments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 17, 2015, we entered into a Settlement and Release Agreement (the &ldquo;Settlement Agreement&rdquo;) with the UrgentRx
Sellers, the Trust, on its own behalf and as the representative of the UrgentRx Sellers, David T. Leyrer, Michael Valentino, Ron
Fugate, and Randall Kaplan (collectively with Leyrer, Valentino, Fugate, the &ldquo;Former Directors&rdquo;) to resolve the post-closing
liabilities. Pursuant to the terms of the Settlement Agreement, 3,000,000 shares of the Equity Consideration were returned by
the Trust to us and our obligation to pay royalties to the Trust was reduced from seven years to five years. The Settlement Agreement
further contained mutual releases among us, the UrgentRx Sellers, and the Former Directors, with limited exceptions. Additionally,
we issued a three-year warrant to the Trust with a $5.00 per share exercise price. We may redeem the warrant at a price of $0.001
per share if our common stock is traded on the OTCBB or on a national securities exchange, and the per share closing sale price
of our common stock equals or exceeds the exercise price for a period of 90 consecutive calendar days. In the event of a reorganization
or reclassification of our capital stock, the merger or consolidation of our company into another entity or the sale or transfer
of all or substantially all of our assets, the warrant will terminate if not exercised prior to the date of such event.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has accounted for this transaction under the acquisition method of accounting. Under the acquisition method of accounting,
the total acquisition consideration price is allocated to the assets acquired and liabilities assumed based on their preliminary
estimated fair values based on the management&rsquo;s estimates as of the date of the acquisition. The Company expects to retain
the services of independent valuation firm to determine the fair value of these identifiable intangible assets. Once determined,
the Company will reallocate the purchase price of the acquisition based on the results of the independent evaluation if they are
materially different from the allocations as recorded on November 12, 2015. The Company expects the purchase price allocations
for the acquisition of UrgentRx to be completed during 2016. The preliminary allocation of the purchase price to the assets acquired
and liabilities assumed based on the estimated fair values is as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-decoration: underline"><FONT STYLE="font-family: Times New Roman, Times, Serif">Assets</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 78%; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 18%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,298,619</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accounts Receivable</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(68,976</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Inventory</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">234,709</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prepaid expenses</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">57,569</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Intellectual property</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">100,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Non-compete provision</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">50,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Goodwill</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,253,160</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-decoration: underline"><FONT STYLE="font-family: Times New Roman, Times, Serif">Liabilities</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accounts Payable</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(741,822</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accrued Expenses</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2,202,848</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,980,411</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Intellectual property will be amortized over its estimated useful live of 5 years and the non-compete provision will be amortized
over its term of 3 years. During the year ended December 31, 2015, the Company charged to operations amortization expense of $4,583.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purchase price allocated to the acquisition of the assets of UrgentRx is made up as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Amount</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 84%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stock payment</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,550,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stock warrants issued</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">430,411</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,980,411</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pro
forma Results of Operations. The historical operating results of the UrgentRx Business prior to its acquisition date have not
been included in the Company&rsquo;s historical consolidated operating results. Pro forma results of operations data (unaudited)
for the year ended December 31, 2014 as if the acquisition had occurred on January 1, 2014, are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2014</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 78%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Revenue</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 18%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,722,288</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net (loss) income</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(10,621,330</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amounts of revenue and net loss of the UrgentRx Business since the acquisition date included in the consolidated statement of
operations for the year ended December 31, 2015 are approximately $90,590 and $80,249, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Stock
Purchase Agreement with TPR Investments Pty Ltd:</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 15, 2015 (the &ldquo;Flat Tummy Tea Closing Date&rdquo;), we entered into a Stock Purchase Agreement (the &ldquo;Flat
Tummy Tea SPA&rdquo;) with TPR Investments Pty Ltd ACN 128 396 654 as trustee for Polmear Family Trust (the &ldquo;Flat Tummy
Tea Seller&rdquo;), Timothy Polmear and Rebecca Polmear and NomadChoice Pty Limited ACN 160 729 939 trading as Flat Tummy Tea,
an Australian proprietary limited company (&ldquo;NomadChoice&rdquo;) for the purchase of all the issued and outstanding capital
stock of NomadChoice for $4,000,000 (AUD) in cash consideration (the &ldquo;Cash Consideration&rdquo;) and 3,571,428 shares of
our common stock (&ldquo;Flat Tummy Tea Equity Consideration&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the Cash Consideration and the Flat Tummy Tea Equity Consideration, we have also agreed to pay the Flat Tummy Tea
Seller certain earn-out payments of up to $3,500,000 (AUD) in aggregate upon certain EBITDA thresholds are met as of June 30,
2016, as described in the Flat Tummy Tea SPA. This earn-out payment was distributed on March 4, 2016.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Flat
Tummy Tea is engaged in the business of developing, manufacturing, and selling herbal detox tea (&ldquo;Flat Tummy Tea&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has accounted for this transaction under the acquisition method of accounting. Under the acquisition method of accounting,
the total acquisition consideration price is allocated to the assets acquired and liabilities assumed based on their preliminary
estimated fair values based on the management&rsquo;s estimates as of the date of the acquisition. The Company expects to retain
the services of independent valuation firm to determine the fair value of these identifiable intangible assets. Once determined,
the Company will reallocate the purchase price of the acquisition based on the results of the independent evaluation if they are
materially different from the allocations as recorded on November 1, 2015. The Company expects the purchase price allocations
for the acquisition of NomadChoice to be completed during 2016. The preliminary allocation of the purchase price to the assets
acquired and liabilities assumed based on the estimated fair values is as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-decoration: underline"><FONT STYLE="font-family: Times New Roman, Times, Serif">Assets</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 78%; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 18%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,584,642</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other receivable</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">30,684</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Inventory</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">134,212</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Prepaid expenses</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">141,070</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fixed Assets, net</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,698</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Intangible assets,
    Net</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,493</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Blogger Database</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">200,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Customer Database</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">500,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Intellectual property</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">100,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Non-compete provision</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">50,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Goodwill</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6,174,899</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-decoration: underline"><FONT STYLE="font-family: Times New Roman, Times, Serif">Liabilities</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accounts Payable</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(77,064</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accrued Expenses</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(56,224</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dividends Payable</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,177,152</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Provision for Income
    Tax</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(518,558</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">7,095,700</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Blogger Database, Customer Database, Intellectual property and non-compete provision will be amortized over its estimated useful
lives of 5 years. During the year ended December 31, 2015, the Company charged to operations amortization expense of $28,333.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purchase price allocated to the acquisition of the assets of NomadChoice is made up as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Amount</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 84%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,848,800</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stock issued at closing</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,750,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Earn-out payment</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,496,900</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">7,095,700</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pro
forma Results of Operations. The historical operating results of the Flat Tummy Tea Business prior to its acquisition date have
not been included in the Company&rsquo;s historical consolidated operating results. Pro forma results of operations data (unaudited)
for the year ended December 31, 2014 as if the acquisition had occurred on January 1, 2014, are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2014</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 78%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Revenue</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 18%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,494,812</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net (loss) income</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(909,280</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s subsidiary Nomad has a fiscal year ended June 30 and the Company&rsquo;s fiscal year end is December 31. The above
proforma information includes revenue and net income of Nomad for the year ended June 30, 2015.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
amounts of revenue and net income of the Flat Tummy Tea Business since the acquisition date included in the consolidated statement
of operations for the year ended December 31, 2015 are approximately $2,513,990 and $966,671 respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
4 &ndash; Income Taxes</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company utilizes FASBASC740, &ldquo;Income Taxes,&rdquo; which requires the recognition of deferred tax assets and liabilities
for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this
method, deferred tax assets and liabilities are determined based on the difference between the tax basis of assets and liabilities
and their financial reporting amounts based on enacted tax laws and statutory tax rates applicable to the periods in which the
differences are expected to affect taxable income. A valuation allowance is recorded when it is &ldquo;more likely-than-not&rdquo;
that a deferred tax asset will not be realized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 31.5pt"></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 31.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company generated a deferred tax asset through net operating loss carry-forwards.</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
Based upon Management&rsquo;s evaluation, a valuation allowance of 100% has been established due to the uncertainty of the Company&rsquo;s
realization of the benefit derived from net operating loss carry-forwards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred
income taxes arise from temporary differences resulting from income and expense items reported for financial accounting and tax
purposes in different periods. Deferred taxes are classified as current or non-current, depending on the classification of assets
and liabilities to which they relate. Deferred taxes arising from temporary differences that are not related to an asset or liability
are classified as current or noncurrent depending on the periods in which the temporary differences are expected to reverse. The
Company does not have any uncertain tax positions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
tax expense for the year ended December 31, 2015 was $389,945, due to Foreign Income Tax relating to NomadChoice in Australia.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
table below summarizes the differences between the U.S. statutory federal rate and the Company&rsquo;s effective tax rate for
the years ended December 31, 2015 and 2014:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 85%; font: 12pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2015</FONT></TD><TD STYLE="padding: 0; font-size: 10pt; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2014</FONT></TD><TD STYLE="padding: 0; font-size: 10pt; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 53%; font-size: 10pt; text-align: left; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">U.S.
    Statutory Rate</FONT></TD><TD STYLE="width: 2%; font-size: 10pt; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 18%; font-size: 10pt; text-align: right; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">34</FONT></TD><TD STYLE="width: 3%; font-size: 10pt; text-align: left; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 18%; font-size: 10pt; text-align: right; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">34</FONT></TD><TD STYLE="width: 3%; font-size: 10pt; text-align: left; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">U.S.
    effective rate in excess of AU rate</FONT></TD><TD STYLE="font-size: 10pt; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">%)</FONT></TD><TD STYLE="font-size: 10pt; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">U.S.
    valuation allowance</FONT></TD><TD STYLE="font-size: 10pt; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">(34</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">%)</FONT></TD><TD STYLE="font-size: 10pt; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">(34</FONT></TD><TD STYLE="font-size: 10pt; text-align: left; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">%)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Foreign
    Tax - Australia</FONT></TD><TD STYLE="font-size: 10pt; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding: 0; font-size: 10pt; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; padding: 0; font-size: 10pt; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.8</FONT></TD><TD STYLE="padding: 0; font-size: 10pt; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD STYLE="font-size: 10pt; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding: 0; font-size: 10pt; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; padding: 0; font-size: 10pt; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding: 0; font-size: 10pt; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    provision for income taxes</FONT></TD><TD STYLE="font-size: 10pt; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; padding: 0; font-size: 10pt; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; padding: 0; font-size: 10pt; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.8</FONT></TD><TD STYLE="padding: 0; font-size: 10pt; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD><TD STYLE="font-size: 10pt; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; padding: 0; font-size: 10pt; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; padding: 0; font-size: 10pt; text-align: right; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding: 0; font-size: 10pt; text-align: left; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Company has deferred tax assets, which have been fully reserved, as follows as of December 31, 2015 and 2014:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 85%; font: 12pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2015</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2014</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 53%; font-size: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Deferred
    tax assets</FONT></TD><TD STYLE="width: 2%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 18%; font-size: 10pt; text-align: right"><P STYLE="margin: 0">11,460,536</P>


</TD><TD STYLE="width: 3%; font-size: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 18%; font-size: 10pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">241,245</FONT></TD><TD STYLE="width: 3%; font-size: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Valuation
    allowance for deferred tax assets</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(11,460,536</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(241,245</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    deferred tax assets</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; font-size: 10pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Company also has net operating loss carryforwards of approximately $25,137,583 included in the deferred tax asset table above
attributable to the acquisition of Breakthrough Products, Inc. However, due to limitations of carryover attributes and separate
return limitation year rules, it is unlikely the company will benefit from these NOL and thus Management has determined a 100%
valuation reserved is required.&nbsp; Further, the Company has not completed an evaluation of the NOL&rsquo;s attributable to
Breakthrough Products, Inc. at the date of this report.</FONT></P>

<P STYLE="font: 12pt Calibri, Helvetica, Sans-Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
total deferred tax asset is calculated by multiplying a domestic (US) 34 percent marginal tax rate by the cumulative Net Operating
Loss Carryforwards (&ldquo;NOL&rdquo;).The Company currently has net operating loss carryforwards approximately aggregating $33,707,458,
which expire through 2035. The deferred tax asset related to the NOL carryforwards Management has determined based on all the
available information that a 100% Valuation reserve is required.</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Company has not completed its evaluation of NOL Utilization Limitations under IRC Section 382, change of ownership rules. If the
Company has had a change in ownership the NOL&rsquo;s would be limited as to the amount that could be utilized each year, based
on the Internal Revenue Code, as amended.&rdquo;</FONT></P>

<P STYLE="font: 12pt Calibri, Helvetica, Sans-Serif; margin: 0; text-indent: 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Company has not filed its Federal and State income tax returns. Such income tax returns remain subject to examination by federal
and most state tax authorities.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
5 &ndash; Accounts Receivable</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
receivable, net of allowances for sales returns and doubtful accounts, consisted of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2015</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2014</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Trade accounts receivable</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 20%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,101,148</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 20%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,898</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Less allowances</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(121,291</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    accounts receivable, net</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-weight: bold; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,979,857</FONT></TD><TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-weight: bold; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,898</FONT></TD><TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2015, the Company charged $50,000 to bad debt expense in setting up an allowance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
6 &ndash; Prepaid Expenses</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
December 31, 2015 and 2014, prepaid expenses consisted of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2015</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2014</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Advances for inventory</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 20%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">171,494</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 20%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Media production</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">55,849</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Insurance</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">54,519</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">10,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Trade shows</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">45,700</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Deposits</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">41,228</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Consultants</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">24,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Rent</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">16,216</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Miscellaneous</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">13,428</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-weight: bold; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">422,434</FONT></TD><TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-weight: bold; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">10,000</FONT></TD><TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
7 &ndash; Concentration of Credit Risk</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Cash
and cash equivalents</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company maintains its cash and cash equivalents in banks insured by the Federal Deposit Insurance Corporation (FDIC) in accounts
that at times may be in excess of the federally insured limit of $250,000 per bank. The Company minimizes this risk by placing
its cash deposits with major financial institutions. At December 31, 2015, the uninsured balance amounted to $3,453,290.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Accounts
receivable</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2015, one customer accounted for 78% of the Company&rsquo;s accounts receivable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Major
customers</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2015, two customers accounted for approximately 71% of the Company&rsquo;s gross revenues. Substantially
all of the Company&rsquo;s business is with companies in the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Major
suppliers</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the year ended December 31, 2015, our products were made by the following suppliers:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 80%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 30%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOCUSfactor</FONT></TD>
    <TD STYLE="width: 40%; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pittsburgh,
    PA</FONT></TD>
    <TD STYLE="width: 30%; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tustin,
    CA</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Flat
    Tummy Tea</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Highland,
    NY</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neuragen</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Linthicum
    Heights, MD</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">UrgentRx</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ogden,
    UT</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">It
is the opinion of management that the products can be produced by other manufacturers and the choice to utilize these suppliers
is not a significant concentration.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
8 &ndash; Inventory</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory
consists of finished goods, components and raw materials. The Company&rsquo;s inventory is stated at the lower of cost (FIFO cost
basis) or market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying value of inventory consisted of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2015</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2014</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Finished goods</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 20%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">535,908</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 20%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Components</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">115,340</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Raw Materials</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">35,406</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Energy product</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">26,064</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total
    inventory</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-weight: bold; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">686,654</FONT></TD><TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-weight: bold; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">26,064</FONT></TD><TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of January 22, 2015, inventory was pledged to Knight under the Loan Agreement (see note 12).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
9 &ndash; Fixed Assets and Intangible Assets</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2015 and 2014, fixed assets and intangible assets consisted of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2015</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2014</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Property and equipment</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">18,187</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Less accumulated
    depreciation</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">(6,170</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fixed
    assets, net</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-weight: bold; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">12,017</FONT></TD><TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-weight: bold; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation
expense for the years ended December 31, 2015 and 2014 was $1,513 and $0, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2015</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2014</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">FOCUSfactor intellectual
    property</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,000,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Intangible assets subject to amortization</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,521,751</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Less accumulated
    amortization</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">(606,489</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Intangible
    assets, net</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-weight: bold; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,915,262</FONT></TD><TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-weight: bold; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization
expense for the years ended December 31, 2015 and 2014 was $606,489 and $0, respectively. These intangible assets were acquired
through Asset Purchase Agreement and Stock Purchase Agreements disclosed in Note 3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
estimated aggregate amortization expense over each of the next five years is as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 78%; font-weight: bold; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">2016</FONT></TD><TD STYLE="width: 2%; font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">$</FONT></TD><TD STYLE="width: 18%; font-weight: bold; text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">1,111,229</FONT></TD><TD STYLE="width: 1%; font-weight: bold; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">2017</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">1,111,229</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">2018</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">1,109,070</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">2019</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">1,094,329</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">2020</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">489,405</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
10 &ndash; Related Party Transactions</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 2, 2014, the Company granted 1,000,000 options valued at approximately $282,000 to a company owned by Mr. Jack Ross, Chief
Executive Officer of the Company (see note 15).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 31, 2014, the Company borrowed $100,000 through a promissory note bearing interest at 10% with a maturity date of October
31, 2015 from a company owned by Mr. Ross, the Company&rsquo;s Chief Executive Officer. During the year ended December 31, 2015,
the note was converted into 400,000 shares of the Company&rsquo;s common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accrued and paid consulting fees of $15,000 per month to a company owned by Mr. Jack Ross, Chief Executive Officer of
the Company. The Company expensed $180,000 as consulting fees and made payments totaling $486,958 towards services to an entity
owned and controlled by an officer and shareholder of the Company for the year ended December 31, 2015. As of December 31, 2015,
the total outstanding balance was $0.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">At
December 31, 2014, $16,077, was due from a company owned by Mr. Jack Ross, Chief Executive Officer of the Company in a form of
an advance in the normal course of business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 22, 2015, the Company entered into a Loan Agreement with Knight Therapeutics (Barbados) Inc., a related party, for the
purchase of the Focus Factor assets. At December 31, 2015, the Company owed Knight $4,267,268 on this loan, net of discount (see
Note 12).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 26, 2015, the Company entered into a Security Agreement with Knight Therapeutics, Inc., through its wholly owned subsidiary
Neuragen Corp., for the purchase of Knight Therapeutics, Inc.&rsquo;s assets. At December 31, 2015, the Company owed Knight $925,000
in relation to this agreement (see Note 12).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 18, 2015, the Company entered into a Consulting Agreement with Kara Harshbarger, the co-founder of Hand MD, LLC, pursuant
to which she will provide marketing and sales related service. The Company will pay Ms. Harshbarger $10,000 a month for one year
unless the Consulting Agreement is terminated earlier by either party. Hand MD, LLC is a 50% owner in Hand MD Corp. The Company
expensed $40,000 through payroll for the year ended December 31, 2015. As of December 31, 2015, the total outstanding balance
was $0.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 12, 2015, the Company entered into a Loan Agreement with Knight Therapeutics (Barbados) Inc., a related party, for the
purchase of NomadChoice Pty Limited and Breakthrough Products, Inc. At December 31, 2015, the Company owed Knight $3,571,314 on
this loan, net of discount (see Note 12).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
December 31, 2015, NomadChoice Pty Ltd. (subsidiary) of the Company owed Knight Therapeutics $71,573 in connection with a royalty
distribution agreement (see Note 3).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
11 &ndash; Accounts Payable and Accrued Liabilities</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2015 and 2014, accounts payable and accrued liabilities consisted of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2015</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2014</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Payroll</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 20%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">128,237</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 20%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">10,867</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Legal fees</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">38,752</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">47,916</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Manufacturers</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,527,333</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Promotions</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,213,021</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Returns allowance</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,128,133</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Customers</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">411,033</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Interest</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">110,754</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Royalties</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">71,573</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Warehousing</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">31,748</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Others</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">371,518</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">15,859</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-weight: bold; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,032,102</FONT></TD><TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="font-weight: bold; text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">74,642</FONT></TD><TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
12 &ndash; Notes Payable</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s loans payable at December 31, 2015 and 2014 are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2015</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2014</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Loans payable</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,406,589</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Unamortized debt
    discount</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">(2,536,419</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">9,870,170</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Less: Current
    portion</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">(3,912,060</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Long-term portion</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,958,110</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>$6,000,000
January 22, 2015 Loan:</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 22, 2015, the Company entered into a Loan and Security Agreement (&ldquo;Loan Agreement&rdquo;) with Knight Therapeutics
(Barbados) Inc. (&ldquo;Knight&rdquo;), pursuant to which Knight agreed to loan the Company $6.0 million (the &ldquo;Loan&rdquo;),
and which amount was borrowed at closing (the &ldquo;Financing&rdquo;) for the purpose of acquiring the Focus Factor Business
(defined below). At closing, the Company paid Knight an origination fee of $120,000 and a work fee of $60,000 and also paid $40,000
of Knight&rsquo;s expenses associated with the Loan. The Loan bears interest at a rate of 15% per year; provided, however, that
upon the occurrence of an equity or convertible equity offering by the Company of at least $1.0 million, the interest rate will
drop to 13% per year. Interest accrues quarterly and is payable in arrears on March 31, June 30, September 30 and December 31
in each year, beginning on March 31, 2015.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
outstanding principal and accrued and unpaid interest is due on the earliest to occur of either January 20, 2017 (the &ldquo;Maturity
Date&rdquo;), or the date that Knight, in its discretion, accelerates the Company&rsquo;s obligations due to an event of default.
The Company may extend the Maturity Date for two successive additional 12-month periods if at March 31, 2016 and March 31, 2017,
respectively, the Company&rsquo;s revenues exceed $13.0 million and its EBITDA exceeds $2.0 million for the respective 12-month
period then ending. Principal payments under the Loan Agreement commenced on June 30, 2015 and continue quarterly as set forth
on the Repayment Schedule to the Loan Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to certain restrictions, the Company may prepay the outstanding principal of the Loan (in whole but not in part) at any time if
the Company pays a concurrent prepayment fee equal to the greater of (i) the total unpaid annual interest that would have been
payable during the year in which the prepayment is made if the prepayment is made prior to the first anniversary of the closing,
and (ii) $300,000. The Company&rsquo;s obligations under the Loan Agreement are secured by a first priority security interest
in all present and future assets of the Company. The Company also agreed to not pledge or otherwise encumber its intellectual
property assets, subject to certain customary exceptions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Loan Agreement includes customary representations, warranties, and affirmative and restrictive covenants, including covenants
to attain and maintain certain financial metrics, and to not merge or dispose of assets, acquire other businesses (except for
businesses substantially similar or complementary to the Company&rsquo;s business and the aggregate consideration to be paid does
not exceed $100,000) or make capital expenditures in excess of $100,000 over the Company&rsquo;s annual business plan in any year.
The Loan Agreement also includes customary events of default, including payment defaults, breaches of covenants, change of control
and material adverse effect default. Upon the occurrence of an event of default and during the continuation thereof, the principal
amount of the Loan will bear a default interest rate of an additional 5%.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Loan Agreement, the Company issued to Knight a warrant that entitled Knight to purchase 4,595,187 shares of
common stock of the Company (&ldquo;Common Stock&rdquo;) on or prior to close of business on January 30, 2015 (the &ldquo;ST Warrant&rdquo;).
The aggregate exercise price of the Common Stock under the ST Warrant is $1.00. Knight exercised the ST Warrant on January 22,
2015. Also in connection with the Loan Agreement, the Company issued to Knight a warrant to purchase 3,584,759 shares of Common
Stock on or prior to the close of business of January 22, 2025 (the &ldquo;LT Warrant&rdquo;). The exercise price per share of
the Common Stock under the LT Warrant is $0.34. The LT Warrant provides for cashless exercise. The LT Warrant also provides that
in the event the closing price of the Common Stock remains above $1.00 for six consecutive months, Knight will forfeit the difference
between the number of shares acquired under the LT Warrant prior to 90 days after such six-month period, and 25% of the shares
purchasable under the LT Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
beneficial conversion feature of the warrants issued to the noteholders amounted to $1,952,953 (ST warrants) and $1,462,560 (LT
warrants), respectively, and was recorded as debt discount of the corresponding debt.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognized amortization of debt discount of $1,952,953 (ST warrants) and $854,828 (LT warrants) during the year ended
December 31, 2015. Unamortized debt discount as of December 31, 2015 amounted to $607,732.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also recorded deferred financing costs of $289,045 with respect to the above loan. The Company recognized amortization
of deferred financing costs of $136,207 during the year ended December 31, 2015.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognized and paid interest expense of $805,686 during the year ended December 31, 2015. Accrued interest expense was
$0 as of December 31, 2015. Loan payable balance was $4,875,000 as of December 31, 2015.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>$1,500,000
January 22, 2015 Loan:</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 22, 2015, the Company issued a 0% promissory note in a principal amount of $1,500,000 in connection with an Asset Purchase
Agreement (see note 1). The note has a maturity date of January 20, 2017, with $750,000 to be paid on or before January 20, 2016
and an additional $750,000 to be paid on or before January 20, 2017. Loan payable balance was $1,500,000 as of December 31, 2015.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>$950,000
June 26, 2015 Security Agreement:</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 26, 2015, the Company, through its wholly owned subsidiary, Neuragen Corp. (&ldquo;Neuragen&rdquo;), issued a 0% promissory
note in a principal amount of $950,000 in connection with an Asset Purchase Agreement (see note 1). The note requires $250,000
to be paid on or before June 30, 2016, and $700,000 to be paid in quarterly installments (beginning with the quarter ending September
30, 2015) equal to the greater of $12,500 or 5% of U.S. net sales, and 2% of U.S. net sales of Neuragen for 60 months thereafter.
The payment of such amounts is secured by a security interest in certain assets, undertakings and property (&ldquo;Collateral&rdquo;)
pursuant to the Security Agreement, which will be released upon receipt of total payments of $1.2 million.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also recorded deferred financing costs of $10,486 with respect to the above agreement. The Company recognized amortization
of deferred financing costs of $2,643 during the year ended December 31, 2015. The balance at December 31, 2015 was $925,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>$5,500,000
November 12, 2015 Loan:</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 12, 2015, we entered into a First Amendment to Loan Agreement (&ldquo;First Amendment&rdquo;) with Knight, pursuant to
which Knight agreed to loan us an additional $5.5 million, and which amount was borrowed at closing (the &ldquo;Financing&rdquo;)
for the purpose of acquiring Breakthrough Products, Inc. and NomadChoice Pty Limited through Stock Purchase Agreements. At closing,
we paid Knight an origination fee of $110,000 and a work fee of $55,000 and also paid $24,000 of Knight&rsquo;s expenses associated
with the Loan. The Loan bears interest at a rate of 15% per year. The interest rate will decrease to 13% if we meet certain equity-fundraising
targets. The New Loan Agreement matures on November 11, 2017.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the New Loan Agreement, we issued Knight a warrant that entitles Knight to purchase 5,550,625 shares of our common
stock (&ldquo;Knight Warrant Shares&rdquo;) representing approximately 6.5% of our fully diluted capital, which Knight exercised
in full on November 12, 2015. Knight also received a 10-year warrant entitling Knight to purchase up to 4,547,243 shares of our
common stock at $0.49 per share (&ldquo;Knight Warrants&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
beneficial conversion feature of the warrants issued to the noteholders amounted to $2,553,287 (5,550,625 warrants) and $2,067,258
(4,547,243 warrants), respectively, and was recorded as debt discount of the corresponding debt. For derivative liability calculation
on 4,547,243 warrants, refer to Note 17.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognized amortization of debt discount of $2,553,287 (5,550,625 warrants) and $138,571 (4,547,243 warrants) during the
year ended December 31, 2015. Unamortized debt discount as of December 31, 2015 amounted to $1,928,686.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company also recorded deferred financing costs of $233,847 with respect to the above loan. The Company recognized amortization
of deferred financing costs of $15,675 during the year ended December 31, 2015.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recognized interest expense of $110,753 during the year ended December 31, 2015. Accrued interest expense was $110,753
as of December 31, 2015. The balance at December 31, 2015 was $5,500,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
13 &ndash; Stockholders&rsquo; Deficit</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
total number of shares of all classes of capital stock which the Company is authorized to issue is 75,000,000 shares of common
stock with $0.00001 par value. On July 30, 2014, the Company&rsquo;s board of directors approved an increase of the Company&rsquo;s
authorized common stock from 75,000,000 to 300,000,000 shares, which increase was approved by the Company&rsquo;s shareholders
and became effective on August 5, 2015.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 17, 2014, upon approval from FINRA, the Company effected a 30 for 1 forward stock split by way of a stock dividend, of all
of its issued and outstanding shares of common stock (the &ldquo;Stock Split&rdquo;). The Stock Split did not affect the number
of the Company&rsquo;s authorized common stock or its par value. All references in the accompanying consolidated financial statements
and notes thereto have been retroactively restated to reflect the stock split.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2015, the Company issued 4,595,187 shares of its common stock upon exercise of the ST Warrant at an
aggregate exercise price of $1.00 in connection with the Loan Agreement (see note1).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2015, the Company issued 5,550,625 shares of its common stock upon exercise of a Warrant at an aggregate
exercise price of $1.00 in connection with the Loan Agreement (see note1).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2015, the Company issued 400,000 shares of its common stock to a note holder in a note conversion
at $0.25 per share. At the time of conversion, the note was valued at $100,000 for outstanding principal.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2015, the Company issued 2,142,857 shares of its common stock valued at $0.70 per share in accordance
with Contribution Agreement entered into with Hand MD Corp. in exchange for 50% of Hand MD Corp.&rsquo;s outstanding capital securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2015, the Company issued 3,571,428 shares of its common stock valued at $0.35 per share in accordance
with a stock purchase agreement entered into with NomadChoice Pty Limited in exchange for 100% of NomadChoice Pty Limited&rsquo;s
outstanding capital securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2015, the Company issued 3,000,000 shares of its common stock valued at $0.85 per share in accordance
with a stock purchase agreement entered into with Breakthrough Products, Inc. in exchange for 100% of Breakthrough Product Inc.&rsquo;s
outstanding capital securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2015, the Company issued 40,000 shares of its common stock valued at $0.65 per share for cash.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2015, the Company issued 292,857 shares of its common stock valued at $0.70 per share to settle accounts
payable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 21, 2014, the Company entered into an agreement with accredited investors for the issuance and sale of 2,000,000 shares
of its common stock at a purchase price of $0.25 per share, for an aggregate consideration of $500,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2014, the Company cancelled 135,900,000 shares of its common stock (4,530,000 pre-Stock Split) as
part of the Merger transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2014, the Company issued 16,000,000 shares of its common stock valued at $25,000 as part of the Merger
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2015 and 2014, the Company committed to issue common stock valued at $28,000 and $40,000, respectively
for services rendered.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2015 and 2014, there were 81,692,954 and 62,100,000 shares of the Company&rsquo;s common stock issued and outstanding,
respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
14 &ndash; Commitments and Contingencies</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Litigation:</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
time to time the Company may become a party to litigation in the normal course of business. Management believes that there are
no current legal matters that would have a material effect on the Company&rsquo;s financial position or results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Operating
leases</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
April 2014, a subsidiary entered into an extension of a non-cancellable operating lease for office space that expires on March
31, 2017. Rent expense under this lease for the period from acquisition until December 31, 2015 was $8,923 per month less a $3,010
per month sublease through March 2017.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2015, a subsidiary entered into a non-cancellable operating lease for office space through November 2016. Rental payments
under this lease are $5,500 Australian dollars per month, which is approximately $4,200.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2015, the Company entered into a non-cancellable operating lease for office space through December 2016. Rental payments
under this lease are $5,500 per month.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a schedule by years of future minimum rental payments required under operating leases that have initial or remaining
non-cancelable lease terms in excess of one year as of December 31, 2015:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Year
    ending December 31:</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 82%; text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2016</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">220,676</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2017</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">27,294</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">247,970</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 8, 2014, a subsidiary entered into a non-cancellable 36 month phone lease with an estimated cost of $894 a month.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a schedule by years of future minimum rental payments required under operating leases that have initial or remaining
non-cancelable lease terms in excess of one year as of December 31, 2015:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Year
    ending December 31:</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 82%; text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2016</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">10,728</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2017</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">9,834</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">20,562</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
15 &ndash; Stock Options</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 30, 2014, the Company&rsquo;s board of directors approved the Company&rsquo;s 2014 Equity Incentive Plan and the reservation
of 15,525,000 shares of common stock for issuance under such plan. Such plan was approved by the Company&rsquo;s shareholders
and became effective on August 5, 2015.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 2, 2014, the Company granted 1,000,000 options with an exercise price of $0.25 per share to the Company owned by Mr. Jack
Ross, Chief Executive Officer of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 14, 2015, the Company granted 1,000,000 options each with an exercise price of $0.25 per share to two Board Members of
the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 14, 2015, the Company granted 1,000,000 options each with an exercise price of $0.65 per share to two employees of the
Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the changes in options outstanding and the related prices for the shares of the Company&rsquo;s common
stock issued to employees and consultants under a stock option plan at December 31, 2015:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="10" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Options
    Outstanding</B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Options
    Exercisable</B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Exercise
    </B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Prices ($)</B></FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Number</B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Outstanding</B></FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Weighted</B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Average</B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Remaining</B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Contractual Life</B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>(Years)</B></FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Weighted</B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Average</B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Exercise </B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Price ($)</B></FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Number</B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Exercisable</B></FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Weighted</B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Average </B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Exercise </B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Price ($)</B></FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 13%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.25
                                         - $0.65</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 13%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,000,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 13%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8.62</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 13%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.41</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 13%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,000,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 13%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.25</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
stock option activity for the year ended December 31, 2015 is as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Options
    Outstanding</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted
    Average</FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif">Exercise Price</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding at December 31, 2014</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 21%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,000,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 21%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.25</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Granted</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,000,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.45</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercised</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Expired or canceled</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding at December 31, 2015</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,000,000</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.41</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based
compensation expense related to vested options was $523,714 and $282,247 during the years ended December 31, 2015 and 2014, respectively.
The Company determined the value of share-based compensation for options vesting during the year ended December 31, 2015 using
the Black-Scholes fair value option-pricing model with the following weighted average assumptions: estimated fair value of Company&rsquo;s
common stock of $0.74, risk-free interest rate of 2.23%, volatility of 154%, expected lives of 10 years, and dividend yield of
0%. The Company determined the value of share-based compensation for options vesting during the year ended December 31, 2014 using
the Black-Scholes fair value option-pricing model with the following weighted average assumptions: estimated fair value of Company&rsquo;s
common stock of $0.33, risk-free interest rate of 1.8%, volatility of 125%, expected lives of 4.5 years, and dividend yield of
0%. Stock options outstanding as of December 31, 2015, as disclosed in the above table, have an intrinsic value of $1,400,000</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
16 &ndash; Stock Warrants</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the warrants outstanding and the related prices for the shares of the Company&rsquo;s common stock
at December 31, 2015:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="10" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Warrants
    Outstanding</B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Warrants
    Exercisable</B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Exercise</B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Prices ($)</B></FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Number</B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Outstanding</B></FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Weighted</B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Average</B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Remaining</B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Contractual Life</B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>(Years)</B></FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Weighted</B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Average</B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Exercise </B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Price ($)</B></FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Number</B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Exercisable</B></FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Weighted</B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Average</B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Exercise</B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Price ($)</B></FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 13%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.34</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 13%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,584,759</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 13%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">9.1</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 13%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.34</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 13%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,584,759</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 13%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.34</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.49</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,547,243</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">9.9</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.49</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,547,243</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.49</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.00</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,000,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.00</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,000,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.00</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
warrant activity for the year ended December 31, 2015 is as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Warrants</FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted
    Average</FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif">Exercise Price</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding at December 31, 2014</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Granted</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 21%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">19,277,814</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 21%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.44</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercised</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(10,145,812</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.00000020</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Expired or canceled</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding at December 31, 2015</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">9,132,002</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.92</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
17 &ndash; Derivatives</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has incurred a liability for the estimated fair value of a derivative warrant instrument. The estimated fair value of
the derivative warrant instruments has been calculated using the Black-Scholes fair value option-pricing model with key input
variables provided by management, as of the issue date, with the valuation offset against additional paid in capital, and at each
reporting date, with changes in fair value recorded as gains or losses on revaluation in non-operating income (expense).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company identified embedded derivatives related to the warrants issued along with loan payable entered into in November 2015.
These embedded derivatives included certain conversion features. The accounting treatment of derivative financial instruments
requires that the Company record the fair value of the derivatives as of the inception date of the warrants and to adjust the
fair value as of each subsequent balance sheet date. At the inception of the warrants, the Company determined a fair value of
$2,067,258 of the embedded derivative. The fair value of the embedded derivative was determined using the Black-Scholes Model
based on the following assumptions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">November
    12, 2015</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 78%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Risk-free interest rate</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 18%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.32</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Expected remaining term</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10
                                         Years</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Expected volatility</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">157.56</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dividend yield</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
initial fair values of the embedded derivative of $2,067,258 was allocated as a debt discount $2,067,258.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
value at December 31, 2015 was estimated to be $3,096,179 and based on the following assumptions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2015</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 78%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Risk-free interest rate</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 18%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.27</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Expected remaining term</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.75
                                         Years</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Expected volatility</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">152.07</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dividend yield</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2015, the increase in the fair value of the warrant derivative liability of $1,028,921 was recorded
as a loss on change in fair value of derivative liability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
18 &ndash; Segments</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Segment
identification and selection is consistent with the management structure used by the Company&rsquo;s chief operating decision
maker to evaluate performance and make decisions regarding resource allocation, as well as the materiality of financial results
consistent with that structure. Based on the Company&rsquo;s management structure and method of internal reporting, the Company
has one operating segment. The Company&rsquo;s chief operating decision maker does not review operating results on a disaggregated
basis; rather, the chief operating decision maker reviews operating results on an aggregate basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
sales attributed to customers in the United States and foreign countries for the years ended December 31, 2015 and 2014 were as
follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2015</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2014</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">United States</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 20%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">13,129,753</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 20%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">9,158</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Foreign countries</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">326,624</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">13,456,377</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">9,158</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s net sales by product group for the years ended December 31, 2015 and 2014 were as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2015</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2014</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Focus Factor</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 20%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">10,482,367</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 20%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Flat Tummy Tea</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,513,990</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Other (1)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">460,020</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">9,158</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">13,456,377</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">9,158</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
Net sales for any other product group of similar products are less than 10% of consolidated net sales.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-lived
assets (net) attributable to operations in the United States and foreign countries as of December 31, 2015 and 2014 were as follows:</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2015</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2014</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 52%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">United States</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 20%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">17,411,598</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 20%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Foreign countries</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,081</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">17,423,679</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
19 &ndash; Subsequent Events</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
evaluated all activities of the Company through the issuance date of the Company&rsquo;s consolidated financial statements and
concluded that no subsequent events have occurred that would require adjustments or disclosure into the consolidated financial
statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><A NAME="a_014"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ITEM
9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><A NAME="a_015"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ITEM
9A. CONTROLS AND PROCEDURES.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Evaluation
of Disclosure Controls and Procedures</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosure
controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed
in our reports filed or submitted under the Securities Exchange Act of 1934 (the &ldquo;Exchange Act&rdquo;) is recorded, processed,
summarized and reported, within the time periods specified in the Securities and Exchange Commission&rsquo;s rules and forms.
Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required
to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to management, including
our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely
decisions regarding required disclosure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
required by paragraph (b) of Rules 13a-15 or 15d-15 under the Exchange Act, our management, with the participation of our president
(our principal executive officer) and our chief financial officer (our principal financial officer and principal accounting officer)
evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this annual report,
being December 31, 2015.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
on this evaluation, these officers concluded that, as of December 31, 2015, these disclosure controls and procedures were not
effective to ensure that the information required to be disclosed by our company in reports it files or submits under the Exchange
Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities
and Exchange Commission. The conclusion that our disclosure controls and procedures were not effective was due to the presence
of material weaknesses in internal control over financial reporting as identified below under the heading &ldquo;Management&rsquo;s
Report on Internal Control over Financial Reporting.&rdquo; Management anticipates that such disclosure controls and procedures
will not be effective until the material weaknesses are remediated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control
issues, if any, within our company have been detected. These inherent limitations include the realities that judgments in decision-making
can be faulty and that breakdowns can occur because of simple error or mistake.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Management&rsquo;s
Annual Report on Internal Control over Financial Reporting</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management is responsible for establishing and maintaining adequate internal control over financial reporting. The term &ldquo;internal
control over financial reporting&rdquo; is defined as a process designed by, or under the supervision of, an issuer&rsquo;s principal
executive and principal financial officers, or persons performing similar functions, and effected by the issuer&rsquo;s board
of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting
and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles
and includes those policies and procedures that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="width: 95%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">pertain
    to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of
    the assets of the issuer;</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">provide reasonable
    assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally
    accepted accounting principles, and that receipts and expenditures of the issuer are being made only in accordance with authorizations
    of management and directors of the issuer; and</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">provide reasonable
    assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the issuer&rsquo;s assets
    that could have a material effect on the financial statements.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the supervision of our president and chief executive officer (our principal executive officer), who is also our chief financial
officer (our principal financial officer and principal accounting officer), we conducted an evaluation of the effectiveness of
our internal control over financial reporting as of December 31, 2015 using the criteria established in Internal Control Integrated
Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). This evaluation included review
of the documentation of controls, evaluation of the design effectiveness of controls, testing of the operating effectiveness of
controls and a conclusion on this evaluation. Based on this evaluation, our management concluded our internal control over financial
reporting was not effective as at December 31, 2015.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 41; Options: NewSection; Value: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there
is a reasonable possibility that a material misstatement of our company&rsquo;s annual or interim financial statements will not
be prevented or detected on a timely basis. In its assessment of the effectiveness of our internal control over financial reporting
as of December 31, 2015, we determined that there were control deficiencies that constituted material weaknesses which are indicative
of many small companies with small staff, such as:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="width: 95%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">inadequate segregation of
    duties and effective risk assessment; and</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">insufficient written
    policies and procedures for accounting and financial reporting with respect to the requirements and application of both generally
    accepted accounting principles in the United States and guidelines of the Securities and Exchange Commission.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
control deficiencies resulted in a reasonable possibility that a material misstatement of the annual or interim financial statements
could not have been prevented or detected on a timely basis. As a result of the material weaknesses described above, we concluded
that we did not maintain effective internal control over financial reporting as of December 31, 2015, based on criteria established
in<I> Internal Control Integrated Framework</I> issued by COSO. Our management is currently evaluating remediation plans for the
above deficiencies. During the period covered by this annual report on Form 10-K, we have not been able to remediate the remaining
weaknesses described above. However, we plan to take steps to enhance and improve the design of our internal control over financial
reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Changes
in Internal Control</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
has been no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange
Act) that occurred during our year ended December 31, 2015 that has materially affected, or is reasonably likely to materially
affect, our internal control over financial reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a &ldquo;smaller reporting company,&rdquo; as defined by Item 10 of the Regulation S-K, we are not required to include an attestation
report of the Company&rsquo;s registered public accounting firm regarding internal control over financial reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><A NAME="a_016"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ITEM
9B. OTHER INFORMATION.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>




<!-- Field: Page; Sequence: 42; Value: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="a_017"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PART
III</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><A NAME="a_018"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ITEM
10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Directors
and Executive Officers</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the names of the members of our Board of Directors, nominees for our Board of Directors, executive
officers, and the position with the Company held by each.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR>
    <TD STYLE="width: 20%; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name</B></FONT></TD>
    <TD STYLE="width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 6%; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Age</B></FONT></TD>
    <TD STYLE="width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 35%; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title</B></FONT></TD>
    <TD STYLE="width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 33%; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Tenure</B></FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jack Ross</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President, CEO, CFO and Director</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since October 2014</FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stephen Fryer</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">77</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since December 2014</FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul SoRelle</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">59</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since December 2014</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
director is elected to hold office until the next annual meeting of shareholders and until his/her successor has been qualified
and elected. Our President, Chief Executive Officer and Chief Executive Officer, our sole executive officer, serves at the discretion
of our Board of Directors. There are no understandings between any of our directors or executive officer or any other person pursuant
to which any executive officer or director was or is to be selected as an executive officer or director. Furthermore, there are
no family relationships between any director, executive officer, or person nominated or chosen by us to become a director or executive
officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Background
of Executive Officer and Board of Directors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a brief account of the business experience of each director, director nominee and executive officer of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Jack
Ross - President, Chief Executive Officer, Chief Financial Officer and Director</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Ross is currently the sole officer and director of Pure Sports Inc., positions he has held since February 2009, the sole officer
and director of Gowan Capital Inc., positions he has held since May 2011, the sole officer and director of Synergy Energy Strips
World Wide Inc., positions he has held since August 2011, the sole officer and director of Rio e Cigs Inc., positions he has held
since December 2011, and the sole officer and director of Kenek Brands Inc., positions he has held since May 2014. From January
2012 to April 2014, Mr. Ross served as the sole officer and director of Synergy Strips Corp., which was acquired by and became
a wholly owned subsidiary of the Company in April 2014 (the &ldquo;Subsidiary&rdquo;) in connection with the Merger. Other than
the Subsidiary, none of these companies are related to or affiliated with the Company. Mr. Ross&rsquo;s significant leadership
experience at various private and public companies led to the conclusion that he should serve as a member of our Board of Directors,
in light of our business and structure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Mr.
Stephen Fryer - Director</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
April 2003, Mr. Fryer has been the Chief Executive Officer and Managing Partner of SC Capital Partners, Inc., a private micro-market
investment banking and private equity intermediary. Prior to joining SC Capital Partners, Inc., Mr. Fryer was a consulting investment
banker with Grant Bettingen, Inc., a broker-dealer based in California, from January 2001 to March 2003. From May 1989 to August
1997, Mr. Fryer was the Principal and Managing Director of Ventana International, Ltd., a venture capital and private investment
banking firm with operations and investors in the United States, Latin America, Europe and Asia. Mr. Fryer earned a B.S. in Mechanical
Engineering, with a minor in Economics, from the University of Southern California. Mr. Fryer&rsquo;s substantial experience in
the investment banking industry, and his demonstrated skill in corporate finance, led to the conclusion that he should serve as
a member of our Board of Directors, in light of our business and structure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Mr.
Paul SoRelle - Director</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
November 1999, Mr. SoRelle has been the Chief Executive Officer and Managing Partner of Pioneer Press of Greeley, Inc., a commercial
offset printing company. Prior to joining Pioneer Press, Mr. SoRelle worked in the gaming business as well as the retail gasoline
and convenience store business. Mr. SoRelle&rsquo;s significant leadership experience at Pioneer Press of Greeley, Inc. led to
the conclusion that he should serve as a member of our Board of Directors, in light of our business and structure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Legal
Proceedings</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
director, director nominee, executive officer, or control person of the Company has been involved in any legal proceeding listed
in Item 401(f) of Regulation S-K in the past 10 years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 43; Value: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CORPORATE
GOVERNANCE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Director
Independence</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 23, 2016, we have three directors. Each director is elected to hold office for a one year period or until the next Annual
Meeting of Shareholders and until his/her successor has been qualified and elected following the one year of service. Mr. Fryer
and Mr. SoRelle are independent directors. Officers serve at the discretion of the Company&rsquo;s directors. There are no understandings
between the director of the Company or any other person pursuant to which any officer or director was or is to be selected as
an officer or director.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Code
of Ethics</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company does not have a code of ethics for our principal executive or principal financial officers, due to our size and current
stage of development. The Company&rsquo;s management intends to promote honest and ethical conduct, full and fair disclosure in
our reports to the SEC, and compliance with applicable governmental laws and regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Committees</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company does not have any standing committees and the Board of Directors performs the duties of an audit committee, nominating
committee and compensation committee. Since the Company has no standing committees, the Company does not have any written charters
governing such committees&rsquo; conduct.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Nominating
Committee</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not have a nominating committee, as we believe the Company is too small to warrant a separate standing nominating committee.
Director Jack Ross is responsible for selecting individuals to stand for election as members of our Board of Directors. The Company
does not have a policy with regards to the consideration of any director candidates recommended by our stockholders. Our Board
of Directors has determined that it is in the best position to evaluate our Company&rsquo;s requirements as well as the qualifications
of each candidate when it considers a nominee for a position on our Board of Directors. If stockholders wish to recommend candidates
directly to our Board of Directors, they may do so by communicating directly with Jack Ross, our President, Chief Executive Officer,
Chief Financial Officer and the Chairman of our Board of Directors by mail, at Synergy CHC Corp., Attn: President, 865 Spring
Street, Westbrook, ME 04092, or by telephone at (615) 939-9004.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Audit
Committee</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not have an audit committee currently serving and, as a result, our Board of Directors performs the duties of an audit committee.
We also do not have an &ldquo;audit committee financial expert,&rdquo; as such term is defined in Item 407(d)(5)(ii) of Regulation
S-K, however we feel that our directors&rsquo; backgrounds and financial sophistication is sufficient to fulfill the duties of
the audit committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Compensation
Committee</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not have a compensation committee, as we believe the Company is too small to warrant a separate standing compensation committee.
As a result, our Board of Directors performs the duties of a compensation committee. While the Company believes that its current
size does not warrant a separate standing compensation committee, it will reassess that need if and when additional directors
are appointed and/or elected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Shareholder
Communications</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders
may send written communications on the Company&rsquo;s web site: <U>www.synergychc.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 44; Value: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECTION
16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
16(a) of the Exchange Act requires the Company&rsquo;s executive officers, directors, and persons who beneficially own more than
10% of a registered class of the Company&rsquo;s equity securities to file with the SEC initial reports of ownership and reports
of changes in ownership of the Company&rsquo;s common stock and other equity securities. These executive officers, directors,
and greater than 10% beneficial owners are required by SEC regulation to furnish the Company with copies of all Section 16(a)
forms filed by such reporting persons. Based solely upon the Company&rsquo;s review of such forms furnished to it, the Company
believes that during the fiscal year ended 2015 and through to March X, 2016, all of its executive officers, directors, and every
person who is directly or indirectly the beneficial owner of more than 10% of any class of the Company&rsquo;s securities, complied
with the filing requirements of Section 16(a) of the Exchange Act except for the following: (a) Jack Ross, our President, Chief
Executive Officer, Chief Financial Officer and a member of our Board of Directors filed a Form 3 on February 9, 2015, to report
the shares of our common stock beneficially owned by Mr. Ross as of October 27, 2014, the date upon which Mr. Ross became our
President, Chief Executive Officer, Chief Financial Officer and a member of our Board of Directors; (b) Stephen J. Fryer, a member
of our Board of Directors, filed a Form 3 on February 9, 2015, to report that he beneficially owns no shares of our common stock
as of December 8, 2014, the date upon which Mr. Fryer became a member of our Board of Directors; (c) James P. SoRelle, a member
of our Board of Directors, filed a Form 3 on February 10, 2015, to report that he beneficially owns no shares of our common stock
as of December 8, 2014, the date upon which Mr. SoRelle became a member of our Board of Directors; and (d) Jack Ross filed a Form
4 on April 27, 2015 to report the acquisition of shares of common stock on April 19, 2015 by Gowan Private Equity, Inc., which
report was due on April 21, 2015.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><A NAME="a_019"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ITEM
11. EXECUTIVE COMPENSATION.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth certain information about compensation paid, earned or accrued for services for each executive officer
for the past two fiscal years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Summary
Compensation Table</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Year</B></FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Salary</B></FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Bonus</B></FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stock
    Awards</B></FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Option
    Awards</B></FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>All
                                         Other Compensation</B></FONT></P></TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Total</B></FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 36%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Jack Ross</B></FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2015</FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 6%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 6%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 6%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 6%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 8%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 6%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman, President, Chief Executive Officer
    and Chief Financial Officer</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2014</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Mark Suponitsky</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2015</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Former President, Chief Executive Officer, Chief
    Financial Officer, Treasurer, Secretary and Director(1)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2014</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,000</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,000</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Danny Aaron</B></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2015</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Former President, Chief Executive Officer, Secretary,
    Treasurer and Director(2)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2014</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="width: 95%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Suponitsky resigned all
    such positions, effective October 27, 2014.</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Aaron resigned all such positions, effective
    April 21, 2014.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not made provisions for paying cash or non-cash compensation to our officers and directors. No salaries or fees are being
paid at the present time to our officers and directors and none have been paid or owed from inception to date. We have no employment
agreement with our sole officer. As of December 31, 2015, we had no pension plans or compensatory plans or other arrangements
that provide compensation in the event of a termination of employment or a change of control of our Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Equity
Compensation Plans</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 30, 2014, the Company&rsquo;s board of directors approved the Company&rsquo;s 2014 Equity Incentive Plan and the reservation
of 15,525,000 shares of common stock for issuance under such plan. Such plan was approved by the Company&rsquo;s shareholders
and became effective on August 5, 2015.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 2, 2014, the Company granted 1,000,000 options with an exercise price of $0.25 per share to the Company owned by Mr. Jack
Ross, Chief Executive Officer of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 45; Value: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 14, 2015, the Company granted 1,000,000 options each with an exercise price of $0.25 per share to two Board Members of
the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 14, 2015, the Company granted 1,000,000 options each with an exercise price of $0.65 per share to two employees of the
Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the changes in options outstanding and the related prices for the shares of the Company&rsquo;s common
stock issued to employees and consultants under a stock option plan at December 31, 2015:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="6" STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="9" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Options
    Outstanding</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="5" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Options
    Exercisable</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exercise</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Prices
                                         ($)</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Outstanding</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Weighted</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Average</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Remaining</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Contractual
                                         Life</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Years)</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Weighted</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Average</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exercise</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Price
                                         ($)</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exercisable</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Weighted</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Average</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exercise</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Price
                                         ($)</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 0%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 0%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 0%"></TD>
    <TD STYLE="width: 0%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 14%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">$<FONT STYLE="font-size: 10pt">0.25
                                         - $0.65</FONT></FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,000,000</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8.62</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 13%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.41</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 13%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,000,000</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 14%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.25</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
stock option activity for the year ended December 31, 2015 is as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Options
    Outstanding</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted
    Average</FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif">Exercise Price</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding at December 31, 2014</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 21%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,000,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 21%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.25</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Granted</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">4,000,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.45</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercised</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Expired or canceled</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding at December 31, 2015</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,000,000</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.41</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based
compensation expense related to vested options was $523,714 and $282,247 during the years ended December 31, 2015 and 2014, respectively.
The Company determined the value of share-based compensation for options vesting during the year ended December 31, 2015 using
the Black-Scholes fair value option-pricing model with the following weighted average assumptions: estimated fair value of Company&rsquo;s
common stock of $0.74, risk-free interest rate of 2.23%, volatility of 154%, expected lives of 10 years, and dividend yield of
0%. The Company determined the value of share-based compensation for options vesting during the year ended December 31, 2014 using
the Black-Scholes fair value option-pricing model with the following weighted average assumptions: estimated fair value of Company&rsquo;s
common stock of $0.33, risk-free interest rate of 1.8%, volatility of 125%, expected lives of 4.5 years, and dividend yield of
0%.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Outstanding
Equity Awards at Fiscal Year-End</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0 0; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table contains certain information concerning unexercised options for our sole executive officer as of December&nbsp;31,
2015.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; padding-left: 0.75pt; padding-bottom: 1.5pt"></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD COLSPAN="17" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Option
                                         awards</B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD COLSPAN="13" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stock
                                         awards</B></FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; padding-left: 0.75pt; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Number
                                         of securities underlying unexercised options</B></FONT><BR><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>
                                         exercisable</B></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number
                                         of securities</B></FONT><BR>
                                         <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>underlying</B></FONT><BR>
                                         <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>unexercised</B></FONT><BR>
                                         <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>options</B></FONT><BR>
                                         <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>unexercisable</B></FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Equity</B></FONT><BR>
                                         <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>incentive</B></FONT><BR>
                                         <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>plan awards:
                                         Number of</B></FONT><BR><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
                                         <B>securities</B></FONT><BR>
                                         <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>underlying</B></FONT><BR>
                                         <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>unexercised</B></FONT><BR>
                                         <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>unearned</B></FONT><BR>
                                         <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>options</B></FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Option</B></FONT><BR>
                                         <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>exercise
                                         price</B></FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Option
                                         expiration date</B></FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number
                                         of shares or units of stock that have not vested</B></FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Market
                                         value of shares of units of stock that have not vested</B></FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Equity</B></FONT><BR>
                                         <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>incentive</B></FONT><BR>
                                         <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>plan awards:
                                         Number of</B></FONT><BR><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
                                         <B>unearned</B></FONT><BR>
                                         <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>shares,
                                         units or other rights that have not vested</B></FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Equity</B></FONT><BR>
                                         <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>incentive</B></FONT><BR>
                                         <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>plan awards:
                                         Market or payout value of</B></FONT><BR><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
                                         <B>unearned</B></FONT><BR><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
                                         <B>shares, units or other rights that have not vested</B></FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 10%; text-align: left; padding-left: 0.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Jack
    Ross</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 6%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 6%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 6%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 6%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 6%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 6%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 6%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 6%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 6%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 0.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Mark Suponitsky</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Danny Aaron</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 46; Value: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 24pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Director
Compensation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 6pt; text-indent: 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table provides information regarding all compensation paid to non-employee directors during the fiscal year ended December
31, 2015.</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Name</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fees
    earned or paid in cash</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stock
    awards</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Option
                                         awards</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(1)</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Non-equity
    incentive plan</FONT><BR><FONT STYLE="font-family: Times New Roman, Times, Serif"> compensation</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Nonqualified
    deferred</FONT><BR><FONT STYLE="font-family: Times New Roman, Times, Serif"> compensation earnings</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>All
                                         other </B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>compensation</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Jack Ross</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 16%; text-align: left; padding-left: 0.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stephen
    Fryer</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 8%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 8%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 8%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">734,508</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 8%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 8%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 8%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 8%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">734,508</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Paul SoRelle</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">734,508</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">734,508</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
This column reflects the aggregate grant date fair value computed in accordance with Financial Accounting Standards Board, or
&ldquo;FASB&rdquo;, issued Accounting Standards Update, or &ldquo;ASC&rdquo;, Topic 718.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 47; Value: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><A NAME="a_020"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ITEM
12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth certain information regarding our common stock beneficially owned as of the date of this report, for
(i) each stockholder known to be the beneficial owner of 5% or more of our outstanding common stock, (ii) each executive officer
and director, and (iii) all executive officers and directors as a group. To the best of our knowledge, subject to community and
marital property laws, all persons named have sole voting and investment power with respect to such shares, except as otherwise
noted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="9" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Common
    Stock Beneficially Owned</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number
                                         of</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>shares</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>beneficially</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>owned</B></FONT></P></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Percentage</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>of
                                         shares</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>beneficially</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>owned</B></FONT></P></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Executive officers
    and directors: (1)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 68%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Jack Ross (4) (5)</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">48,389,399</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">50.5</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stephen Fryer (5)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,000,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.04</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Paul SoRelle (5)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,296,658</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.40</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">All directors and executive officers
    as a group (3 persons)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">51,686,057</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">53.94</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">5% Stockholders:
    (2)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Gowan Private Equity Inc (4)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">43,780,750</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">45.69</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Knight Therapeutics (Barbados) Inc.(3)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">19,290,242</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">20.13</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dunhill Distribution Group, Inc.
    (4)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,208,649</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.35</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">%</FONT></TD></TR>
</TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 95%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless otherwise
    noted, the address for each of the named beneficial owners is: 865 Spring Street, Westbrook, ME 04092.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under Rule 13d-3,
    a beneficial owner of a security includes any person who, directly or indirectly, through any contract, arrangement, understanding,
    relationship, or otherwise has or shares: (i) voting power, which includes the power to vote, or to direct the voting of shares;
    and (ii) investment power, which includes the power to dispose or direct the disposition of shares. Certain shares may be
    deemed to be beneficially owned by more than one person (if, for example, persons share the power to vote or the power to
    dispose of the shares). In addition, shares are deemed to be beneficially owned by a person if the person has the right to
    acquire the shares (for example, upon exercise of an option) within 60 days of the date as of which the information is provided.
    In computing the percentage ownership of any person, the amount of shares outstanding is deemed to include the amount of shares
    beneficially owned by such person (and only such person) by reason of these acquisition rights. As a result, the percentage
    of outstanding shares of any person as shown in this table does not necessarily reflect the person&rsquo;s actual ownership
    or voting power with respect to the number of shares of common stock actually outstanding.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As disclosed pursuant
    to a Schedule 13G filed with the SEC on February 2, 2015. Includes 3,584,759 shares of common stock that may be acquired upon
    exercise of warrants. This stockholder&rsquo;s address is Chancery House, High Street, Bridgetown, Barbados.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This stockholder&rsquo;s
    address is: 275 Canterbury Lane, Fall River NS B2T 1A4, Canada. Jack Ross is the Chief Executive Officer of Kenek Brands,
    Inc., Dunhill Distribution Group, Inc. Gowan Capital Inc. and Gowan Private Equity Inc. Kenek Brands Inc. owns options to
    purchase 1,000,000 shares of common stock. Gowan Private Equity owns 43,780,750.&nbsp;&nbsp;Gowan Capital Inc. owns 400,000
    shares. Dunhill Distribution Group owns 3,208,649.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consists of options
    to purchase shares of common stock.</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 48; Value: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0; text-align: justify"><A NAME="a_021"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ITEM
13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TRANSACTIONS
WITH RELATED PERSONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information required by Item 407(a) of Regulation S-K is included in this Annual Report on Form 10-K under the heading Item 10.
DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE &ndash; Director Independence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
January 1, 2014, the Company has not been a party to any transaction in which the amount involved exceeded or will exceed the
lesser of $120,000 or 1% of the average of its total assets at year end for the last two fiscal years, and in which any of its
directors, named executive officers or beneficial owners of more than 5% of the Company&rsquo;s capital stock, or an affiliate
or immediate family member thereof, had or will have a direct or indirect material interest, other than described below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 7, 2014, an Agreement and Plan of Merger (the &ldquo;Merger Agreement&rdquo;) was entered into by and among the Company,
Synergy Merger Sub, Inc., a Delaware corporation and the wholly owned subsidiary of the Company formed for the purpose of the
transactions under the Merger Agreement (&ldquo;Merger Sub&rdquo;), and Synergy Strips Corp., a Delaware corporation incorporated
on January 24, 2012 (&ldquo;SSC&rdquo;). The Merger Agreement provided for the merger of Merger Sub with and into SSC (the &ldquo;Merger&rdquo;),
with SSC surviving the merger as the wholly owned subsidiary of the Company. The Merger was consummated on April 21, 2014. In
connection with the Merger, Dunhill Distribution Group, Inc. acquired 3,208,649 shares of the Company&rsquo;s Common Stock. Jack
Ross, the Company&rsquo;s President, CEO, CFO and a director, is the Chief Executive Officer of Dunhill Distribution Group, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 2, 2014, the Company granted 1,000,000 options valued at approximately $282,000 to a company owned by Mr. Jack Ross, Chief
Executive Officer of the Company (see note 15).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 31, 2014, the Company borrowed $100,000 through a promissory note bearing interest at 10% with a maturity date of October
31, 2015 from a company owned by Mr. Ross, the Company&rsquo;s chief executive officer. During the year ended December 31, 2015,
the note was converted into 400,000 shares of the Company&rsquo;s common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accrued and paid consulting fees of $15,000 per month to a company owned by Mr. Jack Ross, Chief Executive Officer of
the Company. The Company expensed $180,000 as consulting fees and made payments totaling $486,958 towards services to an entity
owned and controlled by an officer and shareholder of the Company for the year ended December 31, 2015. As of December 31, 2015,
the total outstanding balance was $0.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
December 31, 2014 $16,077, respectively was due from the Company owned by Mr. Jack Ross, Chief Executive Officer of the Company
in a form of an advance in the normal course of business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 22, 2015, the Company entered into a Loan Agreement with Knight Therapeutics (Barbados) Inc. a related party, for the
purchase of the Focus Factor assets. At December 31, 2015, the Company owed Knight $4,267,268 on this loan, net of discount (see
Note 12).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 26, 2015, the Company entered into a Security Agreement with Knight Therapeutics, Inc.(&ldquo;Knight Canada&rdquo;), through
its wholly owned subsidiary, for the purchase of the Neuragen assets. At December 31, 2015, the Company owed Knight Canada $925,000
on this agreement (see Note 12).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 18, 2015, the Company entered into a Consulting Agreement with Kara Harshbarger, the co-founder of Hand MD, LLC, pursuant
to which she will provide marketing and sales related service. The Company will pay Ms. Harshbarger $10,000 a month for one year
unless the Consulting Agreement is terminated earlier by either party. Hand MD, LLC is a 50% owner in Hand MD Corp. The Company
expensed $40,000 through payroll for the year ended December 31, 2015. As of December 31, 2015, the total outstanding balance
was $0.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
November 12, 2015, the Company entered into a Loan Agreement with Knight for the purchase of NomadChoice Pty Limited and Breakthrough
Products, Inc. At December 31, 2015, the Company owed Knight $3,571,314 on this loan, net of discount (see Note 12).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
December 31, 2015, a NomadChoice Pty Ltd. (subsidiary) of the Company owed Knight Canada $71,573 in connection with a royalty
distribution agreement (see Note 12).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 49; Value: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><A NAME="a_022"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ITEM
14. PRINCIPAL ACCOUNTING FEES AND SERVICES.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Audit
Committee&rsquo;s Pre-Approval Practice</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to our engagement of our independent auditor, such engagement was approved by our board of directors. The services provided under
this engagement may include audit services, audit-related services, tax services and other services. Pre-approval is generally
provided for up to one year and any pre-approval is detailed as to the particular service or category of services and is generally
subject to a specific budget. Pursuant our requirements, the independent auditors and management are required to report to our
board of directors at least quarterly regarding the extent of services provided by the independent auditors in accordance with
this pre-approval, and the fees for the services performed to date. Our board of directors may also pre-approve particular services
on a case-by-case basis. All audit-related fees, tax fees and other fees incurred by us for the year ended December 31, 2015,
were approved by our board of directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RBSM
LLP serves as our independent registered public accounting firm.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Independent
Registered Public Accounting Firm Fees and Services</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the aggregate fees including expenses billed to us for the years ended December 31, 2015 and 2014 by
our auditors.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 80%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Year
    Ended</FONT></TD><TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Year
    Ended</FONT></TD><TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2015</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2014</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit
    Fees<SUP>(1)</SUP></FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 21%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">125,500</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 21%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">6,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit-Related Fees<SUP>(2)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax Fees<SUP>(3)</SUP></FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    Other Fees<SUP>(4)</SUP></FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,663</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">127,163</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">6,000</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="width: 95%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit
    Fees - This category includes the audit of the Company&rsquo;s annual financial statements, review of financial statements
    included in its Quarterly Reports on Form 10-Q, and services that are normally provided by independent auditors in connection
    with the engagement for fiscal years.</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit-Related Fees
    - This category consists of fees reasonably related to the performance of the audit or review of the Company&rsquo;s financial
    statements that are not reported as &ldquo;Audit Fees.&rdquo;</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax Fees - This
    category consists of tax compliance, tax advice, and tax planning work.</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All Other Fees -
    This category consists of fees for other miscellaneous items.</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 50; Value: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><A NAME="a_023"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PART
IV</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><A NAME="a_024"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ITEM
15. EXHIBITS FINANCIAL STATEMENT SCHEDULES.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following documents are filed as part of this report:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.&#9;Consolidated
Financial Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">INDEX
TO CONSOLIDATED FINANCIAL STATEMENTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR>
    <TD STYLE="width: 91%; text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 9%; text-align: center; border-bottom: Black 1.5pt solid; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Page</B></FONT></TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Financial Statements</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 20pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reports
                                    of Independent Registered Public Accounting Firm</FONT></P></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1-
    F-2</FONT></TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 20pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated
                                    Balance Sheets</FONT></P></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-3</FONT></TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 20pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated
                                    Statements of Operations</FONT></P></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-4</FONT></TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 20pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated
                                    Statements of Shareholders&rsquo; (Deficit) Equity</FONT></P></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-5</FONT></TD></TR>
<TR STYLE="background-color: White">
    <TD STYLE="text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 20pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated
                                    Statements of Cash Flows</FONT></P></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-6</FONT></TD></TR>
<TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 20pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
                                    to Consolidated Financial Statements</FONT></P></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; padding: 0; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-7</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.&#9;Consolidated
Financial Statement Schedules</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.&#9;Exhibits</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="7" STYLE="font-weight: bold; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">Incorporated
    by Reference</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exhibit</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="7" STYLE="text-align: center; border-bottom: Black 1.5pt solid; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>(Unless
    Otherwise Indicated)</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">Number</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exhibit
    Title</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">Form</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">File</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exhibit</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">Filing
    Date</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 10%; text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.1</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 45%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Agreement and Plan of Merger,
    dated </FONT><BR><FONT STYLE="font-family: Times New Roman, Times, Serif">April 7, 2014, by and among Oro Capital Corporation,
    Synergy Merger Sub, Inc. and Synergy Strips Corp.</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">8-K</FONT></TD><TD STYLE="width: 2%; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 10%; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">000-55098</FONT></TD><TD STYLE="width: 2%; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 8%; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.1</FONT></TD><TD STYLE="width: 2%; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 10%; text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">4/9/2014</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.2</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Agreement and Plan of Merger dated April
    21, 2014 (incorporated by reference to the Registrant&rsquo;s Current Report on Form 8-K filed on April 9, 2014).</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">8-K</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">000-55098</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.1</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">5/7/2014</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.3</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Asset Purchase Agreement, dated January
    22, 2015, by and among Synergy Strips Corp.; Factor Nutrition Labs, LLC; Vita Partners, LLC, RPR Partners, LLC, and Thor Associates,
    Inc.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">10-K</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">000-55098</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.3</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">3/31/2015</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.4</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Asset Purchase Agreement, dated June
    26, 2015, by and between Neuragen Corp. and Knight Therapeutics, Inc.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">8-K</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">000-55098</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.4</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">7/2/2015</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.1</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;Articles of Incorporation</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">S-1</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;333-185103</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.1</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">11/21/2012</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.2</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Amendment to Articles of Incorporation</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">8-K</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">000-55098</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.1(b)</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">5/7/2014</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.3</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Certificate of Amendment to Articles
    of Incorporation</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">8-K</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">000-55098</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.4</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">8/6/2015</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.4</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">By-Laws</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">S-1</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">333-185103</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.2</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">11/21/2012</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.5</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Amendment to By-Laws</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">8-K</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">000-55098</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.2</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">6/26/2015</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.1</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Form of Subscription Agreement</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">S-1/A</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">333-185103</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.1</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">2/19/2013</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 51; Value: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.2</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Synergy Strips Corp. Common
    Stock Purchase Warrant, dated January 22, 2015.</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif">10-K</FONT></TD><TD STYLE="text-align: left; vertical-align: top; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif">000-55098</FONT></TD><TD STYLE="text-align: left; vertical-align: top; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; width: 8%"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.2</FONT></TD><TD STYLE="text-align: left; vertical-align: top; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif">3/31/2015</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.3</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Synergy Strips Corp. Common Stock Purchase
    Warrant (10-Year Warrant), dated January 22, 2015.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">10-K</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">000-55098</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.3</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">3/31/2015</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.4</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Synergy CHC Corp. Common Stock Purchase
    Warrant, dated November 12, 2015.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">8-K</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">000-55098</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.4</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">11/18/2015</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.5</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Synergy CHC Corp. Common Stock Purchase
    Warrant (10-Year Warrant), dated November 12, 2015.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">8-K</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">000-55098</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.5</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">11/18/2015</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.6</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Synergy CHC Corp. Common Stock Warrant
    dated December 17, 2015.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">8-K</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">000-55098</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.6</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">12/22/2015</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.1</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Mineral Claim Agreement for the Shipman
    Diamond Project, dated September 1, 2011.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">S-1</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">333-185103</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.1</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">11/21/2012</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.2</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Transfer of Mineral Dispositions with
    Danny Aaron, dated February 21, 2012.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">S-1</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">333-185103</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.2</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">11/21/2012</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.3</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Form of Sales and Marketing Consultant
    and Distribution Agreement, dated April 2, 2014.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">8-K</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">000-55098</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.1</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">5/7/2014</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.4</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Sales and Marketing Consultant and Distribution
    Agreement, dated April 2, 2014, between Synergy Strips Corp. and Kenek Brands Inc.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">8-K</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">000-55098</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.1</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">5/7/2014</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.5</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Loan Agreement, dated January 22, 2015,
    between Knight Therapeutics (Barbados) Inc. and Synergy Strips Corp.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">10-K</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">000-55098</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.5</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">3/31/2015</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.6</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Product Distribution Option Agreement,
    dated January 22, 2015, between Knight Therapeutics (Barbados) Inc. and Synergy Strips Corp.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">10-K</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">000-55098</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.6</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">3/31/2015</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.7</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Distribution, License and Supply Agreement,
    dated January 22, 2015, by and between Synergy Strips Corp. and Knight Therapeutics (Barbados) Inc.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">10-K</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">000-55098</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">3/31/2015</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.8</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Synergy Strips Corp. 2014 Equity Incentive
    Plan</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">8-K</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">000-55098</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.8</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">8/6/2015</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.9</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Contribution Agreement, dated August
    18, 2015, between Synergy CHC Corp. and Hand MD Corp.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">8-K</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">000-55098</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.9</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">8/21/2015</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.10</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Contribution Agreement, dated August
    18, 2015, among Hand MD, LLC, Principal Owners as listed therein, Synergy CHC Corp. and Hand MD. Corp.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">8-K</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">000-55098</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.10</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">8/21/2015</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.11</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Intellectual Property License Agreement,
    dated August 18, 2015, by and between Synergy CHC Corp. and Hand MD. Corp.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">8-K</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">000-55098</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.11</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">8/21/2015</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.12</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Consulting Agreement, dated August 18,
    2015, by and between Synergy CHC Corp. And Kara Harshbarger.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">8-K</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">000-55098</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.12</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">8/21/2015</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.13</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stock Purchase Agreement, dated November
    12, 2015, by and among Breakthrough Products, Inc., URX ACQUISITION TRUST, Jordan Eisenberg, other shareholders as listed
    therein and Synergy CHC Corp.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">8-K</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">000-55098</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.13</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">11/18/2015</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.14</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Share Purchase Agreement, dated November
    15, 2015, between TPR Investments Pty Ltd CAN 128 396 654 as trustee for Polmear Family Trust, Timothy Polmear and Rebecca
    Polmear, NomadChoice Pty Limited ACN 160 729 939 trading as Flat Tummy Tea and Synergy CHC Corp.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">8-K</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">000-55098</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.14</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">11/18/2015</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 52; Value: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.15</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif">First Amendment to Loan
    Agreement, dated November 12, 2015, between Knight Therapeutics (Barbados) Inc. and Synergy CHC Corp.</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; width: 7%"><FONT STYLE="font-family: Times New Roman, Times, Serif">8-K</FONT></TD><TD STYLE="text-align: left; vertical-align: top; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif">000-55098</FONT></TD><TD STYLE="text-align: left; vertical-align: top; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; width: 8%"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.15</FONT></TD><TD STYLE="text-align: left; vertical-align: top; width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top; width: 10%"><FONT STYLE="font-family: Times New Roman, Times, Serif">11/18/2015</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.16</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Amendment to First Amendment Agreement,
    dated December 3, 2015, between Knight Therapeutics (Barbados) Inc. and Synergy CHC Corp.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">8-K</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">000-55098</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.16</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">12/9/2015</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.17</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Amendment and Confirmation Agreement,
    dated December 3, 2015, by and among Knight Therapeutics (Barbados) Inc., Nomad Choice Pty Ltd., Synergy CHC Corp. and Breakthrough
    Products, Inc.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">8-K</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">000-55098</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.17</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">12/9/2015</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.18</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Settlement and Release Agreement, dated
    December 17, 2015, by and between Synergy CHC Corp., the former shareholders of Breakthrough Products, Inc. and URX ACQUISITION
    TRUST and as representative of certain shareholders.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">8-K</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">000-55098</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">10.18</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">12/22/2015</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">16.1</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Letter from M&amp;K CPAS, PLLC to the
    Securities and Exchange Commission dated June 11, 2014.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">8-K/A</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">000-55098</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">16.1</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">6/12/2014</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">21.1</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">Subsidiaries of
    the Registration</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">Filed herewith</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">23.1</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Promissory Note to Danny Aaron, dated
    May 17, 2013.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">S-1/A</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">333-185103</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">23.2</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">5/17/2013</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">23.2</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Promissory Note and Future Advances
    Note to Danny Aaron , dated May 28, 2013.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">S-1/A</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">333-185103</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">23.2</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">5/28/2013</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">31.1</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Certification of Principal Executive
    Officer pursuant to Rule 13a-14(a)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">Filed herewith</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">31.2</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Certification of Principal Financial
    Officer pursuant to Rule 13a-14(a)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">Filed herewith</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">32.1</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Certification of Principal Executive
    Officer pursuant to 18 U.S.C. Section 1350</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">Filed herewith</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">32.2</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Certification of Principal Financial
    Officer pursuant to 18 U.S.C. Section 1350</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">Filed herewith</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">101.INS</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">XBRL Instance Document.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">Furnished herewith</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">101.SCH</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">XBRL Taxonomy Extension
    Schema Document.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">Furnished herewith</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">101.CAL</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">XBRL Taxonomy Extension
    Calculation Linkbase Document.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">Furnished herewith</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">101.DEF</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">XBRL Taxonomy Extension
    Definition Linkbase Document.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">Furnished herewith</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">101.LAB</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">XBRL Taxonomy Extension
    Label Linkbase Document.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">Furnished herewith</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">101.PRE</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">XBRL Taxonomy Extension
    Presentation Linkbase Document.</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif">Furnished herewith</FONT></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 53; Value: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><A NAME="a_025"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNATURES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of Section 13 or 15(d) of the Exchange Act, the registrant has duly caused this report to be signed on its
behalf by the undersigned, thereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SYNERGY
    CHC CORP.</FONT></TD></TR>
<TR>
    <TD STYLE="width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 3%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 47%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: March 30,
    2016</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Jack Ross</I></FONT></TD></TR>
<TR>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President, Chief
    Executive Officer</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Exchange Act, this report has been signed below by the following persons on behalf of the registrant
and in the capacities and on the dates indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR>
    <TD STYLE="width: 35%; text-align: justify; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNATURE</B></FONT></TD>
    <TD STYLE="width: 2%; text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 46%; text-align: justify; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TITLE</B></FONT></TD>
    <TD STYLE="width: 2%; text-align: justify; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 15%; text-align: justify; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>DATE</B></FONT></TD></TR>
<TR>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR>
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Jack Ross</I></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">President, Chief
    Executive Officer</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 30, 2016</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jack
    Ross</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(principal executive
    officer) Chief Financial Officer, Chief Accounting Officer, (principal financial officer), Director</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR>
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Stephen Fryer</I></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 30, 2016</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stephen
    Fryer</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR>
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Paul SoRelle</I></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 30, 2016</FONT></TD></TR>
<TR>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul SoRelle</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 54; Value: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->











<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !\ 8$# 2(  A$! Q$!_\0
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M#4[>:UOX+\Z;<PRQ[&COH@PO(G7"E#;SI)$1L&[;G;']P!=/K;M^I5K]JO\
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M25(-3KD\YR#R 5*D \C.>0?4$ CG(!Z  5!4*. ,#UX'&.3Z=SGU.:_SP?\
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MA01D,6'RY4<U_(O_ ,&AI'_#3?[4$A4%HO@YX?N"V &=_P#A(61@6 X5B2P
M&%)P <4&,ZDYI*3O9W6B7ET2/[_XR&BC(.0T:D'!7(*@@[225SG."21TR>M?
MQ-_\'7?[6OB[1H?A3^ROX2UN_P!%L-5E77_%L-I-+;'6+6\BGFMH+AX]I^RM
MY"Q#+R(1(7\L8(?^V=<X&<9'!P,#(XX&3@'L,G'3)ZU_G5?\'6\SC]N7P"LA
MN)D'PTTD%8AYN9Y+JY^QPJHV^64@(7=N8X!R!W @DV[]OU/V#_X(_P#_  03
M_9$'[,_@GXQ_M-?#70OC!X^^(]B/$>G6OB*WADTWP[I=_+FT@MK!8</(D;HR
MS23R21C:C^<V)7[C_@J[_P $#OV,M9_97^)/Q%_9W^'.G_"#XH_#GPOJ7B/3
M%\,06,6F^)5@<7%W::O;S6Q+O*#(_FQ280 A80,9_=K]A=)H/V./V;XI8I49
M?A5X+412(Y9(FT^V=<;($)"QL,-EUP"QF8"NH_:TAEN_V;?C6D,4MPR> ?$,
M\<'E/&62+395DB)>(A@0'DY!)!P!M - ^57M;KW/X_O^#4/]IGXB0>._C3^R
M/XCULS>#_#FD2>(/"^FRR-,FFZS-J6J1ZO!8!@H2T@ETN5(%B\M!$Z((D6,;
MO[EXW$B*X& P!&>3@@$9_ U_GH_\&S\1B_X*2_'!4D"M'I.L(@\K9L_XJ3QB
MLJO&'QE^<KD;"<9;%?Z%T?W?3GH.@X%/H_E^9G5]UPY=+MI]=DNY_+;_ ,'6
M.W_AASP0Y4EX?B"TJDD%>+W0DP%96 ;G.[GD#Y>]?S5_\$<_^")/C[_@I)I-
M[\2/'/C_ %#PA^SMX9UV72R^CZD_]I:[K=C.\=_ILVEM+!:I;I)')&9A%-*R
MC)D)Y/\ 2I_P=8#/[#'@]O3QZXQ]-2T$5K?\&J?F/_P3U\2G>NY/B]X@BA+(
M&6)9+NYD;"9 9CD?,3DL QZE:1;24(OJWK]US[D_9(_X(@?L9_L=^./"GQ,^
M'>@:A<^//"7D&RUN]8?,\=JMO+^[WR'$KJ9-^[/S8*5^RHD"HI.,9(8_="XC
M:0G&#P,;<<8SG/&#(JK@<#H.P]*AF"K'*3RN)"P'! \D@@?51Z?Q9[4$+<_S
MA_\ @X=^,_Q(_:D_X*/:'^S9I6NWEMX,\/Q:%X5T+P\9)(=+EU+4]2O!JVL/
M&)7BN+B#[!)&-T*^<9?.W0;1$?ZC?V-_^"#/_!/_ .&7P4\ -\0O@EX:^)7Q
M!U7P_I.I:]XJ\4Q7%W<3WFIZ7;7%Y!:P17:0V\:3R3!';S#P'*)G8O\ ))_P
M4<FCA_X+>Z2[1_8_LOQ#T5Q<.QC*Q7.L^(6DD(E#JZJ[;,X0,/G 7[H_TE/
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MJ^%#_?S&3CS%(<;-_P##G<".#@ J!SD HVZZ_P!?U_P#_-$_X(Z?$*;]EO\
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M3^'WP%L[F2\C\+^&?#6LVVG(2Z)>ZW!<V\D80 ^4\T<K.T@+G'RE#]X>)?\
M!('Q%JG[,_\ P6WU3X4ZA&]C'XL^)OBCPE'9I(ULLEG;:E=:A9[P\91UEL[Q
M"$WA5,.X2/YGR)^UA,O[:W_!?G3_  3$Z:G#=_%C3OAX!M6^\JUT:XU*./<%
M:!0MI$HW0[]I,6WS1G("YMJS7IT/[RO^">?PBL/@G^Q]\#? UA:K9B'P+H>J
MW<(B$96]U#2;":Y4J';E9#MWD_-L+;%W[5^V,87'HN/R%8'AS1X=!T'2/#]J
MJQV^C:3::3;!1Q'%:6\=O& ,\A$B5<9YQG(S@= W0_0_RH,VV]S_ #H_^#J_
M_D^KPC_V)WA[_P!-.A5_<=_P3Y_Y,K_9C_[)%X4_](K.OX</^#JTY_;L\&KT
MW^#M#&?3R])T/\\X]L>]?W'?\$]SG]BK]F(^OPA\)G\[*S-!T5?X5/U_]LB>
M:_\ !6G_ )1V_M8?]DIU7_T,5_(K_P &AO\ R<Q^U+_V17P__P"I*:_KJ_X*
MT_\ *.W]K#_LE.J_^ABOY%?^#0\;?VE_VI3U_P"+)^'S_P"7*>*#F/\ 0#'3
M\6_F:_SI?^#KIIHOVX?!(@8QRM\-M)E21#@I/)9ZC!8'&/F(N(T?J,EMO&-Q
M_P!%H=/Q;^9K_.L_X.M8Y?\ AN+X=S.H6,?#?1D9Y-R>9-!JE]<6J@!&^4P2
M"/>"1M&_!#;0&E/=^GZG$?";XU?\'#5C\,_A];?"[Q5\1K?X>Q>%=&A\(+;:
M>)K6+0K>Z":-;VY:$%XDTU;:..0MED56()-;OBSXH?\ !Q]XX\.:SX5\3:]\
M3-2T/7K"?3[^QFL@$>TNT*74*F.WC.R1&95!)V*0,MBO[IOV$[2V;]CK]FO-
MM:,!\)O"#!E2W9&\K3[9$DB=58D-M#ID*XX1]K@8^N$LK+8O^BVN0H#%K>%.
M0.3@Q'@GWP/4T#E)K;N^Q_#7_P &Z'[$7[5?P&_;*\=_$7XY?#K6/"^FZYX7
M:"75=120?:M3DN-5O;F1F>&,;Y[C4W# =&B+9/F;4_N@CR5R1@]QG.#@9&>,
MX]<#-58K2V@8R0VMO&S.>8X8D8Y)/F%XQE@1\VW ZX/3-7$S@YZ[CG P,\=L
MG'TR?K36S^7YG/4;;A=_:?Y(_EM_X.L/^3%O!_\ V/TG_IST&M;_ (-4/^4>
MOB;_ ++%KO\ Z.GK)_X.L/\ DQ;P?_V/TG_IST&M;_@U0_Y1Z^)O^RQ:[_Z.
MGI&\OX<?7_VT_I]7H/H/Y4W9G?D@ASG! P 4"$'U!QGGZ>].7H/H/Y4M!F?P
M!_\ !R?^P1\<OAW^U/H7[:_P>\,:GK/A#Q!IVF:<UYX=T^XU:^T/Q;I-Y>7\
M\EY8VS;O(G%U(WG.8%A6,G,H;Y?I[]D'_@Z:^'WA;X4Z#X&_:2^&>H:)XI\%
MZ-:^&QK6EQW=XVLKIEM%9"YNS$PE@OIV@:2XB^R1MYS$%8L!%_?3_@L]^U2W
M[*/[#OQ4\:66E:;J^MZSHU_H&B?VM EU9V5]?1O9K=I!)9WR?:84G98VV1E3
ME@RN21_,-_P0(_X)0_LQ_MV?#;XC?M-?M+06?Q U^Z\::OHC?#[YK>VTR.&_
MN"^H[-.GM+@O,V?WCVJNK,NZ1VRU!3G*246[I.Z5EO:W;L>>?\%2/^#AS6OV
MTOA1K?[+G[,OPUU:PT'X@"TT_P 2:LUAKESKNLVM_(KPV5M:VD#R@.S(TS%T
M96'SP H%7]B?^#9__@G=X[_9=^"/B7X\_%G2)O#OC?XOFWMM$T:\:9;^'PS!
M"DUI+?"YA6XC>Y@*2B*XM8I4D#(S2.CFOUL^"W_!(_\ X)Z?L^^(M.\5?"O]
MFOP=H7B+2+HW.GZM<Q:UJ-U'=%BSW,LFH37$4\CR?O%)C5%.=I(((_1^W@6W
M(AMU$,49*^1'$\-LD*$K$EN@A$0*+L5C%]\+R%#*%"303[J\EOE'S$Y)X').
M!DGJ3@?0=*:4R2<]<]O_ *]/4Y4'U /*E3R.ZM\R_P"Z>1T/-+0%['\#O_!V
MC\")]&^,WP=_:!MK/;%KV@Z7X*FOXU.;B6UN/$6IM%Y@;Y'@ELXXQ&0Q(N ^
MY?+V/_2_^P!^U!9:Y_P2P\!?%V:^5Y/A[\+%TS4+HRAA&_A^Q^R*)9?+Q&T8
M3+;E?8549)PP^)/^#H?X(2_%']A#3/%UG9M)<?"CQDWBZZNH(BSP6,%D$>&2
M0.OE)<-/(#/AQ&7)\J0EL_E5_P $[/VF+7PU_P &]7[5WA35-<$7B[3X_B!X
M:T(O,K7"Q:E>M;VUU&"RDBU$.[RLCSBP DBR30-MO?H?GM_P1J^&L_[4W_!9
M#Q+\3)475)/!WQ(\5?%V>ZR\@@#:[J2_;G^10H4S;%'(YR.,9_TND7:,9SR3
M^?;/?Z]Z_AK_ .#2'X):C+XE^//[1.H0R7 U>R'A""^>-0D12/3-0OH%EW,7
M:6\U!BR *8S"<LXD.S^Y4=!SG@<^OOQQSUH$+1110!_/O_P<4?L9/^U5^Q#K
MGBG1-+N-3\;? Y[SQ7H%M;H9+R6WU/997QM8U4%C#'$)V 9RR,4V#:\B_P"8
MC-'/;LZ7$$\$T<C02QS($DCN8F*7$,HZHT,BNC$J,E3\J]*_VVM<T'3_ !!I
M.I:)K%O!J&E:K;7-E>V=U"LR36EY#-#/ V]BK B8F(E"(L !6P"/\N[_ (+H
M?\$R/%7[!_[2_B#Q3X=TV:Y^!_Q3DGU7P9KD%O+'9V6KWE]/>W^GWD"O=QVC
MQ><8MYN%!*Y5,8%!I3;3=GT_4_#3Z'([$=#[U_1O_P &VG[5G[/G[-W[7.K:
M'\<-,LK?4?BG:V6A>!O&NH16[6OAK5%V1"-Y9XV%M]K?@S"X@.&+!7(Q7\X[
M$\L%0)UPC[]@/(4?*-P4< \9'.!3X)[FUN(;RQN9K&YBN;2]2YLWDM[F.XL"
MK6<T,R2;H)$*JTK)DS,"?DSP&DN>>B>W_#'^OC^WW^P3\#O^"C/P#U/X7_$I
M82+G3KG4/ OCO2O[/O+C0=4O%6>PO["ZNHYEGM+G]V[Q0R)$(W!CE<!5?_/O
M_:^_X-[?V[/V:?$/B*?PUX,C^*/PY2ZE3P_XDT&\:\UC4+=+AQ%Y^E6EJZP2
MFV\N24QS1HSL=EO"NV-?IG_@F?\ \'(/QR_98T7P[\)?VA=-G^,'PSM+BRTZ
MQ\2:AJ$L.N>$=&M8X[..*TB33M1DU"*WM(EC@26[MRJHH=GY)_K.^"G_  7F
M_P"";WQST^,Z-\7QH=\3&MQI?B/3XK9[2Y8 SQ22W4D2-)'*TD4A5%4,&*C!
MQ02HSC\6W0_SQO 7_!*C]NOXC^(+?PWX<^ GBV&]NKTV4,FKV-YIUE&XD,8^
MT74EK((54CYF*MCG).,U_6A_P1__ .#<Z^^ WC#PM^T/^V#+I][\0/#EPM[X
M>^&]A-;ZG8Z1.465+C4)Y]-$%[$MRP**8EF0(5WLP+5^]'B3_@J=^P!X(TJ;
MQ%J'QR\&6MK#"999-.?3I;EE(WG]U YD:3'7!'/3@FOQU_;*_P"#H_\ 94^%
M^@ZCH_[+]A<?&SQHL%[:QR:DE]HND6EW(&BAO$FCM=0:5K.8&169Q%<@9$4*
MD !2E)7MI=:WMWN?L%_P4P_X*!?##_@GQ^S;XK\>^)-4T?\ X36ZTB;2/A_X
M/CN8UN]2U66UDM;4BSBB#V]I:>8 )5MS'(D:"..)6Q'_ )/GQ4^(GB+XM_$3
MQC\1_%=Q]IU_QCK&J:MJ#A61(I]1U*XU 1PQM)*8X;8W#0PPF5]D85?,;;D^
M\_ME?MM?M ?MS?$_5/B?\<O&5_KMW++./#^@-+(?#_ARQDN))8K2WT]71)V@
MA=;=)]T+[4#'<217R1P.@ '8#. .P&23@=!DDXZDT"22UZO<4LKLQ'RAV981
MUW.I(D1O[BQG(#X.\#(49P/ZG?\ @UT_8QF^,'[4VL_M&^(](OHO#7P5LHM0
M\+ZO. ;2Z\2SW4NEL-/9D16,2H22IE8!L$+U/\WOP(^!GQ!_:-^+'@GX._"K
M19O$?C/QQXATS3-/L+1)G2&%WN&U1KV01;+14M[=9%D)*R>> " FY_\ 6*_X
M)G?L/>%OV"/V5?A_\&- MK=]>BL[;5_%VJ?8TCN[W6]6$>I:O"P%U</'%;7U
MQ=0PJ;J=(PBL 20J@IMI:==S]#T!\M0P(.Q003N(.T @L -Q!ZG SUP*>!@
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MN]\3Z#I-_<SI!J/@_P 0?VG:ZQ;)<.D>HO9C3Q&;B]B5;F28L&+R$E 20/\
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M,_$&K>))K&_\5-X?N](N]0N)YTM-.MXTN(UAMFDQ#!*L[0H%@:><H9G^.O\
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M:Z+I>G:18QB&STRRM+&UB7D1P6D$<$2 @#.(XPN<#Z=JTJ100J@G<0 "W3)
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M=-U&I))NWFI+6VZTN>K@\JK8S!XBO"3C*A34VW'2S;6EURMV6UWKND?HX+]
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MC@X?:5)&.Q/UJ$W:>8P,L04;27\\;?G8*!D@ GD9&<YR.HK\I=8\:_$+Q/\
M"/X;:./&6H:9K%[\4;WP?-K\$@>6:PL;R6TBEEP83,6CC&[,R[B2^[)P)&\#
M_$]OB5\1OA\WQ@UTZ=X1\(0>+[6Z$)+W%Q&-YM3&-1_=(6S^_,THY_U)SSA_
MK=7=7"T_[+M&MBJ5"3]KJHSI8J<K7NMZ$;>K]#JAPMST\3[+,HU*M/#5JT8R
MIQLE3K86G&2:4=9*O9J7,EM9Z27ZN-?Q1A%)3+[0A:38'^;:Q!*$?+@GOGI[
MU(U[&%+YB"(<3,TNT1GT!V$-SVRI]L\#\J?$GC/XC>+OAO\ !31(O&5]H^K^
M(/B!)X6O/$,##<+>%,>=<(IB:=V"893/&68E]_\ "?4OAC'XPTGX@?%GX0>(
M_B#>ZGH5GX?M]4CU^Y,:-I\]R-QEBDDN69(P?G"^<OR@9(QFC"<7NKBJ5+$X
M/V-.IA<#63YT^:IB<)7K5(]+*+IQE&[VT?8C%\+8C"T\0GB8SJT<1CH6C#:G
MA\90H0=O>;]VHU:W-=_:=FOT%BO8)?N/&^>5\M_,X[AL*-C ?>4YVD$9X-(E
M[&[, 4VK]YQ(K*HSP20.,_C^7-?F1X&\47O@KXUVW@[P[\3M4\;Z9J.D7#7X
MD0-:0W[-.DTZ7!N+N/?'+$T@B08Y"K+\H8^96-U\3[WPEXX^+D'Q+UN%M*^(
M]_I=CX>#EK$V$>NRP6\<D_GJ"%A9%*?8^0F"1VSEQI3C[/DH.JY8RM1GRZ\M
M.%-23T\W:_RNS7_5+$SE?ZU&E".&H5GS1LYRK5'!0M):.Z\O-(_8C[5%DX92
MH4,2&!P#TRH&0""""?QQW=%.LH# 84_Q;@0",Y!]QW[9^E?G*GQ/\4>%_$_C
MVY\1:Q,]M+\(M.\6V8W>3;Q:G=10J(X<AU'G32^8&4#R@1&(V #5]/\ [.;Z
M]=_#?3-8\17USJ%]K2MJRM<,V%CN5$ZK&"S 1L7!'0!2% ^7->Y@L\I9C75&
MC%P<(QG43U=I2Y%NKK7M8X,?DL\!AUB)S4X3FZ<)):.48\TK.]GIKI?;4^@-
MW^[_ -]?_6HIU%?0778^<YY=_P $%%%%(V"BBB@ HHHH **** "BBB@ HHHH
M *C4L"_R\9.#GKC/MW_.I*BW'=CMG&/;./K43E&'*W&]VTG>UFUO;KVL_43@
MY[.R6K6FJ[:[;=#YM_::\&^*/&OPYN-+\)1?:+^VU""]GL#(42^MHW#R1.P(
M)$@)R@# ;CQQ7SC\(OAQX[;XK^&]<F\"Z;X5\.:3H-C#=RVK9FEOTM8DG+2>
M1;G E5LIM?/3<3S7Z-NBL48Y!C=]N"1GG@-C[P&> >/:HK<AX@Q55+HKMM&
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MP=^(0^#&D>'GT>(:G'\0-3U&6 G+)97DWEK,>.0B*9.,;L[<KUK]'V17-PI
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..PHJ&BOI3P.2/;\6?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_002.jpg
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "0 *P# 2(  A$! Q$!_\0
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M:D><K;S12[0,<MY1./J>E5?&7Q=^'W@6)Y?$OB+2],2-2SM<3QPJ@7).]G&
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MW>5MJ 7-J02>A!#<CD8]3QTYK^$G]C7]C?XU_P#!3+]H;X_Z1_PTQXO^'*^
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M?MC>#;7QEX(TW3]#\1SZ=%)IVMZ3'Y<C&:#S1Y_E.$EC)<EFP?E;IUS]F_\
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M:[C)K51E._(VTY6E9*S-N'L7'&QS:A)IRJ8JO)]$X3CR73>ZT5FEMU/Y*?\
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MV7A6R:?4Y_#VI0WT-K)"T[JDSP,P5P0"%SC)7GK7MG_! ?X/>%]1\)_M+_\
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M](\J:Y=/ALW>^FQ[)_P1-_X*#?LK']D/X6_ [Q%\3] \"_$OP%I_]BZ[X?\
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MLP-=$\]S']IB*0LS.BHP7.%+8-?*W_!;+]B[X7?%SX'^*_BMXHTZ2Z\0>#=
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MMKKL4SQW(9HVAE1D<RY0XYX;D"OV8^,?['?_  1>_P"":OB+5=4_:/\ [/\
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M\&M'C^'?A?3O#FB65_9V3+K<]OH:16UO/=W+7+-)+Y0!=@JAF+'J<U].3_\
M!#SXI:K\(?A_\5_AGKNI_"KX_P#A;1K:X@O="FETV<WL C:)'GL9H7#;H"K;
MI&49^8-TK^S"+P_X5:1W@L-,EDB/*Q)$SH/HKD@CJ!CKT(KYX^/'Q)\5^$M>
M^'7@+P)+INDZAXWU5[2;5+^-;B*PM8EC/[N%C\SR%BBYY'7WKESKQNH<-9/5
MQN7Y+@\!ELL91^L4,+36,_M+%XRO[)4ZL)RG2]Z=90:BDDHQ=ERN_/6R+"T*
M4L9CL;B:\URT*56BXO$<SY5&,97</:)NZ=DK)W2W/Y??!7[=7_!:O]E>PA\
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M&=*AT=?#\6G6J:*MJ;(:>$46XMB"/*6,# 7YF%?FW%GA_+BC.,3F;QJP<O\
M5R65Y=B*+E'%8+,?KZQ7UVG):+FPRE@I1DIPG1K54Z3ERSCXV/R>.-Q,L5*I
MR36"JX>C.FVJU&H]>:+VM-.UFI7L]C\GO@_X[F\'WOP2O]9UJXT3P?>:)K8O
MI9YY(-.^WRV\K0QW <+")49T!)4C<"  >1R^I37OC_X:Z?K&M:OJE_;S_&F\
M@TJ^,LKB739+S;$T$F6/E(@ BQA !\JX( _5J^^#OP\U'0K;PU>^$=(NM$M)
MC-;V$T6Z*&1GWLT9)+*"W)4'!X'%:T/PX\'V^E:?H</AS2X]*TJ43Z?9K;H(
M;293\LT2C'[P9)5B2<\G)KX>GX2<0SP7]E8G/L//*H81QIT8TL0YSQ<J64PJ
MJI%UU%8>EB<!B\3@E&S7U^LY7O&-/SEP]BI48T)8JG+#*D_W<W)2]I>-E))Q
M5DDW>ZU9^=WP?\*W^MR_&#6-2\6^*+F+P ^H6F@63ZC,8X&2S9A)(K'YS& H
M0@ @$#C^+Q^6UG\:>'O@+K6NZUJUWJ=_K^NP277VN8R(EM<R20F(MN92IB1"
M0?\ 5Y! .&'[ V/@WP_I2:C%INCV-I'K#.VJ+#$B+>M(@1WF'\191M;CYAUY
MK-3X;^$4ATZW7P[I:V^DR2S:=$MO&([2:9LRO @&$,F3N8<^W-=M;PBQ57+<
M!@(9O!NE@\53Q:K4L3*ABL2LXH9A@Z\X2Q;2G0PCE@:<HQIRC3IVBU)>T-*F
M05IX>CAW6I\M*G>=G*\YQQ"E"U[MRC12C'7:UT]S\I4\;^*V\+:)H&M^+-;T
MWP)??$_5],\2^*8[J5KVRLK6X=;>R^TDEH+9RH4NY;:I.><,*7B[QEK.AV_C
MWP[\//&NN:OX"M;[08K'7&OKB9[6YN1$L\-I?[RS8:5@V"OS*"V5!5OUEN?A
MIX-NM)O=!G\-:3)HU_.]U=:>;:/R)[F9MTL[)@XD<X)92"",J/6M8?"CP)I>
MBCPY8^%-(AT0S"Y:P6W01&=6#I*0<EG5P""Q/W1["N.?A/Q+*"H0XDC%0PE*
M%'&N.,^M4+86JZN"I)8M4UAOK#@XMTI5.=^]4:]TBIP[C)KD6-IVO&4:KG45
M2$4[NBTFHN+7]V]]+GQ;\.(M0\#?M%>%?#&GZ]K5_H_B?X=V6LZE;:E>RW(G
MU%X"[SH'<HBMM4YV@EN,8R6T_P!J'PM9>(/C1\#+:[O+ZV.H7]Y;,]I,87C6
M+RG1HF4?NW;: 6RV3CY<5]OIX0T)-6M-<72+%=6LK06-MJ"P1K<P6B A+>-P
M.(\,0%& ,GKFI-1\*Z-JVH:=JNHZ;:WFH:2SR:;=3H&ELY'QN: ]$)VCL?PK
MZN?AY6EP_F.0U,9[7#U^(\!G&&=26+E&CA\/5PM2IAH0A7E7A"4L/5DX0JMW
MQ$GS:^[Z"RAK!5<'.KSQJ8I5XV<FJ:48JT6WS)7BW\6[>NR7Y':QX@21OBM>
M>,/B+K^B^._!?B";3O ^AG4;B-I+.WD2*S5+?/F7AG5269-V<@G;SCT?X2V_
MBOXK_&R\T_QGXAU^TLM#\):'J\FDVUY/;+/=L42&2ZC/ #HHE*YR<GG!P/T!
MUGX0_#SQ!KD'B/6?"&BW^MVK!X=0GM4,^Y?F1V(P&97+'+*>U=/9>$M!T_5I
MM<L]*L[;5;F!+:XOH8DCGD@B0)%$[J,LD:@!01P /2O!R[PKS:&:87$9AG,:
MV PF;U,=4PV'KYM%9@I5\5B*=3&_6\5+GG0IU,+A*2H2IT53PZC*G)KFEP4L
M@Q%/$0JSQ%Z$*U.3HQJ5'[91O:512G*TH+1<K@K-WN[,^7?VR=&@OO@Q)!-<
M74:6NI:8L?D2NK2!GCAS*5W;SM.X$G(?G)'RU\1^$?AY977Q$^,%O#KFO6">
M'OAWH>K64MM=O;SR7?\ 90N$-Q<KM9TCD&%08 0!21SG]A]8\/:7X@M'T_6K
M"VU&Q:1'-M<H)(V:,Y1RI(&> <<CKG/2LJ'P%X6M[K4;V#0M/ANM5M8K'4)T
M@C$EW911>0EO,<<Q+$H4*,8!XZFO5XK\,(\2<20S^&*HT.6E@,.Z=3#UG4A]
M0P6;4Z56G..(@K^WQV%?-%1D_JD5-R7,I]./R26,S#ZWS4;0@E33<TU[MDM)
M*SCH^NQ^0VG^.?'7BV^\+:-XM\7G1?#UMX4NI;*^U6^NK.WO+Z!0D=PUTDRB
M>>- 7(+?-C:"VX9_17]GV36Y/@[ VM^)8/%DJKJR6NMP+-Y=Q:(;CR%W3EF<
M1!5C#JQ! Y]_2=8^$'P]U[3;71]5\)Z/>:;8$_8K62W7R[?+ D18P54X&5R0
M0,$'-=IIN@Z;H^FP:1I=A;6.FVT!MX;.WC6.%(BNS8J+P!M]<D\Y.>IPCX?9
MQP_FN*S#,,ZK9G"KA,5A:7-/$*3J8FC1IT_;4Y5I1=##-3E"22:E*=[I6+R_
M*<1@\17K5,4ZGM:7*E&4FK7;4'S::=-+ZK5;'X3W"Z9::/XI\0GQU)_;FA?%
MR:]T7X>LPGCU.X74@B78M1RS3EC&&50N8LY %?6VB1^(OB-\9?$)UC5]=TY=
M#\":;K5GX=LKR6WMH]5CT])HH7A\S#'=$-T>-Q4L XR"OW7'\'/AQ%J1UA/!
M?A[^TC.;HW3:? \QN#@^8'=3M<,-V[;G.2"I-=1;>$]&L]4NM:MM+LX=4O(5
MM[B^CBB2>:$+MV.X7.U%P%'ID#W^>R+P<S' 58+%YM@WAIXJE6Q>'P?]JT%7
ME1GG$GB)NI6A"5:H\9@VW?E?U=<J5K3XL/P]7IN*G7@J4Z_/4IPDTI:5G%SM
MRZ)RC=)K6WF?CO>>)].;X=:[XIO_ (F:_:_%8>,S9#1/[3N8S#:Q7QB6T6R?
MI"T0+F7('RE1C=BNR\;^//&$5A\2$M_$6JPFVT'PN;62.>5F@DNHK?SIH&WX
M1Y,ELJ!@DYR1FOTFN/@E\,KS6+G7KOP7H5SJMXRM<7<MG$SR.C!T<*1M20,
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CEC[>78*>!5:E*K*K"4J4Z7,VU37LTIPBWK;G3;5WJ_D?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_003.jpg
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "& ,X# 2(  A$! Q$!_\0
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M1A_Z2"_![_P6_$#_ .8:@#]H:*_%[_B(8_X(P_\ 207X/?\ @M^('_S#4?\
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M;C4?$7BKQ1\,_CEHV@Z)8?:I[:W^V:GJ=Y;6=L)IXHS-,@9P#7XYM_P;Y_\
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M[SP_>)\*?'.B6E[K4LLWFS:O\/O&S_\ "(BXDCDU#6_"'B7PCJA0V&G1[/\
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MNJ_I%_X->O\ D_KXN?\ 9GWQ _\ 5T_L_4 ?G3_P6:_Y2S?\%'?^SS?VA/\
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M:Z78Z-KZ7G@3X6>$_!FL/<6&GZIJ]NEO+J>B7#V+K>.T]K)'-(D!S&/RUHH
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MHP^;'RYQQ09'.W+$[<X'89 !..G( !XY[\DY_P!,K_B"D_X)\_\ 1R_[6?\
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M7G@  #!X(   '8 =@,*)&&1D8(Q@A2,<#(!!P>!AAAA@8(P*910!(IDQE2^
M#R 2, ACSZ#&[T!&>Y-!ED8 %V("[0,GY5P1M'HN#C'2O[/_ /@AM_P;=_LG
M_P#!4#]A#2?VI/C!\9_CSX%\8W_Q2^(O@6;0OAY=^!8O#@T[P==:5'8WBIX@
M\(:SJ(O;B._D%SNOF@RBM%''DBOV*_X@I/\ @GS_ -'+_M9_^!_PJ_\ G=T
M?YFOF/\ -EB2QRQ/))P1N).3NP2,]0"0#@FD#N.C'H1U[-][_OK^+UYSG)K_
M $R_^(*3_@GS_P!'+_M9_P#@?\*O_G=T?\04G_!/G_HY?]K/_P #_A5_\[N@
M#_,TWMQ\QXZ<_=_W?3\,4OF.=V6/)W$'G)YP0.@(R<8QCMT%?Z97_$%)_P $
M^?\ HY?]K/\ \#_A5_\ .[H_X@I/^"?/_1R_[6?_ ('_  J_^=W0!_F:[VQC
M/&<\@$GZDC)')X)QR>.3EI))R3DGK7^F9_Q!2?\ !/G_ *.7_:S_ / _X5?_
M #NZ/^(*3_@GS_T<O^UG_P"!_P *O_G=T ?YF5?TC?\ !KT"/V^OBV2" ?V/
M?B 0<<$?\+J_9_&1ZC*L/JI'8U_4/_Q!2?\ !/G_ *.7_:S_ / _X5?_ #NZ
M^YO^"?\ _P &S'[(W_!._P",GB7XT_"OXW?M ^+]?\3_  RUGX77FF^.+SP%
M+I<&C:UXJ\&>+)[VV70_!^DW(U".^\%6,$9EGD@^S7-R#$9"CJ ?TBT444 %
M%%% !1110 4444 %?YOW_![K_P G6_L2?]F^?$#_ -6-7^D#7^;]_P 'NO\
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7WQHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_005.jpg
<TEXT>
begin 644 image_005.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !G '0# 2(  A$! Q$!_\0
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MTR75O^SY^RUI-O.[2P:;JNNWYU"RB9B8[:\,?C.(&>-<+(#&K*P92!CGEO\
M@F%ITG[0GQD_:I_;/\1:?'<:Q\;OBY/\/_AQK$H!NM$^'W@V*]?71I$S'=90
MS:?%I5G++;BWGE5Y/.DER G]"-EX:\/P0)!'HFEB.)$2/-C:NP54 "L[1%Y&
M4#F1V9W)RS$Y) /P:_X:"_X+I?\ 1"OV3/\ P>:E_P#-O3O^&@?^"Z(_YH9^
MR5_X/=2_^;:OWN_L#0B,'1M*(]/[/M<?^BJ1O#^AE6QHNE9VG'_$OM.N./\
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M;2"+4=)\$:?J7B D8:7Q+XB+Z]K\I)0,^=3U"X1&?)$:(@.U% *Z#PS\\?\
M@MAXFU7QU:_LN?L<^%P]SKW[1GQBTJ35K6UE_P!(M_"?A*_TM[R>XM]K&2TE
MN-16:1U9/+6PD)W!B8_U3\$Z"/!/PSOW\-Z:)I-&T8Z1X;TZ/<1)IWA'1DTC
M0K2( L")18M+Q&2YG/#E@S?C)H6KZE^T]_P6*^+'CBSL7UWPI^QU\-(/!'A)
M[=GN+2/QAXHTQ;>_O#&OGE)H]6N=0,C1-$/LUF&(PI-?T#:)I4.DZ78Z8R(!
M:6D4)(.Y2XC"RXW$,<N&P< 8VXQ@BIDG*%2"=G.G4A?MSTYPNO1SO<TH3C2K
M4JDZ4*\*=6E4G0J)^SKPIU*<YT)\OO*%:%.=&;C[T85I2C>44G_-M^R%^V5\
M(O@/^S7\:4U_4]1N/VH_''COX@ZA?_#Z/2[]_$NK^+-2O[^S\/6<-L()'CMK
M>.:UB:20C[*$PR+\U>+Z=\%?CCK7B+]G#]F+PDEMHGQ8T6P\0_M;?$B_UNP&
MJV%OXVU^ZNI=#T[6[)98#)<6L2QVZ'SQLFNURC&#$G]0"_!_X4)XH;QFGP[\
M%KXK=O,?Q$OA[2QK#2GDR&_,)N"Q;DL3DMSN)^:NPB\.^&K?69_$,>CZ3%KU
MU9I8W&LK9P#5)[&%_,2TDO-IN)+:.1MZQ-(8U<Y"Y.:^-?"V)KX?#87&9@I4
M\'&-&@J$:U)K#5JKJ8[FDY*2Q%50P\:56+Y(*FY2]Z1_8%3Z3W#N69SQ-Q!P
MEX?8K#9IQ=BZ^?9O_K)G&7YYE^'XCH<.+AOAS"9=E]'+L-"/"O"^%QV>8G+\
MMQE>IBZ^)QN#6(Y*>!C?^6S6]#^('[4OP3_:#^/OQ.\;:YXE_:=^!6G:OX"3
MX4:-HL6CVGP[T^74OL&LWUG::?']HU/^V--MKJ^COF\P;864>6GW?5/$7[6O
M@'P!^PY\)[+]EWX^^&OASXE\"^$;6+Q9\-8O!!\3^(O$OB(Z='#<V>H%I!#H
M3#4I'FU#4;R*ZMIQ-'$95955OZ-['PAX2T^]U;4-/\-Z)97VO;?[:O+;3+6"
MXU?RE=4.I2I$CW@17D"&Y:3"R,%.'.>+L?@1\&=.N]8N]/\ A7\/[.YUM675
MYK;PIHL,NI+)()9%O72W)N%:0!W\P ,XW')&:(<+8JC*M/#8^G3KXS+WA,9B
MZD<4\1*O"K:CBJ52E4C.-2IAE3IXOFG'VLU-Q?)+E<5/I,\,9E#+,#GW F85
M^'N&N,<NXIX5X7R_'<-T^'\!@*>1T,HS'@[&Y5CLHJX'$\/PQ#S3-<EKPHU,
MUR_&9E7JU:LL5.ICH_RT>,?B3+X_^/'P+\-_'WXV)\"K_P"#7PBMM=D\7:!X
M:T^REM/'/B^*'7I+>PTBVM?L%I<RPS1">5[1HW;>(PQF&WZ^^*_Q&T[QW^SI
M\.OV>?AU^T+XE_:(U7]HWX[Z3X0U7Q;JFF0V][I_A:Q-G?\ B?3[:."PLUDL
M+6UAMC.60O%'<W$GF*(B6_>G6_@W\*?$%XU_K?PW\$ZM>O''"UYJ/AO2+NZ>
M*&,11(T\]OYK)%&JI&K.=B@*N !C0T?X9?#S0O[,_L;P1X5TO^Q9KBZTAK'1
M-.MFTRYNU*W-Q8F*+-I-<+E9I8&221#AV-3A.%<7AEC*<L?3J1Q[2Q&(<\U^
ML^QC2ITU15.6,>#:7LY24Y4^?FJMOX%>LW^DUPOF$^#<5A>!<TP%;@J4,;E>
M3T<=PL\@IYUAY<3YEA<RP]>>1U>)<+3AQ+GN!SJKE]/-'@JTLJI4Y4Y2<*D?
MYH/VF/A#XW^ 7QQU7]CCX66,MI\'_P!LO6?AG<V A20PZ"GA^_M+7QA:6%L7
ME$AN;-(IM1,C1^5%,;EMXBWG[D_;UT6?Q3XN_8R_8G\(0A-&\3^+=%U_Q59V
MT2B*/P1\.H;*5K:6,(0;>>6"2X;#^4\R>5)(KS97]FKWPUX;U+4=.U:_T/2[
MW5-),[:5J-SI\,][IQN45+@V-T\336K3HJK,870NH".#1-X9\.76KVGB&?1=
M*GUS3X)K:RU>6R@DU*SMY\>?!;7C*9X(I,+YL<;JK$#<,@8Z*7"T*"S*G2Q'
M+0QN(H0I47&7+A<KI>SKRRZG9Z*KC7B<1*4?=2JI?%<^7QGTCJ^98WP_S?,.
M%Z%?.."LCXAECL=];O+BGQ S3(,1PUE/'><\ZO7S#*,I664^67-5K8G+8XE3
M]IB*[G\S_M7_ !'L_@'^S#\5/&L2_9O^$;\$WFGZ*EO$ 1J=_'%H^APQ(JR?
M.;V[MU&T;%8<\D5_/&-%^.'[-WPB^$/P;^-WQ>@^'?[.'[1FA:UXR\9:KH'@
M^%_&.DZOK4 U35/!.H75U/>7EQ>:O:*\ U&&VC59CY,2*RQR'^K37=&TK7+&
M32]9TNPUC3[LCSK#4K."]LIFA*RQ^?;W221,5D160LC;)%### $?E]\?O^"<
M^I?M)>*OB7XL^)WQ4U'49'TN+3/@+H-C"]IX>^%1MDBGAU6?3  FJZO-J(E2
M:ZPG_$MD%N!E%I\2Y1C,7*ABL!*JL10PKPF$ITZGLZ=*E5J*.8*H[Q4EBL+2
MHT(Q3^*/O24'(]'Z/'BIP;PCA<;P[QM#"Y?E.:\0RXCSS/JN74L]SBIBL/E:
MRCA&7"^%K83$PR?-.$\^S#%\65,YQ->4(QC55+ XFO0PL9^N_L0^,+V?]FVQ
MU&]^%4_P>^'G@R&_L_ASIVJW?VK6M2^'.A67G67BC6[>5(9M*O=52*XNI+>7
MS'*N)G9-Y _!_P")>C:C^T[^T3^R;\*9TBFO?VCOVA?$W[7GQ"L'F:5-/^&>
MB:I/H7@>PO'W_P#'M%X0\/"*RC)2-SJ>](^?,D_;GXZZM\0?@G^Q3:^"O'OB
MC1_$_P 7_&$'AKX+:9K6CVLVDV.JZ]XWU6U\,Q3VEK/.UPB:9H5W>:A=2 2(
MJ6<UR\(0';\ ?\$T?"6G_%K_ (*!?M0_&^TB@O? 7P%\(^'_ -F;X5SJ T$$
M'AN/3K.ZN+1?GC7=!H^H?O(61S'?AG51/\WT6!I2HX'!4JDG[6&'@ITG3I0<
M;*-[NDK737*HIV22\V?S[QMF&%S?B[B7-,%3HPP&/SW-*^"^J8K'X_#.A+%U
ME[:&8YI..99A+&24<;/$YAAJ&)J5<7BIN%.,XTH_T+V4*VMM#:VX$-M;1106
M\:HI"0Q11JBCE0NS!C(&1E"V<D@%7RB'JH-%=9\J?S%_M _L[?M3_L>?M'?M
M#_$'X1_!OQK\=O@#^TYJ.C^(-3C^%'C"Z\)?$SP7XCTMQ>""#4-/2ZU>",7E
MS?2BXM+&[M[VSQ:R(KJ2?%5^,'[4J*J)^Q__ ,%'E1!M51^T-XZ"@>G_ "+V
M2?<D\<5_6]L3&-BX^7Y=JX&TY7C&.#R/0\BGT ?R/_\ "XOVI_\ HT#_ (*/
M?^)#>.__ )GJR-<_:3_:!^'VG3>,_&/[,'_!0SPMX:\.8U35]?U?]H;Q2=/T
MNSM09)+V<:KX?%@RVYVN5N<PN@>.13N&/Z]R0,Y[#)^E?D!_P6Q^*]_X)_8K
MU[P'X=9I?%/QS\4>'/A5H^G0G_3]0AUO4(9=1BLH@"[M+;VXM3L4Y^TXY!()
M_6R#YO\ /]%HNBU]78^Y/V3/C/X?^._P&^&7Q*\/ZOK.KVGBKPS:ZK'<>(H(
M(-=93/)!*NJ"TCAM9+JUFC-M//;Q)%,ZM( "V!],8.XGYB.P!X_GQCVZU\>_
ML9_".#X,?!_X?^ 43RF\%> _"WA!T!=P=3L],CU3Q'*7( \V76M3F$F>28C&
M1^[ 'V+0&[O=_P!?+;\NXT@GD9SZ9X^AP>OT_&@ ^^<'C/ /YY_4^O%.I"P'
M!//7'<_0=3[XSBE;^OZ_R%;S?I?3\OU/RS_X*#_M">._AKJ/@+P;X!^(=[\+
M;:/PK\2?BY\5O'>BZ'H?B/6-!^'?P^TNPAM=/L=)UTBUGO?$OB;6[+3=/9I(
MY))K>YP2J9K\8=._X*A_$#5+2"^TO]H+]L[4K"X17M[VR_9K^'-W:SH0/GAN
M;>XDAF0G.UTD((P"<@UZC_P4\^(6K?$?Q=\5? 7A-HY]?^/?Q;^%?[)?@9T(
MFG'ASP--:^*_B:]O"IS'#)XN\36&DWDL+.\DVGF"X$9@5:_I ^$OPF\(_#/X
M8^ ?AYI?A_2(K#P5X2T+PU:HVGVDC"/2=-M[,EG:$LS.\;NS,=S%BS9))+&?
MR\G_ (*9?$\D$_'+]M@D9(_XQB^'_<8_YZ8Z<<T@_P""F'Q,4'_B^7[:R+G)
M)_9C^'P &<DDF4 8/.20 !R<$U_63_PCV@?] /1__!99?_&*/^$>T =-#T?_
M ,%EE_\ &*?,]-?AOR[:7WZ:[];VZ$N";OJG=R?*W%2DXN-YI-*;BG:#E?DL
MG%72:_D2G_::^/?[0GB?0['X4^!?VH?VEOC-8B]M?AYJOQD\%Z'\-?A=\(-5
MUNSGTF7QP=#T:,Z/JGB*UTZ\NDLM6US48HM'#R7=IN=VC/\ 03_P3L_8]'[&
M7[/^E?#_ %?5(?$/Q#\3ZK?>._B?XCMS*UOJ?C/7DMFO8[1YBTC66G1116$$
MI8B<0&<*IE85]WVNFZ?8AELK"RLU<@N+6U@MPY4\;A%&@8CC!.2.V.*N;5_N
MCKGH.N2<_7))SZDGK3<F]W?6^R_R6GEMY#22N[1YG:\VDZC25DI5&W)Q2VB]
M+ZZL6BBBI&%%%% #7X1CSPK=.3T/0'@FOY\/VV]5G_:&_P""IG[*7[/L:QZA
MX(^ 'AR?X\^.H8F#1KJ=O-<7EG;7ZNPA)6UT[33;AUW+)? QO@L#_0=(2(Y"
M!DA&('J0I./QK^8;]FGXCZ,G[>/_  4?^,OQ,TCQ=KOC7P_XHT3X::1X(\$^
M'[CQ/XS'@"VUM[=[[3="AE@O-1T]K/1M.M9YK".Y>.'4$F D#L0 ?TC>!K":
MP\.Z<;E56\O3+J5\!R3=ZE<2W4I)*CYE\_RCQD+$JY(&3VU?GW#_ ,%"?AHL
M:+_PIK]JA,*ORM^S]XZ+ 8. V+1AO48# $@'(#$ 9D_X>%_#3_HCG[4W_B/O
MCO\ ^0J /T KS7XO>/=/^%WPV\=_$75"/L/@OPEKGB&92=AD;3K&>>")9,_*
M]Q.D=LF0 7F4[A7R0?\ @H9\-<<?!O\ :F/<@?L^^.\X'7'^A8)'H2!ZD"OD
M;]K']M73?BEX$OO!%M\-OB-\-OA)'/IVO_%[XI_&KPW<?#;1XO!OAZ_@UJ[\
M(^%=(UV2'6O%OBKQ7+8PZ59V>GVC6\,4TLDLC;2M 'P5^S+\./$/QG_X*)_L
M^>"_$44=_:?LR?#;7/CY\3?-)GCB^*/QAOSXQDBN9)&<R:I#>^(M*B$G#HVB
M[3(0J[?ZJH<;.,\$C)&,[21ZDX&,#)8XQR:_##_@BGX+\1>*](_:0_;"\9Z9
M-:ZE^TQ\3I;OPG+?6KV]TO@/PC-J>GZ0+<R!%DTZX6XACMG@C6*2/3X70LK$
MK^ZE !1110 4444 %%%% !1110 C?=;Z'^5?EA^U'_P2P^"_[1GQ67XW:)XS
M^(GP0^+=Y96]AK?BWX5ZV^@R^(XK,CR;C5[>V%N9M1CCVP/="?,UND4; >6"
M2B@#PA?^"--_M&?VY/VK,X'_ #.M\!CM_P Q(G@8ZDD]2<TO_#FF^_Z/D_:L
M_P#"VOO_ )8T44 '_#FF^_Z/D_:L]P?&MZ01Z$'4<$'N*T?#O_!$_P""UQXJ
MT?7OCA\9OC?^T#I6CW$-S9>$?B'XMNKKPY=7,$R3PQ:G9^9</?6FY"LEJ9K6
M-XV9&?#$$HH _9GP[X;T+PGHNE^'?#6E6.A:%HME!IVE:1I=M#9:=IUC;1B.
CWM+.T@1(+>"%!MCCC0 #US6Y110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_006.jpg
<TEXT>
begin 644 image_006.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !X 6<# 2(  A$! Q$!_\0
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M5]G?#G]F[X;_ +-'PB\4^#/AKILFFZ(V@7"-#([REY+?3Y(/,WNS-^\)!(.
M#SWS7U/I_P#QY6O_ %[P?^B4KFOB!_R)GB7_ + U_P#^B36H'^;!\7N/B_X\
M49"_\)A= C) _P"/VX!!%?WU_P#!-_C]CCX+_P#8L6?_ *3PU_ I\8/^2P^/
M?^QRO/\ TNN:_OK_ .";_P#R9Q\%_P#L6+/_ -)X:QC\?S?Z@?:^I@'3[T'_
M )];C_T3)7^=Y_P4 ^7]J'XC@9 -[>9Y//\ Q.;WK7^B'J?_ "#[W_KUN/\
MT1)7^=Y_P4!_Y.A^(W_7[>?^GF]ISW7I^K _JR_X) @+^P-$ ,#R?$'\]1K^
M.W]HY5_X7Y\900"/^%@^)<C&<_\ $RE]>N>G/4<=*_L3_P""07_)@T7_ %Q\
M0?SU&OX[?VCCCX^_&4^GQ \2GGI_R$I>M5/9>OZ,#]+O^"4?_!1K5OV6?'=A
M\+_B+J=W>?"'Q3?):(T\\C_\(Y>7 81SVZO,J"*6YDC,Q<@*BX )4$?VR^'_
M !#H_B?1-/U[0]0MM2TK5+9;NRO;699X+B&3+*\<L;,K#J#M8@8(!P*_S&=3
MT'6=+M;&^U73;JRL;^-;C3;Z2,^5<D, C1NF\$;CE2&!& V3W_<S_@GK_P %
M=]9_9X^&^M_"GXL2SZWI6DZ?<R>!]3NFFGFLYH[41VVG2'R9G$1E^89;ODX!
MQ2C))6=[Z^8']"7_  4/_;K\'?LB?"[4[A[^"[\<:K:O:Z'I4,\;72W,_EK'
M+Y*2^<H1Y$+-Y9" @DKDU_"?\5/BCXQ^-'CS6?B-XXU*?4M:UJZFF_TB0RI9
MVTTOF)9VQ))\J%B?+8\D$D@$UZ3^U#^TIX__ &IOBEJ?C_QG?7<\$]X\/A_2
M?,,B64,GDQ$0*VP%IY(4E^16QOVC:%!/ANJZ#K?A^2"WUO3;C3)YXXYX8+J-
MHY&@?YDE /#(PQM(X.?IE2DFE8#^GW_@WJ_Y%[XA>UQ?@>P\^0X'H,L3]23W
MK\G/^"M@4_MG>+0P!']FS'!Y&?[7NR./J<_6OUC_ .#>K_D7OB'_ -?.H?\
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M(_\ 0Q7]<?\ P6E_Y-+UOZ:E_P"D25_(Y^P3_P G:_ C_L<M(_\ 0Q6*^/\
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M-)^'_@VT@L]%TBTM+6"*WA\E/]&MT@)"#(_@7^?->UT132L^X!1115 %%%%
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M_P 0M%AO;OQOIFHZ)HEMJEE!=+#8WUD!;7</G0NB^;YS,K(0T>P<Y) _!/\
M;*^"&M?LQ_M)>-/!C0S6:Z+KO]K^'I?NLL:S+<6[V[J$ 6-V$<84 80#MQZU
M\+O^"EW[8'P<\&V/@+P#XDN-)\-Z; L-E;MI$4CPJJA1AGM7;<%^4'/   /
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MDM[=]\A^8 '@KUQUQZ&OZ]](@>TTVQLY"&:UL[>W+ $!C#$L1;!Y&\KN"GD
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44 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_007.jpg
<TEXT>
begin 644 image_007.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !< /0# 2(  A$! Q$!_\0
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MQ;0S3,J%+/JM.E1S#'4:4%AZ;4*=+&8FG3@GR-M0A"$;]>6[W/.O^$ \8_\
M1Y__  4X_P#%E/[6O_SPZ/\ A /&/_1Y_P#P4X_\64_M:_\ SPZ]%P<XVCZ_
M-CIGKFEV]\+Q[MV_&O&7C7XHN7*N+L9S6O;V4$[=]<.CA_U_XQ_Z*"K_ .$]
M)_E!_P!=#SG_ (0#QC_T>?\ \%./_%E/[6O_ ,\.C_A /&/_ $>?_P %./\
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MKBS&VO;6C".VFTL/%V\[6[-H:X^XR>V?UWZ8:G+?7[--GG7_  @'C'_H\_\
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MO''B7X9:M9>&M T]]4U.]VH1;V,85I9V"NS%(A)N?Y 5"Y8@&OS;U0(N\YW
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ME0P6$HTX1^&,*6'HPA%>2C%)>1^NTURTZ:6J4()?*,5^A_/M^U!_R<;\<?\
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MVI=&S^I8_P PX_4FOX;O^"K Q_P4"^+/MJWAD?\ DC85_<B>W_;3^M?PW_\
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M9G:,AN,5-^R[^T/JWP#^(EGKD]U>WWA:\CEM/$&E"=F2:VD3,4\"LT@6:"8
M\(25..<UX=X'\):AXY\7>&O!NE.D>H^)M4MM+M)),E1<W+,L;.=I.W< "/?K
MV/WHW_!-'XS\_P#$STE@,@E3(1G.,?ZL9YS[<'%?SKD5+Q&XHX@J\;Y%ALPS
M3&83.(XJ=:%2K4A[14:N(HX*<9U??I/"24YPUI.T:<H\R45^4Y8N,LQS.KQ!
MEE/%XS%4,5+VE:G[2<(NM5J.G1UGJH0W:3C%.SLM#P?X_P#[1NN?M$?%3P]J
MUU&+3P]HVLV%MX?TY2<0V\NH6^^9P0K":8@;R5&>G;G]G_VVY'M_V/O'DL4L
MMM+'X;T(++%(4D&ZYTY7 92&7J<@'OCU-?CO\6/V2_'?P!3PEXD\3WMG=V6I
M>+-+TN%;<.'$_P!ICE!.5'WA'@#D\D_7^A7QA\-_#WQ4^&<G@;Q1"UQHNN:3
MID5ZB':[+"MK.FUL\$M"!]#GDBOW[PHRSBS,I>+&$XFI3I<2YUEV5NV-E4I*
MG5QF$S:.$C&3E>*BE3Y4FE2C%+W>56_4."Z&=8O_ %UHYE32S3'TZ-5>UE-.
M'UK#XBG0E>#YHWG3DMURV3=KQ/XR[_6-1;>/[:U(Y /_ !_3]U&3@2<\YS5'
MP->75Y\5/APEQ?W5X(?'/ATHEQ<R3[&;4;8$A9';:<*.GIZ=?Z@G_P""9?[.
M$@^?2+UC@ 'S5Z#)/8]SC^>1U_-/]N+]EKX9_LZ_$;]FNX^']E/;2^)?B##%
MJ;7#*X9+.^L)(-I4 C!?'&, ]PQ%?"5O![BWA'"8?.LXQ^$K87#X_*H8B"Q%
M><E*>+PT$_9NI)591K22C/EE'FM.Z6I\Q6X#SW)J<,SS"K@YT*%?"1JQ]O6=
M5>TQ%/E;C*<G5G&I*\+J5G:5[']&%M*B6UL)'5=T,*(&.,DQ+A1GN20  03Q
M[U_,G_P7R_9J6-O!'[2^@0G=,D7@;Q@D<)P!"L]YI6I3.N",[I+621@/F"KN
M'0?M%^W#\4M0^"O[/Z_$_3[B:W/A/QC\/[Z]\IMIETMM>M8-3A8'@K)8R3!@
M1CID8P*U_P!H#P%X4_; _9,\5:!IJ6VL:9\1?A[_ &SX6N"4E6/4YK!=3T>:
M)HB^R=)RL,C(VY6)7UK^L>*,#A.(LHSKAR491QU'+*./H.Z;YZ=/EA.G_+)X
MC#5HOEM)OW[^^F_V?/*%+.\OQN3+E5>& PF.I+12</9:2BVM'*5)Q:34MKZ6
M/Q[_ .#=@@?#']HP89<>/?"JA2"#QHU[GKVSGOCJ*_G<_P""WWB'5_"__!1O
MXT>(O#>ISZ5K&C^)K"]L-0M79);>XBT73#D%%+$'"JRXP5'((K^D/_@W]T/5
M_#/@_P#:E\)^(+26SUKPU\4-#TG4[>9'CGBO+/3-1CFC='564[E)7(R593Z5
M_.!_P7&TO1M:_P""C?QRT"VU&.#5;BZL;EQ/)M@$\^DV:QPNQVA7V6YR0"%+
M$<@ U^>XVK.CX;\'U,0I1G2S&?M5&$G*#I2Q\'[D5S)Q4'9)75W:W-KX6#4J
M7"W#ZJIQE2Q4XSOJX\U2I&-[:NZCKVZG]N7_  2Q\6ZSX\_X)U_L=>,O$+I+
MKGB3X&>#M5U22-0L;WES:NTK(JJH"DC( 4<=J*R/^"2>FSZ-_P $T_V*M*NM
MIN-/^ G@RTF*G<IDAMI48JPZJ<<'T]**_<\NG&IE^!J0;<:F#PLXMIQ;C.A2
MDFU+5-IJZ>JV>I^B4W>G3?>$']\8GXO_ +4'_)QOQQ_[*EXV_P#3_?5\K_$/
M_D0_&_\ V*/B#_TV7-?5'[4'_)QOQQ_[*EXV_P#3_?5\K_$/_D0_&_\ V*/B
M#_TV7-?Y:9Y_R6^<?]E?F7_K1XP_C3,/^2DQO_8^Q?\ ZM,2?Q8_\$KN?^"B
MGPU&0,Z]XK&2">6CO%7@<D[BN/0X.1C-?2'_  7(_9KNOA_\=-,^.FBZ<L/A
M?XI6L=OJDL$:B&W\4Z;#$LXDVJ )+VV,4H9AEI59V8DU\X?\$K<?\/%?AIG/
M_(P^)\?7-QU]J_J"_P""DW[.(_:6_98\=>%;"'S?%'AR)/&'A/"L\C:GHL:W
M,UH@3+9O[!)[=2<*&(SFOZTXTXL7"'C7P;C*E;V6!Q_"V5Y9FD9.7L_JN)I6
MA5Y4TO:4:EI1E)227-[M]3]IS_._["X\X?Q$YJ&&Q.4X/"8MN^M*I2:V3M>+
M::;3]&?QF_%WX\WWQ5^#/P#\":S<W%YJOPBT_P 6^'X[B=G<-HNI:G97^E1(
MTA8[81]HC"Y^0#&%##=^Y]CEO^""FMJ!R'EX QG_ (K[0S_0^W:OYG+JVGL[
MRYM+F)X;BUFEMYXI%*/#-#(8Y8G4@%61U(8$ @@C'6OZ9M-(_P"'#&MGJ-\O
M3O\ \5]HO3Z]J^W\4,+A\OP7A_AL)3C3P_\ Q$[AZO"$4E&+QV88G$U5!122
MCSUYN.FS5V]SZ+C.A2P]+A>%"*A3_P!:\LQ$8I))2=6I6LDDERN5O.SWZGY.
M_L$?L-7O[;GB/QOH5CXA3P\W@W2;/47D:,-YWVNXEB4-P.-P  4\=3QS7Z>'
M_@@-K !V_$N)B,X)B 4^A/H#[_C7F_\ P0<\?>"O OQ$^-\_C/Q3H?AB"]\*
MZ)'9R:U?Q6"74R:E(7BA>9E$C8(^4<C.3Q7], _:)^ P7GXL^!NA.?\ A(K(
M\'O@R@9*CG) !R.F:_*?%_Q'\2>'>.<RRCARKC8951H8)X=4,M>*BI5,)[2L
MX346YS=63O%/XK05FSXWCCBGBO*N(,;@\JGB5@Z:H>RA3P3J0;J48U*G[Y)V
M;G.5W?W.EK'XY_M"_LN77[)/_!)GXO\ PFFU9-<EM/$%MKSW\2[%,>I>(+5@
MJC/ 0(HVCYN2=H.37RO_ ,&^,\2_$;X_P,P$TGA+PTR1]6*KJEV&8=L D G/
M<=S7[*?M\R:!\;?V%_V@H? &M:;XKM[;PC>7XFT2\@U*(7&AE-4DA#VS2+YR
MQ1<*#G<>^,U_,W_P2%_:3T']G?\ :DAMO&EVFF^$OB1I,WA'5=1F81PZ?="0
M7NFW,[MD1H+I%B=BI"K(<@ $C'A9YQQGX.^+-+$JMB,_QF=XG,*U">'6$Q$J
MCPV QLHRPS7M(:X1J*G>3CSJ[=K99'4QV><"\9*<)3S.IBYXBM2DGSRG3H0J
M>NO*_7H?VU$@^O\ %^N?Y=Z_AM_X*INL_P#P4"^+7E$2;=9\-QMM.=LB6-AN
M0^ZY&>WO7]F/B_X\_"7P5X0U'QQK/COPS'H%CI5UJ<=U'J]JXO!;VS3K#:A'
M=I9+G&V% NXDU_"K\5O'>I?M3?MC:WXML;62:;XE?%2VBTJTC5GD;3Y=8BM;
M,;5W'Y;*%7?C"KN)PM>5]&K*,PI9UQ1GV.P.(P>"P?#^(PLIU;14L57J5<;5
MBKQ7NQJ4-%>\:=U)N33.#PFPF)AF&<9C4PU;#X;#90\/)U=Y5:E*M*HE9+1.
M+Y5T5KMG[8?\%R\C]GG]DM3P5@C!]B/"UGGD>F>WOCI7\_?A;]GWXP^-O!MY
MX^\+>!M9UCPI9B\:ZUBSMFDMHUTU!)>EF('^H1@S@<D'"YQBOZ'O^"]=C_9?
MP<_9GTS:%&G:G?617K@VFAVT#<=<;E. 1G:17U;_ ,$8-#TWQ!^P9!I&I6-M
M<VNK>+/'&G7:RQ@O+;7VRT>(M]XY5E)Q@CDC&*^YX8X\J<">#.2\183#4\6J
M_%V8Y?5A5J^S4,/CLXS*K6JJSC?V;OJ[\L>C>I]+E'$<^&^ ,MS.CAEBXU,X
MK865-N?N4J^-JJ=>T)1TI;N][(_E4_9<^ .N?M+_ !J\(_!_0KVWT_4?$5VW
MF3W(PJ6UF1-=A?F0-*+996C0'YG3').VO[POA+\,_!O[+'P&T?P7H<5O8^'?
MASX5GO-1N5V1M=75CICW6IZA-\BEY;N2"5W8AI&;RRQ9DX_B9\[Q+^Q/^W*;
MI()K*\^%GQ9$J1.K)]L\/-JRNH4N%W0WVDS95N%VOD'%?UJ_M^_'"V\._L _
M$SXFZ!=QLGC/P%I-MH4L<D;*P\;/IML[0ON*[UMKVYZ$XVN!TKR?'J6=<1YU
MX:8/!XAU.%^)*F"6&A0::GCL=5PDI2K23=.HH4*UJ+2NDI:O5'!XCO&YOF?"
M6&A5;RK-)8>K2]FW>56I5H^T5]8.*I2;BY1;32=[<R?\D'PN\5>%_B5^W/X?
M\>?$#5(-/\*ZW\:SXLUW4+[Y[>/2X==_M)4EW##(8XTBVG*[/E(*D _TW?MY
M?M0?LM_%[]D;XT_#SP]\3-#U#6+[P@)] TY N9+_ $F[M9[.W@+LH$A:V 5E
M'\"E6'RU_&/9V.J7DKBPM;VZF0[W^QP33/&#RS,859D!)QEB,>M:K:'XI<;&
MTS767'"M;7I&.>.4QU)/K^'%?L_%7ACE?$>=\*9I6SNOEW^J$,OI8' TYT(J
M4LOE3FZLU-\R]LZ:IU'&*?)'E5C[[..$<)F>-RC%U<PK82>31PL<-2A.G&#>
M%DFI2C-<W[Q)4ZO*XWAHK,_8S_@A-\6(?A[^V;8^%[VX,%C\1-$;1]A)\M]0
MTJ^M-7M#C!4R8LY4B+ %?,<*1N.?]8WXS0-XR_9,\7QV&)9-6^%UO=H% ((_
MLVTO<+DA64*A (.TC!!((K_%G_8T\<S?"C]JKX&^,+EI+(:+\1O#L5_YP,3P
M6U[J$=A<^<DF"J^5='S-P'R@D8XK_: _8^\9Z1\6OV9/!7FSP:@L/AU/"^K(
M)(Y"8[.U6UC25%.,7%D89(R>&1U/(S2QN74?]>^),!%JE+C3@.-.%1)<KQF5
MRQN4U*BMO'ZKCZ$YM\TN=Q:?+H3BL(O]8\VPT6HOB'AB7LVK)SQN$Q4\+*$>
MG)]7J4Y6=Y<S;O;0_GZ^ _B/2?"GQD^&/B37;@V6CZ+XKTR_U&Z*%OL]M;R,
MTDICQO8)D%E"EL_P[AQ_1;X1_:Q^!?CKQ%I?A3PYXRM[_7-8E%OI]H+:YC:X
MN-C,4#M$ &VH[;LA 006Z9_#;]IS]E#QQ\'/&.K7&F:+=ZOX,U"\N[W2=1M(
M9)Q;VTS><+>X1,A)(\NJ@N!M7[IZUT?[#7P@\>:Q\>_ GBB/P]J-IX>\-ZC+
MJ>IZG>0SV\*QK93*(HWD4K(YDE3Y4;;@[2,Y%?S'X9<0<<>&W$/^H<>'?;RS
M//:-/&UJD*[G&-*C+!+$X-PJ1IPHSPBA6O4C4;G&;ORVBOR?A#,N(^%\XJ</
MQRWW\9F]*E4E455VI1;3G#DG&"O3<FVXM/S/T0_X*5@?\*^^%Y]/B9HQ)QR0
M/+^8D#G#$G\3CFOKKXO?%,?!CX+7_P 17L7U"/P]HVDRO: [3*9C:6^ 1S_R
MTXX[GW(^1_\ @I9@?#SX8<]?B1I/_H48KV;]LO2=5US]DOQMIFBV%SJ>I7.@
MZ(+>RLX7GN)MEUI[MLB0%W*HNX[1T&*_H>KB\5@N+/%S'X!U%C\/PSPW7PTJ
M=.6(?MJ&7YM5II4FY12YX*[24K-Q31^GNK7P^>\<U<,[5L/DF2UJ-DKN?L,T
MJI622^-)*R3M9/4^&;G_ (*Y:;!G'@:5ATW&1\=_I_+MV.*^(/VE_P!L:V_:
MI^)/[/UO;Z ^C?\ ")^/;&>1F;<MQ]OO;.,A0>1L9%QUXY/-?*M]\&OBNW3X
M?>*CE3G;HU]P3G_ICSC)]R0<]ZYS0/ GC/PG\3_AG/XH\,ZSH,%SXWT**UEU
M.QN+-9Y4U2%G$32QJLF$VDA<$ L>0!7\T5?$7Q)X@HX7+<_>.CEN,QF5RQ,Y
MY8Z<>98["58*$W&T*;5E.4N9I7:::NOR-<5<59A&AA,U>*>&Q&(PKG#ZES4T
MH8F%2+=9Q?NWMS2WC%:--7/Z)?\ @K1&K_L'_$D$8Q-X5_A/?5;8'CW!P<<@
M<&O"/^"+?[1EM\2/@+??!S5]1-QXK^$]\8;2WN',CR>$;P6[:6T;MPR6;L89
M%R60[5VC&VO?/^"L/S?L*_$E"<#S?"W/?C5;8U_-1_P3;_:%?]GC]JSP1J=]
M.\/ACQS<0^!O$Y9E6)+34I56VN9BQ"K]FO?(DW'D*S#&<8_H?B7B*?#_ (I\
M/UJE7DP68Y7A<OQ=-M^SE[?&XZE2=KKWK][J[9^E9KF[RCC7*:LVEA\3E.$P
MU:#OROVUHPT36J<GO?;;O_6S\#_V?+/X._&+]HOQKHEM;6>@?&37O!_BN.UM
MHQ$L&L:=HE]I6N;D7 S<7+1W3': [2%\NV2/X9?^"T7AV#QC_P %(?CSIUM&
MMIXBM=>T7^S;L,D2W]N^DVYDLW<@$R!F!1V8!2IPP!P?]$6WD2:))HW#QR*'
MC=""C(X+JZ8)!5@VY3DY!7FO\^W_ (*PZ$L7_!4OXS^*+DRS6VCZ[HUS'IZL
M<W4ITJ+(^7G8Q <GID  <XKT_%MTLIX/H2P\G0^KX[%XBBH**C+$5*&+K\D]
M+.G*51^['E=K)2[_ &&;X!2PV%PF%IRG*6-56E2IV3<FG4Y8JUE%)R?HGJ?V
M9_\ !,/0=0\+_P#!/O\ 9(\/:J[R:EH_P6\*V-X\AR[SPPRAV8Y.2>ISSZ\Y
MHKI/^">=U->_L1?LQWEQ<_;)[GX3>&YY+K_GLTD4C%^ !SD#@ <<<45^G<.U
M)U>'\BJU+>TJY-E=2=M%SU,!A9RMY<TG;R/?IQE&G3C).,HPA&47O&2C%23\
MTTT_0_!?]J#_ ).-^./_ &5+QM_Z?[ZOE;XB@GP%XUQDY\)^(?TTRX]CSS_+
M@U]4_M0?\G&_''_LJ7C;_P!/]]7SY?VD=_:7-G,%>"[MI[6='&4:&X38X8=U
M8?*P[@D=SC_+OB*7)QCGU5N=J/%6;UFJ<U3DU1S_ #"HXJ3324E!IZ:[=3^,
MLTJ*EQ!F5645-4\ZQU1Q?50S/$R:^Z+/XC_^"5Z.G_!1/X9,8Y0&\1^)0Q9&
M506%T4R2 !D*>_'U.*_MVEB2>&6.1=T4T)AFC(P)(I(D5U/J,9!'?D=,U\H^
M /V-_A#\-/&>G^/_  UX:T6PU_3I+B6VN[;3((9XY+S?YC1S(=X?YR W<'D'
M-?66258D;<CA?0!0H';KC)XZD]J^P\6>.L%QWG^ S7+L-B,'3P6287+.6O).
M<JN&I<JK)Q?NIS;25[I14KVDDO7XSXCH\2YEA<=AJ$\/'#83"X51GNWAXN]3
M=V;D^^T4^MC^#_\ X*7_ +.K_L[_ +5OC[P]8V\R^&_%5S)XT\-2+"PMVL-=
MG>YDM(2BA2;.Y>6W8 DJ54'D&OUDTU0/^"#6M0;7WAFP@4[B&\>Z25XQG)$3
M=L<9Z5^Z7QH_9E^%WQRO=)U3QIX=TG4-1TJ"6TM[J^TVWNY?L\DGFI$LS@'9
MOWOMXRQ)';;?7]GCX?)\(9?@FND:>O@J8*'TK[%";)@+R*^&;53L#"XB5@<^
MI(^:OO<T\:Z.<<.^'^7X[!8VIFG"V=\/9IFF+^L4U''QRESC7<7RMNI*$HN*
M:2G);IZGTV+X_AC\KX>PN+PV*GB\GS#!8S%5_K$;8SZKS+G;Y/BY7;ELK]S_
M #P[:XU2P=WLI[ZT:0 ,UM)<6Y=0<@,T94L >1GH>?2KHUOQ(2,ZKK/4<_;;
MYL <GCS!G\Q7]W1_X)W_ +/HQGP?X?SS_P P6U/'ZG]>>/2D/_!/']GW''@[
MP\?;^QK5?U/ ^OY<U^GR^DQPC-\U7AK%2GU<YX:4W9RL[RI2=VK67-IMIN_L
MY>+>33<ISR;$2U=G.=&3<59+FYHMNZ3NKO31'Q%_P1%TZ/QA^QK\1?#_ (D:
MYU&RUKQUKVC:A!?/+,)=.OM&M;>>/]\SD*\<CG X#9SDU_/'^W!^R;XT_92^
M.7BSP]=V&H+X0NM9O]3\&>(8X)DMKK2+JXDN+*..<!566T@D2%U# C8&'!X_
MN1^#WP;\'_!;PY=>&?!>GV>F:9=ZC-J+P6-K%;1-<2JJ-(RQ?>=@@#%L$8..
M#63\=/@+X!^/G@K4_"'C70]+O6O+.:WL=4N[&&XN]*DF*9FMI)065B5( # 9
M;C'0?D7#GC51X;\0^(^(XX.K/AWBW&T:N.RS$5%+ZK[&E&C"M0C2ARJ<87YD
M[1E&\7>Y\+DWB!_9?$V;8Z.%2RC.,3&=3#NR>'IJ.LU%6BY.3<7&UG%:Z.Q_
MGQ:E\3?B#K6DV_A[5/&7B&^T:W 2'3I]5OIK954%546[SE,#D!<$=1C!Q7[&
M?\$:?V,_$/Q+^-NF_'?Q=HMS:^ ?AJTFH:/)?6TB0ZSXBFADM[-83(A25+4R
M&=F'"NHP0<5^C_@C_@AE\*?"?CVS\7W7Q"O-<LK+48K\Z%=Z,BV<ZK<+.]M*
M&NV1(QL$8.P_*S CG(_;?P?X,\,^!-$L_#GA/1=/T/2+*-8X;+3;:.U@^4 -
M(RQ*H9WP,L<G/H>OWGB3X_</5>'<3D7!-%>WSBE.AB\="E]2J8:CB:?+5IT8
MTH<LJCBW#VLFK)R2M<^FXJ\2<L>65<!P[1CS8^G.EB:JIQI.C&K%J4HJ'Q2C
M>VK6C:5M3\ ?^#@I'?X>? <*KN1XJ\1L0JL2JFP5N H/!SE03GG!S@U]6?\
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M;V.8R>/M^<Y/B2P(SUZ'0B/\CTKV?PS_ ,$^_@#9F%8_^$U8;<YDU^R8C@C
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M!Q7ZT:W^S;\.9BP<Z_@GH-2@ Z$]/L)'7VKS/5OV3OA7=9,K^)_F^8A-7ME
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AA1PU/_!AZ4*,/_):43Z[FE+WI.\I>])]Y/5OYMM_,__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image_008.jpg
<TEXT>
begin 644 image_008.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" '* ML# 2(  A$! Q$!_\0
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MOG_OH5%13 EP/[Y_[Z%&!_?/_?0J*B@"7 _OG_OH48']\_\ ?0J*C!ZXX]:
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MP5>,Y+ #IGJ3CVZU$;V)1EI85&/O&10,@9(R6QD4 7:*Q)_$&D6H)N=5TNW
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M':1@C -<9HW_  ;J?LYZQ,#:^)_VD9[59?*DFM_$?@)PK;BNWS/^%7,FXG
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M]J  N,'EOX.R_P!T^U!<8/+?P=E_NGVI"AP>1_!Z_P!T^U!0X/(_@]?[I]J
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M_=_[Y_\ KT 1[O\ >_[Z_P#K4;O][_OK_P"M4FW_ '?^^?\ Z]&W_=_[Y_\
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MX(:XT*3BVA\GS05875LQ<%./W<<K2_,K9P5' 9L@ U]XC0M/0?+&C[0,CKT
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MUM)-'N1]RNA<LC JV&!K^%?XG_!_Q+X12/5&MYPDP:6)X)/-CPV&7Y075&9
M&( P6R".!GJ/@)^UC\7/@=JD4G@SQMXA\,&-T\^WL[Z9].NRA^5;[2KD2Z=>
M)D<I<6[KS\H! (XL7EZJ**@_9RBW9R3<7=)I-WO%*S=[.[=K';A,TG2;]K&5
M92BD^1PC-<B;<DFHQE=;IM-6TOL_[N=W^]_WU_\ 6HW?[W_?7_UJ_ GX)_\
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M>X]!0! >OX+_ "%!Z_@O\A4Y(SU'1>X]!02,]1T7N/04 0'K^"_R%!Z_@O\
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MQQX?5L8P;S;DD C[RX(R."#R1CTK.7XV?#<@C_A._#APW3[?$/;KD>]?-?\
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M,QRS YA6CAZ4:U=RPE%XV%"A6E*,J_L:E5TX*44,P?0_D:,'T/Y&G[_\[?\
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MO(M4U/5M2TJQMM.M=6U6_O-/TJSD\V"PTS[2Z65C;"5(I3;"20I"X"[X70E
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MG &GWMVUK!]LC&)W%KJ5E)<>'M5#?<$EG?$R@X\I,J*^IK7]A_QYX(U6XD^
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M-;O-5/@SXDVND7?]H>&M5T>^O9]3FD%W-J/V6TN-.?T?_@H-X\_9._9&\ _
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M$L<^LV.HW\NIVEA!IMF=4TJ#4[R2ZO9H8KUEM-2\F\0_"GP[XX^('A[X=?\
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MCQU\.=+U3X&>#/%?C7X;> AXETG0-5D\"Z?XFT/P]>K<Z1\2+^'2]3U;3+N
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M'U2RT54,%]I9O&NUD9HM0TU7DN(;VSDG^4-'\2?MA?$Z]MOCGX>\$:[XEL_
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M_P"R4OK]!_Z U $NT<_*.@_B/]QO:C:.?E'0?Q'^XWM47K]!_P"@-1Z_0?\
MH#4 2%1@_*/X/XC_ '3[4%1@_*/X/XC_ '3[5$>A_P" ?^@F@]#_ , _]!-
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M1W6O>,?!G@S7]0LO#NC>4LM[/IK0ZU<6VCZ+:B*QMI=7T^=V6"WAM868H0A
M#?M69>%>891DN2<28BO"KEN<9C5PV%E3JT'4M@ZE1U)XBBX1G0BO83TG4::B
MMG-6_+,J\:\HSW/<]X6PV&E3S7)LHHXS%T94L2H*ICZ4%0I4,0G.&(DY8BG&
MU*CS.4KQORR9ZQ\-+&*U>XU-X8XK;2K%S&H3RU221#M10,@!8E<*JDX!48!S
M7IWPZM9-1\6:;<R(6>6\%Y/U.=K^;MZG;F0@  GK@8YSPFE/'8^&K?3GCO;+
M4-5G:::VOK*[L9S!#M)$8N8H6D"JJ!C"67#,&(->V?"ZS6WG6_ERK/-'#&V
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M$W@6/Q/<Q>"[FW@FT[1=$.G:+X4@TCP\DWAK2K/3-4O=-O\ 7G7[5K,\</\
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MA^[[?W*A[_\  ?\ V2CO_P !_P#9*[1$WR9_A^[[?W*/DS_#]WV_N5#W_P"
M_P#LE'?_ (#_ .R4 3?)G^'[OM_<I?DY^[T'I_<:H.__  '_ -DI?7Z#_P!
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M% $XV9_AZ-Z>AJ2/'.,=NGX^E51U_!OY&K$'1OJ/Y4 3T444 %%%% !1110
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M^=LOC.XLIXRR7-M<PR?)))&WEMG !5E)VY'!!*\D;<CBMH?'WQ5I4?DD.\8
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M@_A_V3[T%>#][^#^'_9/O0 XR<'C^YW_ -D^U(9.>G9>_L/:D*\'[W\'\/\
MLGWI"O/\71?X?8>] #C)ST[+W]A[4&3GIV7O[#VII7G^+HO\/L/>@KS_ !=%
M_A]A[T .,G/3LO?V'M09.>G9>_L/:FE>?XNB_P /L/>@KS_%T7^'V'O0 XR<
M].R]_8>U)YGM^O\ ]:D*\_Q=%_A]A[TFW_>_[Y_^O0 [S/;]?_K4>9[?K_\
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M--T?X@^%_CUXITJZ^*&J^.O%7@O1]"UWX3Z#IL.K>%=&\/Z(\'@Z?Q5\/H=
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M7W'\-T=_<6MPQMI[B!QSF&>6+T!.493WZ?SKI;7QKXHLPJQ:W?LJXPDTPG7
MX'$RR'TYS]:Y'7M+U;0=8U#1M<TV_P!&U?3;B6TU'2M6L[G3]2L+N!C'-:WE
MC=QPW5K<0R!DE@GB22-U9752,53CE8-@G Z<9]1Z&OWK#XRO3C%T<36IQDDX
MNG6DE:23T:FTU9Z6;T?F<-2A1K756A2J;<RG1INUMKW@OSUTN>MV_P 5O%UO
M@&YMY@,9$D&W) QDF%HCDY.?RZ<5TEC\;O$%L4,MI:S8&#LGGA/)R<9,I!'0
M=3^'%>%+)UP<_7-3*V>G48S[&O4H9WFM"WLLPQ*2W7M.:_KS)W^9Q5,HRRK\
M>!PS]*:C:W;EY;?(^MM%_:9O--96DT21\'GRM2PW'//F6G('?GIP/;U;3?VT
M[:Q10WA_6F*X!*7-FPZ<@,TX.,XY*CC'&>GY\*_J<8Z=?QI&8D\'CVR/SKT%
MQ1G,8^[C+NR^*$'+9+>_W]]=$<<N&<DF[RP2OKM4FEKY=/D]NY^BNI?MU17-
MLT:>&=8#;=JF6ZL0I &,LPD<K[X1CGH".OB'B+]K3Q!J9D6UT9;=7W@-)?;V
M QA3\D  /KW YR2:^493[\@'^0Q6>[$G![9Q^//\ZX,5Q#G&(TJXR;O9W48)
MJS>E[-_):/L.GPWDM*5X8&"WU<IMZZ/:WY_>>HZ[\8O%FL,XDG$08G(\R20X
M)/ )*=.W&>^>U>:W7B'59W:26Z=FR?F(1CR>Q=6VX&0-N#[UGM]X]?Q_.JTB
M]0._/ZUXF)Q6(JO][7JR4M'><K-O=:-+\CTL/EV!HR7LL)AXV6ZI1;\M6F]S
M7TF:YO=3@:>:><^8G,LKR$$L,!0[';@8P%&!C K_ $C?^#8'P?J6@_L,?$'Q
M/=P2P6GB_P"-NI#2VEB>,75OH'A'PQ8W%S 715E@%[<3V?F1,\8N+.YB)66*
M5!_"]_P3X_X)X?M*_M\_%K2/!7P5\$ZA)X:M]2LAXV^*6L6=U:?#[P)ICRJ;
MF[UC7#&(+O4EMP\EAX<TQKO7-1<#R+(6Z3W,'^K5^RG^SCX'_9-_9^^&/[/_
M ,/;>1/#?PY\-VNCQWLR1)?:YJ;L]YKGB+4_+PIU+7]9N;_5KP+^[BENV@A"
MP11(OY5QOCJ4H4L#&K&I6YHSJ14U/V<(MM<UI2Y9N22496=KNUCTZ,4FW%14
M;**M%).WFDMMGYO4^AM[9Z_P^@_N?2C>V>O\/H/[GTIVP9Z-]WU7^Y]:-@ST
M;[OJO]SZU^=&XW>V>O\ #Z#^Y]*-[9Z_P^@_N?2G;!GHWW?5?[GUHV#/1ON^
MJ_W/K0 W>V>O\/H/[GTI=[<\]AV']QO:EV#/1ON^J_W/K2[!SPW0=U_N-[T
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M<J4ZN$YY)R=/!3PF+G[MY24OJ>)QGLVKN4XRDG:SEHKK]K+109(RR_N8\!5
MPS/SE_7GT/3)YYX[G2,A][YW$!4XS@$8&<#@@D'MR..E?G9_PV[X)>:\@TO3
M[.6>PU2#1;F.^\3Z?%)9ZO<"3R+"]@LH+][>>98IG6.61"4AE8'9$[#3TO\
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M3DKW2_EOMOJ9*M65XPERQ;;LKJ6MNJZZ'C.F_LH_"FUL4=-%MS*'(;?%"%9
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M3^XWM0 SU^@_] :CU^@_] :G[AS\@Z#T_N-[4;AS\@Z#T_N-[4 1GH?^ ?\
MH)H/0_\  /\ T$T\L,'Y!_!Z?W3[4%A@_(/X/3^Z?:@!AZ'_ (!_Z":#T/\
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M-UKVCZ#J6O67B6+0-)\1&WB?Q+8>%M3T_3?$?V>&76[;4A;1;/MGX7?\%)O
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M;Q/X9^-WCZQT^?2K/QWX&^!GB:TL+IDDN;2WU>V\;ZE#;3R1@))-!'>".1T
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M@\G^#N?[IH <0F#R?X/_ $$^U(0F>IZ+_(>U(2<'D_P=S_=-(2<]3T7N?04
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M+EGMM3FTI]&\-Z1+X=U&]M8K]OB#I^D7,/B#ZK\ WWQ 35_#4/A+_@EK\*/
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M@!VY/[OZ"C<G]W]!3=C>GZC_ !HV-Z?J/\: ';D_N_H*-R?W?T%-V-Z?J/\
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M;:YJP\,2^*_$KY_VY_@=IK75EX*_8-^!WA_2)/!?C7PY:7.K:C)XJ\6VVO\
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M.1[?RJN$;/3LW<>A]ZGA! ;/J* )J*** "BBB@ HHHH **** "BBB@ HHHH
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M$_C77/!/B/4/#]AX.BT.^U?1I5MKV;2'U+7?MC6#R@^2;G$Q!+.JY%?-S?\
M!T7_ ,$_K@*&^"O[3EL%.W<;;P#*Q"D@?<\11J,\_P )/KSS7\CW_!56[>[_
M ."C'[:-U(Q?SOVCOBCM?DAECU^2/AB><;<$YZ^E?GV''H>I]/4^] '^@!I_
M_!T!_P $ZF,4<_PP_:>MD:0*X?0_!-TJ9(7<JQ>)=SYY)7D\# YP/Z O^"8'
M[;GP+_X*/?"SQ_\ $+]FRR\>:3H7P\\96/A?Q1%\2=%M?#.J_P!N:CI9OK1K
M Z==WJW5G%9!Q)B7/F,N]%(!;_('L1YEU;J ?]>A/3IY@_\ U_2O])?_ (,^
M863]D?\ :R7/'_#0'A4#N Q\&#*\$\COTY^E ']8VG^"?$]LIWK;7  ^5EN0
M3*  !*Q;YMSJ Q+?-GD@'BNF&DZI90O=WEDKQVD+S2JDD3L\$:>;,HR5+/M4
M[!CK@#.*]#TX,\*DX!$>"#D8PB^WUZ\U%KBG^R-6R<+_ &5?9Z_\^LHX./R_
M.@#YEC_:^^%&W#KXDB*;XRC:2V08BT1&5<!AF/Y6[@@U<C_; ^$"H=UQKXX!
MYT:Y;(VD<%<CKVSG@U^72P$K*GFD#SKH[0-S+FXD.03@X.">N!5A+8! BRL3
M@9WJ3V8X.<<]/U[4 ?J+%^U]\').#?:TA.T8;1;L'[I&>GO2O^U_\$H-L=QK
MNI1N^% ?1[[))4@ 8CY/.,?AUK\MFM7!1LKOX! X& O'^?J*IW&F0RNLT^&>
M-@0 1DG!. ".QZ^P/?B@#]6G_:T^":*"=;U$9"G!T;401P>H\H_7J<YI8/VL
M_@E<$"+7KTY8#G2M0QE1@C'EXZFORFDMDFQ@\D+\I/( 7'?(^F<\4D&D!'V(
MVU9"&#+R58XRQ(Z=NI ZT ?K<?VG_@V !)XK^S[L82;3KY7Q@]O*/;H>^?RZ
M#P]\<_AEXLU*WTC0?$:7]_=NL5O$EG>1JTQ4!8RTD*IO8GY03V/3%?DM:^';
M><J[N3+&00[\DX';/.W' &3[=37T;^SWX7>]^)&CF&3S8M+<ZK<>5'L2,V\3
M&,2. <;FP,9Y/RX(Z@'Z=1MM5N,DL"V&)&XKSC(!Q[=NE/,G/3LO?V'M2>6<
M'&.=I[]U)STH*'/4=%]?0>U "F3GIV7O[#VH,G/3LO?V'M2%#GJ.B^OH/:@H
M<]1T7U]![4 *9.>G9>_L/:@R<].R]_8>U(4.>HZ+Z^@]J"ASU'1?7T'M0 ID
MYZ=E[^P]J3S/;]?_ *U!0YZCHOKZ#VI-A]1^O^% "^9[?K_]:CS/;]?_ *U)
ML/J/U_PHV'U'Z_X4 +YGM^O_ -:CS/;]?_K4FP^H_7_"C8?4?K_A0 OF>WZ_
M_6JI?R?Z'<\?\LF[^WTJUL/J/U_PJI?H?L=SR/\ 5-Z^GTH _E8_X+%2[?B[
M^S>W0_VG\44SU^_%X$&.AZD=,=<?4?"/PJ_X.!_@_P#\$^-#U;X=^(?B)X*^
M+OAB"\O+VU^&NB7M_P")O$'A[6)'9[ZVT;6?#$&K:;H2WEX3<7NDZ^\5LM\9
M[BW-C<SWDUQ]N_\ !9R0P?%?]FHDXWZ[\2DX)YW)X%!!Z9SG.!UQBOX?=&^#
M7P@_8\^-_BOP;^VW\$[+Q;X9\=:CK.H_"GX\0W'B;4/!UNUR99(;/5_#EO>I
MI5Q'%+) ^HPW.GW&MZ!<RF6>TU31+RSU"'^9<^P-"7BWQ'FL,WS_  N;Y3DF
M3U\OR3AJIE=/-L_PM2A"&8T:4<XC+"XFE@J<:>(Q&%I4\1BZE)^UH4)2HQ:^
M"QE*G_K+C<1'$XNGBZ.$PTJ6%P4Z$<1C:33]O&"Q/-3G&E%1G.FH2G)+FC%N
M*M_1#HW_  5WE_X*T?%_XH>,$\%:QX*\/_"C2_".D^%M.U*ZM5@BT?Q)=^*9
MEMK?3;6>^,5TLVAR7FI:G=:G<7&I3WD*+;:?:6-M;+^(/P1\<6MO_P %'?C)
M\1-=FM;GP19^!?BSJ'Q#TZ_\36_A.T\0^&)_AQ%H=CX9FU>[U72MCZ_XQO/"
MNDV,=O-<7HU.YL;BTMOM5M#<V_WU_P $K](TBQ_8J^&.I6&F:;9:AK5UXXEU
M;4;2QM;:]U9K/Q]XIM;&;4[J&)+B_>TM$6VM7NY)FM[91!"4B&ROQ6\9W'CC
MPW^U7\9=.^'L_P 78-8O-*\=:9=P?!6ZU:S\77>D1>$!K=W#J']B1R7MUX*M
MKG3+/5O'-H56W?PSI^I33R1"#SH_OO B>&Q7B)XVO"T\?*EAJ^482I];Q3S'
M&XFO@,1C,%B\3*M+ZMSO%5X3KTL/%4H86FJ=&DHPH1BN+!8BG#-,^JPC7E[/
M'8:G*,YNOB*E2C#%4YU&VH.4JDXJIR*,8PC:,8QBDG\4W@MI;RZELK<VEI)<
M3/;6I=IVMK>29FA@:=L/,88F2,RLJM(4WL 6(K]7_@CX(@\?>$OAMX=F@UZ[
M%_X7NC'!X;TN\UC6'N++1M0OK0V^G:?8:K>3P1SVT4VH""PGD73H[N1-A7S$
M_)Y6&XYZ$9SCCKGW_K7Z\? /QI?^ _ G@[7].TW2-7FF^'^N^&[O3==@OI]*
MO=(\9^&=:\(:W;W$>F:CI5\&?2-:O/L\EO?0-#<B&4EU0QM_6>;83,I9'G%/
M*(+^U98-K+^>O]7A];:E##N6(=&NJ*A*4IRG[&K\*4H.$IN/K8/%4OK>%>,G
M)815D\5^[=27L.=.KR4HRA*<N5)*,9)M.6ONV>/I_P"RC:7.O^-+6/X)_%#Q
MYXCTB^M[.\.NWUGX \)S:MJ^JZ9I&B>&;#4]1FL7TOQUK8UCS+3PAKTC:\)[
M"6&.PL=306T-/7OV,?$+?#E)_'6H_"#X3:AX?N_%<-]:VNH:3J/BJXU+X>^$
M=#U.Z\*:KXCN;_1/"P\2WMMKITZQ\*2^*(M1U+Q5$]WKEXL'V2ZA\7^,O[:/
M[3GB_P 2^*]-U#XO^)M/LKS7[R^O+;PPNF^$#=7!DNE7[7>>%[+2M0OH[=;N
MY%K#?7EQ%:_:9S;I&TLC/X5X.^'?Q5^->I7)\,:1XG\=ZM;6T"W$L:7VM7RQ
M0B&UM(?,<SW&R%?(MX$W!(E$,2;%"*/R++^!O%F5;^UN(N.N&>&80QN#QJ>"
M>><2UZ,H15%X>CB,^QW#V08*EBJF)E1]A1R;$2C)X=JK6K1IV^IQ?%'!]"C*
MCA,GS'&I4:M*I/$5,MR?#R<YJI[6HL#2QV/JNE*$%%U<=2BHJ;Y:;E&,?N/X
M-_ 751KWQP^%7PQ\26GQ:^&^O_"S3+B^^(?AO2)?L%KXE@LM%\6?V5<7=I/J
M-E:-9S0ZOH=XEOJFJ:?)J=M;QVFHW$X9'_8?XQ?M"?"K]C[_ ()X?LXZ?\9_
M@Q<_'CPY\3? W@/P0_P^ECT1]*U/4!X$M-;236_[:MK^..&*?25>TN+/2[Z]
MM]02"YM8XY[>*5?@#X*^*?C'^RI\+?$7P+T;PIK6H7GCW[.OQ.UZ#1IVTO1Y
M;BRNK:/2=!U(6^V[FT :C))J6IQ7/D7U]$T%@K6,45S>?L9\>OVI_!/[&7[#
M_P"S/\5/B=X;G\8>/M=^!_PCL?AWX/6P:XUCQ'\2]=\"Q3K;+?7%M=2Z+ J6
MUU<ZSJ3;KQ;..2WLX+[4;FULY_&^DQE'&>$\,^#LEXOR6OQ2\!XIY!EW#"RS
M-:N2<1<2X&608_'SQ6:8S+<+@\#PYC(9S*>*ME,GA\'EF7UZSQ5*<ZT8?D4\
M91S+,LRQ&!P"EA<3C<KG2R[ XRM"7M(5L71IQI8N=6IB:4(4XN<J\ZD9*G3E
M)N*=U^ OA?\ ;=^,T7A7XA>-/V+_ /@F[\"_@OX.^%=IJEUXZ^)0^&TGC3Q!
MX(CTRR?5+\:OXWU2W\+6D&I6NGQ_:FTB^LM0O"I3R[20-&C?W^_\$#_'7B/X
ME_L]Z7\1?&%W%J'BOQU\%O@%XN\1WT%I;6$%WK?B+POJFK:I<0V5G%#:VD4U
M[=S.EO;11PPJ5CC154 ?Y[&@_MD>/_AG\,_V\?V9/C!\&?&\/[4W[8WCO^W=
M)\-:5HT%MI^GZM\:-'LQJ5A>:5)J4NN6-S#IFLVUSX:TVTM-7N[^[OXM/U.2
MRFM9W?\ T-?^"$?@'4OA=\"[;X::R5.L^ /@[\!?!VL%2CI_:OASPQJ6E:BL
M;QED>-+VUG2-U9@Z*&4E6!K^>,/E^!R[Q*\.XOA_+LIQ-;BC.?['S.CG&8<0
MYCQ%D"\-HU\7F=;.,RSG-\1C,%2X@QM?+L+B(_5</7EA95X4G.K*2^HIT:-'
M/,G2P=##SGF.(>&KPQ%;&5<;A/[%]I4Q$L36Q&(G4I1Q=6I0A)>SA-TU*,=+
M+]Z_,]OU_P#K4>9[?K_]:DV'U'Z_X4;#ZC]?\*_J8_0!PDYZ=F[^Q]JFB.X,
M<8Y J (<]1T;U]#[5-""H8'U% $U%%% !1110 444W</?O\ H,F@!U%-WCW[
M_H,^M&\>_?\ 09]: '44W>/?O^@SZT;A[]_T /\ (T .HINX>_?] #_(T;A[
M]_T /\C0 ZBF[Q[],_IGUHWCWZ9_3/K0 ZBF[Q[],_IGUHWCWZ9_3/K0 ZBF
M[Q[],_IGUI X/KW].PSZT /HI@<'U[^G89]: X/KW].PSZT /HI@<'U[^G89
M]: X/KW].PSZT /HIF\>A_3_ !HWCT/Z?XT /HIF\>A_3_&C>/0_I_C0 ^BH
MS*H(R&P<\X&!CU.>,]J!*A.!G/TH DHIH<$XY_S^-.H **** "BBB@"CN_V5
M_*C=_LK^5.VI_>_44;4_O?J* &[O]E?RHW?[*_E3MJ?WOU%&U/[WZB@!N[_9
M7\J-W^ROY4[:G][]11M3^]^HH ;N_P!E?RHW?[*_E3MJ?WOU%&U/[WZB@!N[
M_97\J-W^ROY4[:G][]11M3^]^HH ;N_V5_*J%ZX^U:<-JY,[8&/2!L_E6CM3
M^]^HKBO&NK76AQ:=>64,-Q(UUY92>614^:%AP$X]3Q@^] ':%N?NKT7M["N?
MU,D7=FH7EIXFZ#&5(*_EZ>X'6O']6^*/BC381*-*T5\DJJ?:+D'Y0",[0>OK
MC'XUYMJOQS\:HY9/#GAQO+97#23W?)3D?<#2%D W?-\A. >E '^.O_P4SWR?
MM[_M>2.Y8M^T7\6@2&R R^*;I67/JI!!'KFOA(+Q]YNK=_<U_H=?'?\ X-J?
MV2_CY\7OB1\9?%?[0OQWT7Q%\4/''B3QYK>CZ1HGA*;0],U7Q-J4^I7=EICW
M:O=/:P23&.)Y3O,8 ."#7F.D_P#!II^QGK%TUE:_M.?'])UMY;IC+X<\&!-D
M>6*D[ =Q' QG'?L2 ?P1:8C&\@V@MB9">^ )0,_K^?-?Z3/_  : 1D_LB_M7
M;64M)^T7X<1]IRT6WP>%W. ?ER2 "2,DFOBY?^#4G]C^&9C:_M1_'J'#L"K>
M%O!LK#8&8DN H ,BC;G'H.:_=?\ X)4_L8>#O^"6/P\^*'PT^%OC3Q-\7=%^
M)OCC2O']_J/CVTLM%O\ 2]6TS2FTE;*SBT%&BN(+F [V-T(E60#)))R ?T0V
M(,:[&5054KDCER!C=U_#O4.O'.B:P JY.DW^,#G/V.7&.>QQ7S=H_P =-;E6
M-)_"EDF/E81ZC*WE[B2 7:)RQ *Y(8KN)&3BNVG^)%_?:=>++HD$2SV4\6Y;
MQY,++;RJ6(\I#@''09(Z<T ?C]&SI-*>&!N+C/)& )I<@@_K].E;7FPQQ-++
M-!;0QQM)<7%U-';VEK"B_//<3RLL<42@_-([*H YQ@U=U/35MKFY4J"IEF;(
M)*@M([%06&>"?ZU\U?MC#ROV-?VM9"^U8?V=_B9(K/(4$<ZZ%+Y,L<:)ND>-
M\$/YJ>4>01W /H>WN]-O-PLM=\-WH' :Q\0Z3<!@ PW*T5TX.?09^IK2BTF>
M4CR1;R[L8 N[63<=IY!6;G/'KG.:_P F2Q\4>*].TW3#:>+O&5ENM860V/B?
M7K5D9T620C[-JBHH\QB5PNT*< UO6OQ7^*]NRI:?%CXFPHFXJL/Q#\6A1DC/
M U52K$@ J!CCDGB@#_5WO=-FM=IN(?)9@-H#QMG"G)PK/MZCKC(YJ*)5158@
M<@'+>F,Y_,?I[\_RL_\ !L'XX\9^+;?]MJ/QAXQ\4^*O[+L_A2UB?$GB'5-=
M:R2YO]06Y^RMJUW=M#YN$640LC.J*IXK^J=BKL""-TA21MA(4LZC 6,Y*#:
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M&%#C!R<'N#V]JL51R!1110 4444 4,GV_(?X49/M^0_PJ3*^I_-J,KZG\VH
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M(5D.[* Z!J&XH5^82[@K)(/FC(R".30!\#^*=*6T>9KR\T^Q4RR$_;=0M+,
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MII"5SU/1>[>@H C).>W1>P]![4$G/;HO8>@]JD)7/4]%[MZ"@E<]3T7NWH*
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M[S3-"^$E_?ZKH%OIUSK6AOJ,>OZ?%/I.HQ6UW+-9Z1=:AJTEK)9Z==M%^J>
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M'3W4I<]:=;%3NE:-*E&_*STKXT::SZ_K<\<962VEN(Y"&$6'WL)2@3Y "Q8
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M'^-2%QGH>B^GH/>DWCT/Z?XT ,V-Z?J/\:-C>GZC_&G[QZ']/\:-X]#^G^-
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M&/[W;&]/U'^-&QO3]1_C3]X]#^G^-&\>A_3_ !K]T/U@:$;/3LW<>A]ZGA!
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MQ$VW"<XN,?Z]?$W_  6$MO#CSV\?[/\ <K);)&[_ &KXD:5-Y8F:1467^RM
MN8!+A2[)'=2[0PW,"2J\M<_\%D-;F)-G\&?#=LBH,F\\8:G=$'"C'^BZ7"N5
M!4'U]B !^,&BZYX<\;ZGH^@/I^CZ&L?VFZ-U%.;5;DQ0C_1W2ST^./;,-QWS
MB2.$1N^0Q9W]'@T*#Q);W>GV&F>';VRMXKB+2-7\-:C;7MY#>6QD58KRS'DW
M40G*_.$MTB1PJ%"6WU_%.8^+OB%F$JJR;B&O",)2A>G@,%-3@HQE*,HK"2<&
MKKEGRN[U3339_EQB./N.,>ZD\OSWV<)5I0H0HY=A54DW3ER+GEAE6O&\7.<J
M2<G%2;TT^Q]8_P"#A>31=<D\/S? /0+F^CU#4]->2+QEJ<,33:=?)8K+M?2Y
M"D<C/YC*QSL 4."<UC>*_P#@O#\9H=#BUCPW\-O@-9O/:2S?V3>^(/&FK:S#
M*I"K;RV5LVFHTQE98V"3QA$W3!S&IS_+C^T5<:CX/^)WC+S;*XT^XL]9U><1
M-&RE<W>F7X+?*"!NF^;#$X5@2#@GZ3T;Q+J$%G801Z?ITXM(O*7STO"\H+/B
M298[F! RET=3&J@F- 0<"OVS@WB;B+%9+2Q.:9QB<36Q-'#5'4JTL/&I1JSI
M0E4A"-'#TY)Q;=O:>TDXWYK,_P!6?V?/A?PWXQ</\;8_C[*J7%6:Y!FG#'U2
M&8S="G1P68Y1CGB\+/#X>I@Z3I5\9A75=64:M=-^ZU%<L?URU#_@OG^V==3-
M!:^!_@?HHGB\RVEA\)^)]1>0$XRJWOBV5)L C/R  @E0>_,M_P %N_VZY;GS
M7UOX96J1%P]E;_#>S2)CY9&UFN+^:X!#\J/,4C;R2"<_ .C6%E+X='B*34]#
MTS5I]1ET^"+4M/O(+#3]USYGEI,D=S%<(\<QNIW+(Q9$CECG5$,D/BKX>:]J
M?AR?7$M]%O;S3T9YKSPYJ-A=V]U8+&K//=012)+:S01N'9)(]S;"0,AQ7TE3
M&9URN<<TQ<KQC54?:1@Y0;NO=5)RBY*]E;\-3_36AX$_1_P4JF'Q/A3P9AFL
M1/"1K8G"8JZQ$H\D&I8C$2I3HPFXIU/K"=YJU/WD?J'\/O\ @O-^U$+A?#WB
MO1?A7K%Y)>_9SJTOA6_L+F"&19G<I::7KEO:3NH5$B_=KD#,@D(9F^AO%O\
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M!+ BQEV#F00J\DKR.S']U?\ @W/29OCG\;)Y553;_"72+3"C)&_QEH#A<[L
MX3' /3L:^PX)HNEG>#A+FLL6YVA47LW+V%5KFC#W9/9O31Z)Z)G\V?2?S#"Y
MEX3<4YEA53E1Q/#U*E)3IINE7AFF5J=*/M\+3JQE3:?+4BX-\W(IMJ1_97"A
M5\D==W?/7_\ 5Z5;JO&P9@!GOU^E6*_?S_'T**** "BBB@"EL/J/U_PHV'U'
MZ_X4;QZ'_OHT;QZ'_OHT &P^H_7_  HV'U'Z_P"%&\>A_P"^C1O'H?\ OHT
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MP=&U"&(JSY<35C*K&-./LXG]0FP^H_7_  HV'U'Z_P"%&\>A_P"^C1O'H?\
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M@G'FAU7[#\>_M;>.?#MDWAOPYJWA^+Q?I/Q \4^%=0TG^SK[6M6T?P?H=MX
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ML:_-O7OBCX#N9[JVM]5GE>+3]2U%PNF3LGV"PC9[KYBG_'T9 !;@Y9USMX%
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MCU@VTMXI^-'.0,_Z)\-.,\8Y//7BOYE? ^F^(?&^J1:/X>LKC4+U]@98(GD
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M=:WNEWEH9FETB*<Q(EM;NWW?HMS;:9^VW\5[3 6._P!2\):4D0/#EOAA#<;
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M1HM\2N6&?MCX2:KH?B*RT_5]!GM;_1]5Q+;:E;VYBAO$C<(&):*"Y&74J%=
M@ &W(Y/SAHNE:?<_9#J&F:'>7:):R7EY_9EM_I&IP1*K7=L98MZP32F9UBE#
M+;HRIG S7U5\.(XTGLX;>"W@B$J VUM%'#%$,J2$CA C4,V3@#!YQ@4 ?HSX
M,54TVV0';MM(?ERO!/89&1QZ\G.>]=H2"#\_]WNO8$>E<;X24MI[R!6 W1Q
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M !H DWKZ_H?\*-Z^OZ'_  J/8WI^H_QHV-Z?J/\ &@"3>OK^A_PHWKZ_H?\
M"H]C>GZC_&C8WI^H_P : )-Z^OZ'_"C>OK^A_P *CV-Z?J/\:-C>GZC_ !H
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M@\_W>Q_NGVKY3_8E^,.D?M"?LK_!CXV:!HNI>']*^)?A&T\4VNC:Q=07FIV
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MBB@ K&U>,2V%_%@'S+6[1LY_B@<#H.>2/PSWXK9JE/$95D3H'$BYXXRF.F:
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MQ!@^),/*G/AO+J'"V)KP^M9;CG*M_:6-E6HSP3HPG1A.G5J\C+KX2:GXQ_:
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MH'GX8Y/+< Y^4<<'WI QS]X]&_A'H?>NEOM'N(;:XE18Y'CAE**?XV2-F3)
M1L%L \_0]:\AO1\<M!D/]M_!O4[JT S]MT&ZAU560J#Y@2Q,KJI'S -" ,X9
M@1D+ZS17Q3Y4MVXR=G_VZF]]/4#N0QS]X]&_A'H?>@,<_>/1OX1Z'WKD_#7B
M:[U_5[#09?"^OZ/JFI7265M#J=A-;1K/*0JB>:5$$: _>DP0HSNQ@BO9Y_AQ
MXQMB0V@33* PWV\]K.O&1G:L_F'((QQSSQQ6D:M.6TXV_FZ>FFM_D!P>X_WC
M_P!\C_&C<?[Q_P"^1_C6W<^'-=MLFXT35( IP2]A<[<\G[RJ5X[\]NI%9$D,
MD1Q)$\9])8Y8SW[.!Z52:>S3]&G^38$>X_WC_P!\C_&E$A7!!.1WV\_^A4!2
M>@7KCJPY]\GC\:=Y9SSL'N&)_DW-,!Z2N2#N+,IW L,Y**Q48)(/..,'()R"
M,@_1W@Z:2XU737E.7%HY&%"A2+=CP 1@@;A]3VQ7SO;Q-+/#'&@8O($PJLS$
MM@8"@$DG. !R3TYKZV\*>&380VU_= K>>3B*(G ACD3&)% YD*D@C.%'&,].
M+%Q;J45VU>]M'?IU?0J4YSLIMR44E!RE*7(NJ@F[03^URI<UDGL=U$<N.2>#
MU '\C5FJ\:D.#@=#TSZ>]6*@D**** "BBB@"AD^I_,T9/J?S-2[?]W_OG_Z]
M&W_=_P"^?_KT 19/J?S-&3ZG\S4NW_=_[Y_^O1M_W?\ OG_Z] $63ZG\S1D^
MI_,U+M_W?^^?_KT;?]W_ +Y_^O0!%D^I_,T9/J?S-2[?]W_OG_Z]&W_=_P"^
M?_KT 19/J?S-&3ZG\S4NW_=_[Y_^O1M_W?\ OG_Z] $63ZG\S7(Z_?6UEJ=K
M)=7=M:QO831I)=3I"K2>="=JLY + '.T>N3BNSV_[O\ WS_]>L74=)CU"XC:
M>WMKB*.*10MS"DT0=]N#Y+]3CDN&' "@=P <3>:OIC@JNJ:;(QYPMY QY'<"
M2O(_'4D;Z#K31R13,=,OP%BD1VYMY1P%))R2 ..>V:]TNO!6CS(RMH.C2%@2
M2MC;Q;F8 $Y.6!([Y(KA]9^%%E<V%]'9Z!I:SSVD\44<;)!B213L8S;U !..
M",+]>@!^,4-M*L0$ME=ALL /L\AVDNQZ;>#Z].>O:E_LRX?K9W3C(*G8X('8
M8VG'^37WVW[,/C<_*=%TP#>Q4C7U3"%B5&U) #A2#D_-ZG-,/[+WC<8QHVG#
MA2<>(B.<>THS0!\"M97,14?8KP'((589'X&.?N]"#@_KQ7W'^RXLD7@;4FFB
MN(7;Q5=E/.5HV:-8$.X!P#LSGD#'4CC%;/\ PR]XW 7&CZ>"H(_Y&$GAN3SY
MV>.O7UXKV7X;_ NX\.Z)/9Z]HMFUZVH23Q[=2>Y1K=HP%RZSD*<@X7 P#DGG
M% 'I.E7=O;(-]S @8[LRS(A^8DXY89'<=NI]:V)=5TR2>&+^UM-,ER1''"+V
M!I';<OR(@?+-SPN"?;/%):?#S2(&3=H&G,%15/F>7-PH!SF0LV.IV[JWHO".
MEV[1RVNB:+#)&RM'BP@6:(@9,B3 C!X!'&<_A@ _'7_@NU^P?\2/V\?V/M+\
M&?!S4_#UM\4?AA\0-)^)/A#1/%6H)H^D>,I["PN]-U+PQ_;,BRPZ7J6H:;=S
M_P!FW-U;R69N52*X**X:OX(O'?\ P2H_X*0>$[NXLK_]BKXP7S0[_-O?"]MH
MVLZ:L<17+6UYIVIF.6&1/]4L440*#/E*<@?ZIGQ+\,ZOXGT2VT_28()IDO4N
M)4N)TA7RTB9=P=R 6SV&"-V1[_/E_P#!OXFW.]8## &50NW65 "[/NX64 #C
MT_''4 _RF]9_89_;1MC)#<?LA_M!VTJ.RRPGX<Z](48.00SJDJMT;YE?:1RO
M KC&_8C_ &PO/"+^RC\?P^!^Z3X:^("#R.6<P]QNSGD#H<$X_P!5;4?V?OC-
M-O\ L_D'=_"-?MXT^[U.YSDD 98\G'/7CF#^S9\<M^_R;4'C!'B.RW+E6)P0
MQ_\ U\T ?YAWA?\ 8(_;CURZAL=%_8X_:#U"ZE)4PGP)J=A'C(V_Z3?26\'_
M  %CC/J,X^NOAG_P1C_X*;_$V^BT6R_90\2^ 4OI6T\:_P#%SQ#X<\'Z!IB7
M49SJ-U+)?7=P;:U^^TUM:/<>6KPQQ3.X8?Z+FE?L^?&:W=?M/V8*I&6;Q! Y
MY&0,)(,@<D$8/;-=O!\#OB+'O2>*TN4=2&,NKI(O*_=$4DC+_P "&<]\XH T
M_P!@#]GJ^_91_8S_ &>/V>=3\1Z9XLU7X6_#C1?#NK>(=$B,.C:GJZB>]U27
M2D/SG3H]0N[B"SED EFMXHY9%5W*C[#).#R?X.Y_NFN=\&Z5=Z-X7T?2[^..
M.[LK.*&9%9945@9#A9$8HP (Y7C&*Z<KP?N_P?P_[)]Z (B3@\G^#N?[II"3
MGJ>B]SZ"IBO!^[_!_#_LGWI"O/\ #T7^'V'O0!$2<]3T7N?04$G/4]%[GT%2
ME>?X>B_P^P]Z"O/\/1?X?8>] $1)SU/1>Y]!02<]3T7N?05*5Y_AZ+_#[#WH
M*\_P]%_A]A[T 1$G/4]%[GT%)D^I_,U,5Y_AZ+_#[#WI-O\ N_\ ?/\ ]>@"
M+)]3^9HR?4_F:EV_[O\ WS_]>C;_ +O_ 'S_ /7H BR?4_F:,GU/YFI=O^[_
M -\__7HV_P"[_P!\_P#UZ (LGU/YFC)]3^9J7;_N_P#?/_UZ-O\ N_\ ?/\
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M_P!E5BB@"OY'^W_X[_\ 94I@S_%V ^[Z#'K4]% $!@S_ !=@/N^@QZT&#/\
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M_D?[?_CO_P!E1Y'^W_X[_P#958HH K^1_M_^._\ V5'D?[?_ ([_ /958HH
MK^1_M_\ CO\ ]E1Y'^W_ ..__958HH K^1_M_P#CO_V5'D?[?_CO_P!E5BB@
M"OY'^W_X[_\ 94>1_M_^._\ V56** *_D?[?_CO_ -E1Y'^W_P"._P#V56**
M (!!C^+L1]WU&/6I(TV C.<G/3']33Z* "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
%HHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>9
<FILENAME>ex21-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><B>EXHIBIT 21.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Subsidiaries</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 25%; border-bottom: Black 1.5pt solid"><B>Name</B></TD>
    <TD STYLE="width: 4%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 26%; border-bottom: Black 1.5pt solid"><B>State of Incorporation</B></TD>
    <TD STYLE="width: 45%; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Neuragen Corp.</TD>
    <TD>&nbsp;</TD>
    <TD>Delaware</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>Breakthrough Products Inc.</TD>
    <TD>&nbsp;</TD>
    <TD>Delaware</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>NomadChoice Pty Ltd.</TD>
    <TD>&nbsp;</TD>
    <TD>Tasmania, Australia</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10 Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>10
<FILENAME>ex31-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
31.1</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Jack Ross, certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I have
    reviewed this Annual Report on Form 10-K of Synergy CHC Corp.</FONT></TD></TR>
<TR>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 90%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
    to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect
    to the period covered by this report;</FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on my knowledge, the financial statements, and other financial information included in this report, fairly present in all
    material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods
    presented in this report;</FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    registrant&rsquo;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls
    and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as
    defined in&nbsp;&nbsp;Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed such disclosure
    controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure
    that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others
    within those entities, particularly during the period in which this report is being prepared;</FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed such internal
    control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision,
    to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
    for external purposes in accordance with generally accepted accounting principles;</FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluated the effectiveness
    of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness
    of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosed in this
    report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s
    most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially
    affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting;
    and</FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    registrant&rsquo;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control
    over financial reporting, to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors
    (or persons performing the equivalent functions):</FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All significant
    deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably
    likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information;
    and</FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any fraud, whether
    or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s internal
    control over financial reporting.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
30, 2016</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Jack Ross</I></FONT></TD>
    <TD STYLE="width: 50%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jack Ross</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Executive Officer)</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10 Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>11
<FILENAME>ex31-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
31.2</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Jack Ross, certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I have
    reviewed this Annual Report on Form 10-K of Synergy CHC Corp.</FONT></TD></TR>
<TR>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 90%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
    to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect
    to the period covered by this report;</FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
    on my knowledge, the financial statements, and other financial information included in this report, fairly present in all
    material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods
    presented in this report;</FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    registrant&rsquo;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls
    and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as
    defined in&nbsp;&nbsp;Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed such disclosure
    controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure
    that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others
    within those entities, particularly during the period in which this report is being prepared;</FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Designed such internal
    control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision,
    to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
    for external purposes in accordance with generally accepted accounting principles;</FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Evaluated the effectiveness
    of the registrant&rsquo;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness
    of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosed in this
    report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s
    most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially
    affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting;
    and</FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    registrant&rsquo;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control
    over financial reporting, to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors
    (or persons performing the equivalent functions):</FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All significant
    deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably
    likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information;
    and</FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any fraud, whether
    or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s internal
    control over financial reporting.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
30, 2016</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Jack Ross</I></FONT></TD>
    <TD STYLE="width: 50%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jack Ross</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
Financial Officer<BR>
(Principal Financial and Accounting Officer)</FONT></P></TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10 Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>12
<FILENAME>ex32-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
32.1</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CERTIFICATION
OF PRINCIPAL EXECUTIVE OFFICER</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PURSUANT
TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned, Jack Ross, Chief Executive Officer of Synergy CHC Corp. (the &ldquo;Company&rdquo;) hereby certifies pursuant to
18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="width: 90%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    Report on Form 10-K of the Company for the year ended December 31, 2015 (the &ldquo;Report&rdquo;) fully complies with the
    requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and</FONT></TD></TR>
<TR>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR>
    <TD></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the information
    contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the
    Company.</FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    March 30, 2016</FONT></TD>
    <TD STYLE="width: 5%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 45%; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Jack Ross</I></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jack Ross</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive
    Officer</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Executive
    Officer)</FONT></TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10 Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>13
<FILENAME>ex32-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Exhibit 32.2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY
ACT OF 2002</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The undersigned, Jack Ross, Chief Financial
Officer of Synergy CHC Corp. (the &ldquo;Company&rdquo;) hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002, that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 5%">(1)</TD>
    <TD STYLE="width: 90%; text-align: justify">the Report on Form 10-K of the Company for the year ended December 31, 2015 (the &ldquo;Report&rdquo;) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">(2)</TD>
    <TD STYLE="text-align: justify">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-bottom: 1.5pt">Dated: March 30, 2016</TD>
    <TD STYLE="width: 5%; padding-bottom: 1.5pt">By:</TD>
    <TD STYLE="width: 45%; border-bottom: Black 1.5pt solid"><I>/s/ Jack Ross</I></TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">Name:</TD>
    <TD STYLE="vertical-align: bottom">Jack Ross</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Chief Financial Officer<BR>
(Principal Financial and Accounting
Officer)</P></TD></TR>
</TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10 Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>14
<FILENAME>snyr-20151231.xml
<DESCRIPTION>XBRL INSTANCE FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 4.11b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: SNYR %2D 20151231 10K FY DFN.xfr; Date: 2016%2D03%2D30T14:49:24Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80130003 -->
<xbrli:xbrl xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2015-01-31" xmlns:us-roles="http://fasb.org/us-roles/2015-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2015-01-31" xmlns:SNYR="http://synergystripscorp.com/20151231">
    <link:schemaRef xlink:href="snyr-20151231.xsd" xlink:type="simple" />
    <xbrli:context id="From2014-10-01to2014-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-10-01</xbrli:startDate>
        <xbrli:endDate>2014-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-01-01to2014-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-01-01</xbrli:startDate>
        <xbrli:endDate>2014-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_custom_StockOptionPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SNYR:StockOptionPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_StockOptionPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SNYR:StockOptionPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-07-30_custom_EquityIncentivePlanTwoThousandsAndFourteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SNYR:EquityIncentivePlanTwoThousandsAndFourteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-07-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_us-gaap_BoardOfDirectorsChairmanMember_us-gaap_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_us-gaap_BoardOfDirectorsChairmanMember_us-gaap_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:BoardOfDirectorsChairmanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-01-01to2014-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-01-01</xbrli:startDate>
        <xbrli:endDate>2014-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-01-01to2014-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-01-01</xbrli:startDate>
        <xbrli:endDate>2014-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-01-01to2014-12-31_custom_CommonStockToBeIssuedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SNYR:CommonStockToBeIssuedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-01-01</xbrli:startDate>
        <xbrli:endDate>2014-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-12-31_custom_CommonStockToBeIssuedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SNYR:CommonStockToBeIssuedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-12-31_custom_CommonStockToBeIssuedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SNYR:CommonStockToBeIssuedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-01-01to2014-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-01-01</xbrli:startDate>
        <xbrli:endDate>2014-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-04-01to2014-04-02_us-gaap_ChiefExecutiveOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-04-01</xbrli:startDate>
        <xbrli:endDate>2014-04-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-10-01to2014-10-31_us-gaap_ChiefExecutiveOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-10-01</xbrli:startDate>
        <xbrli:endDate>2014-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-10-31_us-gaap_ChiefExecutiveOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2013-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2013-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_custom_FocusFactorBusinessMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">SNYR:FocusFactorBusinessMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-01-01to2014-12-31_custom_FocusFactorBusinessMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">SNYR:FocusFactorBusinessMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-01-01</xbrli:startDate>
        <xbrli:endDate>2014-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2013-01-01to2013-12-31_custom_FocusFactorBusinessMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">SNYR:FocusFactorBusinessMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2013-01-01</xbrli:startDate>
        <xbrli:endDate>2013-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-12-31_custom_StockOptionPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SNYR:StockOptionPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-12-31_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_STWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SNYR:STWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_FactorNutritionLabsLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SNYR:FactorNutritionLabsLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_KnightTherapeuticsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SNYR:KnightTherapeuticsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-06-24to2015-06-26_custom_KnightTherapeuticsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SNYR:KnightTherapeuticsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-06-24</xbrli:startDate>
        <xbrli:endDate>2015-06-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_custom_KnightTherapeuticsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SNYR:KnightTherapeuticsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_ContributionAgreementMember_custom_HandMDCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:ContributionAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SNYR:HandMDCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-03-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-03-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_custom_CommonStockToBeIssuedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SNYR:CommonStockToBeIssuedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_CommonStockToBeIssuedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SNYR:CommonStockToBeIssuedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-11-11to2015-11-12">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-11-11</xbrli:startDate>
        <xbrli:endDate>2015-11-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-11-12">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-11-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-21to2015-01-22_custom_FocusFactorBusinessMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">SNYR:FocusFactorBusinessMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-21</xbrli:startDate>
        <xbrli:endDate>2015-01-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-21to2015-01-22_custom_FocusFactorBusinessMember_custom_JanuaryTwentyTwoThousandSixteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">SNYR:FocusFactorBusinessMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">SNYR:JanuaryTwentyTwoThousandSixteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-21</xbrli:startDate>
        <xbrli:endDate>2015-01-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-21to2015-01-22_custom_FocusFactorBusinessMember_custom_JanuaryTwentyTwoThousandSeventeenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">SNYR:FocusFactorBusinessMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CreationDateAxis">SNYR:JanuaryTwentyTwoThousandSeventeenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-21</xbrli:startDate>
        <xbrli:endDate>2015-01-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-12-02to2015-12-03_custom_KnightTherapeuticsBarbadosIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SNYR:KnightTherapeuticsBarbadosIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-12-02</xbrli:startDate>
        <xbrli:endDate>2015-12-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_custom_KnightTherapeuticsBarbadosIncMember200683570">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SNYR:KnightTherapeuticsBarbadosIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_custom_KnightTherapeuticsIncMember_custom_SecurityAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SNYR:KnightTherapeuticsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:SecurityAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_custom_HandMDLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SNYR:HandMDLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-08-17to2015-08-18_custom_HandMDLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SNYR:HandMDLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-08-17</xbrli:startDate>
        <xbrli:endDate>2015-08-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-08-18_custom_HandMDLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SNYR:HandMDLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-08-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-08-17to2015-08-18_custom_HandMDLLCMember_custom_LicenseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SNYR:HandMDLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:LicenseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-08-17</xbrli:startDate>
        <xbrli:endDate>2015-08-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-08-18_custom_HandMDLLCMember_custom_LicenseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SNYR:HandMDLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:LicenseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-08-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-08-17to2015-08-18_custom_HandMDLLCMember_custom_LicenseAgreementMember_custom_SecondYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SNYR:HandMDLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:LicenseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">SNYR:SecondYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-08-17</xbrli:startDate>
        <xbrli:endDate>2015-08-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-08-17to2015-08-18_custom_HandMDLLCMember_custom_LicenseAgreementMember_custom_ThiredYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SNYR:HandMDLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:LicenseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">SNYR:ThiredYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-08-17</xbrli:startDate>
        <xbrli:endDate>2015-08-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-08-18_custom_HandMDLLCMember_custom_ConsultingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SNYR:HandMDLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:ConsultingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-08-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-08-17to2015-08-18_custom_HandMDLLCMember_custom_ConsultingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SNYR:HandMDLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:ConsultingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-08-17</xbrli:startDate>
        <xbrli:endDate>2015-08-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-08-17to2015-08-18_custom_BreakthroughProductsIncMember_custom_StockPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SNYR:BreakthroughProductsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:StockPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-08-17</xbrli:startDate>
        <xbrli:endDate>2015-08-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-12-16to2015-12-17_custom_BreakthroughProductsIncMember_custom_SettlementAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SNYR:BreakthroughProductsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:SettlementAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-12-16</xbrli:startDate>
        <xbrli:endDate>2015-12-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-17_custom_BreakthroughProductsIncMember_custom_SettlementAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SNYR:BreakthroughProductsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:SettlementAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-17</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-12-16to2015-12-17_custom_BreakthroughProductsIncMember_custom_SettlementAgreementMember_custom_NoncompeteProvisionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SNYR:BreakthroughProductsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:SettlementAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">SNYR:NoncompeteProvisionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-12-16</xbrli:startDate>
        <xbrli:endDate>2015-12-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-12-16to2015-12-17_custom_BreakthroughProductsIncMember_custom_SettlementAgreementMember_custom_UrgentRxSellersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SNYR:BreakthroughProductsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:SettlementAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SNYR:UrgentRxSellersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-12-16</xbrli:startDate>
        <xbrli:endDate>2015-12-17</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-11-14to2015-11-15_custom_TprInvestmentsPtyLtdMember_custom_StockPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SNYR:TprInvestmentsPtyLtdMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:StockPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-11-14</xbrli:startDate>
        <xbrli:endDate>2015-11-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-11-14to2015-11-15_custom_TprInvestmentsPtyLtdMember_custom_StockPurchaseAgreementMember_custom_AustralianDollerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SNYR:TprInvestmentsPtyLtdMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:StockPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CurrencyAxis">SNYR:AustralianDollerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-11-14</xbrli:startDate>
        <xbrli:endDate>2015-11-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-11-14to2015-11-15_custom_TprInvestmentsPtyLtdMember_custom_StockPurchaseAgreementMember_custom_NoncompeteProvisionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SNYR:TprInvestmentsPtyLtdMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:StockPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">SNYR:NoncompeteProvisionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-11-14</xbrli:startDate>
        <xbrli:endDate>2015-11-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_custom_TprInvestmentsPtyLtdMember_custom_StockPurchaseAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SNYR:TprInvestmentsPtyLtdMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:StockPurchaseAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_HandMDLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SNYR:HandMDLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_BreakthroughProductsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SNYR:BreakthroughProductsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_TprInvestmentsPtyLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SNYR:TprInvestmentsPtyLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_custom_TprInvestmentsPtyLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SNYR:TprInvestmentsPtyLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-01-01to2014-12-31_custom_BreakthroughProductsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SNYR:BreakthroughProductsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-01-01</xbrli:startDate>
        <xbrli:endDate>2014-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-01-01to2014-12-31_custom_TprInvestmentsPtyLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SNYR:TprInvestmentsPtyLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-01-01</xbrli:startDate>
        <xbrli:endDate>2014-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_FactorNutritionLabsLLCMember_custom_JanuaryTwentyTwoTwoThousandFifteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SNYR:FactorNutritionLabsLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">SNYR:JanuaryTwentyTwoTwoThousandFifteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_FactorNutritionLabsLLCMember_custom_JanuaryTwentyTwoThousandSixteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SNYR:FactorNutritionLabsLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">SNYR:JanuaryTwentyTwoThousandSixteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_FactorNutritionLabsLLCMember_custom_JanuaryTwentyTwoThousandSaventeenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SNYR:FactorNutritionLabsLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">SNYR:JanuaryTwentyTwoThousandSaventeenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_FactorNutritionLabsLLCMember209497907">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SNYR:FactorNutritionLabsLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_BreakthroughProductsIncMember_custom_UrgentRxMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SNYR:BreakthroughProductsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SNYR:UrgentRxMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_TprInvestmentsPtyLtdMember_custom_NomadChoiceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SNYR:TprInvestmentsPtyLtdMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SNYR:NomadChoiceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_custom_SuppliersOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SNYR:SuppliersOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_custom_SuppliersTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SNYR:SuppliersTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_custom_SuppliersThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SNYR:SuppliersThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_custom_SuppliersFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SNYR:SuppliersFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_us-gaap_ChiefExecutiveOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SNYR:KnightTherapeuticsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:LoanAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_KnightTherapeuticsIncMember_custom_SecurityAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SNYR:KnightTherapeuticsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:SecurityAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_ConsultingAgreementMember_custom_MsHarshbargerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:ConsultingAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">SNYR:MsHarshbargerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_HandMDLLCMember216380656">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SNYR:HandMDLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-11-12_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SNYR:KnightTherapeuticsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:LoanAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-11-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_KnightTherapeuticsIncMember_custom_RoyaltyDistributionAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SNYR:KnightTherapeuticsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:RoyaltyDistributionAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-01-22_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SNYR:KnightTherapeuticsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:LoanAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-01-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-21to2015-01-22_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_OriginationFeeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SNYR:KnightTherapeuticsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:LoanAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">SNYR:OriginationFeeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-21</xbrli:startDate>
        <xbrli:endDate>2015-01-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-21to2015-01-22_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_WorkFeeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SNYR:KnightTherapeuticsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:LoanAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">SNYR:WorkFeeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-21</xbrli:startDate>
        <xbrli:endDate>2015-01-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-21to2015-01-22_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SNYR:KnightTherapeuticsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:LoanAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-21</xbrli:startDate>
        <xbrli:endDate>2015-01-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-01-22_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_JanuaryTwentyTwoThousandFifteenLoanOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SNYR:KnightTherapeuticsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:LoanAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">SNYR:JanuaryTwentyTwoThousandFifteenLoanOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-01-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-21to2015-01-22_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_JanuaryTwentyTwoThousandFifteenLoanOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SNYR:KnightTherapeuticsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:LoanAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">SNYR:JanuaryTwentyTwoThousandFifteenLoanOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-21</xbrli:startDate>
        <xbrli:endDate>2015-01-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-21to2015-01-22_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_STWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SNYR:KnightTherapeuticsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:LoanAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SNYR:STWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-21</xbrli:startDate>
        <xbrli:endDate>2015-01-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-01-22_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_STWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SNYR:KnightTherapeuticsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:LoanAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SNYR:STWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-01-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-21to2015-01-22_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_LTWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SNYR:KnightTherapeuticsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:LoanAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SNYR:LTWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-21</xbrli:startDate>
        <xbrli:endDate>2015-01-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-01-22_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_LTWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SNYR:KnightTherapeuticsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:LoanAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SNYR:LTWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-01-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_STWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SNYR:KnightTherapeuticsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:LoanAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SNYR:STWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_LTWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SNYR:KnightTherapeuticsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:LoanAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SNYR:LTWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_STWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SNYR:KnightTherapeuticsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:LoanAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SNYR:STWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_LTWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SNYR:KnightTherapeuticsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:LoanAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">SNYR:LTWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember220952640">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SNYR:KnightTherapeuticsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:LoanAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SNYR:KnightTherapeuticsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:LoanAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-21to2015-01-22_custom_AssetPurchaseAgreementMember_custom_JanuaryTwentyTwoTwoThousandFifteenLoanTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:AssetPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">SNYR:JanuaryTwentyTwoTwoThousandFifteenLoanTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-21</xbrli:startDate>
        <xbrli:endDate>2015-01-22</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-01-22_custom_AssetPurchaseAgreementMember_custom_JanuaryTwentyTwoTwoThousandFifteenLoanTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:AssetPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">SNYR:JanuaryTwentyTwoTwoThousandFifteenLoanTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-01-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-01-22_custom_AssetPurchaseAgreementMember_custom_JanuaryTwentyTwoTwoThousandFifteenLoanTwoMember_custom_JanuaryTwentyTwoThousandSaventeenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:AssetPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">SNYR:JanuaryTwentyTwoTwoThousandFifteenLoanTwoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">SNYR:JanuaryTwentyTwoThousandSaventeenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-01-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-01-22_custom_AssetPurchaseAgreementMember_custom_JanuaryTwentyTwoTwoThousandFifteenLoanTwoMember_custom_JanuaryTwentyTwoThousandSixteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:AssetPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">SNYR:JanuaryTwentyTwoTwoThousandFifteenLoanTwoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">SNYR:JanuaryTwentyTwoThousandSixteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-01-22</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_AssetPurchaseAgreementMember_custom_JanuaryTwentyTwoTwoThousandFifteenLoanTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:AssetPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">SNYR:JanuaryTwentyTwoTwoThousandFifteenLoanTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-06-25to2015-06-26_custom_SecurityAgreementMember_custom_JuneTwentySixTwoThousandFifteenMember_custom_NeuragenCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:SecurityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">SNYR:JuneTwentySixTwoThousandFifteenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SNYR:NeuragenCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-06-25</xbrli:startDate>
        <xbrli:endDate>2015-06-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-26_custom_SecurityAgreementMember_custom_JuneTwentySixTwoThousandFifteenMember_custom_NeuragenCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:SecurityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">SNYR:JuneTwentySixTwoThousandFifteenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SNYR:NeuragenCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-26</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-26_custom_SecurityAgreementMember_custom_JuneTwentySixTwoThousandFifteenMember_custom_JuneThirtyTwoThousandSixteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:SecurityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">SNYR:JuneTwentySixTwoThousandFifteenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">SNYR:JuneThirtyTwoThousandSixteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-26</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-26_custom_SecurityAgreementMember_custom_JuneTwentySixTwoThousandFifteenMember_custom_QuarterEndingSeptemberThirtyTwoThousandSaventeenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:SecurityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">SNYR:JuneTwentySixTwoThousandFifteenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">SNYR:QuarterEndingSeptemberThirtyTwoThousandSaventeenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-26</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-06-26_custom_SecurityAgreementMember_custom_JuneTwentySixTwoThousandFifteenMember_custom_JuneThirtyTwoThousandSixteenMember_us-gaap_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:SecurityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">SNYR:JuneTwentySixTwoThousandFifteenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">SNYR:JuneThirtyTwoThousandSixteenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-06-26</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-06-25to2015-06-26_custom_SecurityAgreementMember_custom_JuneTwentySixTwoThousandFifteenMember_custom_USMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:SecurityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">SNYR:JuneTwentySixTwoThousandFifteenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">SNYR:USMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-06-25</xbrli:startDate>
        <xbrli:endDate>2015-06-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-06-25to2015-06-26_custom_SecurityAgreementMember_custom_JuneTwentySixTwoThousandFifteenMember_custom_USMember_custom_NeuragenCorpMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:SecurityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">SNYR:JuneTwentySixTwoThousandFifteenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">SNYR:USMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SNYR:NeuragenCorpMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-06-25</xbrli:startDate>
        <xbrli:endDate>2015-06-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_SecurityAgreementMember_custom_JuneTwentySixTwoThousandFifteenMember_custom_QuarterEndingSeptemberThirtyTwoThousandSaventeenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:SecurityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">SNYR:JuneTwentySixTwoThousandFifteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_custom_SecurityAgreementMember_custom_JuneTwentySixTwoThousandFifteenMember_custom_QuarterEndingSeptemberThirtyTwoThousandSaventeenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:SecurityAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">SNYR:JuneTwentySixTwoThousandFifteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_custom_SecurityAgreementMember_custom_JuneTwentySixTwoThousandFifteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:SecurityAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-11-12_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember223527046">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SNYR:KnightTherapeuticsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:LoanAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-11-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-11-11to2015-11-12_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_OriginationFeeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SNYR:KnightTherapeuticsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:LoanAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">SNYR:OriginationFeeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-11-11</xbrli:startDate>
        <xbrli:endDate>2015-11-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-11-11to2015-11-12_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_WorkFeeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SNYR:KnightTherapeuticsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:LoanAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">SNYR:WorkFeeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-11-11</xbrli:startDate>
        <xbrli:endDate>2015-11-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-11-11to2015-11-12_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SNYR:KnightTherapeuticsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:LoanAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-11-11</xbrli:startDate>
        <xbrli:endDate>2015-11-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-11-11to2015-11-12_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_us-gaap_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SNYR:KnightTherapeuticsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:LoanAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-11-11</xbrli:startDate>
        <xbrli:endDate>2015-11-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-11-12_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_KnightWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SNYR:KnightTherapeuticsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:LoanAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">SNYR:KnightWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-11-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-11-11to2015-11-12_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_KnightWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SNYR:KnightTherapeuticsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:LoanAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">SNYR:KnightWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-11-11</xbrli:startDate>
        <xbrli:endDate>2015-11-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-11-12_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_KnightWarrantsOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SNYR:KnightTherapeuticsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:LoanAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">SNYR:KnightWarrantsOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-11-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-11-11to2015-11-12_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_KnightWarrantsOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SNYR:KnightTherapeuticsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:LoanAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">SNYR:KnightWarrantsOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-11-11</xbrli:startDate>
        <xbrli:endDate>2015-11-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_KnightWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SNYR:KnightTherapeuticsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:LoanAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">SNYR:KnightWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_KnightWarrantsOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SNYR:KnightTherapeuticsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:LoanAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">SNYR:KnightWarrantsOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_KnightWarrantsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SNYR:KnightTherapeuticsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:LoanAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">SNYR:KnightWarrantsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_KnightWarrantsOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SNYR:KnightTherapeuticsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:LoanAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">SNYR:KnightWarrantsOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_LoanAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:LoanAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_NoteHolderMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SNYR:NoteHolderMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_StockPurchaseAgreementMember_custom_NomadChoiceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:StockPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SNYR:NomadChoiceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_StockPurchaseAgreementMember_custom_BreakthroughProductsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:StockPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">SNYR:BreakthroughProductsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_us-gaap_AccountsPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_us-gaap_AccountsPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_StockPurchaseAgreementMember_us-gaap_InvestorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:StockPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-12-31_custom_MergerAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:MergerAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-04-01to2014-04-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-04-01</xbrli:startDate>
        <xbrli:endDate>2014-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_custom_NovemberTwoThousandSixteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">SNYR:NovemberTwoThousandSixteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_custom_DecemberTwoThousandSixteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">SNYR:DecemberTwoThousandSixteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_custom_NovemberTwoThousandSixteenMember_custom_AustralianDollerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">SNYR:NovemberTwoThousandSixteenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CurrencyAxis">SNYR:AustralianDollerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_custom_DecemberTwoThousandSixteenMember_custom_AustralianDollerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementScenarioAxis">SNYR:DecemberTwoThousandSixteenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:CurrencyAxis">SNYR:AustralianDollerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-12-07to2014-12-08_custom_SubsidiaryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SNYR:SubsidiaryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-12-07</xbrli:startDate>
        <xbrli:endDate>2014-12-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_custom_SubsidiaryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SNYR:SubsidiaryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_SubsidiaryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SNYR:SubsidiaryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-03-30to2014-04-02_us-gaap_ChiefExecutiveOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">us-gaap:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-03-30</xbrli:startDate>
        <xbrli:endDate>2014-04-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-12-13to2015-12-14_custom_TwoBoardMembersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">SNYR:TwoBoardMembersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-12-13</xbrli:startDate>
        <xbrli:endDate>2015-12-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-12-13to2015-12-14_custom_TwoEmployeeMembersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TitleOfIndividualAxis">SNYR:TwoEmployeeMembersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-12-13</xbrli:startDate>
        <xbrli:endDate>2015-12-14</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_custom_StockOptionPlanMember_us-gaap_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SNYR:StockOptionPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_custom_StockOptionPlanMember_us-gaap_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">SNYR:StockOptionPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_us-gaap_WarrantMember_custom_ExercisePriceRangeOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">SNYR:ExercisePriceRangeOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_us-gaap_WarrantMember_custom_ExercisePriceRangeOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">SNYR:ExercisePriceRangeOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_us-gaap_WarrantMember_custom_ExercisePriceRangeTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">SNYR:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_us-gaap_WarrantMember_custom_ExercisePriceRangeTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">SNYR:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_us-gaap_WarrantMember_custom_ExercisePriceRangeThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">SNYR:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_us-gaap_WarrantMember_custom_ExercisePriceRangeThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RangeAxis">SNYR:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_custom_UnitedStatesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">SNYR:UnitedStatesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_custom_ForeignCountriesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">SNYR:ForeignCountriesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-01-01to2014-12-31_custom_UnitedStatesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">SNYR:UnitedStatesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-01-01</xbrli:startDate>
        <xbrli:endDate>2014-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-01-01to2014-12-31_custom_ForeignCountriesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">SNYR:ForeignCountriesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-01-01</xbrli:startDate>
        <xbrli:endDate>2014-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_custom_FocusFactorBusinessMember234188966">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:FocusFactorBusinessMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_custom_FlatTummyTeaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:FlatTummyTeaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_custom_OtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:OtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-01-01to2014-12-31_custom_FocusFactorBusinessMember234273690">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:FocusFactorBusinessMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-01-01</xbrli:startDate>
        <xbrli:endDate>2014-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-01-01to2014-12-31_custom_FlatTummyTeaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:FlatTummyTeaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-01-01</xbrli:startDate>
        <xbrli:endDate>2014-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-01-01to2014-12-31_custom_OtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:OtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-01-01</xbrli:startDate>
        <xbrli:endDate>2014-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_UnitedStatesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">SNYR:UnitedStatesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_ForeignCountriesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">SNYR:ForeignCountriesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-12-31_custom_UnitedStatesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">SNYR:UnitedStatesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2014-12-31_custom_ForeignCountriesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementGeographicalAxis">SNYR:ForeignCountriesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2014-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_custom_OtherMember_us-gaap_SalesRevenueNetMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:OtherMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2014-01-01to2014-12-31_custom_OtherMember_us-gaap_SalesRevenueNetMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">SNYR:OtherMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2014-01-01</xbrli:startDate>
        <xbrli:endDate>2014-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_custom_BreakthroughProductsIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SNYR:BreakthroughProductsIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-01-01to2015-12-31_custom_BreakthroughProductsIncMember_us-gaap_DomesticCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SNYR:BreakthroughProductsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-01-01</xbrli:startDate>
        <xbrli:endDate>2015-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_custom_BreakthroughProductsIncMember_us-gaap_DomesticCountryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001562733</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">SNYR:BreakthroughProductsIncMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPerShare">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Segment">
      <xbrli:measure>SNYR:Segment</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="AUD">
      <xbrli:measure>iso4217:AUD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Customer">
      <xbrli:measure>SNYR:Customer</xbrli:measure>
    </xbrli:unit>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2014-12-31" unitRef="USDPerShare" decimals="INF">0.00001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2015-12-31" unitRef="USDPerShare" decimals="INF">0.00001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2014-12-31" unitRef="Shares" decimals="INF">75000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2015-12-31_us-gaap_BoardOfDirectorsChairmanMember_us-gaap_MaximumMember" unitRef="Shares" decimals="INF">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2015-12-31_us-gaap_BoardOfDirectorsChairmanMember_us-gaap_MinimumMember" unitRef="Shares" decimals="INF">75000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2015-12-31" unitRef="Shares" decimals="INF">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2014-12-31" unitRef="Shares" decimals="INF">62100000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2015-12-31" unitRef="Shares" decimals="INF">81692954</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2015-12-31_custom_STWarrantMember" unitRef="Shares" decimals="INF">4595187</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2015-12-31_custom_ContributionAgreementMember_custom_HandMDCorpMember" unitRef="Shares" decimals="INF">2142857</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2015-12-31_custom_LoanAgreementMember" unitRef="Shares" decimals="INF">5550625</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2015-12-31_custom_NoteHolderMember" unitRef="Shares" decimals="INF">400000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2015-12-31_custom_StockPurchaseAgreementMember_custom_NomadChoiceMember" unitRef="Shares" decimals="INF">3571428</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2015-12-31_custom_StockPurchaseAgreementMember_custom_BreakthroughProductsIncMember" unitRef="Shares" decimals="INF">3000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2015-12-31_custom_StockPurchaseAgreementMember_us-gaap_InvestorMember" unitRef="Shares" decimals="INF">2000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2014-12-31_custom_MergerAgreementMember" unitRef="Shares" decimals="INF">16000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue contextRef="AsOf2014-12-31" unitRef="USD" decimals="0">621</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">817</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2015-12-31_custom_NoteHolderMember" unitRef="USD" decimals="0">100000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2015-12-31_custom_StockPurchaseAgreementMember_us-gaap_InvestorMember" unitRef="USD" decimals="0">500000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2014-12-31_custom_MergerAgreementMember" unitRef="USD" decimals="0">25000</us-gaap:CommonStockValue>
    <us-gaap:NatureOfOperations contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 1 &amp;#150; Nature of the Business&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Synergy CHC Corp. (&amp;#147;Synergy&amp;#148;, &amp;#147;we&amp;#148;,&#13;&amp;#147;us&amp;#148;, &amp;#147;our&amp;#148; or the &amp;#147;Company&amp;#148;) (formerly Synergy Strips Corp.) was incorporated on December&#13;29, 2010 in Nevada under the name &amp;#147;Oro Capital Corporation.&amp;#148; On April 21, 2014, the Company changed its fiscal year&#13;end from July 31 to December 31. On April 28, 2014, the Company changed its name to &amp;#147;Synergy Strips Corp.&amp;#148;. On August&#13;5, 2015, the Company changed its name to &amp;#147;Synergy CHC Corp.&amp;#148;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company is a consumer health care company&#13;that is in the process of building a portfolio of best-in-class consumer product brands. Synergy&amp;#146;s strategy is to grow its&#13;portfolio both organically and by further acquisition.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Synergy is the sole owner of three subsidiaries:&#13;Neuragen Corp., Breakthrough Products, Inc. and NomadChoice Pty Ltd. and the results have been consolidated in these statements.&lt;/p&gt;</us-gaap:NatureOfOperations>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 14 &amp;#150; Commitments and Contingencies&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Litigation:&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;From time to time the Company may become a&#13;party to litigation in the normal course of business. Management believes that there are no current legal matters that would have&#13;a material effect on the Company&amp;#146;s financial position or results of operations.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Operating leases&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In April 2014, a subsidiary entered into an&#13;extension of a non-cancellable operating lease for office space that expires on March 31, 2017. Rent expense under this lease for&#13;the period from acquisition until December 31, 2015 was $8,923 per month less a $3,010 per month sublease through March 2017.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In December 2015, a subsidiary entered into&#13;a non-cancellable operating lease for office space through November 2016. Rental payments under this lease are $5,500 Australian&#13;dollars per month, which is approximately $4,200.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In December 2015, the Company entered into&#13;a non-cancellable operating lease for office space through December 2016. Rental payments under this lease are $5,500 per month.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following is a schedule by years of future&#13;minimum rental payments required under operating leases that have initial or remaining non-cancelable lease terms in excess of&#13;one year as of December 31, 2015:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;Year ending December 31:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 84%"&gt;&lt;font style="font-size: 10pt"&gt;2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;220,676&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;27,294&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;247,970&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On December 8, 2014, a subsidiary entered into&#13;a non-cancellable 36 month phone lease with an estimated cost of $894 a month.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following is a schedule by years of future&#13;minimum rental payments required under operating leases that have initial or remaining non-cancelable lease terms in excess of&#13;one year as of December 31, 2015:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;Year ending December 31:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 84%"&gt;&lt;font style="font-size: 10pt"&gt;2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;10,728&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9,834&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;20,562&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 13 &amp;#150; Stockholders&amp;#146; Deficit&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The total number of shares of all classes of&#13;capital stock which the Company is authorized to issue is 75,000,000 shares of common stock with $0.00001 par value. On July 30,&#13;2014, the Company&amp;#146;s board of directors approved an increase of the Company&amp;#146;s authorized common stock from 75,000,000&#13;to 300,000,000 shares, which increase was approved by the Company&amp;#146;s shareholders and became effective on August 5, 2015.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On April 17, 2014, upon approval from FINRA,&#13;the Company effected a 30 for 1 forward stock split by way of a stock dividend, of all of its issued and outstanding shares of&#13;common stock (the &amp;#147;Stock Split&amp;#148;). The Stock Split did not affect the number of the Company&amp;#146;s authorized common&#13;stock or its par value. All references in the accompanying consolidated financial statements and notes thereto have been retroactively&#13;restated to reflect the stock split.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the year ended December 31, 2015, the&#13;Company issued 4,595,187 shares of its common stock upon exercise of the ST Warrant at an aggregate exercise price of $1.00 in&#13;connection with the Loan Agreement (see note1).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the year ended December 31, 2015, the&#13;Company issued 5,550,625 shares of its common stock upon exercise of a Warrant at an aggregate exercise price of $1.00 in connection&#13;with the Loan Agreement (see note1).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the year ended December 31, 2015, the&#13;Company issued 400,000 shares of its common stock to a note holder in a note conversion at $0.25 per share. At the time of conversion,&#13;the note was valued at $100,000 for outstanding principal.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the year ended December 31, 2015, the&#13;Company issued 2,142,857 shares of its common stock valued at $0.70 per share in accordance with Contribution Agreement entered&#13;into with Hand MD Corp. in exchange for 50% of Hand MD Corp.&amp;#146;s outstanding capital securities.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the year ended December 31, 2015, the&#13;Company issued 3,571,428 shares of its common stock valued at $0.35 per share in accordance with a stock purchase agreement entered&#13;into with NomadChoice Pty Limited in exchange for 100% of NomadChoice Pty Limited&amp;#146;s outstanding capital securities.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the year ended December 31, 2015, the&#13;Company issued 3,000,000 shares of its common stock valued at $0.85 per share in accordance with a stock purchase agreement entered&#13;into with Breakthrough Products, Inc. in exchange for 100% of Breakthrough Product Inc.&amp;#146;s outstanding capital securities.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the year ended December 31, 2015, the&#13;Company issued 40,000 shares of its common stock valued at $0.65 per share for cash.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the year ended December 31, 2015, the&#13;Company issued 292,857 shares of its common stock valued at $0.70 per share to settle accounts payable.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On April 21, 2014, the Company entered into&#13;an agreement with accredited investors for the issuance and sale of 2,000,000 shares of its common stock at a purchase price of&#13;$0.25 per share, for an aggregate consideration of $500,000.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the year ended December 31, 2014, the&#13;Company cancelled 135,900,000 shares of its common stock (4,530,000 pre-Stock Split) as part of the Merger transaction.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the year ended December 31, 2014, the&#13;Company issued 16,000,000 shares of its common stock valued at $25,000 as part of the Merger Agreement.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the year ended December 31, 2015 and&#13;2014, the Company committed to issue common stock valued at $28,000 and $40,000, respectively for services rendered.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As of December 31, 2015 and 2014, there were&#13;81,692,954 and 62,100,000 shares of the Company&amp;#146;s common stock issued and outstanding, respectively.&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 2 &amp;#150; Summary of Significant&#13;Accounting Policies&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Basis of Presentation&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The consolidated financial statements&#13;include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have&#13;been eliminated in consolidation.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Use of Estimates&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The preparation of the consolidated&#13;financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported&#13;amounts of assets and liabilities, and disclosure of contingent liabilities at the date of the financial statements and the reported&#13;amounts of expenses during the reporting period. Actual results could differ from those estimates. At December 31, 2015 and 2014&#13;significant estimates included in these estimates are assumptions about collection of accounts receivable, useful life of fixed&#13;and intangible assets, goodwill and assumptions used in Black-Scholes-Merton, or BSM, valuation methods, such as expected volatility,&#13;stock based compensation, risk-free interest rate, and expected dividend rate.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Cash and Cash Equivalents&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company considers all cash on hand&#13;and in banks, including accounts in book overdraft positions, certificates of deposit and other highly-liquid investments with&#13;maturities of three months or less, when purchased, to be cash and cash equivalents. As of December 31, 2015 the Company had no&#13;cash equivalents. The Company maintains its cash and cash equivalents in banks insured by the Federal Deposit Insurance Corporation&#13;(FDIC) in accounts that at times may be in excess of the federally insured limit of $250,000 per bank. The Company minimizes this&#13;risk by placing its cash deposits with major financial institutions. At December 31, 2015, the uninsured balance amounted to $3,453,290.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Capitalization of Fixed Assets&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company capitalizes expenditures&#13;related to property and equipment, subject to a minimum rule, that have a useful life greater than one year for: (1) assets purchased;&#13;(2) existing assets that are replaced, improved or the useful lives have been extended; or (3) all land, regardless of cost. Acquisitions&#13;of new assets, additions, replacements and improvements (other than land) costing less than the minimum rule in addition to maintenance&#13;and repair costs, including any planned major maintenance activities, are expensed as incurred.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Revenue Recognition&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company recognizes revenue in accordance&#13;with the Financial Accounting Standards Board&amp;#146;s (&amp;#147;FASB&amp;#148;), Accounting Standards Codification (&amp;#147;ASC&amp;#148;)&#13;605, Revenue Recognition (&amp;#147;ASC 605&amp;#148;). ASC 605 requires that four basic criteria must be met before revenue can be recognized:&#13;(1) persuasive evidence of an arrangement exists; (2) delivery has occurred and/or service has been performed; (3) the selling&#13;price is fixed and determinable; and (4) collectability is reasonably assured. The Company believes that these criteria are satisfied&#13;upon shipment from its fulfillment centers. Certain of our distributors may also perform a separate function as a co-packer on&#13;our behalf. In such cases, ownership of and title to our products that are co-packed on our behalf by those co-packers who are&#13;also distributors, passes to such distributors when we are notified by them that they have taken transfer or possession of the&#13;relevant portion of our finished goods. Freight billed to customers is presented as revenues, and the related freight costs are&#13;presented as cost of goods sold. Cancelled orders are refunded if not already dispatched, refunds are only paid if stock is damaged&#13;in transit, discounts are only offered with specific promotions and orders will be refilled if lost in transit.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Accounts receivable&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Accounts receivable are generally unsecured.&#13;The Company establishes an allowance for doubtful accounts receivable based on the age of outstanding invoices and management&amp;#146;s&#13;evaluation of collectability. Accounts are written off after all reasonable collection efforts have been exhausted and management&#13;concludes that likelihood of collection is remote. Any future recoveries are applied against the allowance for doubtful accounts.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Advertising Expense&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company expenses marketing, promotions&#13;and advertising costs as incurred. Such costs are included in general and administrative expense in the accompanying consolidated&#13;statements of operations.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Research and Development&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Costs incurred in connection with the&#13;development of new products and processing methods are charged to general and administrative expenses as incurred.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Income Taxes&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company utilizes FASBASC 740, &amp;#147;Income&#13;Taxes,&amp;#148; which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of&#13;events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities&#13;are determined based on the difference between the tax basis of assets and liabilities and their financial reporting amounts based&#13;on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income.&#13;A valuation allowance is recorded when it is &amp;#147;more likely-than-not&amp;#148; that a deferred tax asset will not be realized.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company generated a deferred tax&#13;asset through net operating loss carry-forward. However, a valuation allowance of 100% has been established due to the uncertainty&#13;of the Company&amp;#146;s realization of the net operating loss carry forward prior to its expiration.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;NomadChoice Pty Ltd, the Company&amp;#146;s&#13;wholly-owned subsidiary is subject to income taxes in the jurisdictions in which it operates. Significant judgment is required&#13;in determining the provision for income tax. There are many transactions and calculations undertaken during the ordinary course&#13;of business for which the ultimate tax determination is uncertain. The company recognizes liabilities for anticipated tax audit&#13;issues based on the Company&amp;#146;s current understanding of the tax law. Where the final tax outcome of these matters is different&#13;from the carrying amounts, such differences will impact the current and deferred tax provisions in the period in which such determination&#13;is made.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Net Earnings (Loss) Per Common Share&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company computes earnings per share&#13;under ASC subtopic 260-10, Earnings Per Share. Basic earnings (loss) per share is computed by dividing the net income (loss) attributable&#13;to the common stockholders (the numerator) by the weighted average number of shares of common stock outstanding (the denominator)&#13;during the reporting periods. Diluted loss per share is computed by increasing the denominator by the weighted average number of&#13;additional shares that could have been outstanding from securities convertible into common stock (using the &amp;#147;treasury stock&amp;#148;&#13;method), unless their effect on net loss per share is anti-dilutive. As of December 31, 2015, options to purchase 5,000,000 shares&#13;of common stock and warrants to purchase 9,132,002 shares of common stock were outstanding these potential shares were excluded&#13;from the shares used to calculate diluted earnings per share as their inclusion would reduce net loss per share.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Going Concern&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company&amp;#146;s consolidated financial&#13;statements are prepared using U.S. GAAP applicable to a going concern, which contemplates the realization of assets and liquidation&#13;of liabilities in the normal course of business. The Company had an accumulated deficit at December 31, 2015 of $8,569,841. The&#13;Company had a working capital deficit of $6,165,812 as of December 31, 2015. Due to acquisitions during 2015 of revenue-producing&#13;products, the Company believes it has established an ongoing source of revenue that is sufficient to cover its operating costs.&#13;The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating&#13;losses until it establishes a revenue stream and becomes profitable. If the Company is unable to obtain adequate capital it could&#13;be forced to cease development of operations.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In order to continue as a going concern&#13;and to develop a reliable source of revenues, and achieve a profitable level of operations the Company will need, among other things,&#13;additional capital resources. Management&amp;#146;s plans to continue as a going concern include raising additional capital through&#13;borrowing and/or sales of equity and debt securities. However, management cannot provide any assurances that the Company will be&#13;successful in accomplishing any of its plans.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The ability of the Company to continue&#13;as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and&#13;eventually secure other sources of financing and attain profitable operations. The accompanying consolidated financial statements&#13;do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Fair Value Measurements&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company measures and discloses the&#13;fair value of assets and liabilities required to be carried at fair value in accordance with ASC 820, Fair Value Measurements and&#13;Disclosures. ASC 820 defines fair value, establishes a framework for measuring fair value, and enhances fair value measurement&#13;disclosure.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;ASC 825 defines fair value as the price&#13;that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants&#13;at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded&#13;at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions&#13;that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk&#13;of nonperformance. ASC 825 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs&#13;and minimize the use of unobservable inputs when measuring fair value. ASC 825 establishes three levels of inputs that may be used&#13;to measure fair value:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Level 1 - Quoted prices for identical&#13;assets or liabilities in active markets to which we have access at the measurement date.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Level 2 - Inputs other than quoted prices&#13;within Level 1 that are observable for the asset or liability, either directly or indirectly.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Level 3 - Unobservable inputs for the&#13;asset or liability.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The determination of where assets and&#13;liabilities fall within this hierarchy is based upon the lowest level of input that is significant to the fair value measurement.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As of December 31, 2015, the Company&#13;has determined that there were no assets or liabilities measured at fair value except for the warrant derivative liability which&#13;is valued using Level 3 estimates.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Inventory&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Inventory consists of raw materials,&#13;components and finished goods. The Company&amp;#146;s inventory is stated at the lower of cost (FIFO cost basis) or market. Finished&#13;goods include the cost of labor to assemble the items.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Stock-Based Compensation&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company adopted the provisions of&#13;ASC 718. We estimate the fair value of stock options using a binomial model, consistent with the provisions of ASC 718 and SEC&#13;Staff Accounting Bulletin No. 107, Share-Based Payment. Option-pricing models require the input of highly subjective assumptions,&#13;including the price volatility of the underlying stock. We determined that the use of implied volatility is expected to be more&#13;reflective of market conditions and, therefore, could reasonably be expected to be a better indicator of our expected volatility&#13;than historical volatility. The expected term assumption used in calculating the estimated fair value of our stock-based compensation&#13;awards using the Black-Scholes-Merton (BSM) model is based on detailed historical data about employees&amp;#146; exercise behavior,&#13;vesting schedules, and death and disability probabilities. In addition, we are required to estimate the expected forfeiture rate&#13;and only recognize expense for those shares expected to vest. We estimate the forfeiture rate based on historical experience of&#13;our stock-based awards that are granted, exercised and cancelled. We believe the resulting BSM calculation provides a more refined&#13;estimate of the fair value of our employee stock options.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Long-lived Assets&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Long-lived assets include equipment&#13;and intangible assets other than those with indefinite lives. We assess the carrying value of our long-lived asset groups when&#13;indicators of impairment exist and recognize an impairment loss when the carrying amount of a long-lived asset is not recoverable&#13;when compared to undiscounted cash flows expected to result from the use and eventual disposition of the asset.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Indicators of impairment include significant&#13;underperformance relative to historical or projected future operating results, significant changes in our use of the assets or&#13;in our business strategy, loss of or changes in customer relationships and significant negative industry or economic trends. When&#13;indications of impairment arise for a particular asset or group of assets, we assess the future recoverability of the carrying&#13;value of the asset (or asset group) based on an undiscounted cash flow analysis. If carrying value exceeds projected, net, undiscounted&#13;cash flows, an additional analysis is performed to determine the fair value of the asset (or asset group), typically a discounted&#13;cash flow analysis, and an impairment charge is recorded for the excess of carrying value over fair value. As of December 31, 2015,&#13;our qualitative analysis of long-lived assets did not indicate any impairment.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Goodwill&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;An asset purchase is accounted for under&#13;the purchase method of accounting. Under that method, assets and liabilities of the business acquired are recorded at their estimated&#13;fair values as of the date of the acquisition, with any excess of the cost of the acquisition over the estimated fair value of&#13;the net tangible and intangible assets acquired recorded as goodwill. As of December 31, 2015 our qualitative analysis of goodwill&#13;did not indicate any impairment.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="background-color: white"&gt;&lt;u&gt;Foreign&#13;Currency Translation&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="background-color: white"&gt;The&#13;functional currency of each of the Company&amp;#146;s foreign subsidiaries is the U.S. Dollar. The Company&amp;#146;s subsidiary maintains&#13;its record using local currency (Australian Dollar). All monetary assets and liabilities of foreign subsidiaries were translated&#13;into U.S. Dollars at fiscal year-end exchange rates, non-monetary assets and liabilities of foreign subsidiaries were translated&#13;into U.S. Dollars at transaction day exchange rates. Income and expense items related to non-monetary items were translated at&#13;exchange rates prevailing during the transaction date and other incomes and expenses were translated using average exchange rate&#13;for the period. The resulting translation adjustments, net of income taxes, were recorded in statements of operations as Remeasurement&#13;gain or loss on translation of foreign subsidiary.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="background-color: white"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="background-color: white"&gt;&lt;u&gt;Concentrations&#13;of Credit Risk&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="background-color: white"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="background-color: white"&gt;In&#13;the normal course of business, the Company provided credit terms to its customers; however, collateral was not required. Accordingly,&#13;the Company performed credit evaluations of its customers and maintained allowances for possible losses which, when realized, were&#13;within the range of management&amp;#146;s expectations. From time to time, a higher concentration of credit risk existed on outstanding&#13;accounts receivable for a select number of customers due to individual buying patterns.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Warehousing costs&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Warehouse costs include all third party&#13;warehouse rent fees and any additional costs relating to assembly or special pack-outs of the Company products are charged to general&#13;and administrative expenses as incurred.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Product display costs&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;All displays manufactured and purchased&#13;by the Company are for placement of product in retail stores. This also includes all costs for display execution and setup and&#13;retail services are charged to general and administrative expenses as incurred.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Warrant Derivative Liabilities&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;ASC 815 generally provides three criteria&#13;that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing&#13;derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks&#13;of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host&#13;contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured&#13;at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings&#13;as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative&#13;instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is&#13;deemed to be conventional, as described.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;A Black-Scholes-Merton option-pricing&#13;model, with dilution effects, was utilized to estimate the fair value of the Warrant Derivative Liabilities as of November 12,&#13;2015 and December 31, 2015. This model is subject to the significant assumptions discussed below and requires the following key&#13;inputs with respect to the Company and/or instrument:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; line-height: 115%"&gt;&lt;b&gt;Input&lt;/b&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"&gt;&lt;b&gt;November 12, 2015&lt;/b&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"&gt;&lt;b&gt;December 31, 2015&lt;/b&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 54%; line-height: 115%"&gt;Stock Price&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right; line-height: 115%"&gt;0.46&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right; line-height: 115%"&gt;0.69&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Exercise Price&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;0.49&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;0.49&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Expected Life (in years)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;10.0&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;9.75&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Stock Volatility&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;157.56&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;%&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;152.07&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;%&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Risk-Free Rate&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;2.32&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;%&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;2.27&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;%&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Dividend Rate&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;0&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;%&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;0&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;%&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt; line-height: 115%"&gt;Outstanding Shares of Common Stock&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;4,547,243&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;4,547,243&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Cost of Sales&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Cost of sales includes the purchase&#13;cost of products sold and all costs associated with getting the products into the retail stores including buying and transportation&#13;costs.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; background-color: white"&gt;&lt;u&gt;Debt&#13;Issuance Costs&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;Debt issuance&#13;costs consist primarily of arrangement fees, professional fees and legal fees. These costs are capitalized and are being amortized&#13;to interest expense over the term of the related debt facilities.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;u&gt;Impairment&#13;of Long-Lived Assets&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;When facts&#13;and circumstances indicate that the carrying values of long-lived assets, including fixed assets, may be impaired, an evaluation&#13;of recoverability is performed by comparing the carrying value of the assets to projected future cash flows in addition to other&#13;quantitative and qualitative analyses. Upon indication that the carrying value of such assets may not be recoverable, the Company&#13;recognizes an impairment loss as a charge against current operations. Long-lived assets to be disposed of are reported at the lower&#13;of the carrying amount or fair value, less estimated costs to sell. The Company makes judgments related to the expected useful&#13;lives of long-lived assets and its ability to realize undiscounted cash flows in excess of the carrying amounts of such assets&#13;which are affected by factors such as the ongoing maintenance and improvements of the assets, changes in economic conditions and&#13;changes in operating performance. As the Company assesses the ongoing expected cash flows and carrying amounts of its long-lived&#13;assets, these factors could cause the Company to realize a material impairment charge.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; background-color: white"&gt;&lt;u&gt;Shipping&#13;Costs&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;Shipping and&#13;handling costs billed to customers are recorded in sales. Shipping costs incurred by the company are recorded in selling and marketing&#13;expenses.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;u&gt;Related&#13;parties&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;Parties are&#13;considered to be related to the Company if the parties that, directly or indirectly, through one or more intermediaries, control,&#13;are controlled by, or are under common control with the Company. Related parties also include principal owners of the Company,&#13;its management, members of the immediate families of principal owners of the Company and its management and other parties with&#13;which the Company may deal if one party controls or can significantly influence the management or operating policies of the other&#13;to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. The All transactions&#13;with related parties shall be recorded at fair value of the goods or services exchanged. Property purchased from a related party&#13;is recorded at the cost to the related party and any payment to or on behalf of the related party in excess of the cost is reflected&#13;as a distribution to the related party.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; background-color: white"&gt;&lt;u&gt;Segment&#13;Reporting&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;font style="background-color: white"&gt;Segment&#13;identification and selection is consistent with the management structure used by the Company&amp;#146;s chief operating decision maker&#13;to evaluate performance and make decisions regarding resource allocation, as well as the materiality of financial results consistent&#13;with that structure. Based on the Company&amp;#146;s management structure and method of internal reporting, the Company has one operating&#13;segment. The Company&amp;#146;s chief operating decision maker does not review operating results on a disaggregated basis; rather,&#13;the chief operating decision maker reviews operating results on an aggregate basis.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Recent Accounting Pronouncements&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;ASU 2015-03&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In April 2015, the FASB issued Accounting&#13;Standards Update (&amp;#147;ASU&amp;#148;) No. 2015-03, Interest - Imputation of Interest (Subtopic 835-30): Simplifying the Presentation&#13;of Debt Issuance Costs. The amendments in this ASU require that debt issuance costs related to a recognized debt liability be presented&#13;in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The&#13;recognition and measurement guidance for debt issuance costs are not affected by the amendments in this ASU. The amendments are&#13;effective for financial statements issued for fiscal years, and interim periods within those fiscal years, beginning after December&#13;15, 2015. The amendments are to be applied on a retrospective basis, wherein the balance sheet of each individual period presented&#13;is adjusted to reflect the period-specific effects of applying the new guidance. The Company is evaluating the possible effect&#13;of this guidance on its financial statements.&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;ASU 2015-02&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In February 2015, the FASB issued ASU&#13;No. 2015-02, Consolidation (Topic 810): Amendments to the Consolidation Analysis, which is intended to improve targeted areas of&#13;consolidation guidance for legal entities such as limited partnerships, limited liability corporations, and securitization structures&#13;(collateralized debt obligations, collateralized loan obligations, and mortgage-backed security transactions). The ASU focuses&#13;on the consolidation evaluation for reporting organizations that are required to evaluate whether they should consolidate certain&#13;legal entities. In addition to reducing the number of consolidation models from four to two, the new standard simplifies the FASB&#13;Accounting Standards Codification and improves current U.S. GAAP by placing more emphasis on risk of loss when determining a controlling&#13;financial interest, reducing the frequency of the application of related-party guidance when determining a controlling financial&#13;interest in a variable interest entity (&amp;#147;VIE&amp;#148;), and changing consolidation conclusions for companies in several industries&#13;that typically make use of limited partnerships or VIEs. The ASU will be effective for fiscal years, and interim periods within&#13;those fiscal years, beginning after December 15, 2015. Early adoption is permitted, including adoption in an interim period. We&#13;do not expect the adoption of ASU 2015-02 to have a material effect on our financial position, results of operations or cash flows.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;ASU 2015-01&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In January 2015, the FASB issued ASU&#13;No. 2015-01, &amp;#147;Income Statement - Extraordinary and Unusual Items (Subtopic 225-20): Simplifying Income Statement Presentation&#13;by Eliminating the Concept of Extraordinary Items.&amp;#148; This ASU eliminates from U.S. GAAP the concept of extraordinary items.&#13;ASU 2015-01 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. A&#13;reporting entity may apply the amendments prospectively. We do not expect the adoption of ASU 2015-01 to have a material effect&#13;on our financial position, results of operations or cash flows.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;ASU 2014-17&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In November 2014, the FASB issued ASU&#13;No. 2014-17, &amp;#147;Business Combinations (Topic 805): Pushdown Accounting.&amp;#148; This ASU provides an acquired entity with an&#13;option to apply pushdown accounting in its separate financial statements upon occurrence of an event in which an acquirer obtains&#13;control of the acquired entity. An acquired entity may elect the option to apply pushdown accounting in the reporting period in&#13;which the change-in-control event occurs. If pushdown accounting is applied to an individual change-in-control event, that election&#13;is irrevocable. ASU 2014-17 was effective on November 18, 2014. The adoption of ASU 2014-17 did not have any effect on our financial&#13;position, results of operations or cash flows.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;ASU 2014-16&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In November 2014, the FASB issued ASU&#13;2014-16, &amp;#147;Derivatives and Hedging (Topic 815).&amp;#148; ASU 2014-16 addresses whether the host contract in a hybrid financial&#13;instrument issued in the form of a share should be accounted for as debt or equity. ASU 2014-16 is effective for fiscal years,&#13;and interim periods within those fiscal years, beginning after December 15, 2015. We do not currently have issued, nor are we investors&#13;in, hybrid financial instruments. Accordingly, we do not expect the adoption of ASU 2014-16 to have any effect on our financial&#13;position, results of operations or cash flows.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;ASU 2014-15&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In August 2014, the FASB issued ASU&#13;No. 2014-15, &amp;#147;Presentation of Financial Statements - Going Concern (Subtopic 205-40)&amp;#148;. ASU 2014-15 provides guidance&#13;related to management&amp;#146;s responsibility to evaluate whether there is substantial doubt about an entity&amp;#146;s ability to&#13;continue as a going concern and to provide related footnote disclosure. ASU 2014-15 is effective for annual periods ending after&#13;December 15, 2016, and for interim and annual periods thereafter. Early application is permitted. We do not expect the adoption&#13;of ASU 2014-15 to have a material effect on our financial position, results of operations or cash flows.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;ASU 2014-12&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In June 2014, the FASB issued ASU No.&#13;2014-12, &amp;#147;Compensation &amp;#150; Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award&#13;Provide That a Performance Target Could Be Achieved after the Requisite Service Period.&amp;#148; This ASU requires that a performance&#13;target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition.&#13;ASU 2014-12 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. We&#13;do not expect the adoption of ASU 2014-12 to have a material effect on our financial position, results of operations or cash flows.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;ASU 2014-09&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In May 2014, the FASB issued ASU No.&#13;2014-09, &amp;#147;Revenue from Contracts with Customers (Topic 606).&amp;#148; ASU 2014-09 affects any entity using U.S. GAAP that either&#13;enters into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets&#13;unless those contracts are within the scope of other standards (e.g., insurance contracts or lease contracts). ASU 2014-09 is effective&#13;for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2016. We are still evaluating the&#13;effect of the adoption of ASU 2014-09. In August 2015, the FASB issued ASU 2015-14, which defers the effective date of ASU 2014-09&#13;by one year for all entities and permits early adoption on a limited basis. ASU 2014-09 will be effective for the Company in the&#13;first quarter of 2018, and early adoption permitted in the first quarter of 2017. The Company does not believe the adoption of&#13;this ASU will have a material impact on its consolidated financial statements.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;ASU 2014-08&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In April 2014, the FASB issued ASU No.&#13;2014-08, &amp;#147;Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360) and Reporting Discontinued&#13;Operations and Disclosures of Disposals of Components of an Entity.&amp;#148; ASU 2014-08 amends the definition for what types of&#13;asset disposals are to be considered discontinued operations, as well as amending the required disclosures for discontinued operations&#13;and assets held for sale. ASU 2014-08 is effective for fiscal years, and interim periods within those fiscal years, beginning on&#13;or after December 15, 2014. The adoption of ASU 2014-08 did not have any effect on our financial position, results of operations&#13;or cash flows.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;There were various updates recently&#13;issued, most of which represented technical corrections to the accounting literature or application to specific industries and&#13;are not expected to a have a material impact on the Company&amp;#146;s condensed financial position, results of operations or cash&#13;flows.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Change in Fiscal Year End&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On April 21, 2014, the Company&amp;#146;s&#13;board of directors approved a change to the Company&amp;#146;s fiscal year end from July 31 to December 31 of each year.&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 15 &amp;#150; Stock Options&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On July 30, 2014, the Company&amp;#146;s board&#13;of directors approved the Company&amp;#146;s 2014 Equity Incentive Plan and the reservation of 15,525,000 shares of common stock for&#13;issuance under such plan. Such plan was approved by the Company&amp;#146;s shareholders and became effective on August 5, 2015.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On April 2, 2014, the Company granted 1,000,000&#13;options with an exercise price of $0.25 per share to the Company owned by Mr. Jack Ross, Chief Executive Officer of the Company.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On December 14, 2015, the Company granted 1,000,000&#13;options each with an exercise price of $0.25 per share to two Board Members of the Company.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On December 14, 2015, the Company granted 1,000,000&#13;options each with an exercise price of $0.65 per share to two employees of the Company.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following table summarizes the changes&#13;in options outstanding and the related prices for the shares of the Company&amp;#146;s common stock issued to employees and consultants&#13;under a stock option plan at December 31, 2015:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="10" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Options Outstanding&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Options Exercisable&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Exercise &lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Prices ($)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Number&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Outstanding&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Remaining&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Contractual Life&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;(Years)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Exercise &lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Price ($)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Number&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Exercisable&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Average &lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Exercise &lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Price ($)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.25 - $0.65&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5,000,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8.62&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.41&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3,000,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The stock option activity for the year ended&#13;December 31, 2015 is as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Options Outstanding&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted Average&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Exercise Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 52%"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding at December 31, 2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 21%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,000,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 21%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,000,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.45&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Expired or canceled&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Outstanding at December 31, 2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5,000,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.41&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Stock-based compensation expense related to&#13;vested options was $523,714 and $282,247 during the years ended December 31, 2015 and 2014, respectively. The Company determined&#13;the value of share-based compensation for options vesting during the year ended December 31, 2015 using the Black-Scholes fair&#13;value option-pricing model with the following weighted average assumptions: estimated fair value of Company&amp;#146;s common stock&#13;of $0.74, risk-free interest rate of 2.23%, volatility of 154%, expected lives of 10 years, and dividend yield of 0%. The Company&#13;determined the value of share-based compensation for options vesting during the year ended December 31, 2014 using the Black-Scholes&#13;fair value option-pricing model with the following weighted average assumptions: estimated fair value of Company&amp;#146;s common&#13;stock of $0.33, risk-free interest rate of 1.8%, volatility of 125%, expected lives of 4.5 years, and dividend yield of 0%. Stock&#13;options outstanding as of December 31, 2015, as disclosed in the above table, have an intrinsic value of $1,400,000.&lt;/p&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The stock option activity for the year ended&#13;December 31, 2015 is as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Options Outstanding&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted Average&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Exercise Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 52%"&gt;&lt;font style="font-size: 10pt"&gt;Outstanding at December 31, 2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 21%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,000,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 21%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,000,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.45&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Expired or canceled&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Outstanding at December 31, 2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5,000,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.41&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"&gt;&lt;/p&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2014-12-31" unitRef="Shares" decimals="INF">62100000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2015-12-31" unitRef="Shares" decimals="INF">81692954</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2015-11-12" unitRef="Shares" decimals="INF">4547243</us-gaap:CommonStockSharesOutstanding>
    <dei:DocumentPeriodEndDate contextRef="From2015-01-01to2015-12-31">2015-12-31</dei:DocumentPeriodEndDate>
    <dei:AmendmentFlag contextRef="From2015-01-01to2015-12-31">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2015-01-01to2015-12-31">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityFilerCategory contextRef="From2015-01-01to2015-12-31">Smaller Reporting Company</dei:EntityFilerCategory>
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2016-03-28" unitRef="Shares" decimals="INF">81692954</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="From2015-01-01to2015-12-31" unitRef="Shares" decimals="INF">400000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="From2015-08-17to2015-08-18_custom_HandMDLLCMember" unitRef="Shares" decimals="INF">2142857</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="From2015-08-17to2015-08-18_custom_BreakthroughProductsIncMember_custom_StockPurchaseAgreementMember" unitRef="Shares" decimals="INF">6000000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="From2015-12-16to2015-12-17_custom_BreakthroughProductsIncMember_custom_SettlementAgreementMember" unitRef="Shares" decimals="INF">3000000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="From2015-11-14to2015-11-15_custom_TprInvestmentsPtyLtdMember_custom_StockPurchaseAgreementMember" unitRef="Shares" decimals="INF">3571428</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="From2015-01-01to2015-12-31_us-gaap_AccountsPayableMember" unitRef="Shares" decimals="INF">292857</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2015-12-31" unitRef="USDPerShare" decimals="INF">0.65</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2015-12-31_custom_STWarrantMember" unitRef="USDPerShare" decimals="INF">1.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2015-12-31_custom_ContributionAgreementMember_custom_HandMDCorpMember" unitRef="USDPerShare" decimals="INF">0.70</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2015-08-18_custom_HandMDLLCMember" unitRef="USDPerShare" decimals="INF">0.70</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2015-12-17_custom_BreakthroughProductsIncMember_custom_SettlementAgreementMember" unitRef="USDPerShare" decimals="INF">5.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2015-01-22_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_LTWarrantMember" unitRef="USDPerShare" decimals="INF">1.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2015-11-12_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember223527046" unitRef="USDPerShare" decimals="INF">0.49</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2015-12-31_custom_LoanAgreementMember" unitRef="USDPerShare" decimals="INF">1.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2015-12-31_custom_NoteHolderMember" unitRef="USDPerShare" decimals="INF">0.25</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2015-12-31_custom_StockPurchaseAgreementMember_custom_NomadChoiceMember" unitRef="USDPerShare" decimals="INF">0.35</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2015-12-31_custom_StockPurchaseAgreementMember_custom_BreakthroughProductsIncMember" unitRef="USDPerShare" decimals="INF">0.85</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2015-12-31_us-gaap_AccountsPayableMember" unitRef="USDPerShare" decimals="INF">0.70</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2015-12-31_custom_StockPurchaseAgreementMember_us-gaap_InvestorMember" unitRef="USDPerShare" decimals="INF">0.25</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">430411</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="From2014-01-01to2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="From2015-01-01to2015-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="From2015-01-01to2015-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">430411</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="From2015-01-01to2015-12-31_custom_CommonStockToBeIssuedMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions contextRef="From2015-01-01to2015-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <dei:DocumentType contextRef="From2015-01-01to2015-12-31">10-K</dei:DocumentType>
    <us-gaap:ProceedsFromNotesPayable contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">11500000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromNotesPayable contextRef="From2014-01-01to2014-12-31" unitRef="USD" decimals="0">100000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromNotesPayable contextRef="From2014-10-01to2014-10-31_us-gaap_ChiefExecutiveOfficerMember" unitRef="USD" decimals="0">100000</us-gaap:ProceedsFromNotesPayable>
    <SNYR:WorkingCapital contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">6165812</SNYR:WorkingCapital>
    <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following table summarizes the changes&#13;in options outstanding and the related prices for the shares of the Company&amp;#146;s common stock issued to employees and consultants&#13;under a stock option plan at December 31, 2015:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="10" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Options Outstanding&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Options Exercisable&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Exercise &lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Prices ($)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Number&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Outstanding&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Remaining&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Contractual Life&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;(Years)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Exercise &lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Price ($)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Number&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Exercisable&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Average &lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Exercise &lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Price ($)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.25 - $0.65&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5,000,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8.62&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.41&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3,000,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
    <dei:EntityRegistrantName contextRef="From2015-01-01to2015-12-31">Synergy CHC Corp.</dei:EntityRegistrantName>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="From2015-01-21to2015-01-22_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_JanuaryTwentyTwoThousandFifteenLoanOneMember" unitRef="USD" decimals="0">100000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 10 &amp;#150; Related Party Transactions&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On April 2, 2014, the Company granted 1,000,000&#13;options valued at approximately $282,000 to a company owned by Mr. Jack Ross, Chief Executive Officer of the Company (see note&#13;15).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On October 31, 2014, the Company borrowed $100,000&#13;through a promissory note bearing interest at 10% with a maturity date of October 31, 2015 from a company owned by Mr. Ross, the&#13;Company&amp;#146;s Chief Executive Officer. During the year ended December 31, 2015, the note was converted into 400,000 shares of&#13;the Company&amp;#146;s common stock.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company accrued and paid consulting fees&#13;of $15,000 per month to a company owned by Mr. Jack Ross, Chief Executive Officer of the Company. The Company expensed $180,000&#13;as consulting fees and made payments totaling $486,958 towards services to an entity owned and controlled by an officer and shareholder&#13;of the Company for the year ended December 31, 2015. As of December 31, 2015, the total outstanding balance was $0.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;At December 31, 2014, $16,077, was due from&#13;a company owned by Mr. Jack Ross, Chief Executive Officer of the Company in a form of an advance in the normal course of business.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On January 22, 2015, the Company entered into&#13;a Loan Agreement with Knight Therapeutics (Barbados) Inc., a related party, for the purchase of the Focus Factor assets. At December&#13;31, 2015, the Company owed Knight $4,267,268 on this loan, net of discount (see Note 12).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On June 26, 2015, the Company entered into&#13;a Security Agreement with Knight Therapeutics, Inc., through its wholly owned subsidiary Neuragen Corp., for the purchase of Knight&#13;Therapeutics, Inc.&amp;#146;s assets. At December 31, 2015, the Company owed Knight $925,000 in relation to this agreement (see Note&#13;12).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On August 18, 2015, the Company entered into&#13;a Consulting Agreement with Kara Harshbarger, the co-founder of Hand MD, LLC, pursuant to which she will provide marketing and&#13;sales related service. The Company will pay Ms. Harshbarger $10,000 a month for one year unless the Consulting Agreement is terminated&#13;earlier by either party. Hand MD, LLC is a 50% owner in Hand MD Corp. The Company expensed $40,000 through payroll for the year&#13;ended December 31, 2015. As of December 31, 2015, the total outstanding balance was $0.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On November 12, 2015, the Company entered into&#13;a Loan Agreement with Knight Therapeutics (Barbados) Inc., a related party, for the purchase of NomadChoice Pty Limited and Breakthrough&#13;Products, Inc. At December 31, 2015, the Company owed Knight $3,571,314 on this loan, net of discount (see Note 12).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;At December 31, 2015, NomadChoice Pty Ltd.&#13;(subsidiary) of the Company owed Knight Therapeutics $71,573 in connection with a royalty distribution agreement (see Note 3).&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 11 &amp;#150; Accounts Payable and Accrued&#13;Liabilities&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As of December 31, 2015 and 2014, accounts&#13;payable and accrued liabilities consisted of the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31, 2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31, 2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 54%"&gt;&lt;font style="font-size: 10pt"&gt;Payroll&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;128,237&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;10,867&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Legal fees&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;38,752&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;47,916&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Manufacturers&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,527,333&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Promotions&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,213,021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Returns allowance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,128,133&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Customers&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;411,033&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Interest&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;110,754&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Royalties&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;71,573&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Warehousing&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;31,748&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Others&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;371,518&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;15,859&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;5,032,102&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;74,642&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Basis of Presentation&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The consolidated financial statements include&#13;the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been&#13;eliminated in consolidation.&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Use of Estimates&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The preparation of the consolidated&#13;financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported&#13;amounts of assets and liabilities, and disclosure of contingent liabilities at the date of the financial statements and the reported&#13;amounts of expenses during the reporting period. Actual results could differ from those estimates. At December 31, 2015 and 2014&#13;significant estimates included in these estimates are assumptions about collection of accounts receivable, useful life of fixed&#13;and intangible assets, goodwill and assumptions used in Black-Scholes-Merton, or BSM, valuation methods, such as expected volatility,&#13;stock based compensation, risk-free interest rate, and expected dividend rate.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Cash and Cash Equivalents&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company considers all cash on hand and&#13;in banks, including accounts in book overdraft positions, certificates of deposit and other highly-liquid investments with maturities&#13;of three months or less, when purchased, to be cash and cash equivalents. As of December 31, 2015 the Company had no cash equivalents.&#13;The Company maintains its cash and cash equivalents in banks insured by the Federal Deposit Insurance Corporation (FDIC) in accounts&#13;that at times may be in excess of the federally insured limit of $250,000 per bank. The Company minimizes this risk by placing&#13;its cash deposits with major financial institutions. At December 31, 2015, the uninsured balance amounted to $3,453,290.&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Capitalization of Fixed Assets&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company capitalizes expenditures related&#13;to property and equipment, subject to a minimum rule, that have a useful life greater than one year for: (1) assets purchased;&#13;(2) existing assets that are replaced, improved or the useful lives have been extended; or (3) all land, regardless of cost. Acquisitions&#13;of new assets, additions, replacements and improvements (other than land) costing less than the minimum rule in addition to maintenance&#13;and repair costs, including any planned major maintenance activities, are expensed as incurred.&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Revenue Recognition&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company recognizes revenue in accordance&#13;with the Financial Accounting Standards Board&amp;#146;s (&amp;#147;FASB&amp;#148;), Accounting Standards Codification (&amp;#147;ASC&amp;#148;)&#13;605, Revenue Recognition (&amp;#147;ASC 605&amp;#148;). ASC 605 requires that four basic criteria must be met before revenue can be&#13;recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred and/or service has been performed; (3)&#13;the selling price is fixed and determinable; and (4) collectability is reasonably assured. The Company believes that these criteria&#13;are satisfied upon shipment from its fulfillment centers. Certain of our distributors may also perform a separate function as&#13;a co-packer on our behalf. In such cases, ownership of and title to our products that are co-packed on our behalf by those co-packers&#13;who are also distributors, passes to such distributors when we are notified by them that they have taken transfer or possession&#13;of the relevant portion of our finished goods. Freight billed to customers is presented as revenues, and the related freight costs&#13;are presented as cost of goods sold. Cancelled orders are refunded if not already dispatched, refunds are only paid if stock is&#13;damaged in transit, discounts are only offered with specific promotions and orders will be refilled if lost in transit.&lt;/p&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Accounts receivable&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Accounts receivable are generally unsecured.&#13;The Company establishes an allowance for doubtful accounts receivable based on the age of outstanding invoices and management&amp;#146;s&#13;evaluation of collectability. Accounts are written off after all reasonable collection efforts have been exhausted and management&#13;concludes that likelihood of collection is remote. Any future recoveries are applied against the allowance for doubtful accounts.&lt;/p&gt;</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Income Taxes&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company utilizes FASBASC 740, &amp;#147;Income&#13;Taxes,&amp;#148; which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of&#13;events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities&#13;are determined based on the difference between the tax basis of assets and liabilities and their financial reporting amounts based&#13;on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income.&#13;A valuation allowance is recorded when it is &amp;#147;more likely-than-not&amp;#148; that a deferred tax asset will not be realized.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company generated a deferred tax asset&#13;through net operating loss carry-forward. However, a valuation allowance of 100% has been established due to the uncertainty of&#13;the Company&amp;#146;s realization of the net operating loss carry forward prior to its expiration.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;NomadChoice Pty Ltd, the Company&amp;#146;s wholly-owned&#13;subsidiary is subject to income taxes in the jurisdictions in which it operates. Significant judgment is required in determining&#13;the provision for income tax. There are many transactions and calculations undertaken during the ordinary course of business for&#13;which the ultimate tax determination is uncertain. The company recognizes liabilities for anticipated tax audit issues based on&#13;the Company&amp;#146;s current understanding of the tax law. Where the final tax outcome of these matters is different from the carrying&#13;amounts, such differences will impact the current and deferred tax provisions in the period in which such determination is made.&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Net Earnings (Loss) Per Common Share&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company computes earnings per share&#13;under ASC subtopic 260-10, Earnings Per Share. Basic earnings (loss) per share is computed by dividing the net income (loss) attributable&#13;to the common stockholders (the numerator) by the weighted average number of shares of common stock outstanding (the denominator)&#13;during the reporting periods. Diluted loss per share is computed by increasing the denominator by the weighted average number&#13;of additional shares that could have been outstanding from securities convertible into common stock (using the &amp;#147;treasury&#13;stock&amp;#148; method), unless their effect on net loss per share is anti-dilutive. As of December 31, 2015, options to purchase&#13;5,000,000 shares of common stock and warrants to purchase 9,132,002 shares of common stock were outstanding these potential shares&#13;were excluded from the shares used to calculate diluted earnings per share as their inclusion would reduce net loss per share.&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Fair Value Measurements&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company measures and discloses the&#13;fair value of assets and liabilities required to be carried at fair value in accordance with ASC 820, Fair Value Measurements and&#13;Disclosures. ASC 820 defines fair value, establishes a framework for measuring fair value, and enhances fair value measurement&#13;disclosure.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;ASC 825 defines fair value as the price&#13;that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants&#13;at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded&#13;at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions&#13;that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk&#13;of nonperformance. ASC 825 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs&#13;and minimize the use of unobservable inputs when measuring fair value. ASC 825 establishes three levels of inputs that may be used&#13;to measure fair value:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Level 1 - Quoted prices for identical&#13;assets or liabilities in active markets to which we have access at the measurement date.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Level 2 - Inputs other than quoted prices&#13;within Level 1 that are observable for the asset or liability, either directly or indirectly.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Level 3 - Unobservable inputs for the&#13;asset or liability.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The determination of where assets and&#13;liabilities fall within this hierarchy is based upon the lowest level of input that is significant to the fair value measurement.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As of December 31, 2015, the Company&#13;has determined that there were no assets or liabilities measured at fair value except for the warrant derivative liability which&#13;is valued using Level 3 estimates.&lt;/p&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:InventoryPolicyTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Inventory&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Inventory consists of raw materials, components&#13;and finished goods. The Company&amp;#146;s inventory is stated at the lower of cost (FIFO cost basis) or market. Finished goods include&#13;the cost of labor to assemble the items.&lt;/p&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Stock-Based Compensation&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company adopted the provisions of ASC&#13;718. We estimate the fair value of stock options using a binomial model, consistent with the provisions of ASC 718 and SEC Staff&#13;Accounting Bulletin No. 107, Share-Based Payment. Option-pricing models require the input of highly subjective assumptions, including&#13;the price volatility of the underlying stock. We determined that the use of implied volatility is expected to be more reflective&#13;of market conditions and, therefore, could reasonably be expected to be a better indicator of our expected volatility than historical&#13;volatility. The expected term assumption used in calculating the estimated fair value of our stock-based compensation awards using&#13;the Black-Scholes-Merton (BSM) model is based on detailed historical data about employees&amp;#146; exercise behavior, vesting schedules,&#13;and death and disability probabilities. In addition, we are required to estimate the expected forfeiture rate and only recognize&#13;expense for those shares expected to vest. We estimate the forfeiture rate based on historical experience of our stock-based awards&#13;that are granted, exercised and cancelled. We believe the resulting BSM calculation provides a more refined estimate of the fair&#13;value of our employee stock options.&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Recent Accounting Pronouncements&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;ASU 2015-03&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In April 2015, the FASB issued Accounting&#13;Standards Update (&amp;#147;ASU&amp;#148;) No. 2015-03, Interest - Imputation of Interest (Subtopic 835-30): Simplifying the Presentation&#13;of Debt Issuance Costs. The amendments in this ASU require that debt issuance costs related to a recognized debt liability be presented&#13;in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The&#13;recognition and measurement guidance for debt issuance costs are not affected by the amendments in this ASU. The amendments are&#13;effective for financial statements issued for fiscal years, and interim periods within those fiscal years, beginning after December&#13;15, 2015. The amendments are to be applied on a retrospective basis, wherein the balance sheet of each individual period presented&#13;is adjusted to reflect the period-specific effects of applying the new guidance. The Company is evaluating the possible effect&#13;of this guidance on its financial statements.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;ASU 2015-02&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In February 2015, the FASB issued ASU&#13;No. 2015-02, Consolidation (Topic 810): Amendments to the Consolidation Analysis, which is intended to improve targeted areas of&#13;consolidation guidance for legal entities such as limited partnerships, limited liability corporations, and securitization structures&#13;(collateralized debt obligations, collateralized loan obligations, and mortgage-backed security transactions). The ASU focuses&#13;on the consolidation evaluation for reporting organizations that are required to evaluate whether they should consolidate certain&#13;legal entities. In addition to reducing the number of consolidation models from four to two, the new standard simplifies the FASB&#13;Accounting Standards Codification and improves current U.S. GAAP by placing more emphasis on risk of loss when determining a controlling&#13;financial interest, reducing the frequency of the application of related-party guidance when determining a controlling financial&#13;interest in a variable interest entity (&amp;#147;VIE&amp;#148;), and changing consolidation conclusions for companies in several industries&#13;that typically make use of limited partnerships or VIEs. The ASU will be effective for fiscal years, and interim periods within&#13;those fiscal years, beginning after December 15, 2015. Early adoption is permitted, including adoption in an interim period. We&#13;do not expect the adoption of ASU 2015-02 to have a material effect on our financial position, results of operations or cash flows.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;ASU 2015-01&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In January 2015, the FASB issued ASU&#13;No. 2015-01, &amp;#147;Income Statement - Extraordinary and Unusual Items (Subtopic 225-20): Simplifying Income Statement Presentation&#13;by Eliminating the Concept of Extraordinary Items.&amp;#148; This ASU eliminates from U.S. GAAP the concept of extraordinary items.&#13;ASU 2015-01 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. A&#13;reporting entity may apply the amendments prospectively. We do not expect the adoption of ASU 2015-01 to have a material effect&#13;on our financial position, results of operations or cash flows.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;ASU 2014-17&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In November 2014, the FASB issued ASU&#13;No. 2014-17, &amp;#147;Business Combinations (Topic 805): Pushdown Accounting.&amp;#148; This ASU provides an acquired entity with an&#13;option to apply pushdown accounting in its separate financial statements upon occurrence of an event in which an acquirer obtains&#13;control of the acquired entity. An acquired entity may elect the option to apply pushdown accounting in the reporting period in&#13;which the change-in-control event occurs. If pushdown accounting is applied to an individual change-in-control event, that election&#13;is irrevocable. ASU 2014-17 was effective on November 18, 2014. The adoption of ASU 2014-17 did not have any effect on our financial&#13;position, results of operations or cash flows.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;ASU 2014-16&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In November 2014, the FASB issued ASU&#13;2014-16, &amp;#147;Derivatives and Hedging (Topic 815).&amp;#148; ASU 2014-16 addresses whether the host contract in a hybrid financial&#13;instrument issued in the form of a share should be accounted for as debt or equity. ASU 2014-16 is effective for fiscal years,&#13;and interim periods within those fiscal years, beginning after December 15, 2015. We do not currently have issued, nor are we investors&#13;in, hybrid financial instruments. Accordingly, we do not expect the adoption of ASU 2014-16 to have any effect on our financial&#13;position, results of operations or cash flows.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;ASU 2014-15&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In August 2014, the FASB issued ASU&#13;No. 2014-15, &amp;#147;Presentation of Financial Statements - Going Concern (Subtopic 205-40)&amp;#148;. ASU 2014-15 provides guidance&#13;related to management&amp;#146;s responsibility to evaluate whether there is substantial doubt about an entity&amp;#146;s ability to&#13;continue as a going concern and to provide related footnote disclosure. ASU 2014-15 is effective for annual periods ending after&#13;December 15, 2016, and for interim and annual periods thereafter. Early application is permitted. We do not expect the adoption&#13;of ASU 2014-15 to have a material effect on our financial position, results of operations or cash flows.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;ASU 2014-12&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In June 2014, the FASB issued ASU No.&#13;2014-12, &amp;#147;Compensation &amp;#150; Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award&#13;Provide That a Performance Target Could Be Achieved after the Requisite Service Period.&amp;#148; This ASU requires that a performance&#13;target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition.&#13;ASU 2014-12 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. We&#13;do not expect the adoption of ASU 2014-12 to have a material effect on our financial position, results of operations or cash flows.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;ASU 2014-09&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In May 2014, the FASB issued ASU No.&#13;2014-09, &amp;#147;Revenue from Contracts with Customers (Topic 606).&amp;#148; ASU 2014-09 affects any entity using U.S. GAAP that either&#13;enters into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets&#13;unless those contracts are within the scope of other standards (e.g., insurance contracts or lease contracts). ASU 2014-09 is effective&#13;for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2016. We are still evaluating the&#13;effect of the adoption of ASU 2014-09. On April 1, 2015, the FASB voted to propose to defer the effective date of the new revenue&#13;recognition standard by one year.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;ASU 2014-08&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In April 2014, the FASB issued ASU No.&#13;2014-08, &amp;#147;Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360) and Reporting Discontinued&#13;Operations and Disclosures of Disposals of Components of an Entity.&amp;#148; ASU 2014-08 amends the definition for what types of&#13;asset disposals are to be considered discontinued operations, as well as amending the required disclosures for discontinued operations&#13;and assets held for sale. ASU 2014-08 is effective for fiscal years, and interim periods within those fiscal years, beginning on&#13;or after December 15, 2014. The adoption of ASU 2014-08 did not have any effect on our financial position, results of operations&#13;or cash flows.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;There were various updates recently&#13;issued, most of which represented technical corrections to the accounting literature or application to specific industries and&#13;are not expected to a have a material impact on the Company&amp;#146;s condensed financial position, results of operations or cash&#13;flows.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:FiscalPeriod contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Change in Fiscal Year End&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On April 21, 2014, the Company&amp;#146;s board&#13;of directors approved a change to the Company&amp;#146;s fiscal year end from July 31 to December 31 of each year.&lt;/p&gt;</us-gaap:FiscalPeriod>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The carrying value of inventory consisted of&#13;the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31, 2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31, 2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 54%"&gt;&lt;font style="font-size: 10pt"&gt;Finished goods&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;535,908&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Components&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;115,340&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Raw Materials&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;35,406&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Energy product&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;26,064&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Total inventory&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;686,654&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;26,064&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="From2014-10-01to2014-12-31" unitRef="Pure" decimals="INF">-0.34</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="From2015-01-01to2015-12-31" unitRef="Pure" decimals="INF">-0.34</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <SNYR:ExpectedEvenues contextRef="From2015-01-01to2015-12-31_custom_FocusFactorBusinessMember" unitRef="USD" decimals="0">10482367</SNYR:ExpectedEvenues>
    <SNYR:ExpectedEvenues contextRef="From2015-12-16to2015-12-17_custom_BreakthroughProductsIncMember_custom_SettlementAgreementMember_custom_UrgentRxSellersMember" unitRef="USD" decimals="0">90590</SNYR:ExpectedEvenues>
    <SNYR:ExpectedEvenues contextRef="From2015-01-01to2015-12-31_custom_TprInvestmentsPtyLtdMember_custom_StockPurchaseAgreementMember" unitRef="USD" decimals="0">2513990</SNYR:ExpectedEvenues>
    <us-gaap:PaymentsToAcquireBusinessesGross contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">250000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross contextRef="From2014-01-01to2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:PaymentsToAcquireBusinessesGross contextRef="From2015-06-24to2015-06-26_custom_KnightTherapeuticsIncMember" unitRef="USD" decimals="0">1200000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross contextRef="From2015-01-21to2015-01-22_custom_FocusFactorBusinessMember" unitRef="USD" decimals="0">6000000</us-gaap:PaymentsToAcquireBusinessesGross>
    <SNYR:AmountPayableUnderPurchaseAgreement contextRef="From2015-01-21to2015-01-22_custom_FocusFactorBusinessMember" unitRef="USD" decimals="0">4500000</SNYR:AmountPayableUnderPurchaseAgreement>
    <SNYR:AmountPayableUnderPurchaseAgreement contextRef="From2015-01-21to2015-01-22_custom_FocusFactorBusinessMember_custom_JanuaryTwentyTwoThousandSixteenMember" unitRef="USD" decimals="0">750000</SNYR:AmountPayableUnderPurchaseAgreement>
    <SNYR:AmountPayableUnderPurchaseAgreement contextRef="From2015-01-21to2015-01-22_custom_FocusFactorBusinessMember_custom_JanuaryTwentyTwoThousandSeventeenMember" unitRef="USD" decimals="0">750000</SNYR:AmountPayableUnderPurchaseAgreement>
    <SNYR:AmountPayableUnderPurchaseAgreement contextRef="From2015-11-14to2015-11-15_custom_TprInvestmentsPtyLtdMember_custom_StockPurchaseAgreementMember_custom_AustralianDollerMember" unitRef="AUD" decimals="0">3500000</SNYR:AmountPayableUnderPurchaseAgreement>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;u&gt;Impairment of Long-Lived&#13;Assets&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;When facts and circumstances&#13;indicate that the carrying values of long-lived assets, including fixed assets, may be impaired, an evaluation of recoverability&#13;is performed by comparing the carrying value of the assets to projected future cash flows in addition to other quantitative and&#13;qualitative analyses. Upon indication that the carrying value of such assets may not be recoverable, the Company recognizes an&#13;impairment loss as a charge against current operations. Long-lived assets to be disposed of are reported at the lower of the carrying&#13;amount or fair value, less estimated costs to sell. The Company makes judgments related to the expected useful lives of long-lived&#13;assets and its ability to realize undiscounted cash flows in excess of the carrying amounts of such assets which are affected&#13;by factors such as the ongoing maintenance and improvements of the assets, changes in economic conditions and changes in operating&#13;performance. As the Company assesses the ongoing expected cash flows and carrying amounts of its long-lived assets, these factors&#13;could cause the Company to realize a material impairment charge.&lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Goodwill&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;An asset purchase is accounted for under the&#13;purchase method of accounting. Under that method, assets and liabilities of the business acquired are recorded at their estimated&#13;fair values as of the date of the acquisition, with any excess of the cost of the acquisition over the estimated fair value of&#13;the net tangible and intangible assets acquired recorded as goodwill. As of December 31, 2015 our qualitative analysis of goodwill&#13;did not indicate any impairment.&lt;/p&gt;</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Research and Development&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Costs incurred in connection with the development&#13;of new products and processing methods are charged to general and administrative expenses as incurred.&lt;/p&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 3 &amp;#150; Acquisitions&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Asset Purchase Agreement with Factor&#13;Nutrition Labs, LLC:&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On January 22, 2015 (the &amp;#147;Closing&#13;Date&amp;#148;), the Company entered into an Asset Purchase Agreement (the &amp;#147;Purchase Agreement&amp;#148;) with Factor Nutrition&#13;Labs, LLC, a Delaware limited liability company (the &amp;#147;Seller&amp;#148;), Vita Partners, LLC, RPR Partners, LLC, and Thor Associates,&#13;Inc. (each a &amp;#147;Principal Owner&amp;#148;). Pursuant to the Purchase Agreement, the Company purchased all of the assets of the&#13;Seller&amp;#146;s line of business and products called FOCUS Factor (the product plus the business related to the product is collectively&#13;referred to as the &amp;#147;Focus Factor Business&amp;#148;) and assumed the accounts payable and contractual obligations of the Focus&#13;Factor Business for an aggregate purchase price of $6.0 million, with $4.5 million paid on the Closing Date, and $750,000 to be&#13;paid on or before January 20, 2016 and an additional $750,000 to be paid on or before January 20, 2017.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Distribution Agreement&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On January 22, 2015, the Company and&#13;Knight entered into a Distribution, License and Supply Agreement (the &amp;#147;Distribution Agreement&amp;#148;), pursuant to which&#13;the Company granted to Knight an exclusive license to commercialize FOCUSFactor, FOCUSFactor Kids and Synergy Strip and all improvements&#13;thereto (together the &amp;#147;Licensed Products&amp;#148;) and appointed Knight as the exclusive distributor to offer to sell and sell&#13;the Licensed Products in Canada, and, at Knight&amp;#146;s election, one or more of Israel, Russia, and Sub-Saharan Africa. The Distribution&#13;Agreement provides that Knight may sublicense its rights or use sub-distributors under the Distribution Agreement on terms consistent&#13;with the terms of the Distribution Agreement. During the term of the Distribution Agreement, Knight agrees to obtain from the Company&#13;all its requirements for the Licensed Products and the Company agrees to supply the Licensed Products at its adjusted production&#13;cost plus a designated percentage and any applicable taxes.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In the event of a long term inability&#13;by the Company to supply Knight with the Licensed Products, Knight is entitled to require, among other remedies, the Company to&#13;grant a Knight-designated third party a non-exclusive license to use all relevant intellectual property to manufacture and supply&#13;Knight with the Licensed Products for commercialization in the Territory. The term of the Distribution Agreement runs until 15&#13;years from the date of the first commercial sale of a Licensed Product in Canada, and the Distribution Agreement will automatically&#13;renew for successive 15-year periods unless either party provides the other with written notice of its intention not to renew (a&#13;&amp;#147;Non-Renewal Notice&amp;#148;). The Company agrees that in the event it issues a Non-Renewal Notice, the Company will pay to&#13;Knight a non-renewal fee equal to the net sales of the Licensed Products achieved by Knight in the Territory during the eight calendar&#13;quarters preceding the date of such notice, plus all applicable taxes.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Distribution Option Agreement&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In connection with the Loan Agreement,&#13;the Company entered into a Product Distribution Option Agreement, dated January 22, 2015 (the &amp;#147;Option Agreement&amp;#148;),&#13;pursuant to which the Company granted Knight the exclusive right to negotiate the exclusive distribution rights of any one or more&#13;of the Company&amp;#146;s products, including products from the Focus Factor Business, for the territories of Canada, Russia, Sub-Saharan&#13;Africa and Israel (the &amp;#147;Option&amp;#148;), pursuant to designated parameters. The Option Agreement is effective upon the date&#13;of the Option Agreement, will run until January 31, 2045, and will automatically renew thereafter for successive five-year periods&#13;unless either party provides a notice of termination prior to the Option Agreement&amp;#146;s expiration. If Knight does not exercise&#13;the option then the Company is free to contract for distribution with other parties, but only on terms no less favorable than those&#13;offered by Knight pursuant to the Option Agreement.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On December 3, 2015, we entered into&#13;an Amendment to First Amendment Agreement (the &amp;#147;Second Amendment Agreement&amp;#148;) with Knight pursuant to which we agreed&#13;to grant distribution rights to Knight for Breakthrough&amp;#146;s products. To satisfy this obligation, on December 3, 2015, we also&#13;entered into an Amendment and Confirmation Agreement (the &amp;#147;Confirmation Agreement&amp;#148;) with Knight, Nomad and Breakthrough&#13;to amend the Distribution, License and Supply Agreement dated January 22, 2015 (the &amp;#147;Distribution Agreement&amp;#148;) between&#13;us and Knight to grant to Knight an exclusive license to commercialize any and all Nomad and Breakthrough products and appoint&#13;Knight as the exclusive distributor to offer and sell those products in Canada, Israel, Romania, Russia and each of the countries&#13;within Sub-Saharan Africa, which is the new &amp;#147;Territory&amp;#148; under the Distribution Agreement, as amended. Pursuant to the&#13;Second Amendment Agreement, Nomad will buy all Flat Tummy Tea products within the Territory for direct to consumer sales exclusively&#13;from Knight and/or its affiliates at cost of goods plus 60% of gross sales.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company has accounted for this transaction&#13;under the acquisition method of accounting. Under the acquisition method of accounting, the total acquisition consideration price&#13;is allocated to the assets acquired and liabilities assumed based on their preliminary estimated fair values based on the management&amp;#146;s&#13;estimates as of the date of the acquisition. The Company expects to retain the services of independent valuation firm to determine&#13;the fair value of these identifiable intangible assets. Once determined, the Company will reallocate the purchase price of the&#13;acquisition based on the results of the independent evaluation if they are materially different from the allocations as recorded&#13;on January 22, 2015. The Company expects the purchase price allocations for the acquisition of Focus Factor Business to be completed&#13;by the filing of first quarter 2016 statements. The preliminary allocation of the purchase price to the assets acquired and liabilities&#13;assumed based on the estimated fair values is as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-decoration: underline; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Assets&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 79%; padding-left: 10pt; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Accounts Receivable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 18%; text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,733,167&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Inventory&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;67,113&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Intellectual Property&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,000,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Non-compete provision&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;50,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Non-solicitation provision&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;50,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Intangible assets-Customer relationships&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,941,030&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Goodwill&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,071,517&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-decoration: underline; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Liabilities&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Accounts Payable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(971,381&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Accrued Expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(941,446&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;6,000,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Customer relationships, the non-compete&#13;and the non-solicitation provisions will be amortized over their estimated useful lives of 5 years. During the year ended December&#13;31, 2015, the Company charged to operations amortization expense of $384,720.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The purchase price allocated to the&#13;acquisition of the assets of Factor Nutrition Labs, LLC is made up as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Amount&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 86%; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Cash payment made on January 22, 2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4,500,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Cash payment to be made on January 20, 2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;750,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Cash payment to be made on January 20, 2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;750,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;6,000,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Pro forma Results of Operations. The&#13;historical operating results of the Focus Factor Business prior to its acquisition date have not been included in the Company&amp;#146;s&#13;historical consolidated operating results. Pro forma results of operations data (unaudited) for the years ended December 31, 2014&#13;and 2013, as if the acquisition had occurred on January 1, 2013, are as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;December 31,&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2013&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 66%; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Revenue&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;12,695,295&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;10,629,171&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net (loss) income&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(183,471&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;932,209&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Pro forma revenue amount above does&#13;not include adjustment/reductions relating to certain discounts, coupons and placement fees and is presented gross.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The amounts of revenue and net income&#13;of the FOCUS Factor Business since the acquisition date included in the consolidated statement of operations for the year ended&#13;December 31, 2015 are approximately $10,482,367 and $1,216,928, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Asset Purchase Agreement with Knight&#13;Therapeutics Inc.:&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On June 26, 2015 (the &amp;#147;Closing&#13;Date&amp;#148;), Neuragen Corp., a Delaware corporation (&amp;#147;Neuragen&amp;#148;) and our wholly owned subsidiary, entered into an&#13;Asset Purchase Agreement (the &amp;#147;Purchase Agreement&amp;#148;) with Knight Therapeutics Inc., a Canadian corporation (&amp;#147;Knight&#13;Canada&amp;#148;). Pursuant to the Purchase Agreement, Neuragen purchased the U.S. rights related to an innovative OTC product that&#13;helps relieve pain caused by diabetic nerve damage (the &amp;#147;Purchased Assets&amp;#148;) for an aggregate purchase price of $1.2&#13;million, with (i) $250,000 paid on the Closing Date, (ii) $250,000 to be paid on or before June 30, 2016, (iii) $700,000 to be&#13;paid in quarterly installments (beginning with the quarter ending September 30, 2015) equal to the greater of $12,500 or 5% of&#13;U.S. net sales, and (iv) 2% of U.S. net sales of Neuragen for 60 months thereafter. The payment of such amounts is secured by a&#13;security interest in certain assets, undertakings and property (&amp;#147;Collateral&amp;#148;) pursuant to the Security Agreement, which&#13;will be released upon receipt of total payments of $1.2 million (collectively, &amp;#147;Total Consideration&amp;#148;). The Company&#13;has recorded present value of future payments of $515,854 as of December 31, 2015. The Company has recorded interest expense of&#13;$37,372 for the year ended December 31, 2015.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Security Agreement&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On the Closing Date, Neuragen entered&#13;into a Security Agreement with Knight Canada, pursuant to which Neuragen granted a lien and security interest to Knight Canada&#13;in Collateral in connection with the Purchase Agreement.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Security Agreement was made to secure&#13;the payment of all indebtedness, obligations and liabilities of Neuragen of the Purchase Agreement, including all expenses and&#13;charges, legal or otherwise, suffered or incurred by Knight Canada in collecting or enforcing such indebtedness of the Purchase&#13;Agreement.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Security Agreement includes customary&#13;events of default, including but not limited to: payment defaults; Neuragen becoming insolvent or entering into bankruptcy; or&#13;if any contemplated security ceases to be a valid and perfected first-priority security interest that is not remedied within fifteen&#13;business days by Neuragen. Upon the occurrence of an event of default and during the continuation thereof, the principal amount&#13;of the outstanding Total Consideration will bear a default interest rate of an additional 10% per annum.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The acquisition was treated as an acquisition&#13;of assets as the transaction involved the acquisition of a brand and a license agreement. The Company expects to retain the services&#13;of independent valuation firm to determine the fair value of these identifiable intangible assets. Once determined, the Company&#13;will reallocate the purchase price of the acquisition based on the results of the independent evaluation if they are materially&#13;different from the allocations as recorded on June 26, 2015. The Company expects the purchase price allocations for the asset acquisition&#13;to be completed by the filing of second quarter 2016 statements. The preliminary allocation of the purchase price to the assets&#13;acquired and liabilities assumed based on the estimated fair values is as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-decoration: underline; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Assets&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 86%; padding-left: 10pt; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Accounts Receivable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;58,054&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Inventory&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;204,925&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Intangible property&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;100,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;License agreement&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;606,553&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-decoration: underline; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Liabilities&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Accounts Payable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(51,795&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Accrued Expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(148,520&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;769,217&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The intangible property and license&#13;agreement will be amortized over their estimated useful lives of 5 years. During the year ended December 31, 2015, the Company&#13;charged to operations amortization expense of $70,655.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Contribution Agreement with Hand&#13;MD Corp.:&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On August 18, 2015 (the &amp;#147;Closing&#13;Date&amp;#148;), we entered into a Contribution Agreement with Hand MD Corp., a Delaware corporation, whereby we contributed to Hand&#13;MD Corp. 2,142,857 shares of our common stock in exchange for 50% of Hand MD Corp.&amp;#146;s outstanding capital securities valued&#13;at $0.70 per share. Simultaneously, Hand MD, LLC, a California limited liability company, entered into a Contribution Agreement&#13;with Hand MD Corp., the principal owners of Hand MD, LLC, and us whereby Hand MD LLC contributed to Hand MD Corp. all of its right,&#13;title and interest in its intellectual property associated with skincare, nail care and nail polish products (the &amp;#147;Hand MD&#13;Business&amp;#148;) in exchange for the other 50% of Hand MD Corp.&amp;#146;s outstanding capital securities. In the Contribution Agreement&#13;among Hand MD Corp., Hand MD, LLC, the principal owners of Hand MD, LLC and us, Hand MD, LLC and its principal owners agreed to&#13;not compete or solicit customers or employees for five years. As part of the transaction, we also purchased from Hand MD Corp.&#13;all inventory related to the Hand MD Business for approximately $106,000. The Company has recorded 50% of the present value of&#13;future royalty payments of $258,897 as of December 31, 2015.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;We also entered into a license agreement&#13;with Hand MD Corp. on August 18, 2015, whereby we acquired the exclusive worldwide license to commercialize Hand MD Corp. skincare&#13;products and all improvements thereto. The license runs in perpetuity unless earlier terminated. We will pay Hand MD Corp. a royalty&#13;of 5% of the net sales price of product sold, transferred or otherwise disposed of by us, as well as 5% of any amount we receive&#13;from sublicensees, subject to a minimum royalty of $250,000 in the second year of the license and $500,000 in the third year of&#13;the license, after which the minimum royalty terminates. We are solely responsible for any regulatory and intellectual property&#13;filings, including those necessary to maintain regulatory approvals for the licensed products. Either we or Hand MD Corp. can terminate&#13;the agreement in the event of bankruptcy or insolvency of the other party, or the uncured material breach of the agreement by the&#13;other party. Upon termination we would be entitled to sell any inventory of licensed product in the normal course of business and&#13;consistent with sales of licensed product during the term of the agreement.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Contribution Agreements and the&#13;License Agreement contain customary representations and warranties and covenants by the respective parties.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;We also entered into a Consulting Agreement&#13;on August 18, 2015, with Kara Harshbarger, the co-founder of Hand MD, LLC, pursuant to which she will provide marketing and sales&#13;related services. We will pay Ms. Harshbarger $10,000 a month for one year unless the Consulting Agreement is terminated earlier&#13;by either party. If we terminate the Consulting Agreement without cause, we will be obligated to pay the remaining term of the&#13;Agreement. Ms. Harshbarger agreed not to compete with us in the United States in any marketing or sales of skincare, nail polish&#13;and nail care products during the term of the Consulting Agreement and for 12 months after its termination. Ms. Harshbarger also&#13;agreed not to solicit customers or employees for the same period.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The acquisition was treated as an acquisition&#13;of assets as the transaction involved the acquisition of a brand and a license agreement. The Company expects to retain the services&#13;of independent valuation firm to determine the fair value of these identifiable intangible assets. Once determined, the Company&#13;will reallocate the purchase price of the acquisition based on the results of the independent evaluation if they are materially&#13;different from the allocations as recorded on August 18, 2015. The Company expects the purchase price allocations for the asset&#13;acquisition to be completed during 2016. The preliminary allocation of the purchase price to the assets acquired and liabilities&#13;assumed based on the estimated fair values is as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-decoration: underline; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Assets&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 86%; padding-left: 10pt; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Intangible property&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;100,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;License agreement&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,670,675&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-decoration: underline; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Liabilities&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Royalty payable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(258,897&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Others&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(11,778&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,500,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The intangible property and license&#13;agreement will be amortized over their estimated useful lives of 5 years. During the year ended December 31, 2015, the Company&#13;charged to operations amortization expense of $118,045.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Stock Purchase Agreement with Breakthrough&#13;Products, Inc.:&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On November 12, 2015 (the &amp;#147;UrgentRx&#13;Closing Date&amp;#148;), we entered into a Stock Purchase Agreement (the &amp;#147;UrgentRx SPA&amp;#148;) with Breakthrough Products, Inc.,&#13;a Delaware corporation (the &amp;#147;Company&amp;#148;), URX ACQUISITION TRUST, a Delaware statutory trust, (the &amp;#147;Trust&amp;#148;),&#13;Jordan Eisenberg, the chief executive officer and a shareholder of the Company (&amp;#147;Eisenberg&amp;#148;), and the other shareholders&#13;of the Company (Eisenberg and such other shareholders collectively referred to as the &amp;#147;UrgentRx Sellers&amp;#148;) for the purchase&#13;of all the issued and outstanding capital stock of the Company for 6,000,000 shares of our common stock (&amp;#147;UrgentRx Equity&#13;Consideration&amp;#148;).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In addition to the UrgentRx Equity Consideration,&#13;we have agreed to pay a royalty to the Trust, for the benefit of the UrgentRx Sellers, equal to 5% of gross sales of the UrgentRx&#13;(as defined below) following the first $5,000,000 in gross sales by the UrgentRx Products, on a quarterly basis for a period of&#13;seven years from the UrgentRx Closing Date.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company is engaged in the business&#13;of developing and selling medications for headache, heart burn, allergy attack, ache and pain, and upset stomach in the form of&#13;powders (&amp;#147;UrgentRx&amp;#148;).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Following the UrgentRx Closing Date,&#13;we discovered certain liabilities and obligations of Breakthrough that required an adjustment to the UrgentRx Equity Consideration&#13;and the royalty payments.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On December 17, 2015, we entered into&#13;a Settlement and Release Agreement (the &amp;#147;Settlement Agreement&amp;#148;) with the UrgentRx Sellers, the Trust, on its own behalf&#13;and as the representative of the UrgentRx Sellers, David T. Leyrer, Michael Valentino, Ron Fugate, and Randall Kaplan (collectively&#13;with Leyrer, Valentino, Fugate, the &amp;#147;Former Directors&amp;#148;) to resolve the post-closing liabilities. Pursuant to the terms&#13;of the Settlement Agreement, 3,000,000 shares of the Equity Consideration were returned by the Trust to us and our obligation to&#13;pay royalties to the Trust was reduced from seven years to five years. The Settlement Agreement further contained mutual releases&#13;among us, the UrgentRx Sellers, and the Former Directors, with limited exceptions. Additionally, we issued a three-year warrant&#13;to the Trust with a $5.00 per share exercise price. We may redeem the warrant at a price of $0.001 per share if our common stock&#13;is traded on the OTCBB or on a national securities exchange, and the per share closing sale price of our common stock equals or&#13;exceeds the exercise price for a period of 90 consecutive calendar days. In the event of a reorganization or reclassification of&#13;our capital stock, the merger or consolidation of our company into another entity or the sale or transfer of all or substantially&#13;all of our assets, the warrant will terminate if not exercised prior to the date of such event.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company has accounted for this transaction&#13;under the acquisition method of accounting. Under the acquisition method of accounting, the total acquisition consideration price&#13;is allocated to the assets acquired and liabilities assumed based on their preliminary estimated fair values based on the management&amp;#146;s&#13;estimates as of the date of the acquisition. The Company expects to retain the services of independent valuation firm to determine&#13;the fair value of these identifiable intangible assets. Once determined, the Company will reallocate the purchase price of the&#13;acquisition based on the results of the independent evaluation if they are materially different from the allocations as recorded&#13;on November 12, 2015. The Company expects the purchase price allocations for the acquisition of UrgentRx to be completed during&#13;2016. The preliminary allocation of the purchase price to the assets acquired and liabilities assumed based on the estimated fair&#13;values is as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-decoration: underline; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Assets&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 79%; padding-left: 10pt; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Cash&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 18%; text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,298,619&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Accounts Receivable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(68,976&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Inventory&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;234,709&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Prepaid expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;57,569&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Intellectual property&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;100,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Non-compete provision&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;50,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Goodwill&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3,253,160&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-decoration: underline; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Liabilities&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Accounts Payable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(741,822&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Accrued Expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(2,202,848&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,980,411&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Intellectual property will be amortized&#13;over its estimated useful live of 5 years and the non-compete provision will be amortized over its term of 3 years. During the&#13;year ended December 31, 2015, the Company charged to operations amortization expense of $4,583.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The purchase price allocated to the&#13;acquisition of the assets of UrgentRx is made up as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Amount&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 86%; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Stock payment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,550,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Stock warrants issued&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;430,411&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,980,411&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Pro forma Results of Operations. The&#13;historical operating results of the UrgentRx Business prior to its acquisition date have not been included in the Company&amp;#146;s&#13;historical consolidated operating results. Pro forma results of operations data (unaudited) for the year ended December 31, 2014&#13;as if the acquisition had occurred on January 1, 2014, are as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;December 31, 2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 79%; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Revenue&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 18%; text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,722,288&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net (loss) income&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(10,621,330&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The amounts of revenue and net loss&#13;of the UrgentRx Business since the acquisition date included in the consolidated statement of operations for the year ended December&#13;31, 2015 are approximately $90,590 and $80,249, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Stock Purchase Agreement with TPR&#13;Investments Pty Ltd:&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On November 15, 2015 (the &amp;#147;Flat&#13;Tummy Tea Closing Date&amp;#148;), we entered into a Stock Purchase Agreement (the &amp;#147;Flat Tummy Tea SPA&amp;#148;) with TPR Investments&#13;Pty Ltd ACN 128 396 654 as trustee for Polmear Family Trust (the &amp;#147;Flat Tummy Tea Seller&amp;#148;), Timothy Polmear and Rebecca&#13;Polmear and NomadChoice Pty Limited ACN 160 729 939 trading as Flat Tummy Tea, an Australian proprietary limited company (&amp;#147;NomadChoice&amp;#148;)&#13;for the purchase of all the issued and outstanding capital stock of NomadChoice for $4,000,000 (AUD) in cash consideration (the&#13;&amp;#147;Cash Consideration&amp;#148;) and 3,571,428 shares of our common stock (&amp;#147;Flat Tummy Tea Equity Consideration&amp;#148;).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In addition to the Cash Consideration&#13;and the Flat Tummy Tea Equity Consideration, we have also agreed to pay the Flat Tummy Tea Seller certain earn-out payments of&#13;up to $3,500,000 (AUD) in aggregate upon certain EBITDA thresholds are met as of June 30, 2016, as described in the Flat Tummy&#13;Tea SPA. This earn-out payment was distributed on March 4, 2016.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Flat Tummy Tea is engaged in the business&#13;of developing, manufacturing, and selling herbal detox tea (&amp;#147;Flat Tummy Tea&amp;#148;).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company has accounted for this transaction&#13;under the acquisition method of accounting. Under the acquisition method of accounting, the total acquisition consideration price&#13;is allocated to the assets acquired and liabilities assumed based on their preliminary estimated fair values based on the management&amp;#146;s&#13;estimates as of the date of the acquisition. The Company expects to retain the services of independent valuation firm to determine&#13;the fair value of these identifiable intangible assets. Once determined, the Company will reallocate the purchase price of the&#13;acquisition based on the results of the independent evaluation if they are materially different from the allocations as recorded&#13;on November 1, 2015. The Company expects the purchase price allocations for the acquisition of NomadChoice to be completed during&#13;2016. The preliminary allocation of the purchase price to the assets acquired and liabilities assumed based on the estimated fair&#13;values is as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-decoration: underline; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Assets&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 79%; padding-left: 10pt; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Cash&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 18%; text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,584,642&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other receivable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;30,684&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Inventory&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;134,212&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Prepaid expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;141,070&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Fixed Assets, net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5,698&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Intangible assets, Net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3,493&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Blogger Database&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;200,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Customer Database&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;500,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Intellectual property&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;100,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Non-compete provision&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;50,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Goodwill&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;6,174,899&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-decoration: underline; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;u&gt;Liabilities&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Accounts Payable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(77,064&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Accrued Expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(56,224&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Dividends Payable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1,177,152&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Provision for Income Tax&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(518,558&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;7,095,700&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Blogger Database, Customer Database,&#13;Intellectual property and non-compete provision will be amortized over its estimated useful lives of 5 years. During the year ended&#13;December 31, 2015, the Company charged to operations amortization expense of $28,333.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The purchase price allocated to the&#13;acquisition of the assets of NomadChoice is made up as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Amount&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 86%; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Cash&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,848,800&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Stock issued at closing&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,750,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Earn-out payment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,496,900&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;7,095,700&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Pro forma Results of Operations. The&#13;historical operating results of the Flat Tummy Tea Business prior to its acquisition date have not been included in the Company&amp;#146;s&#13;historical consolidated operating results. Pro forma results of operations data (unaudited) for the year ended December 31, 2014&#13;as if the acquisition had occurred on January 1, 2014, are as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;December 31, 2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 79%; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Revenue&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 18%; text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,494,812&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net (loss) income&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(909,280&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company&amp;#146;s subsidiary Nomad&#13;has a fiscal year ended June 30 and the Company&amp;#146;s fiscal year end is December 31. The above proforma information includes&#13;revenue and net income of Nomad for the year ended June 30, 2015.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The amounts of revenue and net income&#13;of the Flat Tummy Tea Business since the acquisition date included in the consolidated statement of operations for the year ended&#13;December 31, 2015 are approximately $2,513,990 and $966,671 respectively.&lt;/p&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Pro forma results of operations data (unaudited)&#13;for the years ended December 31, 2014 and 2013, as if the acquisition had occurred on January 1, 2013, are as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31,&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;2013&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 66%"&gt;&lt;font style="font-size: 10pt"&gt;Revenue&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;12,695,295&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;10,629,171&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Net (loss) income&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(183,471&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;932,209&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock contextRef="From2015-01-01to2015-12-31_custom_TprInvestmentsPtyLtdMember">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Pro forma results of operations data (unaudited)&#13;for the year ended December 31, 2014 as if the acquisition had occurred on January 1, 2014, are as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31, 2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 79%"&gt;&lt;font style="font-size: 10pt"&gt;Revenue&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 18%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,494,812&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Net (loss) income&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(909,280&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock contextRef="From2014-01-01to2014-12-31_custom_BreakthroughProductsIncMember">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Pro forma results of operations data (unaudited)&#13;for the year ended December 31, 2014 as if the acquisition had occurred on January 1, 2014, are as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31, 2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 79%"&gt;&lt;font style="font-size: 10pt"&gt;Revenue&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 18%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,722,288&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Net (loss) income&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(10,621,330&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:BusinessAcquisitionsProFormaRevenue contextRef="From2014-01-01to2014-12-31_custom_FocusFactorBusinessMember" unitRef="USD" decimals="0">12695295</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue contextRef="From2013-01-01to2013-12-31_custom_FocusFactorBusinessMember" unitRef="USD" decimals="0">10629171</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue contextRef="From2014-01-01to2014-12-31_custom_BreakthroughProductsIncMember" unitRef="USD" decimals="0">2722288</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue contextRef="From2014-01-01to2014-12-31_custom_TprInvestmentsPtyLtdMember" unitRef="USD" decimals="0">2494812</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue contextRef="From2015-01-21to2015-01-22_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember" unitRef="USD" decimals="0">13000000</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss contextRef="From2014-01-01to2014-12-31_custom_FocusFactorBusinessMember" unitRef="USD" decimals="0">-183471</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss contextRef="From2013-01-01to2013-12-31_custom_FocusFactorBusinessMember" unitRef="USD" decimals="0">932209</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss contextRef="From2014-01-01to2014-12-31_custom_BreakthroughProductsIncMember" unitRef="USD" decimals="0">-10621330</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss contextRef="From2014-01-01to2014-12-31_custom_TprInvestmentsPtyLtdMember" unitRef="USD" decimals="0">-909280</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss contextRef="From2015-01-21to2015-01-22_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember" unitRef="USD" decimals="0">2000000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:InventoryDisclosureTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 8 &amp;#150; Inventory&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Inventory consists of finished goods, components&#13;and raw materials. The Company&amp;#146;s inventory is stated at the lower of cost (FIFO cost basis) or market.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The carrying value of inventory consisted of&#13;the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31, 2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31, 2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 54%"&gt;&lt;font style="font-size: 10pt"&gt;Finished goods&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;535,908&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Components&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;115,340&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Raw Materials&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;35,406&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Energy product&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;26,064&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Total inventory&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;686,654&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;26,064&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As of January 22, 2015, inventory was pledged&#13;to Knight under the Loan Agreement (see note 12).&lt;/p&gt;</us-gaap:InventoryDisclosureTextBlock>
    <SNYR:FixedAssetsAndIntangibleAssetsTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 9 &amp;#150; Fixed Assets and Intangible&#13;Assets&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As of December 31, 2015 and 2014, fixed assets&#13;and intangible assets consisted of the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31, 2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31, 2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 62%"&gt;&lt;font style="font-size: 10pt"&gt;Property and equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;18,187&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Less accumulated depreciation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(6,170&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Fixed assets, net&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;12,017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Depreciation expense for the years ended December&#13;31, 2015 and 2014 was $1,513 and $0, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31, 2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31, 2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 62%"&gt;&lt;font style="font-size: 10pt"&gt;FOCUSfactor intellectual property&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,000,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Intangible assets subject to amortization&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5,521,751&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Less accumulated amortization&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(606,489&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Intangible assets, net&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;5,915,262&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Amortization expense for the years ended December&#13;31, 2015 and 2014 was $606,489 and $0, respectively. These intangible assets were acquired through Asset Purchase Agreement and&#13;Stock Purchase Agreements disclosed in Note 3.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The estimated aggregate amortization expense&#13;over each of the next five years is as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 79%"&gt;&lt;font style="font-size: 10pt"&gt;2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 18%; border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,111,229&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,111,229&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,109,070&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,094,329&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;489,405&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;</SNYR:FixedAssetsAndIntangibleAssetsTextBlock>
    <SNYR:SummaryOfFixedAndIntangibleAssetsTableTextblock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As of December 31, 2015 and 2014, fixed assets&#13;and intangible assets consisted of the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31, 2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31, 2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 62%"&gt;&lt;font style="font-size: 10pt"&gt;Property and equipment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;18,187&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Less accumulated depreciation&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(6,170&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Fixed assets, net&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;12,017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Depreciation expense for the years ended December&#13;31, 2015 and 2014 was $1,513 and $0, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31, 2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31, 2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 62%"&gt;&lt;font style="font-size: 10pt"&gt;FOCUSfactor intellectual property&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,000,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Intangible assets subject to amortization&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5,521,751&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Less accumulated amortization&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(606,489&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Intangible assets, net&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;5,915,262&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;</SNYR:SummaryOfFixedAndIntangibleAssetsTableTextblock>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">18187</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">6170</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">5521751</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">606489</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">5915262</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 12 &amp;#150; Notes Payable&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;The Company&amp;#146;s&#13;loans payable at December 31, 2015 and 2014 are as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31, 2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31, 2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 62%"&gt;&lt;font style="font-size: 10pt"&gt;Loans payable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;12,406,589&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Unamortized debt discount&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(2,536,419&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9,870,170&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Less: Current portion&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(3,912,060&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Long-term portion&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5,958,110&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;$6,000,000 January 22, 2015 Loan:&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On January 22, 2015, the Company entered into&#13;a Loan and Security Agreement (&amp;#147;Loan Agreement&amp;#148;) with Knight Therapeutics (Barbados) Inc. (&amp;#147;Knight&amp;#148;), pursuant&#13;to which Knight agreed to loan the Company $6.0 million (the &amp;#147;Loan&amp;#148;), and which amount was borrowed at closing (the&#13;&amp;#147;Financing&amp;#148;) for the purpose of acquiring the Focus Factor Business (defined below). At closing, the Company paid Knight&#13;an origination fee of $120,000 and a work fee of $60,000 and also paid $40,000 of Knight&amp;#146;s expenses associated with the Loan.&#13;The Loan bears interest at a rate of 15% per year; provided, however, that upon the occurrence of an equity or convertible equity&#13;offering by the Company of at least $1.0 million, the interest rate will drop to 13% per year. Interest accrues quarterly and is&#13;payable in arrears on March 31, June 30, September 30 and December 31 in each year, beginning on March 31, 2015.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;All outstanding principal and accrued and unpaid&#13;interest is due on the earliest to occur of either January 20, 2017 (the &amp;#147;Maturity Date&amp;#148;), or the date that Knight,&#13;in its discretion, accelerates the Company&amp;#146;s obligations due to an event of default. The Company may extend the Maturity&#13;Date for two successive additional 12-month periods if at March 31, 2016 and March 31, 2017, respectively, the Company&amp;#146;s&#13;revenues exceed $13.0 million and its EBITDA exceeds $2.0 million for the respective 12-month period then ending. Principal payments&#13;under the Loan Agreement commenced on June 30, 2015 and continue quarterly as set forth on the Repayment Schedule to the Loan Agreement.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Subject to certain restrictions, the Company&#13;may prepay the outstanding principal of the Loan (in whole but not in part) at any time if the Company pays a concurrent prepayment&#13;fee equal to the greater of (i) the total unpaid annual interest that would have been payable during the year in which the prepayment&#13;is made if the prepayment is made prior to the first anniversary of the closing, and (ii) $300,000. The Company&amp;#146;s obligations&#13;under the Loan Agreement are secured by a first priority security interest in all present and future assets of the Company. The&#13;Company also agreed to not pledge or otherwise encumber its intellectual property assets, subject to certain customary exceptions.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Loan Agreement includes customary representations,&#13;warranties, and affirmative and restrictive covenants, including covenants to attain and maintain certain financial metrics, and&#13;to not merge or dispose of assets, acquire other businesses (except for businesses substantially similar or complementary to the&#13;Company&amp;#146;s business and the aggregate consideration to be paid does not exceed $100,000) or make capital expenditures in excess&#13;of $100,000 over the Company&amp;#146;s annual business plan in any year. The Loan Agreement also includes customary events of default,&#13;including payment defaults, breaches of covenants, change of control and material adverse effect default. Upon the occurrence of&#13;an event of default and during the continuation thereof, the principal amount of the Loan will bear a default interest rate of&#13;an additional 5%.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In connection with the Loan Agreement, the&#13;Company issued to Knight a warrant that entitled Knight to purchase 4,595,187 shares of common stock of the Company (&amp;#147;Common&#13;Stock&amp;#148;) on or prior to close of business on January 30, 2015 (the &amp;#147;ST Warrant&amp;#148;). The aggregate exercise price&#13;of the Common Stock under the ST Warrant is $1.00. Knight exercised the ST Warrant on January 22, 2015. Also in connection with&#13;the Loan Agreement, the Company issued to Knight a warrant to purchase 3,584,759 shares of Common Stock on or prior to the close&#13;of business of January 22, 2025 (the &amp;#147;LT Warrant&amp;#148;). The exercise price per share of the Common Stock under the LT Warrant&#13;is $0.34. The LT Warrant provides for cashless exercise. The LT Warrant also provides that in the event the closing price of the&#13;Common Stock remains above $1.00 for six consecutive months, Knight will forfeit the difference between the number of shares acquired&#13;under the LT Warrant prior to 90 days after such six-month period, and 25% of the shares purchasable under the LT Warrant.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The beneficial conversion feature of the warrants&#13;issued to the noteholders amounted to $1,952,953 (ST warrants) and $1,462,560 (LT warrants), respectively, and was recorded as&#13;debt discount of the corresponding debt.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company recognized amortization of debt&#13;discount of $1,952,953 (ST warrants) and $854,828 (LT warrants) during the year ended December 31, 2015. Unamortized debt discount&#13;as of December 31, 2015 amounted to $607,732.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company also recorded deferred financing&#13;costs of $289,045 with respect to the above loan. The Company recognized amortization of deferred financing costs of $136,207 during&#13;the year ended December 31, 2015.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company recognized and paid interest expense&#13;of $805,686 during the year ended December 31, 2015. Accrued interest expense was $0 as of December 31, 2015. Loan payable balance&#13;was $4,875,000 as of December 31, 2015.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;$1,500,000 January 22, 2015 Loan:&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On January 22, 2015, the Company issued a 0%&#13;promissory note in a principal amount of $1,500,000 in connection with an Asset Purchase Agreement (see note 1). The note has a&#13;maturity date of January 20, 2017, with $750,000 to be paid on or before January 20, 2016 and an additional $750,000 to be paid&#13;on or before January 20, 2017. Loan payable balance was $1,500,000 as of December 31, 2015.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;$950,000 June 26, 2015 Security Agreement:&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On June 26, 2015, the Company, through its&#13;wholly owned subsidiary, Neuragen Corp. (&amp;#147;Neuragen&amp;#148;), issued a 0% promissory note in a principal amount of $950,000&#13;in connection with an Asset Purchase Agreement (see note 1). The note requires $250,000 to be paid on or before June 30, 2016,&#13;and $700,000 to be paid in quarterly installments (beginning with the quarter ending September 30, 2015) equal to the greater of&#13;$12,500 or 5% of U.S. net sales, and 2% of U.S. net sales of Neuragen for 60 months thereafter. The payment of such amounts is&#13;secured by a security interest in certain assets, undertakings and property (&amp;#147;Collateral&amp;#148;) pursuant to the Security&#13;Agreement, which will be released upon receipt of total payments of $1.2 million.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company also recorded deferred financing&#13;costs of $10,486 with respect to the above agreement. The Company recognized amortization of deferred financing costs of $2,643&#13;during the year ended December 31, 2015. The balance at December 31, 2015 was $925,000.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;$5,500,000 November 12, 2015 Loan:&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On November 12, 2015, we entered into a First&#13;Amendment to Loan Agreement (&amp;#147;First Amendment&amp;#148;) with Knight, pursuant to which Knight agreed to loan us an additional&#13;$5.5 million, and which amount was borrowed at closing (the &amp;#147;Financing&amp;#148;) for the purpose of acquiring Breakthrough&#13;Products, Inc. and NomadChoice Pty Limited through Stock Purchase Agreements. At closing, we paid Knight an origination fee of&#13;$110,000 and a work fee of $55,000 and also paid $24,000 of Knight&amp;#146;s expenses associated with the Loan. The Loan bears interest&#13;at a rate of 15% per year. The interest rate will decrease to 13% if we meet certain equity-fundraising targets. The New Loan Agreement&#13;matures on November 11, 2017.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In connection with the New Loan Agreement,&#13;we issued Knight a warrant that entitles Knight to purchase 5,550,625 shares of our common stock (&amp;#147;Knight Warrant Shares&amp;#148;)&#13;representing approximately 6.5% of our fully diluted capital, which Knight exercised in full on November 12, 2015. Knight also&#13;received a 10-year warrant entitling Knight to purchase up to 4,547,243 shares of our common stock at $0.49 per share (&amp;#147;Knight&#13;Warrants&amp;#148;).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The beneficial conversion feature of the warrants&#13;issued to the noteholders amounted to $2,553,287 (5,550,625 warrants) and $2,067,258 (4,547,243 warrants), respectively, and was&#13;recorded as debt discount of the corresponding debt. For derivative liability calculation on 4,547,243 warrants, refer to Note&#13;17.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company recognized amortization of debt&#13;discount of $2,553,287 (5,550,625 warrants) and $138,571 (4,547,243 warrants) during the year ended December 31, 2015. Unamortized&#13;debt discount as of December 31, 2015 amounted to $1,928,686.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company also recorded deferred financing&#13;costs of $233,847 with respect to the above loan. The Company recognized amortization of deferred financing costs of $15,675 during&#13;the year ended December 31, 2015.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company recognized interest expense of&#13;$110,753 during the year ended December 31, 2015. Accrued interest expense was $110,753 as of December 31, 2015. The balance at&#13;December 31, 2015 was $5,500,000.&lt;/p&gt;</us-gaap:DebtDisclosureTextBlock>
    <SNYR:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockWarrantsPlansByExercisePriceRangeTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following table summarizes the warrants&#13;outstanding and the related prices for the shares of the Company&amp;#146;s common stock at December 31, 2015:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="10" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Warrants Outstanding&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Warrants Exercisable&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Prices ($)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Number&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Outstanding&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Remaining&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Contractual Life&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;(Years)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Exercise &lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Price ($)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Number&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Exercisable&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Price ($)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 18%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.34&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3,584,759&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9.1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.34&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3,584,759&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.34&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.49&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,547,243&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9.9&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.49&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,547,243&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.49&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,000,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,000,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;</SNYR:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockWarrantsPlansByExercisePriceRangeTextBlock>
    <SNYR:GoingConcernPolicyTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Going Concern&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company&amp;#146;s consolidated financial&#13;statements are prepared using U.S. GAAP applicable to a going concern, which contemplates the realization of assets and liquidation&#13;of liabilities in the normal course of business. The Company had an accumulated deficit at December 31, 2015 of $8,569,841. The&#13;Company had a working capital deficit of $6,165,812 as of December 31, 2015. Due to acquisitions during 2015 of revenue-producing&#13;products, the Company believes it has established an ongoing source of revenue that is sufficient to cover its operating costs.&#13;The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating&#13;losses until it establishes a revenue stream and becomes profitable. If the Company is unable to obtain adequate capital it could&#13;be forced to cease development of operations.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In order to continue as a going concern&#13;and to develop a reliable source of revenues, and achieve a profitable level of operations the Company will need, among other things,&#13;additional capital resources. Management&amp;#146;s plans to continue as a going concern include raising additional capital through&#13;borrowing and/or sales of equity and debt securities. However, management cannot provide any assurances that the Company will be&#13;successful in accomplishing any of its plans.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The ability of the Company to continue&#13;as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and&#13;eventually secure other sources of financing and attain profitable operations. The accompanying consolidated financial statements&#13;do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.&lt;/p&gt;</SNYR:GoingConcernPolicyTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As of December 31, 2015 and 2014, accounts&#13;payable and accrued liabilities consisted of the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31, 2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31, 2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 54%"&gt;&lt;font style="font-size: 10pt"&gt;Payroll&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;128,237&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;10,867&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Legal fees&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;38,752&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;47,916&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Manufacturers&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,527,333&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Promotions&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,213,021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Returns allowance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,128,133&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Customers&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;411,033&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Interest&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;110,754&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Royalties&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;71,573&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Warehousing&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;31,748&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Others&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;371,518&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;15,859&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;5,032,102&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;74,642&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <dei:TradingSymbol contextRef="From2015-01-01to2015-12-31">SNYR</dei:TradingSymbol>
    <SNYR:StockWarrantsDisclosureTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 16 &amp;#150; Stock Warrants&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following table summarizes the warrants&#13;outstanding and the related prices for the shares of the Company&amp;#146;s common stock at December 31, 2015:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2" style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="10" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Warrants Outstanding&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Warrants Exercisable&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Prices ($)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Number&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Outstanding&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Remaining&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Contractual Life&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;(Years)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Exercise &lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Price ($)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Number&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Exercisable&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Price ($)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 18%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.34&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3,584,759&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9.1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.34&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3,584,759&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.34&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.49&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,547,243&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9.9&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.49&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,547,243&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.49&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,000,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,000,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The warrant activity for the year ended December&#13;31, 2015 is as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Warrants&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Outstanding&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted Average&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Exercise Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Outstanding at December 31, 2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 52%"&gt;&lt;font style="font-size: 10pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 21%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;19,277,814&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 21%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.44&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(10,145,812&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.00000020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Expired or canceled&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Outstanding at December 31, 2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9,132,002&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.92&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"&gt;&lt;/p&gt;</SNYR:StockWarrantsDisclosureTextBlock>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The warrant activity for the year ended December&#13;31, 2015 is as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27.5pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Warrants&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Outstanding&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted Average&lt;/b&gt;&lt;/font&gt;&lt;br /&gt;&#13;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Exercise Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Outstanding at December 31, 2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 52%"&gt;&lt;font style="font-size: 10pt"&gt;Granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 21%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;19,277,814&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 21%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.44&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(10,145,812&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.00000020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Expired or canceled&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Outstanding at December 31, 2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9,132,002&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.92&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"&gt;&lt;/p&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <SNYR:WarrantsToPurchaseOfCommonStock contextRef="AsOf2015-12-31" unitRef="Shares" decimals="INF">9132002</SNYR:WarrantsToPurchaseOfCommonStock>
    <us-gaap:NotesPayable contextRef="AsOf2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:NotesPayable contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">750000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="AsOf2015-01-22_custom_AssetPurchaseAgreementMember_custom_JanuaryTwentyTwoTwoThousandFifteenLoanTwoMember_custom_JanuaryTwentyTwoThousandSaventeenMember" unitRef="USD" decimals="0">750000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="AsOf2015-01-22_custom_AssetPurchaseAgreementMember_custom_JanuaryTwentyTwoTwoThousandFifteenLoanTwoMember_custom_JanuaryTwentyTwoThousandSixteenMember" unitRef="USD" decimals="0">750000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="AsOf2015-12-31_custom_AssetPurchaseAgreementMember_custom_JanuaryTwentyTwoTwoThousandFifteenLoanTwoMember" unitRef="USD" decimals="0">1500000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="AsOf2015-06-26_custom_SecurityAgreementMember_custom_JuneTwentySixTwoThousandFifteenMember_custom_JuneThirtyTwoThousandSixteenMember" unitRef="USD" decimals="0">700000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="AsOf2015-06-26_custom_SecurityAgreementMember_custom_JuneTwentySixTwoThousandFifteenMember_custom_QuarterEndingSeptemberThirtyTwoThousandSaventeenMember" unitRef="USD" decimals="0">250000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="AsOf2015-06-26_custom_SecurityAgreementMember_custom_JuneTwentySixTwoThousandFifteenMember_custom_JuneThirtyTwoThousandSixteenMember_us-gaap_MinimumMember" unitRef="USD" decimals="0">12500</us-gaap:NotesPayable>
    <dei:EntityCentralIndexKey contextRef="From2015-01-01to2015-12-31">0001562733</dei:EntityCentralIndexKey>
    <us-gaap:SellingAndMarketingExpense contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">3685727</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="From2014-01-01to2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2014-12-31" unitRef="USD" decimals="0">338</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">3640893</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2013-12-31" unitRef="USD" decimals="0">3230</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <SNYR:CommonStockIssuedAsPartOfContributionAgreement contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">1500000</SNYR:CommonStockIssuedAsPartOfContributionAgreement>
    <SNYR:CommonStockIssuedAsPartOfContributionAgreement contextRef="From2014-01-01to2014-12-31" unitRef="USD" xsi:nil="true" />
    <SNYR:CommonStockIssuedAsPartOfContributionAgreement contextRef="From2015-01-01to2015-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">21</SNYR:CommonStockIssuedAsPartOfContributionAgreement>
    <SNYR:CommonStockIssuedAsPartOfContributionAgreement contextRef="From2015-01-01to2015-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">1499978</SNYR:CommonStockIssuedAsPartOfContributionAgreement>
    <SNYR:CommonStockIssuedAsPartOfContributionAgreement contextRef="From2015-01-01to2015-12-31_custom_CommonStockToBeIssuedMember" unitRef="USD" xsi:nil="true" />
    <SNYR:CommonStockIssuedAsPartOfContributionAgreement contextRef="From2015-01-01to2015-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <SNYR:IntellectualProperty contextRef="AsOf2014-12-31" unitRef="USD" xsi:nil="true" />
    <SNYR:IntellectualProperty contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">1000000</SNYR:IntellectualProperty>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2015-01-01to2015-12-31_custom_StockOptionPlanMember" unitRef="Shares" decimals="INF">4000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2014-04-01to2014-04-02_us-gaap_ChiefExecutiveOfficerMember" unitRef="Shares" decimals="INF">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2014-03-30to2014-04-02_us-gaap_ChiefExecutiveOfficerMember" unitRef="Shares" decimals="INF">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2015-12-13to2015-12-14_custom_TwoBoardMembersMember" unitRef="Shares" decimals="INF">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2015-12-13to2015-12-14_custom_TwoEmployeeMembersMember" unitRef="Shares" decimals="INF">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation contextRef="From2014-04-01to2014-04-02_us-gaap_ChiefExecutiveOfficerMember" unitRef="USD" decimals="0">282000</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensation>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2014-10-31_us-gaap_ChiefExecutiveOfficerMember" unitRef="Pure" decimals="INF">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2015-01-22_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember" unitRef="Pure" decimals="INF">0.15</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2015-01-22_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_JanuaryTwentyTwoThousandFifteenLoanOneMember" unitRef="Pure" decimals="INF">0.05</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2015-01-22_custom_AssetPurchaseAgreementMember_custom_JanuaryTwentyTwoTwoThousandFifteenLoanTwoMember" unitRef="Pure" decimals="INF">0.00</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2015-06-26_custom_SecurityAgreementMember_custom_JuneTwentySixTwoThousandFifteenMember_custom_NeuragenCorpMember" unitRef="Pure" decimals="INF">0.00</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2015-11-12_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember223527046" unitRef="Pure" decimals="INF">0.15</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2014-10-01to2014-10-31_us-gaap_ChiefExecutiveOfficerMember">2015-10-31</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2015-01-21to2015-01-22_custom_AssetPurchaseAgreementMember_custom_JanuaryTwentyTwoTwoThousandFifteenLoanTwoMember">2017-01-20</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2015-11-11to2015-11-12_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember">2017-11-11</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1 contextRef="From2015-01-01to2015-12-31" unitRef="Shares" decimals="INF">400000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="AsOf2014-12-31" unitRef="USD" decimals="0">10867</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">128237</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="AsOf2015-12-31_custom_HandMDLLCMember216380656" unitRef="USD" decimals="0">40000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent contextRef="AsOf2015-01-22_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember" unitRef="USD" decimals="0">1000000</us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent>
    <us-gaap:SalesRevenueNet contextRef="From2015-08-17to2015-08-18_custom_BreakthroughProductsIncMember_custom_StockPurchaseAgreementMember" unitRef="USD" decimals="0">5000000</us-gaap:SalesRevenueNet>
    <SNYR:PercentageOfSaleRevenueNet contextRef="From2015-06-25to2015-06-26_custom_SecurityAgreementMember_custom_JuneTwentySixTwoThousandFifteenMember_custom_USMember" unitRef="Pure" decimals="INF">0.05</SNYR:PercentageOfSaleRevenueNet>
    <SNYR:PercentageOfSaleRevenueNet contextRef="From2015-06-25to2015-06-26_custom_SecurityAgreementMember_custom_JuneTwentySixTwoThousandFifteenMember_custom_USMember_custom_NeuragenCorpMember" unitRef="Pure" decimals="INF">0.02</SNYR:PercentageOfSaleRevenueNet>
    <us-gaap:PaymentsToAcquireInvestments contextRef="From2015-11-14to2015-11-15_custom_TprInvestmentsPtyLtdMember_custom_StockPurchaseAgreementMember_custom_AustralianDollerMember" unitRef="AUD" decimals="0">4000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments contextRef="From2015-06-25to2015-06-26_custom_SecurityAgreementMember_custom_JuneTwentySixTwoThousandFifteenMember_custom_NeuragenCorpMember" unitRef="USD" decimals="0">1200000</us-gaap:PaymentsToAcquireInvestments>
    <SNYR:PercentageOfOutstandingCapital contextRef="AsOf2015-12-31_custom_ContributionAgreementMember_custom_HandMDCorpMember" unitRef="Pure" decimals="INF">0.50</SNYR:PercentageOfOutstandingCapital>
    <SNYR:PercentageOfOutstandingCapital contextRef="AsOf2015-12-31_custom_StockPurchaseAgreementMember_custom_NomadChoiceMember" unitRef="Pure" decimals="INF">1.00</SNYR:PercentageOfOutstandingCapital>
    <SNYR:PercentageOfOutstandingCapital contextRef="AsOf2015-12-31_custom_StockPurchaseAgreementMember_custom_BreakthroughProductsIncMember" unitRef="Pure" decimals="INF">1.00</SNYR:PercentageOfOutstandingCapital>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="AsOf2014-07-30_custom_EquityIncentivePlanTwoThousandsAndFourteenMember" unitRef="Shares" decimals="INF">15525000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2015-01-01to2015-12-31_custom_StockOptionPlanMember" unitRef="USDPerShare" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2014-03-30to2014-04-02_us-gaap_ChiefExecutiveOfficerMember" unitRef="USDPerShare" decimals="INF">0.25</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2015-12-13to2015-12-14_custom_TwoBoardMembersMember" unitRef="USDPerShare" decimals="INF">0.25</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2015-12-13to2015-12-14_custom_TwoEmployeeMembersMember" unitRef="USDPerShare" decimals="INF">0.65</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="From2015-01-01to2015-12-31_custom_StockOptionPlanMember_us-gaap_MinimumMember" unitRef="USDPerShare" decimals="INF">0.25</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="From2015-01-01to2015-12-31_custom_StockOptionPlanMember_us-gaap_MaximumMember" unitRef="USDPerShare" decimals="INF">65</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="From2015-01-01to2015-12-31_us-gaap_WarrantMember_custom_ExercisePriceRangeOneMember" unitRef="USDPerShare" decimals="INF">0.34</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="From2015-01-01to2015-12-31_us-gaap_WarrantMember_custom_ExercisePriceRangeTwoMember" unitRef="USDPerShare" decimals="INF">0.49</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="From2015-01-01to2015-12-31_us-gaap_WarrantMember_custom_ExercisePriceRangeThreeMember" unitRef="USDPerShare" decimals="INF">5.00</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2015-12-31_custom_StockOptionPlanMember" unitRef="Shares" decimals="INF">5000000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2015-12-31_us-gaap_WarrantMember_custom_ExercisePriceRangeOneMember" unitRef="Shares" decimals="INF">3584759</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2015-12-31_us-gaap_WarrantMember_custom_ExercisePriceRangeTwoMember" unitRef="Shares" decimals="INF">4547243</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="AsOf2015-12-31_us-gaap_WarrantMember_custom_ExercisePriceRangeThreeMember" unitRef="Shares" decimals="INF">1000000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="From2015-01-01to2015-12-31_custom_StockOptionPlanMember">P8Y7M13D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="From2015-01-01to2015-12-31_us-gaap_WarrantMember_custom_ExercisePriceRangeOneMember">P9Y1M6D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="From2015-01-01to2015-12-31_us-gaap_WarrantMember_custom_ExercisePriceRangeTwoMember">P9Y10M24D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 contextRef="From2015-01-01to2015-12-31_us-gaap_WarrantMember_custom_ExercisePriceRangeThreeMember">P3Y</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="AsOf2015-12-31_custom_StockOptionPlanMember" unitRef="USDPerShare" decimals="INF">0.41</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="AsOf2015-12-31_us-gaap_WarrantMember_custom_ExercisePriceRangeOneMember" unitRef="USDPerShare" decimals="INF">0.34</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="AsOf2015-12-31_us-gaap_WarrantMember_custom_ExercisePriceRangeTwoMember" unitRef="USDPerShare" decimals="INF">0.49</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 contextRef="AsOf2015-12-31_us-gaap_WarrantMember_custom_ExercisePriceRangeThreeMember" unitRef="USDPerShare" decimals="INF">5.00</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2015-12-31_custom_StockOptionPlanMember" unitRef="Shares" decimals="INF">3000000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2015-12-31_us-gaap_WarrantMember_custom_ExercisePriceRangeOneMember" unitRef="Shares" decimals="INF">3584759</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2015-12-31_us-gaap_WarrantMember_custom_ExercisePriceRangeTwoMember" unitRef="Shares" decimals="INF">4547243</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="AsOf2015-12-31_us-gaap_WarrantMember_custom_ExercisePriceRangeThreeMember" unitRef="Shares" decimals="INF">1000000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="AsOf2015-12-31_custom_StockOptionPlanMember" unitRef="USDPerShare" decimals="INF">0.25</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="AsOf2015-12-31_us-gaap_WarrantMember_custom_ExercisePriceRangeOneMember" unitRef="USDPerShare" decimals="INF">0.34</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="AsOf2015-12-31_us-gaap_WarrantMember_custom_ExercisePriceRangeTwoMember" unitRef="USDPerShare" decimals="INF">0.49</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 contextRef="AsOf2015-12-31_us-gaap_WarrantMember_custom_ExercisePriceRangeThreeMember" unitRef="USDPerShare" decimals="INF">5.00</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2015-12-31_custom_StockOptionPlanMember" unitRef="Shares" decimals="INF">5000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2014-12-31_custom_StockOptionPlanMember" unitRef="Shares" decimals="INF">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2015-01-01to2015-12-31_custom_StockOptionPlanMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod contextRef="From2015-01-01to2015-12-31_custom_StockOptionPlanMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2015-12-31_custom_StockOptionPlanMember" unitRef="USDPerShare" decimals="INF">0.41</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2014-12-31_custom_StockOptionPlanMember" unitRef="USDPerShare" decimals="INF">0.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2015-01-01to2015-12-31_custom_StockOptionPlanMember" unitRef="USDPerShare" decimals="INF">0.45</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice contextRef="From2015-01-01to2015-12-31_custom_StockOptionPlanMember" unitRef="USDPerShare" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="AsOf2015-12-31_us-gaap_WarrantMember" unitRef="Shares" decimals="INF">9132002</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="AsOf2014-12-31_us-gaap_WarrantMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="From2015-01-01to2015-12-31_us-gaap_WarrantMember" unitRef="Shares" decimals="INF">19277814</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="From2015-01-01to2015-12-31_us-gaap_WarrantMember" unitRef="Shares" decimals="INF">-10145812</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="From2015-01-01to2015-12-31_us-gaap_WarrantMember" unitRef="Shares" xsi:nil="true" />
    <SNYR:ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePriceEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="AsOf2015-12-31_us-gaap_WarrantMember" unitRef="USDPerShare" decimals="INF">0.92</SNYR:ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePriceEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <SNYR:ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePriceEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="AsOf2014-12-31_us-gaap_WarrantMember" unitRef="USDPerShare" xsi:nil="true" />
    <SNYR:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2015-01-01to2015-12-31_us-gaap_WarrantMember" unitRef="USDPerShare" decimals="INF">0.44</SNYR:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <SNYR:ShareBasedCompensationArrangementsByShareBasedPaymentAwardWarrantsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2015-01-01to2015-12-31_us-gaap_WarrantMember" unitRef="USDPerShare" decimals="INF">0.00000020</SNYR:ShareBasedCompensationArrangementsByShareBasedPaymentAwardWarrantsExercisesInPeriodWeightedAverageExercisePrice>
    <SNYR:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageExercisePrice contextRef="From2015-01-01to2015-12-31_us-gaap_WarrantMember" unitRef="USDPerShare" xsi:nil="true" />
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2015-01-01to2015-12-31">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2015-01-01to2015-12-31">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2015-01-01to2015-12-31">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityPublicFloat contextRef="AsOf2015-06-30" unitRef="USD" decimals="0">18900000</dei:EntityPublicFloat>
    <dei:DocumentFiscalPeriodFocus contextRef="From2015-01-01to2015-12-31">FY</dei:DocumentFiscalPeriodFocus>
    <us-gaap:AssetsCurrent contextRef="AsOf2014-12-31" unitRef="USD" decimals="0">55376</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">9336923</us-gaap:AssetsCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2014-12-31" unitRef="USD" decimals="0">10000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">422434</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:DueFromRelatedPartiesCurrent contextRef="AsOf2014-12-31" unitRef="USD" decimals="0">16077</us-gaap:DueFromRelatedPartiesCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2014-12-31" unitRef="USD" decimals="0">2898</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">3979857</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:UnamortizedDebtIssuanceExpense contextRef="AsOf2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:UnamortizedDebtIssuanceExpense contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">378852</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">5915262</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill contextRef="AsOf2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:Goodwill contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">11496402</us-gaap:Goodwill>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">12017</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Assets contextRef="AsOf2014-12-31" unitRef="USD" decimals="0">55376</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">27139456</us-gaap:Assets>
    <us-gaap:LongTermDebtCurrent contextRef="AsOf2014-12-31" unitRef="USD" decimals="0">6400</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">750000</us-gaap:LongTermDebtCurrent>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent contextRef="AsOf2014-12-31" unitRef="USD" decimals="0">100000</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">3162060</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent contextRef="AsOf2015-12-31_custom_ConsultingAgreementMember_custom_MsHarshbargerMember" unitRef="USD" decimals="0">10000</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2014-12-31" unitRef="USD" decimals="0">74642</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">5032102</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2014-12-31" unitRef="USD" decimals="0">181042</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">15502735</us-gaap:LiabilitiesCurrent>
    <us-gaap:Liabilities contextRef="AsOf2014-12-31" unitRef="USD" decimals="0">181042</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">21719743</us-gaap:Liabilities>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">6217008</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LongTermNotesPayable contextRef="AsOf2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:LongTermNotesPayable contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">5208111</us-gaap:LongTermNotesPayable>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2014-12-31" unitRef="USD" decimals="0">55376</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">27139456</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2014-12-31" unitRef="USD" decimals="0">-125666</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2014-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">621</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2014-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">867004</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2014-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-1033291</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">5419713</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2013-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">1800</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2013-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">58578</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2013-12-31_custom_CommonStockToBeIssuedMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2014-12-31_custom_CommonStockToBeIssuedMember" unitRef="USD" decimals="0">40000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2013-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-73199</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2013-12-31" unitRef="USD" decimals="0">-12821</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2015-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">817</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2015-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">13920735</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2015-12-31_custom_CommonStockToBeIssuedMember" unitRef="USD" decimals="0">68000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2015-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-8569839</us-gaap:StockholdersEquity>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2014-12-31" unitRef="USD" decimals="0">-1033291</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">-8569841</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2014-12-31" unitRef="USD" decimals="0">867004</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">13920735</us-gaap:AdditionalPaidInCapital>
    <us-gaap:CommonStockShareSubscribedButUnissuedSubscriptionsReceivable contextRef="AsOf2014-12-31" unitRef="USD" decimals="0">-40000</us-gaap:CommonStockShareSubscribedButUnissuedSubscriptionsReceivable>
    <us-gaap:CommonStockShareSubscribedButUnissuedSubscriptionsReceivable contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">-68000</us-gaap:CommonStockShareSubscribedButUnissuedSubscriptionsReceivable>
    <us-gaap:RestrictedCashAndCashEquivalents contextRef="AsOf2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:RestrictedCashAndCashEquivalents contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">607084</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:TaxesPayableCurrent contextRef="AsOf2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:TaxesPayableCurrent contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">910894</us-gaap:TaxesPayableCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">2551500</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilities contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">3096179</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="AsOf2015-12-31_us-gaap_WarrantMember" unitRef="USD" decimals="0">1028921</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="AsOf2015-11-12" unitRef="USD" decimals="0">2067258</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="AsOf2015-11-12_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_KnightWarrantsMember" unitRef="USD" decimals="0">4547243</us-gaap:DerivativeLiabilities>
    <SNYR:RoyaltyPayable contextRef="AsOf2014-12-31" unitRef="USD" xsi:nil="true" />
    <SNYR:RoyaltyPayable contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">258897</SNYR:RoyaltyPayable>
    <us-gaap:Revenues contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">13456377</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2014-01-01to2014-12-31" unitRef="USD" decimals="0">9158</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2015-01-01to2015-12-31_custom_UnitedStatesMember" unitRef="USD" decimals="0">13129753</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2015-01-01to2015-12-31_custom_ForeignCountriesMember" unitRef="USD" decimals="0">326624</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2014-01-01to2014-12-31_custom_UnitedStatesMember" unitRef="USD" decimals="0">9158</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2014-01-01to2014-12-31_custom_ForeignCountriesMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:Revenues contextRef="From2015-01-01to2015-12-31_custom_FocusFactorBusinessMember234188966" unitRef="USD" decimals="0">10482367</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2015-01-01to2015-12-31_custom_FlatTummyTeaMember" unitRef="USD" decimals="0">2513990</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2015-01-01to2015-12-31_custom_OtherMember" unitRef="USD" id="Foot-00-0" decimals="0">460020</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="From2014-01-01to2014-12-31_custom_FocusFactorBusinessMember234273690" unitRef="USD" xsi:nil="true" />
    <us-gaap:Revenues contextRef="From2014-01-01to2014-12-31_custom_FlatTummyTeaMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:Revenues contextRef="From2014-01-01to2014-12-31_custom_OtherMember" unitRef="USD" id="Foot-00-1" decimals="0">9158</us-gaap:Revenues>
    <us-gaap:CostOfGoodsSold contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">5308130</us-gaap:CostOfGoodsSold>
    <us-gaap:CostOfGoodsSold contextRef="From2014-01-01to2014-12-31" unitRef="USD" decimals="0">5616</us-gaap:CostOfGoodsSold>
    <us-gaap:GrossProfit contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">8148247</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="From2014-01-01to2014-12-31" unitRef="USD" decimals="0">3542</us-gaap:GrossProfit>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">3368495</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2014-01-01to2014-12-31" unitRef="USD" decimals="0">961636</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">7662224</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2014-01-01to2014-12-31" unitRef="USD" decimals="0">961636</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">486023</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2014-01-01to2014-12-31" unitRef="USD" decimals="0">-958094</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">-958740</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From2014-01-01to2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:InterestExpense contextRef="From2015-01-01to2015-12-31_custom_KnightTherapeuticsIncMember" unitRef="USD" decimals="0">37372</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From2015-01-01to2015-12-31_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember" unitRef="USD" decimals="0">805686</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From2015-01-01to2015-12-31_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_KnightWarrantsMember" unitRef="USD" decimals="0">110753</us-gaap:InterestExpense>
    <us-gaap:InvestmentIncomeAmortizationOfDiscount contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">5499640</us-gaap:InvestmentIncomeAmortizationOfDiscount>
    <us-gaap:InvestmentIncomeAmortizationOfDiscount contextRef="From2014-01-01to2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">-154525</us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts>
    <us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts contextRef="From2014-01-01to2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">7632626</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="From2014-01-01to2014-12-31" unitRef="USD" decimals="0">1998</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">-7536548</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2014-01-01to2014-12-31" unitRef="USD" decimals="0">-960092</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2014-01-01to2014-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-960092</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2015-01-01to2015-12-31_custom_FocusFactorBusinessMember" unitRef="USD" decimals="0">1216928</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2015-01-01to2015-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2015-01-01to2015-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2015-01-01to2015-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-7536548</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2015-12-16to2015-12-17_custom_BreakthroughProductsIncMember_custom_SettlementAgreementMember_custom_UrgentRxSellersMember" unitRef="USD" decimals="0">80249</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2015-01-01to2015-12-31_custom_TprInvestmentsPtyLtdMember_custom_StockPurchaseAgreementMember" unitRef="USD" decimals="0">966672</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2015-01-01to2015-12-31" unitRef="USDPerShare" decimals="INF">-0.11</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2014-01-01to2014-12-31" unitRef="USDPerShare" decimals="INF">-0.01</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2015-01-01to2015-12-31" unitRef="Shares" decimals="INF">68852305</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2014-01-01to2014-12-31" unitRef="Shares" decimals="INF">97165479</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:InterestIncomeExpenseNet contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">-1460</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet contextRef="From2014-01-01to2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">54600</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="From2014-01-01to2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">1028921</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax contextRef="From2014-01-01to2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:InterestExpenseOther contextRef="From2015-01-01to2015-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:InterestExpenseOther contextRef="From2014-01-01to2014-12-31" unitRef="USD" decimals="0">1998</us-gaap:InterestExpenseOther>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">-7146603</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="From2014-01-01to2014-12-31" unitRef="USD" decimals="0">-960092</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">389945</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="From2014-01-01to2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:SharesOutstanding contextRef="AsOf2014-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">62100000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2013-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">180000000</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2015-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">81692954</us-gaap:SharesOutstanding>
    <us-gaap:StockRepurchasedDuringPeriodShares contextRef="From2014-01-01to2014-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">135900000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="From2014-01-01to2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="From2014-01-01to2014-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">1359</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="From2014-01-01to2014-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">-1359</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="From2014-01-01to2014-12-31_custom_CommonStockToBeIssuedMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockRepurchasedDuringPeriodValue contextRef="From2014-01-01to2014-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2014-01-01to2014-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">16000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2014-01-01to2014-12-31" unitRef="USD" decimals="0">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2014-01-01to2014-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">160</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2014-01-01to2014-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">24840</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2014-01-01to2014-12-31_custom_CommonStockToBeIssuedMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2014-01-01to2014-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <SNYR:AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptions contextRef="From2014-01-01to2014-12-31" unitRef="USD" decimals="0">282247</SNYR:AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptions>
    <SNYR:AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptions contextRef="From2014-01-01to2014-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <SNYR:AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptions contextRef="From2014-01-01to2014-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">282247</SNYR:AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptions>
    <SNYR:AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptions contextRef="From2014-01-01to2014-12-31_custom_CommonStockToBeIssuedMember" unitRef="USD" xsi:nil="true" />
    <SNYR:AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptions contextRef="From2014-01-01to2014-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">28000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2014-01-01to2014-12-31" unitRef="USD" decimals="0">40000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2014-01-01to2014-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2014-01-01to2014-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2014-01-01to2014-12-31_custom_CommonStockToBeIssuedMember" unitRef="USD" decimals="0">40000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2014-01-01to2014-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2015-01-01to2015-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2015-01-01to2015-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2015-01-01to2015-12-31_custom_CommonStockToBeIssuedMember" unitRef="USD" decimals="0">28000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2015-01-01to2015-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <SNYR:CommonStockIssuedAsPartOfContributionAgreementShares contextRef="From2015-01-01to2015-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">2142857</SNYR:CommonStockIssuedAsPartOfContributionAgreementShares>
    <SNYR:CommonStockIssuedForAcquisitionsShares contextRef="From2015-01-01to2015-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">3000000</SNYR:CommonStockIssuedForAcquisitionsShares>
    <SNYR:CommonStockIssuedForAcquisitions contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">2550000</SNYR:CommonStockIssuedForAcquisitions>
    <SNYR:CommonStockIssuedForAcquisitions contextRef="From2015-01-01to2015-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">30</SNYR:CommonStockIssuedForAcquisitions>
    <SNYR:CommonStockIssuedForAcquisitions contextRef="From2015-01-01to2015-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">2549970</SNYR:CommonStockIssuedForAcquisitions>
    <SNYR:CommonStockIssuedForAcquisitions contextRef="From2015-01-01to2015-12-31_custom_CommonStockToBeIssuedMember" unitRef="USD" xsi:nil="true" />
    <SNYR:CommonStockIssuedForAcquisitions contextRef="From2015-01-01to2015-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <SNYR:CommonStockIssuedForAcquisitionsOneShares contextRef="From2015-01-01to2015-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">3571428</SNYR:CommonStockIssuedForAcquisitionsOneShares>
    <SNYR:CommonStockIssuedForAcquisitionsOne contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">1750000</SNYR:CommonStockIssuedForAcquisitionsOne>
    <SNYR:CommonStockIssuedForAcquisitionsOne contextRef="From2015-01-01to2015-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">36</SNYR:CommonStockIssuedForAcquisitionsOne>
    <SNYR:CommonStockIssuedForAcquisitionsOne contextRef="From2015-01-01to2015-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">1749964</SNYR:CommonStockIssuedForAcquisitionsOne>
    <SNYR:CommonStockIssuedForAcquisitionsOne contextRef="From2015-01-01to2015-12-31_custom_CommonStockToBeIssuedMember" unitRef="USD" xsi:nil="true" />
    <SNYR:CommonStockIssuedForAcquisitionsOne contextRef="From2015-01-01to2015-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <SNYR:CommonStockIssuedToSettleAccountsPayableShares contextRef="From2015-01-01to2015-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">292857</SNYR:CommonStockIssuedToSettleAccountsPayableShares>
    <SNYR:CommonStockIssuedToSettleAccountsPayable contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">205000</SNYR:CommonStockIssuedToSettleAccountsPayable>
    <SNYR:CommonStockIssuedToSettleAccountsPayable contextRef="From2015-01-01to2015-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">3</SNYR:CommonStockIssuedToSettleAccountsPayable>
    <SNYR:CommonStockIssuedToSettleAccountsPayable contextRef="From2015-01-01to2015-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">204997</SNYR:CommonStockIssuedToSettleAccountsPayable>
    <SNYR:CommonStockIssuedToSettleAccountsPayable contextRef="From2015-01-01to2015-12-31_custom_CommonStockToBeIssuedMember" unitRef="USD" xsi:nil="true" />
    <SNYR:CommonStockIssuedToSettleAccountsPayable contextRef="From2015-01-01to2015-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="From2015-01-01to2015-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">400000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">100000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="From2015-01-01to2015-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">4</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="From2015-01-01to2015-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">99996</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="From2015-01-01to2015-12-31_custom_CommonStockToBeIssuedMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="From2015-01-01to2015-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">2</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2015-01-01to2015-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">101</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2015-01-01to2015-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">-99</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2015-01-01to2015-12-31_custom_CommonStockToBeIssuedMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueOther contextRef="From2015-01-01to2015-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodSharesOther contextRef="From2015-01-01to2015-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">10145812</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">5968801</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="From2015-01-01to2015-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="From2015-01-01to2015-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">5968801</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="From2015-01-01to2015-12-31_custom_CommonStockToBeIssuedMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="From2015-01-01to2015-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">523714</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 contextRef="From2015-01-01to2015-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 contextRef="From2015-01-01to2015-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">523714</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 contextRef="From2015-01-01to2015-12-31_custom_CommonStockToBeIssuedMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 contextRef="From2015-01-01to2015-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">154525</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="From2014-01-01to2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ShareBasedCompensation contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">551714</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="From2014-01-01to2014-12-31" unitRef="USD" decimals="0">322247</us-gaap:ShareBasedCompensation>
    <SNYR:GainsLossesOnAcquisition contextRef="From2015-01-01to2015-12-31" unitRef="USD" xsi:nil="true" />
    <SNYR:GainsLossesOnAcquisition contextRef="From2014-01-01to2014-12-31" unitRef="USD" decimals="0">109040</SNYR:GainsLossesOnAcquisition>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">5499640</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2014-01-01to2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2015-11-11to2015-11-12" unitRef="USD" decimals="0">2067258</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2015-01-01to2015-12-31_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_STWarrantMember" unitRef="USD" decimals="0">1952953</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2015-01-01to2015-12-31_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_LTWarrantMember" unitRef="USD" decimals="0">854828</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2015-01-01to2015-12-31_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_KnightWarrantsMember" unitRef="USD" decimals="0">2553287</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2015-01-01to2015-12-31_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_KnightWarrantsOneMember" unitRef="USD" decimals="0">138571</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">1317050</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2014-01-01to2014-12-31" unitRef="USD" decimals="0">2898</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">19632</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2014-01-01to2014-12-31" unitRef="USD" decimals="0">26064</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">194889</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense contextRef="From2014-01-01to2014-12-31" unitRef="USD" decimals="0">-10000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">484141</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2014-01-01to2014-12-31" unitRef="USD" decimals="0">58591</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">-644316</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2014-01-01to2014-12-31" unitRef="USD" decimals="0">-489175</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">7833</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2014-01-01to2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">4500000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities contextRef="From2014-01-01to2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">-4399856</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2014-01-01to2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">16077</us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt>
    <us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt contextRef="From2014-01-01to2014-12-31" unitRef="USD" decimals="0">-16077</us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfNotesPayable contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">1150000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable contextRef="From2014-01-01to2014-12-31" unitRef="USD" decimals="0">97640</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:PaymentsOfDebtIssuanceCosts contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">533377</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts contextRef="From2014-01-01to2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">26000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2014-01-01to2014-12-31" unitRef="USD" decimals="0">500000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">8684727</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2014-01-01to2014-12-31" unitRef="USD" decimals="0">486283</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">3640554</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="From2014-01-01to2014-12-31" unitRef="USD" decimals="0">-2892</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
    <us-gaap:InterestPaid contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">806740</us-gaap:InterestPaid>
    <us-gaap:InterestPaid contextRef="From2014-01-01to2014-12-31" unitRef="USD" decimals="0">1667</us-gaap:InterestPaid>
    <us-gaap:IncomeTaxesPaidNet contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">12688</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="From2014-01-01to2014-12-31" unitRef="USD" xsi:nil="true" />
    <SNYR:LiabilitiesAssumedRelatedParty contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">969532</SNYR:LiabilitiesAssumedRelatedParty>
    <SNYR:LiabilitiesAssumedRelatedParty contextRef="From2014-01-01to2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ConversionOfStockAmountConverted1 contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">205000</us-gaap:ConversionOfStockAmountConverted1>
    <us-gaap:ConversionOfStockAmountConverted1 contextRef="From2014-01-01to2014-12-31" unitRef="USD" xsi:nil="true" />
    <SNYR:CancellationOfCommonStockAsPartOfPurchaseTransaction contextRef="From2015-01-01to2015-12-31" unitRef="USD" xsi:nil="true" />
    <SNYR:CancellationOfCommonStockAsPartOfPurchaseTransaction contextRef="From2014-01-01to2014-12-31" unitRef="USD" decimals="0">1359</SNYR:CancellationOfCommonStockAsPartOfPurchaseTransaction>
    <SNYR:FinancingForPrepaidInsurance contextRef="From2015-01-01to2015-12-31" unitRef="USD" xsi:nil="true" />
    <SNYR:FinancingForPrepaidInsurance contextRef="From2014-01-01to2014-12-31" unitRef="USD" decimals="0">20000</SNYR:FinancingForPrepaidInsurance>
    <us-gaap:LiabilitiesAssumed1 contextRef="From2015-01-01to2015-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:LiabilitiesAssumed1 contextRef="From2014-01-01to2014-12-31" unitRef="USD" decimals="0">84040</us-gaap:LiabilitiesAssumed1>
    <SNYR:IssuanceOfSharesAsPartOfAcquisitionTransaction contextRef="From2015-01-01to2015-12-31" unitRef="USD" xsi:nil="true" />
    <SNYR:IssuanceOfSharesAsPartOfAcquisitionTransaction contextRef="From2014-01-01to2014-12-31" unitRef="USD" decimals="0">25000</SNYR:IssuanceOfSharesAsPartOfAcquisitionTransaction>
    <us-gaap:ForeignCurrencyTransactionGainBeforeTax contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">-7740</us-gaap:ForeignCurrencyTransactionGainBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainBeforeTax contextRef="From2014-01-01to2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">50000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="From2014-01-01to2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncreaseInRestrictedCash contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">-607084</us-gaap:IncreaseInRestrictedCash>
    <us-gaap:IncreaseInRestrictedCash contextRef="From2014-01-01to2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherPaymentsToAcquireBusinesses contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">-2918200</us-gaap:OtherPaymentsToAcquireBusinesses>
    <us-gaap:OtherPaymentsToAcquireBusinesses contextRef="From2014-01-01to2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:CashAcquiredFromAcquisition contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">3883261</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:CashAcquiredFromAcquisition contextRef="From2014-01-01to2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:PaymentsOfDividends contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">-1173975</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends contextRef="From2014-01-01to2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProceedsFromDerivativeInstrumentFinancingActivities contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">2</us-gaap:ProceedsFromDerivativeInstrumentFinancingActivities>
    <us-gaap:ProceedsFromDerivativeInstrumentFinancingActivities contextRef="From2014-01-01to2014-12-31" unitRef="USD" xsi:nil="true" />
    <SNYR:NetAssetsTakenOverAsPartOfAcquisition contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">70801</SNYR:NetAssetsTakenOverAsPartOfAcquisition>
    <SNYR:NetAssetsTakenOverAsPartOfAcquisition contextRef="From2014-01-01to2014-12-31" unitRef="USD" xsi:nil="true" />
    <SNYR:NetLiabilitiesTakenOverAsPartOfAcquisition contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">422749</SNYR:NetLiabilitiesTakenOverAsPartOfAcquisition>
    <SNYR:NetLiabilitiesTakenOverAsPartOfAcquisition contextRef="From2014-01-01to2014-12-31" unitRef="USD" xsi:nil="true" />
    <SNYR:FairValueOfWarrantsIssuedAsPartOfAcquisition contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">430411</SNYR:FairValueOfWarrantsIssuedAsPartOfAcquisition>
    <SNYR:FairValueOfWarrantsIssuedAsPartOfAcquisition contextRef="From2014-01-01to2014-12-31" unitRef="USD" xsi:nil="true" />
    <SNYR:CommonStockIssuedForAcquisition contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">1750000</SNYR:CommonStockIssuedForAcquisition>
    <SNYR:CommonStockIssuedForAcquisition contextRef="From2014-01-01to2014-12-31" unitRef="USD" xsi:nil="true" />
    <SNYR:CommonStockIssuedForAcquisitionOne contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">2550000</SNYR:CommonStockIssuedForAcquisitionOne>
    <SNYR:CommonStockIssuedForAcquisitionOne contextRef="From2014-01-01to2014-12-31" unitRef="USD" xsi:nil="true" />
    <SNYR:DerivativeLiabilityAtInception contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">2067258</SNYR:DerivativeLiabilityAtInception>
    <SNYR:DerivativeLiabilityAtInception contextRef="From2014-01-01to2014-12-31" unitRef="USD" xsi:nil="true" />
    <SNYR:AssumptionOfLiabilitiesAsPartOfAssetPurchaseAgreement contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">1912827</SNYR:AssumptionOfLiabilitiesAsPartOfAssetPurchaseAgreement>
    <SNYR:AssumptionOfLiabilitiesAsPartOfAssetPurchaseAgreement contextRef="From2014-01-01to2014-12-31" unitRef="USD" xsi:nil="true" />
    <SNYR:CommonStockIssuedForConversionOfNotesPayable contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">100000</SNYR:CommonStockIssuedForConversionOfNotesPayable>
    <SNYR:CommonStockIssuedForConversionOfNotesPayable contextRef="From2014-01-01to2014-12-31" unitRef="USD" xsi:nil="true" />
    <SNYR:ProductDisplayCostsPolicyTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Product display costs&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;All displays manufactured and purchased by&#13;the Company are for placement of product in retail stores. This also includes all costs for display execution and setup and retail&#13;services are charged to general and administrative expenses as incurred.&lt;/p&gt;</SNYR:ProductDisplayCostsPolicyTextBlock>
    <us-gaap:CashFDICInsuredAmount contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">250000</us-gaap:CashFDICInsuredAmount>
    <us-gaap:CashUninsuredAmount contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">3453290</us-gaap:CashUninsuredAmount>
    <us-gaap:NumberOfOperatingSegments contextRef="From2015-01-01to2015-12-31" unitRef="Segment" decimals="INF">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:SharePrice contextRef="AsOf2015-12-31" unitRef="USDPerShare" decimals="INF">0.69</us-gaap:SharePrice>
    <us-gaap:SharePrice contextRef="AsOf2015-11-12" unitRef="USDPerShare" decimals="INF">0.46</us-gaap:SharePrice>
    <us-gaap:FairValueAssumptionsExercisePrice contextRef="AsOf2014-12-31" unitRef="USDPerShare" decimals="INF">0.33</us-gaap:FairValueAssumptionsExercisePrice>
    <us-gaap:FairValueAssumptionsExercisePrice contextRef="AsOf2015-12-31" unitRef="USDPerShare" decimals="INF">0.74</us-gaap:FairValueAssumptionsExercisePrice>
    <us-gaap:FairValueAssumptionsExercisePrice contextRef="AsOf2015-11-12" unitRef="USDPerShare" decimals="INF">0.49</us-gaap:FairValueAssumptionsExercisePrice>
    <us-gaap:FairValueAssumptionsExercisePrice contextRef="AsOf2015-12-17_custom_BreakthroughProductsIncMember_custom_SettlementAgreementMember" unitRef="USDPerShare" decimals="INF">0.001</us-gaap:FairValueAssumptionsExercisePrice>
    <us-gaap:FairValueAssumptionsExpectedTerm contextRef="From2014-01-01to2014-12-31">P4Y6M</us-gaap:FairValueAssumptionsExpectedTerm>
    <us-gaap:FairValueAssumptionsExpectedTerm contextRef="From2015-11-11to2015-11-12">P10Y</us-gaap:FairValueAssumptionsExpectedTerm>
    <us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="From2015-01-01to2015-12-31" unitRef="Pure" decimals="INF">152.07</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="From2014-01-01to2014-12-31" unitRef="Pure" decimals="INF">1.25</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:FairValueAssumptionsExpectedVolatilityRate contextRef="From2015-11-11to2015-11-12" unitRef="Pure" decimals="INF">1.54</us-gaap:FairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="From2015-01-01to2015-12-31" unitRef="Pure" decimals="INF">0.0227</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="From2014-01-01to2014-12-31" unitRef="Pure" decimals="INF">0.018</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:FairValueAssumptionsRiskFreeInterestRate contextRef="From2015-11-11to2015-11-12" unitRef="Pure" decimals="INF">0.0232</us-gaap:FairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:FairValueAssumptionsExpectedDividendRate contextRef="From2015-01-01to2015-12-31" unitRef="Pure" decimals="INF">0.00</us-gaap:FairValueAssumptionsExpectedDividendRate>
    <us-gaap:FairValueAssumptionsExpectedDividendRate contextRef="From2014-01-01to2014-12-31" unitRef="Pure" decimals="INF">0.00</us-gaap:FairValueAssumptionsExpectedDividendRate>
    <us-gaap:FairValueAssumptionsExpectedDividendRate contextRef="From2015-11-11to2015-11-12" unitRef="Pure" decimals="INF">0.00</us-gaap:FairValueAssumptionsExpectedDividendRate>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2015-12-02to2015-12-03_custom_KnightTherapeuticsBarbadosIncMember" unitRef="Pure" decimals="INF">0.60</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2015-08-17to2015-08-18_custom_HandMDLLCMember_custom_LicenseAgreementMember" unitRef="Pure" decimals="INF">0.05</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2015-08-17to2015-08-18_custom_BreakthroughProductsIncMember_custom_StockPurchaseAgreementMember" unitRef="Pure" decimals="INF">0.05</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2015-01-01to2015-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember" unitRef="Pure" decimals="INF">0.78</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2015-01-01to2015-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember" unitRef="Pure" decimals="INF">0.71</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2015-01-01to2015-12-31_custom_OtherMember_us-gaap_SalesRevenueNetMember" unitRef="Pure" decimals="INF">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2014-01-01to2014-12-31_custom_OtherMember_us-gaap_SalesRevenueNetMember" unitRef="Pure" decimals="INF">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization contextRef="From2015-01-01to2015-12-31_custom_KnightTherapeuticsBarbadosIncMember200683570" unitRef="USD" decimals="0">384720</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization contextRef="From2015-01-01to2015-12-31_custom_KnightTherapeuticsIncMember_custom_SecurityAgreementMember" unitRef="USD" decimals="0">70655</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization contextRef="From2015-08-17to2015-08-18_custom_HandMDLLCMember_custom_ConsultingAgreementMember" unitRef="USD" decimals="0">118045</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization contextRef="From2015-12-16to2015-12-17_custom_BreakthroughProductsIncMember_custom_SettlementAgreementMember_custom_NoncompeteProvisionMember" unitRef="USD" decimals="0">4583</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization contextRef="From2015-11-14to2015-11-15_custom_TprInvestmentsPtyLtdMember_custom_StockPurchaseAgreementMember" unitRef="USD" decimals="0">28333</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <SNYR:PresentValueOfFuturePayments contextRef="From2015-01-01to2015-12-31_custom_KnightTherapeuticsIncMember" unitRef="USD" decimals="0">515854</SNYR:PresentValueOfFuturePayments>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2015-01-01to2015-12-31_custom_KnightTherapeuticsIncMember_custom_SecurityAgreementMember">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2015-08-17to2015-08-18_custom_HandMDLLCMember_custom_ConsultingAgreementMember">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2015-12-16to2015-12-17_custom_BreakthroughProductsIncMember_custom_SettlementAgreementMember">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2015-12-16to2015-12-17_custom_BreakthroughProductsIncMember_custom_SettlementAgreementMember_custom_NoncompeteProvisionMember">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2015-11-14to2015-11-15_custom_TprInvestmentsPtyLtdMember_custom_StockPurchaseAgreementMember">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="From2015-11-14to2015-11-15_custom_TprInvestmentsPtyLtdMember_custom_StockPurchaseAgreementMember_custom_NoncompeteProvisionMember">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent contextRef="From2015-08-17to2015-08-18_custom_HandMDLLCMember" unitRef="Pure" decimals="INF">0.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory contextRef="AsOf2015-08-18_custom_HandMDLLCMember" unitRef="USD" decimals="0">106000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:RoyaltyExpense contextRef="From2015-01-01to2015-12-31_custom_HandMDLLCMember" unitRef="USD" decimals="0">258897</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense contextRef="From2015-08-17to2015-08-18_custom_HandMDLLCMember_custom_LicenseAgreementMember_custom_SecondYearMember" unitRef="USD" decimals="0">250000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense contextRef="From2015-08-17to2015-08-18_custom_HandMDLLCMember_custom_LicenseAgreementMember_custom_ThiredYearMember" unitRef="USD" decimals="0">500000</us-gaap:RoyaltyExpense>
    <SNYR:PercentageOfAmountReceviedFromSublicensess contextRef="AsOf2015-08-18_custom_HandMDLLCMember_custom_LicenseAgreementMember" unitRef="Pure" decimals="INF">0.05</SNYR:PercentageOfAmountReceviedFromSublicensess>
    <SNYR:ConsultingFeePaid contextRef="AsOf2015-08-18_custom_HandMDLLCMember_custom_ConsultingAgreementMember" unitRef="USD" decimals="0">10000</SNYR:ConsultingFeePaid>
    <SNYR:BusinessAcquisitionsProFormaAccountsReceivable contextRef="AsOf2015-12-31_custom_FactorNutritionLabsLLCMember" unitRef="USD" decimals="0">2733167</SNYR:BusinessAcquisitionsProFormaAccountsReceivable>
    <SNYR:BusinessAcquisitionsProFormaAccountsReceivable contextRef="AsOf2015-12-31_custom_KnightTherapeuticsIncMember" unitRef="USD" decimals="0">58054</SNYR:BusinessAcquisitionsProFormaAccountsReceivable>
    <SNYR:BusinessAcquisitionsProFormaAccountsReceivable contextRef="AsOf2015-12-31_custom_HandMDLLCMember" unitRef="USD" xsi:nil="true" />
    <SNYR:BusinessAcquisitionsProFormaAccountsReceivable contextRef="AsOf2015-12-31_custom_BreakthroughProductsIncMember" unitRef="USD" decimals="0">-68976</SNYR:BusinessAcquisitionsProFormaAccountsReceivable>
    <SNYR:BusinessAcquisitionsProFormaAccountsReceivable contextRef="AsOf2015-12-31_custom_TprInvestmentsPtyLtdMember" unitRef="USD" decimals="0">30684</SNYR:BusinessAcquisitionsProFormaAccountsReceivable>
    <SNYR:BusinessAcquisitionsProFormaInventory contextRef="AsOf2015-12-31_custom_FactorNutritionLabsLLCMember" unitRef="USD" decimals="0">67113</SNYR:BusinessAcquisitionsProFormaInventory>
    <SNYR:BusinessAcquisitionsProFormaInventory contextRef="AsOf2015-12-31_custom_KnightTherapeuticsIncMember" unitRef="USD" decimals="0">204925</SNYR:BusinessAcquisitionsProFormaInventory>
    <SNYR:BusinessAcquisitionsProFormaInventory contextRef="AsOf2015-12-31_custom_HandMDLLCMember" unitRef="USD" xsi:nil="true" />
    <SNYR:BusinessAcquisitionsProFormaInventory contextRef="AsOf2015-12-31_custom_BreakthroughProductsIncMember" unitRef="USD" decimals="0">234709</SNYR:BusinessAcquisitionsProFormaInventory>
    <SNYR:BusinessAcquisitionsProFormaInventory contextRef="AsOf2015-12-31_custom_TprInvestmentsPtyLtdMember" unitRef="USD" decimals="0">134212</SNYR:BusinessAcquisitionsProFormaInventory>
    <SNYR:BusinessAcquisitionsProFormaIntellectualProperty contextRef="AsOf2015-12-31_custom_FactorNutritionLabsLLCMember" unitRef="USD" decimals="0">1000000</SNYR:BusinessAcquisitionsProFormaIntellectualProperty>
    <SNYR:BusinessAcquisitionsProFormaIntellectualProperty contextRef="AsOf2015-12-31_custom_KnightTherapeuticsIncMember" unitRef="USD" decimals="0">100000</SNYR:BusinessAcquisitionsProFormaIntellectualProperty>
    <SNYR:BusinessAcquisitionsProFormaIntellectualProperty contextRef="AsOf2015-12-31_custom_HandMDLLCMember" unitRef="USD" decimals="0">100000</SNYR:BusinessAcquisitionsProFormaIntellectualProperty>
    <SNYR:BusinessAcquisitionsProFormaIntellectualProperty contextRef="AsOf2015-12-31_custom_BreakthroughProductsIncMember" unitRef="USD" decimals="0">100000</SNYR:BusinessAcquisitionsProFormaIntellectualProperty>
    <SNYR:BusinessAcquisitionsProFormaIntellectualProperty contextRef="AsOf2015-12-31_custom_TprInvestmentsPtyLtdMember" unitRef="USD" decimals="0">100000</SNYR:BusinessAcquisitionsProFormaIntellectualProperty>
    <SNYR:BusinessAcquisitionsProFormaNonCompeteProvision contextRef="AsOf2015-12-31_custom_FactorNutritionLabsLLCMember" unitRef="USD" decimals="0">50000</SNYR:BusinessAcquisitionsProFormaNonCompeteProvision>
    <SNYR:BusinessAcquisitionsProFormaNonCompeteProvision contextRef="AsOf2015-12-31_custom_KnightTherapeuticsIncMember" unitRef="USD" xsi:nil="true" />
    <SNYR:BusinessAcquisitionsProFormaNonCompeteProvision contextRef="AsOf2015-12-31_custom_HandMDLLCMember" unitRef="USD" xsi:nil="true" />
    <SNYR:BusinessAcquisitionsProFormaNonCompeteProvision contextRef="AsOf2015-12-31_custom_BreakthroughProductsIncMember" unitRef="USD" decimals="0">50000</SNYR:BusinessAcquisitionsProFormaNonCompeteProvision>
    <SNYR:BusinessAcquisitionsProFormaNonCompeteProvision contextRef="AsOf2015-12-31_custom_TprInvestmentsPtyLtdMember" unitRef="USD" decimals="0">50000</SNYR:BusinessAcquisitionsProFormaNonCompeteProvision>
    <SNYR:BusinessAcquisitionsProFormaNonSolicitationProvision contextRef="AsOf2015-12-31_custom_FactorNutritionLabsLLCMember" unitRef="USD" decimals="0">50000</SNYR:BusinessAcquisitionsProFormaNonSolicitationProvision>
    <SNYR:BusinessAcquisitionsProFormaNonSolicitationProvision contextRef="AsOf2015-12-31_custom_KnightTherapeuticsIncMember" unitRef="USD" xsi:nil="true" />
    <SNYR:BusinessAcquisitionsProFormaNonSolicitationProvision contextRef="AsOf2015-12-31_custom_HandMDLLCMember" unitRef="USD" xsi:nil="true" />
    <SNYR:BusinessAcquisitionsProFormaNonSolicitationProvision contextRef="AsOf2015-12-31_custom_BreakthroughProductsIncMember" unitRef="USD" xsi:nil="true" />
    <SNYR:BusinessAcquisitionsProFormaNonSolicitationProvision contextRef="AsOf2015-12-31_custom_TprInvestmentsPtyLtdMember" unitRef="USD" xsi:nil="true" />
    <SNYR:BusinessAcquisitionsProFormaIntangibleAssetsCustomerRelationships contextRef="AsOf2015-12-31_custom_FactorNutritionLabsLLCMember" unitRef="USD" decimals="0">1941030</SNYR:BusinessAcquisitionsProFormaIntangibleAssetsCustomerRelationships>
    <SNYR:BusinessAcquisitionsProFormaIntangibleAssetsCustomerRelationships contextRef="AsOf2015-12-31_custom_KnightTherapeuticsIncMember" unitRef="USD" xsi:nil="true" />
    <SNYR:BusinessAcquisitionsProFormaIntangibleAssetsCustomerRelationships contextRef="AsOf2015-12-31_custom_HandMDLLCMember" unitRef="USD" xsi:nil="true" />
    <SNYR:BusinessAcquisitionsProFormaIntangibleAssetsCustomerRelationships contextRef="AsOf2015-12-31_custom_BreakthroughProductsIncMember" unitRef="USD" xsi:nil="true" />
    <SNYR:BusinessAcquisitionsProFormaIntangibleAssetsCustomerRelationships contextRef="AsOf2015-12-31_custom_TprInvestmentsPtyLtdMember" unitRef="USD" xsi:nil="true" />
    <SNYR:BusinessAcquisitionsProFormaGoodwill contextRef="AsOf2015-12-31_custom_FactorNutritionLabsLLCMember" unitRef="USD" decimals="0">2071517</SNYR:BusinessAcquisitionsProFormaGoodwill>
    <SNYR:BusinessAcquisitionsProFormaGoodwill contextRef="AsOf2015-12-31_custom_KnightTherapeuticsIncMember" unitRef="USD" xsi:nil="true" />
    <SNYR:BusinessAcquisitionsProFormaGoodwill contextRef="AsOf2015-12-31_custom_HandMDLLCMember" unitRef="USD" xsi:nil="true" />
    <SNYR:BusinessAcquisitionsProFormaGoodwill contextRef="AsOf2015-12-31_custom_BreakthroughProductsIncMember" unitRef="USD" decimals="0">3253160</SNYR:BusinessAcquisitionsProFormaGoodwill>
    <SNYR:BusinessAcquisitionsProFormaGoodwill contextRef="AsOf2015-12-31_custom_TprInvestmentsPtyLtdMember" unitRef="USD" decimals="0">6174899</SNYR:BusinessAcquisitionsProFormaGoodwill>
    <SNYR:BusinessAcquisitionsProFormaAccountsPayable contextRef="AsOf2015-12-31_custom_FactorNutritionLabsLLCMember" unitRef="USD" decimals="0">971381</SNYR:BusinessAcquisitionsProFormaAccountsPayable>
    <SNYR:BusinessAcquisitionsProFormaAccountsPayable contextRef="AsOf2015-12-31_custom_KnightTherapeuticsIncMember" unitRef="USD" decimals="0">51795</SNYR:BusinessAcquisitionsProFormaAccountsPayable>
    <SNYR:BusinessAcquisitionsProFormaAccountsPayable contextRef="AsOf2015-12-31_custom_HandMDLLCMember" unitRef="USD" xsi:nil="true" />
    <SNYR:BusinessAcquisitionsProFormaAccountsPayable contextRef="AsOf2015-12-31_custom_BreakthroughProductsIncMember" unitRef="USD" decimals="0">741822</SNYR:BusinessAcquisitionsProFormaAccountsPayable>
    <SNYR:BusinessAcquisitionsProFormaAccountsPayable contextRef="AsOf2015-12-31_custom_TprInvestmentsPtyLtdMember" unitRef="USD" decimals="0">77064</SNYR:BusinessAcquisitionsProFormaAccountsPayable>
    <SNYR:BusinessAcquisitionsProFormaAccruedExpenses contextRef="AsOf2015-12-31_custom_FactorNutritionLabsLLCMember" unitRef="USD" decimals="0">941446</SNYR:BusinessAcquisitionsProFormaAccruedExpenses>
    <SNYR:BusinessAcquisitionsProFormaAccruedExpenses contextRef="AsOf2015-12-31_custom_KnightTherapeuticsIncMember" unitRef="USD" decimals="0">148520</SNYR:BusinessAcquisitionsProFormaAccruedExpenses>
    <SNYR:BusinessAcquisitionsProFormaAccruedExpenses contextRef="AsOf2015-12-31_custom_HandMDLLCMember" unitRef="USD" xsi:nil="true" />
    <SNYR:BusinessAcquisitionsProFormaAccruedExpenses contextRef="AsOf2015-12-31_custom_BreakthroughProductsIncMember" unitRef="USD" decimals="0">2202848</SNYR:BusinessAcquisitionsProFormaAccruedExpenses>
    <SNYR:BusinessAcquisitionsProFormaAccruedExpenses contextRef="AsOf2015-12-31_custom_TprInvestmentsPtyLtdMember" unitRef="USD" decimals="0">56224</SNYR:BusinessAcquisitionsProFormaAccruedExpenses>
    <SNYR:BusinessAcquisitionsProFormaTotalLiabilities contextRef="AsOf2015-12-31_custom_FactorNutritionLabsLLCMember" unitRef="USD" decimals="0">6000000</SNYR:BusinessAcquisitionsProFormaTotalLiabilities>
    <SNYR:BusinessAcquisitionsProFormaTotalLiabilities contextRef="AsOf2015-12-31_custom_KnightTherapeuticsIncMember" unitRef="USD" decimals="0">769217</SNYR:BusinessAcquisitionsProFormaTotalLiabilities>
    <SNYR:BusinessAcquisitionsProFormaTotalLiabilities contextRef="AsOf2015-12-31_custom_HandMDLLCMember" unitRef="USD" decimals="0">1500000</SNYR:BusinessAcquisitionsProFormaTotalLiabilities>
    <SNYR:BusinessAcquisitionsProFormaTotalLiabilities contextRef="AsOf2015-12-31_custom_BreakthroughProductsIncMember" unitRef="USD" decimals="0">2980411</SNYR:BusinessAcquisitionsProFormaTotalLiabilities>
    <SNYR:BusinessAcquisitionsProFormaTotalLiabilities contextRef="AsOf2015-12-31_custom_TprInvestmentsPtyLtdMember" unitRef="USD" decimals="0">7095700</SNYR:BusinessAcquisitionsProFormaTotalLiabilities>
    <SNYR:BusinessAcquisitionsProFormaLicenseAgreement contextRef="AsOf2015-12-31_custom_FactorNutritionLabsLLCMember" unitRef="USD" xsi:nil="true" />
    <SNYR:BusinessAcquisitionsProFormaLicenseAgreement contextRef="AsOf2015-12-31_custom_KnightTherapeuticsIncMember" unitRef="USD" decimals="0">606553</SNYR:BusinessAcquisitionsProFormaLicenseAgreement>
    <SNYR:BusinessAcquisitionsProFormaLicenseAgreement contextRef="AsOf2015-12-31_custom_HandMDLLCMember" unitRef="USD" decimals="0">1670675</SNYR:BusinessAcquisitionsProFormaLicenseAgreement>
    <SNYR:BusinessAcquisitionsProFormaLicenseAgreement contextRef="AsOf2015-12-31_custom_BreakthroughProductsIncMember" unitRef="USD" xsi:nil="true" />
    <SNYR:BusinessAcquisitionsProFormaLicenseAgreement contextRef="AsOf2015-12-31_custom_TprInvestmentsPtyLtdMember" unitRef="USD" xsi:nil="true" />
    <SNYR:BusinessAcquisitionsProFormaRoyaltyPayable contextRef="AsOf2015-12-31_custom_FactorNutritionLabsLLCMember" unitRef="USD" xsi:nil="true" />
    <SNYR:BusinessAcquisitionsProFormaRoyaltyPayable contextRef="AsOf2015-12-31_custom_KnightTherapeuticsIncMember" unitRef="USD" xsi:nil="true" />
    <SNYR:BusinessAcquisitionsProFormaRoyaltyPayable contextRef="AsOf2015-12-31_custom_HandMDLLCMember" unitRef="USD" decimals="0">-258897</SNYR:BusinessAcquisitionsProFormaRoyaltyPayable>
    <SNYR:BusinessAcquisitionsProFormaRoyaltyPayable contextRef="AsOf2015-12-31_custom_BreakthroughProductsIncMember" unitRef="USD" xsi:nil="true" />
    <SNYR:BusinessAcquisitionsProFormaRoyaltyPayable contextRef="AsOf2015-12-31_custom_TprInvestmentsPtyLtdMember" unitRef="USD" xsi:nil="true" />
    <SNYR:BusinessAcquisitionsProFormaOthers contextRef="AsOf2015-12-31_custom_FactorNutritionLabsLLCMember" unitRef="USD" xsi:nil="true" />
    <SNYR:BusinessAcquisitionsProFormaOthers contextRef="AsOf2015-12-31_custom_KnightTherapeuticsIncMember" unitRef="USD" xsi:nil="true" />
    <SNYR:BusinessAcquisitionsProFormaOthers contextRef="AsOf2015-12-31_custom_HandMDLLCMember" unitRef="USD" decimals="0">-11778</SNYR:BusinessAcquisitionsProFormaOthers>
    <SNYR:BusinessAcquisitionsProFormaOthers contextRef="AsOf2015-12-31_custom_BreakthroughProductsIncMember" unitRef="USD" xsi:nil="true" />
    <SNYR:BusinessAcquisitionsProFormaOthers contextRef="AsOf2015-12-31_custom_TprInvestmentsPtyLtdMember" unitRef="USD" xsi:nil="true" />
    <SNYR:BusinessAcquisitionsProFormaCash contextRef="AsOf2015-12-31_custom_BreakthroughProductsIncMember" unitRef="USD" decimals="0">2298619</SNYR:BusinessAcquisitionsProFormaCash>
    <SNYR:BusinessAcquisitionsProFormaCash contextRef="AsOf2015-12-31_custom_TprInvestmentsPtyLtdMember" unitRef="USD" decimals="0">1584642</SNYR:BusinessAcquisitionsProFormaCash>
    <SNYR:BusinessAcquisitionsProFormaPrepaidExpenses contextRef="AsOf2015-12-31_custom_BreakthroughProductsIncMember" unitRef="USD" decimals="0">57569</SNYR:BusinessAcquisitionsProFormaPrepaidExpenses>
    <SNYR:BusinessAcquisitionsProFormaPrepaidExpenses contextRef="AsOf2015-12-31_custom_TprInvestmentsPtyLtdMember" unitRef="USD" decimals="0">141070</SNYR:BusinessAcquisitionsProFormaPrepaidExpenses>
    <SNYR:BusinessAcquisitionsProFormaFixedAssetsNet contextRef="AsOf2015-12-31_custom_TprInvestmentsPtyLtdMember" unitRef="USD" decimals="0">5698</SNYR:BusinessAcquisitionsProFormaFixedAssetsNet>
    <SNYR:BusinessAcquisitionsProFormaIntangibleAssetsNet contextRef="AsOf2015-12-31_custom_TprInvestmentsPtyLtdMember" unitRef="USD" decimals="0">3493</SNYR:BusinessAcquisitionsProFormaIntangibleAssetsNet>
    <SNYR:BusinessAcquisitionsProFormaBloggerDatabase contextRef="AsOf2015-12-31_custom_TprInvestmentsPtyLtdMember" unitRef="USD" decimals="0">200000</SNYR:BusinessAcquisitionsProFormaBloggerDatabase>
    <SNYR:BusinessAcquisitionsProFormaCustomerDatabase contextRef="AsOf2015-12-31_custom_TprInvestmentsPtyLtdMember" unitRef="USD" decimals="0">500000</SNYR:BusinessAcquisitionsProFormaCustomerDatabase>
    <SNYR:BusinessAcquisitionsProFormaDividendsPayable contextRef="AsOf2015-12-31_custom_TprInvestmentsPtyLtdMember" unitRef="USD" decimals="0">-1177152</SNYR:BusinessAcquisitionsProFormaDividendsPayable>
    <SNYR:BusinessAcquisitionsProFormaProvisionForIncomeTax contextRef="AsOf2015-12-31_custom_TprInvestmentsPtyLtdMember" unitRef="USD" decimals="0">-518558</SNYR:BusinessAcquisitionsProFormaProvisionForIncomeTax>
    <SNYR:BusinessAcquisitionCashPayment contextRef="AsOf2015-12-31_custom_FactorNutritionLabsLLCMember_custom_JanuaryTwentyTwoTwoThousandFifteenMember" unitRef="USD" decimals="0">4500000</SNYR:BusinessAcquisitionCashPayment>
    <SNYR:BusinessAcquisitionCashPayment contextRef="AsOf2015-12-31_custom_FactorNutritionLabsLLCMember_custom_JanuaryTwentyTwoThousandSixteenMember" unitRef="USD" decimals="0">750000</SNYR:BusinessAcquisitionCashPayment>
    <SNYR:BusinessAcquisitionCashPayment contextRef="AsOf2015-12-31_custom_FactorNutritionLabsLLCMember_custom_JanuaryTwentyTwoThousandSaventeenMember" unitRef="USD" decimals="0">750000</SNYR:BusinessAcquisitionCashPayment>
    <SNYR:BusinessAcquisitionCashPayment contextRef="AsOf2015-12-31_custom_TprInvestmentsPtyLtdMember_custom_NomadChoiceMember" unitRef="USD" decimals="0">2848800</SNYR:BusinessAcquisitionCashPayment>
    <us-gaap:BusinessCombinationContingentConsiderationAsset contextRef="AsOf2015-12-31_custom_FactorNutritionLabsLLCMember209497907" unitRef="USD" decimals="0">6000000</us-gaap:BusinessCombinationContingentConsiderationAsset>
    <us-gaap:BusinessCombinationContingentConsiderationAsset contextRef="AsOf2015-12-31_custom_BreakthroughProductsIncMember_custom_UrgentRxMember" unitRef="USD" decimals="0">2980411</us-gaap:BusinessCombinationContingentConsiderationAsset>
    <us-gaap:BusinessCombinationContingentConsiderationAsset contextRef="AsOf2015-12-31_custom_TprInvestmentsPtyLtdMember_custom_NomadChoiceMember" unitRef="USD" decimals="0">7095700</us-gaap:BusinessCombinationContingentConsiderationAsset>
    <SNYR:BusinessAcquisitionsStockPayment contextRef="AsOf2015-12-31_custom_BreakthroughProductsIncMember_custom_UrgentRxMember" unitRef="USD" decimals="0">2550000</SNYR:BusinessAcquisitionsStockPayment>
    <SNYR:BusinessAcquisitionStockWarrantsIssued contextRef="AsOf2015-12-31_custom_BreakthroughProductsIncMember_custom_UrgentRxMember" unitRef="USD" decimals="0">430411</SNYR:BusinessAcquisitionStockWarrantsIssued>
    <SNYR:BusinessAcquisitionStockIssued contextRef="AsOf2015-12-31_custom_TprInvestmentsPtyLtdMember_custom_NomadChoiceMember" unitRef="USD" decimals="0">1750000</SNYR:BusinessAcquisitionStockIssued>
    <SNYR:BusinessAcquisitionEarnoutPayment contextRef="AsOf2015-12-31_custom_TprInvestmentsPtyLtdMember_custom_NomadChoiceMember" unitRef="USD" decimals="0">2496900</SNYR:BusinessAcquisitionEarnoutPayment>
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2015-12-31_custom_BreakthroughProductsIncMember" unitRef="USD" decimals="0">25137583</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2015-12-31_custom_BreakthroughProductsIncMember_us-gaap_DomesticCountryMember" unitRef="USD" decimals="0">33707458</us-gaap:OperatingLossCarryforwards>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 4 &amp;#150; Income Taxes&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company utilizes FASBASC740, &amp;#147;Income&#13;Taxes,&amp;#148; which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of&#13;events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities&#13;are determined based on the difference between the tax basis of assets and liabilities and their financial reporting amounts based&#13;on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income.&#13;A valuation allowance is recorded when it is &amp;#147;more likely-than-not&amp;#148; that a deferred tax asset will not be realized.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company generated a deferred tax&#13;asset through net operating loss carry-forwards. Based upon Management&amp;#146;s evaluation, a valuation allowance of 100% has been&#13;established due to the uncertainty of the Company&amp;#146;s realization of the benefit derived from net operating loss carry-forwards.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Deferred income taxes arise from temporary&#13;differences resulting from income and expense items reported for financial accounting and tax purposes in different periods. Deferred&#13;taxes are classified as current or non-current, depending on the classification of assets and liabilities to which they relate.&#13;Deferred taxes arising from temporary differences that are not related to an asset or liability are classified as current or noncurrent&#13;depending on the periods in which the temporary differences are expected to reverse. The Company does not have any uncertain tax&#13;positions.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Income tax expense for the year ended&#13;December 31, 2015 was $389,945, due to Foreign Income Tax relating to NomadChoice in Australia.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The table below summarizes the differences&#13;between the U.S. statutory federal rate and the Company&amp;#146;s effective tax rate for the years ended December 31, 2015 and 2014:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"&gt;December 31, 2015&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"&gt;December 31, 2014&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 56%; line-height: 115%"&gt;U.S. Statutory Rate&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 18%; text-align: right; line-height: 115%"&gt;34&lt;/td&gt;&#13;    &lt;td style="width: 2%; line-height: 115%"&gt;%&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 18%; text-align: right; line-height: 115%"&gt;34&lt;/td&gt;&#13;    &lt;td style="width: 2%; line-height: 115%"&gt;%&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="line-height: 115%"&gt;U.S. effective rate in excess of AU rate&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;(1&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;%)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="line-height: 115%"&gt;U.S. valuation allowance&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;(34&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;%)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;(34&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;%)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Foreign Tax - Australia&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"&gt;6.8&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;%&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Total provision for income taxes&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"&gt;5.8&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;%&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company has deferred tax assets,&#13;which have been fully reserved, as follows as of December 31, 2015 and 2014:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"&gt;December 31, 2015&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"&gt;December 31, 2014&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 56%; line-height: 115%"&gt;Deferred tax assets&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 18%; text-align: right; line-height: 115%"&gt;11,460,536&lt;/td&gt;&#13;    &lt;td style="width: 2%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 18%; text-align: right; line-height: 115%"&gt;241,245&lt;/td&gt;&#13;    &lt;td style="width: 2%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Valuation allowance for deferred tax assets&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"&gt;(11,460,536&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"&gt;(241,245&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Net deferred tax assets&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company also has net operating loss&#13;carryforwards of approximately $25,137,583 included in the deferred tax asset table above attributable to the acquisition of Breakthrough&#13;Products, Inc. However, due to limitations of carryover attributes and separate return limitation year rules, it is unlikely the&#13;company will benefit from these NOL and thus Management has determined a 100% valuation reserved is required.&amp;#160; Further, the&#13;Company has not completed an evaluation of the NOL&amp;#146;s attributable to Breakthrough Products, Inc. at the date of this report.&lt;/p&gt;&#13;&#13;&lt;p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The total deferred tax asset is calculated&#13;by multiplying a domestic (US) 34 percent marginal tax rate by the cumulative Net Operating Loss Carryforwards (&amp;#147;NOL&amp;#148;).The&#13;Company currently has net operating loss carryforwards approximately aggregating $33,707,458, which expire through 2035. The deferred&#13;tax asset related to the NOL carryforwards Management has determined based on all the available information that a 100% Valuation&#13;reserve is required.&lt;/p&gt;&#13;&#13;&lt;p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company has not completed its evaluation&#13;of NOL Utilization Limitations under IRC Section 382, change of ownership rules. If the Company has had a change in ownership the&#13;NOL&amp;#146;s would be limited as to the amount that could be utilized each year, based on the Internal Revenue Code, as amended.&amp;#148;&lt;/p&gt;&#13;&#13;&lt;p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company has not filed its Federal&#13;and State income tax returns. Such income tax returns remain subject to examination by federal and most state tax authorities.&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <SNYR:ValuationAllowancePercentage contextRef="From2015-01-01to2015-12-31_custom_BreakthroughProductsIncMember" unitRef="Pure" decimals="INF">1.00</SNYR:ValuationAllowancePercentage>
    <SNYR:ValuationAllowancePercentage contextRef="From2015-01-01to2015-12-31_custom_BreakthroughProductsIncMember_us-gaap_DomesticCountryMember" unitRef="Pure" decimals="INF">1.00</SNYR:ValuationAllowancePercentage>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="From2014-10-01to2014-12-31" unitRef="Pure" decimals="INF">0.00</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="From2015-01-01to2015-12-31" unitRef="Pure" decimals="INF">0.058</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="AsOf2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">-121291</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AccountsReceivableGross contextRef="AsOf2014-12-31" unitRef="USD" decimals="0">2898</us-gaap:AccountsReceivableGross>
    <us-gaap:AccountsReceivableGross contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">4101148</us-gaap:AccountsReceivableGross>
    <us-gaap:AccountsReceivableNet contextRef="AsOf2014-12-31" unitRef="USD" decimals="0">2898</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">3979857</us-gaap:AccountsReceivableNet>
    <us-gaap:PrepaidInsurance contextRef="AsOf2014-12-31" unitRef="USD" decimals="0">10000</us-gaap:PrepaidInsurance>
    <us-gaap:PrepaidInsurance contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">54519</us-gaap:PrepaidInsurance>
    <us-gaap:PrepaidAdvertising contextRef="AsOf2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:PrepaidAdvertising contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">45700</us-gaap:PrepaidAdvertising>
    <us-gaap:Supplies contextRef="AsOf2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:Supplies contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">24000</us-gaap:Supplies>
    <us-gaap:OtherAssetsMiscellaneousCurrent contextRef="AsOf2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherAssetsMiscellaneousCurrent contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">13428</us-gaap:OtherAssetsMiscellaneousCurrent>
    <us-gaap:PrepaidExpenseCurrentAndNoncurrent contextRef="AsOf2014-12-31" unitRef="USD" decimals="0">10000</us-gaap:PrepaidExpenseCurrentAndNoncurrent>
    <us-gaap:PrepaidExpenseCurrentAndNoncurrent contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">422434</us-gaap:PrepaidExpenseCurrentAndNoncurrent>
    <SNYR:PrepaidExpensesAdvancesForInventory contextRef="AsOf2014-12-31" unitRef="USD" xsi:nil="true" />
    <SNYR:PrepaidExpensesAdvancesForInventory contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">171494</SNYR:PrepaidExpensesAdvancesForInventory>
    <SNYR:PrepaidExpencesMediaProduction contextRef="AsOf2014-12-31" unitRef="USD" xsi:nil="true" />
    <SNYR:PrepaidExpencesMediaProduction contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">55849</SNYR:PrepaidExpencesMediaProduction>
    <SNYR:PrepaidExpensesDeposits contextRef="AsOf2014-12-31" unitRef="USD" xsi:nil="true" />
    <SNYR:PrepaidExpensesDeposits contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">41228</SNYR:PrepaidExpensesDeposits>
    <us-gaap:PrepaidRent contextRef="AsOf2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:PrepaidRent contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">16216</us-gaap:PrepaidRent>
    <SNYR:NumberOfCustomerAccountedForAccountsReceivable contextRef="From2015-01-01to2015-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_AccountsReceivableMember" unitRef="Customer" decimals="INF">1</SNYR:NumberOfCustomerAccountedForAccountsReceivable>
    <SNYR:NumberOfCustomerAccountedForAccountsReceivable contextRef="From2015-01-01to2015-12-31_us-gaap_CustomerConcentrationRiskMember_us-gaap_SalesRevenueNetMember" unitRef="Customer" decimals="INF">2</SNYR:NumberOfCustomerAccountedForAccountsReceivable>
    <SNYR:NameOfProduct contextRef="From2015-01-01to2015-12-31_custom_SuppliersOneMember">FOCUSfactor</SNYR:NameOfProduct>
    <SNYR:NameOfProduct contextRef="From2015-01-01to2015-12-31_custom_SuppliersTwoMember">Flat Tummy Tea</SNYR:NameOfProduct>
    <SNYR:NameOfProduct contextRef="From2015-01-01to2015-12-31_custom_SuppliersThreeMember">Neuragen</SNYR:NameOfProduct>
    <SNYR:NameOfProduct contextRef="From2015-01-01to2015-12-31_custom_SuppliersFourMember">UrgentRx</SNYR:NameOfProduct>
    <SNYR:AddressOfSuppliers contextRef="From2015-01-01to2015-12-31_custom_SuppliersOneMember">Pittsburgh, PA</SNYR:AddressOfSuppliers>
    <SNYR:AddressOfSuppliers contextRef="From2015-01-01to2015-12-31_custom_SuppliersTwoMember">Highland, NY</SNYR:AddressOfSuppliers>
    <SNYR:AddressOfSuppliers contextRef="From2015-01-01to2015-12-31_custom_SuppliersThreeMember">Linthicum Heights, MD</SNYR:AddressOfSuppliers>
    <SNYR:AddressOfSuppliers contextRef="From2015-01-01to2015-12-31_custom_SuppliersFourMember">Ogden, UT</SNYR:AddressOfSuppliers>
    <SNYR:CityOfSuppliers contextRef="From2015-01-01to2015-12-31_custom_SuppliersOneMember">Tustin, CA</SNYR:CityOfSuppliers>
    <SNYR:CityOfSuppliers contextRef="From2015-01-01to2015-12-31_custom_SuppliersTwoMember">-</SNYR:CityOfSuppliers>
    <SNYR:CityOfSuppliers contextRef="From2015-01-01to2015-12-31_custom_SuppliersThreeMember">-</SNYR:CityOfSuppliers>
    <SNYR:CityOfSuppliers contextRef="From2015-01-01to2015-12-31_custom_SuppliersFourMember">-</SNYR:CityOfSuppliers>
    <us-gaap:InventoryFinishedGoods contextRef="AsOf2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:InventoryFinishedGoods contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">535908</us-gaap:InventoryFinishedGoods>
    <SNYR:InventoryComponents contextRef="AsOf2014-12-31" unitRef="USD" xsi:nil="true" />
    <SNYR:InventoryComponents contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">115340</SNYR:InventoryComponents>
    <us-gaap:InventoryRawMaterialsNetOfReserves contextRef="AsOf2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:InventoryRawMaterialsNetOfReserves contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">35406</us-gaap:InventoryRawMaterialsNetOfReserves>
    <SNYR:InventoryEnergyProduct contextRef="AsOf2014-12-31" unitRef="USD" decimals="0">26064</SNYR:InventoryEnergyProduct>
    <SNYR:InventoryEnergyProduct contextRef="AsOf2015-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:InventoryNet contextRef="AsOf2014-12-31" unitRef="USD" decimals="0">26064</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">686655</us-gaap:InventoryNet>
    <us-gaap:Depreciation contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">1513</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="From2014-01-01to2014-12-31" unitRef="USD" decimals="0">0</us-gaap:Depreciation>
    <us-gaap:AdjustmentForAmortization contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">606489</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization contextRef="From2014-01-01to2014-12-31" unitRef="USD" decimals="0">0</us-gaap:AdjustmentForAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">1111229</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">1111229</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">1109070</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">1094329</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">489405</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <SNYR:AccruedConsultingFeesPerMonth contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">180000</SNYR:AccruedConsultingFeesPerMonth>
    <SNYR:AccruedConsultingFeesPerMonth contextRef="AsOf2015-12-31_us-gaap_ChiefExecutiveOfficerMember" unitRef="USD" decimals="0">15000</SNYR:AccruedConsultingFeesPerMonth>
    <SNYR:OutstandingBalanceOfConsultingFees contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">0</SNYR:OutstandingBalanceOfConsultingFees>
    <us-gaap:DueFromRelatedParties contextRef="AsOf2015-12-31_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember" unitRef="USD" decimals="0">4267268</us-gaap:DueFromRelatedParties>
    <us-gaap:DueFromRelatedParties contextRef="AsOf2015-12-31_custom_KnightTherapeuticsIncMember_custom_SecurityAgreementMember" unitRef="USD" decimals="0">925000</us-gaap:DueFromRelatedParties>
    <us-gaap:DueFromRelatedParties contextRef="AsOf2015-11-12_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember" unitRef="USD" decimals="0">3571314</us-gaap:DueFromRelatedParties>
    <us-gaap:DueFromRelatedParties contextRef="AsOf2015-12-31_custom_KnightTherapeuticsIncMember_custom_RoyaltyDistributionAgreementMember" unitRef="USD" decimals="0">71573</us-gaap:DueFromRelatedParties>
    <us-gaap:MinorityInterestOwnershipPercentageByParent contextRef="AsOf2015-12-31_custom_HandMDLLCMember216380656" unitRef="Pure" decimals="INF">0.50</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="AsOf2014-12-31" unitRef="USD" decimals="0">10867</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">38752</us-gaap:AccruedProfessionalFeesCurrent>
    <SNYR:ManufacturersLiabilitiesCurrent contextRef="AsOf2014-12-31" unitRef="USD" xsi:nil="true" />
    <SNYR:ManufacturersLiabilitiesCurrent contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">1527333</SNYR:ManufacturersLiabilitiesCurrent>
    <SNYR:PromotionsLiabilitiesCurrent contextRef="AsOf2014-12-31" unitRef="USD" xsi:nil="true" />
    <SNYR:PromotionsLiabilitiesCurrent contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">1213021</SNYR:PromotionsLiabilitiesCurrent>
    <SNYR:ReturnsAllowanceAccruedLiabilities contextRef="AsOf2014-12-31" unitRef="USD" xsi:nil="true" />
    <SNYR:ReturnsAllowanceAccruedLiabilities contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">1128133</SNYR:ReturnsAllowanceAccruedLiabilities>
    <SNYR:CustomersAccruedLiabilities contextRef="AsOf2014-12-31" unitRef="USD" xsi:nil="true" />
    <SNYR:CustomersAccruedLiabilities contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">411033</SNYR:CustomersAccruedLiabilities>
    <SNYR:InterestAccruedLiabilities contextRef="AsOf2014-12-31" unitRef="USD" xsi:nil="true" />
    <SNYR:InterestAccruedLiabilities contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">110754</SNYR:InterestAccruedLiabilities>
    <SNYR:RoyaltiesAccruedLiabilities contextRef="AsOf2014-12-31" unitRef="USD" xsi:nil="true" />
    <SNYR:RoyaltiesAccruedLiabilities contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">71573</SNYR:RoyaltiesAccruedLiabilities>
    <SNYR:WarehousingAccruedLiabilities contextRef="AsOf2014-12-31" unitRef="USD" xsi:nil="true" />
    <SNYR:WarehousingAccruedLiabilities contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">31748</SNYR:WarehousingAccruedLiabilities>
    <us-gaap:OtherAccountsPayableAndAccruedLiabilities contextRef="AsOf2014-12-31" unitRef="USD" decimals="0">15859</us-gaap:OtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:OtherAccountsPayableAndAccruedLiabilities contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">371518</us-gaap:OtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent contextRef="AsOf2014-12-31" unitRef="USD" decimals="0">74642</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">5032102</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:DebtIssuanceCosts contextRef="From2015-01-21to2015-01-22_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_OriginationFeeMember" unitRef="USD" decimals="0">120000</us-gaap:DebtIssuanceCosts>
    <us-gaap:DebtIssuanceCosts contextRef="From2015-01-21to2015-01-22_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_WorkFeeMember" unitRef="USD" decimals="0">60000</us-gaap:DebtIssuanceCosts>
    <us-gaap:DebtIssuanceCosts contextRef="From2015-01-21to2015-01-22_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember" unitRef="USD" decimals="0">40000</us-gaap:DebtIssuanceCosts>
    <us-gaap:DebtIssuanceCosts contextRef="From2015-11-11to2015-11-12_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_OriginationFeeMember" unitRef="USD" decimals="0">110000</us-gaap:DebtIssuanceCosts>
    <us-gaap:DebtIssuanceCosts contextRef="From2015-11-11to2015-11-12_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_WorkFeeMember" unitRef="USD" decimals="0">55000</us-gaap:DebtIssuanceCosts>
    <us-gaap:DebtIssuanceCosts contextRef="From2015-11-11to2015-11-12_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember" unitRef="USD" decimals="0">24000</us-gaap:DebtIssuanceCosts>
    <us-gaap:LongTermDebtFairValue contextRef="AsOf2015-01-22_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember" unitRef="USD" decimals="0">6000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue contextRef="AsOf2015-11-12_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember223527046" unitRef="USD" decimals="0">5500000</us-gaap:LongTermDebtFairValue>
    <us-gaap:DebtInstrumentInterestRateIncreaseDecrease contextRef="From2015-01-21to2015-01-22_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember" unitRef="Pure" decimals="INF">0.13</us-gaap:DebtInstrumentInterestRateIncreaseDecrease>
    <us-gaap:DebtInstrumentInterestRateIncreaseDecrease contextRef="From2015-11-11to2015-11-12_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember" unitRef="Pure" decimals="INF">0.13</us-gaap:DebtInstrumentInterestRateIncreaseDecrease>
    <us-gaap:LoansPayable contextRef="AsOf2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:LoansPayable contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">9870170</us-gaap:LoansPayable>
    <us-gaap:LoansPayable contextRef="AsOf2015-01-22_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_JanuaryTwentyTwoThousandFifteenLoanOneMember" unitRef="USD" decimals="0">300000</us-gaap:LoansPayable>
    <us-gaap:LoansPayable contextRef="AsOf2015-12-31_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember220952640" unitRef="USD" decimals="0">4875000</us-gaap:LoansPayable>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh contextRef="AsOf2015-01-22_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_JanuaryTwentyTwoThousandFifteenLoanOneMember" unitRef="USD" decimals="0">100000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:ConversionOfStockSharesIssued1 contextRef="From2015-01-21to2015-01-22_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_STWarrantMember" unitRef="Shares" decimals="INF">4595187</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:ConversionOfStockSharesIssued1 contextRef="From2015-01-21to2015-01-22_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_LTWarrantMember" unitRef="Shares" decimals="INF">3584759</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:ConversionOfStockSharesIssued1 contextRef="From2015-11-11to2015-11-12_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember" unitRef="Shares" decimals="INF">5550625</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:ConversionOfStockSharesIssued1 contextRef="From2015-11-11to2015-11-12_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_us-gaap_MaximumMember" unitRef="Shares" decimals="INF">4547243</us-gaap:ConversionOfStockSharesIssued1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2015-01-22_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_STWarrantMember" unitRef="USDPerShare" decimals="INF">1.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2015-01-22_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_LTWarrantMember" unitRef="USDPerShare" decimals="INF">0.34</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="From2015-01-21to2015-01-22_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_STWarrantMember" unitRef="USD" decimals="0">1952953</us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
    <us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="From2015-01-21to2015-01-22_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_LTWarrantMember" unitRef="USD" decimals="0">1462560</us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
    <us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="From2015-11-11to2015-11-12_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_KnightWarrantsMember" unitRef="USD" decimals="0">2553287</us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
    <us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="From2015-11-11to2015-11-12_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_KnightWarrantsOneMember" unitRef="USD" decimals="0">2067258</us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
    <SNYR:PercentageOfSharesPurchaseableUnderWarrants contextRef="AsOf2015-01-22_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_LTWarrantMember" unitRef="Pure" decimals="INF">0.25</SNYR:PercentageOfSharesPurchaseableUnderWarrants>
    <SNYR:PercentageOfSharesPurchaseableUnderWarrants contextRef="AsOf2015-11-12_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember223527046" unitRef="Pure" decimals="INF">0.065</SNYR:PercentageOfSharesPurchaseableUnderWarrants>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">-2536419</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2015-12-31_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_STWarrantMember" unitRef="USD" decimals="0">607732</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2015-12-31_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_LTWarrantMember" unitRef="USD" decimals="0">607732</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2015-12-31_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_KnightWarrantsMember" unitRef="USD" decimals="0">1928686</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2015-12-31_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_KnightWarrantsOneMember" unitRef="USD" decimals="0">1928686</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DeferredFinanceCostsNet contextRef="AsOf2015-12-31_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember220952640" unitRef="USD" decimals="0">289045</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet contextRef="AsOf2015-12-31_custom_SecurityAgreementMember_custom_JuneTwentySixTwoThousandFifteenMember_custom_QuarterEndingSeptemberThirtyTwoThousandSaventeenMember" unitRef="USD" decimals="0">10486</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet contextRef="AsOf2015-12-31_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_KnightWarrantsMember" unitRef="USD" decimals="0">233847</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:AmortizationOfFinancingCosts contextRef="From2015-01-01to2015-12-31_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember" unitRef="USD" decimals="0">136207</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts contextRef="From2015-01-01to2015-12-31_custom_SecurityAgreementMember_custom_JuneTwentySixTwoThousandFifteenMember_custom_QuarterEndingSeptemberThirtyTwoThousandSaventeenMember" unitRef="USD" decimals="0">2643</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts contextRef="From2015-01-01to2015-12-31_custom_SecurityAgreementMember_custom_JuneTwentySixTwoThousandFifteenMember" unitRef="USD" decimals="0">925000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts contextRef="From2015-01-01to2015-12-31_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_KnightWarrantsMember" unitRef="USD" decimals="0">15675</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:DepositLiabilitiesAccruedInterest contextRef="AsOf2015-12-31_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember220952640" unitRef="USD" decimals="0">0</us-gaap:DepositLiabilitiesAccruedInterest>
    <us-gaap:DepositLiabilitiesAccruedInterest contextRef="AsOf2015-12-31_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_KnightWarrantsMember" unitRef="USD" decimals="0">110753</us-gaap:DepositLiabilitiesAccruedInterest>
    <us-gaap:DepositLiabilitiesAccruedInterest contextRef="AsOf2015-12-31_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_KnightWarrantsOneMember" unitRef="USD" decimals="0">5500000</us-gaap:DepositLiabilitiesAccruedInterest>
    <us-gaap:NotesIssued1 contextRef="From2015-01-21to2015-01-22_custom_AssetPurchaseAgreementMember_custom_JanuaryTwentyTwoTwoThousandFifteenLoanTwoMember" unitRef="USD" decimals="0">1500000</us-gaap:NotesIssued1>
    <us-gaap:NotesIssued1 contextRef="From2015-06-25to2015-06-26_custom_SecurityAgreementMember_custom_JuneTwentySixTwoThousandFifteenMember_custom_NeuragenCorpMember" unitRef="USD" decimals="0">950000</us-gaap:NotesIssued1>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2015-11-12_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_KnightWarrantsMember" unitRef="Shares" decimals="INF">5550625</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2015-11-12_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_KnightWarrantsOneMember" unitRef="Shares" decimals="INF">4547243</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2015-12-31_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_KnightWarrantsMember" unitRef="Shares" decimals="INF">5550625</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2015-12-31_custom_KnightTherapeuticsIncMember_custom_LoanAgreementMember_custom_KnightWarrantsOneMember" unitRef="Shares" decimals="INF">4547243</us-gaap:ClassOfWarrantOrRightOutstanding>
    <SNYR:LoansPayableGross contextRef="AsOf2014-12-31" unitRef="USD" xsi:nil="true" />
    <SNYR:LoansPayableGross contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">12406589</SNYR:LoansPayableGross>
    <us-gaap:LoansPayableCurrent contextRef="AsOf2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:LoansPayableCurrent contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">-3912060</us-gaap:LoansPayableCurrent>
    <us-gaap:LongTermLoansPayable contextRef="AsOf2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:LongTermLoansPayable contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">5958110</us-gaap:LongTermLoansPayable>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="From2015-01-01to2015-12-31">30 for 1 forward stock split </us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="From2014-01-01to2014-12-31" unitRef="Shares" decimals="INF">135900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <SNYR:PrestockSplitShares contextRef="From2014-01-01to2014-12-31" unitRef="Shares" decimals="INF">4530000</SNYR:PrestockSplitShares>
    <us-gaap:CommonStockHeldInTrust contextRef="AsOf2014-12-31" unitRef="USD" decimals="0">40000</us-gaap:CommonStockHeldInTrust>
    <us-gaap:CommonStockHeldInTrust contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">28000</us-gaap:CommonStockHeldInTrust>
    <us-gaap:OperatingLossCarryforwardsExpirationDate contextRef="From2014-04-01to2014-04-30">2017-03-31</us-gaap:OperatingLossCarryforwardsExpirationDate>
    <us-gaap:OperatingLeasesRentExpenseNet contextRef="From2014-04-01to2014-04-30" unitRef="USD" decimals="0">8923</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OperatingLeasesRentExpenseNet contextRef="From2015-01-01to2015-12-31_custom_NovemberTwoThousandSixteenMember" unitRef="USD" decimals="0">4200</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OperatingLeasesRentExpenseNet contextRef="From2015-01-01to2015-12-31_custom_DecemberTwoThousandSixteenMember" unitRef="USD" decimals="0">5500</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OperatingLeasesRentExpenseNet contextRef="From2015-01-01to2015-12-31_custom_NovemberTwoThousandSixteenMember_custom_AustralianDollerMember" unitRef="AUD" decimals="0">5500</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OperatingLeasesRentExpenseNet contextRef="From2015-01-01to2015-12-31_custom_DecemberTwoThousandSixteenMember_custom_AustralianDollerMember" unitRef="AUD" decimals="0">5500</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OperatingLeasesRentExpenseNet contextRef="From2014-12-07to2014-12-08_custom_SubsidiaryMember" unitRef="USD" decimals="0">894</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:SaleLeasebackTransactionRentExpense contextRef="From2014-04-01to2014-04-30" unitRef="USD" decimals="0">3010</us-gaap:SaleLeasebackTransactionRentExpense>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">220676</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent contextRef="AsOf2015-12-31_custom_SubsidiaryMember" unitRef="USD" decimals="0">10728</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">27294</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears contextRef="AsOf2015-12-31_custom_SubsidiaryMember" unitRef="USD" decimals="0">9834</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDue contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">247970</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDue contextRef="AsOf2015-12-31_custom_SubsidiaryMember" unitRef="USD" decimals="0">20562</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">1400000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding>
    <us-gaap:NoncurrentAssets contextRef="AsOf2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:NoncurrentAssets contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">17423679</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="AsOf2015-12-31_custom_UnitedStatesMember" unitRef="USD" decimals="0">17411598</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="AsOf2015-12-31_custom_ForeignCountriesMember" unitRef="USD" decimals="0">12081</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="AsOf2014-12-31_custom_UnitedStatesMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NoncurrentAssets contextRef="AsOf2014-12-31_custom_ForeignCountriesMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">523714</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="From2014-01-01to2014-12-31" unitRef="USD" decimals="0">282247</us-gaap:AllocatedShareBasedCompensationExpense>
    <SNYR:ScheduleOfLoanPayableTableTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;The Company&amp;#146;s&#13;loans payable at December 31, 2015 and 2014 are as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31, 2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31, 2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 62%"&gt;&lt;font style="font-size: 10pt"&gt;Loans payable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;12,406,589&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Unamortized debt discount&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(2,536,419&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9,870,170&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Less: Current portion&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(3,912,060&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Long-term portion&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5,958,110&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;</SNYR:ScheduleOfLoanPayableTableTextBlock>
    <SNYR:CommonStockIssuedForCash contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">26000</SNYR:CommonStockIssuedForCash>
    <SNYR:CommonStockIssuedForCash contextRef="From2014-01-01to2014-12-31" unitRef="USD" decimals="0">500000</SNYR:CommonStockIssuedForCash>
    <SNYR:CommonStockIssuedForCash contextRef="From2014-01-01to2014-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">20</SNYR:CommonStockIssuedForCash>
    <SNYR:CommonStockIssuedForCash contextRef="From2014-01-01to2014-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">499980</SNYR:CommonStockIssuedForCash>
    <SNYR:CommonStockIssuedForCash contextRef="From2014-01-01to2014-12-31_custom_CommonStockToBeIssuedMember" unitRef="USD" xsi:nil="true" />
    <SNYR:CommonStockIssuedForCash contextRef="From2014-01-01to2014-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <SNYR:CommonStockIssuedForCash contextRef="From2015-01-01to2015-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">1</SNYR:CommonStockIssuedForCash>
    <SNYR:CommonStockIssuedForCash contextRef="From2015-01-01to2015-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">25999</SNYR:CommonStockIssuedForCash>
    <SNYR:CommonStockIssuedForCash contextRef="From2015-01-01to2015-12-31_custom_CommonStockToBeIssuedMember" unitRef="USD" xsi:nil="true" />
    <SNYR:CommonStockIssuedForCash contextRef="From2015-01-01to2015-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <SNYR:CommonStockIssuedForCashShares contextRef="From2014-01-01to2014-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">2000000</SNYR:CommonStockIssuedForCashShares>
    <SNYR:CommonStockIssuedForCashShares contextRef="From2015-01-01to2015-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">40000</SNYR:CommonStockIssuedForCashShares>
    <us-gaap:CommitmentsAndContingencies contextRef="AsOf2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:CommitmentsAndContingencies contextRef="AsOf2015-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:DepreciationAndAmortization contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">608002</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="From2014-01-01to2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">5968801</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="From2014-01-01to2014-12-31" unitRef="USD" xsi:nil="true" />
    <SNYR:NoteIssuedAsPartOfAssetPurchaseAgreement contextRef="From2015-01-01to2015-12-31" unitRef="USD" decimals="0">1500000</SNYR:NoteIssuedAsPartOfAssetPurchaseAgreement>
    <SNYR:NoteIssuedAsPartOfAssetPurchaseAgreement contextRef="From2014-01-01to2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:FinancingReceivablesTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 5 &amp;#150; Accounts Receivable&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Accounts receivable, net of allowances for&#13;sales returns and doubtful accounts, consisted of the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31, 2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31, 2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 54%"&gt;&lt;font style="font-size: 10pt"&gt;Trade accounts receivable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,101,148&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,898&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Less allowances&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(121,291&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Total accounts receivable, net&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;3,979,857&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2,898&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the year ended December 31, 2015, the&#13;Company charged $50,000 to bad debt expense in setting up an allowance.&lt;/p&gt;</us-gaap:FinancingReceivablesTextBlock>
    <SNYR:PrepaidExpensesTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 6 &amp;#150; Prepaid Expenses&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;At December 31, 2015 and 2014, prepaid expenses&#13;consisted of the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31, 2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31, 2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 54%"&gt;&lt;font style="font-size: 10pt"&gt;Advances for inventory&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;171,494&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Media production&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;55,849&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Insurance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;54,519&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;10,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Trade shows&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;45,700&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Deposits&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;41,228&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Consultants&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;24,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Rent&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;16,216&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Miscellaneous&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;13,428&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;422,434&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;10,000&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;</SNYR:PrepaidExpensesTextBlock>
    <us-gaap:ConcentrationRiskDisclosureTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 7 &amp;#150; Concentration of Credit Risk&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Cash and cash equivalents&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company maintains its cash and cash equivalents&#13;in banks insured by the Federal Deposit Insurance Corporation (FDIC) in accounts that at times may be in excess of the federally&#13;insured limit of $250,000 per bank. The Company minimizes this risk by placing its cash deposits with major financial institutions.&#13;At December 31, 2015, the uninsured balance amounted to $3,453,290.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Accounts receivable&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As of December 31, 2015, one customer accounted&#13;for 78% of the Company&amp;#146;s accounts receivable.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Major customers&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;For the year ended December 31, 2015, two customers&#13;accounted for approximately 71% of the Company&amp;#146;s gross revenues. Substantially all of the Company&amp;#146;s business is with&#13;companies in the United States.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Major suppliers&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;For the year ended December 31, 2015, our products&#13;were made by the following suppliers:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 30%"&gt;&lt;font style="font-size: 10pt"&gt;FOCUSfactor&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 40%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;Pittsburgh, PA&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 30%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;Tustin, CA&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Flat Tummy Tea&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;Highland, NY&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Neuragen&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;Linthicum Heights, MD&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;UrgentRx&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;Ogden, UT&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;It is the opinion of management that the products&#13;can be produced by other manufacturers and the choice to utilize these suppliers is not a significant concentration.&lt;/p&gt;</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 17 &amp;#150; Derivatives&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company has incurred a liability for the&#13;estimated fair value of a derivative warrant instrument. The estimated fair value of the derivative warrant instruments has been&#13;calculated using the Black-Scholes fair value option-pricing model with key input variables provided by management, as of the issue&#13;date, with the valuation offset against additional paid in capital, and at each reporting date, with changes in fair value recorded&#13;as gains or losses on revaluation in non-operating income (expense).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company identified embedded derivatives&#13;related to the warrants issued along with loan payable entered into in November 2015. These embedded derivatives included certain&#13;conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value&#13;of the derivatives as of the inception date of the warrants and to adjust the fair value as of each subsequent balance sheet date.&#13;At the inception of the warrants, the Company determined a fair value of $2,067,258 of the embedded derivative. The fair value&#13;of the embedded derivative was determined using the Black-Scholes Model based on the following assumptions:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;November 12, 2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 79%"&gt;&lt;font style="font-size: 10pt"&gt;Risk-free interest rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 18%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2.32&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Expected remaining term&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;10 Years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Expected volatility&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;157.56&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Dividend yield&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The initial fair values of the embedded derivative&#13;of $2,067,258 was allocated as a debt discount $2,067,258.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Fair value at December 31, 2015 was estimated&#13;to be $3,096,179 and based on the following assumptions:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31, 2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 79%"&gt;&lt;font style="font-size: 10pt"&gt;Risk-free interest rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 18%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2.27&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Expected remaining term&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9.75 Years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Expected volatility&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;152.07&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Dividend yield&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the year ended December 31, 2015, the&#13;increase in the fair value of the warrant derivative liability of $1,028,921 was recorded as a loss on change in fair value of&#13;derivative liability.&lt;/p&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 18 &amp;#150; Segments&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Segment identification and selection is consistent&#13;with the management structure used by the Company&amp;#146;s chief operating decision maker to evaluate performance and make decisions&#13;regarding resource allocation, as well as the materiality of financial results consistent with that structure. Based on the Company&amp;#146;s&#13;management structure and method of internal reporting, the Company has one operating segment. The Company&amp;#146;s chief operating&#13;decision maker does not review operating results on a disaggregated basis; rather, the chief operating decision maker reviews operating&#13;results on an aggregate basis.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Net sales attributed to customers in the United&#13;States and foreign countries for the years ended December 31, 2015 and 2014 were as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31, 2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31, 2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 54%"&gt;&lt;font style="font-size: 10pt"&gt;United States&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;13,129,753&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9,158&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Foreign countries&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;326,624&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;13,456,377&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9,158&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company&amp;#146;s net sales by product group&#13;for the years ended December 31, 2015 and 2014 were as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31, 2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31, 2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 54%"&gt;&lt;font style="font-size: 10pt"&gt;Focus Factor&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;10,482,367&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Flat Tummy Tea&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,513,990&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Other (1)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;460,020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9,158&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;13,456,377&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9,158&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;(1) Net sales for any other&#13;product group of similar products are less than 10% of consolidated net sales.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Long-lived assets (net) attributable to operations&#13;in the United States and foreign countries as of December 31, 2015 and 2014 were as follows:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31, 2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31, 2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 54%"&gt;&lt;font style="font-size: 10pt"&gt;United States&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;17,451,598&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Foreign countries&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;12,081&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;17,463,679&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 19 &amp;#150; Subsequent Events&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Management evaluated all activities of the&#13;Company through the issuance date of the Company&amp;#146;s consolidated financial statements and concluded that no subsequent events&#13;have occurred that would require adjustments or disclosure into the consolidated financial statements.&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:AdvertisingCostsPolicyTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Advertising Expense&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company expenses marketing, promotions&#13;and advertising costs as incurred. Such costs are included in general and administrative expense in the accompanying consolidated&#13;statements of operations.&lt;/p&gt;</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="background-color: white"&gt;&lt;u&gt;Foreign&#13;Currency Translation&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="background-color: white"&gt;The&#13;functional currency of each of the Company&amp;#146;s foreign subsidiaries is the U.S. Dollar. The Company&amp;#146;s subsidiary maintains&#13;its record using local currency (Australian Dollar). All monetary assets and liabilities of foreign subsidiaries were translated&#13;into U.S. Dollars at fiscal year-end exchange rates, non-monetary assets and liabilities of foreign subsidiaries were translated&#13;into U.S. Dollars at transaction day exchange rates. Income and expense items related to non-monetary items were translated at&#13;exchange rates prevailing during the transaction date and other incomes and expenses were translated using average exchange rate&#13;for the period. The resulting translation adjustments, net of income taxes, were recorded in statements of operations as Remeasurement&#13;gain or loss on translation of foreign subsidiary.&lt;/font&gt;&lt;/p&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="background-color: white"&gt;&lt;u&gt;Concentrations&#13;of Credit Risk&lt;/u&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;font style="background-color: white"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="background-color: white"&gt;In the&#13;normal course of business, the Company provided credit terms to its customers; however, collateral was not required. Accordingly,&#13;the Company performed credit evaluations of its customers and maintained allowances for possible losses which, when realized,&#13;were within the range of management&amp;#146;s expectations. From time to time, a higher concentration of credit risk existed on&#13;outstanding accounts receivable for a select number of customers due to individual buying patterns.&lt;/font&gt;&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <SNYR:WarehousingCostsPolicyTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Warehousing costs&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Warehouse costs include all third party warehouse&#13;rent fees and any additional costs relating to assembly or special pack-outs of the Company products are charged to general and&#13;administrative expenses as incurred.&lt;/p&gt;</SNYR:WarehousingCostsPolicyTextBlock>
    <us-gaap:DerivativesPolicyTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Warrant Derivative Liabilities&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;ASC 815 generally provides three criteria that,&#13;if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative&#13;financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded&#13;derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the&#13;hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value&#13;under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur&#13;and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument&#13;subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be&#13;conventional, as described.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;A Black-Scholes-Merton option-pricing model,&#13;with dilution effects, was utilized to estimate the fair value of the Warrant Derivative Liabilities as of November 12, 2015 and&#13;December 31, 2015. This model is subject to the significant assumptions discussed below and requires the following key inputs with&#13;respect to the Company and/or instrument:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Input&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;November 12, 2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31, 2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 54%"&gt;&lt;font style="font-size: 10pt"&gt;Stock Price&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.46&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.69&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Exercise Price&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.49&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.49&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Expected Life (in years)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;10.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9.75&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Stock Volatility&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;157.56&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;152.07&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Risk-Free Rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2.32&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2.27&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Dividend Rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Outstanding Shares of Common Stock&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,547,243&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,547,243&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:CostOfSalesPolicyTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Cost of Sales&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Cost of sales includes the purchase cost of&#13;products sold and all costs associated with getting the products into the retail stores including buying and transportation costs.&lt;/p&gt;</us-gaap:CostOfSalesPolicyTextBlock>
    <us-gaap:DebtPolicyTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; background-color: white"&gt;&lt;u&gt;Debt Issuance&#13;Costs&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;Debt issuance costs&#13;consist primarily of arrangement fees, professional fees and legal fees. These costs are capitalized and are being amortized to&#13;interest expense over the term of the related debt facilities.&lt;/p&gt;</us-gaap:DebtPolicyTextBlock>
    <us-gaap:ShippingAndHandlingCostPolicyTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; background-color: white"&gt;&lt;u&gt;Shipping&#13;Costs&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;Shipping and handling&#13;costs billed to customers are recorded in sales. Shipping costs incurred by the company are recorded in selling and marketing&#13;expenses.&lt;/p&gt;</us-gaap:ShippingAndHandlingCostPolicyTextBlock>
    <SNYR:RelatedPartiesPolicyTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;u&gt;Related parties&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;Parties are considered&#13;to be related to the Company if the parties that, directly or indirectly, through one or more intermediaries, control, are controlled&#13;by, or are under common control with the Company. Related parties also include principal owners of the Company, its management,&#13;members of the immediate families of principal owners of the Company and its management and other parties with which the Company&#13;may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that&#13;one of the transacting parties might be prevented from fully pursuing its own separate interests. The All transactions with related&#13;parties shall be recorded at fair value of the goods or services exchanged. Property purchased from a related party is recorded&#13;at the cost to the related party and any payment to or on behalf of the related party in excess of the cost is reflected as a&#13;distribution to the related party.&lt;/p&gt;</SNYR:RelatedPartiesPolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; background-color: white"&gt;&lt;u&gt;Segment&#13;Reporting&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;font style="background-color: white"&gt;Segment&#13;identification and selection is consistent with the management structure used by the Company&amp;#146;s chief operating decision&#13;maker to evaluate performance and make decisions regarding resource allocation, as well as the materiality of financial results&#13;consistent with that structure. Based on the Company&amp;#146;s management structure and method of internal reporting, the Company&#13;has one operating segment. The Company&amp;#146;s chief operating decision maker does not review operating results on a disaggregated&#13;basis; rather, the chief operating decision maker reviews operating results on an aggregate basis.&lt;/font&gt;&lt;/p&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;A Black-Scholes-Merton option-pricing model,&#13;with dilution effects, was utilized to estimate the fair value of the Warrant Derivative Liabilities as of November 12, 2015 and&#13;December 31, 2015. This model is subject to the significant assumptions discussed below and requires the following key inputs with&#13;respect to the Company and/or instrument:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Input&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;November 12, 2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31, 2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 54%"&gt;&lt;font style="font-size: 10pt"&gt;Stock Price&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.46&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.69&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Exercise Price&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.49&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.49&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Expected Life (in years)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;10.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9.75&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Stock Volatility&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;157.56&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;152.07&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Risk-Free Rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2.32&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2.27&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Dividend Rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Outstanding Shares of Common Stock&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,547,243&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,547,243&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The preliminary allocation of the purchase&#13;price to the assets acquired and liabilities assumed based on the estimated fair values is as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-decoration: underline"&gt;&lt;font style="font-size: 10pt"&gt;&lt;u&gt;Assets&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 79%"&gt;&lt;font style="font-size: 10pt"&gt;Accounts Receivable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 18%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,733,167&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Inventory&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;67,113&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Intellectual Property&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,000,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Non-compete provision&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;50,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Non-solicitation provision&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;50,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Intangible assets-Customer relationships&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,941,030&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Goodwill&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,071,517&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-decoration: underline"&gt;&lt;font style="font-size: 10pt"&gt;&lt;u&gt;Liabilities&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Accounts Payable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(971,381&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Accrued Expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(941,446&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6,000,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock contextRef="From2015-01-01to2015-12-31_custom_KnightTherapeuticsIncMember">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The preliminary allocation of the purchase&#13;price to the assets acquired and liabilities assumed based on the estimated fair values is as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-decoration: underline"&gt;&lt;font style="font-size: 10pt"&gt;&lt;u&gt;Assets&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 86%"&gt;&lt;font style="font-size: 10pt"&gt;Accounts Receivable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;58,054&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Inventory&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;204,925&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Intangible property&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;100,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;License agreement&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;606,553&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-decoration: underline"&gt;&lt;font style="font-size: 10pt"&gt;&lt;u&gt;Liabilities&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Accounts Payable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(51,795&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Accrued Expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(148,520&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;769,217&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock contextRef="From2015-01-01to2015-12-31_custom_HandMDLLCMember">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The preliminary allocation of the purchase&#13;price to the assets acquired and liabilities assumed based on the estimated fair values is as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-decoration: underline"&gt;&lt;font style="font-size: 10pt"&gt;&lt;u&gt;Assets&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 86%"&gt;&lt;font style="font-size: 10pt"&gt;Intangible property&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;100,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;License agreement&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,670,675&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-decoration: underline"&gt;&lt;font style="font-size: 10pt"&gt;&lt;u&gt;Liabilities&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Royalty payable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(258,897&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Others&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(11,778&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,500,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock contextRef="From2015-01-01to2015-12-31_custom_TprInvestmentsPtyLtdMember">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The preliminary allocation of the purchase&#13;price to the assets acquired and liabilities assumed based on the estimated fair values is as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-decoration: underline"&gt;&lt;font style="font-size: 10pt"&gt;&lt;u&gt;Assets&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 79%"&gt;&lt;font style="font-size: 10pt"&gt;Cash&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 18%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,584,642&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Accounts Receivable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;30,684&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Inventory&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;77,069&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Prepaid expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;141,070&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Fixed Assets, net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5,698&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Intangible assets, Net&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3,493&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Blogger Database&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;200,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Customer Database&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;500,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Intellectual property&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;100,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Non-compete provision&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;50,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Goodwill&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6,214,899&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-decoration: underline"&gt;&lt;font style="font-size: 10pt"&gt;&lt;u&gt;Liabilities&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Accounts Payable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(77,064&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Accrued Expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(56,224&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Dividends Payable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(1,177,152&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Provision for Income Tax&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(501,415&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7,095,700&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock contextRef="From2014-01-01to2014-12-31_custom_BreakthroughProductsIncMember">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The preliminary allocation of the purchase&#13;price to the assets acquired and liabilities assumed based on the estimated fair values is as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-decoration: underline"&gt;&lt;font style="font-size: 10pt"&gt;&lt;u&gt;Assets&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 79%"&gt;&lt;font style="font-size: 10pt"&gt;Cash&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 18%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,298,619&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Accounts Receivable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(68,976&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Inventory&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;234,709&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Prepaid expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;57,569&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Intellectual property&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;100,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Non-compete provision&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;50,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Goodwill&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3,253,160&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-decoration: underline"&gt;&lt;font style="font-size: 10pt"&gt;&lt;u&gt;Liabilities&lt;/u&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Accounts Payable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(741,822&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Accrued Expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(2,202,848&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,980,411&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The purchase price allocated to the acquisition&#13;of the assets of Factor Nutrition Labs, LLC is made up as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;Amount&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 86%"&gt;&lt;font style="font-size: 10pt"&gt;Cash payment made on January 22, 2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,500,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Cash payment to be made on January 20, 2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;750,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Cash payment to be made on January 20, 2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;750,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6,000,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;</us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock>
    <us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock contextRef="From2015-01-01to2015-12-31_custom_TprInvestmentsPtyLtdMember">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The purchase price allocated to the acquisition&#13;of the assets of NomadChoice is made up as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;Amount&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 86%"&gt;&lt;font style="font-size: 10pt"&gt;Cash&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,848,800&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Stock issued at closing&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,750,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Earn-out payment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,496,900&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7,095,700&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;</us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock>
    <us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock contextRef="From2014-01-01to2014-12-31_custom_BreakthroughProductsIncMember">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The purchase price allocated to the acquisition&#13;of the assets of UrgentRx is made up as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;Amount&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 86%"&gt;&lt;font style="font-size: 10pt"&gt;Stock payment&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,550,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Stock warrants issued&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;430,411&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,980,411&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;</us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Accounts receivable, net of allowances for&#13;sales returns and doubtful accounts, consisted of the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31, 2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31, 2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 54%"&gt;&lt;font style="font-size: 10pt"&gt;Trade accounts receivable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4,101,148&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,898&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Less allowances&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(121,291&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Total accounts receivable, net&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;3,979,857&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2,898&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <SNYR:SummaryOfPrepaidExpensesTableTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;At December 31, 2015 and 2014, prepaid expenses&#13;consisted of the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31, 2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31, 2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 54%"&gt;&lt;font style="font-size: 10pt"&gt;Advances for inventory&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;171,494&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Media production&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;55,849&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Insurance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;54,519&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;10,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Trade shows&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;45,700&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Deposits&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;41,228&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Consultants&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;24,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Rent&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;16,216&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Miscellaneous&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;13,428&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;422,434&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;10,000&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;</SNYR:SummaryOfPrepaidExpensesTableTextBlock>
    <SNYR:SummaryOfMajorSuppliersTableTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;For the year ended December 31, 2015, our products&#13;were made by the following suppliers:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td style="width: 30%"&gt;&lt;font style="font-size: 10pt"&gt;FOCUSfactor&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 40%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;Pittsburgh, PA&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 30%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;Tustin, CA&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Flat Tummy Tea&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;Highland, NY&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Neuragen&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;Linthicum Heights, MD&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: top"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;UrgentRx&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;Ogden, UT&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;</SNYR:SummaryOfMajorSuppliersTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The estimated aggregate amortization expense&#13;over each of the next five years is as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 79%"&gt;&lt;font style="font-size: 10pt"&gt;2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 18%; border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,111,229&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,111,229&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,109,070&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,094,329&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;489,405&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock>
    <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following is a schedule by years of future&#13;minimum rental payments required under operating leases that have initial or remaining non-cancelable lease terms in excess of&#13;one year as of December 31, 2015:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;Year ending December 31:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 84%"&gt;&lt;font style="font-size: 10pt"&gt;2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;220,676&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;27,294&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;247,970&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
    <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock contextRef="From2015-01-01to2015-12-31_custom_SubsidiaryMember">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following is a schedule by years of future&#13;minimum rental payments required under operating leases that have initial or remaining non-cancelable lease terms in excess of&#13;one year as of December 31, 2015:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;Year ending December 31:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 84%"&gt;&lt;font style="font-size: 10pt"&gt;2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;10,728&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9,834&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;20,562&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
    <us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The fair value of the embedded derivative was&#13;determined using the Black-Scholes Model based on the following assumptions:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;November 12, 2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 79%"&gt;&lt;font style="font-size: 10pt"&gt;Risk-free interest rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 18%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2.32&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Expected remaining term&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;10 Years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Expected volatility&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;157.56&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Dividend yield&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Fair value at December 31, 2015 was estimated&#13;to be $3,096,179 and based on the following assumptions:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31, 2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 79%"&gt;&lt;font style="font-size: 10pt"&gt;Risk-free interest rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 18%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2.27&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Expected remaining term&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9.75 Years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Expected volatility&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;152.07&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Dividend yield&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;</us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Net sales attributed to customers in the United&#13;States and foreign countries for the years ended December 31, 2015 and 2014 were as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31, 2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31, 2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 54%"&gt;&lt;font style="font-size: 10pt"&gt;United States&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;13,129,753&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9,158&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Foreign countries&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;326,624&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;13,456,377&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9,158&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;</us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <SNYR:SummaryOfNetSalesAttributedToCustomersProductGroupTableTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company&amp;#146;s net sales by product group&#13;for the years ended December 31, 2015 and 2014 were as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31, 2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31, 2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 54%"&gt;&lt;font style="font-size: 10pt"&gt;Focus Factor&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;10,482,367&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Flat Tummy Tea&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,513,990&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Other (1)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;460,020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9,158&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;13,456,377&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9,158&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;(1) Net sales for any&#13;other product group of similar products are less than 10% of consolidated net sales.&lt;/p&gt;</SNYR:SummaryOfNetSalesAttributedToCustomersProductGroupTableTextBlock>
    <us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock contextRef="From2015-01-01to2015-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Long-lived assets (net) attributable to operations&#13;in the United States and foreign countries as of December 31, 2015 and 2014 were as follows:&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31, 2015&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;December 31, 2014&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 54%"&gt;&lt;font style="font-size: 10pt"&gt;United States&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;17,451,598&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 20%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Foreign countries&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;12,081&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;17,463,679&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;</us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock>
    <us-gaap:DerivativeLiabilitiesCurrent contextRef="AsOf2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:DerivativeLiabilitiesCurrent contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">3096179</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2014-01-01to2014-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company has deferred tax assets,&#13;which have been fully reserved, as follows as of December 31, 2015 and 2014:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"&gt;December 31, 2015&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"&gt;December 31, 2014&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 56%; line-height: 115%"&gt;Deferred tax assets&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 18%; text-align: right; line-height: 115%"&gt;11,460,536&lt;/td&gt;&#13;    &lt;td style="width: 2%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="width: 18%; text-align: right; line-height: 115%"&gt;241,245&lt;/td&gt;&#13;    &lt;td style="width: 2%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Valuation allowance for deferred tax assets&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"&gt;(11,460,536&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"&gt;(241,245&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="line-height: 115%"&gt;Net deferred tax assets&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;$&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"&gt;-&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2014-12-31" unitRef="USD" decimals="0">241245</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">11460536</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2014-12-31" unitRef="USD" decimals="0">241245</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">11460536</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2014-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2015-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="From2014-10-01to2014-12-31" unitRef="Pure" decimals="INF">0.34</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="From2015-01-01to2015-12-31" unitRef="Pure" decimals="INF">0.34</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="From2014-10-01to2014-12-31" unitRef="Pure" decimals="INF">0.00</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential contextRef="From2015-01-01to2015-12-31" unitRef="Pure" decimals="INF">0.01</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings contextRef="From2014-10-01to2014-12-31" unitRef="Pure" decimals="INF">0.00</us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings>
    <us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings contextRef="From2015-01-01to2015-12-31" unitRef="Pure" decimals="INF">0.068</us-gaap:EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings>
    <SNYR:BonusPaid contextRef="AsOf2015-12-31" unitRef="USD" decimals="0">486958</SNYR:BonusPaid>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2014-01-01to2014-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The table below summarizes the differences&#13;between the U.S. statutory federal rate and the Company&amp;#146;s effective tax rate for the years ended December 31, 2015 and 2014:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;December 31, 2015&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;December 31, 2014&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 56%; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;U.S. Statutory Rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 18%; text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;34&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 2%; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 18%; text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;34&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 2%; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;U.S. effective rate in excess of AU rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;U.S. valuation allowance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(34&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(34&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Foreign Tax - Australia&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;6.8&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total provision for income taxes&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5.8&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="line-height: 115%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <dei:DocumentFiscalYearFocus contextRef="From2015-01-01to2015-12-31">2015</dei:DocumentFiscalYearFocus>
    <link:footnoteLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="#Foot-00-0" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-1" xlink:label="Foot-00_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-00_loc" xlink:to="Footnote-01" order="1" />
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-01" xml:lang="en-US">Net sales for any other product group of similar products are less than 10% of consolidated net sales.</link:footnote>
    </link:footnoteLink>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>15
<FILENAME>snyr-20151231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 4.11b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: SNYR %2D 20151231 10K FY DFN.xfr; Date: 2016%2D03%2D30T14:49:24Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80130003 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaCH+bP9z5Z8uekhvWB7bXlavyEiq/tU3icUmeuGYZYJ -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2015-01-31" xmlns:us-roles="http://fasb.org/us-roles/2015-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2015-01-31" xmlns:SNYR="http://synergystripscorp.com/20151231" elementFormDefault="qualified" targetNamespace="http://synergystripscorp.com/20151231">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://synergystripscorp.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
	  <link:definition>00000001 - Document - Document and Entity Information</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/BalanceSheets" id="BalanceSheets">
	  <link:definition>00000002 - Statement - Consolidated Balance Sheets</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/StatementsOfOperations" id="StatementsOfOperations">
	  <link:definition>00000004 - Statement - Consolidated Statements of Operations</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/StatementOfStockholdersEquityDeficit" id="StatementOfStockholdersEquityDeficit">
	  <link:definition>00000005 - Statement - Consolidated Statement of Stockholders' Equity (Deficit)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
	  <link:definition>00000006 - Statement - Consolidated Statements of Cash Flows</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/NatureOfBusiness" id="NatureOfBusiness">
	  <link:definition>00000007 - Disclosure - Nature of the Business</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
	  <link:definition>00000008 - Disclosure - Summary of Significant Accounting Policies</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/Acquisitions" id="Acquisitions">
	  <link:definition>00000009 - Disclosure - Acquisitions</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/IncomeTaxes" id="IncomeTaxes">
	  <link:definition>00000010 - Disclosure - Income Taxes</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/AccountsReceivable" id="AccountsReceivable">
	  <link:definition>00000011 - Disclosure - Accounts Receivable</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/PrepaidExpenses" id="PrepaidExpenses">
	  <link:definition>00000012 - Disclosure - Prepaid Expenses</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/ConcentrationOfCreditRisk" id="ConcentrationOfCreditRisk">
	  <link:definition>00000013 - Disclosure - Concentration of Credit Risk</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/Inventory" id="Inventory">
	  <link:definition>00000014 - Disclosure - Inventory</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssets" id="FixedAssetsAndIntangibleAssets">
	  <link:definition>00000015 - Disclosure - Fixed Assets and Intangible Assets</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
	  <link:definition>00000016 - Disclosure - Related Party Transactions</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/AccountsPayableAndAccruedLiabilities" id="AccountsPayableAndAccruedLiabilities">
	  <link:definition>00000017 - Disclosure - Accounts Payable and Accrued Liabilities</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/NotesPayable" id="NotesPayable">
	  <link:definition>00000018 - Disclosure - Notes Payable</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/StockholdersDeficit" id="StockholdersDeficit">
	  <link:definition>00000019 - Disclosure - Stockholders' Deficit</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
	  <link:definition>00000020 - Disclosure - Commitments and Contingencies</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/StockOptions" id="StockOptions">
	  <link:definition>00000021 - Disclosure - Stock Options</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/StockWarrants" id="StockWarrants">
	  <link:definition>00000022 - Disclosure - Stock Warrants</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/Derivatives" id="Derivatives">
	  <link:definition>00000023 - Disclosure - Derivatives</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/Segments" id="Segments">
	  <link:definition>00000024 - Disclosure - Segments</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/SubsequentEvents" id="SubsequentEvents">
	  <link:definition>00000025 - Disclosure - Subsequent Events</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
	  <link:definition>00000026 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
	  <link:definition>00000027 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/AcquisitionsTables" id="AcquisitionsTables">
	  <link:definition>00000028 - Disclosure - Acquisitions (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
	  <link:definition>00000029 - Disclosure - Income Taxes (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/AccountsReceivableTables" id="AccountsReceivableTables">
	  <link:definition>00000030 - Disclosure - Accounts Receivable (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/PrepaidExpensesTables" id="PrepaidExpensesTables">
	  <link:definition>00000031 - Disclosure - Prepaid Expenses (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/ConcentrationOfCreditRiskTables" id="ConcentrationOfCreditRiskTables">
	  <link:definition>00000032 - Disclosure - Concentration of Credit Risk (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/InventoryTables" id="InventoryTables">
	  <link:definition>00000033 - Disclosure - Inventory (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssetsTables" id="FixedAssetsAndIntangibleAssetsTables">
	  <link:definition>00000034 - Disclosure - Fixed Assets and Intangible Assets (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/AccountsPayableAndAccruedLiabilitiesTables" id="AccountsPayableAndAccruedLiabilitiesTables">
	  <link:definition>00000035 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/NotesPayableTables" id="NotesPayableTables">
	  <link:definition>00000036 - Disclosure - Notes Payable (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/CommitmentsAndContingenciesTables" id="CommitmentsAndContingenciesTables">
	  <link:definition>00000037 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/StockOptionsTables" id="StockOptionsTables">
	  <link:definition>00000038 - Disclosure - Stock Options (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/StockWarrantsTables" id="StockWarrantsTables">
	  <link:definition>00000039 - Disclosure - Stock Warrants (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/DerivativesTables" id="DerivativesTables">
	  <link:definition>00000040 - Disclosure - Derivatives (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/SegmentsTables" id="SegmentsTables">
	  <link:definition>00000041 - Disclosure - Segments (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative">
	  <link:definition>00000042 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfAssumptionsUsedForFairValueOfWarrantDerivativeLiabilitiesDetails" id="SummaryOfSignificantAccountingPolicies-ScheduleOfAssumptionsUsedForFairValueOfWarrantDerivativeLiabilitiesDetails">
	  <link:definition>00000043 - Disclosure - Summary of Significant Accounting Policies - Schedule of Assumptions Used for Fair Value of Warrant Derivative Liabilities (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/AcquisitionsDetailsNarrative" id="AcquisitionsDetailsNarrative">
	  <link:definition>00000044 - Disclosure - Acquisitions (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/Acquisitions-PurchasePriceAllocationAssetsAcquiredAndLiabilitiesAssumedOnEstimatedFairValuesDetails" id="Acquisitions-PurchasePriceAllocationAssetsAcquiredAndLiabilitiesAssumedOnEstimatedFairValuesDetails">
	  <link:definition>00000045 - Disclosure - Acquisitions - Purchase Price Allocation Assets Acquired and Liabilities Assumed on Estimated Fair Values (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/Acquisitions-PurchasePriceAllocatedToAcquisitionOfAssetsDetails" id="Acquisitions-PurchasePriceAllocatedToAcquisitionOfAssetsDetails">
	  <link:definition>00000046 - Disclosure - Acquisitions - Purchase Price Allocated to Acquisition of Assets (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/Acquisitions-ProFormaResultsOfAcquisitionDetails" id="Acquisitions-ProFormaResultsOfAcquisitionDetails">
	  <link:definition>00000047 - Disclosure - Acquisitions - Pro forma Results of Acquisition (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
	  <link:definition>00000048 - Disclosure - Income Taxes (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/IncomeTaxes-ScheduleOfEffectiveIncomeTaxRateDetails" id="IncomeTaxes-ScheduleOfEffectiveIncomeTaxRateDetails">
	  <link:definition>00000049 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/IncomeTaxes-ScheduleOfDeferredIncomeTaxAssetsDetails" id="IncomeTaxes-ScheduleOfDeferredIncomeTaxAssetsDetails">
	  <link:definition>00000050 - Disclosure - Income Taxes - Schedule of Deferred Income Tax Assets (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/AccountsReceivableDetailsNarrative" id="AccountsReceivableDetailsNarrative">
	  <link:definition>00000051 - Disclosure - Accounts Receivable (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/AccountsReceivable-AccountsReceivableNetOfAllowancesDetails" id="AccountsReceivable-AccountsReceivableNetOfAllowancesDetails">
	  <link:definition>00000052 - Disclosure - Accounts Receivable - Accounts Receivable, Net of Allowances (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/PrepaidExpenses-SummaryOfPrepaidExpensesDetails" id="PrepaidExpenses-SummaryOfPrepaidExpensesDetails">
	  <link:definition>00000053 - Disclosure - Prepaid Expenses - Summary of Prepaid Expenses (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/ConcentrationOfCreditRiskDetailsNarrative" id="ConcentrationOfCreditRiskDetailsNarrative">
	  <link:definition>00000054 - Disclosure - Concentration of Credit Risk (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/ConcentrationOfCreditRisk-SummaryOfMajorSuppliersDetails" id="ConcentrationOfCreditRisk-SummaryOfMajorSuppliersDetails">
	  <link:definition>00000055 - Disclosure - Concentration of Credit Risk - Summary of Major Suppliers (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/Inventory-ScheduleOfCarryingValueOfInventoryDetails" id="Inventory-ScheduleOfCarryingValueOfInventoryDetails">
	  <link:definition>00000056 - Disclosure - Inventory - Schedule of Carrying Value of Inventory (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssetsDetailsNarrative" id="FixedAssetsAndIntangibleAssetsDetailsNarrative">
	  <link:definition>00000057 - Disclosure - Fixed Assets and Intangible Assets (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssets-SummaryOfFixedAndIntangibleAssetsDetails" id="FixedAssetsAndIntangibleAssets-SummaryOfFixedAndIntangibleAssetsDetails">
	  <link:definition>00000058 - Disclosure - Fixed Assets and Intangible Assets - Summary of Fixed and Intangible Assets (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssets-SummaryOfEstimatedAggregateAmortizationExpenseDetails" id="FixedAssetsAndIntangibleAssets-SummaryOfEstimatedAggregateAmortizationExpenseDetails">
	  <link:definition>00000059 - Disclosure - Fixed Assets and Intangible Assets - Summary of Estimated Aggregate Amortization Expense (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/RelatedPartyTransactionsDetailsNarrative" id="RelatedPartyTransactionsDetailsNarrative">
	  <link:definition>00000060 - Disclosure - Related Party Transactions (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/AccountsPayableAndAccruedLiabilities-ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" id="AccountsPayableAndAccruedLiabilities-ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails">
	  <link:definition>00000061 - Disclosure - Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/NotesPayableDetailsNarrative" id="NotesPayableDetailsNarrative">
	  <link:definition>00000062 - Disclosure - Notes Payable (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/NotesPayable-ScheduleOfLoanPayableDetails" id="NotesPayable-ScheduleOfLoanPayableDetails">
	  <link:definition>00000063 - Disclosure - Notes Payable - Schedule of Loan Payable (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/StockholdersDeficitDetailsNarrative" id="StockholdersDeficitDetailsNarrative">
	  <link:definition>00000064 - Disclosure - Stockholders' Deficit (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/CommitmentsAndContingenciesDetailsNarrative" id="CommitmentsAndContingenciesDetailsNarrative">
	  <link:definition>00000065 - Disclosure - Commitments and Contingencies (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/CommitmentsAndContingencies-ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" id="CommitmentsAndContingencies-ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails">
	  <link:definition>00000066 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Rental Payments For Operating Leases (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/StockOptionsDetailsNarrative" id="StockOptionsDetailsNarrative">
	  <link:definition>00000067 - Disclosure - Stock Options (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/StockOptions-SummaryOfOptionsOutstandingByPriceRangeDetails" id="StockOptions-SummaryOfOptionsOutstandingByPriceRangeDetails">
	  <link:definition>00000068 - Disclosure - Stock Options - Summary of Options Outstanding by Price Range (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/StockOptions-SummaryOfStockOptionsActivityDetails" id="StockOptions-SummaryOfStockOptionsActivityDetails">
	  <link:definition>00000069 - Disclosure - Stock Options - Summary of Stock Options Activity (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/StockWarrants-SummaryOfWarrantsOutstandingByPriceRangeDetails" id="StockWarrants-SummaryOfWarrantsOutstandingByPriceRangeDetails">
	  <link:definition>00000070 - Disclosure - Stock Warrants - Summary of Warrants Outstanding by Price Range (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/StockWarrants-SummaryOfStockWarrantsActivityDetails" id="StockWarrants-SummaryOfStockWarrantsActivityDetails">
	  <link:definition>00000071 - Disclosure - Stock Warrants - Summary of Stock Warrants Activity (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/DerivativesDetailsNarrative" id="DerivativesDetailsNarrative">
	  <link:definition>00000072 - Disclosure - Derivatives (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/Derivatives-ScheduleOfAssumptionsUsedForFairValueOfDerivativeDetails" id="Derivatives-ScheduleOfAssumptionsUsedForFairValueOfDerivativeDetails">
	  <link:definition>00000073 - Disclosure - Derivatives - Schedule of Assumptions Used For Fair Value of Derivative (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/Segments-SummaryOfNetSalesAttributedToCustomersGeographicalSegmentDetails" id="Segments-SummaryOfNetSalesAttributedToCustomersGeographicalSegmentDetails">
	  <link:definition>00000074 - Disclosure - Segments - Summary of Net Sales Attributed to Customers Geographical Segment (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/Segments-SummaryOfNetSalesAttributedToCustomersProductGroupDetails" id="Segments-SummaryOfNetSalesAttributedToCustomersProductGroupDetails">
	  <link:definition>00000075 - Disclosure - Segments - Summary of Net Sales Attributed to Customers Product Group (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/Segments-SummaryOfNetSalesAttributedToCustomersProductGroupDetailsParenthetical" id="Segments-SummaryOfNetSalesAttributedToCustomersProductGroupDetailsParenthetical">
	  <link:definition>00000076 - Disclosure - Segments - Summary of Net Sales Attributed to Customers Product Group (Details) (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://synergystripscorp.com/role/Segments-SummaryOfLong-livedAssetsNetAttributableToOperationsGeographicalSegmentDetails" id="Segments-SummaryOfLong-livedAssetsNetAttributableToOperationsGeographicalSegmentDetails">
	  <link:definition>00000077 - Disclosure - Segments - Summary of Long-lived Assets (Net) Attributable to Operations Geographical Segment (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="snyr-20151231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="snyr-20151231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="snyr-20151231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="snyr-20151231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2014-01-31" schemaLocation="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2015-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2015-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2015/elts/us-types-2015-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <element id="SNYR_WorkingCapital" name="WorkingCapital" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_ExpectedEvenues" name="ExpectedEvenues" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_AmountPayableUnderPurchaseAgreement" name="AmountPayableUnderPurchaseAgreement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_FixedAssetsAndIntangibleAssetsTextBlock" name="FixedAssetsAndIntangibleAssetsTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_SummaryOfFixedAndIntangibleAssetsTableTextblock" name="SummaryOfFixedAndIntangibleAssetsTableTextblock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockWarrantsPlansByExercisePriceRangeTextBlock" name="ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockWarrantsPlansByExercisePriceRangeTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_GoingConcernPolicyTextBlock" name="GoingConcernPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_StockWarrantsDisclosureTextBlock" name="StockWarrantsDisclosureTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_WarrantsToPurchaseOfCommonStock" name="WarrantsToPurchaseOfCommonStock" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_CommonStockIssuedAsPartOfContributionAgreement" name="CommonStockIssuedAsPartOfContributionAgreement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_IntellectualProperty" name="IntellectualProperty" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_PercentageOfSaleRevenueNet" name="PercentageOfSaleRevenueNet" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_PercentageOfOutstandingCapital" name="PercentageOfOutstandingCapital" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePriceEquityInstrumentsOtherThanOptionsNonvestedNumber" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePriceEquityInstrumentsOtherThanOptionsNonvestedNumber" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_ShareBasedCompensationArrangementsByShareBasedPaymentAwardWarrantsExercisesInPeriodWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardWarrantsExercisesInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_RoyaltyPayable" name="RoyaltyPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptions" name="AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_CommonStockIssuedAsPartOfContributionAgreementShares" name="CommonStockIssuedAsPartOfContributionAgreementShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_CommonStockIssuedForAcquisitionsShares" name="CommonStockIssuedForAcquisitionsShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_CommonStockIssuedForAcquisitions" name="CommonStockIssuedForAcquisitions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_CommonStockIssuedForAcquisitionsOneShares" name="CommonStockIssuedForAcquisitionsOneShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_CommonStockIssuedForAcquisitionsOne" name="CommonStockIssuedForAcquisitionsOne" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_CommonStockIssuedToSettleAccountsPayableShares" name="CommonStockIssuedToSettleAccountsPayableShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_CommonStockIssuedToSettleAccountsPayable" name="CommonStockIssuedToSettleAccountsPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_GainsLossesOnAcquisition" name="GainsLossesOnAcquisition" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_LiabilitiesAssumedRelatedParty" name="LiabilitiesAssumedRelatedParty" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_CancellationOfCommonStockAsPartOfPurchaseTransaction" name="CancellationOfCommonStockAsPartOfPurchaseTransaction" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_FinancingForPrepaidInsurance" name="FinancingForPrepaidInsurance" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_IssuanceOfSharesAsPartOfAcquisitionTransaction" name="IssuanceOfSharesAsPartOfAcquisitionTransaction" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_NetAssetsTakenOverAsPartOfAcquisition" name="NetAssetsTakenOverAsPartOfAcquisition" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_NetLiabilitiesTakenOverAsPartOfAcquisition" name="NetLiabilitiesTakenOverAsPartOfAcquisition" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_FairValueOfWarrantsIssuedAsPartOfAcquisition" name="FairValueOfWarrantsIssuedAsPartOfAcquisition" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_CommonStockIssuedForAcquisition" name="CommonStockIssuedForAcquisition" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_CommonStockIssuedForAcquisitionOne" name="CommonStockIssuedForAcquisitionOne" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_DerivativeLiabilityAtInception" name="DerivativeLiabilityAtInception" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_AssumptionOfLiabilitiesAsPartOfAssetPurchaseAgreement" name="AssumptionOfLiabilitiesAsPartOfAssetPurchaseAgreement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_CommonStockIssuedForConversionOfNotesPayable" name="CommonStockIssuedForConversionOfNotesPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_ProductDisplayCostsPolicyTextBlock" name="ProductDisplayCostsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_PresentValueOfFuturePayments" name="PresentValueOfFuturePayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_PercentageOfAmountReceviedFromSublicensess" name="PercentageOfAmountReceviedFromSublicensess" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_ConsultingFeePaid" name="ConsultingFeePaid" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_BusinessAcquisitionsProFormaAccountsReceivable" name="BusinessAcquisitionsProFormaAccountsReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_BusinessAcquisitionsProFormaInventory" name="BusinessAcquisitionsProFormaInventory" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_BusinessAcquisitionsProFormaIntellectualProperty" name="BusinessAcquisitionsProFormaIntellectualProperty" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_BusinessAcquisitionsProFormaNonCompeteProvision" name="BusinessAcquisitionsProFormaNonCompeteProvision" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_BusinessAcquisitionsProFormaNonSolicitationProvision" name="BusinessAcquisitionsProFormaNonSolicitationProvision" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_BusinessAcquisitionsProFormaIntangibleAssetsCustomerRelationships" name="BusinessAcquisitionsProFormaIntangibleAssetsCustomerRelationships" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_BusinessAcquisitionsProFormaGoodwill" name="BusinessAcquisitionsProFormaGoodwill" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_BusinessAcquisitionsProFormaAccountsPayable" name="BusinessAcquisitionsProFormaAccountsPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_BusinessAcquisitionsProFormaAccruedExpenses" name="BusinessAcquisitionsProFormaAccruedExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_BusinessAcquisitionsProFormaTotalLiabilities" name="BusinessAcquisitionsProFormaTotalLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_BusinessAcquisitionsProFormaLicenseAgreement" name="BusinessAcquisitionsProFormaLicenseAgreement" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_BusinessAcquisitionsProFormaRoyaltyPayable" name="BusinessAcquisitionsProFormaRoyaltyPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_BusinessAcquisitionsProFormaOthers" name="BusinessAcquisitionsProFormaOthers" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_BusinessAcquisitionsProFormaCash" name="BusinessAcquisitionsProFormaCash" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_BusinessAcquisitionsProFormaPrepaidExpenses" name="BusinessAcquisitionsProFormaPrepaidExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_BusinessAcquisitionsProFormaFixedAssetsNet" name="BusinessAcquisitionsProFormaFixedAssetsNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_BusinessAcquisitionsProFormaIntangibleAssetsNet" name="BusinessAcquisitionsProFormaIntangibleAssetsNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_BusinessAcquisitionsProFormaBloggerDatabase" name="BusinessAcquisitionsProFormaBloggerDatabase" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_BusinessAcquisitionsProFormaCustomerDatabase" name="BusinessAcquisitionsProFormaCustomerDatabase" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_BusinessAcquisitionsProFormaDividendsPayable" name="BusinessAcquisitionsProFormaDividendsPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_BusinessAcquisitionsProFormaProvisionForIncomeTax" name="BusinessAcquisitionsProFormaProvisionForIncomeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_BusinessAcquisitionCashPayment" name="BusinessAcquisitionCashPayment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_BusinessAcquisitionsStockPayment" name="BusinessAcquisitionsStockPayment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_BusinessAcquisitionStockWarrantsIssued" name="BusinessAcquisitionStockWarrantsIssued" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_BusinessAcquisitionStockIssued" name="BusinessAcquisitionStockIssued" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_BusinessAcquisitionEarnoutPayment" name="BusinessAcquisitionEarnoutPayment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_ValuationAllowancePercentage" name="ValuationAllowancePercentage" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_PrepaidExpensesAdvancesForInventory" name="PrepaidExpensesAdvancesForInventory" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_PrepaidExpencesMediaProduction" name="PrepaidExpencesMediaProduction" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_PrepaidExpensesDeposits" name="PrepaidExpensesDeposits" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_NumberOfCustomerAccountedForAccountsReceivable" name="NumberOfCustomerAccountedForAccountsReceivable" nillable="true" xbrli:periodType="duration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_NameOfProduct" name="NameOfProduct" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_AddressOfSuppliers" name="AddressOfSuppliers" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_CityOfSuppliers" name="CityOfSuppliers" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_InventoryComponents" name="InventoryComponents" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_InventoryEnergyProduct" name="InventoryEnergyProduct" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_AccruedConsultingFeesPerMonth" name="AccruedConsultingFeesPerMonth" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_OutstandingBalanceOfConsultingFees" name="OutstandingBalanceOfConsultingFees" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_ManufacturersLiabilitiesCurrent" name="ManufacturersLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_PromotionsLiabilitiesCurrent" name="PromotionsLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_ReturnsAllowanceAccruedLiabilities" name="ReturnsAllowanceAccruedLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_CustomersAccruedLiabilities" name="CustomersAccruedLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_InterestAccruedLiabilities" name="InterestAccruedLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_RoyaltiesAccruedLiabilities" name="RoyaltiesAccruedLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_WarehousingAccruedLiabilities" name="WarehousingAccruedLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_PercentageOfSharesPurchaseableUnderWarrants" name="PercentageOfSharesPurchaseableUnderWarrants" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_LoansPayableGross" name="LoansPayableGross" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_PrestockSplitShares" name="PrestockSplitShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_ScheduleOfLoanPayableTableTextBlock" name="ScheduleOfLoanPayableTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_CommonStockIssuedForCash" name="CommonStockIssuedForCash" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_CommonStockIssuedForCashShares" name="CommonStockIssuedForCashShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_NoteIssuedAsPartOfAssetPurchaseAgreement" name="NoteIssuedAsPartOfAssetPurchaseAgreement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_PrepaidExpensesTextBlock" name="PrepaidExpensesTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_WarehousingCostsPolicyTextBlock" name="WarehousingCostsPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_RelatedPartiesPolicyTextBlock" name="RelatedPartiesPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_SummaryOfPrepaidExpensesTableTextBlock" name="SummaryOfPrepaidExpensesTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_SummaryOfMajorSuppliersTableTextBlock" name="SummaryOfMajorSuppliersTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_SummaryOfNetSalesAttributedToCustomersProductGroupTableTextBlock" name="SummaryOfNetSalesAttributedToCustomersProductGroupTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_BonusPaid" name="BonusPaid" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_SynergyMergerSubIncMember" name="SynergyMergerSubIncMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_StockOptionPlanMember" name="StockOptionPlanMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_EquityIncentivePlanTwoThousandsAndFourteenMember" name="EquityIncentivePlanTwoThousandsAndFourteenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_MergerAgreementMember" name="MergerAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_ShipmanDiamondProjectMember" name="ShipmanDiamondProjectMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_DirectorsMember" name="DirectorsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_PresidentAndDirectorMember" name="PresidentAndDirectorMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_CommonStockToBeIssuedMember" name="CommonStockToBeIssuedMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_DunhillDistributionGroupMember" name="DunhillDistributionGroupMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_LTWarrantMember" name="LTWarrantMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_FocusFactorBusinessMember" name="FocusFactorBusinessMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_JanuaryTwentyTwoThousandSixteenMember" name="JanuaryTwentyTwoThousandSixteenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_JanuaryTwentyTwoThousandSeventeenMember" name="JanuaryTwentyTwoThousandSeventeenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_KnightTherapeuticsBarbadosIncMember" name="KnightTherapeuticsBarbadosIncMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_FactorNutritionLabsLLCMember" name="FactorNutritionLabsLLCMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_STWarrantMember" name="STWarrantMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_KnightTherapeuticsIncMember" name="KnightTherapeuticsIncMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_JuneThirtyTwoThousandSixteenMember" name="JuneThirtyTwoThousandSixteenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_SeptemberThirtyTwoThousandFifteenMember" name="SeptemberThirtyTwoThousandFifteenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_USMember" name="USMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_ClosingDateMember" name="ClosingDateMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_ContributionAgreementMember" name="ContributionAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_HandMDCorpMember" name="HandMDCorpMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_LicenseAgreementMember" name="LicenseAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_ConsultingAgreementMember" name="ConsultingAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_HandMDLLCMember" name="HandMDLLCMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_SecurityAgreementMember" name="SecurityAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_SecondYearMember" name="SecondYearMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_ThiredYearMember" name="ThiredYearMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_BreakthroughProductsIncMember" name="BreakthroughProductsIncMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_StockPurchaseAgreementMember" name="StockPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_SettlementAgreementMember" name="SettlementAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_NoncompeteProvisionMember" name="NoncompeteProvisionMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_UrgentRxSellersMember" name="UrgentRxSellersMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_TprInvestmentsPtyLtdMember" name="TprInvestmentsPtyLtdMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_AustralianDollerMember" name="AustralianDollerMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_JanuaryTwentyTwoTwoThousandFifteenMember" name="JanuaryTwentyTwoTwoThousandFifteenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_JanuaryTwentyTwoThousandSaventeenMember" name="JanuaryTwentyTwoThousandSaventeenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_UrgentRxMember" name="UrgentRxMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_NomadChoiceMember" name="NomadChoiceMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_SuppliersOneMember" name="SuppliersOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_SuppliersTwoMember" name="SuppliersTwoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_SuppliersThreeMember" name="SuppliersThreeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_SuppliersFourMember" name="SuppliersFourMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_LoanAgreementMember" name="LoanAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_MsHarshbargerMember" name="MsHarshbargerMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_RoyaltyDistributionAgreementMember" name="RoyaltyDistributionAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_OriginationFeeMember" name="OriginationFeeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_WorkFeeMember" name="WorkFeeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_JanuaryTwentyTwoThousandFifteenLoanOneMember" name="JanuaryTwentyTwoThousandFifteenLoanOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_AssetPurchaseAgreementMember" name="AssetPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_JanuaryTwentyTwoTwoThousandFifteenLoanTwoMember" name="JanuaryTwentyTwoTwoThousandFifteenLoanTwoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_JuneTwentySixTwoThousandFifteenMember" name="JuneTwentySixTwoThousandFifteenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_NeuragenCorpMember" name="NeuragenCorpMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_QuarterEndingSeptemberThirtyTwoThousandSaventeenMember" name="QuarterEndingSeptemberThirtyTwoThousandSaventeenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_KnightWarrantsMember" name="KnightWarrantsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_KnightWarrantsOneMember" name="KnightWarrantsOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_NoteHolderMember" name="NoteHolderMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_NovemberTwoThousandSixteenMember" name="NovemberTwoThousandSixteenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_DecemberTwoThousandSixteenMember" name="DecemberTwoThousandSixteenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_SubsidiaryMember" name="SubsidiaryMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_TwoBoardMembersMember" name="TwoBoardMembersMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_TwoEmployeeMembersMember" name="TwoEmployeeMembersMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_ExercisePriceRangeOneMember" name="ExercisePriceRangeOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_ExercisePriceRangeTwoMember" name="ExercisePriceRangeTwoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_ExercisePriceRangeThreeMember" name="ExercisePriceRangeThreeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_UnitedStatesMember" name="UnitedStatesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_ForeignCountriesMember" name="ForeignCountriesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_FlatTummyTeaMember" name="FlatTummyTeaMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_OtherMember" name="OtherMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_DocumentAndEntityInformationAbstract" name="DocumentAndEntityInformationAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_CashPaidDuringPeriodAbstract" name="CashPaidDuringPeriodAbstract" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_StockWarrantsAbstract" name="StockWarrantsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_OptionToPurchaseOfCommonStock" name="OptionToPurchaseOfCommonStock" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_AllCurrenciesDomain" name="AllCurrenciesDomain" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_AssetPurchasePurchasePriceAllocationAssetsAcquiredAndLiabilitiesAssumedOnEstimatedFairValuesDetailsAbstract" name="AssetPurchasePurchasePriceAllocationAssetsAcquiredAndLiabilitiesAssumedOnEstimatedFairValuesDetailsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_AcquisitionsPurchasePriceAllocatedToAcquisitionOfAssetsDetailsAbstract" name="AcquisitionsPurchasePriceAllocatedToAcquisitionOfAssetsDetailsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="SNYR_OperatingLossCarryforwardsExpirationYear" name="OperatingLossCarryforwardsExpirationYear" nillable="true" xbrli:periodType="duration" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>16
<FILENAME>snyr-20151231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 4.11b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: SNYR %2D 20151231 10K FY DFN.xfr; Date: 2016%2D03%2D30T14:49:24Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80130003 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://synergystripscorp.com/role/DocumentAndEntityInformation" xlink:href="snyr-20151231.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/BalanceSheets" xlink:href="snyr-20151231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/BalanceSheetsParenthetical" xlink:href="snyr-20151231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/StatementsOfOperations" xlink:href="snyr-20151231.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/StatementOfStockholdersEquityDeficit" xlink:href="snyr-20151231.xsd#StatementOfStockholdersEquityDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/StatementsOfCashFlows" xlink:href="snyr-20151231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/NatureOfBusiness" xlink:href="snyr-20151231.xsd#NatureOfBusiness" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="snyr-20151231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/Acquisitions" xlink:href="snyr-20151231.xsd#Acquisitions" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/IncomeTaxes" xlink:href="snyr-20151231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/AccountsReceivable" xlink:href="snyr-20151231.xsd#AccountsReceivable" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/PrepaidExpenses" xlink:href="snyr-20151231.xsd#PrepaidExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/ConcentrationOfCreditRisk" xlink:href="snyr-20151231.xsd#ConcentrationOfCreditRisk" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/Inventory" xlink:href="snyr-20151231.xsd#Inventory" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssets" xlink:href="snyr-20151231.xsd#FixedAssetsAndIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/RelatedPartyTransactions" xlink:href="snyr-20151231.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="snyr-20151231.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/NotesPayable" xlink:href="snyr-20151231.xsd#NotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/StockholdersDeficit" xlink:href="snyr-20151231.xsd#StockholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/CommitmentsAndContingencies" xlink:href="snyr-20151231.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/StockOptions" xlink:href="snyr-20151231.xsd#StockOptions" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/StockWarrants" xlink:href="snyr-20151231.xsd#StockWarrants" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/Derivatives" xlink:href="snyr-20151231.xsd#Derivatives" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/Segments" xlink:href="snyr-20151231.xsd#Segments" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/SubsequentEvents" xlink:href="snyr-20151231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="snyr-20151231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="snyr-20151231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/AcquisitionsTables" xlink:href="snyr-20151231.xsd#AcquisitionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/IncomeTaxesTables" xlink:href="snyr-20151231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/AccountsReceivableTables" xlink:href="snyr-20151231.xsd#AccountsReceivableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/PrepaidExpensesTables" xlink:href="snyr-20151231.xsd#PrepaidExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/ConcentrationOfCreditRiskTables" xlink:href="snyr-20151231.xsd#ConcentrationOfCreditRiskTables" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/InventoryTables" xlink:href="snyr-20151231.xsd#InventoryTables" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssetsTables" xlink:href="snyr-20151231.xsd#FixedAssetsAndIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:href="snyr-20151231.xsd#AccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/NotesPayableTables" xlink:href="snyr-20151231.xsd#NotesPayableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/CommitmentsAndContingenciesTables" xlink:href="snyr-20151231.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/StockOptionsTables" xlink:href="snyr-20151231.xsd#StockOptionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/StockWarrantsTables" xlink:href="snyr-20151231.xsd#StockWarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/DerivativesTables" xlink:href="snyr-20151231.xsd#DerivativesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/SegmentsTables" xlink:href="snyr-20151231.xsd#SegmentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="snyr-20151231.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfAssumptionsUsedForFairValueOfWarrantDerivativeLiabilitiesDetails" xlink:href="snyr-20151231.xsd#SummaryOfSignificantAccountingPolicies-ScheduleOfAssumptionsUsedForFairValueOfWarrantDerivativeLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/AcquisitionsDetailsNarrative" xlink:href="snyr-20151231.xsd#AcquisitionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/Acquisitions-PurchasePriceAllocationAssetsAcquiredAndLiabilitiesAssumedOnEstimatedFairValuesDetails" xlink:href="snyr-20151231.xsd#Acquisitions-PurchasePriceAllocationAssetsAcquiredAndLiabilitiesAssumedOnEstimatedFairValuesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/Acquisitions-PurchasePriceAllocatedToAcquisitionOfAssetsDetails" xlink:href="snyr-20151231.xsd#Acquisitions-PurchasePriceAllocatedToAcquisitionOfAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/Acquisitions-ProFormaResultsOfAcquisitionDetails" xlink:href="snyr-20151231.xsd#Acquisitions-ProFormaResultsOfAcquisitionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/IncomeTaxesDetailsNarrative" xlink:href="snyr-20151231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/IncomeTaxes-ScheduleOfEffectiveIncomeTaxRateDetails" xlink:href="snyr-20151231.xsd#IncomeTaxes-ScheduleOfEffectiveIncomeTaxRateDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/IncomeTaxes-ScheduleOfDeferredIncomeTaxAssetsDetails" xlink:href="snyr-20151231.xsd#IncomeTaxes-ScheduleOfDeferredIncomeTaxAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/AccountsReceivableDetailsNarrative" xlink:href="snyr-20151231.xsd#AccountsReceivableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/AccountsReceivable-AccountsReceivableNetOfAllowancesDetails" xlink:href="snyr-20151231.xsd#AccountsReceivable-AccountsReceivableNetOfAllowancesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/PrepaidExpenses-SummaryOfPrepaidExpensesDetails" xlink:href="snyr-20151231.xsd#PrepaidExpenses-SummaryOfPrepaidExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/ConcentrationOfCreditRiskDetailsNarrative" xlink:href="snyr-20151231.xsd#ConcentrationOfCreditRiskDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/ConcentrationOfCreditRisk-SummaryOfMajorSuppliersDetails" xlink:href="snyr-20151231.xsd#ConcentrationOfCreditRisk-SummaryOfMajorSuppliersDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/Inventory-ScheduleOfCarryingValueOfInventoryDetails" xlink:href="snyr-20151231.xsd#Inventory-ScheduleOfCarryingValueOfInventoryDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssetsDetailsNarrative" xlink:href="snyr-20151231.xsd#FixedAssetsAndIntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssets-SummaryOfFixedAndIntangibleAssetsDetails" xlink:href="snyr-20151231.xsd#FixedAssetsAndIntangibleAssets-SummaryOfFixedAndIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssets-SummaryOfEstimatedAggregateAmortizationExpenseDetails" xlink:href="snyr-20151231.xsd#FixedAssetsAndIntangibleAssets-SummaryOfEstimatedAggregateAmortizationExpenseDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="snyr-20151231.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/AccountsPayableAndAccruedLiabilities-ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" xlink:href="snyr-20151231.xsd#AccountsPayableAndAccruedLiabilities-ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/NotesPayableDetailsNarrative" xlink:href="snyr-20151231.xsd#NotesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/NotesPayable-ScheduleOfLoanPayableDetails" xlink:href="snyr-20151231.xsd#NotesPayable-ScheduleOfLoanPayableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/StockholdersDeficitDetailsNarrative" xlink:href="snyr-20151231.xsd#StockholdersDeficitDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="snyr-20151231.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/CommitmentsAndContingencies-ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" xlink:href="snyr-20151231.xsd#CommitmentsAndContingencies-ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/StockOptionsDetailsNarrative" xlink:href="snyr-20151231.xsd#StockOptionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/StockOptions-SummaryOfOptionsOutstandingByPriceRangeDetails" xlink:href="snyr-20151231.xsd#StockOptions-SummaryOfOptionsOutstandingByPriceRangeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/StockOptions-SummaryOfStockOptionsActivityDetails" xlink:href="snyr-20151231.xsd#StockOptions-SummaryOfStockOptionsActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/StockWarrants-SummaryOfWarrantsOutstandingByPriceRangeDetails" xlink:href="snyr-20151231.xsd#StockWarrants-SummaryOfWarrantsOutstandingByPriceRangeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/StockWarrants-SummaryOfStockWarrantsActivityDetails" xlink:href="snyr-20151231.xsd#StockWarrants-SummaryOfStockWarrantsActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/DerivativesDetailsNarrative" xlink:href="snyr-20151231.xsd#DerivativesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/Derivatives-ScheduleOfAssumptionsUsedForFairValueOfDerivativeDetails" xlink:href="snyr-20151231.xsd#Derivatives-ScheduleOfAssumptionsUsedForFairValueOfDerivativeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/Segments-SummaryOfNetSalesAttributedToCustomersGeographicalSegmentDetails" xlink:href="snyr-20151231.xsd#Segments-SummaryOfNetSalesAttributedToCustomersGeographicalSegmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/Segments-SummaryOfNetSalesAttributedToCustomersProductGroupDetails" xlink:href="snyr-20151231.xsd#Segments-SummaryOfNetSalesAttributedToCustomersProductGroupDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/Segments-SummaryOfNetSalesAttributedToCustomersProductGroupDetailsParenthetical" xlink:href="snyr-20151231.xsd#Segments-SummaryOfNetSalesAttributedToCustomersProductGroupDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/Segments-SummaryOfLong-livedAssetsNetAttributableToOperationsGeographicalSegmentDetails" xlink:href="snyr-20151231.xsd#Segments-SummaryOfLong-livedAssetsNetAttributableToOperationsGeographicalSegmentDetails" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DueFromRelatedPartiesCurrent" xlink:label="loc_us-gaapDueFromRelatedPartiesCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapDueFromRelatedPartiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents" xlink:label="loc_us-gaapRestrictedCashAndCashEquivalents" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapRestrictedCashAndCashEquivalents" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense" xlink:label="loc_us-gaapUnamortizedDebtIssuanceExpense" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapUnamortizedDebtIssuanceExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapLongTermDebtCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TaxesPayableCurrent" xlink:label="loc_us-gaapTaxesPayableCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapTaxesPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="loc_us-gaapDerivativeLiabilitiesCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDerivativeLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapNotesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:label="loc_us-gaapLongTermNotesPayable" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapLongTermNotesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_RoyaltyPayable" xlink:label="loc_SNYRRoyaltyPayable" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_SNYRRoyaltyPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:label="loc_us-gaapCommonStockShareSubscribedButUnissuedSubscriptionsReceivable" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Consolidated Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CostOfGoodsSold" xlink:label="loc_us-gaapCostOfGoodsSold" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfGoodsSold" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestmentIncomeAmortizationOfDiscount" xlink:label="loc_us-gaapInvestmentIncomeAmortizationOfDiscount" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:to="loc_us-gaapInvestmentIncomeAmortizationOfDiscount" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" xlink:label="loc_us-gaapDebtRelatedCommitmentFeesAndDebtIssuanceCosts" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:to="loc_us-gaapDebtRelatedCommitmentFeesAndDebtIssuanceCosts" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="loc_us-gaapInterestIncomeExpenseNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestIncomeExpenseNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:label="loc_us-gaapGainLossOnDerivativeInstrumentsNetPretax" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:to="loc_us-gaapGainLossOnDerivativeInstrumentsNetPretax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestExpenseOther" xlink:label="loc_us-gaapInterestExpenseOther" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpenseOther" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainBeforeTax" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:to="loc_us-gaapForeignCurrencyTransactionGainBeforeTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/StatementOfStockholdersEquityDeficit" xlink:title="00000005 - Statement - Consolidated Statement of Stockholders' Equity (Deficit)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_GainsLossesOnAcquisition" xlink:label="loc_SNYRGainsLossesOnAcquisition" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_SNYRGainsLossesOnAcquisition" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:label="loc_us-gaapGainLossOnDerivativeInstrumentsNetPretax" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapGainLossOnDerivativeInstrumentsNetPretax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainBeforeTax" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapForeignCurrencyTransactionGainBeforeTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:label="loc_us-gaapPaymentsForProceedsFromOtherInvestingActivities" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaapPaymentsToAcquireBusinessesGross" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireBusinessesGross" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseInRestrictedCash" xlink:label="loc_us-gaapIncreaseInRestrictedCash" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapIncreaseInRestrictedCash" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherPaymentsToAcquireBusinesses" xlink:label="loc_us-gaapOtherPaymentsToAcquireBusinesses" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapOtherPaymentsToAcquireBusinesses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="loc_us-gaapCashAcquiredFromAcquisition" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapCashAcquiredFromAcquisition" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRepaymentsOfRelatedPartyDebt" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromRepaymentsOfRelatedPartyDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromNotesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfDebtIssuanceCosts" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfDebtIssuanceCosts" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsOfDividends" xlink:label="loc_us-gaapPaymentsOfDividends" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfDividends" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities" xlink:label="loc_us-gaapProceedsFromDerivativeInstrumentFinancingActivities" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromDerivativeInstrumentFinancingActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/NatureOfBusiness" xlink:title="00000007 - Disclosure - Nature of the Business" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - Summary of Significant Accounting Policies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/Acquisitions" xlink:title="00000009 - Disclosure - Acquisitions" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/IncomeTaxes" xlink:title="00000010 - Disclosure - Income Taxes" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/AccountsReceivable" xlink:title="00000011 - Disclosure - Accounts Receivable" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/PrepaidExpenses" xlink:title="00000012 - Disclosure - Prepaid Expenses" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/ConcentrationOfCreditRisk" xlink:title="00000013 - Disclosure - Concentration of Credit Risk" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/Inventory" xlink:title="00000014 - Disclosure - Inventory" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssets" xlink:title="00000015 - Disclosure - Fixed Assets and Intangible Assets" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/RelatedPartyTransactions" xlink:title="00000016 - Disclosure - Related Party Transactions" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="00000017 - Disclosure - Accounts Payable and Accrued Liabilities" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/NotesPayable" xlink:title="00000018 - Disclosure - Notes Payable" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/StockholdersDeficit" xlink:title="00000019 - Disclosure - Stockholders' Deficit" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/CommitmentsAndContingencies" xlink:title="00000020 - Disclosure - Commitments and Contingencies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/StockOptions" xlink:title="00000021 - Disclosure - Stock Options" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/StockWarrants" xlink:title="00000022 - Disclosure - Stock Warrants" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/Derivatives" xlink:title="00000023 - Disclosure - Derivatives" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/Segments" xlink:title="00000024 - Disclosure - Segments" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/SubsequentEvents" xlink:title="00000025 - Disclosure - Subsequent Events" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000026 - Disclosure - Summary of Significant Accounting Policies (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000027 - Disclosure - Summary of Significant Accounting Policies (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/AcquisitionsTables" xlink:title="00000028 - Disclosure - Acquisitions (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/IncomeTaxesTables" xlink:title="00000029 - Disclosure - Income Taxes (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/AccountsReceivableTables" xlink:title="00000030 - Disclosure - Accounts Receivable (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/PrepaidExpensesTables" xlink:title="00000031 - Disclosure - Prepaid Expenses (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/ConcentrationOfCreditRiskTables" xlink:title="00000032 - Disclosure - Concentration of Credit Risk (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/InventoryTables" xlink:title="00000033 - Disclosure - Inventory (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssetsTables" xlink:title="00000034 - Disclosure - Fixed Assets and Intangible Assets (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="00000035 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/NotesPayableTables" xlink:title="00000036 - Disclosure - Notes Payable (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/CommitmentsAndContingenciesTables" xlink:title="00000037 - Disclosure - Commitments and Contingencies (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/StockOptionsTables" xlink:title="00000038 - Disclosure - Stock Options (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/StockWarrantsTables" xlink:title="00000039 - Disclosure - Stock Warrants (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/DerivativesTables" xlink:title="00000040 - Disclosure - Derivatives (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/SegmentsTables" xlink:title="00000041 - Disclosure - Segments (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000042 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfAssumptionsUsedForFairValueOfWarrantDerivativeLiabilitiesDetails" xlink:title="00000043 - Disclosure - Summary of Significant Accounting Policies - Schedule of Assumptions Used for Fair Value of Warrant Derivative Liabilities (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/AcquisitionsDetailsNarrative" xlink:title="00000044 - Disclosure - Acquisitions (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/Acquisitions-PurchasePriceAllocationAssetsAcquiredAndLiabilitiesAssumedOnEstimatedFairValuesDetails" xlink:title="00000045 - Disclosure - Acquisitions - Purchase Price Allocation Assets Acquired and Liabilities Assumed on Estimated Fair Values (Details)">
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaTotalLiabilities" xlink:label="loc_SNYRBusinessAcquisitionsProFormaTotalLiabilities" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaAccountsPayable" xlink:label="loc_SNYRBusinessAcquisitionsProFormaAccountsPayable" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_SNYRBusinessAcquisitionsProFormaTotalLiabilities" xlink:to="loc_SNYRBusinessAcquisitionsProFormaAccountsPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaAccruedExpenses" xlink:label="loc_SNYRBusinessAcquisitionsProFormaAccruedExpenses" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_SNYRBusinessAcquisitionsProFormaTotalLiabilities" xlink:to="loc_SNYRBusinessAcquisitionsProFormaAccruedExpenses" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaAccountsReceivable" xlink:label="loc_SNYRBusinessAcquisitionsProFormaAccountsReceivable" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_SNYRBusinessAcquisitionsProFormaTotalLiabilities" xlink:to="loc_SNYRBusinessAcquisitionsProFormaAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaInventory" xlink:label="loc_SNYRBusinessAcquisitionsProFormaInventory" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_SNYRBusinessAcquisitionsProFormaTotalLiabilities" xlink:to="loc_SNYRBusinessAcquisitionsProFormaInventory" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaIntellectualProperty" xlink:label="loc_SNYRBusinessAcquisitionsProFormaIntellectualProperty" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_SNYRBusinessAcquisitionsProFormaTotalLiabilities" xlink:to="loc_SNYRBusinessAcquisitionsProFormaIntellectualProperty" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaNonCompeteProvision" xlink:label="loc_SNYRBusinessAcquisitionsProFormaNonCompeteProvision" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_SNYRBusinessAcquisitionsProFormaTotalLiabilities" xlink:to="loc_SNYRBusinessAcquisitionsProFormaNonCompeteProvision" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaNonSolicitationProvision" xlink:label="loc_SNYRBusinessAcquisitionsProFormaNonSolicitationProvision" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_SNYRBusinessAcquisitionsProFormaTotalLiabilities" xlink:to="loc_SNYRBusinessAcquisitionsProFormaNonSolicitationProvision" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaIntangibleAssetsCustomerRelationships" xlink:label="loc_SNYRBusinessAcquisitionsProFormaIntangibleAssetsCustomerRelationships" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_SNYRBusinessAcquisitionsProFormaTotalLiabilities" xlink:to="loc_SNYRBusinessAcquisitionsProFormaIntangibleAssetsCustomerRelationships" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaGoodwill" xlink:label="loc_SNYRBusinessAcquisitionsProFormaGoodwill" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_SNYRBusinessAcquisitionsProFormaTotalLiabilities" xlink:to="loc_SNYRBusinessAcquisitionsProFormaGoodwill" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/Acquisitions-PurchasePriceAllocatedToAcquisitionOfAssetsDetails" xlink:title="00000046 - Disclosure - Acquisitions - Purchase Price Allocated to Acquisition of Assets (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/Acquisitions-ProFormaResultsOfAcquisitionDetails" xlink:title="00000047 - Disclosure - Acquisitions - Pro forma Results of Acquisition (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000048 - Disclosure - Income Taxes (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/IncomeTaxes-ScheduleOfEffectiveIncomeTaxRateDetails" xlink:title="00000049 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/IncomeTaxes-ScheduleOfDeferredIncomeTaxAssetsDetails" xlink:title="00000050 - Disclosure - Income Taxes - Schedule of Deferred Income Tax Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/AccountsReceivableDetailsNarrative" xlink:title="00000051 - Disclosure - Accounts Receivable (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/AccountsReceivable-AccountsReceivableNetOfAllowancesDetails" xlink:title="00000052 - Disclosure - Accounts Receivable - Accounts Receivable, Net of Allowances (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/PrepaidExpenses-SummaryOfPrepaidExpensesDetails" xlink:title="00000053 - Disclosure - Prepaid Expenses - Summary of Prepaid Expenses (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidExpenseCurrentAndNoncurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrentAndNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_PrepaidExpensesAdvancesForInventory" xlink:label="loc_SNYRPrepaidExpensesAdvancesForInventory" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPrepaidExpenseCurrentAndNoncurrent" xlink:to="loc_SNYRPrepaidExpensesAdvancesForInventory" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_PrepaidExpencesMediaProduction" xlink:label="loc_SNYRPrepaidExpencesMediaProduction" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPrepaidExpenseCurrentAndNoncurrent" xlink:to="loc_SNYRPrepaidExpencesMediaProduction" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidInsurance" xlink:label="loc_us-gaapPrepaidInsurance" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPrepaidExpenseCurrentAndNoncurrent" xlink:to="loc_us-gaapPrepaidInsurance" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidAdvertising" xlink:label="loc_us-gaapPrepaidAdvertising" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPrepaidExpenseCurrentAndNoncurrent" xlink:to="loc_us-gaapPrepaidAdvertising" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_PrepaidExpensesDeposits" xlink:label="loc_SNYRPrepaidExpensesDeposits" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPrepaidExpenseCurrentAndNoncurrent" xlink:to="loc_SNYRPrepaidExpensesDeposits" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Supplies" xlink:label="loc_us-gaapSupplies" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPrepaidExpenseCurrentAndNoncurrent" xlink:to="loc_us-gaapSupplies" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidRent" xlink:label="loc_us-gaapPrepaidRent" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPrepaidExpenseCurrentAndNoncurrent" xlink:to="loc_us-gaapPrepaidRent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherAssetsMiscellaneousCurrent" xlink:label="loc_us-gaapOtherAssetsMiscellaneousCurrent" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPrepaidExpenseCurrentAndNoncurrent" xlink:to="loc_us-gaapOtherAssetsMiscellaneousCurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/ConcentrationOfCreditRiskDetailsNarrative" xlink:title="00000054 - Disclosure - Concentration of Credit Risk (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/ConcentrationOfCreditRisk-SummaryOfMajorSuppliersDetails" xlink:title="00000055 - Disclosure - Concentration of Credit Risk - Summary of Major Suppliers (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/Inventory-ScheduleOfCarryingValueOfInventoryDetails" xlink:title="00000056 - Disclosure - Inventory - Schedule of Carrying Value of Inventory (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaapInventoryFinishedGoods" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryFinishedGoods" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_InventoryEnergyProduct" xlink:label="loc_SNYRInventoryEnergyProduct" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_SNYRInventoryEnergyProduct" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_InventoryComponents" xlink:label="loc_SNYRInventoryComponents" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_SNYRInventoryComponents" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves" xlink:label="loc_us-gaapInventoryRawMaterialsNetOfReserves" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryRawMaterialsNetOfReserves" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssetsDetailsNarrative" xlink:title="00000057 - Disclosure - Fixed Assets and Intangible Assets (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssets-SummaryOfFixedAndIntangibleAssetsDetails" xlink:title="00000058 - Disclosure - Fixed Assets and Intangible Assets - Summary of Fixed and Intangible Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_IntellectualProperty" xlink:label="loc_SNYRIntellectualProperty" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:to="loc_SNYRIntellectualProperty" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssets-SummaryOfEstimatedAggregateAmortizationExpenseDetails" xlink:title="00000059 - Disclosure - Fixed Assets and Intangible Assets - Summary of Estimated Aggregate Amortization Expense (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000060 - Disclosure - Related Party Transactions (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/AccountsPayableAndAccruedLiabilities-ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" xlink:title="00000061 - Disclosure - Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ManufacturersLiabilitiesCurrent" xlink:label="loc_SNYRManufacturersLiabilitiesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="loc_SNYRManufacturersLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_PromotionsLiabilitiesCurrent" xlink:label="loc_SNYRPromotionsLiabilitiesCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="loc_SNYRPromotionsLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ReturnsAllowanceAccruedLiabilities" xlink:label="loc_SNYRReturnsAllowanceAccruedLiabilities" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="loc_SNYRReturnsAllowanceAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CustomersAccruedLiabilities" xlink:label="loc_SNYRCustomersAccruedLiabilities" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="loc_SNYRCustomersAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_InterestAccruedLiabilities" xlink:label="loc_SNYRInterestAccruedLiabilities" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="loc_SNYRInterestAccruedLiabilities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_RoyaltiesAccruedLiabilities" xlink:label="loc_SNYRRoyaltiesAccruedLiabilities" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="loc_SNYRRoyaltiesAccruedLiabilities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_WarehousingAccruedLiabilities" xlink:label="loc_SNYRWarehousingAccruedLiabilities" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="loc_SNYRWarehousingAccruedLiabilities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapOtherAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="loc_us-gaapOtherAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/NotesPayableDetailsNarrative" xlink:title="00000062 - Disclosure - Notes Payable (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/NotesPayable-ScheduleOfLoanPayableDetails" xlink:title="00000063 - Disclosure - Notes Payable - Schedule of Loan Payable (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LoansPayable" xlink:label="loc_us-gaapLoansPayable" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_LoansPayableGross" xlink:label="loc_SNYRLoansPayableGross" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLoansPayable" xlink:to="loc_SNYRLoansPayableGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscount" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLoansPayable" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscount" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/StockholdersDeficitDetailsNarrative" xlink:title="00000064 - Disclosure - Stockholders' Deficit (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000065 - Disclosure - Commitments and Contingencies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/CommitmentsAndContingencies-ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" xlink:title="00000066 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Rental Payments For Operating Leases (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/StockOptionsDetailsNarrative" xlink:title="00000067 - Disclosure - Stock Options (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/StockOptions-SummaryOfOptionsOutstandingByPriceRangeDetails" xlink:title="00000068 - Disclosure - Stock Options - Summary of Options Outstanding by Price Range (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/StockOptions-SummaryOfStockOptionsActivityDetails" xlink:title="00000069 - Disclosure - Stock Options - Summary of Stock Options Activity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/StockWarrants-SummaryOfWarrantsOutstandingByPriceRangeDetails" xlink:title="00000070 - Disclosure - Stock Warrants - Summary of Warrants Outstanding by Price Range (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/StockWarrants-SummaryOfStockWarrantsActivityDetails" xlink:title="00000071 - Disclosure - Stock Warrants - Summary of Stock Warrants Activity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/DerivativesDetailsNarrative" xlink:title="00000072 - Disclosure - Derivatives (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/Derivatives-ScheduleOfAssumptionsUsedForFairValueOfDerivativeDetails" xlink:title="00000073 - Disclosure - Derivatives - Schedule of Assumptions Used For Fair Value of Derivative (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/Segments-SummaryOfNetSalesAttributedToCustomersGeographicalSegmentDetails" xlink:title="00000074 - Disclosure - Segments - Summary of Net Sales Attributed to Customers Geographical Segment (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/Segments-SummaryOfNetSalesAttributedToCustomersProductGroupDetails" xlink:title="00000075 - Disclosure - Segments - Summary of Net Sales Attributed to Customers Product Group (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/Segments-SummaryOfNetSalesAttributedToCustomersProductGroupDetailsParenthetical" xlink:title="00000076 - Disclosure - Segments - Summary of Net Sales Attributed to Customers Product Group (Details) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/Segments-SummaryOfLong-livedAssetsNetAttributableToOperationsGeographicalSegmentDetails" xlink:title="00000077 - Disclosure - Segments - Summary of Long-lived Assets (Net) Attributable to Operations Geographical Segment (Details)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>17
<FILENAME>snyr-20151231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 4.11b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: SNYR %2D 20151231 10K FY DFN.xfr; Date: 2016%2D03%2D30T14:49:24Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80130003 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://synergystripscorp.com/role/DocumentAndEntityInformation" xlink:href="snyr-20151231.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/BalanceSheets" xlink:href="snyr-20151231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/BalanceSheetsParenthetical" xlink:href="snyr-20151231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/StatementsOfOperations" xlink:href="snyr-20151231.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/StatementOfStockholdersEquityDeficit" xlink:href="snyr-20151231.xsd#StatementOfStockholdersEquityDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/StatementsOfCashFlows" xlink:href="snyr-20151231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/NatureOfBusiness" xlink:href="snyr-20151231.xsd#NatureOfBusiness" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="snyr-20151231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/Acquisitions" xlink:href="snyr-20151231.xsd#Acquisitions" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/IncomeTaxes" xlink:href="snyr-20151231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/AccountsReceivable" xlink:href="snyr-20151231.xsd#AccountsReceivable" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/PrepaidExpenses" xlink:href="snyr-20151231.xsd#PrepaidExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/ConcentrationOfCreditRisk" xlink:href="snyr-20151231.xsd#ConcentrationOfCreditRisk" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/Inventory" xlink:href="snyr-20151231.xsd#Inventory" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssets" xlink:href="snyr-20151231.xsd#FixedAssetsAndIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/RelatedPartyTransactions" xlink:href="snyr-20151231.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="snyr-20151231.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/NotesPayable" xlink:href="snyr-20151231.xsd#NotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/StockholdersDeficit" xlink:href="snyr-20151231.xsd#StockholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/CommitmentsAndContingencies" xlink:href="snyr-20151231.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/StockOptions" xlink:href="snyr-20151231.xsd#StockOptions" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/StockWarrants" xlink:href="snyr-20151231.xsd#StockWarrants" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/Derivatives" xlink:href="snyr-20151231.xsd#Derivatives" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/Segments" xlink:href="snyr-20151231.xsd#Segments" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/SubsequentEvents" xlink:href="snyr-20151231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="snyr-20151231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="snyr-20151231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/AcquisitionsTables" xlink:href="snyr-20151231.xsd#AcquisitionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/IncomeTaxesTables" xlink:href="snyr-20151231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/AccountsReceivableTables" xlink:href="snyr-20151231.xsd#AccountsReceivableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/PrepaidExpensesTables" xlink:href="snyr-20151231.xsd#PrepaidExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/ConcentrationOfCreditRiskTables" xlink:href="snyr-20151231.xsd#ConcentrationOfCreditRiskTables" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/InventoryTables" xlink:href="snyr-20151231.xsd#InventoryTables" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssetsTables" xlink:href="snyr-20151231.xsd#FixedAssetsAndIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:href="snyr-20151231.xsd#AccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/NotesPayableTables" xlink:href="snyr-20151231.xsd#NotesPayableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/CommitmentsAndContingenciesTables" xlink:href="snyr-20151231.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/StockOptionsTables" xlink:href="snyr-20151231.xsd#StockOptionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/StockWarrantsTables" xlink:href="snyr-20151231.xsd#StockWarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/DerivativesTables" xlink:href="snyr-20151231.xsd#DerivativesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/SegmentsTables" xlink:href="snyr-20151231.xsd#SegmentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="snyr-20151231.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfAssumptionsUsedForFairValueOfWarrantDerivativeLiabilitiesDetails" xlink:href="snyr-20151231.xsd#SummaryOfSignificantAccountingPolicies-ScheduleOfAssumptionsUsedForFairValueOfWarrantDerivativeLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/AcquisitionsDetailsNarrative" xlink:href="snyr-20151231.xsd#AcquisitionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/Acquisitions-PurchasePriceAllocationAssetsAcquiredAndLiabilitiesAssumedOnEstimatedFairValuesDetails" xlink:href="snyr-20151231.xsd#Acquisitions-PurchasePriceAllocationAssetsAcquiredAndLiabilitiesAssumedOnEstimatedFairValuesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/Acquisitions-PurchasePriceAllocatedToAcquisitionOfAssetsDetails" xlink:href="snyr-20151231.xsd#Acquisitions-PurchasePriceAllocatedToAcquisitionOfAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/Acquisitions-ProFormaResultsOfAcquisitionDetails" xlink:href="snyr-20151231.xsd#Acquisitions-ProFormaResultsOfAcquisitionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/IncomeTaxesDetailsNarrative" xlink:href="snyr-20151231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/IncomeTaxes-ScheduleOfEffectiveIncomeTaxRateDetails" xlink:href="snyr-20151231.xsd#IncomeTaxes-ScheduleOfEffectiveIncomeTaxRateDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/IncomeTaxes-ScheduleOfDeferredIncomeTaxAssetsDetails" xlink:href="snyr-20151231.xsd#IncomeTaxes-ScheduleOfDeferredIncomeTaxAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/AccountsReceivableDetailsNarrative" xlink:href="snyr-20151231.xsd#AccountsReceivableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/AccountsReceivable-AccountsReceivableNetOfAllowancesDetails" xlink:href="snyr-20151231.xsd#AccountsReceivable-AccountsReceivableNetOfAllowancesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/PrepaidExpenses-SummaryOfPrepaidExpensesDetails" xlink:href="snyr-20151231.xsd#PrepaidExpenses-SummaryOfPrepaidExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/ConcentrationOfCreditRiskDetailsNarrative" xlink:href="snyr-20151231.xsd#ConcentrationOfCreditRiskDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/ConcentrationOfCreditRisk-SummaryOfMajorSuppliersDetails" xlink:href="snyr-20151231.xsd#ConcentrationOfCreditRisk-SummaryOfMajorSuppliersDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/Inventory-ScheduleOfCarryingValueOfInventoryDetails" xlink:href="snyr-20151231.xsd#Inventory-ScheduleOfCarryingValueOfInventoryDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssetsDetailsNarrative" xlink:href="snyr-20151231.xsd#FixedAssetsAndIntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssets-SummaryOfFixedAndIntangibleAssetsDetails" xlink:href="snyr-20151231.xsd#FixedAssetsAndIntangibleAssets-SummaryOfFixedAndIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssets-SummaryOfEstimatedAggregateAmortizationExpenseDetails" xlink:href="snyr-20151231.xsd#FixedAssetsAndIntangibleAssets-SummaryOfEstimatedAggregateAmortizationExpenseDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="snyr-20151231.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/AccountsPayableAndAccruedLiabilities-ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" xlink:href="snyr-20151231.xsd#AccountsPayableAndAccruedLiabilities-ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/NotesPayableDetailsNarrative" xlink:href="snyr-20151231.xsd#NotesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/NotesPayable-ScheduleOfLoanPayableDetails" xlink:href="snyr-20151231.xsd#NotesPayable-ScheduleOfLoanPayableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/StockholdersDeficitDetailsNarrative" xlink:href="snyr-20151231.xsd#StockholdersDeficitDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="snyr-20151231.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/CommitmentsAndContingencies-ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" xlink:href="snyr-20151231.xsd#CommitmentsAndContingencies-ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/StockOptionsDetailsNarrative" xlink:href="snyr-20151231.xsd#StockOptionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/StockOptions-SummaryOfOptionsOutstandingByPriceRangeDetails" xlink:href="snyr-20151231.xsd#StockOptions-SummaryOfOptionsOutstandingByPriceRangeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/StockOptions-SummaryOfStockOptionsActivityDetails" xlink:href="snyr-20151231.xsd#StockOptions-SummaryOfStockOptionsActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/StockWarrants-SummaryOfWarrantsOutstandingByPriceRangeDetails" xlink:href="snyr-20151231.xsd#StockWarrants-SummaryOfWarrantsOutstandingByPriceRangeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/StockWarrants-SummaryOfStockWarrantsActivityDetails" xlink:href="snyr-20151231.xsd#StockWarrants-SummaryOfStockWarrantsActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/DerivativesDetailsNarrative" xlink:href="snyr-20151231.xsd#DerivativesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/Derivatives-ScheduleOfAssumptionsUsedForFairValueOfDerivativeDetails" xlink:href="snyr-20151231.xsd#Derivatives-ScheduleOfAssumptionsUsedForFairValueOfDerivativeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/Segments-SummaryOfNetSalesAttributedToCustomersGeographicalSegmentDetails" xlink:href="snyr-20151231.xsd#Segments-SummaryOfNetSalesAttributedToCustomersGeographicalSegmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/Segments-SummaryOfNetSalesAttributedToCustomersProductGroupDetails" xlink:href="snyr-20151231.xsd#Segments-SummaryOfNetSalesAttributedToCustomersProductGroupDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/Segments-SummaryOfNetSalesAttributedToCustomersProductGroupDetailsParenthetical" xlink:href="snyr-20151231.xsd#Segments-SummaryOfNetSalesAttributedToCustomersProductGroupDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/Segments-SummaryOfLong-livedAssetsNetAttributableToOperationsGeographicalSegmentDetails" xlink:href="snyr-20151231.xsd#Segments-SummaryOfLong-livedAssetsNetAttributableToOperationsGeographicalSegmentDetails" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Consolidated Statements of Operations" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/StatementOfStockholdersEquityDeficit" xlink:title="00000005 - Statement - Consolidated Statement of Stockholders' Equity (Deficit)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CommonStockToBeIssuedMember" xlink:label="loc_SNYRCommonStockToBeIssuedMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_SNYRCommonStockToBeIssuedMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CommonStockIssuedForCash" xlink:label="loc_SNYRCommonStockIssuedForCash_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRCommonStockIssuedForCash_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CommonStockIssuedForCashShares" xlink:label="loc_SNYRCommonStockIssuedForCashShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRCommonStockIssuedForCashShares_60" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptions" xlink:label="loc_SNYRAdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptions_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRAdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptions_60" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_60" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CommonStockIssuedAsPartOfContributionAgreement" xlink:label="loc_SNYRCommonStockIssuedAsPartOfContributionAgreement_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRCommonStockIssuedAsPartOfContributionAgreement_60" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CommonStockIssuedAsPartOfContributionAgreementShares" xlink:label="loc_SNYRCommonStockIssuedAsPartOfContributionAgreementShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRCommonStockIssuedAsPartOfContributionAgreementShares_60" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CommonStockIssuedForAcquisitions" xlink:label="loc_SNYRCommonStockIssuedForAcquisitions_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRCommonStockIssuedForAcquisitions_60" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CommonStockIssuedForAcquisitionsShares" xlink:label="loc_SNYRCommonStockIssuedForAcquisitionsShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRCommonStockIssuedForAcquisitionsShares_60" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CommonStockIssuedForAcquisitionsOne" xlink:label="loc_SNYRCommonStockIssuedForAcquisitionsOne_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRCommonStockIssuedForAcquisitionsOne_60" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CommonStockIssuedForAcquisitionsOneShares" xlink:label="loc_SNYRCommonStockIssuedForAcquisitionsOneShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRCommonStockIssuedForAcquisitionsOneShares_60" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CommonStockIssuedToSettleAccountsPayable" xlink:label="loc_SNYRCommonStockIssuedToSettleAccountsPayable_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRCommonStockIssuedToSettleAccountsPayable_60" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CommonStockIssuedToSettleAccountsPayableShares" xlink:label="loc_SNYRCommonStockIssuedToSettleAccountsPayableShares_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRCommonStockIssuedToSettleAccountsPayableShares_60" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_60" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_60" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueOther_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueOther_60" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther_60" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants_60" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_60" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions_60" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_60" xlink:type="arc" order="26" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/NatureOfBusiness" xlink:title="00000007 - Disclosure - Nature of the Business" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - Summary of Significant Accounting Policies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/Acquisitions" xlink:title="00000009 - Disclosure - Acquisitions" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/IncomeTaxes" xlink:title="00000010 - Disclosure - Income Taxes" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/AccountsReceivable" xlink:title="00000011 - Disclosure - Accounts Receivable" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/PrepaidExpenses" xlink:title="00000012 - Disclosure - Prepaid Expenses" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/ConcentrationOfCreditRisk" xlink:title="00000013 - Disclosure - Concentration of Credit Risk" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/Inventory" xlink:title="00000014 - Disclosure - Inventory" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssets" xlink:title="00000015 - Disclosure - Fixed Assets and Intangible Assets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/RelatedPartyTransactions" xlink:title="00000016 - Disclosure - Related Party Transactions" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="00000017 - Disclosure - Accounts Payable and Accrued Liabilities" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/NotesPayable" xlink:title="00000018 - Disclosure - Notes Payable" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/StockholdersDeficit" xlink:title="00000019 - Disclosure - Stockholders' Deficit" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/CommitmentsAndContingencies" xlink:title="00000020 - Disclosure - Commitments and Contingencies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/StockOptions" xlink:title="00000021 - Disclosure - Stock Options" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/StockWarrants" xlink:title="00000022 - Disclosure - Stock Warrants" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/Derivatives" xlink:title="00000023 - Disclosure - Derivatives" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/Segments" xlink:title="00000024 - Disclosure - Segments" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/SubsequentEvents" xlink:title="00000025 - Disclosure - Subsequent Events" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000026 - Disclosure - Summary of Significant Accounting Policies (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000027 - Disclosure - Summary of Significant Accounting Policies (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/AcquisitionsTables" xlink:title="00000028 - Disclosure - Acquisitions (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_FactorNutritionLabsLLCMember" xlink:label="loc_SNYRFactorNutritionLabsLLCMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_SNYRFactorNutritionLabsLLCMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_KnightTherapeuticsIncMember" xlink:label="loc_SNYRKnightTherapeuticsIncMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRKnightTherapeuticsIncMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_HandMDLLCMember" xlink:label="loc_SNYRHandMDLLCMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRHandMDLLCMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BreakthroughProductsIncMember" xlink:label="loc_SNYRBreakthroughProductsIncMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRBreakthroughProductsIncMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_TprInvestmentsPtyLtdMember" xlink:label="loc_SNYRTprInvestmentsPtyLtdMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRTprInvestmentsPtyLtdMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="loc_us-gaapScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock" xlink:label="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:label="loc_us-gaapBusinessAcquisitionProFormaInformationTextBlock_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessAcquisitionProFormaInformationTextBlock_70" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/IncomeTaxesTables" xlink:title="00000029 - Disclosure - Income Taxes (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/AccountsReceivableTables" xlink:title="00000030 - Disclosure - Accounts Receivable (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/PrepaidExpensesTables" xlink:title="00000031 - Disclosure - Prepaid Expenses (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/ConcentrationOfCreditRiskTables" xlink:title="00000032 - Disclosure - Concentration of Credit Risk (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/InventoryTables" xlink:title="00000033 - Disclosure - Inventory (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssetsTables" xlink:title="00000034 - Disclosure - Fixed Assets and Intangible Assets (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="00000035 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/NotesPayableTables" xlink:title="00000036 - Disclosure - Notes Payable (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/CommitmentsAndContingenciesTables" xlink:title="00000037 - Disclosure - Commitments and Contingencies (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_SubsidiaryMember" xlink:label="loc_SNYRSubsidiaryMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRSubsidiaryMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="loc_us-gaapScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/StockOptionsTables" xlink:title="00000038 - Disclosure - Stock Options (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/StockWarrantsTables" xlink:title="00000039 - Disclosure - Stock Warrants (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/DerivativesTables" xlink:title="00000040 - Disclosure - Derivatives (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/SegmentsTables" xlink:title="00000041 - Disclosure - Segments (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000042 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfAssumptionsUsedForFairValueOfWarrantDerivativeLiabilitiesDetails" xlink:title="00000043 - Disclosure - Summary of Significant Accounting Policies - Schedule of Assumptions Used for Fair Value of Warrant Derivative Liabilities (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/AcquisitionsDetailsNarrative" xlink:title="00000044 - Disclosure - Acquisitions (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaapTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTitleOfIndividualAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_FocusFactorBusinessMember" xlink:label="loc_SNYRFocusFactorBusinessMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SNYRFocusFactorBusinessMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CreationDateAxis" xlink:label="loc_us-gaapCreationDateAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapCreationDateAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DefaultFinancialStatementsDateMember" xlink:label="loc_us-gaapDefaultFinancialStatementsDateMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapCreationDateAxis" xlink:to="loc_us-gaapDefaultFinancialStatementsDateMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DefaultFinancialStatementsDateMember" xlink:label="loc_us-gaapDefaultFinancialStatementsDateMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCreationDateAxis" xlink:to="loc_us-gaapDefaultFinancialStatementsDateMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_JanuaryTwentyTwoThousandSixteenMember" xlink:label="loc_SNYRJanuaryTwentyTwoThousandSixteenMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefaultFinancialStatementsDateMember" xlink:to="loc_SNYRJanuaryTwentyTwoThousandSixteenMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_JanuaryTwentyTwoThousandSeventeenMember" xlink:label="loc_SNYRJanuaryTwentyTwoThousandSeventeenMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefaultFinancialStatementsDateMember" xlink:to="loc_SNYRJanuaryTwentyTwoThousandSeventeenMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_JuneThirtyTwoThousandSixteenMember" xlink:label="loc_SNYRJuneThirtyTwoThousandSixteenMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefaultFinancialStatementsDateMember" xlink:to="loc_SNYRJuneThirtyTwoThousandSixteenMember_70" xlink:type="arc" order="72" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_SeptemberThirtyTwoThousandFifteenMember" xlink:label="loc_SNYRSeptemberThirtyTwoThousandFifteenMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDefaultFinancialStatementsDateMember" xlink:to="loc_SNYRSeptemberThirtyTwoThousandFifteenMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_KnightTherapeuticsBarbadosIncMember" xlink:label="loc_SNYRKnightTherapeuticsBarbadosIncMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_SNYRKnightTherapeuticsBarbadosIncMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_UrgentRxSellersMember" xlink:label="loc_SNYRUrgentRxSellersMember_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_SNYRUrgentRxSellersMember_270" xlink:type="arc" order="273" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_KnightTherapeuticsIncMember" xlink:label="loc_SNYRKnightTherapeuticsIncMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRKnightTherapeuticsIncMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_HandMDLLCMember" xlink:label="loc_SNYRHandMDLLCMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRHandMDLLCMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BreakthroughProductsIncMember" xlink:label="loc_SNYRBreakthroughProductsIncMember_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRBreakthroughProductsIncMember_230" xlink:type="arc" order="231" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_TprInvestmentsPtyLtdMember" xlink:label="loc_SNYRTprInvestmentsPtyLtdMember_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRTprInvestmentsPtyLtdMember_280" xlink:type="arc" order="281" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="loc_us-gaapStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementGeographicalAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="loc_us-gaapSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementGeographicalAxis" xlink:to="loc_us-gaapSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="loc_us-gaapSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementGeographicalAxis" xlink:to="loc_us-gaapSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_USMember" xlink:label="loc_SNYRUSMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentGeographicalDomain" xlink:to="loc_SNYRUSMember_90" xlink:type="arc" order="93" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRangeAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaapMaximumMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMaximumMember_90" xlink:type="arc" order="94" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_SecurityAgreementMember" xlink:label="loc_SNYRSecurityAgreementMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SNYRSecurityAgreementMember_130" xlink:type="arc" order="132" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_LicenseAgreementMember" xlink:label="loc_SNYRLicenseAgreementMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SNYRLicenseAgreementMember_170" xlink:type="arc" order="172" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ConsultingAgreementMember" xlink:label="loc_SNYRConsultingAgreementMember_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SNYRConsultingAgreementMember_210" xlink:type="arc" order="212" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_StockPurchaseAgreementMember" xlink:label="loc_SNYRStockPurchaseAgreementMember_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SNYRStockPurchaseAgreementMember_230" xlink:type="arc" order="232" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_SettlementAgreementMember" xlink:label="loc_SNYRSettlementAgreementMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SNYRSettlementAgreementMember_240" xlink:type="arc" order="242" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaapStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementScenarioAxis" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaapScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementScenarioAxis" xlink:to="loc_us-gaapScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaapScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementScenarioAxis" xlink:to="loc_us-gaapScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_SecondYearMember" xlink:label="loc_SNYRSecondYearMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScenarioUnspecifiedDomain" xlink:to="loc_SNYRSecondYearMember_190" xlink:type="arc" order="193" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ThiredYearMember" xlink:label="loc_SNYRThiredYearMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScenarioUnspecifiedDomain" xlink:to="loc_SNYRThiredYearMember_200" xlink:type="arc" order="203" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_NoncompeteProvisionMember" xlink:label="loc_SNYRNoncompeteProvisionMember_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScenarioUnspecifiedDomain" xlink:to="loc_SNYRNoncompeteProvisionMember_260" xlink:type="arc" order="263" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CurrencyAxis" xlink:label="loc_us-gaapCurrencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapCurrencyAxis" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_AllCurrenciesDomain" xlink:label="loc_SNYRAllCurrenciesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapCurrencyAxis" xlink:to="loc_SNYRAllCurrenciesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_AllCurrenciesDomain" xlink:label="loc_SNYRAllCurrenciesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCurrencyAxis" xlink:to="loc_SNYRAllCurrenciesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_AustralianDollerMember" xlink:label="loc_SNYRAustralianDollerMember_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_SNYRAllCurrenciesDomain" xlink:to="loc_SNYRAustralianDollerMember_290" xlink:type="arc" order="293" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaapPaymentsToAcquireBusinessesGross_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsToAcquireBusinessesGross_330" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_AmountPayableUnderPurchaseAgreement" xlink:label="loc_SNYRAmountPayableUnderPurchaseAgreement_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRAmountPayableUnderPurchaseAgreement_330" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_330" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:label="loc_us-gaapCostOfGoodsAndServicesSoldAmortization_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostOfGoodsAndServicesSoldAmortization_330" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ExpectedEvenues" xlink:label="loc_SNYRExpectedEvenues_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRExpectedEvenues_330" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_330" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaapSalesRevenueNet_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSalesRevenueNet_330" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_PercentageOfSaleRevenueNet" xlink:label="loc_SNYRPercentageOfSaleRevenueNet_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRPercentageOfSaleRevenueNet_330" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="loc_us-gaapPaymentsToAcquireInvestments_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsToAcquireInvestments_330" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_PresentValueOfFuturePayments" xlink:label="loc_SNYRPresentValueOfFuturePayments_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRPresentValueOfFuturePayments_330" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInterestExpense_330" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_330" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife_330" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_330" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_330" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare_330" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_330" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RoyaltyExpense" xlink:label="loc_us-gaapRoyaltyExpense_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRoyaltyExpense_330" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_PercentageOfAmountReceviedFromSublicensess" xlink:label="loc_SNYRPercentageOfAmountReceviedFromSublicensess_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRPercentageOfAmountReceviedFromSublicensess_330" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ConsultingFeePaid" xlink:label="loc_SNYRConsultingFeePaid_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRConsultingFeePaid_330" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsExercisePrice" xlink:label="loc_us-gaapFairValueAssumptionsExercisePrice_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFairValueAssumptionsExercisePrice_330" xlink:type="arc" order="20" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/Acquisitions-PurchasePriceAllocationAssetsAcquiredAndLiabilitiesAssumedOnEstimatedFairValuesDetails" xlink:title="00000045 - Disclosure - Acquisitions - Purchase Price Allocation Assets Acquired and Liabilities Assumed on Estimated Fair Values (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_FactorNutritionLabsLLCMember" xlink:label="loc_SNYRFactorNutritionLabsLLCMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRFactorNutritionLabsLLCMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_KnightTherapeuticsIncMember" xlink:label="loc_SNYRKnightTherapeuticsIncMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRKnightTherapeuticsIncMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_HandMDLLCMember" xlink:label="loc_SNYRHandMDLLCMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRHandMDLLCMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BreakthroughProductsIncMember" xlink:label="loc_SNYRBreakthroughProductsIncMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRBreakthroughProductsIncMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_TprInvestmentsPtyLtdMember" xlink:label="loc_SNYRTprInvestmentsPtyLtdMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRTprInvestmentsPtyLtdMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaCash" xlink:label="loc_SNYRBusinessAcquisitionsProFormaCash_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionsProFormaCash_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaAccountsReceivable" xlink:label="loc_SNYRBusinessAcquisitionsProFormaAccountsReceivable_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionsProFormaAccountsReceivable_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaInventory" xlink:label="loc_SNYRBusinessAcquisitionsProFormaInventory_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionsProFormaInventory_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaPrepaidExpenses" xlink:label="loc_SNYRBusinessAcquisitionsProFormaPrepaidExpenses_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionsProFormaPrepaidExpenses_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaFixedAssetsNet" xlink:label="loc_SNYRBusinessAcquisitionsProFormaFixedAssetsNet_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionsProFormaFixedAssetsNet_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaIntangibleAssetsNet" xlink:label="loc_SNYRBusinessAcquisitionsProFormaIntangibleAssetsNet_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionsProFormaIntangibleAssetsNet_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaBloggerDatabase" xlink:label="loc_SNYRBusinessAcquisitionsProFormaBloggerDatabase_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionsProFormaBloggerDatabase_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaCustomerDatabase" xlink:label="loc_SNYRBusinessAcquisitionsProFormaCustomerDatabase_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionsProFormaCustomerDatabase_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaIntellectualProperty" xlink:label="loc_SNYRBusinessAcquisitionsProFormaIntellectualProperty_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionsProFormaIntellectualProperty_60" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaLicenseAgreement" xlink:label="loc_SNYRBusinessAcquisitionsProFormaLicenseAgreement_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionsProFormaLicenseAgreement_60" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaNonCompeteProvision" xlink:label="loc_SNYRBusinessAcquisitionsProFormaNonCompeteProvision_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionsProFormaNonCompeteProvision_60" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaNonSolicitationProvision" xlink:label="loc_SNYRBusinessAcquisitionsProFormaNonSolicitationProvision_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionsProFormaNonSolicitationProvision_60" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaIntangibleAssetsCustomerRelationships" xlink:label="loc_SNYRBusinessAcquisitionsProFormaIntangibleAssetsCustomerRelationships_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionsProFormaIntangibleAssetsCustomerRelationships_60" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaGoodwill" xlink:label="loc_SNYRBusinessAcquisitionsProFormaGoodwill_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionsProFormaGoodwill_60" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaAccountsPayable" xlink:label="loc_SNYRBusinessAcquisitionsProFormaAccountsPayable_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionsProFormaAccountsPayable_60" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaRoyaltyPayable" xlink:label="loc_SNYRBusinessAcquisitionsProFormaRoyaltyPayable_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionsProFormaRoyaltyPayable_60" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaAccruedExpenses" xlink:label="loc_SNYRBusinessAcquisitionsProFormaAccruedExpenses_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionsProFormaAccruedExpenses_60" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaDividendsPayable" xlink:label="loc_SNYRBusinessAcquisitionsProFormaDividendsPayable_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionsProFormaDividendsPayable_60" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaProvisionForIncomeTax" xlink:label="loc_SNYRBusinessAcquisitionsProFormaProvisionForIncomeTax_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionsProFormaProvisionForIncomeTax_60" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaOthers" xlink:label="loc_SNYRBusinessAcquisitionsProFormaOthers_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionsProFormaOthers_60" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaTotalLiabilities" xlink:label="loc_SNYRBusinessAcquisitionsProFormaTotalLiabilities_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionsProFormaTotalLiabilities_60" xlink:type="arc" order="20" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/Acquisitions-PurchasePriceAllocatedToAcquisitionOfAssetsDetails" xlink:title="00000046 - Disclosure - Acquisitions - Purchase Price Allocated to Acquisition of Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_FactorNutritionLabsLLCMember" xlink:label="loc_SNYRFactorNutritionLabsLLCMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_SNYRFactorNutritionLabsLLCMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BreakthroughProductsIncMember" xlink:label="loc_SNYRBreakthroughProductsIncMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_SNYRBreakthroughProductsIncMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_TprInvestmentsPtyLtdMember" xlink:label="loc_SNYRTprInvestmentsPtyLtdMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_SNYRTprInvestmentsPtyLtdMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaapStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementScenarioAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaapScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementScenarioAxis" xlink:to="loc_us-gaapScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaapScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementScenarioAxis" xlink:to="loc_us-gaapScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_JanuaryTwentyTwoTwoThousandFifteenMember" xlink:label="loc_SNYRJanuaryTwentyTwoTwoThousandFifteenMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScenarioUnspecifiedDomain" xlink:to="loc_SNYRJanuaryTwentyTwoTwoThousandFifteenMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_JanuaryTwentyTwoThousandSixteenMember" xlink:label="loc_SNYRJanuaryTwentyTwoThousandSixteenMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScenarioUnspecifiedDomain" xlink:to="loc_SNYRJanuaryTwentyTwoThousandSixteenMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_JanuaryTwentyTwoThousandSaventeenMember" xlink:label="loc_SNYRJanuaryTwentyTwoThousandSaventeenMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScenarioUnspecifiedDomain" xlink:to="loc_SNYRJanuaryTwentyTwoThousandSaventeenMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_UrgentRxMember" xlink:label="loc_SNYRUrgentRxMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRUrgentRxMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_NomadChoiceMember" xlink:label="loc_SNYRNomadChoiceMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRNomadChoiceMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionCashPayment" xlink:label="loc_SNYRBusinessAcquisitionCashPayment_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionCashPayment_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsStockPayment" xlink:label="loc_SNYRBusinessAcquisitionsStockPayment_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionsStockPayment_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionStockWarrantsIssued" xlink:label="loc_SNYRBusinessAcquisitionStockWarrantsIssued_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionStockWarrantsIssued_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionStockIssued" xlink:label="loc_SNYRBusinessAcquisitionStockIssued_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionStockIssued_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionEarnoutPayment" xlink:label="loc_SNYRBusinessAcquisitionEarnoutPayment_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionEarnoutPayment_70" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationAsset" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationAsset_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationAsset_70" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/Acquisitions-ProFormaResultsOfAcquisitionDetails" xlink:title="00000047 - Disclosure - Acquisitions - Pro forma Results of Acquisition (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaapTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTitleOfIndividualAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_FocusFactorBusinessMember" xlink:label="loc_SNYRFocusFactorBusinessMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SNYRFocusFactorBusinessMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BreakthroughProductsIncMember" xlink:label="loc_SNYRBreakthroughProductsIncMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRBreakthroughProductsIncMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_TprInvestmentsPtyLtdMember" xlink:label="loc_SNYRTprInvestmentsPtyLtdMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRTprInvestmentsPtyLtdMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="loc_us-gaapBusinessAcquisitionsProFormaRevenue_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessAcquisitionsProFormaRevenue_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="loc_us-gaapBusinessAcquisitionsProFormaNetIncomeLoss_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessAcquisitionsProFormaNetIncomeLoss_50" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000048 - Disclosure - Income Taxes (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BreakthroughProductsIncMember" xlink:label="loc_SNYRBreakthroughProductsIncMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRBreakthroughProductsIncMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeTaxAuthorityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaapDomesticCountryMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapDomesticCountryMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ValuationAllowancePercentage" xlink:label="loc_SNYRValuationAllowancePercentage_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRValuationAllowancePercentage_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_OperatingLossCarryforwardsExpirationYear" xlink:label="loc_SNYROperatingLossCarryforwardsExpirationYear_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYROperatingLossCarryforwardsExpirationYear_60" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/IncomeTaxes-ScheduleOfEffectiveIncomeTaxRateDetails" xlink:title="00000049 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/IncomeTaxes-ScheduleOfDeferredIncomeTaxAssetsDetails" xlink:title="00000050 - Disclosure - Income Taxes - Schedule of Deferred Income Tax Assets (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/AccountsReceivableDetailsNarrative" xlink:title="00000051 - Disclosure - Accounts Receivable (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/AccountsReceivable-AccountsReceivableNetOfAllowancesDetails" xlink:title="00000052 - Disclosure - Accounts Receivable - Accounts Receivable, Net of Allowances (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/PrepaidExpenses-SummaryOfPrepaidExpensesDetails" xlink:title="00000053 - Disclosure - Prepaid Expenses - Summary of Prepaid Expenses (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/ConcentrationOfCreditRiskDetailsNarrative" xlink:title="00000054 - Disclosure - Concentration of Credit Risk (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsReceivableMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="loc_us-gaapCashFDICInsuredAmount_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashFDICInsuredAmount_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashUninsuredAmount" xlink:label="loc_us-gaapCashUninsuredAmount_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashUninsuredAmount_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_NumberOfCustomerAccountedForAccountsReceivable" xlink:label="loc_SNYRNumberOfCustomerAccountedForAccountsReceivable_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRNumberOfCustomerAccountedForAccountsReceivable_40" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/ConcentrationOfCreditRisk-SummaryOfMajorSuppliersDetails" xlink:title="00000055 - Disclosure - Concentration of Credit Risk - Summary of Major Suppliers (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_SuppliersOneMember" xlink:label="loc_SNYRSuppliersOneMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRSuppliersOneMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_SuppliersTwoMember" xlink:label="loc_SNYRSuppliersTwoMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRSuppliersTwoMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_SuppliersThreeMember" xlink:label="loc_SNYRSuppliersThreeMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRSuppliersThreeMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_SuppliersFourMember" xlink:label="loc_SNYRSuppliersFourMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRSuppliersFourMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_NameOfProduct" xlink:label="loc_SNYRNameOfProduct_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRNameOfProduct_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_AddressOfSuppliers" xlink:label="loc_SNYRAddressOfSuppliers_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRAddressOfSuppliers_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CityOfSuppliers" xlink:label="loc_SNYRCityOfSuppliers_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRCityOfSuppliers_50" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/Inventory-ScheduleOfCarryingValueOfInventoryDetails" xlink:title="00000056 - Disclosure - Inventory - Schedule of Carrying Value of Inventory (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssetsDetailsNarrative" xlink:title="00000057 - Disclosure - Fixed Assets and Intangible Assets (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssets-SummaryOfFixedAndIntangibleAssetsDetails" xlink:title="00000058 - Disclosure - Fixed Assets and Intangible Assets - Summary of Fixed and Intangible Assets (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssets-SummaryOfEstimatedAggregateAmortizationExpenseDetails" xlink:title="00000059 - Disclosure - Fixed Assets and Intangible Assets - Summary of Estimated Aggregate Amortization Expense (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000060 - Disclosure - Related Party Transactions (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaapTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTitleOfIndividualAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ChiefExecutiveOfficerMember" xlink:label="loc_us-gaapChiefExecutiveOfficerMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_us-gaapChiefExecutiveOfficerMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_MsHarshbargerMember" xlink:label="loc_SNYRMsHarshbargerMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SNYRMsHarshbargerMember_90" xlink:type="arc" order="92" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_KnightTherapeuticsIncMember" xlink:label="loc_SNYRKnightTherapeuticsIncMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRKnightTherapeuticsIncMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_LoanAgreementMember" xlink:label="loc_SNYRLoanAgreementMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SNYRLoanAgreementMember_70" xlink:type="arc" order="72" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_SecurityAgreementMember" xlink:label="loc_SNYRSecurityAgreementMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SNYRSecurityAgreementMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ConsultingAgreementMember" xlink:label="loc_SNYRConsultingAgreementMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SNYRConsultingAgreementMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_RoyaltyDistributionAgreementMember" xlink:label="loc_SNYRRoyaltyDistributionAgreementMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SNYRRoyaltyDistributionAgreementMember_120" xlink:type="arc" order="122" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_HandMDLLCMember" xlink:label="loc_SNYRHandMDLLCMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_SNYRHandMDLLCMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_140" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:label="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensation_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensation_140" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromNotesPayable_140" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_140" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_140" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1_140" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_AccruedConsultingFeesPerMonth" xlink:label="loc_SNYRAccruedConsultingFeesPerMonth_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRAccruedConsultingFeesPerMonth_140" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BonusPaid" xlink:label="loc_SNYRBonusPaid_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBonusPaid_140" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_OutstandingBalanceOfConsultingFees" xlink:label="loc_SNYROutstandingBalanceOfConsultingFees_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYROutstandingBalanceOfConsultingFees_140" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DueFromRelatedPartiesCurrent" xlink:label="loc_us-gaapDueFromRelatedPartiesCurrent_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDueFromRelatedPartiesCurrent_140" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DueFromRelatedParties" xlink:label="loc_us-gaapDueFromRelatedParties_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDueFromRelatedParties_140" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent_140" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaapMinorityInterestOwnershipPercentageByParent_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMinorityInterestOwnershipPercentageByParent_140" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent_140" xlink:type="arc" order="14" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/AccountsPayableAndAccruedLiabilities-ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" xlink:title="00000061 - Disclosure - Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/NotesPayableDetailsNarrative" xlink:title="00000062 - Disclosure - Notes Payable (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_KnightTherapeuticsIncMember" xlink:label="loc_SNYRKnightTherapeuticsIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_SNYRKnightTherapeuticsIncMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_NeuragenCorpMember" xlink:label="loc_SNYRNeuragenCorpMember_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_SNYRNeuragenCorpMember_210" xlink:type="arc" order="213" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_LoanAgreementMember" xlink:label="loc_SNYRLoanAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SNYRLoanAgreementMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_AssetPurchaseAgreementMember" xlink:label="loc_SNYRAssetPurchaseAgreementMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SNYRAssetPurchaseAgreementMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_SecurityAgreementMember" xlink:label="loc_SNYRSecurityAgreementMember_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SNYRSecurityAgreementMember_210" xlink:type="arc" order="211" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NatureOfExpenseAxis" xlink:label="loc_us-gaapNatureOfExpenseAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapNatureOfExpenseAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:label="loc_us-gaapInterimPeriodCostsNotAllocableDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapNatureOfExpenseAxis" xlink:to="loc_us-gaapInterimPeriodCostsNotAllocableDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:label="loc_us-gaapInterimPeriodCostsNotAllocableDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapNatureOfExpenseAxis" xlink:to="loc_us-gaapInterimPeriodCostsNotAllocableDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_OriginationFeeMember" xlink:label="loc_SNYROriginationFeeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapInterimPeriodCostsNotAllocableDomain" xlink:to="loc_SNYROriginationFeeMember_10" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_WorkFeeMember" xlink:label="loc_SNYRWorkFeeMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapInterimPeriodCostsNotAllocableDomain" xlink:to="loc_SNYRWorkFeeMember_20" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_JanuaryTwentyTwoThousandFifteenLoanOneMember" xlink:label="loc_SNYRJanuaryTwentyTwoThousandFifteenLoanOneMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_SNYRJanuaryTwentyTwoThousandFifteenLoanOneMember_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_JanuaryTwentyTwoTwoThousandFifteenLoanTwoMember" xlink:label="loc_SNYRJanuaryTwentyTwoTwoThousandFifteenLoanTwoMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_SNYRJanuaryTwentyTwoTwoThousandFifteenLoanTwoMember_160" xlink:type="arc" order="162" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_JuneTwentySixTwoThousandFifteenMember" xlink:label="loc_SNYRJuneTwentySixTwoThousandFifteenMember_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_SNYRJuneTwentySixTwoThousandFifteenMember_210" xlink:type="arc" order="212" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_KnightWarrantsMember" xlink:label="loc_SNYRKnightWarrantsMember_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_SNYRKnightWarrantsMember_360" xlink:type="arc" order="363" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_KnightWarrantsOneMember" xlink:label="loc_SNYRKnightWarrantsOneMember_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_SNYRKnightWarrantsOneMember_380" xlink:type="arc" order="383" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_STWarrantMember" xlink:label="loc_SNYRSTWarrantMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_SNYRSTWarrantMember_60" xlink:type="arc" order="63" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_LTWarrantMember" xlink:label="loc_SNYRLTWarrantMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_SNYRLTWarrantMember_80" xlink:type="arc" order="83" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaapStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementScenarioAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaapScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementScenarioAxis" xlink:to="loc_us-gaapScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaapScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementScenarioAxis" xlink:to="loc_us-gaapScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_JanuaryTwentyTwoThousandSixteenMember" xlink:label="loc_SNYRJanuaryTwentyTwoThousandSixteenMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScenarioUnspecifiedDomain" xlink:to="loc_SNYRJanuaryTwentyTwoThousandSixteenMember_180" xlink:type="arc" order="183" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_JanuaryTwentyTwoThousandSaventeenMember" xlink:label="loc_SNYRJanuaryTwentyTwoThousandSaventeenMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScenarioUnspecifiedDomain" xlink:to="loc_SNYRJanuaryTwentyTwoThousandSaventeenMember_190" xlink:type="arc" order="193" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_QuarterEndingSeptemberThirtyTwoThousandSaventeenMember" xlink:label="loc_SNYRQuarterEndingSeptemberThirtyTwoThousandSaventeenMember_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScenarioUnspecifiedDomain" xlink:to="loc_SNYRQuarterEndingSeptemberThirtyTwoThousandSaventeenMember_230" xlink:type="arc" order="233" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_JuneThirtyTwoThousandSixteenMember" xlink:label="loc_SNYRJuneThirtyTwoThousandSixteenMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScenarioUnspecifiedDomain" xlink:to="loc_SNYRJuneThirtyTwoThousandSixteenMember_240" xlink:type="arc" order="243" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRangeAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaapMinimumMember_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMinimumMember_250" xlink:type="arc" order="254" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaapMaximumMember_350" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMaximumMember_350" xlink:type="arc" order="353" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="loc_us-gaapStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementGeographicalAxis" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="loc_us-gaapSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementGeographicalAxis" xlink:to="loc_us-gaapSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="loc_us-gaapSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementGeographicalAxis" xlink:to="loc_us-gaapSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_USMember" xlink:label="loc_SNYRUSMember_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentGeographicalDomain" xlink:to="loc_SNYRUSMember_260" xlink:type="arc" order="263" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermDebtFairValue" xlink:label="loc_us-gaapLongTermDebtFairValue_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLongTermDebtFairValue_450" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtIssuanceCosts" xlink:label="loc_us-gaapDebtIssuanceCosts_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtIssuanceCosts_450" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_450" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:label="loc_us-gaapDebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_450" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xlink:label="loc_us-gaapDebtInstrumentInterestRateIncreaseDecrease_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateIncreaseDecrease_450" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="loc_us-gaapBusinessAcquisitionsProFormaRevenue_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessAcquisitionsProFormaRevenue_450" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="loc_us-gaapBusinessAcquisitionsProFormaNetIncomeLoss_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessAcquisitionsProFormaNetIncomeLoss_450" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LoansPayable" xlink:label="loc_us-gaapLoansPayable_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLoansPayable_450" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_450" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="loc_us-gaapCapitalExpendituresIncurredButNotYetPaid_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCapitalExpendituresIncurredButNotYetPaid_450" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="loc_us-gaapConversionOfStockSharesIssued1_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConversionOfStockSharesIssued1_450" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_450" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare_450" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_PercentageOfSharesPurchaseableUnderWarrants" xlink:label="loc_SNYRPercentageOfSharesPurchaseableUnderWarrants_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRPercentageOfSharesPurchaseableUnderWarrants_450" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" xlink:label="loc_us-gaapDebtInstrumentConvertibleBeneficialConversionFeature_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleBeneficialConversionFeature_450" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_450" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium_450" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscount_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscount_450" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="loc_us-gaapDeferredFinanceCostsNet_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredFinanceCostsNet_450" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaapAmortizationOfFinancingCosts_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAmortizationOfFinancingCosts_450" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInterestExpense_450" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DepositLiabilitiesAccruedInterest" xlink:label="loc_us-gaapDepositLiabilitiesAccruedInterest_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDepositLiabilitiesAccruedInterest_450" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NotesIssued1" xlink:label="loc_us-gaapNotesIssued1_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNotesIssued1_450" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_450" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNotesPayable_450" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_PercentageOfSaleRevenueNet" xlink:label="loc_SNYRPercentageOfSaleRevenueNet_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRPercentageOfSaleRevenueNet_450" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="loc_us-gaapPaymentsToAcquireInvestments_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsToAcquireInvestments_450" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaapSalesRevenueNet_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSalesRevenueNet_450" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaapDerivativeLiabilities_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDerivativeLiabilities_450" xlink:type="arc" order="28" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/NotesPayable-ScheduleOfLoanPayableDetails" xlink:title="00000063 - Disclosure - Notes Payable - Schedule of Loan Payable (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/StockholdersDeficitDetailsNarrative" xlink:title="00000064 - Disclosure - Stockholders' Deficit (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaapTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTitleOfIndividualAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BoardOfDirectorsChairmanMember" xlink:label="loc_us-gaapBoardOfDirectorsChairmanMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_us-gaapBoardOfDirectorsChairmanMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestorMember" xlink:label="loc_us-gaapInvestorMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_us-gaapInvestorMember_120" xlink:type="arc" order="122" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaapMinimumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMinimumMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaapMaximumMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMaximumMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_STWarrantMember" xlink:label="loc_SNYRSTWarrantMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_SNYRSTWarrantMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_LoanAgreementMember" xlink:label="loc_SNYRLoanAgreementMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SNYRLoanAgreementMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ContributionAgreementMember" xlink:label="loc_SNYRContributionAgreementMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SNYRContributionAgreementMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_StockPurchaseAgreementMember" xlink:label="loc_SNYRStockPurchaseAgreementMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SNYRStockPurchaseAgreementMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_MergerAgreementMember" xlink:label="loc_SNYRMergerAgreementMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SNYRMergerAgreementMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_NoteHolderMember" xlink:label="loc_SNYRNoteHolderMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRNoteHolderMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_HandMDCorpMember" xlink:label="loc_SNYRHandMDCorpMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_SNYRHandMDCorpMember_70" xlink:type="arc" order="72" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_NomadChoiceMember" xlink:label="loc_SNYRNomadChoiceMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_SNYRNomadChoiceMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BreakthroughProductsIncMember" xlink:label="loc_SNYRBreakthroughProductsIncMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_SNYRBreakthroughProductsIncMember_90" xlink:type="arc" order="92" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NatureOfExpenseAxis" xlink:label="loc_us-gaapNatureOfExpenseAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapNatureOfExpenseAxis" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:label="loc_us-gaapInterimPeriodCostsNotAllocableDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapNatureOfExpenseAxis" xlink:to="loc_us-gaapInterimPeriodCostsNotAllocableDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:label="loc_us-gaapInterimPeriodCostsNotAllocableDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapNatureOfExpenseAxis" xlink:to="loc_us-gaapInterimPeriodCostsNotAllocableDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableMember" xlink:label="loc_us-gaapAccountsPayableMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapInterimPeriodCostsNotAllocableDomain" xlink:to="loc_us-gaapAccountsPayableMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_170" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaapStockholdersEquityReverseStockSplit_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityReverseStockSplit_170" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_170" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare_170" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockValue_170" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_PercentageOfOutstandingCapital" xlink:label="loc_SNYRPercentageOfOutstandingCapital_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRPercentageOfOutstandingCapital_170" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction_170" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_170" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_PrestockSplitShares" xlink:label="loc_SNYRPrestockSplitShares_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRPrestockSplitShares_170" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockHeldInTrust" xlink:label="loc_us-gaapCommonStockHeldInTrust_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockHeldInTrust_170" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_170" xlink:type="arc" order="11" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000065 - Disclosure - Commitments and Contingencies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaapStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementScenarioAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaapScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementScenarioAxis" xlink:to="loc_us-gaapScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaapScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementScenarioAxis" xlink:to="loc_us-gaapScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_NovemberTwoThousandSixteenMember" xlink:label="loc_SNYRNovemberTwoThousandSixteenMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScenarioUnspecifiedDomain" xlink:to="loc_SNYRNovemberTwoThousandSixteenMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_DecemberTwoThousandSixteenMember" xlink:label="loc_SNYRDecemberTwoThousandSixteenMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapScenarioUnspecifiedDomain" xlink:to="loc_SNYRDecemberTwoThousandSixteenMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CurrencyAxis" xlink:label="loc_us-gaapCurrencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapCurrencyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_AllCurrenciesDomain" xlink:label="loc_SNYRAllCurrenciesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapCurrencyAxis" xlink:to="loc_SNYRAllCurrenciesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_AllCurrenciesDomain" xlink:label="loc_SNYRAllCurrenciesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapCurrencyAxis" xlink:to="loc_SNYRAllCurrenciesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_AustralianDollerMember" xlink:label="loc_SNYRAustralianDollerMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_SNYRAllCurrenciesDomain" xlink:to="loc_SNYRAustralianDollerMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_SubsidiaryMember" xlink:label="loc_SNYRSubsidiaryMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRSubsidiaryMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLossCarryforwardsExpirationDate" xlink:label="loc_us-gaapOperatingLossCarryforwardsExpirationDate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwardsExpirationDate_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="loc_us-gaapOperatingLeasesRentExpenseNet_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeasesRentExpenseNet_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleLeasebackTransactionRentExpense" xlink:label="loc_us-gaapSaleLeasebackTransactionRentExpense_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleLeasebackTransactionRentExpense_70" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/CommitmentsAndContingencies-ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" xlink:title="00000066 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Rental Payments For Operating Leases (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_SubsidiaryMember" xlink:label="loc_SNYRSubsidiaryMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRSubsidiaryMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue_30" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/StockOptionsDetailsNarrative" xlink:title="00000067 - Disclosure - Stock Options (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_EquityIncentivePlanTwoThousandsAndFourteenMember" xlink:label="loc_SNYREquityIncentivePlanTwoThousandsAndFourteenMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SNYREquityIncentivePlanTwoThousandsAndFourteenMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaapTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ChiefExecutiveOfficerMember" xlink:label="loc_us-gaapChiefExecutiveOfficerMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_us-gaapChiefExecutiveOfficerMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_TwoBoardMembersMember" xlink:label="loc_SNYRTwoBoardMembersMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SNYRTwoBoardMembersMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_TwoEmployeeMembersMember" xlink:label="loc_SNYRTwoEmployeeMembersMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SNYRTwoEmployeeMembersMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsExercisePrice" xlink:label="loc_us-gaapFairValueAssumptionsExercisePrice_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFairValueAssumptionsExercisePrice_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapFairValueAssumptionsRiskFreeInterestRate_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFairValueAssumptionsRiskFreeInterestRate_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapFairValueAssumptionsExpectedVolatilityRate_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFairValueAssumptionsExpectedVolatilityRate_90" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsExpectedTerm" xlink:label="loc_us-gaapFairValueAssumptionsExpectedTerm_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFairValueAssumptionsExpectedTerm_90" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapFairValueAssumptionsExpectedDividendRate_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFairValueAssumptionsExpectedDividendRate_90" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_90" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/StockOptions-SummaryOfOptionsOutstandingByPriceRangeDetails" xlink:title="00000068 - Disclosure - Stock Options - Summary of Options Outstanding by Price Range (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_StockOptionPlanMember" xlink:label="loc_SNYRStockOptionPlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SNYRStockOptionPlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaapMinimumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMinimumMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaapMaximumMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMaximumMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_50" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/StockOptions-SummaryOfStockOptionsActivityDetails" xlink:title="00000069 - Disclosure - Stock Options - Summary of Stock Options Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_StockOptionPlanMember" xlink:label="loc_SNYRStockOptionPlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SNYRStockOptionPlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_20" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_20" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_20" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_20" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_20" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_20" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_20" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_20" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/StockWarrants-SummaryOfWarrantsOutstandingByPriceRangeDetails" xlink:title="00000070 - Disclosure - Stock Warrants - Summary of Warrants Outstanding by Price Range (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_us-gaapWarrantMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ExercisePriceRangeOneMember" xlink:label="loc_SNYRExercisePriceRangeOneMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_SNYRExercisePriceRangeOneMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ExercisePriceRangeTwoMember" xlink:label="loc_SNYRExercisePriceRangeTwoMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_SNYRExercisePriceRangeTwoMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ExercisePriceRangeThreeMember" xlink:label="loc_SNYRExercisePriceRangeThreeMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_SNYRExercisePriceRangeThreeMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_70" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/StockWarrants-SummaryOfStockWarrantsActivityDetails" xlink:title="00000071 - Disclosure - Stock Warrants - Summary of Stock Warrants Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_us-gaapWarrantMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_20" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_20" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_20" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_20" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePriceEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_SNYRShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePriceEquityInstrumentsOtherThanOptionsNonvestedNumber_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePriceEquityInstrumentsOtherThanOptionsNonvestedNumber_20" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_SNYRShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice_20" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ShareBasedCompensationArrangementsByShareBasedPaymentAwardWarrantsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_SNYRShareBasedCompensationArrangementsByShareBasedPaymentAwardWarrantsExercisesInPeriodWeightedAverageExercisePrice_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRShareBasedCompensationArrangementsByShareBasedPaymentAwardWarrantsExercisesInPeriodWeightedAverageExercisePrice_20" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageExercisePrice" xlink:label="loc_SNYRShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageExercisePrice_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageExercisePrice_20" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/DerivativesDetailsNarrative" xlink:title="00000072 - Disclosure - Derivatives (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_us-gaapWarrantMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaapDerivativeLiabilities_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDerivativeLiabilities_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium_50" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/Derivatives-ScheduleOfAssumptionsUsedForFairValueOfDerivativeDetails" xlink:title="00000073 - Disclosure - Derivatives - Schedule of Assumptions Used For Fair Value of Derivative (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/Segments-SummaryOfNetSalesAttributedToCustomersGeographicalSegmentDetails" xlink:title="00000074 - Disclosure - Segments - Summary of Net Sales Attributed to Customers Geographical Segment (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="loc_us-gaapStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementGeographicalAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="loc_us-gaapSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementGeographicalAxis" xlink:to="loc_us-gaapSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="loc_us-gaapSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementGeographicalAxis" xlink:to="loc_us-gaapSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_UnitedStatesMember" xlink:label="loc_SNYRUnitedStatesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentGeographicalDomain" xlink:to="loc_SNYRUnitedStatesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ForeignCountriesMember" xlink:label="loc_SNYRForeignCountriesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentGeographicalDomain" xlink:to="loc_SNYRForeignCountriesMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues_70" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/Segments-SummaryOfNetSalesAttributedToCustomersProductGroupDetails" xlink:title="00000075 - Disclosure - Segments - Summary of Net Sales Attributed to Customers Product Group (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_FocusFactorBusinessMember" xlink:label="loc_SNYRFocusFactorBusinessMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SNYRFocusFactorBusinessMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_FlatTummyTeaMember" xlink:label="loc_SNYRFlatTummyTeaMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SNYRFlatTummyTeaMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_OtherMember" xlink:label="loc_SNYROtherMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SNYROtherMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues_90" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/Segments-SummaryOfNetSalesAttributedToCustomersProductGroupDetailsParenthetical" xlink:title="00000076 - Disclosure - Segments - Summary of Net Sales Attributed to Customers Product Group (Details) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_OtherMember" xlink:label="loc_SNYROtherMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SNYROtherMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapSalesRevenueNetMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/Segments-SummaryOfLong-livedAssetsNetAttributableToOperationsGeographicalSegmentDetails" xlink:title="00000077 - Disclosure - Segments - Summary of Long-lived Assets (Net) Attributable to Operations Geographical Segment (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="loc_us-gaapStatementGeographicalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementGeographicalAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="loc_us-gaapSegmentGeographicalDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementGeographicalAxis" xlink:to="loc_us-gaapSegmentGeographicalDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="loc_us-gaapSegmentGeographicalDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementGeographicalAxis" xlink:to="loc_us-gaapSegmentGeographicalDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_UnitedStatesMember" xlink:label="loc_SNYRUnitedStatesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentGeographicalDomain" xlink:to="loc_SNYRUnitedStatesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ForeignCountriesMember" xlink:label="loc_SNYRForeignCountriesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentGeographicalDomain" xlink:to="loc_SNYRForeignCountriesMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NoncurrentAssets" xlink:label="loc_us-gaapNoncurrentAssets_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNoncurrentAssets_70" xlink:type="arc" order="0" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>18
<FILENAME>snyr-20151231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 4.11b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: SNYR %2D 20151231 10K FY DFN.xfr; Date: 2016%2D03%2D30T14:49:24Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80130003 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_SynergyMergerSubIncMember" xlink:label="SNYR_SynergyMergerSubIncMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_SynergyMergerSubIncMember" xlink:to="SNYR_SynergyMergerSubIncMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_SynergyMergerSubIncMember_lbl" xml:lang="en-US">Synergy Merger Sub Inc [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US">Business Acquisition [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScenarioPlanMember" xlink:label="us-gaap_ScenarioPlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScenarioPlanMember" xlink:to="us-gaap_ScenarioPlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScenarioPlanMember_lbl" xml:lang="en-US">Scenario, Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="us-gaap_StatementScenarioAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementScenarioAxis" xlink:to="us-gaap_StatementScenarioAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_StockOptionPlanMember" xlink:label="SNYR_StockOptionPlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_StockOptionPlanMember" xlink:to="SNYR_StockOptionPlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_StockOptionPlanMember_lbl" xml:lang="en-US">Stock Option Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US">Plan Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xml:lang="en-US">Employee Stock Option [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_EquityIncentivePlanTwoThousandsAndFourteenMember" xlink:label="SNYR_EquityIncentivePlanTwoThousandsAndFourteenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_EquityIncentivePlanTwoThousandsAndFourteenMember" xlink:to="SNYR_EquityIncentivePlanTwoThousandsAndFourteenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_EquityIncentivePlanTwoThousandsAndFourteenMember_lbl" xml:lang="en-US">Equity Incentive Plan 2014 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BoardOfDirectorsChairmanMember" xlink:label="us-gaap_BoardOfDirectorsChairmanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BoardOfDirectorsChairmanMember" xlink:to="us-gaap_BoardOfDirectorsChairmanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BoardOfDirectorsChairmanMember_lbl" xml:lang="en-US">Board of Directors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="us-gaap_TitleOfIndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TitleOfIndividualAxis" xlink:to="us-gaap_TitleOfIndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title of Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MaximumMember" xlink:to="us-gaap_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RangeAxis_lbl" xml:lang="en-US">Range [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinimumMember" xlink:to="us-gaap_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestorMember" xlink:label="us-gaap_InvestorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestorMember" xlink:to="us-gaap_InvestorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestorMember_lbl" xml:lang="en-US">Investor [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related Party [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_MergerAgreementMember" xlink:label="SNYR_MergerAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_MergerAgreementMember" xlink:to="SNYR_MergerAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_MergerAgreementMember_lbl" xml:lang="en-US">Merger Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US">Type of Arrangement and Non-arrangement Transactions [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-In Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Accumulated Deficit [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ShipmanDiamondProjectMember" xlink:label="SNYR_ShipmanDiamondProjectMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_ShipmanDiamondProjectMember" xlink:to="SNYR_ShipmanDiamondProjectMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_ShipmanDiamondProjectMember_lbl" xml:lang="en-US">Shipman Diamond Project [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_DirectorsMember" xlink:label="SNYR_DirectorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_DirectorsMember" xlink:to="SNYR_DirectorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_DirectorsMember_lbl" xml:lang="en-US">Directors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_PresidentAndDirectorMember" xlink:label="SNYR_PresidentAndDirectorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_PresidentAndDirectorMember" xlink:to="SNYR_PresidentAndDirectorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_PresidentAndDirectorMember_lbl" xml:lang="en-US">President And Director [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CommonStockToBeIssuedMember" xlink:label="SNYR_CommonStockToBeIssuedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_CommonStockToBeIssuedMember" xlink:to="SNYR_CommonStockToBeIssuedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_CommonStockToBeIssuedMember_lbl" xml:lang="en-US">Common Stock To Be Issued [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_DunhillDistributionGroupMember" xlink:label="SNYR_DunhillDistributionGroupMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_DunhillDistributionGroupMember" xlink:to="SNYR_DunhillDistributionGroupMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_DunhillDistributionGroupMember_lbl" xml:lang="en-US">Dunhill Distribution Group [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ChiefExecutiveOfficerMember" xlink:label="us-gaap_ChiefExecutiveOfficerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChiefExecutiveOfficerMember" xlink:to="us-gaap_ChiefExecutiveOfficerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ChiefExecutiveOfficerMember_lbl" xml:lang="en-US">Mr. Jack Ross [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_LTWarrantMember" xlink:label="SNYR_LTWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_LTWarrantMember" xlink:to="SNYR_LTWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_LTWarrantMember_lbl" xml:lang="en-US">LT Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_FocusFactorBusinessMember" xlink:label="SNYR_FocusFactorBusinessMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_FocusFactorBusinessMember" xlink:to="SNYR_FocusFactorBusinessMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_FocusFactorBusinessMember_lbl" xml:lang="en-US">Focus Factor Business [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_JanuaryTwentyTwoThousandSixteenMember" xlink:label="SNYR_JanuaryTwentyTwoThousandSixteenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_JanuaryTwentyTwoThousandSixteenMember" xlink:to="SNYR_JanuaryTwentyTwoThousandSixteenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_JanuaryTwentyTwoThousandSixteenMember_lbl" xml:lang="en-US">January 20, 2016 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CreationDateAxis" xlink:label="us-gaap_CreationDateAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CreationDateAxis" xlink:to="us-gaap_CreationDateAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CreationDateAxis_lbl" xml:lang="en-US">Report Date [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_JanuaryTwentyTwoThousandSeventeenMember" xlink:label="SNYR_JanuaryTwentyTwoThousandSeventeenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_JanuaryTwentyTwoThousandSeventeenMember" xlink:to="SNYR_JanuaryTwentyTwoThousandSeventeenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_JanuaryTwentyTwoThousandSeventeenMember_lbl" xml:lang="en-US">January 20, 2017 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_KnightTherapeuticsBarbadosIncMember" xlink:label="SNYR_KnightTherapeuticsBarbadosIncMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_KnightTherapeuticsBarbadosIncMember" xlink:to="SNYR_KnightTherapeuticsBarbadosIncMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_KnightTherapeuticsBarbadosIncMember_lbl" xml:lang="en-US">Knight [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_FactorNutritionLabsLLCMember" xlink:label="SNYR_FactorNutritionLabsLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_FactorNutritionLabsLLCMember" xlink:to="SNYR_FactorNutritionLabsLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_FactorNutritionLabsLLCMember_lbl" xml:lang="en-US">Factor Nutrition Labs, LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_STWarrantMember" xlink:label="SNYR_STWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_STWarrantMember" xlink:to="SNYR_STWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_STWarrantMember_lbl" xml:lang="en-US">ST Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_KnightTherapeuticsIncMember" xlink:label="SNYR_KnightTherapeuticsIncMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_KnightTherapeuticsIncMember" xlink:to="SNYR_KnightTherapeuticsIncMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_KnightTherapeuticsIncMember_lbl" xml:lang="en-US">Knight Therapeutics Inc [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_JuneThirtyTwoThousandSixteenMember" xlink:label="SNYR_JuneThirtyTwoThousandSixteenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_JuneThirtyTwoThousandSixteenMember" xlink:to="SNYR_JuneThirtyTwoThousandSixteenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_JuneThirtyTwoThousandSixteenMember_lbl" xml:lang="en-US">June 30, 2016 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_SeptemberThirtyTwoThousandFifteenMember" xlink:label="SNYR_SeptemberThirtyTwoThousandFifteenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_SeptemberThirtyTwoThousandFifteenMember" xlink:to="SNYR_SeptemberThirtyTwoThousandFifteenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_SeptemberThirtyTwoThousandFifteenMember_lbl" xml:lang="en-US">September 30, 2015 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_USMember" xlink:label="SNYR_USMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_USMember" xlink:to="SNYR_USMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_USMember_lbl" xml:lang="en-US">U.S [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="us-gaap_StatementGeographicalAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementGeographicalAxis" xlink:to="us-gaap_StatementGeographicalAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementGeographicalAxis_lbl" xml:lang="en-US">Geographical [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ClosingDateMember" xlink:label="SNYR_ClosingDateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_ClosingDateMember" xlink:to="SNYR_ClosingDateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_ClosingDateMember_lbl" xml:lang="en-US">Closing Date [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ContributionAgreementMember" xlink:label="SNYR_ContributionAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_ContributionAgreementMember" xlink:to="SNYR_ContributionAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_ContributionAgreementMember_lbl" xml:lang="en-US">Contribution Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_HandMDCorpMember" xlink:label="SNYR_HandMDCorpMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_HandMDCorpMember" xlink:to="SNYR_HandMDCorpMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_HandMDCorpMember_lbl" xml:lang="en-US">Hand Md Corp [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Legal Entity [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_LicenseAgreementMember" xlink:label="SNYR_LicenseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_LicenseAgreementMember" xlink:to="SNYR_LicenseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_LicenseAgreementMember_lbl" xml:lang="en-US">License Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ConsultingAgreementMember" xlink:label="SNYR_ConsultingAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_ConsultingAgreementMember" xlink:to="SNYR_ConsultingAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_ConsultingAgreementMember_lbl" xml:lang="en-US">Consulting Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_HandMDLLCMember" xlink:label="SNYR_HandMDLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_HandMDLLCMember" xlink:to="SNYR_HandMDLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_HandMDLLCMember_lbl" xml:lang="en-US">Hand MD LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AdditionalPaidInCapitalMember_2_lbl" xml:lang="en-US">Additional Paid in Capital [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_CommonStockToBeIssuedMember" xlink:to="SNYR_CommonStockToBeIssuedMember_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SNYR_CommonStockToBeIssuedMember_2_lbl" xml:lang="en-US">Common Stock to be Issued [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_SecurityAgreementMember" xlink:label="SNYR_SecurityAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_SecurityAgreementMember" xlink:to="SNYR_SecurityAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_SecurityAgreementMember_lbl" xml:lang="en-US">Security Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_SecondYearMember" xlink:label="SNYR_SecondYearMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_SecondYearMember" xlink:to="SNYR_SecondYearMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_SecondYearMember_lbl" xml:lang="en-US">Second Year [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ThiredYearMember" xlink:label="SNYR_ThiredYearMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_ThiredYearMember" xlink:to="SNYR_ThiredYearMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_ThiredYearMember_lbl" xml:lang="en-US">Thired Year [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BreakthroughProductsIncMember" xlink:label="SNYR_BreakthroughProductsIncMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BreakthroughProductsIncMember" xlink:to="SNYR_BreakthroughProductsIncMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_BreakthroughProductsIncMember_lbl" xml:lang="en-US">Breakthrough Products, Inc [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_StockPurchaseAgreementMember" xlink:label="SNYR_StockPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_StockPurchaseAgreementMember" xlink:to="SNYR_StockPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_StockPurchaseAgreementMember_lbl" xml:lang="en-US">Stock Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_SettlementAgreementMember" xlink:label="SNYR_SettlementAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_SettlementAgreementMember" xlink:to="SNYR_SettlementAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_SettlementAgreementMember_lbl" xml:lang="en-US">Settlement Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_NoncompeteProvisionMember" xlink:label="SNYR_NoncompeteProvisionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_NoncompeteProvisionMember" xlink:to="SNYR_NoncompeteProvisionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_NoncompeteProvisionMember_lbl" xml:lang="en-US">Non-compete Provision [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_UrgentRxSellersMember" xlink:label="SNYR_UrgentRxSellersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_UrgentRxSellersMember" xlink:to="SNYR_UrgentRxSellersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_UrgentRxSellersMember_lbl" xml:lang="en-US">UrgentRx Sellers [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_TprInvestmentsPtyLtdMember" xlink:label="SNYR_TprInvestmentsPtyLtdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_TprInvestmentsPtyLtdMember" xlink:to="SNYR_TprInvestmentsPtyLtdMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_TprInvestmentsPtyLtdMember_lbl" xml:lang="en-US">TPR Investments Pty Ltd [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_AustralianDollerMember" xlink:label="SNYR_AustralianDollerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_AustralianDollerMember" xlink:to="SNYR_AustralianDollerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_AustralianDollerMember_lbl" xml:lang="en-US">AUD [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CurrencyAxis" xlink:label="us-gaap_CurrencyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrencyAxis" xlink:to="us-gaap_CurrencyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrencyAxis_lbl" xml:lang="en-US">Currency [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_JanuaryTwentyTwoTwoThousandFifteenMember" xlink:label="SNYR_JanuaryTwentyTwoTwoThousandFifteenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_JanuaryTwentyTwoTwoThousandFifteenMember" xlink:to="SNYR_JanuaryTwentyTwoTwoThousandFifteenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_JanuaryTwentyTwoTwoThousandFifteenMember_lbl" xml:lang="en-US">January 22, 2015 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_JanuaryTwentyTwoThousandSaventeenMember" xlink:label="SNYR_JanuaryTwentyTwoThousandSaventeenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_JanuaryTwentyTwoThousandSaventeenMember" xlink:to="SNYR_JanuaryTwentyTwoThousandSaventeenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SNYR_JanuaryTwentyTwoThousandSaventeenMember_lbl" xml:lang="en-US">January 20, 2017 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_UrgentRxMember" xlink:label="SNYR_UrgentRxMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_UrgentRxMember" xlink:to="SNYR_UrgentRxMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_UrgentRxMember_lbl" xml:lang="en-US">UrgentRx [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_NomadChoiceMember" xlink:label="SNYR_NomadChoiceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_NomadChoiceMember" xlink:to="SNYR_NomadChoiceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_NomadChoiceMember_lbl" xml:lang="en-US">Nomad Choice [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="us-gaap_CustomerConcentrationRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerConcentrationRiskMember" xlink:to="us-gaap_CustomerConcentrationRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerConcentrationRiskMember_lbl" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="us-gaap_ConcentrationRiskByTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByTypeAxis" xlink:to="us-gaap_ConcentrationRiskByTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByTypeAxis_lbl" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableMember_lbl" xml:lang="en-US">Accounts Receivable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskByBenchmarkAxis_lbl" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="us-gaap_SalesRevenueNetMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNetMember" xlink:to="us-gaap_SalesRevenueNetMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNetMember_lbl" xml:lang="en-US">Sales Revenue, Net [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_SuppliersOneMember" xlink:label="SNYR_SuppliersOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_SuppliersOneMember" xlink:to="SNYR_SuppliersOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_SuppliersOneMember_lbl" xml:lang="en-US">Suppliers One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_SuppliersTwoMember" xlink:label="SNYR_SuppliersTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_SuppliersTwoMember" xlink:to="SNYR_SuppliersTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_SuppliersTwoMember_lbl" xml:lang="en-US">Suppliers Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_SuppliersThreeMember" xlink:label="SNYR_SuppliersThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_SuppliersThreeMember" xlink:to="SNYR_SuppliersThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_SuppliersThreeMember_lbl" xml:lang="en-US">Suppliers Three [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_SuppliersFourMember" xlink:label="SNYR_SuppliersFourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_SuppliersFourMember" xlink:to="SNYR_SuppliersFourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_SuppliersFourMember_lbl" xml:lang="en-US">Suppliers Four [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_LoanAgreementMember" xlink:label="SNYR_LoanAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_LoanAgreementMember" xlink:to="SNYR_LoanAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_LoanAgreementMember_lbl" xml:lang="en-US">Loan Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_MsHarshbargerMember" xlink:label="SNYR_MsHarshbargerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_MsHarshbargerMember" xlink:to="SNYR_MsHarshbargerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_MsHarshbargerMember_lbl" xml:lang="en-US">Ms. Harshbarger [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_RoyaltyDistributionAgreementMember" xlink:label="SNYR_RoyaltyDistributionAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_RoyaltyDistributionAgreementMember" xlink:to="SNYR_RoyaltyDistributionAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_RoyaltyDistributionAgreementMember_lbl" xml:lang="en-US">Royalty Distribution Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_OriginationFeeMember" xlink:label="SNYR_OriginationFeeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_OriginationFeeMember" xlink:to="SNYR_OriginationFeeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_OriginationFeeMember_lbl" xml:lang="en-US">Origination Fee [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NatureOfExpenseAxis" xlink:label="us-gaap_NatureOfExpenseAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NatureOfExpenseAxis" xlink:to="us-gaap_NatureOfExpenseAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NatureOfExpenseAxis_lbl" xml:lang="en-US">Nature of Expense [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_WorkFeeMember" xlink:label="SNYR_WorkFeeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_WorkFeeMember" xlink:to="SNYR_WorkFeeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_WorkFeeMember_lbl" xml:lang="en-US">Work Fee [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_JanuaryTwentyTwoThousandFifteenLoanOneMember" xlink:label="SNYR_JanuaryTwentyTwoThousandFifteenLoanOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_JanuaryTwentyTwoThousandFifteenLoanOneMember" xlink:to="SNYR_JanuaryTwentyTwoThousandFifteenLoanOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_JanuaryTwentyTwoThousandFifteenLoanOneMember_lbl" xml:lang="en-US">January 22, 2015 Loan One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_STWarrantMember" xlink:to="SNYR_STWarrantMember_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SNYR_STWarrantMember_2_lbl" xml:lang="en-US">StWarrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_AssetPurchaseAgreementMember" xlink:label="SNYR_AssetPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_AssetPurchaseAgreementMember" xlink:to="SNYR_AssetPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_AssetPurchaseAgreementMember_lbl" xml:lang="en-US">Asset Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_JanuaryTwentyTwoTwoThousandFifteenLoanTwoMember" xlink:label="SNYR_JanuaryTwentyTwoTwoThousandFifteenLoanTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_JanuaryTwentyTwoTwoThousandFifteenLoanTwoMember" xlink:to="SNYR_JanuaryTwentyTwoTwoThousandFifteenLoanTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_JanuaryTwentyTwoTwoThousandFifteenLoanTwoMember_lbl" xml:lang="en-US">January 22, 2015 Loan Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_JuneTwentySixTwoThousandFifteenMember" xlink:label="SNYR_JuneTwentySixTwoThousandFifteenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_JuneTwentySixTwoThousandFifteenMember" xlink:to="SNYR_JuneTwentySixTwoThousandFifteenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_JuneTwentySixTwoThousandFifteenMember_lbl" xml:lang="en-US">June 26, 2015 Security Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_NeuragenCorpMember" xlink:label="SNYR_NeuragenCorpMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_NeuragenCorpMember" xlink:to="SNYR_NeuragenCorpMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_NeuragenCorpMember_lbl" xml:lang="en-US">Neuragen Corp [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_QuarterEndingSeptemberThirtyTwoThousandSaventeenMember" xlink:label="SNYR_QuarterEndingSeptemberThirtyTwoThousandSaventeenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_QuarterEndingSeptemberThirtyTwoThousandSaventeenMember" xlink:to="SNYR_QuarterEndingSeptemberThirtyTwoThousandSaventeenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_QuarterEndingSeptemberThirtyTwoThousandSaventeenMember_lbl" xml:lang="en-US">Quarter Ending September 30, 2015 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_KnightWarrantsMember" xlink:label="SNYR_KnightWarrantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_KnightWarrantsMember" xlink:to="SNYR_KnightWarrantsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_KnightWarrantsMember_lbl" xml:lang="en-US">Knight Warrants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_KnightWarrantsOneMember" xlink:label="SNYR_KnightWarrantsOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_KnightWarrantsOneMember" xlink:to="SNYR_KnightWarrantsOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_KnightWarrantsOneMember_lbl" xml:lang="en-US">Knight Warrants One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_NoteHolderMember" xlink:label="SNYR_NoteHolderMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_NoteHolderMember" xlink:to="SNYR_NoteHolderMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_NoteHolderMember_lbl" xml:lang="en-US">Note Holder [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableMember" xlink:label="us-gaap_AccountsPayableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableMember" xlink:to="us-gaap_AccountsPayableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableMember_lbl" xml:lang="en-US">Accounts Payable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_NovemberTwoThousandSixteenMember" xlink:label="SNYR_NovemberTwoThousandSixteenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_NovemberTwoThousandSixteenMember" xlink:to="SNYR_NovemberTwoThousandSixteenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_NovemberTwoThousandSixteenMember_lbl" xml:lang="en-US">November 2016 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_DecemberTwoThousandSixteenMember" xlink:label="SNYR_DecemberTwoThousandSixteenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_DecemberTwoThousandSixteenMember" xlink:to="SNYR_DecemberTwoThousandSixteenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_DecemberTwoThousandSixteenMember_lbl" xml:lang="en-US">December 2016 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_SubsidiaryMember" xlink:label="SNYR_SubsidiaryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_SubsidiaryMember" xlink:to="SNYR_SubsidiaryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_SubsidiaryMember_lbl" xml:lang="en-US">Subsidiary [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_TwoBoardMembersMember" xlink:label="SNYR_TwoBoardMembersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_TwoBoardMembersMember" xlink:to="SNYR_TwoBoardMembersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_TwoBoardMembersMember_lbl" xml:lang="en-US">Two Board Members [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_TwoEmployeeMembersMember" xlink:label="SNYR_TwoEmployeeMembersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_TwoEmployeeMembersMember" xlink:to="SNYR_TwoEmployeeMembersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_TwoEmployeeMembersMember_lbl" xml:lang="en-US">Two Employees Members [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ExercisePriceRangeOneMember" xlink:label="SNYR_ExercisePriceRangeOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_ExercisePriceRangeOneMember" xlink:to="SNYR_ExercisePriceRangeOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_ExercisePriceRangeOneMember_lbl" xml:lang="en-US">Exercise Price Range One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ExercisePriceRangeTwoMember" xlink:label="SNYR_ExercisePriceRangeTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_ExercisePriceRangeTwoMember" xlink:to="SNYR_ExercisePriceRangeTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_ExercisePriceRangeTwoMember_lbl" xml:lang="en-US">Exercise Price Range Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ExercisePriceRangeThreeMember" xlink:label="SNYR_ExercisePriceRangeThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_ExercisePriceRangeThreeMember" xlink:to="SNYR_ExercisePriceRangeThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_ExercisePriceRangeThreeMember_lbl" xml:lang="en-US">Exercise Price Range Three [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_UnitedStatesMember" xlink:label="SNYR_UnitedStatesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_UnitedStatesMember" xlink:to="SNYR_UnitedStatesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_UnitedStatesMember_lbl" xml:lang="en-US">United States [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ForeignCountriesMember" xlink:label="SNYR_ForeignCountriesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_ForeignCountriesMember" xlink:to="SNYR_ForeignCountriesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_ForeignCountriesMember_lbl" xml:lang="en-US">Foreign Countries [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_FlatTummyTeaMember" xlink:label="SNYR_FlatTummyTeaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_FlatTummyTeaMember" xlink:to="SNYR_FlatTummyTeaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_FlatTummyTeaMember_lbl" xml:lang="en-US">Flat Tummy Tea [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_OtherMember" xlink:label="SNYR_OtherMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_OtherMember" xlink:to="SNYR_OtherMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_OtherMember_lbl" xml:lang="en-US">Other [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DomesticCountryMember_lbl" xml:lang="en-US">US Tax Authority [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_DocumentAndEntityInformationAbstract" xlink:label="SNYR_DocumentAndEntityInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_DocumentAndEntityInformationAbstract" xlink:to="SNYR_DocumentAndEntityInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_DocumentAndEntityInformationAbstract_lbl" xml:lang="en-US">Document And Entity Information [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filer</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents" xlink:label="us-gaap_RestrictedCashAndCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashAndCashEquivalents" xlink:to="us-gaap_RestrictedCashAndCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedCashAndCashEquivalents_lbl" xml:lang="en-US">Restricted cash</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts Receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DueFromRelatedPartiesCurrent" xlink:label="us-gaap_DueFromRelatedPartiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueFromRelatedPartiesCurrent" xlink:to="us-gaap_DueFromRelatedPartiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueFromRelatedPartiesCurrent_lbl" xml:lang="en-US">Note receivable from related party</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xml:lang="en-US">Prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Fixed assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Goodwill_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">Intangible assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense" xlink:label="us-gaap_UnamortizedDebtIssuanceExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnamortizedDebtIssuanceExpense" xlink:to="us-gaap_UnamortizedDebtIssuanceExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UnamortizedDebtIssuanceExpense_lbl" xml:lang="en-US">Debt issuance cost, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">Liabilities and Stockholders&#8217; Equity (Deficit)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current Liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TaxesPayableCurrent" xlink:label="us-gaap_TaxesPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxesPayableCurrent" xlink:to="us-gaap_TaxesPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TaxesPayableCurrent_lbl" xml:lang="en-US">Provision for income taxes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US">Earn out payment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_lbl" xml:lang="en-US">Current portion of long-term debt, net of debt discount, related party</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xml:lang="en-US">Current portion of long-term debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="us-gaap_DerivativeLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilitiesCurrent" xlink:to="us-gaap_DerivativeLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeLiabilitiesCurrent_lbl" xml:lang="en-US">Warrant derivative liability</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xml:lang="en-US">Long-term Liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NotesPayable" xlink:label="us-gaap_NotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayable_lbl" xml:lang="en-US">Note payable</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_RoyaltyPayable" xlink:label="SNYR_RoyaltyPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_RoyaltyPayable" xlink:to="SNYR_RoyaltyPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_RoyaltyPayable_lbl" xml:lang="en-US">Royalty payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:label="us-gaap_LongTermNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermNotesPayable" xlink:to="us-gaap_LongTermNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermNotesPayable_lbl" xml:lang="en-US">Notes payable, net of debt discount, related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xml:lang="en-US">Total long-term liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US">Commitments and contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders&#8217; Equity (Deficit):</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, $0.00001 par value; 300,000,000 and 75,000,000 shares authorized, respectively; 81,692,954 and 62,100,000, shares issued and outstanding, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:label="us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:to="us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable_lbl" xml:lang="en-US">Common stock to be issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total stockholders&#8217; equity (deficit)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total Liabilities and Stockholders&#8217; Equity (Deficit)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CostOfGoodsSold" xlink:label="us-gaap_CostOfGoodsSold" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsSold" xlink:to="us-gaap_CostOfGoodsSold_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsSold_lbl" xml:lang="en-US">Cost of Sales</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">Gross Profit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="us-gaap_SellingAndMarketingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpense" xlink:to="us-gaap_SellingAndMarketingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingAndMarketingExpense_lbl" xml:lang="en-US">Selling and marketing</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="us-gaap_DepreciationAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationAndAmortization" xlink:to="us-gaap_DepreciationAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Income (loss) from operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="us-gaap_OtherIncomeAndExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherIncomeAndExpensesAbstract_lbl" xml:lang="en-US">Other income (expenses)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="us-gaap_InterestIncomeExpenseNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeExpenseNet" xlink:to="us-gaap_InterestIncomeExpenseNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestIncomeExpenseNet_lbl" xml:lang="en-US">Interest income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainBeforeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainBeforeTax" xlink:to="us-gaap_ForeignCurrencyTransactionGainBeforeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionGainBeforeTax_lbl" xml:lang="en-US">Remeasurement gain on translation of foreign subsidiary</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:label="us-gaap_GainLossOnDerivativeInstrumentsNetPretax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:to="us-gaap_GainLossOnDerivativeInstrumentsNetPretax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnDerivativeInstrumentsNetPretax_lbl" xml:lang="en-US">Loss on change in fair value of derivative liability</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestmentIncomeAmortizationOfDiscount" xlink:label="us-gaap_InvestmentIncomeAmortizationOfDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeAmortizationOfDiscount" xlink:to="us-gaap_InvestmentIncomeAmortizationOfDiscount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeAmortizationOfDiscount_lbl" xml:lang="en-US">Amortization of debt discount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" xlink:label="us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" xlink:to="us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts_lbl" xml:lang="en-US">Amortization of debt issuance cost</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestExpenseOther" xlink:label="us-gaap_InterestExpenseOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseOther" xlink:to="us-gaap_InterestExpenseOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpenseOther_lbl" xml:lang="en-US">Imputed and other interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US">Total other expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Net loss before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Income tax expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss after tax</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US">Net loss per share - basic and diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US">Weighted average common shares - basic and diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue_lbl" xml:lang="en-US">Cancellation of Oro Corporation shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xml:lang="en-US">Cancellation of Oro Corporation shares, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Common stock issued to Synergy shareholders</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Common stock issued to Synergy shareholders, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CommonStockIssuedForCash" xlink:label="SNYR_CommonStockIssuedForCash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_CommonStockIssuedForCash" xlink:to="SNYR_CommonStockIssuedForCash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_CommonStockIssuedForCash_lbl" xml:lang="en-US">Common stock issued for cash</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CommonStockIssuedForCashShares" xlink:label="SNYR_CommonStockIssuedForCashShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_CommonStockIssuedForCashShares" xlink:to="SNYR_CommonStockIssuedForCashShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_CommonStockIssuedForCashShares_lbl" xml:lang="en-US">Common stock issued for cash, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptions" xlink:label="SNYR_AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptions" xlink:to="SNYR_AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptions_lbl" xml:lang="en-US">Fair value of vested stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xml:lang="en-US">Common stock to be issued for services</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CommonStockIssuedAsPartOfContributionAgreement" xlink:label="SNYR_CommonStockIssuedAsPartOfContributionAgreement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_CommonStockIssuedAsPartOfContributionAgreement" xlink:to="SNYR_CommonStockIssuedAsPartOfContributionAgreement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_CommonStockIssuedAsPartOfContributionAgreement_lbl" xml:lang="en-US">Common stock issued as part of the Contribution Agreement with Hand MD</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CommonStockIssuedAsPartOfContributionAgreementShares" xlink:label="SNYR_CommonStockIssuedAsPartOfContributionAgreementShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_CommonStockIssuedAsPartOfContributionAgreementShares" xlink:to="SNYR_CommonStockIssuedAsPartOfContributionAgreementShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_CommonStockIssuedAsPartOfContributionAgreementShares_lbl" xml:lang="en-US">Common stock issued as part of the Contribution Agreement with Hand MD, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CommonStockIssuedForAcquisitions" xlink:label="SNYR_CommonStockIssuedForAcquisitions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_CommonStockIssuedForAcquisitions" xlink:to="SNYR_CommonStockIssuedForAcquisitions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_CommonStockIssuedForAcquisitions_lbl" xml:lang="en-US">Common stock issued for acquisitions of Breakthrough Products, Inc.</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CommonStockIssuedForAcquisitionsShares" xlink:label="SNYR_CommonStockIssuedForAcquisitionsShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_CommonStockIssuedForAcquisitionsShares" xlink:to="SNYR_CommonStockIssuedForAcquisitionsShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_CommonStockIssuedForAcquisitionsShares_lbl" xml:lang="en-US">Common stock issued for acquisitions of Breakthrough Products, Inc., shares</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CommonStockIssuedForAcquisitionsOne" xlink:label="SNYR_CommonStockIssuedForAcquisitionsOne" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_CommonStockIssuedForAcquisitionsOne" xlink:to="SNYR_CommonStockIssuedForAcquisitionsOne_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_CommonStockIssuedForAcquisitionsOne_lbl" xml:lang="en-US">Common stock issued for acquisitions of NomadChoice Pty Ltd.</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CommonStockIssuedForAcquisitionsOneShares" xlink:label="SNYR_CommonStockIssuedForAcquisitionsOneShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_CommonStockIssuedForAcquisitionsOneShares" xlink:to="SNYR_CommonStockIssuedForAcquisitionsOneShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_CommonStockIssuedForAcquisitionsOneShares_lbl" xml:lang="en-US">Common stock issued for acquisitions of NomadChoice Pty Ltd., shares</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CommonStockIssuedToSettleAccountsPayable" xlink:label="SNYR_CommonStockIssuedToSettleAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_CommonStockIssuedToSettleAccountsPayable" xlink:to="SNYR_CommonStockIssuedToSettleAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_CommonStockIssuedToSettleAccountsPayable_lbl" xml:lang="en-US">Common stock issued to settle accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CommonStockIssuedToSettleAccountsPayableShares" xlink:label="SNYR_CommonStockIssuedToSettleAccountsPayableShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_CommonStockIssuedToSettleAccountsPayableShares" xlink:to="SNYR_CommonStockIssuedToSettleAccountsPayableShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_CommonStockIssuedToSettleAccountsPayableShares_lbl" xml:lang="en-US">Common stock issued to settle accounts payable, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Common stock issued for conversion of notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Common stock issued for conversion of notes payable, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueOther" xlink:to="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueOther_lbl" xml:lang="en-US">Common stock issued for exercise of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xml:lang="en-US">Common stock issued for exercise of warrants, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="us-gaap_FairValueAdjustmentOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAdjustmentOfWarrants" xlink:to="us-gaap_FairValueAdjustmentOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAdjustmentOfWarrants_lbl" xml:lang="en-US">Fair value of warrants issued along with notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xml:lang="en-US">Fair value of vested stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueAcquisitions_lbl" xml:lang="en-US">Fair value of warrants issued to Breakthrough Products, Inc. as part of acquisition</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Operating Activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfFinancingCostsAndDiscounts_lbl" xml:lang="en-US">Amortization of debt issuance cost</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US">Stock based compensation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_GainsLossesOnAcquisition" xlink:label="SNYR_GainsLossesOnAcquisition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_GainsLossesOnAcquisition" xlink:to="SNYR_GainsLossesOnAcquisition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_GainsLossesOnAcquisition_lbl" xml:lang="en-US">Loss on acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xml:lang="en-US">Amortization of debt discount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xml:lang="en-US">Foreign currency transaction loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:to="us-gaap_GainLossOnDerivativeInstrumentsNetPretax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GainLossOnDerivativeInstrumentsNetPretax_2_lbl" xml:lang="en-US">Fair value of derivative loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="us-gaap_ProvisionForDoubtfulAccounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProvisionForDoubtfulAccounts" xlink:to="us-gaap_ProvisionForDoubtfulAccounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_lbl" xml:lang="en-US">Bad debts</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xml:lang="en-US">Prepaid expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Investing Activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Payments for acquisition of fixed assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseInRestrictedCash" xlink:label="us-gaap_IncreaseInRestrictedCash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseInRestrictedCash" xlink:to="us-gaap_IncreaseInRestrictedCash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseInRestrictedCash_lbl" xml:lang="en-US">Restricted cash</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:label="us-gaap_PaymentsForProceedsFromOtherInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="us-gaap_PaymentsForProceedsFromOtherInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsForProceedsFromOtherInvestingActivities_lbl" xml:lang="en-US">Payments for acquisition of Focus Factor</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross_lbl" xml:lang="en-US">Payments for acquisition transaction with Knight Therapeutics Inc.</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherPaymentsToAcquireBusinesses" xlink:label="us-gaap_OtherPaymentsToAcquireBusinesses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherPaymentsToAcquireBusinesses" xlink:to="us-gaap_OtherPaymentsToAcquireBusinesses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherPaymentsToAcquireBusinesses_lbl" xml:lang="en-US">Payments for acquisition of NomadChoice Pty Ltd</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="us-gaap_CashAcquiredFromAcquisition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAcquiredFromAcquisition" xlink:to="us-gaap_CashAcquiredFromAcquisition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAcquiredFromAcquisition_lbl" xml:lang="en-US">Cash acquired in acquisitions</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Financing Activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_lbl" xml:lang="en-US">(Repayments to) advances from related party notes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="us-gaap_ProceedsFromNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromNotesPayable" xlink:to="us-gaap_ProceedsFromNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromNotesPayable_lbl" xml:lang="en-US">Proceeds from notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xml:lang="en-US">Repayment of notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts_lbl" xml:lang="en-US">Payment of debt issuance cost</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsOfDividends" xlink:label="us-gaap_PaymentsOfDividends" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividends" xlink:to="us-gaap_PaymentsOfDividends_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfDividends_lbl" xml:lang="en-US">Dividends paid</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities" xlink:label="us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities" xlink:to="us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities_lbl" xml:lang="en-US">Proceeds from exercise of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Proceeds from issuance of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xml:lang="en-US">Net increase (decrease) in cash and cash equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_2_lbl" xml:lang="en-US">Cash and Cash Equivalents, beginning of period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_3_lbl" xml:lang="en-US">Cash and Cash Equivalents, end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental Disclosure of Cash Flow Information:</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CashPaidDuringPeriodAbstract" xlink:label="SNYR_CashPaidDuringPeriodAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_CashPaidDuringPeriodAbstract" xlink:to="SNYR_CashPaidDuringPeriodAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_CashPaidDuringPeriodAbstract_lbl" xml:lang="en-US">Cash paid during the period for:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestPaid" xlink:label="us-gaap_InterestPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaid" xlink:to="us-gaap_InterestPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaid_lbl" xml:lang="en-US">Interest</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="us-gaap_IncomeTaxesPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xml:lang="en-US">Income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xml:lang="en-US">Supplemental Disclosure of Non-cash Investing and Financing Activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CommonStockIssuedForConversionOfNotesPayable" xlink:label="SNYR_CommonStockIssuedForConversionOfNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_CommonStockIssuedForConversionOfNotesPayable" xlink:to="SNYR_CommonStockIssuedForConversionOfNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SNYR_CommonStockIssuedForConversionOfNotesPayable_lbl" xml:lang="en-US">Common stock issued for conversion of notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xml:lang="en-US">Beneficial conversion feature on warrants issued concurrent with debt</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_DerivativeLiabilityAtInception" xlink:label="SNYR_DerivativeLiabilityAtInception" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_DerivativeLiabilityAtInception" xlink:to="SNYR_DerivativeLiabilityAtInception_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_DerivativeLiabilityAtInception_lbl" xml:lang="en-US">Derivative liability at inception</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_AssumptionOfLiabilitiesAsPartOfAssetPurchaseAgreement" xlink:label="SNYR_AssumptionOfLiabilitiesAsPartOfAssetPurchaseAgreement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_AssumptionOfLiabilitiesAsPartOfAssetPurchaseAgreement" xlink:to="SNYR_AssumptionOfLiabilitiesAsPartOfAssetPurchaseAgreement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_AssumptionOfLiabilitiesAsPartOfAssetPurchaseAgreement_lbl" xml:lang="en-US">Assumption of liabilities as part of asset purchase agreement with Factor Nutrition Labs, LLC</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_LiabilitiesAssumedRelatedParty" xlink:label="SNYR_LiabilitiesAssumedRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_LiabilitiesAssumedRelatedParty" xlink:to="SNYR_LiabilitiesAssumedRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_LiabilitiesAssumedRelatedParty_lbl" xml:lang="en-US">Assumption of liabilities as part of acquisition transaction with Knight Therapeutics Inc.</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_NoteIssuedAsPartOfAssetPurchaseAgreement" xlink:label="SNYR_NoteIssuedAsPartOfAssetPurchaseAgreement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_NoteIssuedAsPartOfAssetPurchaseAgreement" xlink:to="SNYR_NoteIssuedAsPartOfAssetPurchaseAgreement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_NoteIssuedAsPartOfAssetPurchaseAgreement_lbl" xml:lang="en-US">Note issued as part of asset purchase agreement with Factor Nutrition Labs, LLC</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_CommonStockIssuedAsPartOfContributionAgreement" xlink:to="SNYR_CommonStockIssuedAsPartOfContributionAgreement_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SNYR_CommonStockIssuedAsPartOfContributionAgreement_2_lbl" xml:lang="en-US">Common stock issued as part of contribution agreement with Hand MD</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CommonStockIssuedForAcquisitionOne" xlink:label="SNYR_CommonStockIssuedForAcquisitionOne" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_CommonStockIssuedForAcquisitionOne" xlink:to="SNYR_CommonStockIssuedForAcquisitionOne_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_CommonStockIssuedForAcquisitionOne_lbl" xml:lang="en-US">Common stock issued for the acquisition of Breakthrough Products, Inc.</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CommonStockIssuedForAcquisition" xlink:label="SNYR_CommonStockIssuedForAcquisition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_CommonStockIssuedForAcquisition" xlink:to="SNYR_CommonStockIssuedForAcquisition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_CommonStockIssuedForAcquisition_lbl" xml:lang="en-US">Common stock issued for the acquisition of NomadChoice Pty Ltd.</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_FairValueOfWarrantsIssuedAsPartOfAcquisition" xlink:label="SNYR_FairValueOfWarrantsIssuedAsPartOfAcquisition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_FairValueOfWarrantsIssuedAsPartOfAcquisition" xlink:to="SNYR_FairValueOfWarrantsIssuedAsPartOfAcquisition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_FairValueOfWarrantsIssuedAsPartOfAcquisition_lbl" xml:lang="en-US">Fair value of warrants issued as part of acquisition of Breakthrough Products, Inc.</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_NetLiabilitiesTakenOverAsPartOfAcquisition" xlink:label="SNYR_NetLiabilitiesTakenOverAsPartOfAcquisition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_NetLiabilitiesTakenOverAsPartOfAcquisition" xlink:to="SNYR_NetLiabilitiesTakenOverAsPartOfAcquisition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_NetLiabilitiesTakenOverAsPartOfAcquisition_lbl" xml:lang="en-US">Net liabilities taken over as part of acquisition of Breakthrough Products, Inc.</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_NetAssetsTakenOverAsPartOfAcquisition" xlink:label="SNYR_NetAssetsTakenOverAsPartOfAcquisition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_NetAssetsTakenOverAsPartOfAcquisition" xlink:to="SNYR_NetAssetsTakenOverAsPartOfAcquisition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_NetAssetsTakenOverAsPartOfAcquisition_lbl" xml:lang="en-US">Net assets taken over as part of acquisition of NomadChoice Pty Ltd.</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConversionOfStockAmountConverted1" xlink:label="us-gaap_ConversionOfStockAmountConverted1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockAmountConverted1" xlink:to="us-gaap_ConversionOfStockAmountConverted1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockAmountConverted1_lbl" xml:lang="en-US">Common stock issued to settle payables</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CancellationOfCommonStockAsPartOfPurchaseTransaction" xlink:label="SNYR_CancellationOfCommonStockAsPartOfPurchaseTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_CancellationOfCommonStockAsPartOfPurchaseTransaction" xlink:to="SNYR_CancellationOfCommonStockAsPartOfPurchaseTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_CancellationOfCommonStockAsPartOfPurchaseTransaction_lbl" xml:lang="en-US">Cancellation of common stock as part of purchase transaction</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_FinancingForPrepaidInsurance" xlink:label="SNYR_FinancingForPrepaidInsurance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_FinancingForPrepaidInsurance" xlink:to="SNYR_FinancingForPrepaidInsurance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_FinancingForPrepaidInsurance_lbl" xml:lang="en-US">Financing for prepaid insurance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAssumed1" xlink:label="us-gaap_LiabilitiesAssumed1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAssumed1" xlink:to="us-gaap_LiabilitiesAssumed1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAssumed1_lbl" xml:lang="en-US">Assumption of liabilities as part of acquisition transaction</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_IssuanceOfSharesAsPartOfAcquisitionTransaction" xlink:label="SNYR_IssuanceOfSharesAsPartOfAcquisitionTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_IssuanceOfSharesAsPartOfAcquisitionTransaction" xlink:to="SNYR_IssuanceOfSharesAsPartOfAcquisitionTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_IssuanceOfSharesAsPartOfAcquisitionTransaction_lbl" xml:lang="en-US">Issuance of shares as part of acquisition transaction</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="us-gaap_NatureOfOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NatureOfOperations" xlink:to="us-gaap_NatureOfOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NatureOfOperations_lbl" xml:lang="en-US">Nature of the Business</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="us-gaap_BusinessCombinationsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationsAbstract" xlink:to="us-gaap_BusinessCombinationsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationsAbstract_lbl" xml:lang="en-US">Business Combinations [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xml:lang="en-US">Acquisitions</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ReceivablesAbstract" xlink:label="us-gaap_ReceivablesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesAbstract" xlink:to="us-gaap_ReceivablesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReceivablesAbstract_lbl" xml:lang="en-US">Receivables [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FinancingReceivablesTextBlock" xlink:label="us-gaap_FinancingReceivablesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancingReceivablesTextBlock" xlink:to="us-gaap_FinancingReceivablesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinancingReceivablesTextBlock_lbl" xml:lang="en-US">Accounts Receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsAbstract" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsAbstract_lbl" xml:lang="en-US">Prepaid Expense and Other Assets [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_PrepaidExpensesTextBlock" xlink:label="SNYR_PrepaidExpensesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_PrepaidExpensesTextBlock" xlink:to="SNYR_PrepaidExpensesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_PrepaidExpensesTextBlock_lbl" xml:lang="en-US">Prepaid Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="us-gaap_RisksAndUncertaintiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RisksAndUncertaintiesAbstract" xlink:to="us-gaap_RisksAndUncertaintiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RisksAndUncertaintiesAbstract_lbl" xml:lang="en-US">Risks and Uncertainties [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskDisclosureTextBlock_lbl" xml:lang="en-US">Concentration of Credit Risk</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US">Inventory</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AssetsAbstract_2_lbl" xml:lang="en-US">Assets [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_FixedAssetsAndIntangibleAssetsTextBlock" xlink:label="SNYR_FixedAssetsAndIntangibleAssetsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_FixedAssetsAndIntangibleAssetsTextBlock" xlink:to="SNYR_FixedAssetsAndIntangibleAssetsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_FixedAssetsAndIntangibleAssetsTextBlock_lbl" xml:lang="en-US">Fixed Assets and Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">Related Party Transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US">Accounts Payable and Accrued Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US">Notes Payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">Stockholders' Deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">Commitments and Contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">Stock Options</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_StockWarrantsAbstract" xlink:label="SNYR_StockWarrantsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_StockWarrantsAbstract" xlink:to="SNYR_StockWarrantsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_StockWarrantsAbstract_lbl" xml:lang="en-US">Stock Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_StockWarrantsDisclosureTextBlock" xlink:label="SNYR_StockWarrantsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_StockWarrantsDisclosureTextBlock" xlink:to="SNYR_StockWarrantsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SNYR_StockWarrantsDisclosureTextBlock_lbl" xml:lang="en-US">Stock Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_lbl" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_lbl" xml:lang="en-US">Derivatives</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xml:lang="en-US">Segments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Subsequent Events</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of Presentation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xml:lang="en-US">Capitalization of Fixed Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xml:lang="en-US">Accounts Receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="us-gaap_AdvertisingCostsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdvertisingCostsPolicyTextBlock_lbl" xml:lang="en-US">Advertising Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xml:lang="en-US">Research and Development</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Net Earnings (Loss) Per Common Share</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_GoingConcernPolicyTextBlock" xlink:label="SNYR_GoingConcernPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_GoingConcernPolicyTextBlock" xlink:to="SNYR_GoingConcernPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_GoingConcernPolicyTextBlock_lbl" xml:lang="en-US">Going Concern</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xml:lang="en-US">Fair Value Measurements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Stock-Based Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xml:lang="en-US">Long-lived Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xml:lang="en-US">Foreign Currency Translation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentrations of Credit Risk</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_WarehousingCostsPolicyTextBlock" xlink:label="SNYR_WarehousingCostsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_WarehousingCostsPolicyTextBlock" xlink:to="SNYR_WarehousingCostsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_WarehousingCostsPolicyTextBlock_lbl" xml:lang="en-US">Warehousing costs</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ProductDisplayCostsPolicyTextBlock" xlink:label="SNYR_ProductDisplayCostsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_ProductDisplayCostsPolicyTextBlock" xlink:to="SNYR_ProductDisplayCostsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_ProductDisplayCostsPolicyTextBlock_lbl" xml:lang="en-US">Product display costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="us-gaap_DerivativesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesPolicyTextBlock" xlink:to="us-gaap_DerivativesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativesPolicyTextBlock_lbl" xml:lang="en-US">Warrant Derivative Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock" xlink:label="us-gaap_CostOfSalesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesPolicyTextBlock" xlink:to="us-gaap_CostOfSalesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CostOfSalesPolicyTextBlock_lbl" xml:lang="en-US">Cost of Sales</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtPolicyTextBlock" xlink:label="us-gaap_DebtPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtPolicyTextBlock" xlink:to="us-gaap_DebtPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtPolicyTextBlock_lbl" xml:lang="en-US">Debt Issuance Costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_2_lbl" xml:lang="en-US">Impairment of Long-Lived Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShippingAndHandlingCostPolicyTextBlock" xlink:label="us-gaap_ShippingAndHandlingCostPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShippingAndHandlingCostPolicyTextBlock" xlink:to="us-gaap_ShippingAndHandlingCostPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShippingAndHandlingCostPolicyTextBlock_lbl" xml:lang="en-US">Shipping Costs</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_RelatedPartiesPolicyTextBlock" xlink:label="SNYR_RelatedPartiesPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_RelatedPartiesPolicyTextBlock" xlink:to="SNYR_RelatedPartiesPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_RelatedPartiesPolicyTextBlock_lbl" xml:lang="en-US">Related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Segment Reporting</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiscalPeriod" xlink:label="us-gaap_FiscalPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiscalPeriod" xlink:to="us-gaap_FiscalPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiscalPeriod_lbl" xml:lang="en-US">Change in Fiscal Year End</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">Schedule of Assumptions Used for Fair Value of Warrant Derivative Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xml:lang="en-US">Purchase Price Allocation Assets Acquired and Liabilities Assumed on Estimated Fair Values</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock" xlink:to="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock_lbl" xml:lang="en-US">Purchase Price Allocated to Acquisition of Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="us-gaap_BusinessAcquisitionProFormaInformationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationTextBlock_lbl" xml:lang="en-US">Pro forma Results of Acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xml:lang="en-US">Schedule of Effective Income Tax Rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Deferred Income Tax Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_lbl" xml:lang="en-US">Accounts Receivable, Net of Allowances</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_SummaryOfPrepaidExpensesTableTextBlock" xlink:label="SNYR_SummaryOfPrepaidExpensesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_SummaryOfPrepaidExpensesTableTextBlock" xlink:to="SNYR_SummaryOfPrepaidExpensesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_SummaryOfPrepaidExpensesTableTextBlock_lbl" xml:lang="en-US">Summary of Prepaid Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_SummaryOfMajorSuppliersTableTextBlock" xlink:label="SNYR_SummaryOfMajorSuppliersTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_SummaryOfMajorSuppliersTableTextBlock" xlink:to="SNYR_SummaryOfMajorSuppliersTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_SummaryOfMajorSuppliersTableTextBlock_lbl" xml:lang="en-US">Summary of Major Suppliers</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US">Schedule of Carrying Value of Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_SummaryOfFixedAndIntangibleAssetsTableTextblock" xlink:label="SNYR_SummaryOfFixedAndIntangibleAssetsTableTextblock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_SummaryOfFixedAndIntangibleAssetsTableTextblock" xlink:to="SNYR_SummaryOfFixedAndIntangibleAssetsTableTextblock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_SummaryOfFixedAndIntangibleAssetsTableTextblock_lbl" xml:lang="en-US">Summary of Fixed and Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_lbl" xml:lang="en-US">Summary of Estimated Aggregate Amortization Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ScheduleOfLoanPayableTableTextBlock" xlink:label="SNYR_ScheduleOfLoanPayableTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_ScheduleOfLoanPayableTableTextBlock" xlink:to="SNYR_ScheduleOfLoanPayableTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_ScheduleOfLoanPayableTableTextBlock_lbl" xml:lang="en-US">Schedule of Loan Payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xml:lang="en-US">Schedule of Future Minimum Rental Payments For Operating Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_lbl" xml:lang="en-US">Summary of Options Outstanding by Price Range</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of Stock Options Activity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_StockWarrantsAbstract" xlink:to="SNYR_StockWarrantsAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SNYR_StockWarrantsAbstract_2_lbl" xml:lang="en-US">Stock Warrants Tables</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockWarrantsPlansByExercisePriceRangeTextBlock" xlink:label="SNYR_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockWarrantsPlansByExercisePriceRangeTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockWarrantsPlansByExercisePriceRangeTextBlock" xlink:to="SNYR_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockWarrantsPlansByExercisePriceRangeTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockWarrantsPlansByExercisePriceRangeTextBlock_lbl" xml:lang="en-US">Summary of Warrants Outstanding by Price Range</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xml:lang="en-US">Schedule of Stock Warrants Activity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:label="us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:to="us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_lbl" xml:lang="en-US">Schedule of Assumptions Used For Fair Value of Derivative</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:label="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:to="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_lbl" xml:lang="en-US">Summary of Net Sales Attributed to Customers Geographical Segment</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_SummaryOfNetSalesAttributedToCustomersProductGroupTableTextBlock" xlink:label="SNYR_SummaryOfNetSalesAttributedToCustomersProductGroupTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_SummaryOfNetSalesAttributedToCustomersProductGroupTableTextBlock" xlink:to="SNYR_SummaryOfNetSalesAttributedToCustomersProductGroupTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_SummaryOfNetSalesAttributedToCustomersProductGroupTableTextBlock_lbl" xml:lang="en-US">Summary of Net Sales Attributed to Customers Product Group</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:label="us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:to="us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_lbl" xml:lang="en-US">Summary of Long-lived Assets (Net) Attributable to Operations Geographical Segment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="us-gaap_CashFDICInsuredAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFDICInsuredAmount" xlink:to="us-gaap_CashFDICInsuredAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFDICInsuredAmount_lbl" xml:lang="en-US">Cash frderally insured limit per bank</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashUninsuredAmount" xlink:label="us-gaap_CashUninsuredAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashUninsuredAmount" xlink:to="us-gaap_CashUninsuredAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashUninsuredAmount_lbl" xml:lang="en-US">Cash uninsured amount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Percentage of valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_OptionToPurchaseOfCommonStock" xlink:label="SNYR_OptionToPurchaseOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_OptionToPurchaseOfCommonStock" xlink:to="SNYR_OptionToPurchaseOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_OptionToPurchaseOfCommonStock_lbl" xml:lang="en-US">Option to purchase of common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_WarrantsToPurchaseOfCommonStock" xlink:label="SNYR_WarrantsToPurchaseOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_WarrantsToPurchaseOfCommonStock" xlink:to="SNYR_WarrantsToPurchaseOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_WarrantsToPurchaseOfCommonStock_lbl" xml:lang="en-US">Warrants to purchase of common stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_2_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_WorkingCapital" xlink:label="SNYR_WorkingCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_WorkingCapital" xlink:to="SNYR_WorkingCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_WorkingCapital_lbl" xml:lang="en-US">Working capital deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfOperatingSegments" xlink:to="us-gaap_NumberOfOperatingSegments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xml:lang="en-US">Number of operating segment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US">Stock Price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsExercisePrice" xlink:label="us-gaap_FairValueAssumptionsExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssumptionsExercisePrice" xlink:to="us-gaap_FairValueAssumptionsExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssumptionsExercisePrice_lbl" xml:lang="en-US">Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsExpectedTerm" xlink:label="us-gaap_FairValueAssumptionsExpectedTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssumptionsExpectedTerm" xlink:to="us-gaap_FairValueAssumptionsExpectedTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssumptionsExpectedTerm_lbl" xml:lang="en-US">Expected Life (in years)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_FairValueAssumptionsExpectedVolatilityRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_FairValueAssumptionsExpectedVolatilityRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US">Stock Volatility</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_FairValueAssumptionsRiskFreeInterestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_FairValueAssumptionsRiskFreeInterestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US">Risk-Free Rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_FairValueAssumptionsExpectedDividendRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_FairValueAssumptionsExpectedDividendRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Dividend Rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_2_lbl" xml:lang="en-US">Outstanding Shares of Common Stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross_2_lbl" xml:lang="en-US">Aggregate purchase price of business</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_AmountPayableUnderPurchaseAgreement" xlink:label="SNYR_AmountPayableUnderPurchaseAgreement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_AmountPayableUnderPurchaseAgreement" xlink:to="SNYR_AmountPayableUnderPurchaseAgreement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_AmountPayableUnderPurchaseAgreement_lbl" xml:lang="en-US">Amount payable under the purchase agreement</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Sales percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:label="us-gaap_CostOfGoodsAndServicesSoldAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:to="us-gaap_CostOfGoodsAndServicesSoldAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsAndServicesSoldAmortization_lbl" xml:lang="en-US">Amortization expense</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ExpectedEvenues" xlink:label="SNYR_ExpectedEvenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_ExpectedEvenues" xlink:to="SNYR_ExpectedEvenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_ExpectedEvenues_lbl" xml:lang="en-US">Company's expected revenues</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_3_lbl" xml:lang="en-US">Net inocme</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="us-gaap_SalesRevenueNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesRevenueNet" xlink:to="us-gaap_SalesRevenueNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesRevenueNet_lbl" xml:lang="en-US">Net sales</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_PercentageOfSaleRevenueNet" xlink:label="SNYR_PercentageOfSaleRevenueNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_PercentageOfSaleRevenueNet" xlink:to="SNYR_PercentageOfSaleRevenueNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_PercentageOfSaleRevenueNet_lbl" xml:lang="en-US">Percentage of sale revenue net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="us-gaap_PaymentsToAcquireInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireInvestments" xlink:to="us-gaap_PaymentsToAcquireInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireInvestments_lbl" xml:lang="en-US">Total payments of acquire assets</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_PresentValueOfFuturePayments" xlink:label="SNYR_PresentValueOfFuturePayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_PresentValueOfFuturePayments" xlink:to="SNYR_PresentValueOfFuturePayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_PresentValueOfFuturePayments_lbl" xml:lang="en-US">Present value of future payments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_2_lbl" xml:lang="en-US">Interest expense recorded</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US">Interest rate percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US">Estimated useful lives of intangible property</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xml:lang="en-US">Number of shares contibuted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_lbl" xml:lang="en-US">Common stock percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xml:lang="en-US">Capital stock per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_lbl" xml:lang="en-US">Inventory purchase</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RoyaltyExpense" xlink:label="us-gaap_RoyaltyExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RoyaltyExpense" xlink:to="us-gaap_RoyaltyExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RoyaltyExpense_lbl" xml:lang="en-US">Present value of future royalty payments</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_PercentageOfAmountReceviedFromSublicensess" xlink:label="SNYR_PercentageOfAmountReceviedFromSublicensess" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_PercentageOfAmountReceviedFromSublicensess" xlink:to="SNYR_PercentageOfAmountReceviedFromSublicensess_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_PercentageOfAmountReceviedFromSublicensess_lbl" xml:lang="en-US">Percentage of amount recevied from sublicensess</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ConsultingFeePaid" xlink:label="SNYR_ConsultingFeePaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_ConsultingFeePaid" xlink:to="SNYR_ConsultingFeePaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_ConsultingFeePaid_lbl" xml:lang="en-US">Consulting fee paid</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssumptionsExercisePrice" xlink:to="us-gaap_FairValueAssumptionsExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueAssumptionsExercisePrice_2_lbl" xml:lang="en-US">Warrant exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaCash" xlink:label="SNYR_BusinessAcquisitionsProFormaCash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaCash" xlink:to="SNYR_BusinessAcquisitionsProFormaCash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_BusinessAcquisitionsProFormaCash_lbl" xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaAccountsReceivable" xlink:label="SNYR_BusinessAcquisitionsProFormaAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaAccountsReceivable" xlink:to="SNYR_BusinessAcquisitionsProFormaAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SNYR_BusinessAcquisitionsProFormaAccountsReceivable_lbl" xml:lang="en-US">Accounts Receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaInventory" xlink:label="SNYR_BusinessAcquisitionsProFormaInventory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaInventory" xlink:to="SNYR_BusinessAcquisitionsProFormaInventory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SNYR_BusinessAcquisitionsProFormaInventory_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaPrepaidExpenses" xlink:label="SNYR_BusinessAcquisitionsProFormaPrepaidExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaPrepaidExpenses" xlink:to="SNYR_BusinessAcquisitionsProFormaPrepaidExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SNYR_BusinessAcquisitionsProFormaPrepaidExpenses_lbl" xml:lang="en-US">Prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaFixedAssetsNet" xlink:label="SNYR_BusinessAcquisitionsProFormaFixedAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaFixedAssetsNet" xlink:to="SNYR_BusinessAcquisitionsProFormaFixedAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_BusinessAcquisitionsProFormaFixedAssetsNet_lbl" xml:lang="en-US">Fixed Assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaIntangibleAssetsNet" xlink:label="SNYR_BusinessAcquisitionsProFormaIntangibleAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaIntangibleAssetsNet" xlink:to="SNYR_BusinessAcquisitionsProFormaIntangibleAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_BusinessAcquisitionsProFormaIntangibleAssetsNet_lbl" xml:lang="en-US">Intangible assets, Net</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaBloggerDatabase" xlink:label="SNYR_BusinessAcquisitionsProFormaBloggerDatabase" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaBloggerDatabase" xlink:to="SNYR_BusinessAcquisitionsProFormaBloggerDatabase_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_BusinessAcquisitionsProFormaBloggerDatabase_lbl" xml:lang="en-US">Blogger Database</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaCustomerDatabase" xlink:label="SNYR_BusinessAcquisitionsProFormaCustomerDatabase" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaCustomerDatabase" xlink:to="SNYR_BusinessAcquisitionsProFormaCustomerDatabase_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_BusinessAcquisitionsProFormaCustomerDatabase_lbl" xml:lang="en-US">Customer Database</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaIntellectualProperty" xlink:label="SNYR_BusinessAcquisitionsProFormaIntellectualProperty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaIntellectualProperty" xlink:to="SNYR_BusinessAcquisitionsProFormaIntellectualProperty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_BusinessAcquisitionsProFormaIntellectualProperty_lbl" xml:lang="en-US">Intellectual Property</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaLicenseAgreement" xlink:label="SNYR_BusinessAcquisitionsProFormaLicenseAgreement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaLicenseAgreement" xlink:to="SNYR_BusinessAcquisitionsProFormaLicenseAgreement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_BusinessAcquisitionsProFormaLicenseAgreement_lbl" xml:lang="en-US">License agreement</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaNonCompeteProvision" xlink:label="SNYR_BusinessAcquisitionsProFormaNonCompeteProvision" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaNonCompeteProvision" xlink:to="SNYR_BusinessAcquisitionsProFormaNonCompeteProvision_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_BusinessAcquisitionsProFormaNonCompeteProvision_lbl" xml:lang="en-US">Non-compete provision</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaNonSolicitationProvision" xlink:label="SNYR_BusinessAcquisitionsProFormaNonSolicitationProvision" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaNonSolicitationProvision" xlink:to="SNYR_BusinessAcquisitionsProFormaNonSolicitationProvision_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_BusinessAcquisitionsProFormaNonSolicitationProvision_lbl" xml:lang="en-US">Non-solicitation provision</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaIntangibleAssetsCustomerRelationships" xlink:label="SNYR_BusinessAcquisitionsProFormaIntangibleAssetsCustomerRelationships" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaIntangibleAssetsCustomerRelationships" xlink:to="SNYR_BusinessAcquisitionsProFormaIntangibleAssetsCustomerRelationships_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_BusinessAcquisitionsProFormaIntangibleAssetsCustomerRelationships_lbl" xml:lang="en-US">Intangible assets-Customer relationships</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaGoodwill" xlink:label="SNYR_BusinessAcquisitionsProFormaGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaGoodwill" xlink:to="SNYR_BusinessAcquisitionsProFormaGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SNYR_BusinessAcquisitionsProFormaGoodwill_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaAccountsPayable" xlink:label="SNYR_BusinessAcquisitionsProFormaAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaAccountsPayable" xlink:to="SNYR_BusinessAcquisitionsProFormaAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="SNYR_BusinessAcquisitionsProFormaAccountsPayable_lbl" xml:lang="en-US">Accounts Payable</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaRoyaltyPayable" xlink:label="SNYR_BusinessAcquisitionsProFormaRoyaltyPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaRoyaltyPayable" xlink:to="SNYR_BusinessAcquisitionsProFormaRoyaltyPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SNYR_BusinessAcquisitionsProFormaRoyaltyPayable_lbl" xml:lang="en-US">Royalty payable</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaAccruedExpenses" xlink:label="SNYR_BusinessAcquisitionsProFormaAccruedExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaAccruedExpenses" xlink:to="SNYR_BusinessAcquisitionsProFormaAccruedExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="SNYR_BusinessAcquisitionsProFormaAccruedExpenses_lbl" xml:lang="en-US">Accrued Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaDividendsPayable" xlink:label="SNYR_BusinessAcquisitionsProFormaDividendsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaDividendsPayable" xlink:to="SNYR_BusinessAcquisitionsProFormaDividendsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_BusinessAcquisitionsProFormaDividendsPayable_lbl" xml:lang="en-US">Dividends Payable</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaProvisionForIncomeTax" xlink:label="SNYR_BusinessAcquisitionsProFormaProvisionForIncomeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaProvisionForIncomeTax" xlink:to="SNYR_BusinessAcquisitionsProFormaProvisionForIncomeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_BusinessAcquisitionsProFormaProvisionForIncomeTax_lbl" xml:lang="en-US">Provision for Income Tax</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaOthers" xlink:label="SNYR_BusinessAcquisitionsProFormaOthers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaOthers" xlink:to="SNYR_BusinessAcquisitionsProFormaOthers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_BusinessAcquisitionsProFormaOthers_lbl" xml:lang="en-US">Others</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaTotalLiabilities" xlink:label="SNYR_BusinessAcquisitionsProFormaTotalLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaTotalLiabilities" xlink:to="SNYR_BusinessAcquisitionsProFormaTotalLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="SNYR_BusinessAcquisitionsProFormaTotalLiabilities_lbl" xml:lang="en-US">Total Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionCashPayment" xlink:label="SNYR_BusinessAcquisitionCashPayment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionCashPayment" xlink:to="SNYR_BusinessAcquisitionCashPayment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_BusinessAcquisitionCashPayment_lbl" xml:lang="en-US">Cash payment</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsStockPayment" xlink:label="SNYR_BusinessAcquisitionsStockPayment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsStockPayment" xlink:to="SNYR_BusinessAcquisitionsStockPayment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_BusinessAcquisitionsStockPayment_lbl" xml:lang="en-US">Stock payment</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionStockWarrantsIssued" xlink:label="SNYR_BusinessAcquisitionStockWarrantsIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionStockWarrantsIssued" xlink:to="SNYR_BusinessAcquisitionStockWarrantsIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_BusinessAcquisitionStockWarrantsIssued_lbl" xml:lang="en-US">Stock warrants issued</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionStockIssued" xlink:label="SNYR_BusinessAcquisitionStockIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionStockIssued" xlink:to="SNYR_BusinessAcquisitionStockIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_BusinessAcquisitionStockIssued_lbl" xml:lang="en-US">Stock issued</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionEarnoutPayment" xlink:label="SNYR_BusinessAcquisitionEarnoutPayment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionEarnoutPayment" xlink:to="SNYR_BusinessAcquisitionEarnoutPayment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_BusinessAcquisitionEarnoutPayment_lbl" xml:lang="en-US">Earn-out payment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationAsset" xlink:label="us-gaap_BusinessCombinationContingentConsiderationAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationContingentConsiderationAsset" xlink:to="us-gaap_BusinessCombinationContingentConsiderationAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationContingentConsiderationAsset_lbl" xml:lang="en-US">Total assets acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="us-gaap_BusinessAcquisitionsProFormaRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue_lbl" xml:lang="en-US">Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_lbl" xml:lang="en-US">Net income (loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ValuationAllowancePercentage" xlink:label="SNYR_ValuationAllowancePercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_ValuationAllowancePercentage" xlink:to="SNYR_ValuationAllowancePercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_ValuationAllowancePercentage_lbl" xml:lang="en-US">Valuation allowance percentage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Provision for income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xml:lang="en-US">Percentage of deferred tax asset</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Net operating loss carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_OperatingLossCarryforwardsExpirationYear" xlink:label="SNYR_OperatingLossCarryforwardsExpirationYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_OperatingLossCarryforwardsExpirationYear" xlink:to="SNYR_OperatingLossCarryforwardsExpirationYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_OperatingLossCarryforwardsExpirationYear_lbl" xml:lang="en-US">Operating loss carryforwards expiration year</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">U.S. Statutory Rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl" xml:lang="en-US">U.S. effective rate in excess of AU rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_2_lbl" xml:lang="en-US">U.S. valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_lbl" xml:lang="en-US">Foreign Tax - Australia</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_2_lbl" xml:lang="en-US">Total provision for income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xml:lang="en-US">Deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Valuation allowance for deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Net deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable_lbl" xml:lang="en-US">Bad debt expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsReceivableGross" xlink:label="us-gaap_AccountsReceivableGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableGross" xlink:to="us-gaap_AccountsReceivableGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableGross_lbl" xml:lang="en-US">Trade accounts receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="us-gaap_AllowanceForDoubtfulAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AllowanceForDoubtfulAccountsReceivable_2_lbl" xml:lang="en-US">Less allowances</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsReceivableNet" xlink:label="us-gaap_AccountsReceivableNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNet" xlink:to="us-gaap_AccountsReceivableNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNet_lbl" xml:lang="en-US">Total accounts receivable, net</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_PrepaidExpensesAdvancesForInventory" xlink:label="SNYR_PrepaidExpensesAdvancesForInventory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_PrepaidExpensesAdvancesForInventory" xlink:to="SNYR_PrepaidExpensesAdvancesForInventory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_PrepaidExpensesAdvancesForInventory_lbl" xml:lang="en-US">Advances for inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_PrepaidExpencesMediaProduction" xlink:label="SNYR_PrepaidExpencesMediaProduction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_PrepaidExpencesMediaProduction" xlink:to="SNYR_PrepaidExpencesMediaProduction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_PrepaidExpencesMediaProduction_lbl" xml:lang="en-US">Media production</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidInsurance" xlink:label="us-gaap_PrepaidInsurance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidInsurance" xlink:to="us-gaap_PrepaidInsurance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidInsurance_lbl" xml:lang="en-US">Insurance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidAdvertising" xlink:label="us-gaap_PrepaidAdvertising" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidAdvertising" xlink:to="us-gaap_PrepaidAdvertising_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidAdvertising_lbl" xml:lang="en-US">Trade shows</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_PrepaidExpensesDeposits" xlink:label="SNYR_PrepaidExpensesDeposits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_PrepaidExpensesDeposits" xlink:to="SNYR_PrepaidExpensesDeposits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_PrepaidExpensesDeposits_lbl" xml:lang="en-US">Deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Supplies" xlink:label="us-gaap_Supplies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Supplies" xlink:to="us-gaap_Supplies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Supplies_lbl" xml:lang="en-US">Consultants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidRent" xlink:label="us-gaap_PrepaidRent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidRent" xlink:to="us-gaap_PrepaidRent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidRent_lbl" xml:lang="en-US">Rent</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherAssetsMiscellaneousCurrent" xlink:label="us-gaap_OtherAssetsMiscellaneousCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsMiscellaneousCurrent" xlink:to="us-gaap_OtherAssetsMiscellaneousCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsMiscellaneousCurrent_lbl" xml:lang="en-US">Miscellaneous</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidExpenseCurrentAndNoncurrent" xlink:label="us-gaap_PrepaidExpenseCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrentAndNoncurrent" xlink:to="us-gaap_PrepaidExpenseCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PrepaidExpenseCurrentAndNoncurrent_lbl" xml:lang="en-US">Total</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ConcentrationRiskPercentage1_2_lbl" xml:lang="en-US">Concentration risk percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_NumberOfCustomerAccountedForAccountsReceivable" xlink:label="SNYR_NumberOfCustomerAccountedForAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_NumberOfCustomerAccountedForAccountsReceivable" xlink:to="SNYR_NumberOfCustomerAccountedForAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_NumberOfCustomerAccountedForAccountsReceivable_lbl" xml:lang="en-US">Number of customer accounted for accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_NameOfProduct" xlink:label="SNYR_NameOfProduct" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_NameOfProduct" xlink:to="SNYR_NameOfProduct_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_NameOfProduct_lbl" xml:lang="en-US">Name of the Product</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_AddressOfSuppliers" xlink:label="SNYR_AddressOfSuppliers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_AddressOfSuppliers" xlink:to="SNYR_AddressOfSuppliers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_AddressOfSuppliers_lbl" xml:lang="en-US">Address of the suppliers</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CityOfSuppliers" xlink:label="SNYR_CityOfSuppliers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_CityOfSuppliers" xlink:to="SNYR_CityOfSuppliers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_CityOfSuppliers_lbl" xml:lang="en-US">City of suppliers</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="us-gaap_InventoryFinishedGoods" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoods" xlink:to="us-gaap_InventoryFinishedGoods_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryFinishedGoods_lbl" xml:lang="en-US">Finished goods</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_InventoryComponents" xlink:label="SNYR_InventoryComponents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_InventoryComponents" xlink:to="SNYR_InventoryComponents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_InventoryComponents_lbl" xml:lang="en-US">Components</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="us-gaap_InventoryRawMaterialsNetOfReserves_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryRawMaterialsNetOfReserves_lbl" xml:lang="en-US">Raw Materials</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_InventoryEnergyProduct" xlink:label="SNYR_InventoryEnergyProduct" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_InventoryEnergyProduct" xlink:to="SNYR_InventoryEnergyProduct_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_InventoryEnergyProduct_lbl" xml:lang="en-US">Energy product</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_InventoryNet_2_lbl" xml:lang="en-US">Total inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation expenes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdjustmentForAmortization" xlink:label="us-gaap_AdjustmentForAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentForAmortization" xlink:to="us-gaap_AdjustmentForAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AdjustmentForAmortization_lbl" xml:lang="en-US">Amortization expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xml:lang="en-US">Property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Less accumulated depreciation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_2_lbl" xml:lang="en-US">Fixed assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_IntellectualProperty" xlink:label="SNYR_IntellectualProperty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_IntellectualProperty" xlink:to="SNYR_IntellectualProperty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_IntellectualProperty_lbl" xml:lang="en-US">FOCUSfactor intellectual property</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xml:lang="en-US">Intangible assets subject to amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Less accumulated amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US">Intangible assets, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_lbl" xml:lang="en-US">2016</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_lbl" xml:lang="en-US">2017</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_lbl" xml:lang="en-US">2018</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_lbl" xml:lang="en-US">2019</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_lbl" xml:lang="en-US">2020</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Options Outstanding, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:label="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:to="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation_lbl" xml:lang="en-US">Value of granted options</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromNotesPayable" xlink:to="us-gaap_ProceedsFromNotesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromNotesPayable_2_lbl" xml:lang="en-US">Proceeds from promissory note</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_2_lbl" xml:lang="en-US">Debt instruments interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xml:lang="en-US">Debt instruments maturity date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" xml:lang="en-US">Promissory note converted into number of shares</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_AccruedConsultingFeesPerMonth" xlink:label="SNYR_AccruedConsultingFeesPerMonth" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_AccruedConsultingFeesPerMonth" xlink:to="SNYR_AccruedConsultingFeesPerMonth_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_AccruedConsultingFeesPerMonth_lbl" xml:lang="en-US">Accrued consulting fees per month</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BonusPaid" xlink:label="SNYR_BonusPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BonusPaid" xlink:to="SNYR_BonusPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_BonusPaid_lbl" xml:lang="en-US">Bonus paid</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_OutstandingBalanceOfConsultingFees" xlink:label="SNYR_OutstandingBalanceOfConsultingFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_OutstandingBalanceOfConsultingFees" xlink:to="SNYR_OutstandingBalanceOfConsultingFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_OutstandingBalanceOfConsultingFees_lbl" xml:lang="en-US">Outstanding balance of consulting fees</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueFromRelatedPartiesCurrent" xlink:to="us-gaap_DueFromRelatedPartiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DueFromRelatedPartiesCurrent_2_lbl" xml:lang="en-US">Due from related party</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DueFromRelatedParties" xlink:label="us-gaap_DueFromRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueFromRelatedParties" xlink:to="us-gaap_DueFromRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueFromRelatedParties_lbl" xml:lang="en-US">Amount owed to related party</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_2_lbl" xml:lang="en-US">Due to related party</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestOwnershipPercentageByParent_lbl" xml:lang="en-US">Percentage of ownership interest</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US">Payroll expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_2_lbl" xml:lang="en-US">Payroll</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xml:lang="en-US">Legal fees</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ManufacturersLiabilitiesCurrent" xlink:label="SNYR_ManufacturersLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_ManufacturersLiabilitiesCurrent" xlink:to="SNYR_ManufacturersLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_ManufacturersLiabilitiesCurrent_lbl" xml:lang="en-US">Manufacturers</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_PromotionsLiabilitiesCurrent" xlink:label="SNYR_PromotionsLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_PromotionsLiabilitiesCurrent" xlink:to="SNYR_PromotionsLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_PromotionsLiabilitiesCurrent_lbl" xml:lang="en-US">Promotions</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ReturnsAllowanceAccruedLiabilities" xlink:label="SNYR_ReturnsAllowanceAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_ReturnsAllowanceAccruedLiabilities" xlink:to="SNYR_ReturnsAllowanceAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_ReturnsAllowanceAccruedLiabilities_lbl" xml:lang="en-US">Returns allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CustomersAccruedLiabilities" xlink:label="SNYR_CustomersAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_CustomersAccruedLiabilities" xlink:to="SNYR_CustomersAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_CustomersAccruedLiabilities_lbl" xml:lang="en-US">Customers</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_InterestAccruedLiabilities" xlink:label="SNYR_InterestAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_InterestAccruedLiabilities" xlink:to="SNYR_InterestAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SNYR_InterestAccruedLiabilities_lbl" xml:lang="en-US">Interest</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_RoyaltiesAccruedLiabilities" xlink:label="SNYR_RoyaltiesAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_RoyaltiesAccruedLiabilities" xlink:to="SNYR_RoyaltiesAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_RoyaltiesAccruedLiabilities_lbl" xml:lang="en-US">Royalties</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_WarehousingAccruedLiabilities" xlink:label="SNYR_WarehousingAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_WarehousingAccruedLiabilities" xlink:to="SNYR_WarehousingAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_WarehousingAccruedLiabilities_lbl" xml:lang="en-US">Warehousing</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_OtherAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_OtherAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_lbl" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermDebtFairValue" xlink:label="us-gaap_LongTermDebtFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtFairValue" xlink:to="us-gaap_LongTermDebtFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtFairValue_lbl" xml:lang="en-US">Loan amount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtIssuanceCosts" xlink:label="us-gaap_DebtIssuanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtIssuanceCosts" xlink:to="us-gaap_DebtIssuanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtIssuanceCosts_lbl" xml:lang="en-US">Expences associated with loan</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_3_lbl" xml:lang="en-US">Debt instrument interest rate percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:label="us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:to="us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_lbl" xml:lang="en-US">Convertible equity offering</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xlink:label="us-gaap_DebtInstrumentInterestRateIncreaseDecrease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xlink:to="us-gaap_DebtInstrumentInterestRateIncreaseDecrease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateIncreaseDecrease_lbl" xml:lang="en-US">Change in loan interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LoansPayable" xlink:label="us-gaap_LoansPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansPayable" xlink:to="us-gaap_LoansPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoansPayable_lbl" xml:lang="en-US">Amount of loan obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:to="us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_lbl" xml:lang="en-US">Aggregate consideration to be paid</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xml:lang="en-US">Capital expenditures</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="us-gaap_ConversionOfStockSharesIssued1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesIssued1" xlink:to="us-gaap_ConversionOfStockSharesIssued1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockSharesIssued1_lbl" xml:lang="en-US">Number of warrants to purchase common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Warrants exercise price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SaleOfStockPricePerShare_2_lbl" xml:lang="en-US">Common stock price per share</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_PercentageOfSharesPurchaseableUnderWarrants" xlink:label="SNYR_PercentageOfSharesPurchaseableUnderWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_PercentageOfSharesPurchaseableUnderWarrants" xlink:to="SNYR_PercentageOfSharesPurchaseableUnderWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_PercentageOfSharesPurchaseableUnderWarrants_lbl" xml:lang="en-US">Percentage of shares purchaseable under warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" xlink:label="us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" xlink:to="us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature_lbl" xml:lang="en-US">Beneficial conversion feature of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xml:lang="en-US">Number of warrants outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xml:lang="en-US">Unamortized debt discount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="us-gaap_DeferredFinanceCostsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFinanceCostsNet" xlink:to="us-gaap_DeferredFinanceCostsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFinanceCostsNet_lbl" xml:lang="en-US">Deferred financing costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="us-gaap_AmortizationOfFinancingCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfFinancingCosts" xlink:to="us-gaap_AmortizationOfFinancingCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfFinancingCosts_lbl" xml:lang="en-US">Recognized amortization of deferred financing costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InterestExpense_3_lbl" xml:lang="en-US">Interest expense paid</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DepositLiabilitiesAccruedInterest" xlink:label="us-gaap_DepositLiabilitiesAccruedInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositLiabilitiesAccruedInterest" xlink:to="us-gaap_DepositLiabilitiesAccruedInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepositLiabilitiesAccruedInterest_lbl" xml:lang="en-US">Accrued interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NotesIssued1" xlink:label="us-gaap_NotesIssued1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesIssued1" xlink:to="us-gaap_NotesIssued1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesIssued1_lbl" xml:lang="en-US">Note issued as part of asset purchase agreement</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentMaturityDate_2_lbl" xml:lang="en-US">Note maturity date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeLiabilities" xlink:label="us-gaap_DerivativeLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativeLiabilities" xlink:to="us-gaap_DerivativeLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativeLiabilities_lbl" xml:lang="en-US">Fair value of derivative liability</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_LoansPayableGross" xlink:label="SNYR_LoansPayableGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_LoansPayableGross" xlink:to="SNYR_LoansPayableGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_LoansPayableGross_lbl" xml:lang="en-US">Loans payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansPayable" xlink:to="us-gaap_LoansPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LoansPayable_2_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LoansPayableCurrent" xlink:label="us-gaap_LoansPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansPayableCurrent" xlink:to="us-gaap_LoansPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoansPayableCurrent_lbl" xml:lang="en-US">Less: Current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermLoansPayable" xlink:label="us-gaap_LongTermLoansPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermLoansPayable" xlink:to="us-gaap_LongTermLoansPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermLoansPayable_lbl" xml:lang="en-US">Long-term portion</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityReverseStockSplit" xlink:to="us-gaap_StockholdersEquityReverseStockSplit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl" xml:lang="en-US">Forward stock split</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SaleOfStockPricePerShare_3_lbl" xml:lang="en-US">Common stock purchase price per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockValue_2_lbl" xml:lang="en-US">Common stock value</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_PercentageOfOutstandingCapital" xlink:label="SNYR_PercentageOfOutstandingCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_PercentageOfOutstandingCapital" xlink:to="SNYR_PercentageOfOutstandingCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_PercentageOfOutstandingCapital_lbl" xml:lang="en-US">Percentage of outstanding capital</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_2_lbl" xml:lang="en-US">Common stock issued for cash shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US">Number of shares cancelled</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_PrestockSplitShares" xlink:label="SNYR_PrestockSplitShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_PrestockSplitShares" xlink:to="SNYR_PrestockSplitShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_PrestockSplitShares_lbl" xml:lang="en-US">Pre-Stock Split shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockHeldInTrust" xlink:label="us-gaap_CommonStockHeldInTrust" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockHeldInTrust" xlink:to="us-gaap_CommonStockHeldInTrust_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockHeldInTrust_lbl" xml:lang="en-US">Value of stock held for future issuance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLossCarryforwardsExpirationDate" xlink:label="us-gaap_OperatingLossCarryforwardsExpirationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsExpirationDate" xlink:to="us-gaap_OperatingLossCarryforwardsExpirationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwardsExpirationDate_lbl" xml:lang="en-US">Operating lease expiration date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="us-gaap_OperatingLeasesRentExpenseNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesRentExpenseNet" xlink:to="us-gaap_OperatingLeasesRentExpenseNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesRentExpenseNet_lbl" xml:lang="en-US">Rent expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleLeasebackTransactionRentExpense" xlink:label="us-gaap_SaleLeasebackTransactionRentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleLeasebackTransactionRentExpense" xlink:to="us-gaap_SaleLeasebackTransactionRentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleLeasebackTransactionRentExpense_lbl" xml:lang="en-US">Sublease rent</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl" xml:lang="en-US">2016</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xml:lang="en-US">2017</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xml:lang="en-US">Common stock shares reserved for issuance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Stock options exercise price per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US">Stock-based compensation expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssumptionsExercisePrice" xlink:to="us-gaap_FairValueAssumptionsExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueAssumptionsExercisePrice_3_lbl" xml:lang="en-US">Estimated fair value of Company's common stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_FairValueAssumptionsRiskFreeInterestRate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueAssumptionsRiskFreeInterestRate_2_lbl" xml:lang="en-US">Risk-free interest rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_FairValueAssumptionsExpectedVolatilityRate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueAssumptionsExpectedVolatilityRate_2_lbl" xml:lang="en-US">Volatility rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssumptionsExpectedTerm" xlink:to="us-gaap_FairValueAssumptionsExpectedTerm_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueAssumptionsExpectedTerm_2_lbl" xml:lang="en-US">Expected lives</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_FairValueAssumptionsExpectedDividendRate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FairValueAssumptionsExpectedDividendRate_2_lbl" xml:lang="en-US">Dividend yield</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_lbl" xml:lang="en-US">Stock options outstanding intrinsic value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_lbl" xml:lang="en-US">Options Outstanding, exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_lbl" xml:lang="en-US">Options Outstanding, Number Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Options Outstanding, Remaining Average Contractual Life</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_lbl" xml:lang="en-US">Options Outstanding, Weighted Average Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_lbl" xml:lang="en-US">Options Exercisable, Number Exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_lbl" xml:lang="en-US">Options Exercisable, Weighted Average Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Options Outstanding, Outstanding at Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Options Outstanding, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xml:lang="en-US">Options Outstanding, Expired or canceled</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xml:lang="en-US">Options Outstanding, Outstanding at Ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Outstanding at Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Weighted Average Exercise Price, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Expired or canceled</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Weighted Average Exercise Price, Outstanding at Ending balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_2_lbl" xml:lang="en-US">Warrants Outstanding, exercise prices</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_2_lbl" xml:lang="en-US">Warrants Outstanding, Number Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_2_lbl" xml:lang="en-US">Warrants Outstanding, Remaining Average Contractual Life</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_2_lbl" xml:lang="en-US">Warrants Outstanding, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_2_lbl" xml:lang="en-US">Warrants Exercisable, Number Exercisable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:to="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1_2_lbl" xml:lang="en-US">Warrants Exercisable, Weighted Average Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xml:lang="en-US">Warrants Outstanding, Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xml:lang="en-US">Warrants, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xml:lang="en-US">Warrants, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xml:lang="en-US">Warrants, Expired or canceled</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2_lbl" xml:lang="en-US">Warrants Outstanding, Ending balance</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePriceEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePriceEquityInstrumentsOtherThanOptionsNonvestedNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePriceEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePriceEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePriceEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xml:lang="en-US">Warrants Outstanding, Weighted Average Exercise Price, Beginning balance</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ShareBasedCompensationArrangementsByShareBasedPaymentAwardWarrantsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="SNYR_ShareBasedCompensationArrangementsByShareBasedPaymentAwardWarrantsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_ShareBasedCompensationArrangementsByShareBasedPaymentAwardWarrantsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="SNYR_ShareBasedCompensationArrangementsByShareBasedPaymentAwardWarrantsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_ShareBasedCompensationArrangementsByShareBasedPaymentAwardWarrantsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageExercisePrice" xlink:label="SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageExercisePrice" xlink:to="SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Expired or canceled</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePriceEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePriceEquityInstrumentsOtherThanOptionsNonvestedNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePriceEquityInstrumentsOtherThanOptionsNonvestedNumber_2_lbl" xml:lang="en-US">Warrants Outstanding, Weighted Average Exercise Price, Ending balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssumptionsExpectedTerm" xlink:to="us-gaap_FairValueAssumptionsExpectedTerm_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueAssumptionsExpectedTerm_3_lbl" xml:lang="en-US">Expected remaining term</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_FairValueAssumptionsExpectedVolatilityRate_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueAssumptionsExpectedVolatilityRate_3_lbl" xml:lang="en-US">Expected volatility</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NoncurrentAssets" xlink:label="us-gaap_NoncurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncurrentAssets" xlink:to="us-gaap_NoncurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncurrentAssets_lbl" xml:lang="en-US">Long-lived assets net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_AccruedConsultingFeesPerMonth" xlink:to="SNYR_AccruedConsultingFeesPerMonth_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_AccruedConsultingFeesPerMonth_doc" xml:lang="en-US">Accrued Consulting Fees Per Month.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_CashPaidDuringPeriodAbstract" xlink:to="SNYR_CashPaidDuringPeriodAbstract_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_CashPaidDuringPeriodAbstract_doc" xml:lang="en-US">Cash paid during the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_CommonStockToBeIssuedMember" xlink:to="SNYR_CommonStockToBeIssuedMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_CommonStockToBeIssuedMember_doc" xml:lang="en-US">Common Stock To Be Issued [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_DirectorsMember" xlink:to="SNYR_DirectorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_DirectorsMember_doc" xml:lang="en-US">Directors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_DocumentAndEntityInformationAbstract" xlink:to="SNYR_DocumentAndEntityInformationAbstract_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_DocumentAndEntityInformationAbstract_doc" xml:lang="en-US">Document and Entity Information [Abstract]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_DunhillDistributionGroupMember" xlink:to="SNYR_DunhillDistributionGroupMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_DunhillDistributionGroupMember_doc" xml:lang="en-US">Dunhill Distribution Group [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_EquityIncentivePlanTwoThousandsAndFourteenMember" xlink:to="SNYR_EquityIncentivePlanTwoThousandsAndFourteenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_EquityIncentivePlanTwoThousandsAndFourteenMember_doc" xml:lang="en-US">Equity Incentive Plan Two Thousands And Fourteen [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_FactorNutritionLabsLLCMember" xlink:to="SNYR_FactorNutritionLabsLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_FactorNutritionLabsLLCMember_doc" xml:lang="en-US">Factor Nutrition Labs LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_KnightTherapeuticsBarbadosIncMember" xlink:to="SNYR_KnightTherapeuticsBarbadosIncMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_KnightTherapeuticsBarbadosIncMember_doc" xml:lang="en-US">Knight Therapeutics Barbados Inc [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_LTWarrantMember" xlink:to="SNYR_LTWarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_LTWarrantMember_doc" xml:lang="en-US">LT Warrant [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_MergerAgreementMember" xlink:to="SNYR_MergerAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_MergerAgreementMember_doc" xml:lang="en-US">Merger Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_PresidentAndDirectorMember" xlink:to="SNYR_PresidentAndDirectorMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_PresidentAndDirectorMember_doc" xml:lang="en-US">President And Director [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_STWarrantMember" xlink:to="SNYR_STWarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_STWarrantMember_doc" xml:lang="en-US">ST Warrant [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_ShipmanDiamondProjectMember" xlink:to="SNYR_ShipmanDiamondProjectMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_ShipmanDiamondProjectMember_doc" xml:lang="en-US">Shipman Diamond Project [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_StockOptionPlanMember" xlink:to="SNYR_StockOptionPlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_StockOptionPlanMember_doc" xml:lang="en-US">Stock Option Plan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_SynergyMergerSubIncMember" xlink:to="SNYR_SynergyMergerSubIncMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_SynergyMergerSubIncMember_doc" xml:lang="en-US">Synergy Merger Sub, Inc. [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_WorkingCapital" xlink:to="SNYR_WorkingCapital_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_WorkingCapital_doc" xml:lang="en-US">Working Capital.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_ExpectedEvenues" xlink:to="SNYR_ExpectedEvenues_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_ExpectedEvenues_doc" xml:lang="en-US">Company's expected evenues.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_FocusFactorBusinessMember" xlink:to="SNYR_FocusFactorBusinessMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_FocusFactorBusinessMember_doc" xml:lang="en-US">Focus Factor Business [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_AmountPayableUnderPurchaseAgreement" xlink:to="SNYR_AmountPayableUnderPurchaseAgreement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_AmountPayableUnderPurchaseAgreement_doc" xml:lang="en-US">Amount payable under the purchase agreement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_JanuaryTwentyTwoThousandSixteenMember" xlink:to="SNYR_JanuaryTwentyTwoThousandSixteenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_JanuaryTwentyTwoThousandSixteenMember_doc" xml:lang="en-US">January 22, 2016 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_JanuaryTwentyTwoThousandSeventeenMember" xlink:to="SNYR_JanuaryTwentyTwoThousandSeventeenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_JanuaryTwentyTwoThousandSeventeenMember_doc" xml:lang="en-US">January 22, 2017 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaAccountsReceivable" xlink:to="SNYR_BusinessAcquisitionsProFormaAccountsReceivable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_BusinessAcquisitionsProFormaAccountsReceivable_doc" xml:lang="en-US">Business acquisitions Pro forma accounts receivable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaInventory" xlink:to="SNYR_BusinessAcquisitionsProFormaInventory_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_BusinessAcquisitionsProFormaInventory_doc" xml:lang="en-US">Business acquisitions pro forma inventory.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaIntellectualProperty" xlink:to="SNYR_BusinessAcquisitionsProFormaIntellectualProperty_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_BusinessAcquisitionsProFormaIntellectualProperty_doc" xml:lang="en-US">Business acquisitions pro forma intellectual property.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaNonCompeteProvision" xlink:to="SNYR_BusinessAcquisitionsProFormaNonCompeteProvision_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_BusinessAcquisitionsProFormaNonCompeteProvision_doc" xml:lang="en-US">Business acquisitions pro forma non compete provision.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaNonSolicitationProvision" xlink:to="SNYR_BusinessAcquisitionsProFormaNonSolicitationProvision_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_BusinessAcquisitionsProFormaNonSolicitationProvision_doc" xml:lang="en-US">Business acquisitions pro forma non-solicitation provision.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaIntangibleAssetsCustomerRelationships" xlink:to="SNYR_BusinessAcquisitionsProFormaIntangibleAssetsCustomerRelationships_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_BusinessAcquisitionsProFormaIntangibleAssetsCustomerRelationships_doc" xml:lang="en-US">Business acquisitions pro forma Intangible assets-Customer relationships.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaGoodwill" xlink:to="SNYR_BusinessAcquisitionsProFormaGoodwill_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_BusinessAcquisitionsProFormaGoodwill_doc" xml:lang="en-US">Business acquisitions pro forma goodwil.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaAccountsPayable" xlink:to="SNYR_BusinessAcquisitionsProFormaAccountsPayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_BusinessAcquisitionsProFormaAccountsPayable_doc" xml:lang="en-US">Business acquisitions pro forma accounts payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaAccruedExpenses" xlink:to="SNYR_BusinessAcquisitionsProFormaAccruedExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_BusinessAcquisitionsProFormaAccruedExpenses_doc" xml:lang="en-US">Business acquisitions pro forma accrued expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaTotalLiabilities" xlink:to="SNYR_BusinessAcquisitionsProFormaTotalLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_BusinessAcquisitionsProFormaTotalLiabilities_doc" xml:lang="en-US">Business acquisitions pro forma total liabilities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_InventoryEnergyProduct" xlink:to="SNYR_InventoryEnergyProduct_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_InventoryEnergyProduct_doc" xml:lang="en-US">Inventory energy product.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_InventoryComponents" xlink:to="SNYR_InventoryComponents_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_InventoryComponents_doc" xml:lang="en-US">Inventory components.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_FixedAssetsAndIntangibleAssetsTextBlock" xlink:to="SNYR_FixedAssetsAndIntangibleAssetsTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_FixedAssetsAndIntangibleAssetsTextBlock_doc" xml:lang="en-US">Fixed assets and intangible assets [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_SummaryOfFixedAndIntangibleAssetsTableTextblock" xlink:to="SNYR_SummaryOfFixedAndIntangibleAssetsTableTextblock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_SummaryOfFixedAndIntangibleAssetsTableTextblock_doc" xml:lang="en-US">Summary of fixed and intangible assets table text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_ManufacturersLiabilitiesCurrent" xlink:to="SNYR_ManufacturersLiabilitiesCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_ManufacturersLiabilitiesCurrent_doc" xml:lang="en-US">Manufactures liabilities current.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_PromotionsLiabilitiesCurrent" xlink:to="SNYR_PromotionsLiabilitiesCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_PromotionsLiabilitiesCurrent_doc" xml:lang="en-US">Promotions liabilities current.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockWarrantsPlansByExercisePriceRangeTextBlock" xlink:to="SNYR_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockWarrantsPlansByExercisePriceRangeTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockWarrantsPlansByExercisePriceRangeTextBlock_doc" xml:lang="en-US">Summary of warrants outstanding by price range.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_GoingConcernPolicyTextBlock" xlink:to="SNYR_GoingConcernPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_GoingConcernPolicyTextBlock_doc" xml:lang="en-US">Going concern policy text block.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_StockWarrantsDisclosureTextBlock" xlink:to="SNYR_StockWarrantsDisclosureTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_StockWarrantsDisclosureTextBlock_doc" xml:lang="en-US">Stock Warrants Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePriceEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePriceEquityInstrumentsOtherThanOptionsNonvestedNumber_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePriceEquityInstrumentsOtherThanOptionsNonvestedNumber_doc" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Warrants Outstanding Weighted Average Exercise Price Equity Instruments Other Than Options Nonvested Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice_doc" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Exercise Price.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_ShareBasedCompensationArrangementsByShareBasedPaymentAwardWarrantsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="SNYR_ShareBasedCompensationArrangementsByShareBasedPaymentAwardWarrantsExercisesInPeriodWeightedAverageExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_ShareBasedCompensationArrangementsByShareBasedPaymentAwardWarrantsExercisesInPeriodWeightedAverageExercisePrice_doc" xml:lang="en-US">Share Based Compensation Arrangements By Share Based Payment Award Warrants Exercises In Period Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageExercisePrice" xlink:to="SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageExercisePrice_doc" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Exercise Price.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_CancellationOfCommonStockAsPartOfPurchaseTransaction" xlink:to="SNYR_CancellationOfCommonStockAsPartOfPurchaseTransaction_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_CancellationOfCommonStockAsPartOfPurchaseTransaction_doc" xml:lang="en-US">Cancellation of common stock as part of purchase transaction.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_FinancingForPrepaidInsurance" xlink:to="SNYR_FinancingForPrepaidInsurance_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_FinancingForPrepaidInsurance_doc" xml:lang="en-US">Financing for prepaid insurance.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_IssuanceOfSharesAsPartOfAcquisitionTransaction" xlink:to="SNYR_IssuanceOfSharesAsPartOfAcquisitionTransaction_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_IssuanceOfSharesAsPartOfAcquisitionTransaction_doc" xml:lang="en-US">Issuance of shares as part of acquisition transaction.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_USMember" xlink:to="SNYR_USMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_USMember_doc" xml:lang="en-US">US [Member].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_PercentageOfSaleRevenueNet" xlink:to="SNYR_PercentageOfSaleRevenueNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_PercentageOfSaleRevenueNet_doc" xml:lang="en-US">Percentage of sale revenue net.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_OptionToPurchaseOfCommonStock" xlink:to="SNYR_OptionToPurchaseOfCommonStock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_OptionToPurchaseOfCommonStock_doc" xml:lang="en-US">Option to purchase of common stock.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_WarrantsToPurchaseOfCommonStock" xlink:to="SNYR_WarrantsToPurchaseOfCommonStock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_WarrantsToPurchaseOfCommonStock_doc" xml:lang="en-US">Warrants to purchase of common stock.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_KnightTherapeuticsIncMember" xlink:to="SNYR_KnightTherapeuticsIncMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_KnightTherapeuticsIncMember_doc" xml:lang="en-US">Knight Therapeutics Inc [Member].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_JuneThirtyTwoThousandSixteenMember" xlink:to="SNYR_JuneThirtyTwoThousandSixteenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_JuneThirtyTwoThousandSixteenMember_doc" xml:lang="en-US">June 30, 2015 [Member].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_ClosingDateMember" xlink:to="SNYR_ClosingDateMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_ClosingDateMember_doc" xml:lang="en-US">Closing Date [Member].</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_LiabilitiesAssumedRelatedParty" xlink:to="SNYR_LiabilitiesAssumedRelatedParty_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_LiabilitiesAssumedRelatedParty_doc" xml:lang="en-US">Liabilities Assumed Related Party.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_GainsLossesOnAcquisition" xlink:to="SNYR_GainsLossesOnAcquisition_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_GainsLossesOnAcquisition_doc" xml:lang="en-US">Gains Losses on Acquisition.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_CommonStockIssuedAsPartOfContributionAgreement" xlink:to="SNYR_CommonStockIssuedAsPartOfContributionAgreement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_CommonStockIssuedAsPartOfContributionAgreement_doc" xml:lang="en-US">Common stock issued as part of contribution agreement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_ContributionAgreementMember" xlink:to="SNYR_ContributionAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_ContributionAgreementMember_doc" xml:lang="en-US">Contribution Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_HandMDCorpMember" xlink:to="SNYR_HandMDCorpMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_HandMDCorpMember_doc" xml:lang="en-US">Hand Md Corp [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_LicenseAgreementMember" xlink:to="SNYR_LicenseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_LicenseAgreementMember_doc" xml:lang="en-US">License Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_ConsultingAgreementMember" xlink:to="SNYR_ConsultingAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_ConsultingAgreementMember_doc" xml:lang="en-US">Consulting Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_HandMDLLCMember" xlink:to="SNYR_HandMDLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_HandMDLLCMember_doc" xml:lang="en-US">Hand MD LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_IntellectualProperty" xlink:to="SNYR_IntellectualProperty_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_IntellectualProperty_doc" xml:lang="en-US">Intellectual property.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_PercentageOfOutstandingCapital" xlink:to="SNYR_PercentageOfOutstandingCapital_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_PercentageOfOutstandingCapital_doc" xml:lang="en-US">Percentage of outstanding capital.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_RoyaltyPayable" xlink:to="SNYR_RoyaltyPayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_RoyaltyPayable_doc" xml:lang="en-US">Royalty payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptions" xlink:to="SNYR_AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptions_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptions_doc" xml:lang="en-US">Adjustments To Additional Paid In Capital Fair Value Of Vested Stock Options.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_CommonStockIssuedAsPartOfContributionAgreementShares" xlink:to="SNYR_CommonStockIssuedAsPartOfContributionAgreementShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_CommonStockIssuedAsPartOfContributionAgreementShares_doc" xml:lang="en-US">Common stock issued as part of the Contribution Agreement, shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_CommonStockIssuedForAcquisitions" xlink:to="SNYR_CommonStockIssuedForAcquisitions_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_CommonStockIssuedForAcquisitions_doc" xml:lang="en-US">Common stock issued for acquisitions of Breakthrough Products, Inc.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_CommonStockIssuedForAcquisitionsShares" xlink:to="SNYR_CommonStockIssuedForAcquisitionsShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_CommonStockIssuedForAcquisitionsShares_doc" xml:lang="en-US">Common stock issued for acquisitions of Breakthrough Products, Inc., shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_CommonStockIssuedForAcquisitionsOne" xlink:to="SNYR_CommonStockIssuedForAcquisitionsOne_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_CommonStockIssuedForAcquisitionsOne_doc" xml:lang="en-US">Common stock issued for acquisitions of NomadChoice Pty Ltd.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_CommonStockIssuedForAcquisitionsOneShares" xlink:to="SNYR_CommonStockIssuedForAcquisitionsOneShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_CommonStockIssuedForAcquisitionsOneShares_doc" xml:lang="en-US">Common stock issued for acquisitions of NomadChoice Pty Ltd., shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_CommonStockIssuedToSettleAccountsPayable" xlink:to="SNYR_CommonStockIssuedToSettleAccountsPayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_CommonStockIssuedToSettleAccountsPayable_doc" xml:lang="en-US">Common stock issued to settle accounts payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_CommonStockIssuedToSettleAccountsPayableShares" xlink:to="SNYR_CommonStockIssuedToSettleAccountsPayableShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_CommonStockIssuedToSettleAccountsPayableShares_doc" xml:lang="en-US">Common stock issued to settle accounts payable, shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_NetAssetsTakenOverAsPartOfAcquisition" xlink:to="SNYR_NetAssetsTakenOverAsPartOfAcquisition_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_NetAssetsTakenOverAsPartOfAcquisition_doc" xml:lang="en-US">Net assets taken over as part of acquisition of NomadChoice Pty Ltd.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_NetLiabilitiesTakenOverAsPartOfAcquisition" xlink:to="SNYR_NetLiabilitiesTakenOverAsPartOfAcquisition_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_NetLiabilitiesTakenOverAsPartOfAcquisition_doc" xml:lang="en-US">Net liabilities taken over as part of acquisition of Breakthrough Products, Inc.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_FairValueOfWarrantsIssuedAsPartOfAcquisition" xlink:to="SNYR_FairValueOfWarrantsIssuedAsPartOfAcquisition_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_FairValueOfWarrantsIssuedAsPartOfAcquisition_doc" xml:lang="en-US">Fair value of warrants issued as part of acquisition of Breakthrough Products, Inc.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_CommonStockIssuedForAcquisition" xlink:to="SNYR_CommonStockIssuedForAcquisition_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_CommonStockIssuedForAcquisition_doc" xml:lang="en-US">Common stock issued for the acquisition of NomadChoice Pty Ltd.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_CommonStockIssuedForAcquisitionOne" xlink:to="SNYR_CommonStockIssuedForAcquisitionOne_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_CommonStockIssuedForAcquisitionOne_doc" xml:lang="en-US">Common stock issued for the acquisition of Breakthrough Products, Inc.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_DerivativeLiabilityAtInception" xlink:to="SNYR_DerivativeLiabilityAtInception_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_DerivativeLiabilityAtInception_doc" xml:lang="en-US">Derivative liability at inception.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_AssumptionOfLiabilitiesAsPartOfAssetPurchaseAgreement" xlink:to="SNYR_AssumptionOfLiabilitiesAsPartOfAssetPurchaseAgreement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_AssumptionOfLiabilitiesAsPartOfAssetPurchaseAgreement_doc" xml:lang="en-US">Assumption of liabilities as part of asset purchase agreement with Factor Nutrition Labs, LLC.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_CommonStockIssuedForConversionOfNotesPayable" xlink:to="SNYR_CommonStockIssuedForConversionOfNotesPayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_CommonStockIssuedForConversionOfNotesPayable_doc" xml:lang="en-US">Common stock issued for conversion of notes payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_WarehousingCostsPolicyTextBlock" xlink:to="SNYR_WarehousingCostsPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_WarehousingCostsPolicyTextBlock_doc" xml:lang="en-US">Warehousing Costs [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_ProductDisplayCostsPolicyTextBlock" xlink:to="SNYR_ProductDisplayCostsPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_ProductDisplayCostsPolicyTextBlock_doc" xml:lang="en-US">Product Display Costs [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_RelatedPartiesPolicyTextBlock" xlink:to="SNYR_RelatedPartiesPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_RelatedPartiesPolicyTextBlock_doc" xml:lang="en-US">Related Parties [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_SeptemberThirtyTwoThousandFifteenMember" xlink:to="SNYR_SeptemberThirtyTwoThousandFifteenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_SeptemberThirtyTwoThousandFifteenMember_doc" xml:lang="en-US">September 30, 2015 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_PresentValueOfFuturePayments" xlink:to="SNYR_PresentValueOfFuturePayments_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_PresentValueOfFuturePayments_doc" xml:lang="en-US">Present value of future payments.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_SecurityAgreementMember" xlink:to="SNYR_SecurityAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_SecurityAgreementMember_doc" xml:lang="en-US">Security Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_PercentageOfAmountReceviedFromSublicensess" xlink:to="SNYR_PercentageOfAmountReceviedFromSublicensess_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_PercentageOfAmountReceviedFromSublicensess_doc" xml:lang="en-US">Percentage of amount recevied from sublicensess.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_SecondYearMember" xlink:to="SNYR_SecondYearMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_SecondYearMember_doc" xml:lang="en-US">Second Year [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_ThiredYearMember" xlink:to="SNYR_ThiredYearMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_ThiredYearMember_doc" xml:lang="en-US">Thired Year [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_ConsultingFeePaid" xlink:to="SNYR_ConsultingFeePaid_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_ConsultingFeePaid_doc" xml:lang="en-US">Consulting fee paid.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BreakthroughProductsIncMember" xlink:to="SNYR_BreakthroughProductsIncMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_BreakthroughProductsIncMember_doc" xml:lang="en-US">Breakthrough Products, Inc [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_StockPurchaseAgreementMember" xlink:to="SNYR_StockPurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_StockPurchaseAgreementMember_doc" xml:lang="en-US">Stock Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_SettlementAgreementMember" xlink:to="SNYR_SettlementAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_SettlementAgreementMember_doc" xml:lang="en-US">Settlement Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_NoncompeteProvisionMember" xlink:to="SNYR_NoncompeteProvisionMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_NoncompeteProvisionMember_doc" xml:lang="en-US">Non-compete Provision [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_UrgentRxSellersMember" xlink:to="SNYR_UrgentRxSellersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_UrgentRxSellersMember_doc" xml:lang="en-US">UrgentRx Sellers [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_TprInvestmentsPtyLtdMember" xlink:to="SNYR_TprInvestmentsPtyLtdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_TprInvestmentsPtyLtdMember_doc" xml:lang="en-US">TPR Investments Pty Ltd [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_AustralianDollerMember" xlink:to="SNYR_AustralianDollerMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_AustralianDollerMember_doc" xml:lang="en-US">AUD [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaLicenseAgreement" xlink:to="SNYR_BusinessAcquisitionsProFormaLicenseAgreement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_BusinessAcquisitionsProFormaLicenseAgreement_doc" xml:lang="en-US">Business Acquisitions Pro Forma License Agreement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaRoyaltyPayable" xlink:to="SNYR_BusinessAcquisitionsProFormaRoyaltyPayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_BusinessAcquisitionsProFormaRoyaltyPayable_doc" xml:lang="en-US">Business Acquisitions Pro Forma Royalty Payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaOthers" xlink:to="SNYR_BusinessAcquisitionsProFormaOthers_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_BusinessAcquisitionsProFormaOthers_doc" xml:lang="en-US">Business Acquisitions Pro Forma Others.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaCash" xlink:to="SNYR_BusinessAcquisitionsProFormaCash_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_BusinessAcquisitionsProFormaCash_doc" xml:lang="en-US">Business Acquisitions Pro Forma Cash.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaPrepaidExpenses" xlink:to="SNYR_BusinessAcquisitionsProFormaPrepaidExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_BusinessAcquisitionsProFormaPrepaidExpenses_doc" xml:lang="en-US">Business Acquisitions Pro Forma Prepaid Expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaFixedAssetsNet" xlink:to="SNYR_BusinessAcquisitionsProFormaFixedAssetsNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_BusinessAcquisitionsProFormaFixedAssetsNet_doc" xml:lang="en-US">Business Acquisitions Pro Forma Fixed Assets Net.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaIntangibleAssetsNet" xlink:to="SNYR_BusinessAcquisitionsProFormaIntangibleAssetsNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_BusinessAcquisitionsProFormaIntangibleAssetsNet_doc" xml:lang="en-US">Business Acquisitions Pro Forma Intangible Assets Net.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaBloggerDatabase" xlink:to="SNYR_BusinessAcquisitionsProFormaBloggerDatabase_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_BusinessAcquisitionsProFormaBloggerDatabase_doc" xml:lang="en-US">Business Acquisitions Pro Forma Blogger Database.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaCustomerDatabase" xlink:to="SNYR_BusinessAcquisitionsProFormaCustomerDatabase_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_BusinessAcquisitionsProFormaCustomerDatabase_doc" xml:lang="en-US">Business Acquisitions Pro Forma Customer Database.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaDividendsPayable" xlink:to="SNYR_BusinessAcquisitionsProFormaDividendsPayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_BusinessAcquisitionsProFormaDividendsPayable_doc" xml:lang="en-US">Business Acquisitions Pro Forma Dividends Payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaProvisionForIncomeTax" xlink:to="SNYR_BusinessAcquisitionsProFormaProvisionForIncomeTax_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_BusinessAcquisitionsProFormaProvisionForIncomeTax_doc" xml:lang="en-US">Business Acquisitions Pro Forma Provision For Income Tax.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionCashPayment" xlink:to="SNYR_BusinessAcquisitionCashPayment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_BusinessAcquisitionCashPayment_doc" xml:lang="en-US">Business Acquisition Cash Payment.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsStockPayment" xlink:to="SNYR_BusinessAcquisitionsStockPayment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_BusinessAcquisitionsStockPayment_doc" xml:lang="en-US">BusinessAcquisitionsStockPayment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionStockWarrantsIssued" xlink:to="SNYR_BusinessAcquisitionStockWarrantsIssued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_BusinessAcquisitionStockWarrantsIssued_doc" xml:lang="en-US">Business Acquisition Stock Warrants Issued.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionStockIssued" xlink:to="SNYR_BusinessAcquisitionStockIssued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_BusinessAcquisitionStockIssued_doc" xml:lang="en-US">Business Acquisition Stock Issued.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionEarnoutPayment" xlink:to="SNYR_BusinessAcquisitionEarnoutPayment_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_BusinessAcquisitionEarnoutPayment_doc" xml:lang="en-US">Business Acquisition Earnout Payment.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_JanuaryTwentyTwoTwoThousandFifteenMember" xlink:to="SNYR_JanuaryTwentyTwoTwoThousandFifteenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_JanuaryTwentyTwoTwoThousandFifteenMember_doc" xml:lang="en-US">January 22, 2015 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_JanuaryTwentyTwoThousandSaventeenMember" xlink:to="SNYR_JanuaryTwentyTwoThousandSaventeenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_JanuaryTwentyTwoThousandSaventeenMember_doc" xml:lang="en-US">January 20, 2017 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_UrgentRxMember" xlink:to="SNYR_UrgentRxMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_UrgentRxMember_doc" xml:lang="en-US">UrgentRx [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_NomadChoiceMember" xlink:to="SNYR_NomadChoiceMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_NomadChoiceMember_doc" xml:lang="en-US">Nomad Choice [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_OperatingLossCarryforwardsExpirationYear" xlink:to="SNYR_OperatingLossCarryforwardsExpirationYear_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_OperatingLossCarryforwardsExpirationYear_doc" xml:lang="en-US">Operating loss carryforwards expiration year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_ValuationAllowancePercentage" xlink:to="SNYR_ValuationAllowancePercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_ValuationAllowancePercentage_doc" xml:lang="en-US">Valuation allowance percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_PrepaidExpensesTextBlock" xlink:to="SNYR_PrepaidExpensesTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_PrepaidExpensesTextBlock_doc" xml:lang="en-US">Prepaid Expenses [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_SummaryOfPrepaidExpensesTableTextBlock" xlink:to="SNYR_SummaryOfPrepaidExpensesTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_SummaryOfPrepaidExpensesTableTextBlock_doc" xml:lang="en-US">Summary Of Prepaid Expenses [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_PrepaidExpensesAdvancesForInventory" xlink:to="SNYR_PrepaidExpensesAdvancesForInventory_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_PrepaidExpensesAdvancesForInventory_doc" xml:lang="en-US">Prepaid Expenses Advances For Inventory.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_PrepaidExpencesMediaProduction" xlink:to="SNYR_PrepaidExpencesMediaProduction_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_PrepaidExpencesMediaProduction_doc" xml:lang="en-US">Prepaid Expences Media Production.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_PrepaidExpensesDeposits" xlink:to="SNYR_PrepaidExpensesDeposits_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_PrepaidExpensesDeposits_doc" xml:lang="en-US">Prepaid Expenses Deposits.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_SummaryOfMajorSuppliersTableTextBlock" xlink:to="SNYR_SummaryOfMajorSuppliersTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_SummaryOfMajorSuppliersTableTextBlock_doc" xml:lang="en-US">Summary Of Major Suppliers [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_NumberOfCustomerAccountedForAccountsReceivable" xlink:to="SNYR_NumberOfCustomerAccountedForAccountsReceivable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_NumberOfCustomerAccountedForAccountsReceivable_doc" xml:lang="en-US">Number of customer accounted for accounts receivable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_NameOfProduct" xlink:to="SNYR_NameOfProduct_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_NameOfProduct_doc" xml:lang="en-US">Name of the Product.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_AddressOfSuppliers" xlink:to="SNYR_AddressOfSuppliers_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_AddressOfSuppliers_doc" xml:lang="en-US">Address of the suppliers .</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_CityOfSuppliers" xlink:to="SNYR_CityOfSuppliers_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_CityOfSuppliers_doc" xml:lang="en-US">City of suppliers.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_SuppliersOneMember" xlink:to="SNYR_SuppliersOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_SuppliersOneMember_doc" xml:lang="en-US">Suppliers One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_SuppliersTwoMember" xlink:to="SNYR_SuppliersTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_SuppliersTwoMember_doc" xml:lang="en-US">Suppliers Two [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_SuppliersThreeMember" xlink:to="SNYR_SuppliersThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_SuppliersThreeMember_doc" xml:lang="en-US">Suppliers Three [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_SuppliersFourMember" xlink:to="SNYR_SuppliersFourMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_SuppliersFourMember_doc" xml:lang="en-US">Suppliers Four [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_OutstandingBalanceOfConsultingFees" xlink:to="SNYR_OutstandingBalanceOfConsultingFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_OutstandingBalanceOfConsultingFees_doc" xml:lang="en-US">Outstanding balance of consulting fees.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_LoanAgreementMember" xlink:to="SNYR_LoanAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_LoanAgreementMember_doc" xml:lang="en-US">Loan Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_MsHarshbargerMember" xlink:to="SNYR_MsHarshbargerMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_MsHarshbargerMember_doc" xml:lang="en-US">Ms. Harshbarger [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_RoyaltyDistributionAgreementMember" xlink:to="SNYR_RoyaltyDistributionAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_RoyaltyDistributionAgreementMember_doc" xml:lang="en-US">Royalty Distribution Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_ReturnsAllowanceAccruedLiabilities" xlink:to="SNYR_ReturnsAllowanceAccruedLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_ReturnsAllowanceAccruedLiabilities_doc" xml:lang="en-US">Returns Allowance Accrued Liabilities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_CustomersAccruedLiabilities" xlink:to="SNYR_CustomersAccruedLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_CustomersAccruedLiabilities_doc" xml:lang="en-US">Customers Accrued Liabilities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_InterestAccruedLiabilities" xlink:to="SNYR_InterestAccruedLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_InterestAccruedLiabilities_doc" xml:lang="en-US">Interest Accrued Liabilities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_RoyaltiesAccruedLiabilities" xlink:to="SNYR_RoyaltiesAccruedLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_RoyaltiesAccruedLiabilities_doc" xml:lang="en-US">Royalties Accrued Liabilities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_WarehousingAccruedLiabilities" xlink:to="SNYR_WarehousingAccruedLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_WarehousingAccruedLiabilities_doc" xml:lang="en-US">Warehousing Accrued Liabilities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_OriginationFeeMember" xlink:to="SNYR_OriginationFeeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_OriginationFeeMember_doc" xml:lang="en-US">Origination Fee [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_WorkFeeMember" xlink:to="SNYR_WorkFeeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_WorkFeeMember_doc" xml:lang="en-US">Work Fee [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_PercentageOfSharesPurchaseableUnderWarrants" xlink:to="SNYR_PercentageOfSharesPurchaseableUnderWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_PercentageOfSharesPurchaseableUnderWarrants_doc" xml:lang="en-US">Percentage of shares purchaseable under warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_AssetPurchaseAgreementMember" xlink:to="SNYR_AssetPurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_AssetPurchaseAgreementMember_doc" xml:lang="en-US">Asset Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_JanuaryTwentyTwoThousandFifteenLoanOneMember" xlink:to="SNYR_JanuaryTwentyTwoThousandFifteenLoanOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_JanuaryTwentyTwoThousandFifteenLoanOneMember_doc" xml:lang="en-US">January 22, 2015 Loan One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_JanuaryTwentyTwoTwoThousandFifteenLoanTwoMember" xlink:to="SNYR_JanuaryTwentyTwoTwoThousandFifteenLoanTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_JanuaryTwentyTwoTwoThousandFifteenLoanTwoMember_doc" xml:lang="en-US">January 22, 2015 Loan Two [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_JuneTwentySixTwoThousandFifteenMember" xlink:to="SNYR_JuneTwentySixTwoThousandFifteenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_JuneTwentySixTwoThousandFifteenMember_doc" xml:lang="en-US">June 26, 2015 Security Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_NeuragenCorpMember" xlink:to="SNYR_NeuragenCorpMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_NeuragenCorpMember_doc" xml:lang="en-US">Neuragen Corp [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_QuarterEndingSeptemberThirtyTwoThousandSaventeenMember" xlink:to="SNYR_QuarterEndingSeptemberThirtyTwoThousandSaventeenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_QuarterEndingSeptemberThirtyTwoThousandSaventeenMember_doc" xml:lang="en-US">Quarter Ending September 30, 2015 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_KnightWarrantsMember" xlink:to="SNYR_KnightWarrantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_KnightWarrantsMember_doc" xml:lang="en-US">Knight Warrants [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_KnightWarrantsOneMember" xlink:to="SNYR_KnightWarrantsOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_KnightWarrantsOneMember_doc" xml:lang="en-US">Knight Warrants One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_LoansPayableGross" xlink:to="SNYR_LoansPayableGross_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_LoansPayableGross_doc" xml:lang="en-US">Loans Payable Gross.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_NoteHolderMember" xlink:to="SNYR_NoteHolderMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_NoteHolderMember_doc" xml:lang="en-US">Note Holder [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_PrestockSplitShares" xlink:to="SNYR_PrestockSplitShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_PrestockSplitShares_doc" xml:lang="en-US">Pre-Stock Split shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_NovemberTwoThousandSixteenMember" xlink:to="SNYR_NovemberTwoThousandSixteenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_NovemberTwoThousandSixteenMember_doc" xml:lang="en-US">November 2016 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_DecemberTwoThousandSixteenMember" xlink:to="SNYR_DecemberTwoThousandSixteenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_DecemberTwoThousandSixteenMember_doc" xml:lang="en-US">December 2016 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_SubsidiaryMember" xlink:to="SNYR_SubsidiaryMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_SubsidiaryMember_doc" xml:lang="en-US">Subsidiary [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_TwoBoardMembersMember" xlink:to="SNYR_TwoBoardMembersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_TwoBoardMembersMember_doc" xml:lang="en-US">Two Board Members [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_TwoEmployeeMembersMember" xlink:to="SNYR_TwoEmployeeMembersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_TwoEmployeeMembersMember_doc" xml:lang="en-US">Two Employees Members [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_ExercisePriceRangeOneMember" xlink:to="SNYR_ExercisePriceRangeOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_ExercisePriceRangeOneMember_doc" xml:lang="en-US">Exercise Price Range One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_ExercisePriceRangeTwoMember" xlink:to="SNYR_ExercisePriceRangeTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_ExercisePriceRangeTwoMember_doc" xml:lang="en-US">Exercise Price Range Two [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_ExercisePriceRangeThreeMember" xlink:to="SNYR_ExercisePriceRangeThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_ExercisePriceRangeThreeMember_doc" xml:lang="en-US">Exercise Price Range Three [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_SummaryOfNetSalesAttributedToCustomersProductGroupTableTextBlock" xlink:to="SNYR_SummaryOfNetSalesAttributedToCustomersProductGroupTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_SummaryOfNetSalesAttributedToCustomersProductGroupTableTextBlock_doc" xml:lang="en-US">Summary of Net Sales Attributed to Customers Product Group [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_UnitedStatesMember" xlink:to="SNYR_UnitedStatesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_UnitedStatesMember_doc" xml:lang="en-US">United States [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_ForeignCountriesMember" xlink:to="SNYR_ForeignCountriesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_ForeignCountriesMember_doc" xml:lang="en-US">Foreign Countries [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_FlatTummyTeaMember" xlink:to="SNYR_FlatTummyTeaMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_FlatTummyTeaMember_doc" xml:lang="en-US">Flat Tummy Tea [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_OtherMember" xlink:to="SNYR_OtherMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_OtherMember_doc" xml:lang="en-US">Other [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_ScheduleOfLoanPayableTableTextBlock" xlink:to="SNYR_ScheduleOfLoanPayableTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_ScheduleOfLoanPayableTableTextBlock_doc" xml:lang="en-US">Schedule Of Loan Payable [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_CommonStockIssuedForCash" xlink:to="SNYR_CommonStockIssuedForCash_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_CommonStockIssuedForCash_doc" xml:lang="en-US">Common stock issued for cash.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_CommonStockIssuedForCashShares" xlink:to="SNYR_CommonStockIssuedForCashShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_CommonStockIssuedForCashShares_doc" xml:lang="en-US">Common stock issued for cash, shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_NoteIssuedAsPartOfAssetPurchaseAgreement" xlink:to="SNYR_NoteIssuedAsPartOfAssetPurchaseAgreement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_NoteIssuedAsPartOfAssetPurchaseAgreement_doc" xml:lang="en-US">Note issued as part of asset purchase agreement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BonusPaid" xlink:to="SNYR_BonusPaid_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="SNYR_BonusPaid_doc" xml:lang="en-US">Bonus paid.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_JanuaryTwentyTwoThousandSaventeenMember" xlink:to="SNYR_JanuaryTwentyTwoThousandSaventeenMember_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_JanuaryTwentyTwoThousandSaventeenMember_3_lbl" xml:lang="en-US">JanuaryTwentyTwoThousandSaventeenMember</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrent_2_lbl" xml:lang="en-US">Liabilities, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:to="us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable_2_lbl" xml:lang="en-US">Common Stock, Share Subscribed but Unissued, Subscriptions Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_4_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_2_lbl" xml:lang="en-US">Gross Profit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" xlink:to="us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts_2_lbl" xml:lang="en-US">Debt Related Commitment Fees and Debt Issuance Costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_2_lbl" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue_2_lbl" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_2_lbl" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_2_lbl" xml:lang="en-US">Amortization of Debt Discount (Premium)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseInRestrictedCash" xlink:to="us-gaap_IncreaseInRestrictedCash_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseInRestrictedCash_2_lbl" xml:lang="en-US">Increase in Restricted Cash</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="us-gaap_PaymentsForProceedsFromOtherInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForProceedsFromOtherInvestingActivities_2_lbl" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfNotesPayable_2_lbl" xml:lang="en-US">Repayments of Notes Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="us-gaap_PaymentsOfDebtIssuanceCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfDebtIssuanceCosts_2_lbl" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_2_lbl" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_CommonStockIssuedForConversionOfNotesPayable" xlink:to="SNYR_CommonStockIssuedForConversionOfNotesPayable_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_CommonStockIssuedForConversionOfNotesPayable_3_lbl" xml:lang="en-US">CommonStockIssuedForConversionOfNotesPayable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancingReceivablesTextBlock" xlink:to="us-gaap_FinancingReceivablesTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinancingReceivablesTextBlock_2_lbl" xml:lang="en-US">Financing Receivables [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_2_lbl" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_StockWarrantsDisclosureTextBlock" xlink:to="SNYR_StockWarrantsDisclosureTextBlock_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_StockWarrantsDisclosureTextBlock_3_lbl" xml:lang="en-US">StockWarrantsDisclosureTextBlock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy_2_lbl" xml:lang="en-US">Trade and Other Accounts Receivable, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_2_lbl" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryPolicyTextBlock_2_lbl" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_2_lbl" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfSalesPolicyTextBlock" xlink:to="us-gaap_CostOfSalesPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfSalesPolicyTextBlock_2_lbl" xml:lang="en-US">Cost of Sales, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaAccountsReceivable" xlink:to="SNYR_BusinessAcquisitionsProFormaAccountsReceivable_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_BusinessAcquisitionsProFormaAccountsReceivable_3_lbl" xml:lang="en-US">BusinessAcquisitionsProFormaAccountsReceivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaInventory" xlink:to="SNYR_BusinessAcquisitionsProFormaInventory_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_BusinessAcquisitionsProFormaInventory_3_lbl" xml:lang="en-US">BusinessAcquisitionsProFormaInventory</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaPrepaidExpenses" xlink:to="SNYR_BusinessAcquisitionsProFormaPrepaidExpenses_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_BusinessAcquisitionsProFormaPrepaidExpenses_3_lbl" xml:lang="en-US">BusinessAcquisitionsProFormaPrepaidExpenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaGoodwill" xlink:to="SNYR_BusinessAcquisitionsProFormaGoodwill_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_BusinessAcquisitionsProFormaGoodwill_3_lbl" xml:lang="en-US">BusinessAcquisitionsProFormaGoodwill</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaAccountsPayable" xlink:to="SNYR_BusinessAcquisitionsProFormaAccountsPayable_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_BusinessAcquisitionsProFormaAccountsPayable_3_lbl" xml:lang="en-US">BusinessAcquisitionsProFormaAccountsPayable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaRoyaltyPayable" xlink:to="SNYR_BusinessAcquisitionsProFormaRoyaltyPayable_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_BusinessAcquisitionsProFormaRoyaltyPayable_3_lbl" xml:lang="en-US">BusinessAcquisitionsProFormaRoyaltyPayable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaAccruedExpenses" xlink:to="SNYR_BusinessAcquisitionsProFormaAccruedExpenses_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_BusinessAcquisitionsProFormaAccruedExpenses_3_lbl" xml:lang="en-US">BusinessAcquisitionsProFormaAccruedExpenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_BusinessAcquisitionsProFormaTotalLiabilities" xlink:to="SNYR_BusinessAcquisitionsProFormaTotalLiabilities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_BusinessAcquisitionsProFormaTotalLiabilities_3_lbl" xml:lang="en-US">BusinessAcquisitionsProFormaTotalLiabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="us-gaap_BusinessAcquisitionsProFormaRevenue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue_2_lbl" xml:lang="en-US">Business Acquisition, Pro Forma Revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrentAndNoncurrent" xlink:to="us-gaap_PrepaidExpenseCurrentAndNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseCurrentAndNoncurrent_2_lbl" xml:lang="en-US">Prepaid Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentForAmortization" xlink:to="us-gaap_AdjustmentForAmortization_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentForAmortization_2_lbl" xml:lang="en-US">Amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_2_lbl" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_InterestAccruedLiabilities" xlink:to="SNYR_InterestAccruedLiabilities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_InterestAccruedLiabilities_3_lbl" xml:lang="en-US">InterestAccruedLiabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_2_lbl" xml:lang="en-US">Accounts Payable and Accrued Liabilities [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_2_lbl" xml:lang="en-US">Operating Leases, Future Minimum Payments Due, Next Twelve Months</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_2_lbl" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Two Years</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_2_lbl" xml:lang="en-US">Operating Leases, Future Minimum Payments Due</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePriceEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePriceEquityInstrumentsOtherThanOptionsNonvestedNumber_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePriceEquityInstrumentsOtherThanOptionsNonvestedNumber_4_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePriceEquityInstrumentsOtherThanOptionsNonvestedNumber</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageExercisePrice" xlink:to="SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageExercisePrice</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>19
<FILENAME>snyr-20151231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 4.11b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: SNYR %2D 20151231 10K FY DFN.xfr; Date: 2016%2D03%2D30T14:49:24Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80130003 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://synergystripscorp.com/role/DocumentAndEntityInformation" xlink:href="snyr-20151231.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/BalanceSheets" xlink:href="snyr-20151231.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/BalanceSheetsParenthetical" xlink:href="snyr-20151231.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/StatementsOfOperations" xlink:href="snyr-20151231.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/StatementOfStockholdersEquityDeficit" xlink:href="snyr-20151231.xsd#StatementOfStockholdersEquityDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/StatementsOfCashFlows" xlink:href="snyr-20151231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/NatureOfBusiness" xlink:href="snyr-20151231.xsd#NatureOfBusiness" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="snyr-20151231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/Acquisitions" xlink:href="snyr-20151231.xsd#Acquisitions" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/IncomeTaxes" xlink:href="snyr-20151231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/AccountsReceivable" xlink:href="snyr-20151231.xsd#AccountsReceivable" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/PrepaidExpenses" xlink:href="snyr-20151231.xsd#PrepaidExpenses" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/ConcentrationOfCreditRisk" xlink:href="snyr-20151231.xsd#ConcentrationOfCreditRisk" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/Inventory" xlink:href="snyr-20151231.xsd#Inventory" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssets" xlink:href="snyr-20151231.xsd#FixedAssetsAndIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/RelatedPartyTransactions" xlink:href="snyr-20151231.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/AccountsPayableAndAccruedLiabilities" xlink:href="snyr-20151231.xsd#AccountsPayableAndAccruedLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/NotesPayable" xlink:href="snyr-20151231.xsd#NotesPayable" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/StockholdersDeficit" xlink:href="snyr-20151231.xsd#StockholdersDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/CommitmentsAndContingencies" xlink:href="snyr-20151231.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/StockOptions" xlink:href="snyr-20151231.xsd#StockOptions" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/StockWarrants" xlink:href="snyr-20151231.xsd#StockWarrants" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/Derivatives" xlink:href="snyr-20151231.xsd#Derivatives" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/Segments" xlink:href="snyr-20151231.xsd#Segments" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/SubsequentEvents" xlink:href="snyr-20151231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="snyr-20151231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="snyr-20151231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/AcquisitionsTables" xlink:href="snyr-20151231.xsd#AcquisitionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/IncomeTaxesTables" xlink:href="snyr-20151231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/AccountsReceivableTables" xlink:href="snyr-20151231.xsd#AccountsReceivableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/PrepaidExpensesTables" xlink:href="snyr-20151231.xsd#PrepaidExpensesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/ConcentrationOfCreditRiskTables" xlink:href="snyr-20151231.xsd#ConcentrationOfCreditRiskTables" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/InventoryTables" xlink:href="snyr-20151231.xsd#InventoryTables" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssetsTables" xlink:href="snyr-20151231.xsd#FixedAssetsAndIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:href="snyr-20151231.xsd#AccountsPayableAndAccruedLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/NotesPayableTables" xlink:href="snyr-20151231.xsd#NotesPayableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/CommitmentsAndContingenciesTables" xlink:href="snyr-20151231.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/StockOptionsTables" xlink:href="snyr-20151231.xsd#StockOptionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/StockWarrantsTables" xlink:href="snyr-20151231.xsd#StockWarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/DerivativesTables" xlink:href="snyr-20151231.xsd#DerivativesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/SegmentsTables" xlink:href="snyr-20151231.xsd#SegmentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="snyr-20151231.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfAssumptionsUsedForFairValueOfWarrantDerivativeLiabilitiesDetails" xlink:href="snyr-20151231.xsd#SummaryOfSignificantAccountingPolicies-ScheduleOfAssumptionsUsedForFairValueOfWarrantDerivativeLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/AcquisitionsDetailsNarrative" xlink:href="snyr-20151231.xsd#AcquisitionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/Acquisitions-PurchasePriceAllocationAssetsAcquiredAndLiabilitiesAssumedOnEstimatedFairValuesDetails" xlink:href="snyr-20151231.xsd#Acquisitions-PurchasePriceAllocationAssetsAcquiredAndLiabilitiesAssumedOnEstimatedFairValuesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/Acquisitions-PurchasePriceAllocatedToAcquisitionOfAssetsDetails" xlink:href="snyr-20151231.xsd#Acquisitions-PurchasePriceAllocatedToAcquisitionOfAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/Acquisitions-ProFormaResultsOfAcquisitionDetails" xlink:href="snyr-20151231.xsd#Acquisitions-ProFormaResultsOfAcquisitionDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/IncomeTaxesDetailsNarrative" xlink:href="snyr-20151231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/IncomeTaxes-ScheduleOfEffectiveIncomeTaxRateDetails" xlink:href="snyr-20151231.xsd#IncomeTaxes-ScheduleOfEffectiveIncomeTaxRateDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/IncomeTaxes-ScheduleOfDeferredIncomeTaxAssetsDetails" xlink:href="snyr-20151231.xsd#IncomeTaxes-ScheduleOfDeferredIncomeTaxAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/AccountsReceivableDetailsNarrative" xlink:href="snyr-20151231.xsd#AccountsReceivableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/AccountsReceivable-AccountsReceivableNetOfAllowancesDetails" xlink:href="snyr-20151231.xsd#AccountsReceivable-AccountsReceivableNetOfAllowancesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/PrepaidExpenses-SummaryOfPrepaidExpensesDetails" xlink:href="snyr-20151231.xsd#PrepaidExpenses-SummaryOfPrepaidExpensesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/ConcentrationOfCreditRiskDetailsNarrative" xlink:href="snyr-20151231.xsd#ConcentrationOfCreditRiskDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/ConcentrationOfCreditRisk-SummaryOfMajorSuppliersDetails" xlink:href="snyr-20151231.xsd#ConcentrationOfCreditRisk-SummaryOfMajorSuppliersDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/Inventory-ScheduleOfCarryingValueOfInventoryDetails" xlink:href="snyr-20151231.xsd#Inventory-ScheduleOfCarryingValueOfInventoryDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssetsDetailsNarrative" xlink:href="snyr-20151231.xsd#FixedAssetsAndIntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssets-SummaryOfFixedAndIntangibleAssetsDetails" xlink:href="snyr-20151231.xsd#FixedAssetsAndIntangibleAssets-SummaryOfFixedAndIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssets-SummaryOfEstimatedAggregateAmortizationExpenseDetails" xlink:href="snyr-20151231.xsd#FixedAssetsAndIntangibleAssets-SummaryOfEstimatedAggregateAmortizationExpenseDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="snyr-20151231.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/AccountsPayableAndAccruedLiabilities-ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" xlink:href="snyr-20151231.xsd#AccountsPayableAndAccruedLiabilities-ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/NotesPayableDetailsNarrative" xlink:href="snyr-20151231.xsd#NotesPayableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/NotesPayable-ScheduleOfLoanPayableDetails" xlink:href="snyr-20151231.xsd#NotesPayable-ScheduleOfLoanPayableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/StockholdersDeficitDetailsNarrative" xlink:href="snyr-20151231.xsd#StockholdersDeficitDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="snyr-20151231.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/CommitmentsAndContingencies-ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" xlink:href="snyr-20151231.xsd#CommitmentsAndContingencies-ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/StockOptionsDetailsNarrative" xlink:href="snyr-20151231.xsd#StockOptionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/StockOptions-SummaryOfOptionsOutstandingByPriceRangeDetails" xlink:href="snyr-20151231.xsd#StockOptions-SummaryOfOptionsOutstandingByPriceRangeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/StockOptions-SummaryOfStockOptionsActivityDetails" xlink:href="snyr-20151231.xsd#StockOptions-SummaryOfStockOptionsActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/StockWarrants-SummaryOfWarrantsOutstandingByPriceRangeDetails" xlink:href="snyr-20151231.xsd#StockWarrants-SummaryOfWarrantsOutstandingByPriceRangeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/StockWarrants-SummaryOfStockWarrantsActivityDetails" xlink:href="snyr-20151231.xsd#StockWarrants-SummaryOfStockWarrantsActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/DerivativesDetailsNarrative" xlink:href="snyr-20151231.xsd#DerivativesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/Derivatives-ScheduleOfAssumptionsUsedForFairValueOfDerivativeDetails" xlink:href="snyr-20151231.xsd#Derivatives-ScheduleOfAssumptionsUsedForFairValueOfDerivativeDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/Segments-SummaryOfNetSalesAttributedToCustomersGeographicalSegmentDetails" xlink:href="snyr-20151231.xsd#Segments-SummaryOfNetSalesAttributedToCustomersGeographicalSegmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/Segments-SummaryOfNetSalesAttributedToCustomersProductGroupDetails" xlink:href="snyr-20151231.xsd#Segments-SummaryOfNetSalesAttributedToCustomersProductGroupDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/Segments-SummaryOfNetSalesAttributedToCustomersProductGroupDetailsParenthetical" xlink:href="snyr-20151231.xsd#Segments-SummaryOfNetSalesAttributedToCustomersProductGroupDetailsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://synergystripscorp.com/role/Segments-SummaryOfLong-livedAssetsNetAttributableToOperationsGeographicalSegmentDetails" xlink:href="snyr-20151231.xsd#Segments-SummaryOfLong-livedAssetsNetAttributableToOperationsGeographicalSegmentDetails" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information">
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_DocumentAndEntityInformationAbstract" xlink:label="loc_SNYRDocumentAndEntityInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SNYRDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SNYRDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SNYRDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SNYRDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SNYRDocumentAndEntityInformationAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SNYRDocumentAndEntityInformationAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SNYRDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SNYRDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SNYRDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SNYRDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SNYRDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SNYRDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SNYRDocumentAndEntityInformationAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SNYRDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SNYRDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents" xlink:label="loc_us-gaapRestrictedCashAndCashEquivalents" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapRestrictedCashAndCashEquivalents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DueFromRelatedPartiesCurrent" xlink:label="loc_us-gaapDueFromRelatedPartiesCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapDueFromRelatedPartiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense" xlink:label="loc_us-gaapUnamortizedDebtIssuanceExpense" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapUnamortizedDebtIssuanceExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TaxesPayableCurrent" xlink:label="loc_us-gaapTaxesPayableCurrent" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapTaxesPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLongTermDebtCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="loc_us-gaapDerivativeLiabilitiesCurrent" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapDerivativeLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_RoyaltyPayable" xlink:label="loc_SNYRRoyaltyPayable" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_SNYRRoyaltyPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermNotesPayable" xlink:label="loc_us-gaapLongTermNotesPayable" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLongTermNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:label="loc_us-gaapCommonStockShareSubscribedButUnissuedSubscriptionsReceivable" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockShareSubscribedButUnissuedSubscriptionsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Consolidated Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CostOfGoodsSold" xlink:label="loc_us-gaapCostOfGoodsSold" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapCostOfGoodsSold" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherIncomeAndExpensesAbstract" xlink:label="loc_us-gaapOtherIncomeAndExpensesAbstract" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestIncomeExpenseNet" xlink:label="loc_us-gaapInterestIncomeExpenseNet" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapInterestIncomeExpenseNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainBeforeTax" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionGainBeforeTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:label="loc_us-gaapGainLossOnDerivativeInstrumentsNetPretax" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapGainLossOnDerivativeInstrumentsNetPretax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestmentIncomeAmortizationOfDiscount" xlink:label="loc_us-gaapInvestmentIncomeAmortizationOfDiscount" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapInvestmentIncomeAmortizationOfDiscount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts" xlink:label="loc_us-gaapDebtRelatedCommitmentFeesAndDebtIssuanceCosts" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapDebtRelatedCommitmentFeesAndDebtIssuanceCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestExpenseOther" xlink:label="loc_us-gaapInterestExpenseOther" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapInterestExpenseOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOtherIncomeAndExpensesAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaapEarningsPerShareBasicAndDiluted" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicAndDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/StatementOfStockholdersEquityDeficit" xlink:title="00000005 - Statement - Consolidated Statement of Stockholders' Equity (Deficit)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CommonStockToBeIssuedMember" xlink:label="loc_SNYRCommonStockToBeIssuedMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_SNYRCommonStockToBeIssuedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CommonStockIssuedForCash" xlink:label="loc_SNYRCommonStockIssuedForCash" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRCommonStockIssuedForCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CommonStockIssuedForCashShares" xlink:label="loc_SNYRCommonStockIssuedForCashShares" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRCommonStockIssuedForCashShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptions" xlink:label="loc_SNYRAdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptions" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRAdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CommonStockIssuedAsPartOfContributionAgreement" xlink:label="loc_SNYRCommonStockIssuedAsPartOfContributionAgreement" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRCommonStockIssuedAsPartOfContributionAgreement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CommonStockIssuedAsPartOfContributionAgreementShares" xlink:label="loc_SNYRCommonStockIssuedAsPartOfContributionAgreementShares" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRCommonStockIssuedAsPartOfContributionAgreementShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CommonStockIssuedForAcquisitions" xlink:label="loc_SNYRCommonStockIssuedForAcquisitions" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRCommonStockIssuedForAcquisitions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CommonStockIssuedForAcquisitionsShares" xlink:label="loc_SNYRCommonStockIssuedForAcquisitionsShares" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRCommonStockIssuedForAcquisitionsShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CommonStockIssuedForAcquisitionsOne" xlink:label="loc_SNYRCommonStockIssuedForAcquisitionsOne" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRCommonStockIssuedForAcquisitionsOne" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CommonStockIssuedForAcquisitionsOneShares" xlink:label="loc_SNYRCommonStockIssuedForAcquisitionsOneShares" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRCommonStockIssuedForAcquisitionsOneShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CommonStockIssuedToSettleAccountsPayable" xlink:label="loc_SNYRCommonStockIssuedToSettleAccountsPayable" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRCommonStockIssuedToSettleAccountsPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CommonStockIssuedToSettleAccountsPayableShares" xlink:label="loc_SNYRCommonStockIssuedToSettleAccountsPayableShares" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRCommonStockIssuedToSettleAccountsPayableShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueOther" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesOther" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants" xlink:label="loc_us-gaapFairValueAdjustmentOfWarrants" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFairValueAdjustmentOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_GainsLossesOnAcquisition" xlink:label="loc_SNYRGainsLossesOnAcquisition" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_SNYRGainsLossesOnAcquisition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:label="loc_us-gaapGainLossOnDerivativeInstrumentsNetPretax" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapGainLossOnDerivativeInstrumentsNetPretax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainBeforeTax" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionGainBeforeTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncreaseInRestrictedCash" xlink:label="loc_us-gaapIncreaseInRestrictedCash" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseInRestrictedCash" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:label="loc_us-gaapPaymentsForProceedsFromOtherInvestingActivities" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaapPaymentsToAcquireBusinessesGross" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireBusinessesGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherPaymentsToAcquireBusinesses" xlink:label="loc_us-gaapOtherPaymentsToAcquireBusinesses" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapOtherPaymentsToAcquireBusinesses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAcquiredFromAcquisition" xlink:label="loc_us-gaapCashAcquiredFromAcquisition" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapCashAcquiredFromAcquisition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRepaymentsOfRelatedPartyDebt" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromRepaymentsOfRelatedPartyDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfDebtIssuanceCosts" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsOfDebtIssuanceCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsOfDividends" xlink:label="loc_us-gaapPaymentsOfDividends" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsOfDividends" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities" xlink:label="loc_us-gaapProceedsFromDerivativeInstrumentFinancingActivities" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromDerivativeInstrumentFinancingActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_2" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CashPaidDuringPeriodAbstract" xlink:label="loc_SNYRCashPaidDuringPeriodAbstract" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_SNYRCashPaidDuringPeriodAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestPaid" xlink:label="loc_us-gaapInterestPaid" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SNYRCashPaidDuringPeriodAbstract" xlink:to="loc_us-gaapInterestPaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaapIncomeTaxesPaidNet" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SNYRCashPaidDuringPeriodAbstract" xlink:to="loc_us-gaapIncomeTaxesPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CommonStockIssuedForConversionOfNotesPayable" xlink:label="loc_SNYRCommonStockIssuedForConversionOfNotesPayable" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_SNYRCommonStockIssuedForConversionOfNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentAmount1" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentAmount1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_DerivativeLiabilityAtInception" xlink:label="loc_SNYRDerivativeLiabilityAtInception" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_SNYRDerivativeLiabilityAtInception" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_AssumptionOfLiabilitiesAsPartOfAssetPurchaseAgreement" xlink:label="loc_SNYRAssumptionOfLiabilitiesAsPartOfAssetPurchaseAgreement" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_SNYRAssumptionOfLiabilitiesAsPartOfAssetPurchaseAgreement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_LiabilitiesAssumedRelatedParty" xlink:label="loc_SNYRLiabilitiesAssumedRelatedParty" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_SNYRLiabilitiesAssumedRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_NoteIssuedAsPartOfAssetPurchaseAgreement" xlink:label="loc_SNYRNoteIssuedAsPartOfAssetPurchaseAgreement" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_SNYRNoteIssuedAsPartOfAssetPurchaseAgreement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CommonStockIssuedAsPartOfContributionAgreement" xlink:label="loc_SNYRCommonStockIssuedAsPartOfContributionAgreement" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_SNYRCommonStockIssuedAsPartOfContributionAgreement" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CommonStockIssuedForAcquisitionOne" xlink:label="loc_SNYRCommonStockIssuedForAcquisitionOne" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_SNYRCommonStockIssuedForAcquisitionOne" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CommonStockIssuedForAcquisition" xlink:label="loc_SNYRCommonStockIssuedForAcquisition" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_SNYRCommonStockIssuedForAcquisition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_FairValueOfWarrantsIssuedAsPartOfAcquisition" xlink:label="loc_SNYRFairValueOfWarrantsIssuedAsPartOfAcquisition" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_SNYRFairValueOfWarrantsIssuedAsPartOfAcquisition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_NetLiabilitiesTakenOverAsPartOfAcquisition" xlink:label="loc_SNYRNetLiabilitiesTakenOverAsPartOfAcquisition" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_SNYRNetLiabilitiesTakenOverAsPartOfAcquisition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_NetAssetsTakenOverAsPartOfAcquisition" xlink:label="loc_SNYRNetAssetsTakenOverAsPartOfAcquisition" />
      <link:presentationArc order="590" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_SNYRNetAssetsTakenOverAsPartOfAcquisition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConversionOfStockAmountConverted1" xlink:label="loc_us-gaapConversionOfStockAmountConverted1" />
      <link:presentationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_us-gaapConversionOfStockAmountConverted1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CancellationOfCommonStockAsPartOfPurchaseTransaction" xlink:label="loc_SNYRCancellationOfCommonStockAsPartOfPurchaseTransaction" />
      <link:presentationArc order="610" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_SNYRCancellationOfCommonStockAsPartOfPurchaseTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_FinancingForPrepaidInsurance" xlink:label="loc_SNYRFinancingForPrepaidInsurance" />
      <link:presentationArc order="620" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_SNYRFinancingForPrepaidInsurance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LiabilitiesAssumed1" xlink:label="loc_us-gaapLiabilitiesAssumed1" />
      <link:presentationArc order="630" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_us-gaapLiabilitiesAssumed1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_IssuanceOfSharesAsPartOfAcquisitionTransaction" xlink:label="loc_SNYRIssuanceOfSharesAsPartOfAcquisitionTransaction" />
      <link:presentationArc order="640" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_SNYRIssuanceOfSharesAsPartOfAcquisitionTransaction" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/NatureOfBusiness" xlink:title="00000007 - Disclosure - Nature of the Business">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="loc_us-gaapNatureOfOperations" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapNatureOfOperations" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - Summary of Significant Accounting Policies">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/Acquisitions" xlink:title="00000009 - Disclosure - Acquisitions">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaapBusinessCombinationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="loc_us-gaapBusinessCombinationDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapBusinessCombinationDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/IncomeTaxes" xlink:title="00000010 - Disclosure - Income Taxes">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/AccountsReceivable" xlink:title="00000011 - Disclosure - Accounts Receivable">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FinancingReceivablesTextBlock" xlink:label="loc_us-gaapFinancingReceivablesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapFinancingReceivablesTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/PrepaidExpenses" xlink:title="00000012 - Disclosure - Prepaid Expenses">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsAbstract" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_PrepaidExpensesTextBlock" xlink:label="loc_SNYRPrepaidExpensesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPrepaidExpenseAndOtherAssetsAbstract" xlink:to="loc_SNYRPrepaidExpensesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/ConcentrationOfCreditRisk" xlink:title="00000013 - Disclosure - Concentration of Credit Risk">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaapRisksAndUncertaintiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:label="loc_us-gaapConcentrationRiskDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRisksAndUncertaintiesAbstract" xlink:to="loc_us-gaapConcentrationRiskDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/Inventory" xlink:title="00000014 - Disclosure - Inventory">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaapInventoryDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssets" xlink:title="00000015 - Disclosure - Fixed Assets and Intangible Assets">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_FixedAssetsAndIntangibleAssetsTextBlock" xlink:label="loc_SNYRFixedAssetsAndIntangibleAssetsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_SNYRFixedAssetsAndIntangibleAssetsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/RelatedPartyTransactions" xlink:title="00000016 - Disclosure - Related Party Transactions">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/AccountsPayableAndAccruedLiabilities" xlink:title="00000017 - Disclosure - Accounts Payable and Accrued Liabilities">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/NotesPayable" xlink:title="00000018 - Disclosure - Notes Payable">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaapDebtDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/StockholdersDeficit" xlink:title="00000019 - Disclosure - Stockholders' Deficit">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/CommitmentsAndContingencies" xlink:title="00000020 - Disclosure - Commitments and Contingencies">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/StockOptions" xlink:title="00000021 - Disclosure - Stock Options">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/StockWarrants" xlink:title="00000022 - Disclosure - Stock Warrants">
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_StockWarrantsAbstract" xlink:label="loc_SNYRStockWarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_StockWarrantsDisclosureTextBlock" xlink:label="loc_SNYRStockWarrantsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SNYRStockWarrantsAbstract" xlink:to="loc_SNYRStockWarrantsDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/Derivatives" xlink:title="00000023 - Disclosure - Derivatives">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:label="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/Segments" xlink:title="00000024 - Disclosure - Segments">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaapSegmentReportingDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapSegmentReportingDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/SubsequentEvents" xlink:title="00000025 - Disclosure - Subsequent Events">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000026 - Disclosure - Summary of Significant Accounting Policies (Policies)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaapRevenueRecognitionPolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRecognitionPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="loc_us-gaapTradeAndOtherAccountsReceivablePolicy" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapTradeAndOtherAccountsReceivablePolicy" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock" xlink:label="loc_us-gaapAdvertisingCostsPolicyTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapAdvertisingCostsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="loc_us-gaapResearchAndDevelopmentExpensePolicy" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpensePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_GoingConcernPolicyTextBlock" xlink:label="loc_SNYRGoingConcernPolicyTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_SNYRGoingConcernPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="loc_us-gaapFairValueMeasurementPolicyPolicyTextBlock" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaapInventoryPolicyTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInventoryPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsGoodwillPolicy" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaapConcentrationRiskCreditRisk" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConcentrationRiskCreditRisk" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_WarehousingCostsPolicyTextBlock" xlink:label="loc_SNYRWarehousingCostsPolicyTextBlock" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_SNYRWarehousingCostsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ProductDisplayCostsPolicyTextBlock" xlink:label="loc_SNYRProductDisplayCostsPolicyTextBlock" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_SNYRProductDisplayCostsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="loc_us-gaapDerivativesPolicyTextBlock" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDerivativesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock" xlink:label="loc_us-gaapCostOfSalesPolicyTextBlock" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCostOfSalesPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtPolicyTextBlock" xlink:label="loc_us-gaapDebtPolicyTextBlock" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDebtPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_2" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShippingAndHandlingCostPolicyTextBlock" xlink:label="loc_us-gaapShippingAndHandlingCostPolicyTextBlock" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapShippingAndHandlingCostPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_RelatedPartiesPolicyTextBlock" xlink:label="loc_SNYRRelatedPartiesPolicyTextBlock" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_SNYRRelatedPartiesPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="loc_us-gaapSegmentReportingPolicyPolicyTextBlock" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSegmentReportingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiscalPeriod" xlink:label="loc_us-gaapFiscalPeriod" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFiscalPeriod" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000027 - Disclosure - Summary of Significant Accounting Policies (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/AcquisitionsTables" xlink:title="00000028 - Disclosure - Acquisitions (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaapBusinessCombinationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_FactorNutritionLabsLLCMember" xlink:label="loc_SNYRFactorNutritionLabsLLCMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_SNYRFactorNutritionLabsLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_KnightTherapeuticsIncMember" xlink:label="loc_SNYRKnightTherapeuticsIncMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRKnightTherapeuticsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_HandMDLLCMember" xlink:label="loc_SNYRHandMDLLCMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRHandMDLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BreakthroughProductsIncMember" xlink:label="loc_SNYRBreakthroughProductsIncMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRBreakthroughProductsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_TprInvestmentsPtyLtdMember" xlink:label="loc_SNYRTprInvestmentsPtyLtdMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRTprInvestmentsPtyLtdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="loc_us-gaapScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock" xlink:label="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:label="loc_us-gaapBusinessAcquisitionProFormaInformationTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/IncomeTaxesTables" xlink:title="00000029 - Disclosure - Income Taxes (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/AccountsReceivableTables" xlink:title="00000030 - Disclosure - Accounts Receivable (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:label="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/PrepaidExpensesTables" xlink:title="00000031 - Disclosure - Prepaid Expenses (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsAbstract" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_SummaryOfPrepaidExpensesTableTextBlock" xlink:label="loc_SNYRSummaryOfPrepaidExpensesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPrepaidExpenseAndOtherAssetsAbstract" xlink:to="loc_SNYRSummaryOfPrepaidExpensesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/ConcentrationOfCreditRiskTables" xlink:title="00000032 - Disclosure - Concentration of Credit Risk (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaapRisksAndUncertaintiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_SummaryOfMajorSuppliersTableTextBlock" xlink:label="loc_SNYRSummaryOfMajorSuppliersTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRisksAndUncertaintiesAbstract" xlink:to="loc_SNYRSummaryOfMajorSuppliersTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/InventoryTables" xlink:title="00000033 - Disclosure - Inventory (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssetsTables" xlink:title="00000034 - Disclosure - Fixed Assets and Intangible Assets (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_SummaryOfFixedAndIntangibleAssetsTableTextblock" xlink:label="loc_SNYRSummaryOfFixedAndIntangibleAssetsTableTextblock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_SNYRSummaryOfFixedAndIntangibleAssetsTableTextblock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/AccountsPayableAndAccruedLiabilitiesTables" xlink:title="00000035 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/NotesPayableTables" xlink:title="00000036 - Disclosure - Notes Payable (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ScheduleOfLoanPayableTableTextBlock" xlink:label="loc_SNYRScheduleOfLoanPayableTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_SNYRScheduleOfLoanPayableTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/CommitmentsAndContingenciesTables" xlink:title="00000037 - Disclosure - Commitments and Contingencies (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_SubsidiaryMember" xlink:label="loc_SNYRSubsidiaryMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRSubsidiaryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="loc_us-gaapScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/StockOptionsTables" xlink:title="00000038 - Disclosure - Stock Options (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/StockWarrantsTables" xlink:title="00000039 - Disclosure - Stock Warrants (Tables)">
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_StockWarrantsAbstract" xlink:label="loc_SNYRStockWarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockWarrantsPlansByExercisePriceRangeTextBlock" xlink:label="loc_SNYRScheduleOfShareBasedCompensationSharesAuthorizedUnderStockWarrantsPlansByExercisePriceRangeTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SNYRStockWarrantsAbstract" xlink:to="loc_SNYRScheduleOfShareBasedCompensationSharesAuthorizedUnderStockWarrantsPlansByExercisePriceRangeTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SNYRStockWarrantsAbstract" xlink:to="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/DerivativesTables" xlink:title="00000040 - Disclosure - Derivatives (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:label="loc_us-gaapScheduleOfDerivativeAssetsAtFairValueTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/SegmentsTables" xlink:title="00000041 - Disclosure - Segments (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:label="loc_us-gaapRevenueFromExternalCustomersByGeographicAreasTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapRevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_SummaryOfNetSalesAttributedToCustomersProductGroupTableTextBlock" xlink:label="loc_SNYRSummaryOfNetSalesAttributedToCustomersProductGroupTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_SNYRSummaryOfNetSalesAttributedToCustomersProductGroupTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:label="loc_us-gaapLongLivedAssetsByGeographicAreasTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapLongLivedAssetsByGeographicAreasTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000042 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="loc_us-gaapCashFDICInsuredAmount" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashFDICInsuredAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashUninsuredAmount" xlink:label="loc_us-gaapCashUninsuredAmount" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashUninsuredAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_OptionToPurchaseOfCommonStock" xlink:label="loc_SNYROptionToPurchaseOfCommonStock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_SNYROptionToPurchaseOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_WarrantsToPurchaseOfCommonStock" xlink:label="loc_SNYRWarrantsToPurchaseOfCommonStock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_SNYRWarrantsToPurchaseOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_WorkingCapital" xlink:label="loc_SNYRWorkingCapital" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_SNYRWorkingCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="loc_us-gaapNumberOfOperatingSegments" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNumberOfOperatingSegments" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfAssumptionsUsedForFairValueOfWarrantDerivativeLiabilitiesDetails" xlink:title="00000043 - Disclosure - Summary of Significant Accounting Policies - Schedule of Assumptions Used for Fair Value of Warrant Derivative Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharePrice" xlink:label="loc_us-gaapSharePrice" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSharePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsExercisePrice" xlink:label="loc_us-gaapFairValueAssumptionsExercisePrice" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueAssumptionsExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsExpectedTerm" xlink:label="loc_us-gaapFairValueAssumptionsExpectedTerm" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueAssumptionsExpectedTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueAssumptionsExpectedDividendRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/AcquisitionsDetailsNarrative" xlink:title="00000044 - Disclosure - Acquisitions (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaapBusinessCombinationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaapTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTitleOfIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_FocusFactorBusinessMember" xlink:label="loc_SNYRFocusFactorBusinessMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SNYRFocusFactorBusinessMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CreationDateAxis" xlink:label="loc_us-gaapCreationDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapCreationDateAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DefaultFinancialStatementsDateMember" xlink:label="loc_us-gaapDefaultFinancialStatementsDateMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCreationDateAxis" xlink:to="loc_us-gaapDefaultFinancialStatementsDateMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_JanuaryTwentyTwoThousandSixteenMember" xlink:label="loc_SNYRJanuaryTwentyTwoThousandSixteenMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefaultFinancialStatementsDateMember" xlink:to="loc_SNYRJanuaryTwentyTwoThousandSixteenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_JanuaryTwentyTwoThousandSeventeenMember" xlink:label="loc_SNYRJanuaryTwentyTwoThousandSeventeenMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefaultFinancialStatementsDateMember" xlink:to="loc_SNYRJanuaryTwentyTwoThousandSeventeenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_JuneThirtyTwoThousandSixteenMember" xlink:label="loc_SNYRJuneThirtyTwoThousandSixteenMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefaultFinancialStatementsDateMember" xlink:to="loc_SNYRJuneThirtyTwoThousandSixteenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_SeptemberThirtyTwoThousandFifteenMember" xlink:label="loc_SNYRSeptemberThirtyTwoThousandFifteenMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDefaultFinancialStatementsDateMember" xlink:to="loc_SNYRSeptemberThirtyTwoThousandFifteenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_KnightTherapeuticsBarbadosIncMember" xlink:label="loc_SNYRKnightTherapeuticsBarbadosIncMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_SNYRKnightTherapeuticsBarbadosIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_UrgentRxSellersMember" xlink:label="loc_SNYRUrgentRxSellersMember" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_SNYRUrgentRxSellersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_KnightTherapeuticsIncMember" xlink:label="loc_SNYRKnightTherapeuticsIncMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRKnightTherapeuticsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_HandMDLLCMember" xlink:label="loc_SNYRHandMDLLCMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRHandMDLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BreakthroughProductsIncMember" xlink:label="loc_SNYRBreakthroughProductsIncMember" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRBreakthroughProductsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_TprInvestmentsPtyLtdMember" xlink:label="loc_SNYRTprInvestmentsPtyLtdMember" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRTprInvestmentsPtyLtdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="loc_us-gaapStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementGeographicalAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="loc_us-gaapSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementGeographicalAxis" xlink:to="loc_us-gaapSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_USMember" xlink:label="loc_SNYRUSMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentGeographicalDomain" xlink:to="loc_SNYRUSMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRangeAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaapMaximumMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_SecurityAgreementMember" xlink:label="loc_SNYRSecurityAgreementMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SNYRSecurityAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_LicenseAgreementMember" xlink:label="loc_SNYRLicenseAgreementMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SNYRLicenseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ConsultingAgreementMember" xlink:label="loc_SNYRConsultingAgreementMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SNYRConsultingAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_StockPurchaseAgreementMember" xlink:label="loc_SNYRStockPurchaseAgreementMember" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SNYRStockPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_SettlementAgreementMember" xlink:label="loc_SNYRSettlementAgreementMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SNYRSettlementAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaapStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementScenarioAxis" order="80" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaapScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementScenarioAxis" xlink:to="loc_us-gaapScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_SecondYearMember" xlink:label="loc_SNYRSecondYearMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScenarioUnspecifiedDomain" xlink:to="loc_SNYRSecondYearMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ThiredYearMember" xlink:label="loc_SNYRThiredYearMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScenarioUnspecifiedDomain" xlink:to="loc_SNYRThiredYearMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_NoncompeteProvisionMember" xlink:label="loc_SNYRNoncompeteProvisionMember" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScenarioUnspecifiedDomain" xlink:to="loc_SNYRNoncompeteProvisionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CurrencyAxis" xlink:label="loc_us-gaapCurrencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapCurrencyAxis" order="90" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_AllCurrenciesDomain" xlink:label="loc_SNYRAllCurrenciesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCurrencyAxis" xlink:to="loc_SNYRAllCurrenciesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_AustralianDollerMember" xlink:label="loc_SNYRAustralianDollerMember" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SNYRAllCurrenciesDomain" xlink:to="loc_SNYRAustralianDollerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaapPaymentsToAcquireBusinessesGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsToAcquireBusinessesGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_AmountPayableUnderPurchaseAgreement" xlink:label="loc_SNYRAmountPayableUnderPurchaseAgreement" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRAmountPayableUnderPurchaseAgreement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:label="loc_us-gaapCostOfGoodsAndServicesSoldAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostOfGoodsAndServicesSoldAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ExpectedEvenues" xlink:label="loc_SNYRExpectedEvenues" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRExpectedEvenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaapSalesRevenueNet" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSalesRevenueNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_PercentageOfSaleRevenueNet" xlink:label="loc_SNYRPercentageOfSaleRevenueNet" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRPercentageOfSaleRevenueNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="loc_us-gaapPaymentsToAcquireInvestments" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsToAcquireInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_PresentValueOfFuturePayments" xlink:label="loc_SNYRPresentValueOfFuturePayments" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRPresentValueOfFuturePayments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RoyaltyExpense" xlink:label="loc_us-gaapRoyaltyExpense" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRoyaltyExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_PercentageOfAmountReceviedFromSublicensess" xlink:label="loc_SNYRPercentageOfAmountReceviedFromSublicensess" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRPercentageOfAmountReceviedFromSublicensess" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ConsultingFeePaid" xlink:label="loc_SNYRConsultingFeePaid" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRConsultingFeePaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsExercisePrice" xlink:label="loc_us-gaapFairValueAssumptionsExercisePrice" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFairValueAssumptionsExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/Acquisitions-PurchasePriceAllocationAssetsAcquiredAndLiabilitiesAssumedOnEstimatedFairValuesDetails" xlink:title="00000045 - Disclosure - Acquisitions - Purchase Price Allocation Assets Acquired and Liabilities Assumed on Estimated Fair Values (Details)">
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_AssetPurchasePurchasePriceAllocationAssetsAcquiredAndLiabilitiesAssumedOnEstimatedFairValuesDetailsAbstract" xlink:label="loc_SNYRAssetPurchasePurchasePriceAllocationAssetsAcquiredAndLiabilitiesAssumedOnEstimatedFairValuesDetailsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SNYRAssetPurchasePurchasePriceAllocationAssetsAcquiredAndLiabilitiesAssumedOnEstimatedFairValuesDetailsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_FactorNutritionLabsLLCMember" xlink:label="loc_SNYRFactorNutritionLabsLLCMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRFactorNutritionLabsLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_KnightTherapeuticsIncMember" xlink:label="loc_SNYRKnightTherapeuticsIncMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRKnightTherapeuticsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_HandMDLLCMember" xlink:label="loc_SNYRHandMDLLCMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRHandMDLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BreakthroughProductsIncMember" xlink:label="loc_SNYRBreakthroughProductsIncMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRBreakthroughProductsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_TprInvestmentsPtyLtdMember" xlink:label="loc_SNYRTprInvestmentsPtyLtdMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRTprInvestmentsPtyLtdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaCash" xlink:label="loc_SNYRBusinessAcquisitionsProFormaCash" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionsProFormaCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaAccountsReceivable" xlink:label="loc_SNYRBusinessAcquisitionsProFormaAccountsReceivable" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionsProFormaAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaInventory" xlink:label="loc_SNYRBusinessAcquisitionsProFormaInventory" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionsProFormaInventory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaPrepaidExpenses" xlink:label="loc_SNYRBusinessAcquisitionsProFormaPrepaidExpenses" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionsProFormaPrepaidExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaFixedAssetsNet" xlink:label="loc_SNYRBusinessAcquisitionsProFormaFixedAssetsNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionsProFormaFixedAssetsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaIntangibleAssetsNet" xlink:label="loc_SNYRBusinessAcquisitionsProFormaIntangibleAssetsNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionsProFormaIntangibleAssetsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaBloggerDatabase" xlink:label="loc_SNYRBusinessAcquisitionsProFormaBloggerDatabase" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionsProFormaBloggerDatabase" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaCustomerDatabase" xlink:label="loc_SNYRBusinessAcquisitionsProFormaCustomerDatabase" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionsProFormaCustomerDatabase" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaIntellectualProperty" xlink:label="loc_SNYRBusinessAcquisitionsProFormaIntellectualProperty" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionsProFormaIntellectualProperty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaLicenseAgreement" xlink:label="loc_SNYRBusinessAcquisitionsProFormaLicenseAgreement" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionsProFormaLicenseAgreement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaNonCompeteProvision" xlink:label="loc_SNYRBusinessAcquisitionsProFormaNonCompeteProvision" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionsProFormaNonCompeteProvision" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaNonSolicitationProvision" xlink:label="loc_SNYRBusinessAcquisitionsProFormaNonSolicitationProvision" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionsProFormaNonSolicitationProvision" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaIntangibleAssetsCustomerRelationships" xlink:label="loc_SNYRBusinessAcquisitionsProFormaIntangibleAssetsCustomerRelationships" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionsProFormaIntangibleAssetsCustomerRelationships" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaGoodwill" xlink:label="loc_SNYRBusinessAcquisitionsProFormaGoodwill" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionsProFormaGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaAccountsPayable" xlink:label="loc_SNYRBusinessAcquisitionsProFormaAccountsPayable" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionsProFormaAccountsPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaRoyaltyPayable" xlink:label="loc_SNYRBusinessAcquisitionsProFormaRoyaltyPayable" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionsProFormaRoyaltyPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaAccruedExpenses" xlink:label="loc_SNYRBusinessAcquisitionsProFormaAccruedExpenses" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionsProFormaAccruedExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaDividendsPayable" xlink:label="loc_SNYRBusinessAcquisitionsProFormaDividendsPayable" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionsProFormaDividendsPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaProvisionForIncomeTax" xlink:label="loc_SNYRBusinessAcquisitionsProFormaProvisionForIncomeTax" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionsProFormaProvisionForIncomeTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaOthers" xlink:label="loc_SNYRBusinessAcquisitionsProFormaOthers" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionsProFormaOthers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsProFormaTotalLiabilities" xlink:label="loc_SNYRBusinessAcquisitionsProFormaTotalLiabilities" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionsProFormaTotalLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/Acquisitions-PurchasePriceAllocatedToAcquisitionOfAssetsDetails" xlink:title="00000046 - Disclosure - Acquisitions - Purchase Price Allocated to Acquisition of Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_AcquisitionsPurchasePriceAllocatedToAcquisitionOfAssetsDetailsAbstract" xlink:label="loc_SNYRAcquisitionsPurchasePriceAllocatedToAcquisitionOfAssetsDetailsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SNYRAcquisitionsPurchasePriceAllocatedToAcquisitionOfAssetsDetailsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_FactorNutritionLabsLLCMember" xlink:label="loc_SNYRFactorNutritionLabsLLCMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_SNYRFactorNutritionLabsLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BreakthroughProductsIncMember" xlink:label="loc_SNYRBreakthroughProductsIncMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_SNYRBreakthroughProductsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_TprInvestmentsPtyLtdMember" xlink:label="loc_SNYRTprInvestmentsPtyLtdMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_SNYRTprInvestmentsPtyLtdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaapStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementScenarioAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaapScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementScenarioAxis" xlink:to="loc_us-gaapScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_JanuaryTwentyTwoTwoThousandFifteenMember" xlink:label="loc_SNYRJanuaryTwentyTwoTwoThousandFifteenMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScenarioUnspecifiedDomain" xlink:to="loc_SNYRJanuaryTwentyTwoTwoThousandFifteenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_JanuaryTwentyTwoThousandSixteenMember" xlink:label="loc_SNYRJanuaryTwentyTwoThousandSixteenMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScenarioUnspecifiedDomain" xlink:to="loc_SNYRJanuaryTwentyTwoThousandSixteenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_JanuaryTwentyTwoThousandSaventeenMember" xlink:label="loc_SNYRJanuaryTwentyTwoThousandSaventeenMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScenarioUnspecifiedDomain" xlink:to="loc_SNYRJanuaryTwentyTwoThousandSaventeenMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_UrgentRxMember" xlink:label="loc_SNYRUrgentRxMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRUrgentRxMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_NomadChoiceMember" xlink:label="loc_SNYRNomadChoiceMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRNomadChoiceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionCashPayment" xlink:label="loc_SNYRBusinessAcquisitionCashPayment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionCashPayment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionsStockPayment" xlink:label="loc_SNYRBusinessAcquisitionsStockPayment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionsStockPayment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionStockWarrantsIssued" xlink:label="loc_SNYRBusinessAcquisitionStockWarrantsIssued" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionStockWarrantsIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionStockIssued" xlink:label="loc_SNYRBusinessAcquisitionStockIssued" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionStockIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BusinessAcquisitionEarnoutPayment" xlink:label="loc_SNYRBusinessAcquisitionEarnoutPayment" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBusinessAcquisitionEarnoutPayment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationAsset" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationAsset" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationAsset" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/Acquisitions-ProFormaResultsOfAcquisitionDetails" xlink:title="00000047 - Disclosure - Acquisitions - Pro forma Results of Acquisition (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaapBusinessCombinationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaapTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTitleOfIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_FocusFactorBusinessMember" xlink:label="loc_SNYRFocusFactorBusinessMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SNYRFocusFactorBusinessMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BreakthroughProductsIncMember" xlink:label="loc_SNYRBreakthroughProductsIncMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRBreakthroughProductsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_TprInvestmentsPtyLtdMember" xlink:label="loc_SNYRTprInvestmentsPtyLtdMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRTprInvestmentsPtyLtdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="loc_us-gaapBusinessAcquisitionsProFormaRevenue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessAcquisitionsProFormaRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="loc_us-gaapBusinessAcquisitionsProFormaNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000048 - Disclosure - Income Taxes (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BreakthroughProductsIncMember" xlink:label="loc_SNYRBreakthroughProductsIncMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRBreakthroughProductsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="loc_us-gaapIncomeTaxAuthorityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeTaxAuthorityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="loc_us-gaapIncomeTaxAuthorityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityAxis" xlink:to="loc_us-gaapIncomeTaxAuthorityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="loc_us-gaapDomesticCountryMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxAuthorityDomain" xlink:to="loc_us-gaapDomesticCountryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ValuationAllowancePercentage" xlink:label="loc_SNYRValuationAllowancePercentage" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRValuationAllowancePercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_OperatingLossCarryforwardsExpirationYear" xlink:label="loc_SNYROperatingLossCarryforwardsExpirationYear" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYROperatingLossCarryforwardsExpirationYear" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/IncomeTaxes-ScheduleOfEffectiveIncomeTaxRateDetails" xlink:title="00000049 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/IncomeTaxes-ScheduleOfDeferredIncomeTaxAssetsDetails" xlink:title="00000050 - Disclosure - Income Taxes - Schedule of Deferred Income Tax Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/AccountsReceivableDetailsNarrative" xlink:title="00000051 - Disclosure - Accounts Receivable (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivable" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivable" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/AccountsReceivable-AccountsReceivableNetOfAllowancesDetails" xlink:title="00000052 - Disclosure - Accounts Receivable - Accounts Receivable, Net of Allowances (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsReceivableGross" xlink:label="loc_us-gaapAccountsReceivableGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapAccountsReceivableGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:label="loc_us-gaapAllowanceForDoubtfulAccountsReceivable" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapAllowanceForDoubtfulAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsReceivableNet" xlink:label="loc_us-gaapAccountsReceivableNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapAccountsReceivableNet" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/PrepaidExpenses-SummaryOfPrepaidExpensesDetails" xlink:title="00000053 - Disclosure - Prepaid Expenses - Summary of Prepaid Expenses (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsAbstract" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_PrepaidExpensesAdvancesForInventory" xlink:label="loc_SNYRPrepaidExpensesAdvancesForInventory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPrepaidExpenseAndOtherAssetsAbstract" xlink:to="loc_SNYRPrepaidExpensesAdvancesForInventory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_PrepaidExpencesMediaProduction" xlink:label="loc_SNYRPrepaidExpencesMediaProduction" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPrepaidExpenseAndOtherAssetsAbstract" xlink:to="loc_SNYRPrepaidExpencesMediaProduction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidInsurance" xlink:label="loc_us-gaapPrepaidInsurance" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPrepaidExpenseAndOtherAssetsAbstract" xlink:to="loc_us-gaapPrepaidInsurance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidAdvertising" xlink:label="loc_us-gaapPrepaidAdvertising" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPrepaidExpenseAndOtherAssetsAbstract" xlink:to="loc_us-gaapPrepaidAdvertising" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_PrepaidExpensesDeposits" xlink:label="loc_SNYRPrepaidExpensesDeposits" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPrepaidExpenseAndOtherAssetsAbstract" xlink:to="loc_SNYRPrepaidExpensesDeposits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Supplies" xlink:label="loc_us-gaapSupplies" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPrepaidExpenseAndOtherAssetsAbstract" xlink:to="loc_us-gaapSupplies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidRent" xlink:label="loc_us-gaapPrepaidRent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPrepaidExpenseAndOtherAssetsAbstract" xlink:to="loc_us-gaapPrepaidRent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherAssetsMiscellaneousCurrent" xlink:label="loc_us-gaapOtherAssetsMiscellaneousCurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPrepaidExpenseAndOtherAssetsAbstract" xlink:to="loc_us-gaapOtherAssetsMiscellaneousCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PrepaidExpenseCurrentAndNoncurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrentAndNoncurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPrepaidExpenseAndOtherAssetsAbstract" xlink:to="loc_us-gaapPrepaidExpenseCurrentAndNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/ConcentrationOfCreditRiskDetailsNarrative" xlink:title="00000054 - Disclosure - Concentration of Credit Risk (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaapRisksAndUncertaintiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRisksAndUncertaintiesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CustomerConcentrationRiskMember" xlink:label="loc_us-gaapCustomerConcentrationRiskMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapCustomerConcentrationRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:label="loc_us-gaapConcentrationRiskByBenchmarkAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapConcentrationRiskByBenchmarkAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain" xlink:label="loc_us-gaapConcentrationRiskBenchmarkDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByBenchmarkAxis" xlink:to="loc_us-gaapConcentrationRiskBenchmarkDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapAccountsReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskBenchmarkDomain" xlink:to="loc_us-gaapSalesRevenueNetMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="loc_us-gaapCashFDICInsuredAmount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashFDICInsuredAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CashUninsuredAmount" xlink:label="loc_us-gaapCashUninsuredAmount" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCashUninsuredAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_NumberOfCustomerAccountedForAccountsReceivable" xlink:label="loc_SNYRNumberOfCustomerAccountedForAccountsReceivable" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRNumberOfCustomerAccountedForAccountsReceivable" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/ConcentrationOfCreditRisk-SummaryOfMajorSuppliersDetails" xlink:title="00000055 - Disclosure - Concentration of Credit Risk - Summary of Major Suppliers (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract" xlink:label="loc_us-gaapRisksAndUncertaintiesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRisksAndUncertaintiesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_SuppliersOneMember" xlink:label="loc_SNYRSuppliersOneMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRSuppliersOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_SuppliersTwoMember" xlink:label="loc_SNYRSuppliersTwoMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRSuppliersTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_SuppliersThreeMember" xlink:label="loc_SNYRSuppliersThreeMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRSuppliersThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_SuppliersFourMember" xlink:label="loc_SNYRSuppliersFourMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRSuppliersFourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_NameOfProduct" xlink:label="loc_SNYRNameOfProduct" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRNameOfProduct" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_AddressOfSuppliers" xlink:label="loc_SNYRAddressOfSuppliers" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRAddressOfSuppliers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CityOfSuppliers" xlink:label="loc_SNYRCityOfSuppliers" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRCityOfSuppliers" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/Inventory-ScheduleOfCarryingValueOfInventoryDetails" xlink:title="00000056 - Disclosure - Inventory - Schedule of Carrying Value of Inventory (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaapInventoryFinishedGoods" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryFinishedGoods" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_InventoryComponents" xlink:label="loc_SNYRInventoryComponents" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_SNYRInventoryComponents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves" xlink:label="loc_us-gaapInventoryRawMaterialsNetOfReserves" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryRawMaterialsNetOfReserves" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_InventoryEnergyProduct" xlink:label="loc_SNYRInventoryEnergyProduct" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_SNYRInventoryEnergyProduct" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssetsDetailsNarrative" xlink:title="00000057 - Disclosure - Fixed Assets and Intangible Assets (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AdjustmentForAmortization" xlink:label="loc_us-gaapAdjustmentForAmortization" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAdjustmentForAmortization" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssets-SummaryOfFixedAndIntangibleAssetsDetails" xlink:title="00000058 - Disclosure - Fixed Assets and Intangible Assets - Summary of Fixed and Intangible Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_IntellectualProperty" xlink:label="loc_SNYRIntellectualProperty" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_SNYRIntellectualProperty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssets-SummaryOfEstimatedAggregateAmortizationExpenseDetails" xlink:title="00000059 - Disclosure - Fixed Assets and Intangible Assets - Summary of Estimated Aggregate Amortization Expense (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000060 - Disclosure - Related Party Transactions (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaapTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTitleOfIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ChiefExecutiveOfficerMember" xlink:label="loc_us-gaapChiefExecutiveOfficerMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_us-gaapChiefExecutiveOfficerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_MsHarshbargerMember" xlink:label="loc_SNYRMsHarshbargerMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SNYRMsHarshbargerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_KnightTherapeuticsIncMember" xlink:label="loc_SNYRKnightTherapeuticsIncMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRKnightTherapeuticsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_LoanAgreementMember" xlink:label="loc_SNYRLoanAgreementMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SNYRLoanAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_SecurityAgreementMember" xlink:label="loc_SNYRSecurityAgreementMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SNYRSecurityAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ConsultingAgreementMember" xlink:label="loc_SNYRConsultingAgreementMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SNYRConsultingAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_RoyaltyDistributionAgreementMember" xlink:label="loc_SNYRRoyaltyDistributionAgreementMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SNYRRoyaltyDistributionAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_HandMDLLCMember" xlink:label="loc_SNYRHandMDLLCMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_SNYRHandMDLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation" xlink:label="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensation" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockGrantedDuringPeriodValueSharebasedCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ProceedsFromNotesPayable" xlink:label="loc_us-gaapProceedsFromNotesPayable" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_AccruedConsultingFeesPerMonth" xlink:label="loc_SNYRAccruedConsultingFeesPerMonth" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRAccruedConsultingFeesPerMonth" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BonusPaid" xlink:label="loc_SNYRBonusPaid" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRBonusPaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_OutstandingBalanceOfConsultingFees" xlink:label="loc_SNYROutstandingBalanceOfConsultingFees" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYROutstandingBalanceOfConsultingFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DueFromRelatedPartiesCurrent" xlink:label="loc_us-gaapDueFromRelatedPartiesCurrent" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDueFromRelatedPartiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DueFromRelatedParties" xlink:label="loc_us-gaapDueFromRelatedParties" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDueFromRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:label="loc_us-gaapMinorityInterestOwnershipPercentageByParent" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMinorityInterestOwnershipPercentageByParent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/AccountsPayableAndAccruedLiabilities-ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails" xlink:title="00000061 - Disclosure - Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ManufacturersLiabilitiesCurrent" xlink:label="loc_SNYRManufacturersLiabilitiesCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_SNYRManufacturersLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_PromotionsLiabilitiesCurrent" xlink:label="loc_SNYRPromotionsLiabilitiesCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_SNYRPromotionsLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ReturnsAllowanceAccruedLiabilities" xlink:label="loc_SNYRReturnsAllowanceAccruedLiabilities" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_SNYRReturnsAllowanceAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_CustomersAccruedLiabilities" xlink:label="loc_SNYRCustomersAccruedLiabilities" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_SNYRCustomersAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_InterestAccruedLiabilities" xlink:label="loc_SNYRInterestAccruedLiabilities" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_SNYRInterestAccruedLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_RoyaltiesAccruedLiabilities" xlink:label="loc_SNYRRoyaltiesAccruedLiabilities" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_SNYRRoyaltiesAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_WarehousingAccruedLiabilities" xlink:label="loc_SNYRWarehousingAccruedLiabilities" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_SNYRWarehousingAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OtherAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapOtherAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherAccountsPayableAndAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/NotesPayableDetailsNarrative" xlink:title="00000062 - Disclosure - Notes Payable (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_KnightTherapeuticsIncMember" xlink:label="loc_SNYRKnightTherapeuticsIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_SNYRKnightTherapeuticsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_NeuragenCorpMember" xlink:label="loc_SNYRNeuragenCorpMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_SNYRNeuragenCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_LoanAgreementMember" xlink:label="loc_SNYRLoanAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SNYRLoanAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_AssetPurchaseAgreementMember" xlink:label="loc_SNYRAssetPurchaseAgreementMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SNYRAssetPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_SecurityAgreementMember" xlink:label="loc_SNYRSecurityAgreementMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SNYRSecurityAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NatureOfExpenseAxis" xlink:label="loc_us-gaapNatureOfExpenseAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapNatureOfExpenseAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:label="loc_us-gaapInterimPeriodCostsNotAllocableDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNatureOfExpenseAxis" xlink:to="loc_us-gaapInterimPeriodCostsNotAllocableDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_OriginationFeeMember" xlink:label="loc_SNYROriginationFeeMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInterimPeriodCostsNotAllocableDomain" xlink:to="loc_SNYROriginationFeeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_WorkFeeMember" xlink:label="loc_SNYRWorkFeeMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInterimPeriodCostsNotAllocableDomain" xlink:to="loc_SNYRWorkFeeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_JanuaryTwentyTwoThousandFifteenLoanOneMember" xlink:label="loc_SNYRJanuaryTwentyTwoThousandFifteenLoanOneMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_SNYRJanuaryTwentyTwoThousandFifteenLoanOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_JanuaryTwentyTwoTwoThousandFifteenLoanTwoMember" xlink:label="loc_SNYRJanuaryTwentyTwoTwoThousandFifteenLoanTwoMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_SNYRJanuaryTwentyTwoTwoThousandFifteenLoanTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_JuneTwentySixTwoThousandFifteenMember" xlink:label="loc_SNYRJuneTwentySixTwoThousandFifteenMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_SNYRJuneTwentySixTwoThousandFifteenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_KnightWarrantsMember" xlink:label="loc_SNYRKnightWarrantsMember" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_SNYRKnightWarrantsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_KnightWarrantsOneMember" xlink:label="loc_SNYRKnightWarrantsOneMember" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_SNYRKnightWarrantsOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_STWarrantMember" xlink:label="loc_SNYRSTWarrantMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_SNYRSTWarrantMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_LTWarrantMember" xlink:label="loc_SNYRLTWarrantMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_SNYRLTWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaapStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementScenarioAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaapScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementScenarioAxis" xlink:to="loc_us-gaapScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_JanuaryTwentyTwoThousandSixteenMember" xlink:label="loc_SNYRJanuaryTwentyTwoThousandSixteenMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScenarioUnspecifiedDomain" xlink:to="loc_SNYRJanuaryTwentyTwoThousandSixteenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_JanuaryTwentyTwoThousandSaventeenMember" xlink:label="loc_SNYRJanuaryTwentyTwoThousandSaventeenMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScenarioUnspecifiedDomain" xlink:to="loc_SNYRJanuaryTwentyTwoThousandSaventeenMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_QuarterEndingSeptemberThirtyTwoThousandSaventeenMember" xlink:label="loc_SNYRQuarterEndingSeptemberThirtyTwoThousandSaventeenMember" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScenarioUnspecifiedDomain" xlink:to="loc_SNYRQuarterEndingSeptemberThirtyTwoThousandSaventeenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_JuneThirtyTwoThousandSixteenMember" xlink:label="loc_SNYRJuneThirtyTwoThousandSixteenMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScenarioUnspecifiedDomain" xlink:to="loc_SNYRJuneThirtyTwoThousandSixteenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRangeAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaapMinimumMember" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaapMaximumMember" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="loc_us-gaapStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementGeographicalAxis" order="80" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="loc_us-gaapSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementGeographicalAxis" xlink:to="loc_us-gaapSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_USMember" xlink:label="loc_SNYRUSMember" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentGeographicalDomain" xlink:to="loc_SNYRUSMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermDebtFairValue" xlink:label="loc_us-gaapLongTermDebtFairValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLongTermDebtFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtIssuanceCosts" xlink:label="loc_us-gaapDebtIssuanceCosts" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtIssuanceCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:label="loc_us-gaapDebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentInterestRateIncreaseDecrease" xlink:label="loc_us-gaapDebtInstrumentInterestRateIncreaseDecrease" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateIncreaseDecrease" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="loc_us-gaapBusinessAcquisitionsProFormaRevenue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessAcquisitionsProFormaRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="loc_us-gaapBusinessAcquisitionsProFormaNetIncomeLoss" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LoansPayable" xlink:label="loc_us-gaapLoansPayable" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLoansPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:label="loc_us-gaapBusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="loc_us-gaapCapitalExpendituresIncurredButNotYetPaid" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1" xlink:label="loc_us-gaapConversionOfStockSharesIssued1" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConversionOfStockSharesIssued1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_PercentageOfSharesPurchaseableUnderWarrants" xlink:label="loc_SNYRPercentageOfSharesPurchaseableUnderWarrants" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRPercentageOfSharesPurchaseableUnderWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" xlink:label="loc_us-gaapDebtInstrumentConvertibleBeneficialConversionFeature" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleBeneficialConversionFeature" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscount" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DeferredFinanceCostsNet" xlink:label="loc_us-gaapDeferredFinanceCostsNet" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDeferredFinanceCostsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AmortizationOfFinancingCosts" xlink:label="loc_us-gaapAmortizationOfFinancingCosts" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAmortizationOfFinancingCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DepositLiabilitiesAccruedInterest" xlink:label="loc_us-gaapDepositLiabilitiesAccruedInterest" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDepositLiabilitiesAccruedInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NotesIssued1" xlink:label="loc_us-gaapNotesIssued1" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNotesIssued1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_PercentageOfSaleRevenueNet" xlink:label="loc_SNYRPercentageOfSaleRevenueNet" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRPercentageOfSaleRevenueNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="loc_us-gaapPaymentsToAcquireInvestments" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsToAcquireInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaapSalesRevenueNet" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSalesRevenueNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaapDerivativeLiabilities" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDerivativeLiabilities" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/NotesPayable-ScheduleOfLoanPayableDetails" xlink:title="00000063 - Disclosure - Notes Payable - Schedule of Loan Payable (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_LoansPayableGross" xlink:label="loc_SNYRLoansPayableGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_SNYRLoansPayableGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscount" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LoansPayable" xlink:label="loc_us-gaapLoansPayable" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLoansPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LoansPayableCurrent" xlink:label="loc_us-gaapLoansPayableCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLoansPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_LongTermLoansPayable" xlink:label="loc_us-gaapLongTermLoansPayable" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermLoansPayable" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/StockholdersDeficitDetailsNarrative" xlink:title="00000064 - Disclosure - Stockholders' Deficit (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaapTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTitleOfIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_BoardOfDirectorsChairmanMember" xlink:label="loc_us-gaapBoardOfDirectorsChairmanMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_us-gaapBoardOfDirectorsChairmanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InvestorMember" xlink:label="loc_us-gaapInvestorMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_us-gaapInvestorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaapMinimumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaapMaximumMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_STWarrantMember" xlink:label="loc_SNYRSTWarrantMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_SNYRSTWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_LoanAgreementMember" xlink:label="loc_SNYRLoanAgreementMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SNYRLoanAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ContributionAgreementMember" xlink:label="loc_SNYRContributionAgreementMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SNYRContributionAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_StockPurchaseAgreementMember" xlink:label="loc_SNYRStockPurchaseAgreementMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SNYRStockPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_MergerAgreementMember" xlink:label="loc_SNYRMergerAgreementMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SNYRMergerAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_NoteHolderMember" xlink:label="loc_SNYRNoteHolderMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRNoteHolderMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_HandMDCorpMember" xlink:label="loc_SNYRHandMDCorpMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_SNYRHandMDCorpMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_NomadChoiceMember" xlink:label="loc_SNYRNomadChoiceMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_SNYRNomadChoiceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_BreakthroughProductsIncMember" xlink:label="loc_SNYRBreakthroughProductsIncMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_SNYRBreakthroughProductsIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NatureOfExpenseAxis" xlink:label="loc_us-gaapNatureOfExpenseAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapNatureOfExpenseAxis" order="70" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:label="loc_us-gaapInterimPeriodCostsNotAllocableDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNatureOfExpenseAxis" xlink:to="loc_us-gaapInterimPeriodCostsNotAllocableDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AccountsPayableMember" xlink:label="loc_us-gaapAccountsPayableMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInterimPeriodCostsNotAllocableDomain" xlink:to="loc_us-gaapAccountsPayableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="loc_us-gaapStockholdersEquityReverseStockSplit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityReverseStockSplit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_PercentageOfOutstandingCapital" xlink:label="loc_SNYRPercentageOfOutstandingCapital" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRPercentageOfOutstandingCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_PrestockSplitShares" xlink:label="loc_SNYRPrestockSplitShares" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRPrestockSplitShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockHeldInTrust" xlink:label="loc_us-gaapCommonStockHeldInTrust" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockHeldInTrust" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000065 - Disclosure - Commitments and Contingencies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementScenarioAxis" xlink:label="loc_us-gaapStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementScenarioAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ScenarioUnspecifiedDomain" xlink:label="loc_us-gaapScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementScenarioAxis" xlink:to="loc_us-gaapScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_NovemberTwoThousandSixteenMember" xlink:label="loc_SNYRNovemberTwoThousandSixteenMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScenarioUnspecifiedDomain" xlink:to="loc_SNYRNovemberTwoThousandSixteenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_DecemberTwoThousandSixteenMember" xlink:label="loc_SNYRDecemberTwoThousandSixteenMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScenarioUnspecifiedDomain" xlink:to="loc_SNYRDecemberTwoThousandSixteenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CurrencyAxis" xlink:label="loc_us-gaapCurrencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapCurrencyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_AllCurrenciesDomain" xlink:label="loc_SNYRAllCurrenciesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCurrencyAxis" xlink:to="loc_SNYRAllCurrenciesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_AustralianDollerMember" xlink:label="loc_SNYRAustralianDollerMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SNYRAllCurrenciesDomain" xlink:to="loc_SNYRAustralianDollerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_SubsidiaryMember" xlink:label="loc_SNYRSubsidiaryMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRSubsidiaryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLossCarryforwardsExpirationDate" xlink:label="loc_us-gaapOperatingLossCarryforwardsExpirationDate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLossCarryforwardsExpirationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet" xlink:label="loc_us-gaapOperatingLeasesRentExpenseNet" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeasesRentExpenseNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SaleLeasebackTransactionRentExpense" xlink:label="loc_us-gaapSaleLeasebackTransactionRentExpense" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleLeasebackTransactionRentExpense" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/CommitmentsAndContingencies-ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" xlink:title="00000066 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Rental Payments For Operating Leases (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_SubsidiaryMember" xlink:label="loc_SNYRSubsidiaryMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_SNYRSubsidiaryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/StockOptionsDetailsNarrative" xlink:title="00000067 - Disclosure - Stock Options (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_EquityIncentivePlanTwoThousandsAndFourteenMember" xlink:label="loc_SNYREquityIncentivePlanTwoThousandsAndFourteenMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SNYREquityIncentivePlanTwoThousandsAndFourteenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualAxis" xlink:label="loc_us-gaapTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualAxis" xlink:to="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ChiefExecutiveOfficerMember" xlink:label="loc_us-gaapChiefExecutiveOfficerMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_us-gaapChiefExecutiveOfficerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_TwoBoardMembersMember" xlink:label="loc_SNYRTwoBoardMembersMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SNYRTwoBoardMembersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_TwoEmployeeMembersMember" xlink:label="loc_SNYRTwoEmployeeMembersMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_SNYRTwoEmployeeMembersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="loc_us-gaapAllocatedShareBasedCompensationExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAllocatedShareBasedCompensationExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsExercisePrice" xlink:label="loc_us-gaapFairValueAssumptionsExercisePrice" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFairValueAssumptionsExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsExpectedTerm" xlink:label="loc_us-gaapFairValueAssumptionsExpectedTerm" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFairValueAssumptionsExpectedTerm" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFairValueAssumptionsExpectedDividendRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/StockOptions-SummaryOfOptionsOutstandingByPriceRangeDetails" xlink:title="00000068 - Disclosure - Stock Options - Summary of Options Outstanding by Price Range (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_StockOptionPlanMember" xlink:label="loc_SNYRStockOptionPlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SNYRStockOptionPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MinimumMember" xlink:label="loc_us-gaapMinimumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_MaximumMember" xlink:label="loc_us-gaapMaximumMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_us-gaapMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/StockOptions-SummaryOfStockOptionsActivityDetails" xlink:title="00000069 - Disclosure - Stock Options - Summary of Stock Options Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_StockOptionPlanMember" xlink:label="loc_SNYRStockOptionPlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_SNYRStockOptionPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/StockWarrants-SummaryOfWarrantsOutstandingByPriceRangeDetails" xlink:title="00000070 - Disclosure - Stock Warrants - Summary of Warrants Outstanding by Price Range (Details)">
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_StockWarrantsAbstract" xlink:label="loc_SNYRStockWarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SNYRStockWarrantsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeAxis" xlink:label="loc_us-gaapRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_RangeMember" xlink:label="loc_us-gaapRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeAxis" xlink:to="loc_us-gaapRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ExercisePriceRangeOneMember" xlink:label="loc_SNYRExercisePriceRangeOneMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_SNYRExercisePriceRangeOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ExercisePriceRangeTwoMember" xlink:label="loc_SNYRExercisePriceRangeTwoMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_SNYRExercisePriceRangeTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ExercisePriceRangeThreeMember" xlink:label="loc_SNYRExercisePriceRangeThreeMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRangeMember" xlink:to="loc_SNYRExercisePriceRangeThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:label="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/StockWarrants-SummaryOfStockWarrantsActivityDetails" xlink:title="00000071 - Disclosure - Stock Warrants - Summary of Stock Warrants Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_StockWarrantsAbstract" xlink:label="loc_SNYRStockWarrantsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_SNYRStockWarrantsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePriceEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_SNYRShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePriceEquityInstrumentsOtherThanOptionsNonvestedNumber" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePriceEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_SNYRShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ShareBasedCompensationArrangementsByShareBasedPaymentAwardWarrantsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_SNYRShareBasedCompensationArrangementsByShareBasedPaymentAwardWarrantsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRShareBasedCompensationArrangementsByShareBasedPaymentAwardWarrantsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageExercisePrice" xlink:label="loc_SNYRShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageExercisePrice" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePriceEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="loc_SNYRShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePriceEquityInstrumentsOtherThanOptionsNonvestedNumber_2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_SNYRShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePriceEquityInstrumentsOtherThanOptionsNonvestedNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/DerivativesDetailsNarrative" xlink:title="00000072 - Disclosure - Derivatives (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeLiabilities" xlink:label="loc_us-gaapDerivativeLiabilities" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDerivativeLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/Derivatives-ScheduleOfAssumptionsUsedForFairValueOfDerivativeDetails" xlink:title="00000073 - Disclosure - Derivatives - Schedule of Assumptions Used For Fair Value of Derivative (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsRiskFreeInterestRate" xlink:label="loc_us-gaapFairValueAssumptionsRiskFreeInterestRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsExpectedTerm" xlink:label="loc_us-gaapFairValueAssumptionsExpectedTerm" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapFairValueAssumptionsExpectedTerm" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsExpectedVolatilityRate" xlink:label="loc_us-gaapFairValueAssumptionsExpectedVolatilityRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_FairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapFairValueAssumptionsExpectedDividendRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/Segments-SummaryOfNetSalesAttributedToCustomersGeographicalSegmentDetails" xlink:title="00000074 - Disclosure - Segments - Summary of Net Sales Attributed to Customers Geographical Segment (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="loc_us-gaapStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementGeographicalAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="loc_us-gaapSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementGeographicalAxis" xlink:to="loc_us-gaapSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_UnitedStatesMember" xlink:label="loc_SNYRUnitedStatesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentGeographicalDomain" xlink:to="loc_SNYRUnitedStatesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ForeignCountriesMember" xlink:label="loc_SNYRForeignCountriesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentGeographicalDomain" xlink:to="loc_SNYRForeignCountriesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/Segments-SummaryOfNetSalesAttributedToCustomersProductGroupDetails" xlink:title="00000075 - Disclosure - Segments - Summary of Net Sales Attributed to Customers Product Group (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_FocusFactorBusinessMember" xlink:label="loc_SNYRFocusFactorBusinessMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SNYRFocusFactorBusinessMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_FlatTummyTeaMember" xlink:label="loc_SNYRFlatTummyTeaMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SNYRFlatTummyTeaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_OtherMember" xlink:label="loc_SNYROtherMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SNYROtherMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/Segments-SummaryOfNetSalesAttributedToCustomersProductGroupDetailsParenthetical" xlink:title="00000076 - Disclosure - Segments - Summary of Net Sales Attributed to Customers Product Group (Details) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_OtherMember" xlink:label="loc_SNYROtherMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_SNYROtherMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis" xlink:label="loc_us-gaapConcentrationRiskByTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapConcentrationRiskByTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain" xlink:label="loc_us-gaapConcentrationRiskTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskByTypeAxis" xlink:to="loc_us-gaapConcentrationRiskTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SalesRevenueNetMember" xlink:label="loc_us-gaapSalesRevenueNetMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapConcentrationRiskTypeDomain" xlink:to="loc_us-gaapSalesRevenueNetMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://synergystripscorp.com/role/Segments-SummaryOfLong-livedAssetsNetAttributableToOperationsGeographicalSegmentDetails" xlink:title="00000077 - Disclosure - Segments - Summary of Long-lived Assets (Net) Attributable to Operations Geographical Segment (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_StatementGeographicalAxis" xlink:label="loc_us-gaapStatementGeographicalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementGeographicalAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_SegmentGeographicalDomain" xlink:label="loc_us-gaapSegmentGeographicalDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementGeographicalAxis" xlink:to="loc_us-gaapSegmentGeographicalDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_UnitedStatesMember" xlink:label="loc_SNYRUnitedStatesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentGeographicalDomain" xlink:to="loc_SNYRUnitedStatesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="snyr-20151231.xsd#SNYR_ForeignCountriesMember" xlink:label="loc_SNYRForeignCountriesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentGeographicalDomain" xlink:to="loc_SNYRForeignCountriesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2015/elts/us-gaap-2015-01-31.xsd#us-gaap_NoncurrentAssets" xlink:label="loc_us-gaapNoncurrentAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNoncurrentAssets" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6795717296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Mar. 28, 2016</div></th>
<th class="th"><div>Jun. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_DocumentAndEntityInformationAbstract', window );"><strong>Document And Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Synergy CHC Corp.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001562733<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Smaller Reporting Company<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,692,954<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SNYR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Document and Entity Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>State aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold, or average bid and asked price of such common equity, as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6796142848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 3,640,893<span></span>
</td>
<td class="nump">$ 338<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Restricted cash</a></td>
<td class="nump">607,084<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts Receivable</a></td>
<td class="nump">3,979,857<span></span>
</td>
<td class="nump">$ 2,898<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueFromRelatedPartiesCurrent', window );">Note receivable from related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,077<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">422,434<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">686,655<span></span>
</td>
<td class="nump">26,064<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">9,336,923<span></span>
</td>
<td class="nump">$ 55,376<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Fixed assets, net</a></td>
<td class="nump">12,017<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">11,496,402<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">5,915,262<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Debt issuance cost, net</a></td>
<td class="nump">378,852<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">27,139,456<span></span>
</td>
<td class="nump">$ 55,376<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">5,032,102<span></span>
</td>
<td class="nump">$ 74,642<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Provision for income taxes payable</a></td>
<td class="nump">910,894<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Earn out payment</a></td>
<td class="nump">2,551,500<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent', window );">Current portion of long-term debt, net of debt discount, related party</a></td>
<td class="nump">3,162,060<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">750,000<span></span>
</td>
<td class="nump">$ 6,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Warrant derivative liability</a></td>
<td class="nump">3,096,179<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">15,502,735<span></span>
</td>
<td class="nump">$ 181,042<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-term Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Note payable</a></td>
<td class="nump">750,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_RoyaltyPayable', window );">Royalty payable</a></td>
<td class="nump">258,897<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Notes payable, net of debt discount, related parties</a></td>
<td class="nump">5,208,111<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total long-term liabilities</a></td>
<td class="nump">6,217,008<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">$ 21,719,743<span></span>
</td>
<td class="nump">$ 181,042<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; Equity (Deficit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.00001 par value; 300,000,000 and 75,000,000 shares authorized, respectively; 81,692,954 and 62,100,000, shares issued and outstanding, respectively</a></td>
<td class="nump">$ 817<span></span>
</td>
<td class="nump">$ 621<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable', window );">Common stock to be issued</a></td>
<td class="nump">68,000<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid in capital</a></td>
<td class="nump">13,920,735<span></span>
</td>
<td class="nump">867,004<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(8,569,841)<span></span>
</td>
<td class="num">(1,033,291)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity (deficit)</a></td>
<td class="nump">5,419,713<span></span>
</td>
<td class="num">(125,666)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Stockholders&#8217; Equity (Deficit)</a></td>
<td class="nump">$ 27,139,456<span></span>
</td>
<td class="nump">$ 55,376<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_RoyaltyPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Royalty payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_RoyaltyPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3-4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 3<br> -Subparagraph a(1)<br> -Article 5<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 4<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.30(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 31<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.18)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 03<br> -Paragraph 12<br> -Article 7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6801-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3044-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14326-108349<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of subscription receivable from investors who have been allocated common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Liabilities<br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41228-113958<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41271-113958<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13433-108611<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13495-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueFromRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 08<br> -Paragraph k<br> -Subparagraph 2<br> -Article 4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueFromRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(3),(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388280&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=51655945&amp;loc=d3e3927-108312<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.32)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 03<br> -Paragraph 25<br> -Article 7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 22, 23, 24, 25, 26, 27<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt, after unamortized discount or premium, scheduled to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 03<br> -Paragraph 13, 16<br> -Article 9<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 19, 20, 22<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of current liabilities (due within one year or within the normal operating cycle if longer) not separately disclosed in the balance sheet. Includes costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered and of liabilities not separately disclosed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6904-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6787-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=51662447&amp;loc=d3e5879-108316<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Assets<br> -URI http://asc.fasb.org/extlink&amp;oid=6509628<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 13<br> -Subparagraph a<br> -Article 5<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 03<br> -Paragraph 8<br> -Article 7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amounts of cash and cash equivalent items which are restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. This element is for unclassified presentations; for classified presentations there is a separate and distinct element.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br> -Article 3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 4<br> -Section E<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnamortizedDebtIssuanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnamortizedDebtIssuanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6796201200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">300,000,000<span></span>
</td>
<td class="nump">75,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">81,692,954<span></span>
</td>
<td class="nump">62,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">81,692,954<span></span>
</td>
<td class="nump">62,100,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6795569744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 13,456,377<span></span>
</td>
<td class="nump">$ 9,158<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsSold', window );">Cost of Sales</a></td>
<td class="nump">5,308,130<span></span>
</td>
<td class="nump">5,616<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross Profit</a></td>
<td class="nump">8,148,247<span></span>
</td>
<td class="nump">$ 3,542<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Selling and marketing</a></td>
<td class="nump">3,685,727<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">3,368,495<span></span>
</td>
<td class="nump">$ 961,636<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">608,002<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">7,662,224<span></span>
</td>
<td class="nump">$ 961,636<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">486,023<span></span>
</td>
<td class="num">$ (958,094)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other income (expenses)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest income</a></td>
<td class="num">(1,460)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">958,740<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainBeforeTax', window );">Remeasurement gain on translation of foreign subsidiary</a></td>
<td class="num">(7,740)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Loss on change in fair value of derivative liability</a></td>
<td class="nump">1,028,921<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeAmortizationOfDiscount', window );">Amortization of debt discount</a></td>
<td class="nump">5,499,640<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts', window );">Amortization of debt issuance cost</a></td>
<td class="nump">$ 154,525<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseOther', window );">Imputed and other interest expense</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,998<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Total other expenses</a></td>
<td class="nump">$ 7,632,626<span></span>
</td>
<td class="nump">1,998<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net loss before income taxes</a></td>
<td class="num">(7,146,603)<span></span>
</td>
<td class="num">$ (960,092)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">389,945<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss after tax</a></td>
<td class="num">$ (7,536,548)<span></span>
</td>
<td class="num">$ (960,092)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share - basic and diluted</a></td>
<td class="num">$ (0.11)<span></span>
</td>
<td class="num">$ (0.01)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average common shares - basic and diluted</a></td>
<td class="nump">68,852,305<span></span>
</td>
<td class="nump">97,165,479<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs related to goods produced and sold during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the charge against earnings during the period for commitment fees and debt issuance expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtRelatedCommitmentFeesAndDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450189&amp;loc=d3e30690-110894<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6450189&amp;loc=d3e30700-110894<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDerivativeInstrumentsNetPretax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses from ongoing operations, after income or loss from equity method investments, but before income taxes, extraordinary items, and noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=51673353&amp;loc=d3e41242-110953<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 03<br> -Paragraph 10<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Income Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=6515339<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest expense on all other items not previously classified. For example, includes dividends associated with redeemable preferred stock of a subsidiary that is treated as a liability in the parent's consolidated balance sheet.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4D<br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=SL5624177-113959<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph -4<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeAmortizationOfDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accretion of purchase discount on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeAmortizationOfDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.18)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 03<br> -Paragraph 19<br> -Article 5<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br> -Paragraph 20<br> -Article 9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of other income and expense amounts, the components of which are not separately disclosed on the income statement, resulting from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business) also known as other nonoperating income (expense) recognized for the period. Such amounts may include: (a) dividends, (b) interest on securities, (c) net gains or losses on securities, (d) unusual costs, (e) gains or losses on foreign exchange transactions, and (f) miscellaneous other income and expense items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6796436736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statement of Stockholders' Equity (Deficit) - USD ($)<br></strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-In Capital [Member]</div></th>
<th class="th"><div>Common Stock To Be Issued [Member]</div></th>
<th class="th"><div>Accumulated Deficit [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2013</a></td>
<td class="nump">$ 1,800<span></span>
</td>
<td class="nump">$ 58,578<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (73,199)<span></span>
</td>
<td class="num">$ (12,821)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2013</a></td>
<td class="nump">180,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Cancellation of Oro Corporation shares</a></td>
<td class="num">$ (1,359)<span></span>
</td>
<td class="nump">1,359<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Cancellation of Oro Corporation shares, shares</a></td>
<td class="num">(135,900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Common stock issued to Synergy shareholders</a></td>
<td class="nump">$ 160<span></span>
</td>
<td class="nump">24,840<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common stock issued to Synergy shareholders, shares</a></td>
<td class="nump">16,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_CommonStockIssuedForCash', window );">Common stock issued for cash</a></td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">499,980<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_CommonStockIssuedForCashShares', window );">Common stock issued for cash, shares</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptions', window );">Fair value of vested stock options</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 282,247<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">282,247<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Common stock to be issued for services</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 40,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_CommonStockIssuedAsPartOfContributionAgreement', window );">Common stock issued as part of the Contribution Agreement with Hand MD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Fair value of warrants issued to Breakthrough Products, Inc. as part of acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (960,092)<span></span>
</td>
<td class="num">$ (960,092)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2014</a></td>
<td class="nump">$ 621<span></span>
</td>
<td class="nump">$ 867,004<span></span>
</td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="num">$ (1,033,291)<span></span>
</td>
<td class="num">(125,666)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2014</a></td>
<td class="nump">62,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_CommonStockIssuedForCash', window );">Common stock issued for cash</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 25,999<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">26,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_CommonStockIssuedForCashShares', window );">Common stock issued for cash, shares</a></td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Common stock to be issued for services</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 28,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">28,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_CommonStockIssuedAsPartOfContributionAgreement', window );">Common stock issued as part of the Contribution Agreement with Hand MD</a></td>
<td class="nump">$ 21<span></span>
</td>
<td class="nump">$ 1,499,978<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_CommonStockIssuedAsPartOfContributionAgreementShares', window );">Common stock issued as part of the Contribution Agreement with Hand MD, shares</a></td>
<td class="nump">2,142,857<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_CommonStockIssuedForAcquisitions', window );">Common stock issued for acquisitions of Breakthrough Products, Inc.</a></td>
<td class="nump">$ 30<span></span>
</td>
<td class="nump">2,549,970<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,550,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_CommonStockIssuedForAcquisitionsShares', window );">Common stock issued for acquisitions of Breakthrough Products, Inc., shares</a></td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_CommonStockIssuedForAcquisitionsOne', window );">Common stock issued for acquisitions of NomadChoice Pty Ltd.</a></td>
<td class="nump">$ 36<span></span>
</td>
<td class="nump">1,749,964<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,750,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_CommonStockIssuedForAcquisitionsOneShares', window );">Common stock issued for acquisitions of NomadChoice Pty Ltd., shares</a></td>
<td class="nump">3,571,428<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_CommonStockIssuedToSettleAccountsPayable', window );">Common stock issued to settle accounts payable</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">204,997<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">205,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_CommonStockIssuedToSettleAccountsPayableShares', window );">Common stock issued to settle accounts payable, shares</a></td>
<td class="nump">292,857<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Common stock issued for conversion of notes payable</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">99,996<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Common stock issued for conversion of notes payable, shares</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueOther', window );">Common stock issued for exercise of warrants</a></td>
<td class="nump">$ 101<span></span>
</td>
<td class="num">(99)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Common stock issued for exercise of warrants, shares</a></td>
<td class="nump">10,145,812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Fair value of warrants issued along with notes payable</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">5,968,801<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">5,968,801<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Fair value of vested stock options</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">523,714<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">523,714<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Fair value of warrants issued to Breakthrough Products, Inc. as part of acquisition</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 430,411<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">430,411<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (7,536,548)<span></span>
</td>
<td class="num">(7,536,548)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2015</a></td>
<td class="nump">$ 817<span></span>
</td>
<td class="nump">$ 13,920,735<span></span>
</td>
<td class="nump">$ 68,000<span></span>
</td>
<td class="num">$ (8,569,839)<span></span>
</td>
<td class="nump">$ 5,419,713<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2015</a></td>
<td class="nump">81,692,954<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments To Additional Paid In Capital Fair Value Of Vested Stock Options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_AdjustmentsToAdditionalPaidInCapitalFairValueOfVestedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_CommonStockIssuedAsPartOfContributionAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock issued as part of contribution agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_CommonStockIssuedAsPartOfContributionAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_CommonStockIssuedAsPartOfContributionAgreementShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock issued as part of the Contribution Agreement, shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_CommonStockIssuedAsPartOfContributionAgreementShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_CommonStockIssuedForAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock issued for acquisitions of Breakthrough Products, Inc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_CommonStockIssuedForAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_CommonStockIssuedForAcquisitionsOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock issued for acquisitions of NomadChoice Pty Ltd.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_CommonStockIssuedForAcquisitionsOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_CommonStockIssuedForAcquisitionsOneShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock issued for acquisitions of NomadChoice Pty Ltd., shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_CommonStockIssuedForAcquisitionsOneShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_CommonStockIssuedForAcquisitionsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock issued for acquisitions of Breakthrough Products, Inc., shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_CommonStockIssuedForAcquisitionsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_CommonStockIssuedForCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock issued for cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_CommonStockIssuedForCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_CommonStockIssuedForCashShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock issued for cash, shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_CommonStockIssuedForCashShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_CommonStockIssuedToSettleAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock issued to settle accounts payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_CommonStockIssuedToSettleAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_CommonStockIssuedToSettleAccountsPayableShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock issued to settle accounts payable, shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_CommonStockIssuedToSettleAccountsPayableShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 25<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=6939902&amp;loc=d3e20148-110875<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.18)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 03<br> -Paragraph 19<br> -Article 5<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br> -Paragraph 20<br> -Article 9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 29, 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period that is attributable to transactions involving issuance of stock not separately disclosed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 29, 30, 31<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of shares of stock issued during the period that is attributable to transactions involving issuance of stock not separately disclosed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br> -Article 3<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 29, 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 29, 30, 31<br> -Article 5<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br> -Article 3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 4<br> -Section E<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=SNYR_CommonStockToBeIssuedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=SNYR_CommonStockToBeIssuedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6796346832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows from Operating Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (7,536,548)<span></span>
</td>
<td class="num">$ (960,092)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt issuance cost</a></td>
<td class="nump">154,525<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">608,002<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock based compensation expense</a></td>
<td class="nump">$ 551,714<span></span>
</td>
<td class="nump">$ 322,247<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_GainsLossesOnAcquisition', window );">Loss on acquisition</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 109,040<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td>
<td class="nump">$ 5,499,640<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign currency transaction loss</a></td>
<td class="nump">54,600<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Fair value of derivative loss</a></td>
<td class="nump">1,028,921<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainBeforeTax', window );">Remeasurement gain on translation of foreign subsidiary</a></td>
<td class="num">(7,740)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Bad debts</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(1,317,050)<span></span>
</td>
<td class="num">$ (2,898)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="num">(19,632)<span></span>
</td>
<td class="num">(26,064)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expense</a></td>
<td class="num">(194,889)<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">484,141<span></span>
</td>
<td class="nump">58,591<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(644,316)<span></span>
</td>
<td class="num">$ (489,175)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows from Investing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Payments for acquisition of fixed assets</a></td>
<td class="num">(7,833)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseInRestrictedCash', window );">Restricted cash</a></td>
<td class="num">(607,084)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Payments for acquisition of Focus Factor</a></td>
<td class="num">(4,500,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments for acquisition transaction with Knight Therapeutics Inc.</a></td>
<td class="num">(250,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherPaymentsToAcquireBusinesses', window );">Payments for acquisition of NomadChoice Pty Ltd</a></td>
<td class="num">(2,918,200)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Cash acquired in acquisitions</a></td>
<td class="nump">3,883,261<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(4,399,856)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows from Financing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt', window );">(Repayments to) advances from related party notes</a></td>
<td class="nump">16,077<span></span>
</td>
<td class="num">$ (16,077)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from notes payable</a></td>
<td class="nump">11,500,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayment of notes payable</a></td>
<td class="num">(1,150,000)<span></span>
</td>
<td class="num">$ (97,640)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payment of debt issuance cost</a></td>
<td class="num">(533,377)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Dividends paid</a></td>
<td class="num">(1,173,975)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities', window );">Proceeds from exercise of warrants</a></td>
<td class="nump">2<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="nump">26,000<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">8,684,727<span></span>
</td>
<td class="nump">486,283<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Net increase (decrease) in cash and cash equivalents</a></td>
<td class="nump">3,640,554<span></span>
</td>
<td class="num">(2,892)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents, beginning of period</a></td>
<td class="nump">338<span></span>
</td>
<td class="nump">3,230<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents, end of period</a></td>
<td class="nump">3,640,893<span></span>
</td>
<td class="nump">338<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Disclosure of Cash Flow Information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Interest</a></td>
<td class="nump">806,740<span></span>
</td>
<td class="nump">$ 1,667<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes</a></td>
<td class="nump">12,688<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental Disclosure of Non-cash Investing and Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_CommonStockIssuedForConversionOfNotesPayable', window );">Common stock issued for conversion of notes payable</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Beneficial conversion feature on warrants issued concurrent with debt</a></td>
<td class="nump">5,968,801<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_DerivativeLiabilityAtInception', window );">Derivative liability at inception</a></td>
<td class="nump">2,067,258<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_AssumptionOfLiabilitiesAsPartOfAssetPurchaseAgreement', window );">Assumption of liabilities as part of asset purchase agreement with Factor Nutrition Labs, LLC</a></td>
<td class="nump">1,912,827<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_LiabilitiesAssumedRelatedParty', window );">Assumption of liabilities as part of acquisition transaction with Knight Therapeutics Inc.</a></td>
<td class="nump">969,532<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_NoteIssuedAsPartOfAssetPurchaseAgreement', window );">Note issued as part of asset purchase agreement with Factor Nutrition Labs, LLC</a></td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_CommonStockIssuedAsPartOfContributionAgreement', window );">Common stock issued as part of contribution agreement with Hand MD</a></td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_CommonStockIssuedForAcquisitionOne', window );">Common stock issued for the acquisition of Breakthrough Products, Inc.</a></td>
<td class="nump">2,550,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_CommonStockIssuedForAcquisition', window );">Common stock issued for the acquisition of NomadChoice Pty Ltd.</a></td>
<td class="nump">1,750,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_FairValueOfWarrantsIssuedAsPartOfAcquisition', window );">Fair value of warrants issued as part of acquisition of Breakthrough Products, Inc.</a></td>
<td class="nump">430,411<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_NetLiabilitiesTakenOverAsPartOfAcquisition', window );">Net liabilities taken over as part of acquisition of Breakthrough Products, Inc.</a></td>
<td class="nump">422,749<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_NetAssetsTakenOverAsPartOfAcquisition', window );">Net assets taken over as part of acquisition of NomadChoice Pty Ltd.</a></td>
<td class="nump">70,801<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountConverted1', window );">Common stock issued to settle payables</a></td>
<td class="nump">$ 205,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_CancellationOfCommonStockAsPartOfPurchaseTransaction', window );">Cancellation of common stock as part of purchase transaction</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1,359<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_FinancingForPrepaidInsurance', window );">Financing for prepaid insurance</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">20,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAssumed1', window );">Assumption of liabilities as part of acquisition transaction</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">84,040<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_IssuanceOfSharesAsPartOfAcquisitionTransaction', window );">Issuance of shares as part of acquisition transaction</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_AssumptionOfLiabilitiesAsPartOfAssetPurchaseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Assumption of liabilities as part of asset purchase agreement with Factor Nutrition Labs, LLC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_AssumptionOfLiabilitiesAsPartOfAssetPurchaseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_CancellationOfCommonStockAsPartOfPurchaseTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cancellation of common stock as part of purchase transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_CancellationOfCommonStockAsPartOfPurchaseTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_CommonStockIssuedAsPartOfContributionAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock issued as part of contribution agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_CommonStockIssuedAsPartOfContributionAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_CommonStockIssuedForAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock issued for the acquisition of NomadChoice Pty Ltd.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_CommonStockIssuedForAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_CommonStockIssuedForAcquisitionOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock issued for the acquisition of Breakthrough Products, Inc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_CommonStockIssuedForAcquisitionOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_CommonStockIssuedForConversionOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock issued for conversion of notes payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_CommonStockIssuedForConversionOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_DerivativeLiabilityAtInception">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivative liability at inception.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_DerivativeLiabilityAtInception</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_FairValueOfWarrantsIssuedAsPartOfAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of warrants issued as part of acquisition of Breakthrough Products, Inc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_FairValueOfWarrantsIssuedAsPartOfAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_FinancingForPrepaidInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financing for prepaid insurance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_FinancingForPrepaidInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_GainsLossesOnAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gains Losses on Acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_GainsLossesOnAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_IssuanceOfSharesAsPartOfAcquisitionTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance of shares as part of acquisition transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_IssuanceOfSharesAsPartOfAcquisitionTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_LiabilitiesAssumedRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Liabilities Assumed Related Party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_LiabilitiesAssumedRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_NetAssetsTakenOverAsPartOfAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net assets taken over as part of acquisition of NomadChoice Pty Ltd.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_NetAssetsTakenOverAsPartOfAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_NetLiabilitiesTakenOverAsPartOfAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net liabilities taken over as part of acquisition of Breakthrough Products, Inc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_NetLiabilitiesTakenOverAsPartOfAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_NoteIssuedAsPartOfAssetPurchaseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Note issued as part of asset purchase agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_NoteIssuedAsPartOfAssetPurchaseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28541-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to allocate debt discount and premium, and the costs to issue debt and obtain financing over the related debt instruments. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3044-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49171198&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4313-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450189&amp;loc=d3e30690-110894<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6450189&amp;loc=d3e30700-110894<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6450189&amp;loc=d3e30700-110894<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450189&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDerivativeInstrumentsNetPretax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseInRestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow associated with funds that are not available for withdrawal or use (such as funds held in escrow) and are associated with underlying transactions that are classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseInRestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for interest during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAssumed1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of liabilities assumed in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4313-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAssumed1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3574-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3574-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.18)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 03<br> -Paragraph 19<br> -Article 5<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br> -Paragraph 20<br> -Article 9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPaymentsToAcquireBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with other payments to acquire businesses including deposit on pending acquisitions and preacquisition costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPaymentsToAcquireBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash outflow or inflow from other investing activities. This element is used when there is not a more specific and appropriate element in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3098-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3095-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow provided by derivative instruments during the period, which are classified as financing activities, excluding those designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3505-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to write-down of receivables to the amount expected to be collected. Includes, but is not limited to, accounts receivable and notes receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.5)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6786118512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of the Business<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Nature of the Business</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 1 &#150; Nature of the Business</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Synergy CHC Corp. (&#147;Synergy&#148;, &#147;we&#148;,
&#147;us&#148;, &#147;our&#148; or the &#147;Company&#148;) (formerly Synergy Strips Corp.) was incorporated on December
29, 2010 in Nevada under the name &#147;Oro Capital Corporation.&#148; On April 21, 2014, the Company changed its fiscal year
end from July 31 to December 31. On April 28, 2014, the Company changed its name to &#147;Synergy Strips Corp.&#148;. On August
5, 2015, the Company changed its name to &#147;Synergy CHC Corp.&#148;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is a consumer health care company
that is in the process of building a portfolio of best-in-class consumer product brands. Synergy&#146;s strategy is to grow its
portfolio both organically and by further acquisition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Synergy is the sole owner of three subsidiaries:
Neuragen Corp., Breakthrough Products, Inc. and NomadChoice Pty Ltd. and the results have been consolidated in these statements.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=51801978&amp;loc=d3e6003-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -URI http://asc.fasb.org/extlink&amp;oid=51801978&amp;loc=SL51803626-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6781728816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 2 &#150; Summary of Significant
Accounting Policies</b></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Basis of Presentation</u></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The consolidated financial statements
include the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have
been eliminated in consolidation.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Use of Estimates</u></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of the consolidated
financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities, and disclosure of contingent liabilities at the date of the financial statements and the reported
amounts of expenses during the reporting period. Actual results could differ from those estimates. At December 31, 2015 and 2014
significant estimates included in these estimates are assumptions about collection of accounts receivable, useful life of fixed
and intangible assets, goodwill and assumptions used in Black-Scholes-Merton, or BSM, valuation methods, such as expected volatility,
stock based compensation, risk-free interest rate, and expected dividend rate.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Cash and Cash Equivalents</u></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company considers all cash on hand
and in banks, including accounts in book overdraft positions, certificates of deposit and other highly-liquid investments with
maturities of three months or less, when purchased, to be cash and cash equivalents. As of December 31, 2015 the Company had no
cash equivalents. The Company maintains its cash and cash equivalents in banks insured by the Federal Deposit Insurance Corporation
(FDIC) in accounts that at times may be in excess of the federally insured limit of $250,000 per bank. The Company minimizes this
risk by placing its cash deposits with major financial institutions. At December 31, 2015, the uninsured balance amounted to $3,453,290.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Capitalization of Fixed Assets</u></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company capitalizes expenditures
related to property and equipment, subject to a minimum rule, that have a useful life greater than one year for: (1) assets purchased;
(2) existing assets that are replaced, improved or the useful lives have been extended; or (3) all land, regardless of cost. Acquisitions
of new assets, additions, replacements and improvements (other than land) costing less than the minimum rule in addition to maintenance
and repair costs, including any planned major maintenance activities, are expensed as incurred.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Revenue Recognition</u></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company recognizes revenue in accordance
with the Financial Accounting Standards Board&#146;s (&#147;FASB&#148;), Accounting Standards Codification (&#147;ASC&#148;)
605, Revenue Recognition (&#147;ASC 605&#148;). ASC 605 requires that four basic criteria must be met before revenue can be recognized:
(1) persuasive evidence of an arrangement exists; (2) delivery has occurred and/or service has been performed; (3) the selling
price is fixed and determinable; and (4) collectability is reasonably assured. The Company believes that these criteria are satisfied
upon shipment from its fulfillment centers. Certain of our distributors may also perform a separate function as a co-packer on
our behalf. In such cases, ownership of and title to our products that are co-packed on our behalf by those co-packers who are
also distributors, passes to such distributors when we are notified by them that they have taken transfer or possession of the
relevant portion of our finished goods. Freight billed to customers is presented as revenues, and the related freight costs are
presented as cost of goods sold. Cancelled orders are refunded if not already dispatched, refunds are only paid if stock is damaged
in transit, discounts are only offered with specific promotions and orders will be refilled if lost in transit.&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Accounts receivable</u></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Accounts receivable are generally unsecured.
The Company establishes an allowance for doubtful accounts receivable based on the age of outstanding invoices and management&#146;s
evaluation of collectability. Accounts are written off after all reasonable collection efforts have been exhausted and management
concludes that likelihood of collection is remote. Any future recoveries are applied against the allowance for doubtful accounts.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Advertising Expense</u></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company expenses marketing, promotions
and advertising costs as incurred. Such costs are included in general and administrative expense in the accompanying consolidated
statements of operations.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Research and Development</u></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Costs incurred in connection with the
development of new products and processing methods are charged to general and administrative expenses as incurred.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Income Taxes</u></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company utilizes FASBASC 740, &#147;Income
Taxes,&#148; which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of
events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities
are determined based on the difference between the tax basis of assets and liabilities and their financial reporting amounts based
on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income.
A valuation allowance is recorded when it is &#147;more likely-than-not&#148; that a deferred tax asset will not be realized.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company generated a deferred tax
asset through net operating loss carry-forward. However, a valuation allowance of 100% has been established due to the uncertainty
of the Company&#146;s realization of the net operating loss carry forward prior to its expiration.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">NomadChoice Pty Ltd, the Company&#146;s
wholly-owned subsidiary is subject to income taxes in the jurisdictions in which it operates. Significant judgment is required
in determining the provision for income tax. There are many transactions and calculations undertaken during the ordinary course
of business for which the ultimate tax determination is uncertain. The company recognizes liabilities for anticipated tax audit
issues based on the Company&#146;s current understanding of the tax law. Where the final tax outcome of these matters is different
from the carrying amounts, such differences will impact the current and deferred tax provisions in the period in which such determination
is made.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Net Earnings (Loss) Per Common Share</u></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company computes earnings per share
under ASC subtopic 260-10, Earnings Per Share. Basic earnings (loss) per share is computed by dividing the net income (loss) attributable
to the common stockholders (the numerator) by the weighted average number of shares of common stock outstanding (the denominator)
during the reporting periods. Diluted loss per share is computed by increasing the denominator by the weighted average number of
additional shares that could have been outstanding from securities convertible into common stock (using the &#147;treasury stock&#148;
method), unless their effect on net loss per share is anti-dilutive. As of December 31, 2015, options to purchase 5,000,000 shares
of common stock and warrants to purchase 9,132,002 shares of common stock were outstanding these potential shares were excluded
from the shares used to calculate diluted earnings per share as their inclusion would reduce net loss per share.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Going Concern</u></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#146;s consolidated financial
statements are prepared using U.S. GAAP applicable to a going concern, which contemplates the realization of assets and liquidation
of liabilities in the normal course of business. The Company had an accumulated deficit at December 31, 2015 of $8,569,841. The
Company had a working capital deficit of $6,165,812 as of December 31, 2015. Due to acquisitions during 2015 of revenue-producing
products, the Company believes it has established an ongoing source of revenue that is sufficient to cover its operating costs.
The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating
losses until it establishes a revenue stream and becomes profitable. If the Company is unable to obtain adequate capital it could
be forced to cease development of operations.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In order to continue as a going concern
and to develop a reliable source of revenues, and achieve a profitable level of operations the Company will need, among other things,
additional capital resources. Management&#146;s plans to continue as a going concern include raising additional capital through
borrowing and/or sales of equity and debt securities. However, management cannot provide any assurances that the Company will be
successful in accomplishing any of its plans.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The ability of the Company to continue
as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and
eventually secure other sources of financing and attain profitable operations. The accompanying consolidated financial statements
do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Fair Value Measurements</u></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company measures and discloses the
fair value of assets and liabilities required to be carried at fair value in accordance with ASC 820, Fair Value Measurements and
Disclosures. ASC 820 defines fair value, establishes a framework for measuring fair value, and enhances fair value measurement
disclosure.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">ASC 825 defines fair value as the price
that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants
at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded
at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions
that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk
of nonperformance. ASC 825 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs
and minimize the use of unobservable inputs when measuring fair value. ASC 825 establishes three levels of inputs that may be used
to measure fair value:</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Level 1 - Quoted prices for identical
assets or liabilities in active markets to which we have access at the measurement date.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Level 2 - Inputs other than quoted prices
within Level 1 that are observable for the asset or liability, either directly or indirectly.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Level 3 - Unobservable inputs for the
asset or liability.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The determination of where assets and
liabilities fall within this hierarchy is based upon the lowest level of input that is significant to the fair value measurement.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">As of December 31, 2015, the Company
has determined that there were no assets or liabilities measured at fair value except for the warrant derivative liability which
is valued using Level 3 estimates.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Inventory</u></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Inventory consists of raw materials,
components and finished goods. The Company&#146;s inventory is stated at the lower of cost (FIFO cost basis) or market. Finished
goods include the cost of labor to assemble the items.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Stock-Based Compensation</u></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company adopted the provisions of
ASC 718. We estimate the fair value of stock options using a binomial model, consistent with the provisions of ASC 718 and SEC
Staff Accounting Bulletin No. 107, Share-Based Payment. Option-pricing models require the input of highly subjective assumptions,
including the price volatility of the underlying stock. We determined that the use of implied volatility is expected to be more
reflective of market conditions and, therefore, could reasonably be expected to be a better indicator of our expected volatility
than historical volatility. The expected term assumption used in calculating the estimated fair value of our stock-based compensation
awards using the Black-Scholes-Merton (BSM) model is based on detailed historical data about employees&#146; exercise behavior,
vesting schedules, and death and disability probabilities. In addition, we are required to estimate the expected forfeiture rate
and only recognize expense for those shares expected to vest. We estimate the forfeiture rate based on historical experience of
our stock-based awards that are granted, exercised and cancelled. We believe the resulting BSM calculation provides a more refined
estimate of the fair value of our employee stock options.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Long-lived Assets</u></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Long-lived assets include equipment
and intangible assets other than those with indefinite lives. We assess the carrying value of our long-lived asset groups when
indicators of impairment exist and recognize an impairment loss when the carrying amount of a long-lived asset is not recoverable
when compared to undiscounted cash flows expected to result from the use and eventual disposition of the asset.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Indicators of impairment include significant
underperformance relative to historical or projected future operating results, significant changes in our use of the assets or
in our business strategy, loss of or changes in customer relationships and significant negative industry or economic trends. When
indications of impairment arise for a particular asset or group of assets, we assess the future recoverability of the carrying
value of the asset (or asset group) based on an undiscounted cash flow analysis. If carrying value exceeds projected, net, undiscounted
cash flows, an additional analysis is performed to determine the fair value of the asset (or asset group), typically a discounted
cash flow analysis, and an impairment charge is recorded for the excess of carrying value over fair value. As of December 31, 2015,
our qualitative analysis of long-lived assets did not indicate any impairment.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Goodwill</u></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">An asset purchase is accounted for under
the purchase method of accounting. Under that method, assets and liabilities of the business acquired are recorded at their estimated
fair values as of the date of the acquisition, with any excess of the cost of the acquisition over the estimated fair value of
the net tangible and intangible assets acquired recorded as goodwill. As of December 31, 2015 our qualitative analysis of goodwill
did not indicate any impairment.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="background-color: white"><u>Foreign
Currency Translation</u></font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="background-color: white">The
functional currency of each of the Company&#146;s foreign subsidiaries is the U.S. Dollar. The Company&#146;s subsidiary maintains
its record using local currency (Australian Dollar). All monetary assets and liabilities of foreign subsidiaries were translated
into U.S. Dollars at fiscal year-end exchange rates, non-monetary assets and liabilities of foreign subsidiaries were translated
into U.S. Dollars at transaction day exchange rates. Income and expense items related to non-monetary items were translated at
exchange rates prevailing during the transaction date and other incomes and expenses were translated using average exchange rate
for the period. The resulting translation adjustments, net of income taxes, were recorded in statements of operations as Remeasurement
gain or loss on translation of foreign subsidiary.</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="background-color: white">&#160;</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="background-color: white"><u>Concentrations
of Credit Risk</u></font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="background-color: white">&#160;</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="background-color: white">In
the normal course of business, the Company provided credit terms to its customers; however, collateral was not required. Accordingly,
the Company performed credit evaluations of its customers and maintained allowances for possible losses which, when realized, were
within the range of management&#146;s expectations. From time to time, a higher concentration of credit risk existed on outstanding
accounts receivable for a select number of customers due to individual buying patterns.</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Warehousing costs</u></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Warehouse costs include all third party
warehouse rent fees and any additional costs relating to assembly or special pack-outs of the Company products are charged to general
and administrative expenses as incurred.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Product display costs</u></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">All displays manufactured and purchased
by the Company are for placement of product in retail stores. This also includes all costs for display execution and setup and
retail services are charged to general and administrative expenses as incurred.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Warrant Derivative Liabilities</u></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">ASC 815 generally provides three criteria
that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing
derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks
of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host
contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured
at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings
as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative
instrument subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is
deemed to be conventional, as described.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">A Black-Scholes-Merton option-pricing
model, with dilution effects, was utilized to estimate the fair value of the Warrant Derivative Liabilities as of November 12,
2015 and December 31, 2015. This model is subject to the significant assumptions discussed below and requires the following key
inputs with respect to the Company and/or instrument:</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; line-height: 115%"><b>Input</b></td>
    <td style="line-height: 115%">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><b>November 12, 2015</b></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><b>December 31, 2015</b></td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 54%; line-height: 115%">Stock Price</td>
    <td style="width: 1%; line-height: 115%">&#160;</td>
    <td style="width: 1%; line-height: 115%">$</td>
    <td style="width: 20%; text-align: right; line-height: 115%">0.46</td>
    <td style="width: 1%; line-height: 115%">&#160;</td>
    <td style="width: 1%; line-height: 115%">&#160;</td>
    <td style="width: 1%; line-height: 115%">$</td>
    <td style="width: 20%; text-align: right; line-height: 115%">0.69</td>
    <td style="width: 1%; line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="line-height: 115%">Exercise Price</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">$</td>
    <td style="text-align: right; line-height: 115%">0.49</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">$</td>
    <td style="text-align: right; line-height: 115%">0.49</td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="line-height: 115%">Expected Life (in years)</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%">10.0</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%">9.75</td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="line-height: 115%">Stock Volatility</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%">157.56</td>
    <td style="line-height: 115%">%</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%">152.07</td>
    <td style="line-height: 115%">%</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="line-height: 115%">Risk-Free Rate</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%">2.32</td>
    <td style="line-height: 115%">%</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%">2.27</td>
    <td style="line-height: 115%">%</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="line-height: 115%">Dividend Rate</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%">0</td>
    <td style="line-height: 115%">%</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%">0</td>
    <td style="line-height: 115%">%</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt; line-height: 115%">Outstanding Shares of Common Stock</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%">4,547,243</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%">4,547,243</td>
    <td style="line-height: 115%">&#160;</td></tr>
</table>
<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Cost of Sales</u></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Cost of sales includes the purchase
cost of products sold and all costs associated with getting the products into the retail stores including buying and transportation
costs.&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; background-color: white"><u>Debt
Issuance Costs</u></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Debt issuance
costs consist primarily of arrangement fees, professional fees and legal fees. These costs are capitalized and are being amortized
to interest expense over the term of the related debt facilities.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><u>Impairment
of Long-Lived Assets</u></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">When facts
and circumstances indicate that the carrying values of long-lived assets, including fixed assets, may be impaired, an evaluation
of recoverability is performed by comparing the carrying value of the assets to projected future cash flows in addition to other
quantitative and qualitative analyses. Upon indication that the carrying value of such assets may not be recoverable, the Company
recognizes an impairment loss as a charge against current operations. Long-lived assets to be disposed of are reported at the lower
of the carrying amount or fair value, less estimated costs to sell. The Company makes judgments related to the expected useful
lives of long-lived assets and its ability to realize undiscounted cash flows in excess of the carrying amounts of such assets
which are affected by factors such as the ongoing maintenance and improvements of the assets, changes in economic conditions and
changes in operating performance. As the Company assesses the ongoing expected cash flows and carrying amounts of its long-lived
assets, these factors could cause the Company to realize a material impairment charge.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; background-color: white"><u>Shipping
Costs</u></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Shipping and
handling costs billed to customers are recorded in sales. Shipping costs incurred by the company are recorded in selling and marketing
expenses.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><u>Related
parties</u></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Parties are
considered to be related to the Company if the parties that, directly or indirectly, through one or more intermediaries, control,
are controlled by, or are under common control with the Company. Related parties also include principal owners of the Company,
its management, members of the immediate families of principal owners of the Company and its management and other parties with
which the Company may deal if one party controls or can significantly influence the management or operating policies of the other
to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. The All transactions
with related parties shall be recorded at fair value of the goods or services exchanged. Property purchased from a related party
is recorded at the cost to the related party and any payment to or on behalf of the related party in excess of the cost is reflected
as a distribution to the related party.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; background-color: white"><u>Segment
Reporting</u></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><font style="background-color: white">Segment
identification and selection is consistent with the management structure used by the Company&#146;s chief operating decision maker
to evaluate performance and make decisions regarding resource allocation, as well as the materiality of financial results consistent
with that structure. Based on the Company&#146;s management structure and method of internal reporting, the Company has one operating
segment. The Company&#146;s chief operating decision maker does not review operating results on a disaggregated basis; rather,
the chief operating decision maker reviews operating results on an aggregate basis.</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Recent Accounting Pronouncements</u></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">ASU 2015-03</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In April 2015, the FASB issued Accounting
Standards Update (&#147;ASU&#148;) No. 2015-03, Interest - Imputation of Interest (Subtopic 835-30): Simplifying the Presentation
of Debt Issuance Costs. The amendments in this ASU require that debt issuance costs related to a recognized debt liability be presented
in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The
recognition and measurement guidance for debt issuance costs are not affected by the amendments in this ASU. The amendments are
effective for financial statements issued for fiscal years, and interim periods within those fiscal years, beginning after December
15, 2015. The amendments are to be applied on a retrospective basis, wherein the balance sheet of each individual period presented
is adjusted to reflect the period-specific effects of applying the new guidance. The Company is evaluating the possible effect
of this guidance on its financial statements.&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">ASU 2015-02</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In February 2015, the FASB issued ASU
No. 2015-02, Consolidation (Topic 810): Amendments to the Consolidation Analysis, which is intended to improve targeted areas of
consolidation guidance for legal entities such as limited partnerships, limited liability corporations, and securitization structures
(collateralized debt obligations, collateralized loan obligations, and mortgage-backed security transactions). The ASU focuses
on the consolidation evaluation for reporting organizations that are required to evaluate whether they should consolidate certain
legal entities. In addition to reducing the number of consolidation models from four to two, the new standard simplifies the FASB
Accounting Standards Codification and improves current U.S. GAAP by placing more emphasis on risk of loss when determining a controlling
financial interest, reducing the frequency of the application of related-party guidance when determining a controlling financial
interest in a variable interest entity (&#147;VIE&#148;), and changing consolidation conclusions for companies in several industries
that typically make use of limited partnerships or VIEs. The ASU will be effective for fiscal years, and interim periods within
those fiscal years, beginning after December 15, 2015. Early adoption is permitted, including adoption in an interim period. We
do not expect the adoption of ASU 2015-02 to have a material effect on our financial position, results of operations or cash flows.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">ASU 2015-01</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In January 2015, the FASB issued ASU
No. 2015-01, &#147;Income Statement - Extraordinary and Unusual Items (Subtopic 225-20): Simplifying Income Statement Presentation
by Eliminating the Concept of Extraordinary Items.&#148; This ASU eliminates from U.S. GAAP the concept of extraordinary items.
ASU 2015-01 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. A
reporting entity may apply the amendments prospectively. We do not expect the adoption of ASU 2015-01 to have a material effect
on our financial position, results of operations or cash flows.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">ASU 2014-17</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In November 2014, the FASB issued ASU
No. 2014-17, &#147;Business Combinations (Topic 805): Pushdown Accounting.&#148; This ASU provides an acquired entity with an
option to apply pushdown accounting in its separate financial statements upon occurrence of an event in which an acquirer obtains
control of the acquired entity. An acquired entity may elect the option to apply pushdown accounting in the reporting period in
which the change-in-control event occurs. If pushdown accounting is applied to an individual change-in-control event, that election
is irrevocable. ASU 2014-17 was effective on November 18, 2014. The adoption of ASU 2014-17 did not have any effect on our financial
position, results of operations or cash flows.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">ASU 2014-16</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In November 2014, the FASB issued ASU
2014-16, &#147;Derivatives and Hedging (Topic 815).&#148; ASU 2014-16 addresses whether the host contract in a hybrid financial
instrument issued in the form of a share should be accounted for as debt or equity. ASU 2014-16 is effective for fiscal years,
and interim periods within those fiscal years, beginning after December 15, 2015. We do not currently have issued, nor are we investors
in, hybrid financial instruments. Accordingly, we do not expect the adoption of ASU 2014-16 to have any effect on our financial
position, results of operations or cash flows.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">ASU 2014-15</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In August 2014, the FASB issued ASU
No. 2014-15, &#147;Presentation of Financial Statements - Going Concern (Subtopic 205-40)&#148;. ASU 2014-15 provides guidance
related to management&#146;s responsibility to evaluate whether there is substantial doubt about an entity&#146;s ability to
continue as a going concern and to provide related footnote disclosure. ASU 2014-15 is effective for annual periods ending after
December 15, 2016, and for interim and annual periods thereafter. Early application is permitted. We do not expect the adoption
of ASU 2014-15 to have a material effect on our financial position, results of operations or cash flows.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">ASU 2014-12</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In June 2014, the FASB issued ASU No.
2014-12, &#147;Compensation &#150; Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award
Provide That a Performance Target Could Be Achieved after the Requisite Service Period.&#148; This ASU requires that a performance
target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition.
ASU 2014-12 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. We
do not expect the adoption of ASU 2014-12 to have a material effect on our financial position, results of operations or cash flows.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">ASU 2014-09</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In May 2014, the FASB issued ASU No.
2014-09, &#147;Revenue from Contracts with Customers (Topic 606).&#148; ASU 2014-09 affects any entity using U.S. GAAP that either
enters into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets
unless those contracts are within the scope of other standards (e.g., insurance contracts or lease contracts). ASU 2014-09 is effective
for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2016. We are still evaluating the
effect of the adoption of ASU 2014-09. In August 2015, the FASB issued ASU 2015-14, which defers the effective date of ASU 2014-09
by one year for all entities and permits early adoption on a limited basis. ASU 2014-09 will be effective for the Company in the
first quarter of 2018, and early adoption permitted in the first quarter of 2017. The Company does not believe the adoption of
this ASU will have a material impact on its consolidated financial statements.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">ASU 2014-08</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In April 2014, the FASB issued ASU No.
2014-08, &#147;Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360) and Reporting Discontinued
Operations and Disclosures of Disposals of Components of an Entity.&#148; ASU 2014-08 amends the definition for what types of
asset disposals are to be considered discontinued operations, as well as amending the required disclosures for discontinued operations
and assets held for sale. ASU 2014-08 is effective for fiscal years, and interim periods within those fiscal years, beginning on
or after December 15, 2014. The adoption of ASU 2014-08 did not have any effect on our financial position, results of operations
or cash flows.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">There were various updates recently
issued, most of which represented technical corrections to the accounting literature or application to specific industries and
are not expected to a have a material impact on the Company&#146;s condensed financial position, results of operations or cash
flows.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Change in Fiscal Year End</u></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 21, 2014, the Company&#146;s
board of directors approved a change to the Company&#146;s fiscal year end from July 31 to December 31 of each year.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18861-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18726-107790<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18743-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18854-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6786137328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Acquisitions</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="margin: 0pt"></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 3 &#150; Acquisitions</b></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Asset Purchase Agreement with Factor
Nutrition Labs, LLC:</u></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 22, 2015 (the &#147;Closing
Date&#148;), the Company entered into an Asset Purchase Agreement (the &#147;Purchase Agreement&#148;) with Factor Nutrition
Labs, LLC, a Delaware limited liability company (the &#147;Seller&#148;), Vita Partners, LLC, RPR Partners, LLC, and Thor Associates,
Inc. (each a &#147;Principal Owner&#148;). Pursuant to the Purchase Agreement, the Company purchased all of the assets of the
Seller&#146;s line of business and products called FOCUS Factor (the product plus the business related to the product is collectively
referred to as the &#147;Focus Factor Business&#148;) and assumed the accounts payable and contractual obligations of the Focus
Factor Business for an aggregate purchase price of $6.0 million, with $4.5 million paid on the Closing Date, and $750,000 to be
paid on or before January 20, 2016 and an additional $750,000 to be paid on or before January 20, 2017.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Distribution Agreement</i></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 22, 2015, the Company and
Knight entered into a Distribution, License and Supply Agreement (the &#147;Distribution Agreement&#148;), pursuant to which
the Company granted to Knight an exclusive license to commercialize FOCUSFactor, FOCUSFactor Kids and Synergy Strip and all improvements
thereto (together the &#147;Licensed Products&#148;) and appointed Knight as the exclusive distributor to offer to sell and sell
the Licensed Products in Canada, and, at Knight&#146;s election, one or more of Israel, Russia, and Sub-Saharan Africa. The Distribution
Agreement provides that Knight may sublicense its rights or use sub-distributors under the Distribution Agreement on terms consistent
with the terms of the Distribution Agreement. During the term of the Distribution Agreement, Knight agrees to obtain from the Company
all its requirements for the Licensed Products and the Company agrees to supply the Licensed Products at its adjusted production
cost plus a designated percentage and any applicable taxes.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In the event of a long term inability
by the Company to supply Knight with the Licensed Products, Knight is entitled to require, among other remedies, the Company to
grant a Knight-designated third party a non-exclusive license to use all relevant intellectual property to manufacture and supply
Knight with the Licensed Products for commercialization in the Territory. The term of the Distribution Agreement runs until 15
years from the date of the first commercial sale of a Licensed Product in Canada, and the Distribution Agreement will automatically
renew for successive 15-year periods unless either party provides the other with written notice of its intention not to renew (a
&#147;Non-Renewal Notice&#148;). The Company agrees that in the event it issues a Non-Renewal Notice, the Company will pay to
Knight a non-renewal fee equal to the net sales of the Licensed Products achieved by Knight in the Territory during the eight calendar
quarters preceding the date of such notice, plus all applicable taxes.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Distribution Option Agreement</i></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In connection with the Loan Agreement,
the Company entered into a Product Distribution Option Agreement, dated January 22, 2015 (the &#147;Option Agreement&#148;),
pursuant to which the Company granted Knight the exclusive right to negotiate the exclusive distribution rights of any one or more
of the Company&#146;s products, including products from the Focus Factor Business, for the territories of Canada, Russia, Sub-Saharan
Africa and Israel (the &#147;Option&#148;), pursuant to designated parameters. The Option Agreement is effective upon the date
of the Option Agreement, will run until January 31, 2045, and will automatically renew thereafter for successive five-year periods
unless either party provides a notice of termination prior to the Option Agreement&#146;s expiration. If Knight does not exercise
the option then the Company is free to contract for distribution with other parties, but only on terms no less favorable than those
offered by Knight pursuant to the Option Agreement.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 3, 2015, we entered into
an Amendment to First Amendment Agreement (the &#147;Second Amendment Agreement&#148;) with Knight pursuant to which we agreed
to grant distribution rights to Knight for Breakthrough&#146;s products. To satisfy this obligation, on December 3, 2015, we also
entered into an Amendment and Confirmation Agreement (the &#147;Confirmation Agreement&#148;) with Knight, Nomad and Breakthrough
to amend the Distribution, License and Supply Agreement dated January 22, 2015 (the &#147;Distribution Agreement&#148;) between
us and Knight to grant to Knight an exclusive license to commercialize any and all Nomad and Breakthrough products and appoint
Knight as the exclusive distributor to offer and sell those products in Canada, Israel, Romania, Russia and each of the countries
within Sub-Saharan Africa, which is the new &#147;Territory&#148; under the Distribution Agreement, as amended. Pursuant to the
Second Amendment Agreement, Nomad will buy all Flat Tummy Tea products within the Territory for direct to consumer sales exclusively
from Knight and/or its affiliates at cost of goods plus 60% of gross sales.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has accounted for this transaction
under the acquisition method of accounting. Under the acquisition method of accounting, the total acquisition consideration price
is allocated to the assets acquired and liabilities assumed based on their preliminary estimated fair values based on the management&#146;s
estimates as of the date of the acquisition. The Company expects to retain the services of independent valuation firm to determine
the fair value of these identifiable intangible assets. Once determined, the Company will reallocate the purchase price of the
acquisition based on the results of the independent evaluation if they are materially different from the allocations as recorded
on January 22, 2015. The Company expects the purchase price allocations for the acquisition of Focus Factor Business to be completed
by the filing of first quarter 2016 statements. The preliminary allocation of the purchase price to the assets acquired and liabilities
assumed based on the estimated fair values is as follows:</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-decoration: underline; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif"><u>Assets</u></font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="width: 79%; padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Accounts Receivable</font></td>
    <td style="width: 1%; line-height: 115%">&#160;</td>
    <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="width: 18%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">2,733,167</font></td>
    <td style="width: 1%; line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Inventory</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">67,113</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Intellectual Property</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">1,000,000</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Non-compete provision</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">50,000</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Non-solicitation provision</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">50,000</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Intangible assets-Customer relationships</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">1,941,030</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Goodwill</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">2,071,517</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-decoration: underline; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif"><u>Liabilities</u></font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Accounts Payable</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(971,381</font></td>
    <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Accrued Expenses</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(941,446</font></td>
    <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">6,000,000</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
</table>
<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Customer relationships, the non-compete
and the non-solicitation provisions will be amortized over their estimated useful lives of 5 years. During the year ended December
31, 2015, the Company charged to operations amortization expense of $384,720.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The purchase price allocated to the
acquisition of the assets of Factor Nutrition Labs, LLC is made up as follows:</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Amount</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 86%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Cash payment made on January 22, 2015</font></td>
    <td style="width: 1%; line-height: 115%">&#160;</td>
    <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="width: 11%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">4,500,000</font></td>
    <td style="width: 1%; line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Cash payment to be made on January 20, 2016</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">750,000</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Cash payment to be made on January 20, 2017</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">750,000</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">6,000,000</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
</table>
<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Pro forma Results of Operations. The
historical operating results of the Focus Factor Business prior to its acquisition date have not been included in the Company&#146;s
historical consolidated operating results. Pro forma results of operations data (unaudited) for the years ended December 31, 2014
and 2013, as if the acquisition had occurred on January 1, 2013, are as follows:</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: center; line-height: 115%">&#160;</td>
    <td style="text-align: center; line-height: 115%">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">December 31,</font></td>
    <td style="text-align: center; line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center; line-height: 115%">&#160;</td>
    <td style="text-align: center; line-height: 115%">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">2014</font></td>
    <td style="text-align: center; line-height: 115%">&#160;</td>
    <td style="text-align: center; line-height: 115%">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">2013</font></td>
    <td style="text-align: center; line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 66%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Revenue</font></td>
    <td style="width: 1%; line-height: 115%">&#160;</td>
    <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="width: 14%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">12,695,295</font></td>
    <td style="width: 1%; line-height: 115%">&#160;</td>
    <td style="width: 1%; line-height: 115%">&#160;</td>
    <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="width: 14%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">10,629,171</font></td>
    <td style="width: 1%; line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Net (loss) income</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(183,471</font></td>
    <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">932,209</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
</table>
<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Pro forma revenue amount above does
not include adjustment/reductions relating to certain discounts, coupons and placement fees and is presented gross.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The amounts of revenue and net income
of the FOCUS Factor Business since the acquisition date included in the consolidated statement of operations for the year ended
December 31, 2015 are approximately $10,482,367 and $1,216,928, respectively.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Asset Purchase Agreement with Knight
Therapeutics Inc.:</u></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 26, 2015 (the &#147;Closing
Date&#148;), Neuragen Corp., a Delaware corporation (&#147;Neuragen&#148;) and our wholly owned subsidiary, entered into an
Asset Purchase Agreement (the &#147;Purchase Agreement&#148;) with Knight Therapeutics Inc., a Canadian corporation (&#147;Knight
Canada&#148;). Pursuant to the Purchase Agreement, Neuragen purchased the U.S. rights related to an innovative OTC product that
helps relieve pain caused by diabetic nerve damage (the &#147;Purchased Assets&#148;) for an aggregate purchase price of $1.2
million, with (i) $250,000 paid on the Closing Date, (ii) $250,000 to be paid on or before June 30, 2016, (iii) $700,000 to be
paid in quarterly installments (beginning with the quarter ending September 30, 2015) equal to the greater of $12,500 or 5% of
U.S. net sales, and (iv) 2% of U.S. net sales of Neuragen for 60 months thereafter. The payment of such amounts is secured by a
security interest in certain assets, undertakings and property (&#147;Collateral&#148;) pursuant to the Security Agreement, which
will be released upon receipt of total payments of $1.2 million (collectively, &#147;Total Consideration&#148;). The Company
has recorded present value of future payments of $515,854 as of December 31, 2015. The Company has recorded interest expense of
$37,372 for the year ended December 31, 2015.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Security Agreement</i></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On the Closing Date, Neuragen entered
into a Security Agreement with Knight Canada, pursuant to which Neuragen granted a lien and security interest to Knight Canada
in Collateral in connection with the Purchase Agreement.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Security Agreement was made to secure
the payment of all indebtedness, obligations and liabilities of Neuragen of the Purchase Agreement, including all expenses and
charges, legal or otherwise, suffered or incurred by Knight Canada in collecting or enforcing such indebtedness of the Purchase
Agreement.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Security Agreement includes customary
events of default, including but not limited to: payment defaults; Neuragen becoming insolvent or entering into bankruptcy; or
if any contemplated security ceases to be a valid and perfected first-priority security interest that is not remedied within fifteen
business days by Neuragen. Upon the occurrence of an event of default and during the continuation thereof, the principal amount
of the outstanding Total Consideration will bear a default interest rate of an additional 10% per annum.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The acquisition was treated as an acquisition
of assets as the transaction involved the acquisition of a brand and a license agreement. The Company expects to retain the services
of independent valuation firm to determine the fair value of these identifiable intangible assets. Once determined, the Company
will reallocate the purchase price of the acquisition based on the results of the independent evaluation if they are materially
different from the allocations as recorded on June 26, 2015. The Company expects the purchase price allocations for the asset acquisition
to be completed by the filing of second quarter 2016 statements. The preliminary allocation of the purchase price to the assets
acquired and liabilities assumed based on the estimated fair values is as follows:</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-decoration: underline; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif"><u>Assets</u></font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="width: 86%; padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Accounts Receivable</font></td>
    <td style="width: 1%; line-height: 115%">&#160;</td>
    <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="width: 11%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">58,054</font></td>
    <td style="width: 1%; line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Inventory</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">204,925</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Intangible property</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">100,000</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">License agreement</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">606,553</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-decoration: underline; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif"><u>Liabilities</u></font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Accounts Payable</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(51,795</font></td>
    <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Accrued Expenses</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(148,520</font></td>
    <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">769,217</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
</table>
<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The intangible property and license
agreement will be amortized over their estimated useful lives of 5 years. During the year ended December 31, 2015, the Company
charged to operations amortization expense of $70,655.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Contribution Agreement with Hand
MD Corp.:</u></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 18, 2015 (the &#147;Closing
Date&#148;), we entered into a Contribution Agreement with Hand MD Corp., a Delaware corporation, whereby we contributed to Hand
MD Corp. 2,142,857 shares of our common stock in exchange for 50% of Hand MD Corp.&#146;s outstanding capital securities valued
at $0.70 per share. Simultaneously, Hand MD, LLC, a California limited liability company, entered into a Contribution Agreement
with Hand MD Corp., the principal owners of Hand MD, LLC, and us whereby Hand MD LLC contributed to Hand MD Corp. all of its right,
title and interest in its intellectual property associated with skincare, nail care and nail polish products (the &#147;Hand MD
Business&#148;) in exchange for the other 50% of Hand MD Corp.&#146;s outstanding capital securities. In the Contribution Agreement
among Hand MD Corp., Hand MD, LLC, the principal owners of Hand MD, LLC and us, Hand MD, LLC and its principal owners agreed to
not compete or solicit customers or employees for five years. As part of the transaction, we also purchased from Hand MD Corp.
all inventory related to the Hand MD Business for approximately $106,000. The Company has recorded 50% of the present value of
future royalty payments of $258,897 as of December 31, 2015.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">We also entered into a license agreement
with Hand MD Corp. on August 18, 2015, whereby we acquired the exclusive worldwide license to commercialize Hand MD Corp. skincare
products and all improvements thereto. The license runs in perpetuity unless earlier terminated. We will pay Hand MD Corp. a royalty
of 5% of the net sales price of product sold, transferred or otherwise disposed of by us, as well as 5% of any amount we receive
from sublicensees, subject to a minimum royalty of $250,000 in the second year of the license and $500,000 in the third year of
the license, after which the minimum royalty terminates. We are solely responsible for any regulatory and intellectual property
filings, including those necessary to maintain regulatory approvals for the licensed products. Either we or Hand MD Corp. can terminate
the agreement in the event of bankruptcy or insolvency of the other party, or the uncured material breach of the agreement by the
other party. Upon termination we would be entitled to sell any inventory of licensed product in the normal course of business and
consistent with sales of licensed product during the term of the agreement.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Contribution Agreements and the
License Agreement contain customary representations and warranties and covenants by the respective parties.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">We also entered into a Consulting Agreement
on August 18, 2015, with Kara Harshbarger, the co-founder of Hand MD, LLC, pursuant to which she will provide marketing and sales
related services. We will pay Ms. Harshbarger $10,000 a month for one year unless the Consulting Agreement is terminated earlier
by either party. If we terminate the Consulting Agreement without cause, we will be obligated to pay the remaining term of the
Agreement. Ms. Harshbarger agreed not to compete with us in the United States in any marketing or sales of skincare, nail polish
and nail care products during the term of the Consulting Agreement and for 12 months after its termination. Ms. Harshbarger also
agreed not to solicit customers or employees for the same period.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The acquisition was treated as an acquisition
of assets as the transaction involved the acquisition of a brand and a license agreement. The Company expects to retain the services
of independent valuation firm to determine the fair value of these identifiable intangible assets. Once determined, the Company
will reallocate the purchase price of the acquisition based on the results of the independent evaluation if they are materially
different from the allocations as recorded on August 18, 2015. The Company expects the purchase price allocations for the asset
acquisition to be completed during 2016. The preliminary allocation of the purchase price to the assets acquired and liabilities
assumed based on the estimated fair values is as follows:</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-decoration: underline; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif"><u>Assets</u></font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="width: 86%; padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Intangible property</font></td>
    <td style="width: 1%; line-height: 115%">&#160;</td>
    <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="width: 11%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">100,000</font></td>
    <td style="width: 1%; line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">License agreement</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">1,670,675</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-decoration: underline; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif"><u>Liabilities</u></font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Royalty payable</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(258,897</font></td>
    <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Others</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(11,778</font></td>
    <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">1,500,000</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
</table>
<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The intangible property and license
agreement will be amortized over their estimated useful lives of 5 years. During the year ended December 31, 2015, the Company
charged to operations amortization expense of $118,045.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Stock Purchase Agreement with Breakthrough
Products, Inc.:</u></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On November 12, 2015 (the &#147;UrgentRx
Closing Date&#148;), we entered into a Stock Purchase Agreement (the &#147;UrgentRx SPA&#148;) with Breakthrough Products, Inc.,
a Delaware corporation (the &#147;Company&#148;), URX ACQUISITION TRUST, a Delaware statutory trust, (the &#147;Trust&#148;),
Jordan Eisenberg, the chief executive officer and a shareholder of the Company (&#147;Eisenberg&#148;), and the other shareholders
of the Company (Eisenberg and such other shareholders collectively referred to as the &#147;UrgentRx Sellers&#148;) for the purchase
of all the issued and outstanding capital stock of the Company for 6,000,000 shares of our common stock (&#147;UrgentRx Equity
Consideration&#148;).</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition to the UrgentRx Equity Consideration,
we have agreed to pay a royalty to the Trust, for the benefit of the UrgentRx Sellers, equal to 5% of gross sales of the UrgentRx
(as defined below) following the first $5,000,000 in gross sales by the UrgentRx Products, on a quarterly basis for a period of
seven years from the UrgentRx Closing Date.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is engaged in the business
of developing and selling medications for headache, heart burn, allergy attack, ache and pain, and upset stomach in the form of
powders (&#147;UrgentRx&#148;).</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Following the UrgentRx Closing Date,
we discovered certain liabilities and obligations of Breakthrough that required an adjustment to the UrgentRx Equity Consideration
and the royalty payments.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 17, 2015, we entered into
a Settlement and Release Agreement (the &#147;Settlement Agreement&#148;) with the UrgentRx Sellers, the Trust, on its own behalf
and as the representative of the UrgentRx Sellers, David T. Leyrer, Michael Valentino, Ron Fugate, and Randall Kaplan (collectively
with Leyrer, Valentino, Fugate, the &#147;Former Directors&#148;) to resolve the post-closing liabilities. Pursuant to the terms
of the Settlement Agreement, 3,000,000 shares of the Equity Consideration were returned by the Trust to us and our obligation to
pay royalties to the Trust was reduced from seven years to five years. The Settlement Agreement further contained mutual releases
among us, the UrgentRx Sellers, and the Former Directors, with limited exceptions. Additionally, we issued a three-year warrant
to the Trust with a $5.00 per share exercise price. We may redeem the warrant at a price of $0.001 per share if our common stock
is traded on the OTCBB or on a national securities exchange, and the per share closing sale price of our common stock equals or
exceeds the exercise price for a period of 90 consecutive calendar days. In the event of a reorganization or reclassification of
our capital stock, the merger or consolidation of our company into another entity or the sale or transfer of all or substantially
all of our assets, the warrant will terminate if not exercised prior to the date of such event.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has accounted for this transaction
under the acquisition method of accounting. Under the acquisition method of accounting, the total acquisition consideration price
is allocated to the assets acquired and liabilities assumed based on their preliminary estimated fair values based on the management&#146;s
estimates as of the date of the acquisition. The Company expects to retain the services of independent valuation firm to determine
the fair value of these identifiable intangible assets. Once determined, the Company will reallocate the purchase price of the
acquisition based on the results of the independent evaluation if they are materially different from the allocations as recorded
on November 12, 2015. The Company expects the purchase price allocations for the acquisition of UrgentRx to be completed during
2016. The preliminary allocation of the purchase price to the assets acquired and liabilities assumed based on the estimated fair
values is as follows:</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-decoration: underline; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif"><u>Assets</u></font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="width: 79%; padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Cash</font></td>
    <td style="width: 1%; line-height: 115%">&#160;</td>
    <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="width: 18%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">2,298,619</font></td>
    <td style="width: 1%; line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Accounts Receivable</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(68,976</font></td>
    <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Inventory</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">234,709</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Prepaid expenses</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">57,569</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Intellectual property</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">100,000</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Non-compete provision</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">50,000</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Goodwill</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">3,253,160</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-decoration: underline; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif"><u>Liabilities</u></font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Accounts Payable</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(741,822</font></td>
    <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Accrued Expenses</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(2,202,848</font></td>
    <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">2,980,411</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
</table>
<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Intellectual property will be amortized
over its estimated useful live of 5 years and the non-compete provision will be amortized over its term of 3 years. During the
year ended December 31, 2015, the Company charged to operations amortization expense of $4,583.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The purchase price allocated to the
acquisition of the assets of UrgentRx is made up as follows:</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Amount</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 86%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Stock payment</font></td>
    <td style="width: 1%; line-height: 115%">&#160;</td>
    <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="width: 11%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">2,550,000</font></td>
    <td style="width: 1%; line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Stock warrants issued</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">430,411</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">2,980,411</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
</table>
<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Pro forma Results of Operations. The
historical operating results of the UrgentRx Business prior to its acquisition date have not been included in the Company&#146;s
historical consolidated operating results. Pro forma results of operations data (unaudited) for the year ended December 31, 2014
as if the acquisition had occurred on January 1, 2014, are as follows:</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">December 31, 2014</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 79%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Revenue</font></td>
    <td style="width: 1%; line-height: 115%">&#160;</td>
    <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="width: 18%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">2,722,288</font></td>
    <td style="width: 1%; line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Net (loss) income</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(10,621,330</font></td>
    <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
</table>
<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The amounts of revenue and net loss
of the UrgentRx Business since the acquisition date included in the consolidated statement of operations for the year ended December
31, 2015 are approximately $90,590 and $80,249, respectively.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Stock Purchase Agreement with TPR
Investments Pty Ltd:</u></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On November 15, 2015 (the &#147;Flat
Tummy Tea Closing Date&#148;), we entered into a Stock Purchase Agreement (the &#147;Flat Tummy Tea SPA&#148;) with TPR Investments
Pty Ltd ACN 128 396 654 as trustee for Polmear Family Trust (the &#147;Flat Tummy Tea Seller&#148;), Timothy Polmear and Rebecca
Polmear and NomadChoice Pty Limited ACN 160 729 939 trading as Flat Tummy Tea, an Australian proprietary limited company (&#147;NomadChoice&#148;)
for the purchase of all the issued and outstanding capital stock of NomadChoice for $4,000,000 (AUD) in cash consideration (the
&#147;Cash Consideration&#148;) and 3,571,428 shares of our common stock (&#147;Flat Tummy Tea Equity Consideration&#148;).</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In addition to the Cash Consideration
and the Flat Tummy Tea Equity Consideration, we have also agreed to pay the Flat Tummy Tea Seller certain earn-out payments of
up to $3,500,000 (AUD) in aggregate upon certain EBITDA thresholds are met as of June 30, 2016, as described in the Flat Tummy
Tea SPA. This earn-out payment was distributed on March 4, 2016.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Flat Tummy Tea is engaged in the business
of developing, manufacturing, and selling herbal detox tea (&#147;Flat Tummy Tea&#148;).</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has accounted for this transaction
under the acquisition method of accounting. Under the acquisition method of accounting, the total acquisition consideration price
is allocated to the assets acquired and liabilities assumed based on their preliminary estimated fair values based on the management&#146;s
estimates as of the date of the acquisition. The Company expects to retain the services of independent valuation firm to determine
the fair value of these identifiable intangible assets. Once determined, the Company will reallocate the purchase price of the
acquisition based on the results of the independent evaluation if they are materially different from the allocations as recorded
on November 1, 2015. The Company expects the purchase price allocations for the acquisition of NomadChoice to be completed during
2016. The preliminary allocation of the purchase price to the assets acquired and liabilities assumed based on the estimated fair
values is as follows:</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-decoration: underline; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif"><u>Assets</u></font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="width: 79%; padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Cash</font></td>
    <td style="width: 1%; line-height: 115%">&#160;</td>
    <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="width: 18%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">1,584,642</font></td>
    <td style="width: 1%; line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Other receivable</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">30,684</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Inventory</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">134,212</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Prepaid expenses</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">141,070</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Fixed Assets, net</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">5,698</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Intangible assets, Net</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">3,493</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Blogger Database</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">200,000</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Customer Database</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">500,000</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Intellectual property</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">100,000</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Non-compete provision</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">50,000</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Goodwill</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">6,174,899</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-decoration: underline; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif"><u>Liabilities</u></font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Accounts Payable</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(77,064</font></td>
    <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Accrued Expenses</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(56,224</font></td>
    <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Dividends Payable</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(1,177,152</font></td>
    <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Provision for Income Tax</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(518,558</font></td>
    <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">7,095,700</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
</table>
<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Blogger Database, Customer Database,
Intellectual property and non-compete provision will be amortized over its estimated useful lives of 5 years. During the year ended
December 31, 2015, the Company charged to operations amortization expense of $28,333.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The purchase price allocated to the
acquisition of the assets of NomadChoice is made up as follows:</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Amount</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 86%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Cash</font></td>
    <td style="width: 1%; line-height: 115%">&#160;</td>
    <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="width: 11%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">2,848,800</font></td>
    <td style="width: 1%; line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Stock issued at closing</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">1,750,000</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Earn-out payment</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">2,496,900</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="border-bottom: black 2.25pt double; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">7,095,700</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
</table>
<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Pro forma Results of Operations. The
historical operating results of the Flat Tummy Tea Business prior to its acquisition date have not been included in the Company&#146;s
historical consolidated operating results. Pro forma results of operations data (unaudited) for the year ended December 31, 2014
as if the acquisition had occurred on January 1, 2014, are as follows:</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">December 31, 2014</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 79%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Revenue</font></td>
    <td style="width: 1%; line-height: 115%">&#160;</td>
    <td style="width: 1%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="width: 18%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">2,494,812</font></td>
    <td style="width: 1%; line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Net (loss) income</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(909,280</font></td>
    <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
</table>
<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#146;s subsidiary Nomad
has a fiscal year ended June 30 and the Company&#146;s fiscal year end is December 31. The above proforma information includes
revenue and net income of Nomad for the year ended June 30, 2015.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The amounts of revenue and net income
of the Flat Tummy Tea Business since the acquisition date included in the consolidated statement of operations for the year ended
December 31, 2015 are approximately $2,513,990 and $966,671 respectively.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=56956515&amp;loc=d3e1497-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=56956515&amp;loc=d3e1490-128463<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=56956515&amp;loc=d3e1392-128463<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e7008-128479<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=56956515&amp;loc=d3e1486-128463<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=56956791&amp;loc=d3e4845-128472<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=56956515&amp;loc=d3e1500-128463<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=56956515&amp;loc=d3e1524-128463<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e7000-128479<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=56956791&amp;loc=d3e4922-128472<br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=56956791&amp;loc=d3e4934-128472<br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=56956791&amp;loc=d3e4926-128472<br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=56956515&amp;loc=d3e1383-128463<br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6996-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6781689968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 4 &#150; Income Taxes</b></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company utilizes FASBASC740, &#147;Income
Taxes,&#148; which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of
events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities
are determined based on the difference between the tax basis of assets and liabilities and their financial reporting amounts based
on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income.
A valuation allowance is recorded when it is &#147;more likely-than-not&#148; that a deferred tax asset will not be realized.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company generated a deferred tax
asset through net operating loss carry-forwards. Based upon Management&#146;s evaluation, a valuation allowance of 100% has been
established due to the uncertainty of the Company&#146;s realization of the benefit derived from net operating loss carry-forwards.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Deferred income taxes arise from temporary
differences resulting from income and expense items reported for financial accounting and tax purposes in different periods. Deferred
taxes are classified as current or non-current, depending on the classification of assets and liabilities to which they relate.
Deferred taxes arising from temporary differences that are not related to an asset or liability are classified as current or noncurrent
depending on the periods in which the temporary differences are expected to reverse. The Company does not have any uncertain tax
positions.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Income tax expense for the year ended
December 31, 2015 was $389,945, due to Foreign Income Tax relating to NomadChoice in Australia.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The table below summarizes the differences
between the U.S. statutory federal rate and the Company&#146;s effective tax rate for the years ended December 31, 2015 and 2014:</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31, 2015</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31, 2014</td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 56%; line-height: 115%">U.S. Statutory Rate</td>
    <td style="width: 1%; line-height: 115%">&#160;</td>
    <td style="width: 1%; line-height: 115%">&#160;</td>
    <td style="width: 18%; text-align: right; line-height: 115%">34</td>
    <td style="width: 2%; line-height: 115%">%</td>
    <td style="width: 1%; line-height: 115%">&#160;</td>
    <td style="width: 1%; line-height: 115%">&#160;</td>
    <td style="width: 18%; text-align: right; line-height: 115%">34</td>
    <td style="width: 2%; line-height: 115%">%</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="line-height: 115%">U.S. effective rate in excess of AU rate</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%">(1</td>
    <td style="line-height: 115%">%)</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%">-</td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="line-height: 115%">U.S. valuation allowance</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%">(34</td>
    <td style="line-height: 115%">%)</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%">(34</td>
    <td style="line-height: 115%">%)</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="line-height: 115%">Foreign Tax - Australia</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">6.8</td>
    <td style="line-height: 115%">%</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="line-height: 115%">Total provision for income taxes</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">5.8</td>
    <td style="line-height: 115%">%</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">-</td>
    <td style="line-height: 115%">&#160;</td></tr>
</table>
<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has deferred tax assets,
which have been fully reserved, as follows as of December 31, 2015 and 2014:</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31, 2015</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31, 2014</td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 56%; line-height: 115%">Deferred tax assets</td>
    <td style="width: 1%; line-height: 115%">&#160;</td>
    <td style="width: 1%; line-height: 115%">$</td>
    <td style="width: 18%; text-align: right; line-height: 115%">11,460,536</td>
    <td style="width: 2%; line-height: 115%">&#160;</td>
    <td style="width: 1%; line-height: 115%">&#160;</td>
    <td style="width: 1%; line-height: 115%">$</td>
    <td style="width: 18%; text-align: right; line-height: 115%">241,245</td>
    <td style="width: 2%; line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="line-height: 115%">Valuation allowance for deferred tax assets</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(11,460,536</td>
    <td style="line-height: 115%">)</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(241,245</td>
    <td style="line-height: 115%">)</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="line-height: 115%">Net deferred tax assets</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td>
    <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">-</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td>
    <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">-</td>
    <td style="line-height: 115%">&#160;</td></tr>
</table>
<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company also has net operating loss
carryforwards of approximately $25,137,583 included in the deferred tax asset table above attributable to the acquisition of Breakthrough
Products, Inc. However, due to limitations of carryover attributes and separate return limitation year rules, it is unlikely the
company will benefit from these NOL and thus Management has determined a 100% valuation reserved is required.&#160; Further, the
Company has not completed an evaluation of the NOL&#146;s attributable to Breakthrough Products, Inc. at the date of this report.</p>

<p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The total deferred tax asset is calculated
by multiplying a domestic (US) 34 percent marginal tax rate by the cumulative Net Operating Loss Carryforwards (&#147;NOL&#148;).The
Company currently has net operating loss carryforwards approximately aggregating $33,707,458, which expire through 2035. The deferred
tax asset related to the NOL carryforwards Management has determined based on all the available information that a 100% Valuation
reserve is required.</p>

<p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has not completed its evaluation
of NOL Utilization Limitations under IRC Section 382, change of ownership rules. If the Company has had a change in ownership the
NOL&#146;s would be limited as to the amount that could be utilized each year, based on the Internal Revenue Code, as amended.&#148;</p>

<p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has not filed its Federal
and State income tax returns. Such income tax returns remain subject to examination by federal and most state tax authorities.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32718-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6786147072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Receivable<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivablesTextBlock', window );">Accounts Receivable</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 5 &#150; Accounts Receivable</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Accounts receivable, net of allowances for
sales returns and doubtful accounts, consisted of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2015</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2014</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 54%"><font style="font-size: 10pt">Trade accounts receivable</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">4,101,148</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">2,898</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Less allowances</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(121,291</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt"><b>Total accounts receivable, net</b></font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt"><b>$</b></font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt"><b>3,979,857</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt"><b>$</b></font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt"><b>2,898</b></font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended December 31, 2015, the
Company charged $50,000 to bad debt expense in setting up an allowance.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivablesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financing receivables. Examples of financing receivables include, but are not limited to, loans, trade accounts receivables, notes receivable, credit cards, and receivables relating to a lessor's right(s) to payment(s) from a lease other than an operating lease that is recognized as assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 55<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=32702940&amp;loc=SL6953791-111525<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49124121&amp;loc=d3e4975-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivablesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6781776432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaid Expenses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsAbstract', window );"><strong>Prepaid Expense and Other Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_PrepaidExpensesTextBlock', window );">Prepaid Expenses</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 6 &#150; Prepaid Expenses</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">At December 31, 2015 and 2014, prepaid expenses
consisted of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2015</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2014</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 54%"><font style="font-size: 10pt">Advances for inventory</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">171,494</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Media production</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">55,849</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Insurance</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">54,519</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">10,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Trade shows</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">45,700</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Deposits</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">41,228</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Consultants</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">24,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Rent</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">16,216</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Miscellaneous</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">13,428</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt"><b>Total</b></font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt"><b>$</b></font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt"><b>422,434</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt"><b>$</b></font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt"><b>10,000</b></font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_PrepaidExpensesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid Expenses [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_PrepaidExpensesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6781780560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Concentration of Credit Risk<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Risks and Uncertainties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">Concentration of Credit Risk</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 7 &#150; Concentration of Credit Risk</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Cash and cash equivalents</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company maintains its cash and cash equivalents
in banks insured by the Federal Deposit Insurance Corporation (FDIC) in accounts that at times may be in excess of the federally
insured limit of $250,000 per bank. The Company minimizes this risk by placing its cash deposits with major financial institutions.
At December 31, 2015, the uninsured balance amounted to $3,453,290.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Accounts receivable</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of December 31, 2015, one customer accounted
for 78% of the Company&#146;s accounts receivable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Major customers</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the year ended December 31, 2015, two customers
accounted for approximately 71% of the Company&#146;s gross revenues. Substantially all of the Company&#146;s business is with
companies in the United States.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Major suppliers</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the year ended December 31, 2015, our products
were made by the following suppliers:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 30%"><font style="font-size: 10pt">FOCUSfactor</font></td>
    <td style="width: 40%; text-align: right"><font style="font-size: 10pt">Pittsburgh, PA</font></td>
    <td style="width: 30%; text-align: right"><font style="font-size: 10pt">Tustin, CA</font></td></tr>
<tr style="vertical-align: top">
    <td><font style="font-size: 10pt">Flat Tummy Tea</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">Highland, NY</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td></tr>
<tr style="vertical-align: top">
    <td><font style="font-size: 10pt">Neuragen</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">Linthicum Heights, MD</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td></tr>
<tr style="vertical-align: top">
    <td><font style="font-size: 10pt">UrgentRx</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">Ogden, UT</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">It is the opinion of management that the products
can be produced by other manufacturers and the choice to utilize these suppliers is not a significant concentration.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=51801978&amp;loc=d3e6327-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13531-108611<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=51801978&amp;loc=d3e6404-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=51801978&amp;loc=d3e6442-108592<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=51801978&amp;loc=d3e6351-108592<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13537-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6786106064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventory</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 8 &#150; Inventory</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Inventory consists of finished goods, components
and raw materials. The Company&#146;s inventory is stated at the lower of cost (FIFO cost basis) or market.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The carrying value of inventory consisted of
the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2015</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2014</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 54%"><font style="font-size: 10pt">Finished goods</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">535,908</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Components</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">115,340</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Raw Materials</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">35,406</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Energy product</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">26,064</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt"><b>Total inventory</b></font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt"><b>$</b></font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt"><b>686,654</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt"><b>$</b></font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt"><b>26,064</b></font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of January 22, 2015, inventory was pledged
to Knight under the Loan Agreement (see note 12).</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. This may include, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the major classes of inventory, and the nature of the cost elements included in inventory. If inventory is stated above cost, accrued net losses on firm purchase commitments for inventory and losses resulting from valuing inventory at the lower-of-cost-or-market may also be included. For LIFO inventory, may disclose the amount and basis for determining the excess of replacement or current cost over stated LIFO value and the effects of a LIFO quantities liquidation that impacts net income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 6<br> -Subparagraph a, b, c<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6781777456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fixed Assets and Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_FixedAssetsAndIntangibleAssetsTextBlock', window );">Fixed Assets and Intangible Assets</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 9 &#150; Fixed Assets and Intangible
Assets</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of December 31, 2015 and 2014, fixed assets
and intangible assets consisted of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2015</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2014</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 62%"><font style="font-size: 10pt">Property and equipment</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">18,187</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Less accumulated depreciation</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(6,170</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt"><b>Fixed assets, net</b></font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt"><b>$</b></font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">12,017</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt"><b>$</b></font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt"><b>-</b></font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Depreciation expense for the years ended December
31, 2015 and 2014 was $1,513 and $0, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2015</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2014</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 62%"><font style="font-size: 10pt">FOCUSfactor intellectual property</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">1,000,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Intangible assets subject to amortization</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5,521,751</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Less accumulated amortization</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(606,489</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt"><b>Intangible assets, net</b></font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt"><b>$</b></font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt"><b>5,915,262</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt"><b>$</b></font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt"><b>-</b></font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Amortization expense for the years ended December
31, 2015 and 2014 was $606,489 and $0, respectively. These intangible assets were acquired through Asset Purchase Agreement and
Stock Purchase Agreements disclosed in Note 3.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The estimated aggregate amortization expense
over each of the next five years is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 79%"><font style="font-size: 10pt">2016</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td>
    <td style="width: 18%; border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1,111,229</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">2017</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1,111,229</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">2018</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1,109,070</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">2019</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1,094,329</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">2020</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">489,405</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b></b></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_FixedAssetsAndIntangibleAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fixed assets and intangible assets [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_FixedAssetsAndIntangibleAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6786147072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 10 &#150; Related Party Transactions</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 2, 2014, the Company granted 1,000,000
options valued at approximately $282,000 to a company owned by Mr. Jack Ross, Chief Executive Officer of the Company (see note
15).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On October 31, 2014, the Company borrowed $100,000
through a promissory note bearing interest at 10% with a maturity date of October 31, 2015 from a company owned by Mr. Ross, the
Company&#146;s Chief Executive Officer. During the year ended December 31, 2015, the note was converted into 400,000 shares of
the Company&#146;s common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accrued and paid consulting fees
of $15,000 per month to a company owned by Mr. Jack Ross, Chief Executive Officer of the Company. The Company expensed $180,000
as consulting fees and made payments totaling $486,958 towards services to an entity owned and controlled by an officer and shareholder
of the Company for the year ended December 31, 2015. As of December 31, 2015, the total outstanding balance was $0.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">At December 31, 2014, $16,077, was due from
a company owned by Mr. Jack Ross, Chief Executive Officer of the Company in a form of an advance in the normal course of business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 22, 2015, the Company entered into
a Loan Agreement with Knight Therapeutics (Barbados) Inc., a related party, for the purchase of the Focus Factor assets. At December
31, 2015, the Company owed Knight $4,267,268 on this loan, net of discount (see Note 12).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 26, 2015, the Company entered into
a Security Agreement with Knight Therapeutics, Inc., through its wholly owned subsidiary Neuragen Corp., for the purchase of Knight
Therapeutics, Inc.&#146;s assets. At December 31, 2015, the Company owed Knight $925,000 in relation to this agreement (see Note
12).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 18, 2015, the Company entered into
a Consulting Agreement with Kara Harshbarger, the co-founder of Hand MD, LLC, pursuant to which she will provide marketing and
sales related service. The Company will pay Ms. Harshbarger $10,000 a month for one year unless the Consulting Agreement is terminated
earlier by either party. Hand MD, LLC is a 50% owner in Hand MD Corp. The Company expensed $40,000 through payroll for the year
ended December 31, 2015. As of December 31, 2015, the total outstanding balance was $0.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On November 12, 2015, the Company entered into
a Loan Agreement with Knight Therapeutics (Barbados) Inc., a related party, for the purchase of NomadChoice Pty Limited and Breakthrough
Products, Inc. At December 31, 2015, the Company owed Knight $3,571,314 on this loan, net of discount (see Note 12).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">At December 31, 2015, NomadChoice Pty Ltd.
(subsidiary) of the Company owed Knight Therapeutics $71,573 in connection with a royalty distribution agreement (see Note 3).</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39622-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39678-107864<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br> -Paragraph b<br> -Article 3A<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6781755792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Payable and Accrued Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accounts Payable and Accrued Liabilities</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 11 &#150; Accounts Payable and Accrued
Liabilities</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of December 31, 2015 and 2014, accounts
payable and accrued liabilities consisted of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2015</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2014</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 54%"><font style="font-size: 10pt">Payroll</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">128,237</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">10,867</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Legal fees</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">38,752</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">47,916</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Manufacturers</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1,527,333</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Promotions</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1,213,021</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Returns allowance</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1,128,133</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Customers</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">411,033</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Interest</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">110,754</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Royalties</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">71,573</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Warehousing</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">31,748</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Others</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">371,518</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">15,859</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt"><b>Total</b></font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt"><b>$</b></font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt"><b>5,032,102</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt"><b>$</b></font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt"><b>74,642</b></font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6781721472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes Payable<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Notes Payable</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 12 &#150; Notes Payable</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The Company&#146;s
loans payable at December 31, 2015 and 2014 are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2015</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2014</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 62%"><font style="font-size: 10pt">Loans payable</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">12,406,589</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Unamortized debt discount</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(2,536,419</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Total</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">9,870,170</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Less: Current portion</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(3,912,060</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Long-term portion</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">5,958,110</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>$6,000,000 January 22, 2015 Loan:</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 22, 2015, the Company entered into
a Loan and Security Agreement (&#147;Loan Agreement&#148;) with Knight Therapeutics (Barbados) Inc. (&#147;Knight&#148;), pursuant
to which Knight agreed to loan the Company $6.0 million (the &#147;Loan&#148;), and which amount was borrowed at closing (the
&#147;Financing&#148;) for the purpose of acquiring the Focus Factor Business (defined below). At closing, the Company paid Knight
an origination fee of $120,000 and a work fee of $60,000 and also paid $40,000 of Knight&#146;s expenses associated with the Loan.
The Loan bears interest at a rate of 15% per year; provided, however, that upon the occurrence of an equity or convertible equity
offering by the Company of at least $1.0 million, the interest rate will drop to 13% per year. Interest accrues quarterly and is
payable in arrears on March 31, June 30, September 30 and December 31 in each year, beginning on March 31, 2015.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All outstanding principal and accrued and unpaid
interest is due on the earliest to occur of either January 20, 2017 (the &#147;Maturity Date&#148;), or the date that Knight,
in its discretion, accelerates the Company&#146;s obligations due to an event of default. The Company may extend the Maturity
Date for two successive additional 12-month periods if at March 31, 2016 and March 31, 2017, respectively, the Company&#146;s
revenues exceed $13.0 million and its EBITDA exceeds $2.0 million for the respective 12-month period then ending. Principal payments
under the Loan Agreement commenced on June 30, 2015 and continue quarterly as set forth on the Repayment Schedule to the Loan Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Subject to certain restrictions, the Company
may prepay the outstanding principal of the Loan (in whole but not in part) at any time if the Company pays a concurrent prepayment
fee equal to the greater of (i) the total unpaid annual interest that would have been payable during the year in which the prepayment
is made if the prepayment is made prior to the first anniversary of the closing, and (ii) $300,000. The Company&#146;s obligations
under the Loan Agreement are secured by a first priority security interest in all present and future assets of the Company. The
Company also agreed to not pledge or otherwise encumber its intellectual property assets, subject to certain customary exceptions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Loan Agreement includes customary representations,
warranties, and affirmative and restrictive covenants, including covenants to attain and maintain certain financial metrics, and
to not merge or dispose of assets, acquire other businesses (except for businesses substantially similar or complementary to the
Company&#146;s business and the aggregate consideration to be paid does not exceed $100,000) or make capital expenditures in excess
of $100,000 over the Company&#146;s annual business plan in any year. The Loan Agreement also includes customary events of default,
including payment defaults, breaches of covenants, change of control and material adverse effect default. Upon the occurrence of
an event of default and during the continuation thereof, the principal amount of the Loan will bear a default interest rate of
an additional 5%.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In connection with the Loan Agreement, the
Company issued to Knight a warrant that entitled Knight to purchase 4,595,187 shares of common stock of the Company (&#147;Common
Stock&#148;) on or prior to close of business on January 30, 2015 (the &#147;ST Warrant&#148;). The aggregate exercise price
of the Common Stock under the ST Warrant is $1.00. Knight exercised the ST Warrant on January 22, 2015. Also in connection with
the Loan Agreement, the Company issued to Knight a warrant to purchase 3,584,759 shares of Common Stock on or prior to the close
of business of January 22, 2025 (the &#147;LT Warrant&#148;). The exercise price per share of the Common Stock under the LT Warrant
is $0.34. The LT Warrant provides for cashless exercise. The LT Warrant also provides that in the event the closing price of the
Common Stock remains above $1.00 for six consecutive months, Knight will forfeit the difference between the number of shares acquired
under the LT Warrant prior to 90 days after such six-month period, and 25% of the shares purchasable under the LT Warrant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The beneficial conversion feature of the warrants
issued to the noteholders amounted to $1,952,953 (ST warrants) and $1,462,560 (LT warrants), respectively, and was recorded as
debt discount of the corresponding debt.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company recognized amortization of debt
discount of $1,952,953 (ST warrants) and $854,828 (LT warrants) during the year ended December 31, 2015. Unamortized debt discount
as of December 31, 2015 amounted to $607,732.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company also recorded deferred financing
costs of $289,045 with respect to the above loan. The Company recognized amortization of deferred financing costs of $136,207 during
the year ended December 31, 2015.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company recognized and paid interest expense
of $805,686 during the year ended December 31, 2015. Accrued interest expense was $0 as of December 31, 2015. Loan payable balance
was $4,875,000 as of December 31, 2015.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>$1,500,000 January 22, 2015 Loan:</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 22, 2015, the Company issued a 0%
promissory note in a principal amount of $1,500,000 in connection with an Asset Purchase Agreement (see note 1). The note has a
maturity date of January 20, 2017, with $750,000 to be paid on or before January 20, 2016 and an additional $750,000 to be paid
on or before January 20, 2017. Loan payable balance was $1,500,000 as of December 31, 2015.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>$950,000 June 26, 2015 Security Agreement:</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 26, 2015, the Company, through its
wholly owned subsidiary, Neuragen Corp. (&#147;Neuragen&#148;), issued a 0% promissory note in a principal amount of $950,000
in connection with an Asset Purchase Agreement (see note 1). The note requires $250,000 to be paid on or before June 30, 2016,
and $700,000 to be paid in quarterly installments (beginning with the quarter ending September 30, 2015) equal to the greater of
$12,500 or 5% of U.S. net sales, and 2% of U.S. net sales of Neuragen for 60 months thereafter. The payment of such amounts is
secured by a security interest in certain assets, undertakings and property (&#147;Collateral&#148;) pursuant to the Security
Agreement, which will be released upon receipt of total payments of $1.2 million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company also recorded deferred financing
costs of $10,486 with respect to the above agreement. The Company recognized amortization of deferred financing costs of $2,643
during the year ended December 31, 2015. The balance at December 31, 2015 was $925,000.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>$5,500,000 November 12, 2015 Loan:</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On November 12, 2015, we entered into a First
Amendment to Loan Agreement (&#147;First Amendment&#148;) with Knight, pursuant to which Knight agreed to loan us an additional
$5.5 million, and which amount was borrowed at closing (the &#147;Financing&#148;) for the purpose of acquiring Breakthrough
Products, Inc. and NomadChoice Pty Limited through Stock Purchase Agreements. At closing, we paid Knight an origination fee of
$110,000 and a work fee of $55,000 and also paid $24,000 of Knight&#146;s expenses associated with the Loan. The Loan bears interest
at a rate of 15% per year. The interest rate will decrease to 13% if we meet certain equity-fundraising targets. The New Loan Agreement
matures on November 11, 2017.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In connection with the New Loan Agreement,
we issued Knight a warrant that entitles Knight to purchase 5,550,625 shares of our common stock (&#147;Knight Warrant Shares&#148;)
representing approximately 6.5% of our fully diluted capital, which Knight exercised in full on November 12, 2015. Knight also
received a 10-year warrant entitling Knight to purchase up to 4,547,243 shares of our common stock at $0.49 per share (&#147;Knight
Warrants&#148;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The beneficial conversion feature of the warrants
issued to the noteholders amounted to $2,553,287 (5,550,625 warrants) and $2,067,258 (4,547,243 warrants), respectively, and was
recorded as debt discount of the corresponding debt. For derivative liability calculation on 4,547,243 warrants, refer to Note
17.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company recognized amortization of debt
discount of $2,553,287 (5,550,625 warrants) and $138,571 (4,547,243 warrants) during the year ended December 31, 2015. Unamortized
debt discount as of December 31, 2015 amounted to $1,928,686.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company also recorded deferred financing
costs of $233,847 with respect to the above loan. The Company recognized amortization of deferred financing costs of $15,675 during
the year ended December 31, 2015.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company recognized interest expense of
$110,753 during the year ended December 31, 2015. Accrued interest expense was $110,753 as of December 31, 2015. The balance at
December 31, 2015 was $5,500,000.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20,22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6786143632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Deficit<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Deficit</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 13 &#150; Stockholders&#146; Deficit</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The total number of shares of all classes of
capital stock which the Company is authorized to issue is 75,000,000 shares of common stock with $0.00001 par value. On July 30,
2014, the Company&#146;s board of directors approved an increase of the Company&#146;s authorized common stock from 75,000,000
to 300,000,000 shares, which increase was approved by the Company&#146;s shareholders and became effective on August 5, 2015.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 17, 2014, upon approval from FINRA,
the Company effected a 30 for 1 forward stock split by way of a stock dividend, of all of its issued and outstanding shares of
common stock (the &#147;Stock Split&#148;). The Stock Split did not affect the number of the Company&#146;s authorized common
stock or its par value. All references in the accompanying consolidated financial statements and notes thereto have been retroactively
restated to reflect the stock split.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended December 31, 2015, the
Company issued 4,595,187 shares of its common stock upon exercise of the ST Warrant at an aggregate exercise price of $1.00 in
connection with the Loan Agreement (see note1).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended December 31, 2015, the
Company issued 5,550,625 shares of its common stock upon exercise of a Warrant at an aggregate exercise price of $1.00 in connection
with the Loan Agreement (see note1).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended December 31, 2015, the
Company issued 400,000 shares of its common stock to a note holder in a note conversion at $0.25 per share. At the time of conversion,
the note was valued at $100,000 for outstanding principal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended December 31, 2015, the
Company issued 2,142,857 shares of its common stock valued at $0.70 per share in accordance with Contribution Agreement entered
into with Hand MD Corp. in exchange for 50% of Hand MD Corp.&#146;s outstanding capital securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended December 31, 2015, the
Company issued 3,571,428 shares of its common stock valued at $0.35 per share in accordance with a stock purchase agreement entered
into with NomadChoice Pty Limited in exchange for 100% of NomadChoice Pty Limited&#146;s outstanding capital securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended December 31, 2015, the
Company issued 3,000,000 shares of its common stock valued at $0.85 per share in accordance with a stock purchase agreement entered
into with Breakthrough Products, Inc. in exchange for 100% of Breakthrough Product Inc.&#146;s outstanding capital securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended December 31, 2015, the
Company issued 40,000 shares of its common stock valued at $0.65 per share for cash.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended December 31, 2015, the
Company issued 292,857 shares of its common stock valued at $0.70 per share to settle accounts payable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 21, 2014, the Company entered into
an agreement with accredited investors for the issuance and sale of 2,000,000 shares of its common stock at a purchase price of
$0.25 per share, for an aggregate consideration of $500,000.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended December 31, 2014, the
Company cancelled 135,900,000 shares of its common stock (4,530,000 pre-Stock Split) as part of the Merger transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended December 31, 2014, the
Company issued 16,000,000 shares of its common stock valued at $25,000 as part of the Merger Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended December 31, 2015 and
2014, the Company committed to issue common stock valued at $28,000 and $40,000, respectively for services rendered.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of December 31, 2015 and 2014, there were
81,692,954 and 62,100,000 shares of the Company&#146;s common stock issued and outstanding, respectively.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(d),(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21484-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21488-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB TOPIC 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Preferred Stock<br> -URI http://asc.fasb.org/extlink&amp;oid=6521494<br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21564-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 4<br> -Section E<br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 4<br> -Section C<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6786273952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 14 &#150; Commitments and Contingencies</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Litigation:</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">From time to time the Company may become a
party to litigation in the normal course of business. Management believes that there are no current legal matters that would have
a material effect on the Company&#146;s financial position or results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Operating leases</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In April 2014, a subsidiary entered into an
extension of a non-cancellable operating lease for office space that expires on March 31, 2017. Rent expense under this lease for
the period from acquisition until December 31, 2015 was $8,923 per month less a $3,010 per month sublease through March 2017.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In December 2015, a subsidiary entered into
a non-cancellable operating lease for office space through November 2016. Rental payments under this lease are $5,500 Australian
dollars per month, which is approximately $4,200.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In December 2015, the Company entered into
a non-cancellable operating lease for office space through December 2016. Rental payments under this lease are $5,500 per month.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following is a schedule by years of future
minimum rental payments required under operating leases that have initial or remaining non-cancelable lease terms in excess of
one year as of December 31, 2015:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">Year ending December 31:</font></td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 84%"><font style="font-size: 10pt">2016</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 13%; text-align: right"><font style="font-size: 10pt">220,676</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">2017</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">27,294</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Total</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">247,970</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 8, 2014, a subsidiary entered into
a non-cancellable 36 month phone lease with an estimated cost of $894 a month.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following is a schedule by years of future
minimum rental payments required under operating leases that have initial or remaining non-cancelable lease terms in excess of
one year as of December 31, 2015:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">Year ending December 31:</font></td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 84%"><font style="font-size: 10pt">2016</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 13%; text-align: right"><font style="font-size: 10pt">10,728</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">2017</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">9,834</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Total</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">20,562</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6449706&amp;loc=d3e16207-108621<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=51674963&amp;loc=d3e12565-110249<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14435-108349<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6394976&amp;loc=d3e25287-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6781652832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Options<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock Options</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 15 &#150; Stock Options</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 30, 2014, the Company&#146;s board
of directors approved the Company&#146;s 2014 Equity Incentive Plan and the reservation of 15,525,000 shares of common stock for
issuance under such plan. Such plan was approved by the Company&#146;s shareholders and became effective on August 5, 2015.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 2, 2014, the Company granted 1,000,000
options with an exercise price of $0.25 per share to the Company owned by Mr. Jack Ross, Chief Executive Officer of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 14, 2015, the Company granted 1,000,000
options each with an exercise price of $0.25 per share to two Board Members of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 14, 2015, the Company granted 1,000,000
options each with an exercise price of $0.65 per share to two employees of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table summarizes the changes
in options outstanding and the related prices for the shares of the Company&#146;s common stock issued to employees and consultants
under a stock option plan at December 31, 2015:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td colspan="2" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="10" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Options Outstanding</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Options Exercisable</b></font></td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Exercise </b></font><br />
<font style="font-size: 10pt"><b>Prices ($)</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Number</b></font><br />
<font style="font-size: 10pt"><b>Outstanding</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted</b></font><br />
<font style="font-size: 10pt"><b>Average</b></font><br />
<font style="font-size: 10pt"><b>Remaining</b></font><br />
<font style="font-size: 10pt"><b>Contractual Life</b></font><br />
<font style="font-size: 10pt"><b>(Years)</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted</b></font><br />
<font style="font-size: 10pt"><b>Average</b></font><br />
<font style="font-size: 10pt"><b>Exercise </b></font><br />
<font style="font-size: 10pt"><b>Price ($)</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Number</b></font><br />
<font style="font-size: 10pt"><b>Exercisable</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted</b></font><br />
<font style="font-size: 10pt"><b>Average </b></font><br />
<font style="font-size: 10pt"><b>Exercise </b></font><br />
<font style="font-size: 10pt"><b>Price ($)</b></font></td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.25 - $0.65</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5,000,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">8.62</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.41</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">3,000,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.25</font></td>
    <td>&#160;</td></tr>
<tr>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The stock option activity for the year ended
December 31, 2015 is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27.5pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Options Outstanding</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average</b></font><br />
<font style="font-size: 10pt"><b>Exercise Price</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 52%"><font style="font-size: 10pt">Outstanding at December 31, 2014</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 21%; text-align: right"><font style="font-size: 10pt">1,000,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 21%; text-align: right"><font style="font-size: 10pt">0.25</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">4,000,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.45</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Exercised</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Expired or canceled</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Outstanding at December 31, 2015</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">5,000,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.41</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Stock-based compensation expense related to
vested options was $523,714 and $282,247 during the years ended December 31, 2015 and 2014, respectively. The Company determined
the value of share-based compensation for options vesting during the year ended December 31, 2015 using the Black-Scholes fair
value option-pricing model with the following weighted average assumptions: estimated fair value of Company&#146;s common stock
of $0.74, risk-free interest rate of 2.23%, volatility of 154%, expected lives of 10 years, and dividend yield of 0%. The Company
determined the value of share-based compensation for options vesting during the year ended December 31, 2014 using the Black-Scholes
fair value option-pricing model with the following weighted average assumptions: estimated fair value of Company&#146;s common
stock of $0.33, risk-free interest rate of 1.8%, volatility of 125%, expected lives of 4.5 years, and dividend yield of 0%. Stock
options outstanding as of December 31, 2015, as disclosed in the above table, have an intrinsic value of $1,400,000.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 40<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6418621&amp;loc=d3e17540-113929<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=51659978&amp;loc=d3e25284-112666<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5444-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 14<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6781777456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Warrants<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_StockWarrantsAbstract', window );"><strong>Stock Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_StockWarrantsDisclosureTextBlock', window );">Stock Warrants</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 16 &#150; Stock Warrants</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table summarizes the warrants
outstanding and the related prices for the shares of the Company&#146;s common stock at December 31, 2015:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td colspan="2" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="10" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Warrants Outstanding</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Warrants Exercisable</b></font></td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Exercise</b></font><br />
<font style="font-size: 10pt"><b>Prices ($)</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Number</b></font><br />
<font style="font-size: 10pt"><b>Outstanding</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted</b></font><br />
<font style="font-size: 10pt"><b>Average</b></font><br />
<font style="font-size: 10pt"><b>Remaining</b></font><br />
<font style="font-size: 10pt"><b>Contractual Life</b></font><br />
<font style="font-size: 10pt"><b>(Years)</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted</b></font><br />
<font style="font-size: 10pt"><b>Average</b></font><br />
<font style="font-size: 10pt"><b>Exercise </b></font><br />
<font style="font-size: 10pt"><b>Price ($)</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Number</b></font><br />
<font style="font-size: 10pt"><b>Exercisable</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted</b></font><br />
<font style="font-size: 10pt"><b>Average</b></font><br />
<font style="font-size: 10pt"><b>Exercise</b></font><br />
<font style="font-size: 10pt"><b>Price ($)</b></font></td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 18%; text-align: right"><font style="font-size: 10pt">0.34</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 13%; text-align: right"><font style="font-size: 10pt">3,584,759</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 13%; text-align: right"><font style="font-size: 10pt">9.1</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 13%; text-align: right"><font style="font-size: 10pt">0.34</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 13%; text-align: right"><font style="font-size: 10pt">3,584,759</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 13%; text-align: right"><font style="font-size: 10pt">0.34</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.49</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">4,547,243</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">9.9</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.49</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">4,547,243</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.49</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5.00</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1,000,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">3</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5.00</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1,000,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5.00</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The warrant activity for the year ended December
31, 2015 is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27.5pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Warrants</b></font><br />
<font style="font-size: 10pt"><b>Outstanding</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average</b></font><br />
<font style="font-size: 10pt"><b>Exercise Price</b></font></td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Outstanding at December 31, 2014</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="width: 52%"><font style="font-size: 10pt">Granted</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 21%; text-align: right"><font style="font-size: 10pt">19,277,814</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 21%; text-align: right"><font style="font-size: 10pt">0.44</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Exercised</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(10,145,812</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.00000020</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Expired or canceled</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Outstanding at December 31, 2015</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">9,132,002</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.92</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_StockWarrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_StockWarrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_StockWarrantsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Warrants Disclosure [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_StockWarrantsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6786106064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivatives</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 17 &#150; Derivatives</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has incurred a liability for the
estimated fair value of a derivative warrant instrument. The estimated fair value of the derivative warrant instruments has been
calculated using the Black-Scholes fair value option-pricing model with key input variables provided by management, as of the issue
date, with the valuation offset against additional paid in capital, and at each reporting date, with changes in fair value recorded
as gains or losses on revaluation in non-operating income (expense).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company identified embedded derivatives
related to the warrants issued along with loan payable entered into in November 2015. These embedded derivatives included certain
conversion features. The accounting treatment of derivative financial instruments requires that the Company record the fair value
of the derivatives as of the inception date of the warrants and to adjust the fair value as of each subsequent balance sheet date.
At the inception of the warrants, the Company determined a fair value of $2,067,258 of the embedded derivative. The fair value
of the embedded derivative was determined using the Black-Scholes Model based on the following assumptions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">November 12, 2015</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 79%"><font style="font-size: 10pt">Risk-free interest rate</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 18%; text-align: right"><font style="font-size: 10pt">2.32</font></td>
    <td style="width: 1%"><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Expected remaining term</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">10 Years</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Expected volatility</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">157.56</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Dividend yield</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The initial fair values of the embedded derivative
of $2,067,258 was allocated as a debt discount $2,067,258.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Fair value at December 31, 2015 was estimated
to be $3,096,179 and based on the following assumptions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2015</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 79%"><font style="font-size: 10pt">Risk-free interest rate</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 18%; text-align: right"><font style="font-size: 10pt">2.27</font></td>
    <td style="width: 1%"><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Expected remaining term</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">9.75 Years</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Expected volatility</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">152.07</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Dividend yield</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended December 31, 2015, the
increase in the fair value of the warrant derivative liability of $1,028,921 was recorded as a loss on change in fair value of
derivative liability.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6441202&amp;loc=d3e80720-113993<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=SL5624171-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=d3e41620-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=SL5624163-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=SL5579240-113959<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4D<br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=SL5624177-113959<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=35736893&amp;loc=d3e80784-113994<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=d3e41641-113959<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=SL5579245-113959<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4H<br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=SL5624258-113959<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35736893&amp;loc=d3e80748-113994<br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=SL5708775-113959<br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=SL5708773-113959<br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=SL5618551-113959<br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=SL5580258-113959<br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=SL5624181-113959<br><br>Reference 17: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 25<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6886632&amp;loc=d3e76258-113986<br><br>Reference 18: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=d3e41638-113959<br><br>Reference 19: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6779502544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segments</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 18 &#150; Segments</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Segment identification and selection is consistent
with the management structure used by the Company&#146;s chief operating decision maker to evaluate performance and make decisions
regarding resource allocation, as well as the materiality of financial results consistent with that structure. Based on the Company&#146;s
management structure and method of internal reporting, the Company has one operating segment. The Company&#146;s chief operating
decision maker does not review operating results on a disaggregated basis; rather, the chief operating decision maker reviews operating
results on an aggregate basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Net sales attributed to customers in the United
States and foreign countries for the years ended December 31, 2015 and 2014 were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2015</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2014</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 54%"><font style="font-size: 10pt">United States</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">13,129,753</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">9,158</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Foreign countries</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">326,624</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">13,456,377</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">9,158</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#146;s net sales by product group
for the years ended December 31, 2015 and 2014 were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2015</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2014</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 54%"><font style="font-size: 10pt">Focus Factor</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">10,482,367</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Flat Tummy Tea</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,513,990</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Other (1)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">460,020</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">9,158</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">13,456,377</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">9,158</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(1) Net sales for any other
product group of similar products are less than 10% of consolidated net sales.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Long-lived assets (net) attributable to operations
in the United States and foreign countries as of December 31, 2015 and 2014 were as follows:</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2015</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2014</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 54%"><font style="font-size: 10pt">United States</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">17,451,598</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Foreign countries</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">12,081</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">17,463,679</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=51669610&amp;loc=d3e8981-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=51669610&amp;loc=d3e9038-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 33<br> -URI http://asc.fasb.org/extlink&amp;oid=51669610&amp;loc=d3e8971-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=51669610&amp;loc=d3e8595-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=51669610&amp;loc=d3e8380-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -URI http://asc.fasb.org/extlink&amp;oid=51669610&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=51669610&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 35<br> -URI http://asc.fasb.org/extlink&amp;oid=51669610&amp;loc=d3e8984-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=51669610&amp;loc=d3e9031-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=51669610&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=51669610&amp;loc=d3e8538-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=51669610&amp;loc=d3e8864-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=51669610&amp;loc=d3e8924-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=51669610&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6786106064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 19 &#150; Subsequent Events</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Management evaluated all activities of the
Company through the issuance date of the Company&#146;s consolidated financial statements and concluded that no subsequent events
have occurred that would require adjustments or disclosure into the consolidated financial statements.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6795588832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Basis of Presentation</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The consolidated financial statements include
the accounts of the Company and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been
eliminated in consolidation.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Use of Estimates</u></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of the consolidated
financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities, and disclosure of contingent liabilities at the date of the financial statements and the reported
amounts of expenses during the reporting period. Actual results could differ from those estimates. At December 31, 2015 and 2014
significant estimates included in these estimates are assumptions about collection of accounts receivable, useful life of fixed
and intangible assets, goodwill and assumptions used in Black-Scholes-Merton, or BSM, valuation methods, such as expected volatility,
stock based compensation, risk-free interest rate, and expected dividend rate.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Cash and Cash Equivalents</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company considers all cash on hand and
in banks, including accounts in book overdraft positions, certificates of deposit and other highly-liquid investments with maturities
of three months or less, when purchased, to be cash and cash equivalents. As of December 31, 2015 the Company had no cash equivalents.
The Company maintains its cash and cash equivalents in banks insured by the Federal Deposit Insurance Corporation (FDIC) in accounts
that at times may be in excess of the federally insured limit of $250,000 per bank. The Company minimizes this risk by placing
its cash deposits with major financial institutions. At December 31, 2015, the uninsured balance amounted to $3,453,290.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Capitalization of Fixed Assets</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Capitalization of Fixed Assets</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company capitalizes expenditures related
to property and equipment, subject to a minimum rule, that have a useful life greater than one year for: (1) assets purchased;
(2) existing assets that are replaced, improved or the useful lives have been extended; or (3) all land, regardless of cost. Acquisitions
of new assets, additions, replacements and improvements (other than land) costing less than the minimum rule in addition to maintenance
and repair costs, including any planned major maintenance activities, are expensed as incurred.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Revenue Recognition</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company recognizes revenue in accordance
with the Financial Accounting Standards Board&#146;s (&#147;FASB&#148;), Accounting Standards Codification (&#147;ASC&#148;)
605, Revenue Recognition (&#147;ASC 605&#148;). ASC 605 requires that four basic criteria must be met before revenue can be
recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred and/or service has been performed; (3)
the selling price is fixed and determinable; and (4) collectability is reasonably assured. The Company believes that these criteria
are satisfied upon shipment from its fulfillment centers. Certain of our distributors may also perform a separate function as
a co-packer on our behalf. In such cases, ownership of and title to our products that are co-packed on our behalf by those co-packers
who are also distributors, passes to such distributors when we are notified by them that they have taken transfer or possession
of the relevant portion of our finished goods. Freight billed to customers is presented as revenues, and the related freight costs
are presented as cost of goods sold. Cancelled orders are refunded if not already dispatched, refunds are only paid if stock is
damaged in transit, discounts are only offered with specific promotions and orders will be refilled if lost in transit.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts Receivable</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Accounts receivable</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Accounts receivable are generally unsecured.
The Company establishes an allowance for doubtful accounts receivable based on the age of outstanding invoices and management&#146;s
evaluation of collectability. Accounts are written off after all reasonable collection efforts have been exhausted and management
concludes that likelihood of collection is remote. Any future recoveries are applied against the allowance for doubtful accounts.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising Expense</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Advertising Expense</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company expenses marketing, promotions
and advertising costs as incurred. Such costs are included in general and administrative expense in the accompanying consolidated
statements of operations.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Research and Development</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Costs incurred in connection with the development
of new products and processing methods are charged to general and administrative expenses as incurred.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Income Taxes</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company utilizes FASBASC 740, &#147;Income
Taxes,&#148; which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of
events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities
are determined based on the difference between the tax basis of assets and liabilities and their financial reporting amounts based
on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income.
A valuation allowance is recorded when it is &#147;more likely-than-not&#148; that a deferred tax asset will not be realized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company generated a deferred tax asset
through net operating loss carry-forward. However, a valuation allowance of 100% has been established due to the uncertainty of
the Company&#146;s realization of the net operating loss carry forward prior to its expiration.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">NomadChoice Pty Ltd, the Company&#146;s wholly-owned
subsidiary is subject to income taxes in the jurisdictions in which it operates. Significant judgment is required in determining
the provision for income tax. There are many transactions and calculations undertaken during the ordinary course of business for
which the ultimate tax determination is uncertain. The company recognizes liabilities for anticipated tax audit issues based on
the Company&#146;s current understanding of the tax law. Where the final tax outcome of these matters is different from the carrying
amounts, such differences will impact the current and deferred tax provisions in the period in which such determination is made.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Earnings (Loss) Per Common Share</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Net Earnings (Loss) Per Common Share</u></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company computes earnings per share
under ASC subtopic 260-10, Earnings Per Share. Basic earnings (loss) per share is computed by dividing the net income (loss) attributable
to the common stockholders (the numerator) by the weighted average number of shares of common stock outstanding (the denominator)
during the reporting periods. Diluted loss per share is computed by increasing the denominator by the weighted average number
of additional shares that could have been outstanding from securities convertible into common stock (using the &#147;treasury
stock&#148; method), unless their effect on net loss per share is anti-dilutive. As of December 31, 2015, options to purchase
5,000,000 shares of common stock and warrants to purchase 9,132,002 shares of common stock were outstanding these potential shares
were excluded from the shares used to calculate diluted earnings per share as their inclusion would reduce net loss per share.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_GoingConcernPolicyTextBlock', window );">Going Concern</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Going Concern</u></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#146;s consolidated financial
statements are prepared using U.S. GAAP applicable to a going concern, which contemplates the realization of assets and liquidation
of liabilities in the normal course of business. The Company had an accumulated deficit at December 31, 2015 of $8,569,841. The
Company had a working capital deficit of $6,165,812 as of December 31, 2015. Due to acquisitions during 2015 of revenue-producing
products, the Company believes it has established an ongoing source of revenue that is sufficient to cover its operating costs.
The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating
losses until it establishes a revenue stream and becomes profitable. If the Company is unable to obtain adequate capital it could
be forced to cease development of operations.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In order to continue as a going concern
and to develop a reliable source of revenues, and achieve a profitable level of operations the Company will need, among other things,
additional capital resources. Management&#146;s plans to continue as a going concern include raising additional capital through
borrowing and/or sales of equity and debt securities. However, management cannot provide any assurances that the Company will be
successful in accomplishing any of its plans.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The ability of the Company to continue
as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and
eventually secure other sources of financing and attain profitable operations. The accompanying consolidated financial statements
do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Fair Value Measurements</u></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company measures and discloses the
fair value of assets and liabilities required to be carried at fair value in accordance with ASC 820, Fair Value Measurements and
Disclosures. ASC 820 defines fair value, establishes a framework for measuring fair value, and enhances fair value measurement
disclosure.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">ASC 825 defines fair value as the price
that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants
at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded
at fair value, the Company considers the principal or most advantageous market in which it would transact and considers assumptions
that market participants would use when pricing the asset or liability, such as inherent risk, transfer restrictions, and risk
of nonperformance. ASC 825 establishes a fair value hierarchy that requires an entity to maximize the use of observable inputs
and minimize the use of unobservable inputs when measuring fair value. ASC 825 establishes three levels of inputs that may be used
to measure fair value:</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Level 1 - Quoted prices for identical
assets or liabilities in active markets to which we have access at the measurement date.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Level 2 - Inputs other than quoted prices
within Level 1 that are observable for the asset or liability, either directly or indirectly.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Level 3 - Unobservable inputs for the
asset or liability.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The determination of where assets and
liabilities fall within this hierarchy is based upon the lowest level of input that is significant to the fair value measurement.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">As of December 31, 2015, the Company
has determined that there were no assets or liabilities measured at fair value except for the warrant derivative liability which
is valued using Level 3 estimates.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Inventory</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Inventory consists of raw materials, components
and finished goods. The Company&#146;s inventory is stated at the lower of cost (FIFO cost basis) or market. Finished goods include
the cost of labor to assemble the items.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Stock-Based Compensation</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company adopted the provisions of ASC
718. We estimate the fair value of stock options using a binomial model, consistent with the provisions of ASC 718 and SEC Staff
Accounting Bulletin No. 107, Share-Based Payment. Option-pricing models require the input of highly subjective assumptions, including
the price volatility of the underlying stock. We determined that the use of implied volatility is expected to be more reflective
of market conditions and, therefore, could reasonably be expected to be a better indicator of our expected volatility than historical
volatility. The expected term assumption used in calculating the estimated fair value of our stock-based compensation awards using
the Black-Scholes-Merton (BSM) model is based on detailed historical data about employees&#146; exercise behavior, vesting schedules,
and death and disability probabilities. In addition, we are required to estimate the expected forfeiture rate and only recognize
expense for those shares expected to vest. We estimate the forfeiture rate based on historical experience of our stock-based awards
that are granted, exercised and cancelled. We believe the resulting BSM calculation provides a more refined estimate of the fair
value of our employee stock options.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Long-lived Assets</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><u>Impairment of Long-Lived
Assets</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">When facts and circumstances
indicate that the carrying values of long-lived assets, including fixed assets, may be impaired, an evaluation of recoverability
is performed by comparing the carrying value of the assets to projected future cash flows in addition to other quantitative and
qualitative analyses. Upon indication that the carrying value of such assets may not be recoverable, the Company recognizes an
impairment loss as a charge against current operations. Long-lived assets to be disposed of are reported at the lower of the carrying
amount or fair value, less estimated costs to sell. The Company makes judgments related to the expected useful lives of long-lived
assets and its ability to realize undiscounted cash flows in excess of the carrying amounts of such assets which are affected
by factors such as the ongoing maintenance and improvements of the assets, changes in economic conditions and changes in operating
performance. As the Company assesses the ongoing expected cash flows and carrying amounts of its long-lived assets, these factors
could cause the Company to realize a material impairment charge.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Goodwill</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">An asset purchase is accounted for under the
purchase method of accounting. Under that method, assets and liabilities of the business acquired are recorded at their estimated
fair values as of the date of the acquisition, with any excess of the cost of the acquisition over the estimated fair value of
the net tangible and intangible assets acquired recorded as goodwill. As of December 31, 2015 our qualitative analysis of goodwill
did not indicate any impairment.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Translation</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="background-color: white"><u>Foreign
Currency Translation</u></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="background-color: white">The
functional currency of each of the Company&#146;s foreign subsidiaries is the U.S. Dollar. The Company&#146;s subsidiary maintains
its record using local currency (Australian Dollar). All monetary assets and liabilities of foreign subsidiaries were translated
into U.S. Dollars at fiscal year-end exchange rates, non-monetary assets and liabilities of foreign subsidiaries were translated
into U.S. Dollars at transaction day exchange rates. Income and expense items related to non-monetary items were translated at
exchange rates prevailing during the transaction date and other incomes and expenses were translated using average exchange rate
for the period. The resulting translation adjustments, net of income taxes, were recorded in statements of operations as Remeasurement
gain or loss on translation of foreign subsidiary.</font></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of Credit Risk</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="background-color: white"><u>Concentrations
of Credit Risk</u></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><font style="background-color: white">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="background-color: white">In the
normal course of business, the Company provided credit terms to its customers; however, collateral was not required. Accordingly,
the Company performed credit evaluations of its customers and maintained allowances for possible losses which, when realized,
were within the range of management&#146;s expectations. From time to time, a higher concentration of credit risk existed on
outstanding accounts receivable for a select number of customers due to individual buying patterns.</font></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_WarehousingCostsPolicyTextBlock', window );">Warehousing costs</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Warehousing costs</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Warehouse costs include all third party warehouse
rent fees and any additional costs relating to assembly or special pack-outs of the Company products are charged to general and
administrative expenses as incurred.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_ProductDisplayCostsPolicyTextBlock', window );">Product display costs</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Product display costs</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All displays manufactured and purchased by
the Company are for placement of product in retail stores. This also includes all costs for display execution and setup and retail
services are charged to general and administrative expenses as incurred.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Warrant Derivative Liabilities</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Warrant Derivative Liabilities</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">ASC 815 generally provides three criteria that,
if met, require companies to bifurcate conversion options from their host instruments and account for them as free standing derivative
financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded
derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the
hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value
under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur
and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument
subject to the requirements of ASC 815. ASC 815 also provides an exception to this rule when the host instrument is deemed to be
conventional, as described.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A Black-Scholes-Merton option-pricing model,
with dilution effects, was utilized to estimate the fair value of the Warrant Derivative Liabilities as of November 12, 2015 and
December 31, 2015. This model is subject to the significant assumptions discussed below and requires the following key inputs with
respect to the Company and/or instrument:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt"><b>Input</b></font></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>November 12, 2015</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2015</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 54%"><font style="font-size: 10pt">Stock Price</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">0.46</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">0.69</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Exercise Price</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.49</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.49</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Expected Life (in years)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">10.0</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">9.75</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Stock Volatility</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">157.56</font></td>
    <td><font style="font-size: 10pt">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">152.07</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Risk-Free Rate</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2.32</font></td>
    <td><font style="font-size: 10pt">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2.27</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Dividend Rate</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0</font></td>
    <td><font style="font-size: 10pt">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Outstanding Shares of Common Stock</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">4,547,243</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">4,547,243</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfSalesPolicyTextBlock', window );">Cost of Sales</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Cost of Sales</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cost of sales includes the purchase cost of
products sold and all costs associated with getting the products into the retail stores including buying and transportation costs.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtPolicyTextBlock', window );">Debt Issuance Costs</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; background-color: white"><u>Debt Issuance
Costs</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Debt issuance costs
consist primarily of arrangement fees, professional fees and legal fees. These costs are capitalized and are being amortized to
interest expense over the term of the related debt facilities.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><u>Impairment of Long-Lived
Assets</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">When facts and circumstances
indicate that the carrying values of long-lived assets, including fixed assets, may be impaired, an evaluation of recoverability
is performed by comparing the carrying value of the assets to projected future cash flows in addition to other quantitative and
qualitative analyses. Upon indication that the carrying value of such assets may not be recoverable, the Company recognizes an
impairment loss as a charge against current operations. Long-lived assets to be disposed of are reported at the lower of the carrying
amount or fair value, less estimated costs to sell. The Company makes judgments related to the expected useful lives of long-lived
assets and its ability to realize undiscounted cash flows in excess of the carrying amounts of such assets which are affected
by factors such as the ongoing maintenance and improvements of the assets, changes in economic conditions and changes in operating
performance. As the Company assesses the ongoing expected cash flows and carrying amounts of its long-lived assets, these factors
could cause the Company to realize a material impairment charge.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShippingAndHandlingCostPolicyTextBlock', window );">Shipping Costs</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; background-color: white"><u>Shipping
Costs</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Shipping and handling
costs billed to customers are recorded in sales. Shipping costs incurred by the company are recorded in selling and marketing
expenses.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_RelatedPartiesPolicyTextBlock', window );">Related parties</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><u>Related parties</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Parties are considered
to be related to the Company if the parties that, directly or indirectly, through one or more intermediaries, control, are controlled
by, or are under common control with the Company. Related parties also include principal owners of the Company, its management,
members of the immediate families of principal owners of the Company and its management and other parties with which the Company
may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that
one of the transacting parties might be prevented from fully pursuing its own separate interests. The All transactions with related
parties shall be recorded at fair value of the goods or services exchanged. Property purchased from a related party is recorded
at the cost to the related party and any payment to or on behalf of the related party in excess of the cost is reflected as a
distribution to the related party.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Reporting</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; background-color: white"><u>Segment
Reporting</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><font style="background-color: white">Segment
identification and selection is consistent with the management structure used by the Company&#146;s chief operating decision
maker to evaluate performance and make decisions regarding resource allocation, as well as the materiality of financial results
consistent with that structure. Based on the Company&#146;s management structure and method of internal reporting, the Company
has one operating segment. The Company&#146;s chief operating decision maker does not review operating results on a disaggregated
basis; rather, the chief operating decision maker reviews operating results on an aggregate basis.</font></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="margin: 0pt"></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Recent Accounting Pronouncements</u></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">ASU 2015-03</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In April 2015, the FASB issued Accounting
Standards Update (&#147;ASU&#148;) No. 2015-03, Interest - Imputation of Interest (Subtopic 835-30): Simplifying the Presentation
of Debt Issuance Costs. The amendments in this ASU require that debt issuance costs related to a recognized debt liability be presented
in the balance sheet as a direct deduction from the carrying amount of that debt liability, consistent with debt discounts. The
recognition and measurement guidance for debt issuance costs are not affected by the amendments in this ASU. The amendments are
effective for financial statements issued for fiscal years, and interim periods within those fiscal years, beginning after December
15, 2015. The amendments are to be applied on a retrospective basis, wherein the balance sheet of each individual period presented
is adjusted to reflect the period-specific effects of applying the new guidance. The Company is evaluating the possible effect
of this guidance on its financial statements.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">ASU 2015-02</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In February 2015, the FASB issued ASU
No. 2015-02, Consolidation (Topic 810): Amendments to the Consolidation Analysis, which is intended to improve targeted areas of
consolidation guidance for legal entities such as limited partnerships, limited liability corporations, and securitization structures
(collateralized debt obligations, collateralized loan obligations, and mortgage-backed security transactions). The ASU focuses
on the consolidation evaluation for reporting organizations that are required to evaluate whether they should consolidate certain
legal entities. In addition to reducing the number of consolidation models from four to two, the new standard simplifies the FASB
Accounting Standards Codification and improves current U.S. GAAP by placing more emphasis on risk of loss when determining a controlling
financial interest, reducing the frequency of the application of related-party guidance when determining a controlling financial
interest in a variable interest entity (&#147;VIE&#148;), and changing consolidation conclusions for companies in several industries
that typically make use of limited partnerships or VIEs. The ASU will be effective for fiscal years, and interim periods within
those fiscal years, beginning after December 15, 2015. Early adoption is permitted, including adoption in an interim period. We
do not expect the adoption of ASU 2015-02 to have a material effect on our financial position, results of operations or cash flows.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">ASU 2015-01</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In January 2015, the FASB issued ASU
No. 2015-01, &#147;Income Statement - Extraordinary and Unusual Items (Subtopic 225-20): Simplifying Income Statement Presentation
by Eliminating the Concept of Extraordinary Items.&#148; This ASU eliminates from U.S. GAAP the concept of extraordinary items.
ASU 2015-01 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. A
reporting entity may apply the amendments prospectively. We do not expect the adoption of ASU 2015-01 to have a material effect
on our financial position, results of operations or cash flows.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">ASU 2014-17</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In November 2014, the FASB issued ASU
No. 2014-17, &#147;Business Combinations (Topic 805): Pushdown Accounting.&#148; This ASU provides an acquired entity with an
option to apply pushdown accounting in its separate financial statements upon occurrence of an event in which an acquirer obtains
control of the acquired entity. An acquired entity may elect the option to apply pushdown accounting in the reporting period in
which the change-in-control event occurs. If pushdown accounting is applied to an individual change-in-control event, that election
is irrevocable. ASU 2014-17 was effective on November 18, 2014. The adoption of ASU 2014-17 did not have any effect on our financial
position, results of operations or cash flows.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">ASU 2014-16</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In November 2014, the FASB issued ASU
2014-16, &#147;Derivatives and Hedging (Topic 815).&#148; ASU 2014-16 addresses whether the host contract in a hybrid financial
instrument issued in the form of a share should be accounted for as debt or equity. ASU 2014-16 is effective for fiscal years,
and interim periods within those fiscal years, beginning after December 15, 2015. We do not currently have issued, nor are we investors
in, hybrid financial instruments. Accordingly, we do not expect the adoption of ASU 2014-16 to have any effect on our financial
position, results of operations or cash flows.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">ASU 2014-15</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In August 2014, the FASB issued ASU
No. 2014-15, &#147;Presentation of Financial Statements - Going Concern (Subtopic 205-40)&#148;. ASU 2014-15 provides guidance
related to management&#146;s responsibility to evaluate whether there is substantial doubt about an entity&#146;s ability to
continue as a going concern and to provide related footnote disclosure. ASU 2014-15 is effective for annual periods ending after
December 15, 2016, and for interim and annual periods thereafter. Early application is permitted. We do not expect the adoption
of ASU 2014-15 to have a material effect on our financial position, results of operations or cash flows.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">ASU 2014-12</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In June 2014, the FASB issued ASU No.
2014-12, &#147;Compensation &#150; Stock Compensation (Topic 718): Accounting for Share-Based Payments When the Terms of an Award
Provide That a Performance Target Could Be Achieved after the Requisite Service Period.&#148; This ASU requires that a performance
target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition.
ASU 2014-12 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. We
do not expect the adoption of ASU 2014-12 to have a material effect on our financial position, results of operations or cash flows.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">ASU 2014-09</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In May 2014, the FASB issued ASU No.
2014-09, &#147;Revenue from Contracts with Customers (Topic 606).&#148; ASU 2014-09 affects any entity using U.S. GAAP that either
enters into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets
unless those contracts are within the scope of other standards (e.g., insurance contracts or lease contracts). ASU 2014-09 is effective
for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2016. We are still evaluating the
effect of the adoption of ASU 2014-09. On April 1, 2015, the FASB voted to propose to defer the effective date of the new revenue
recognition standard by one year.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">ASU 2014-08</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In April 2014, the FASB issued ASU No.
2014-08, &#147;Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360) and Reporting Discontinued
Operations and Disclosures of Disposals of Components of an Entity.&#148; ASU 2014-08 amends the definition for what types of
asset disposals are to be considered discontinued operations, as well as amending the required disclosures for discontinued operations
and assets held for sale. ASU 2014-08 is effective for fiscal years, and interim periods within those fiscal years, beginning on
or after December 15, 2014. The adoption of ASU 2014-08 did not have any effect on our financial position, results of operations
or cash flows.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">There were various updates recently
issued, most of which represented technical corrections to the accounting literature or application to specific industries and
are not expected to a have a material impact on the Company&#146;s condensed financial position, results of operations or cash
flows.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiscalPeriod', window );">Change in Fiscal Year End</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Change in Fiscal Year End</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 21, 2014, the Company&#146;s board
of directors approved a change to the Company&#146;s fiscal year end from July 31 to December 31 of each year.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_GoingConcernPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Going concern policy text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_GoingConcernPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_ProductDisplayCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product Display Costs [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_ProductDisplayCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_RelatedPartiesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Related Parties [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_RelatedPartiesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_WarehousingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warehousing Costs [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_WarehousingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising costs. For those costs that cannot be capitalized, discloses whether such costs are expensed as incurred or the first period in which the advertising takes place. For direct response advertising costs that are capitalized, describes those assets and the accounting policy used, including a description of the qualifying activity, the types of costs capitalized and the related amortization period. An entity also may disclose its accounting policy for cooperative advertising arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 20<br> -Section 55<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=51677389&amp;loc=d3e8384-108330<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51662920&amp;loc=d3e8275-108329<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 305<br> -SubTopic 10<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6375392&amp;loc=d3e26790-107797<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4273-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Financial Reporting Release (FRR)<br> -Number 203<br> -Paragraph 02-03<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 1<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 55<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6875567&amp;loc=d3e14489-108613<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=51676700&amp;loc=d3e61082-112788<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=28088331&amp;loc=SL29635902-196195<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13537-108611<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13531-108611<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=51676700&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfSalesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognition of costs in the period which correspond to the sales and revenue categories presented in the statement of operations. The accounting policy may include the amount and nature of costs incurred, provisions associated with inventories, purchase discounts, freight and other costs included in cost of sales incurred and recorded in the period. This disclosure also includes the nature of costs of sales incurred and recorded in the statement of operations for the period relating to transactions with related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 50<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=51666513&amp;loc=d3e63676-111659<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfSalesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs incurred to obtain or issue debt, the effects of refinancings, method of amortizing deferred financing costs and original issue discount, and classifications of debt on the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=d3e41620-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=SL5579240-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=SL5579245-113959<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=d3e41675-113959<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=56946850&amp;loc=d3e41638-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiscalPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=51664549&amp;loc=d3e5291-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.3A-03.(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=27015204&amp;loc=d3e355100-122828<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.3A-02.(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=27015204&amp;loc=d3e355033-122828<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph k<br> -Article 1<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 06<br> -Article 3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiscalPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=51717228&amp;loc=d3e202-110218<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 5<br> -Section CC<br> -Subsection 3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32840-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6423966&amp;loc=d3e40913-109327<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32809-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=37586315&amp;loc=d3e32247-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=37586315&amp;loc=d3e32280-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for major classes of inventories, bases of stating inventories (for example, lower of cost or market), methods by which amounts are added and removed from inventory classes (for example, FIFO, LIFO, or average cost), loss recognition on impairment of inventories, and situations in which inventories are stated above cost. If inventory is carried at cost, this disclosure includes the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=28360613&amp;loc=d3e4492-108314<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=28360613&amp;loc=d3e4556-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Financial Reporting Release (FRR)<br> -Number 206<br> -Paragraph b<br> -Subparagraph i, ii<br> -Chapter 2<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 6<br> -Subparagraph a<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Research and Development<br> -URI http://asc.fasb.org/extlink&amp;oid=6523717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18726-107790<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 13.B.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012821&amp;loc=d3e214044-122780<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 13<br> -Section B<br> -Paragraph Question 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for stock option and stock incentive plans. This disclosure may include (1) the types of stock option or incentive plans sponsored by the entity (2) the groups that participate in (or are covered by) each plan (3) significant plan provisions and (4) how stock compensation is measured, and the methodologies and significant assumptions used to determine that measurement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShippingAndHandlingCostPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the classification of shipping and handling costs, including whether the costs are included in cost of sales or included in other income statement accounts. If shipping and handling fees are significant and are not included in cost of sales, disclosure includes both the amounts of such costs and the line item on the income statement which includes such costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Shipping Costs<br> -URI http://asc.fasb.org/extlink&amp;oid=51575562<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 45<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6408413&amp;loc=d3e221937-122793<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 45<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=51671805&amp;loc=d3e60635-111653<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 45<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=51667946&amp;loc=d3e61069-111654<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Handling Costs<br> -URI http://asc.fasb.org/extlink&amp;oid=51575068<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18726-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShippingAndHandlingCostPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for trade and other accounts receivables. This disclosure may include the basis at which such receivables are carried in the entity's statements of financial position (for example, net realizable value), how the entity determines the level of its allowance for doubtful accounts, when impairments, charge-offs or recoveries are recognized, and the entity's income recognition policies for such receivables, including its treatment of related fees and costs, its treatment of premiums, discounts or unearned income, when accrual of interest is discontinued, how the entity records payments received on nonaccrual receivables and its policy for resuming accrual of interest on such receivables.  If the enterprise holds a large number of similar loans, disclosure may include the accounting policy for the anticipation of prepayments and significant assumptions underlying prepayment estimates for amortization of premiums, discounts, and nonrefundable fees and costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51655414&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6378556&amp;loc=d3e10133-111534<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=49124121&amp;loc=d3e5212-111524<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=49124121&amp;loc=d3e5093-111524<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 3, 4<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=51801978&amp;loc=d3e6061-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=51801978&amp;loc=d3e6143-108592<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=51801978&amp;loc=d3e6132-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6786172864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Assumptions Used for Fair Value of Warrant Derivative Liabilities</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A Black-Scholes-Merton option-pricing model,
with dilution effects, was utilized to estimate the fair value of the Warrant Derivative Liabilities as of November 12, 2015 and
December 31, 2015. This model is subject to the significant assumptions discussed below and requires the following key inputs with
respect to the Company and/or instrument:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt"><b>Input</b></font></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>November 12, 2015</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2015</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 54%"><font style="font-size: 10pt">Stock Price</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">0.46</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">0.69</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Exercise Price</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.49</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.49</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Expected Life (in years)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">10.0</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">9.75</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Stock Volatility</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">157.56</font></td>
    <td><font style="font-size: 10pt">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">152.07</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Risk-Free Rate</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2.32</font></td>
    <td><font style="font-size: 10pt">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2.27</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Dividend Rate</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0</font></td>
    <td><font style="font-size: 10pt">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Outstanding Shares of Common Stock</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">4,547,243</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">4,547,243</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6782401680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions (Tables)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Purchase Price Allocation Assets Acquired and Liabilities Assumed on Estimated Fair Values</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preliminary allocation of the purchase
price to the assets acquired and liabilities assumed based on the estimated fair values is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-decoration: underline"><font style="font-size: 10pt"><u>Assets</u></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="width: 79%"><font style="font-size: 10pt">Accounts Receivable</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 18%; text-align: right"><font style="font-size: 10pt">2,733,167</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Inventory</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">67,113</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Intellectual Property</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1,000,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Non-compete provision</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">50,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Non-solicitation provision</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">50,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Intangible assets-Customer relationships</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1,941,030</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Goodwill</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,071,517</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-decoration: underline"><font style="font-size: 10pt"><u>Liabilities</u></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Accounts Payable</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(971,381</font></td>
    <td><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Accrued Expenses</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(941,446</font></td>
    <td><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">6,000,000</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock', window );">Purchase Price Allocated to Acquisition of Assets</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The purchase price allocated to the acquisition
of the assets of Factor Nutrition Labs, LLC is made up as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Amount</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 86%"><font style="font-size: 10pt">Cash payment made on January 22, 2015</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">4,500,000</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Cash payment to be made on January 20, 2016</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">750,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Cash payment to be made on January 20, 2017</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">750,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Total</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">6,000,000</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Pro forma Results of Acquisition</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Pro forma results of operations data (unaudited)
for the years ended December 31, 2014 and 2013, as if the acquisition had occurred on January 1, 2013, are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31,</font></td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2014</font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2013</font></td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 66%"><font style="font-size: 10pt">Revenue</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">12,695,295</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">10,629,171</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Net (loss) income</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(183,471</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">932,209</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_KnightTherapeuticsIncMember', window );">Knight Therapeutics Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Purchase Price Allocation Assets Acquired and Liabilities Assumed on Estimated Fair Values</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preliminary allocation of the purchase
price to the assets acquired and liabilities assumed based on the estimated fair values is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-decoration: underline"><font style="font-size: 10pt"><u>Assets</u></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="width: 86%"><font style="font-size: 10pt">Accounts Receivable</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">58,054</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Inventory</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">204,925</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Intangible property</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">100,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">License agreement</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">606,553</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-decoration: underline"><font style="font-size: 10pt"><u>Liabilities</u></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Accounts Payable</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(51,795</font></td>
    <td><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Accrued Expenses</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(148,520</font></td>
    <td><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">769,217</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_HandMDLLCMember', window );">Hand MD LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Purchase Price Allocation Assets Acquired and Liabilities Assumed on Estimated Fair Values</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preliminary allocation of the purchase
price to the assets acquired and liabilities assumed based on the estimated fair values is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-decoration: underline"><font style="font-size: 10pt"><u>Assets</u></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="width: 86%"><font style="font-size: 10pt">Intangible property</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">100,000</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">License agreement</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1,670,675</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-decoration: underline"><font style="font-size: 10pt"><u>Liabilities</u></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Royalty payable</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(258,897</font></td>
    <td><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Others</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(11,778</font></td>
    <td><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,500,000</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_BreakthroughProductsIncMember', window );">Breakthrough Products, Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Purchase Price Allocation Assets Acquired and Liabilities Assumed on Estimated Fair Values</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preliminary allocation of the purchase
price to the assets acquired and liabilities assumed based on the estimated fair values is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-decoration: underline"><font style="font-size: 10pt"><u>Assets</u></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="width: 79%"><font style="font-size: 10pt">Cash</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 18%; text-align: right"><font style="font-size: 10pt">2,298,619</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Accounts Receivable</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(68,976</font></td>
    <td><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Inventory</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">234,709</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Prepaid expenses</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">57,569</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Intellectual property</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">100,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Non-compete provision</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">50,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Goodwill</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">3,253,160</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-decoration: underline"><font style="font-size: 10pt"><u>Liabilities</u></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Accounts Payable</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(741,822</font></td>
    <td><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Accrued Expenses</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(2,202,848</font></td>
    <td><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">2,980,411</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock', window );">Purchase Price Allocated to Acquisition of Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The purchase price allocated to the acquisition
of the assets of UrgentRx is made up as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Amount</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 86%"><font style="font-size: 10pt">Stock payment</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">2,550,000</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Stock warrants issued</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">430,411</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Total</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">2,980,411</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Pro forma Results of Acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Pro forma results of operations data (unaudited)
for the year ended December 31, 2014 as if the acquisition had occurred on January 1, 2014, are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2014</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 79%"><font style="font-size: 10pt">Revenue</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 18%; text-align: right"><font style="font-size: 10pt">2,722,288</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Net (loss) income</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(10,621,330</font></td>
    <td><font style="font-size: 10pt">)</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_TprInvestmentsPtyLtdMember', window );">TPR Investments Pty Ltd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Purchase Price Allocation Assets Acquired and Liabilities Assumed on Estimated Fair Values</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preliminary allocation of the purchase
price to the assets acquired and liabilities assumed based on the estimated fair values is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-decoration: underline"><font style="font-size: 10pt"><u>Assets</u></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="width: 79%"><font style="font-size: 10pt">Cash</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 18%; text-align: right"><font style="font-size: 10pt">1,584,642</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Accounts Receivable</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">30,684</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Inventory</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">77,069</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Prepaid expenses</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">141,070</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Fixed Assets, net</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5,698</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Intangible assets, Net</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">3,493</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Blogger Database</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">200,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Customer Database</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">500,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Intellectual property</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">100,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Non-compete provision</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">50,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Goodwill</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">6,214,899</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-decoration: underline"><font style="font-size: 10pt"><u>Liabilities</u></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Accounts Payable</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(77,064</font></td>
    <td><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Accrued Expenses</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(56,224</font></td>
    <td><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Dividends Payable</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(1,177,152</font></td>
    <td><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Provision for Income Tax</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(501,415</font></td>
    <td><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">7,095,700</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock', window );">Purchase Price Allocated to Acquisition of Assets</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The purchase price allocated to the acquisition
of the assets of NomadChoice is made up as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Amount</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 86%"><font style="font-size: 10pt">Cash</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">2,848,800</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Stock issued at closing</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1,750,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Earn-out payment</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">2,496,900</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Total</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">7,095,700</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Pro forma Results of Acquisition</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Pro forma results of operations data (unaudited)
for the year ended December 31, 2014 as if the acquisition had occurred on January 1, 2014, are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2014</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 79%"><font style="font-size: 10pt">Revenue</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 18%; text-align: right"><font style="font-size: 10pt">2,494,812</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Net (loss) income</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(909,280</font></td>
    <td><font style="font-size: 10pt">)</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)-(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=56956515&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=56956515&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=56956791&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_KnightTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_KnightTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_HandMDLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_HandMDLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_BreakthroughProductsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_BreakthroughProductsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_TprInvestmentsPtyLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_TprInvestmentsPtyLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6781696976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2014</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="margin: 0pt"></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The table below summarizes the differences
between the U.S. statutory federal rate and the Company&#146;s effective tax rate for the years ended December 31, 2015 and 2014:</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">December 31, 2015</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">December 31, 2014</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 56%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">U.S. Statutory Rate</font></td>
    <td style="width: 1%; line-height: 115%">&#160;</td>
    <td style="width: 1%; line-height: 115%">&#160;</td>
    <td style="width: 18%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">34</font></td>
    <td style="width: 2%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td style="width: 1%; line-height: 115%">&#160;</td>
    <td style="width: 1%; line-height: 115%">&#160;</td>
    <td style="width: 18%; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">34</font></td>
    <td style="width: 2%; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">U.S. effective rate in excess of AU rate</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(1</font></td>
    <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">%)</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">U.S. valuation allowance</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(34</font></td>
    <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">%)</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">(34</font></td>
    <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">%)</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Foreign Tax - Australia</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">6.8</font></td>
    <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">Total provision for income taxes</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">5.8</font></td>
    <td style="line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td>
    <td style="line-height: 115%">&#160;</td>
    <td style="border-bottom: black 2.25pt double; line-height: 115%">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td>
    <td style="line-height: 115%">&#160;</td></tr>
</table>


<p style="margin: 0pt"></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Income Tax Assets</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has deferred tax assets,
which have been fully reserved, as follows as of December 31, 2015 and 2014:</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31, 2015</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31, 2014</td>
    <td style="line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 56%; line-height: 115%">Deferred tax assets</td>
    <td style="width: 1%; line-height: 115%">&#160;</td>
    <td style="width: 1%; line-height: 115%">$</td>
    <td style="width: 18%; text-align: right; line-height: 115%">11,460,536</td>
    <td style="width: 2%; line-height: 115%">&#160;</td>
    <td style="width: 1%; line-height: 115%">&#160;</td>
    <td style="width: 1%; line-height: 115%">$</td>
    <td style="width: 18%; text-align: right; line-height: 115%">241,245</td>
    <td style="width: 2%; line-height: 115%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="line-height: 115%">Valuation allowance for deferred tax assets</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(11,460,536</td>
    <td style="line-height: 115%">)</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; line-height: 115%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(241,245</td>
    <td style="line-height: 115%">)</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="line-height: 115%">Net deferred tax assets</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td>
    <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">-</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="line-height: 115%">&#160;</td>
    <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td>
    <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">-</td>
    <td style="line-height: 115%">&#160;</td></tr>
</table>
<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6779092016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Receivable (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Accounts Receivable, Net of Allowances</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Accounts receivable, net of allowances for
sales returns and doubtful accounts, consisted of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2015</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2014</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 54%"><font style="font-size: 10pt">Trade accounts receivable</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">4,101,148</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">2,898</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Less allowances</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(121,291</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt"><b>Total accounts receivable, net</b></font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt"><b>$</b></font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt"><b>3,979,857</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt"><b>$</b></font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt"><b>2,898</b></font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6786204304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaid Expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsAbstract', window );"><strong>Prepaid Expense and Other Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_SummaryOfPrepaidExpensesTableTextBlock', window );">Summary of Prepaid Expenses</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">At December 31, 2015 and 2014, prepaid expenses
consisted of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2015</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2014</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 54%"><font style="font-size: 10pt">Advances for inventory</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">171,494</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Media production</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">55,849</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Insurance</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">54,519</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">10,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Trade shows</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">45,700</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Deposits</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">41,228</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Consultants</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">24,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Rent</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">16,216</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Miscellaneous</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">13,428</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt"><b>Total</b></font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt"><b>$</b></font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt"><b>422,434</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt"><b>$</b></font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt"><b>10,000</b></font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_SummaryOfPrepaidExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Summary Of Prepaid Expenses [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_SummaryOfPrepaidExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6781761152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Concentration of Credit Risk (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Risks and Uncertainties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_SummaryOfMajorSuppliersTableTextBlock', window );">Summary of Major Suppliers</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the year ended December 31, 2015, our products
were made by the following suppliers:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 30%"><font style="font-size: 10pt">FOCUSfactor</font></td>
    <td style="width: 40%; text-align: right"><font style="font-size: 10pt">Pittsburgh, PA</font></td>
    <td style="width: 30%; text-align: right"><font style="font-size: 10pt">Tustin, CA</font></td></tr>
<tr style="vertical-align: top">
    <td><font style="font-size: 10pt">Flat Tummy Tea</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">Highland, NY</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td></tr>
<tr style="vertical-align: top">
    <td><font style="font-size: 10pt">Neuragen</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">Linthicum Heights, MD</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td></tr>
<tr style="vertical-align: top">
    <td><font style="font-size: 10pt">UrgentRx</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">Ogden, UT</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_SummaryOfMajorSuppliersTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Summary Of Major Suppliers [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_SummaryOfMajorSuppliersTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6786195184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Carrying Value of Inventory</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The carrying value of inventory consisted of
the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2015</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2014</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 54%"><font style="font-size: 10pt">Finished goods</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">535,908</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Components</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">115,340</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Raw Materials</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">35,406</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Energy product</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">26,064</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt"><b>Total inventory</b></font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt"><b>$</b></font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt"><b>686,654</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt"><b>$</b></font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt"><b>26,064</b></font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 2<br> -Paragraph 6<br> -Subparagraph a,b,c<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6782299456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fixed Assets and Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_SummaryOfFixedAndIntangibleAssetsTableTextblock', window );">Summary of Fixed and Intangible Assets</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of December 31, 2015 and 2014, fixed assets
and intangible assets consisted of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2015</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2014</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 62%"><font style="font-size: 10pt">Property and equipment</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">18,187</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Less accumulated depreciation</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(6,170</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt"><b>Fixed assets, net</b></font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt"><b>$</b></font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">12,017</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt"><b>$</b></font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt"><b>-</b></font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Depreciation expense for the years ended December
31, 2015 and 2014 was $1,513 and $0, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2015</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2014</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 62%"><font style="font-size: 10pt">FOCUSfactor intellectual property</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">1,000,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Intangible assets subject to amortization</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5,521,751</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Less accumulated amortization</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(606,489</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt"><b>Intangible assets, net</b></font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt"><b>$</b></font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt"><b>5,915,262</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt"><b>$</b></font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt"><b>-</b></font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock', window );">Summary of Estimated Aggregate Amortization Expense</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The estimated aggregate amortization expense
over each of the next five years is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 79%"><font style="font-size: 10pt">2016</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%; border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td>
    <td style="width: 18%; border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1,111,229</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">2017</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1,111,229</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">2018</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1,109,070</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">2019</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1,094,329</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">2020</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">489,405</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><b></b></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_SummaryOfFixedAndIntangibleAssetsTableTextblock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Summary of fixed and intangible assets table text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_SummaryOfFixedAndIntangibleAssetsTableTextblock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6781734384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Payable and Accrued Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Accounts Payable and Accrued Liabilities</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of December 31, 2015 and 2014, accounts
payable and accrued liabilities consisted of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2015</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2014</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 54%"><font style="font-size: 10pt">Payroll</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">128,237</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">10,867</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Legal fees</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">38,752</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">47,916</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Manufacturers</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1,527,333</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Promotions</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1,213,021</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Returns allowance</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1,128,133</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Customers</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">411,033</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Interest</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">110,754</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Royalties</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">71,573</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Warehousing</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">31,748</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Others</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">371,518</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">15,859</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt"><b>Total</b></font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt"><b>$</b></font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt"><b>5,032,102</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt"><b>$</b></font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt"><b>74,642</b></font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6781643712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes Payable (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_ScheduleOfLoanPayableTableTextBlock', window );">Schedule of Loan Payable</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The Company&#146;s
loans payable at December 31, 2015 and 2014 are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2015</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2014</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 62%"><font style="font-size: 10pt">Loans payable</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">12,406,589</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Unamortized debt discount</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(2,536,419</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Total</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">9,870,170</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Less: Current portion</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(3,912,060</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Long-term portion</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">5,958,110</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_ScheduleOfLoanPayableTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Loan Payable [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_ScheduleOfLoanPayableTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6625146496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">Schedule of Future Minimum Rental Payments For Operating Leases</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following is a schedule by years of future
minimum rental payments required under operating leases that have initial or remaining non-cancelable lease terms in excess of
one year as of December 31, 2015:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">Year ending December 31:</font></td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 84%"><font style="font-size: 10pt">2016</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 13%; text-align: right"><font style="font-size: 10pt">220,676</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">2017</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">27,294</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Total</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">247,970</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_SubsidiaryMember', window );">Subsidiary [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">Schedule of Future Minimum Rental Payments For Operating Leases</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following is a schedule by years of future
minimum rental payments required under operating leases that have initial or remaining non-cancelable lease terms in excess of
one year as of December 31, 2015:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">Year ending December 31:</font></td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 84%"><font style="font-size: 10pt">2016</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 13%; text-align: right"><font style="font-size: 10pt">10,728</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">2017</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">9,834</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Total</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">20,562</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_SubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_SubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6781838416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Options (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">Summary of Options Outstanding by Price Range</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table summarizes the changes
in options outstanding and the related prices for the shares of the Company&#146;s common stock issued to employees and consultants
under a stock option plan at December 31, 2015:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td colspan="2" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="10" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Options Outstanding</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Options Exercisable</b></font></td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Exercise </b></font><br />
<font style="font-size: 10pt"><b>Prices ($)</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Number</b></font><br />
<font style="font-size: 10pt"><b>Outstanding</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted</b></font><br />
<font style="font-size: 10pt"><b>Average</b></font><br />
<font style="font-size: 10pt"><b>Remaining</b></font><br />
<font style="font-size: 10pt"><b>Contractual Life</b></font><br />
<font style="font-size: 10pt"><b>(Years)</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted</b></font><br />
<font style="font-size: 10pt"><b>Average</b></font><br />
<font style="font-size: 10pt"><b>Exercise </b></font><br />
<font style="font-size: 10pt"><b>Price ($)</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Number</b></font><br />
<font style="font-size: 10pt"><b>Exercisable</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted</b></font><br />
<font style="font-size: 10pt"><b>Average </b></font><br />
<font style="font-size: 10pt"><b>Exercise </b></font><br />
<font style="font-size: 10pt"><b>Price ($)</b></font></td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.25 - $0.65</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5,000,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">8.62</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.41</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">3,000,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.25</font></td>
    <td>&#160;</td></tr>
<tr>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Options Activity</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The stock option activity for the year ended
December 31, 2015 is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27.5pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Options Outstanding</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average</b></font><br />
<font style="font-size: 10pt"><b>Exercise Price</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 52%"><font style="font-size: 10pt">Outstanding at December 31, 2014</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 21%; text-align: right"><font style="font-size: 10pt">1,000,000</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 21%; text-align: right"><font style="font-size: 10pt">0.25</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">4,000,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.45</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Exercised</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Expired or canceled</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Outstanding at December 31, 2015</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">5,000,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.41</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6781612656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Warrants (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_StockWarrantsAbstract', window );"><strong>Stock Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockWarrantsPlansByExercisePriceRangeTextBlock', window );">Summary of Warrants Outstanding by Price Range</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table summarizes the warrants
outstanding and the related prices for the shares of the Company&#146;s common stock at December 31, 2015:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td colspan="2" style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="10" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Warrants Outstanding</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Warrants Exercisable</b></font></td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Exercise</b></font><br />
<font style="font-size: 10pt"><b>Prices ($)</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Number</b></font><br />
<font style="font-size: 10pt"><b>Outstanding</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted</b></font><br />
<font style="font-size: 10pt"><b>Average</b></font><br />
<font style="font-size: 10pt"><b>Remaining</b></font><br />
<font style="font-size: 10pt"><b>Contractual Life</b></font><br />
<font style="font-size: 10pt"><b>(Years)</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted</b></font><br />
<font style="font-size: 10pt"><b>Average</b></font><br />
<font style="font-size: 10pt"><b>Exercise </b></font><br />
<font style="font-size: 10pt"><b>Price ($)</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Number</b></font><br />
<font style="font-size: 10pt"><b>Exercisable</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted</b></font><br />
<font style="font-size: 10pt"><b>Average</b></font><br />
<font style="font-size: 10pt"><b>Exercise</b></font><br />
<font style="font-size: 10pt"><b>Price ($)</b></font></td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 18%; text-align: right"><font style="font-size: 10pt">0.34</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 13%; text-align: right"><font style="font-size: 10pt">3,584,759</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 13%; text-align: right"><font style="font-size: 10pt">9.1</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 13%; text-align: right"><font style="font-size: 10pt">0.34</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 13%; text-align: right"><font style="font-size: 10pt">3,584,759</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 13%; text-align: right"><font style="font-size: 10pt">0.34</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.49</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">4,547,243</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">9.9</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.49</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">4,547,243</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.49</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5.00</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1,000,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">3</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5.00</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1,000,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5.00</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of Stock Warrants Activity</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The warrant activity for the year ended December
31, 2015 is as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 27.5pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Warrants</b></font><br />
<font style="font-size: 10pt"><b>Outstanding</b></font></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average</b></font><br />
<font style="font-size: 10pt"><b>Exercise Price</b></font></td>
    <td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Outstanding at December 31, 2014</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="width: 52%"><font style="font-size: 10pt">Granted</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 21%; text-align: right"><font style="font-size: 10pt">19,277,814</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 21%; text-align: right"><font style="font-size: 10pt">0.44</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Exercised</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(10,145,812</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.00000020</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Expired or canceled</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Outstanding at December 31, 2015</font></td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double">&#160;</td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">9,132,002</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.92</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27.5pt"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockWarrantsPlansByExercisePriceRangeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Summary of warrants outstanding by price range.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockWarrantsPlansByExercisePriceRangeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_StockWarrantsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_StockWarrantsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6784392&amp;loc=d3e188667-122775<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=51659978&amp;loc=d3e25284-112666<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 28<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6786104144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock', window );">Schedule of Assumptions Used For Fair Value of Derivative</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The fair value of the embedded derivative was
determined using the Black-Scholes Model based on the following assumptions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">November 12, 2015</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 79%"><font style="font-size: 10pt">Risk-free interest rate</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 18%; text-align: right"><font style="font-size: 10pt">2.32</font></td>
    <td style="width: 1%"><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Expected remaining term</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">10 Years</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Expected volatility</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">157.56</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Dividend yield</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>



<p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Fair value at December 31, 2015 was estimated
to be $3,096,179 and based on the following assumptions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2015</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 79%"><font style="font-size: 10pt">Risk-free interest rate</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 18%; text-align: right"><font style="font-size: 10pt">2.27</font></td>
    <td style="width: 1%"><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Expected remaining term</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">9.75 Years</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Expected volatility</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">152.07</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Dividend yield</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative assets at fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6796109456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Summary of Net Sales Attributed to Customers Geographical Segment</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Net sales attributed to customers in the United
States and foreign countries for the years ended December 31, 2015 and 2014 were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2015</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2014</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 54%"><font style="font-size: 10pt">United States</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">13,129,753</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">9,158</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Foreign countries</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">326,624</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">13,456,377</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">9,158</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_SummaryOfNetSalesAttributedToCustomersProductGroupTableTextBlock', window );">Summary of Net Sales Attributed to Customers Product Group</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#146;s net sales by product group
for the years ended December 31, 2015 and 2014 were as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2015</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2014</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 54%"><font style="font-size: 10pt">Focus Factor</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">10,482,367</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Flat Tummy Tea</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,513,990</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Other (1)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">460,020</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">9,158</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">13,456,377</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">9,158</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">(1) Net sales for any
other product group of similar products are less than 10% of consolidated net sales.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock', window );">Summary of Long-lived Assets (Net) Attributable to Operations Geographical Segment</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Long-lived assets (net) attributable to operations
in the United States and foreign countries as of December 31, 2015 and 2014 were as follows:</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2015</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2014</b></font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 54%"><font style="font-size: 10pt">United States</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">17,451,598</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 20%; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Foreign countries</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">12,081</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">17,463,679</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_SummaryOfNetSalesAttributedToCustomersProductGroupTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Summary of Net Sales Attributed to Customers Product Group [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_SummaryOfNetSalesAttributedToCustomersProductGroupTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=51669610&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph a<br> -URI http://asc.fasb.org/extlink&amp;oid=51669610&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6782988720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2014 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>USD ($) </div>
<div>Segment </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFDICInsuredAmount', window );">Cash frderally insured limit per bank</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashUninsuredAmount', window );">Cash uninsured amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,453,290<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Percentage of valuation allowance</a></td>
<td class="num">(34.00%)<span></span>
</td>
<td class="num">(34.00%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_WarrantsToPurchaseOfCommonStock', window );">Warrants to purchase of common stock | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,132,002<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="nump">$ 1,033,291<span></span>
</td>
<td class="nump">$ 8,569,841<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_WorkingCapital', window );">Working capital deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,165,812<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segment | Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_WarrantsToPurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants to purchase of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_WarrantsToPurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_WorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Working Capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_WorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFDICInsuredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFDICInsuredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashUninsuredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashUninsuredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br> -Article 3<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6782190368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Assumptions Used for Fair Value of Warrant Derivative Liabilities (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 12, 2015</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Stock Price</a></td>
<td class="nump">$ 0.46<span></span>
</td>
<td class="nump">$ 0.69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExercisePrice', window );">Exercise Price</a></td>
<td class="nump">$ 0.49<span></span>
</td>
<td class="nump">$ 0.74<span></span>
</td>
<td class="nump">$ 0.33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExpectedTerm', window );">Expected Life (in years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExpectedVolatilityRate', window );">Stock Volatility</a></td>
<td class="nump">154.00%<span></span>
</td>
<td class="nump">15207.00%<span></span>
</td>
<td class="nump">125.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsRiskFreeInterestRate', window );">Risk-Free Rate</a></td>
<td class="nump">2.32%<span></span>
</td>
<td class="nump">2.27%<span></span>
</td>
<td class="nump">1.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExpectedDividendRate', window );">Dividend Rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Outstanding Shares of Common Stock</a></td>
<td class="nump">4,547,243<span></span>
</td>
<td class="nump">81,692,954<span></span>
</td>
<td class="nump">62,100,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Agreed upon price for the exchange of the underlying asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssumptionsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected dividends to be paid to holders of the underlying shares or financial instruments (expressed as a percentage of the share or instrument's price).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsExpectedTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period the instrument, asset or liability is expected to be outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssumptionsExpectedTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Measure of dispersion, in percentage terms (for instance, the standard deviation or variance), for a given stock price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Risk-free interest rate assumption used in valuing an instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6800713456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 17, 2015 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th"><div>Dec. 03, 2015</div></th>
<th class="th">
<div>Nov. 15, 2015 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 15, 2015 </div>
<div>AUD </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 18, 2015 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 26, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 22, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2014 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Nov. 12, 2015 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Aggregate purchase price of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net inocme</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,536,548)<span></span>
</td>
<td class="num">$ (960,092)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense recorded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (958,740)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares contibuted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Capital stock per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExercisePrice', window );">Warrant exercise price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.74<span></span>
</td>
<td class="nump">$ 0.33<span></span>
</td>
<td class="nump">$ 0.49<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_KnightTherapeuticsIncMember', window );">Knight Therapeutics Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Aggregate purchase price of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_PresentValueOfFuturePayments', window );">Present value of future payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 515,854<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense recorded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,372<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_KnightTherapeuticsIncMember', window );">Knight Therapeutics Inc [Member] | Security Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldAmortization', window );">Amortization expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70,655<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful lives of intangible property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_HandMDLLCMember', window );">Hand MD LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares contibuted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,142,857<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Common stock percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Capital stock per share | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 106,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Present value of future royalty payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 258,897<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_HandMDLLCMember', window );">Hand MD LLC [Member] | License Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Sales percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_PercentageOfAmountReceviedFromSublicensess', window );">Percentage of amount recevied from sublicensess</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_HandMDLLCMember', window );">Hand MD LLC [Member] | License Agreement [Member] | Second Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Present value of future royalty payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_HandMDLLCMember', window );">Hand MD LLC [Member] | License Agreement [Member] | Thired Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Present value of future royalty payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_HandMDLLCMember', window );">Hand MD LLC [Member] | Consulting Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldAmortization', window );">Amortization expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 118,045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful lives of intangible property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_ConsultingFeePaid', window );">Consulting fee paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_BreakthroughProductsIncMember', window );">Breakthrough Products, Inc [Member] | Stock Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Sales percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SalesRevenueNet', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares contibuted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_BreakthroughProductsIncMember', window );">Breakthrough Products, Inc [Member] | Settlement Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful lives of intangible property</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares contibuted | shares</a></td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Capital stock per share | $ / shares</a></td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExercisePrice', window );">Warrant exercise price | $ / shares</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_BreakthroughProductsIncMember', window );">Breakthrough Products, Inc [Member] | Settlement Agreement [Member] | Non-compete Provision [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldAmortization', window );">Amortization expense</a></td>
<td class="nump">$ 4,583<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful lives of intangible property</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_TprInvestmentsPtyLtdMember', window );">TPR Investments Pty Ltd [Member] | Stock Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldAmortization', window );">Amortization expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_ExpectedEvenues', window );">Company's expected revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,513,990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net inocme</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">966,672<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful lives of intangible property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares contibuted | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,571,428<span></span>
</td>
<td class="nump">3,571,428<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_TprInvestmentsPtyLtdMember', window );">TPR Investments Pty Ltd [Member] | Stock Purchase Agreement [Member] | AUD [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_AmountPayableUnderPurchaseAgreement', window );">Amount payable under the purchase agreement | AUD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">AUD 3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Total payments of acquire assets | AUD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">AUD 4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_TprInvestmentsPtyLtdMember', window );">TPR Investments Pty Ltd [Member] | Stock Purchase Agreement [Member] | Non-compete Provision [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful lives of intangible property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=SNYR_KnightTherapeuticsBarbadosIncMember', window );">Knight [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Sales percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldAmortization', window );">Amortization expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">384,720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=SNYR_UrgentRxSellersMember', window );">UrgentRx Sellers [Member] | Breakthrough Products, Inc [Member] | Settlement Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_ExpectedEvenues', window );">Company's expected revenues</a></td>
<td class="nump">$ 90,590<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net inocme</a></td>
<td class="nump">$ 80,249<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=SNYR_FocusFactorBusinessMember', window );">Focus Factor Business [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Aggregate purchase price of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_AmountPayableUnderPurchaseAgreement', window );">Amount payable under the purchase agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_ExpectedEvenues', window );">Company's expected revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,482,367<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net inocme</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,216,928<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=SNYR_FocusFactorBusinessMember', window );">Focus Factor Business [Member] | January 20, 2016 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_AmountPayableUnderPurchaseAgreement', window );">Amount payable under the purchase agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=SNYR_FocusFactorBusinessMember', window );">Focus Factor Business [Member] | January 20, 2017 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_AmountPayableUnderPurchaseAgreement', window );">Amount payable under the purchase agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_AmountPayableUnderPurchaseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount payable under the purchase agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_AmountPayableUnderPurchaseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_ConsultingFeePaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Consulting fee paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_ConsultingFeePaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_ExpectedEvenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Company's expected evenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_ExpectedEvenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_PercentageOfAmountReceviedFromSublicensess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of amount recevied from sublicensess.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_PercentageOfAmountReceviedFromSublicensess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_PresentValueOfFuturePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of future payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_PresentValueOfFuturePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=56956791&amp;loc=d3e4845-128472<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=35744172&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=51801978&amp;loc=d3e6351-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13531-108611<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=51801978&amp;loc=d3e6404-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13537-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization of property, plant and equipment directly related to goods produced and sold and services rendered by an entity during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Agreed upon price for the exchange of the underlying asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssumptionsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.18)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879464&amp;loc=d3e573970-122913<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 03<br> -Paragraph 19<br> -Article 5<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br> -Paragraph 20<br> -Article 9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesRevenueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesRevenueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_KnightTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_KnightTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SNYR_SecurityAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SNYR_SecurityAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_HandMDLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_HandMDLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SNYR_LicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SNYR_LicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementScenarioAxis=SNYR_SecondYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementScenarioAxis=SNYR_SecondYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementScenarioAxis=SNYR_ThiredYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementScenarioAxis=SNYR_ThiredYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SNYR_ConsultingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SNYR_ConsultingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_BreakthroughProductsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_BreakthroughProductsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SNYR_StockPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SNYR_StockPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SNYR_SettlementAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SNYR_SettlementAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementScenarioAxis=SNYR_NoncompeteProvisionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementScenarioAxis=SNYR_NoncompeteProvisionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_TprInvestmentsPtyLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_TprInvestmentsPtyLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrencyAxis=SNYR_AustralianDollerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrencyAxis=SNYR_AustralianDollerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=SNYR_KnightTherapeuticsBarbadosIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=SNYR_KnightTherapeuticsBarbadosIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=SNYR_UrgentRxSellersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=SNYR_UrgentRxSellersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=SNYR_FocusFactorBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=SNYR_FocusFactorBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreationDateAxis=SNYR_JanuaryTwentyTwoThousandSixteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreationDateAxis=SNYR_JanuaryTwentyTwoThousandSixteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreationDateAxis=SNYR_JanuaryTwentyTwoThousandSeventeenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreationDateAxis=SNYR_JanuaryTwentyTwoThousandSeventeenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6782655968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisitions - Purchase Price Allocation Assets Acquired and Liabilities Assumed on Estimated Fair Values (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_FactorNutritionLabsLLCMember', window );">Factor Nutrition Labs, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaAccountsReceivable', window );">Accounts Receivable</a></td>
<td class="nump">$ 2,733,167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaInventory', window );">Inventory</a></td>
<td class="nump">67,113<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaIntellectualProperty', window );">Intellectual Property</a></td>
<td class="nump">$ 1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaLicenseAgreement', window );">License agreement</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaNonCompeteProvision', window );">Non-compete provision</a></td>
<td class="nump">$ 50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaNonSolicitationProvision', window );">Non-solicitation provision</a></td>
<td class="nump">50,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaIntangibleAssetsCustomerRelationships', window );">Intangible assets-Customer relationships</a></td>
<td class="nump">1,941,030<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaGoodwill', window );">Goodwill</a></td>
<td class="nump">2,071,517<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaAccountsPayable', window );">Accounts Payable</a></td>
<td class="num">$ (971,381)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaRoyaltyPayable', window );">Royalty payable</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaAccruedExpenses', window );">Accrued Expenses</a></td>
<td class="num">$ (941,446)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaOthers', window );">Others</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaTotalLiabilities', window );">Total Liabilities</a></td>
<td class="nump">$ 6,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_KnightTherapeuticsIncMember', window );">Knight Therapeutics Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaAccountsReceivable', window );">Accounts Receivable</a></td>
<td class="nump">58,054<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaInventory', window );">Inventory</a></td>
<td class="nump">204,925<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaIntellectualProperty', window );">Intellectual Property</a></td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaLicenseAgreement', window );">License agreement</a></td>
<td class="nump">$ 606,553<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaNonCompeteProvision', window );">Non-compete provision</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaNonSolicitationProvision', window );">Non-solicitation provision</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaIntangibleAssetsCustomerRelationships', window );">Intangible assets-Customer relationships</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaGoodwill', window );">Goodwill</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaAccountsPayable', window );">Accounts Payable</a></td>
<td class="num">$ (51,795)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaRoyaltyPayable', window );">Royalty payable</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaAccruedExpenses', window );">Accrued Expenses</a></td>
<td class="num">$ (148,520)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaOthers', window );">Others</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaTotalLiabilities', window );">Total Liabilities</a></td>
<td class="nump">$ 769,217<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_HandMDLLCMember', window );">Hand MD LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaAccountsReceivable', window );">Accounts Receivable</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaInventory', window );">Inventory</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaIntellectualProperty', window );">Intellectual Property</a></td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaLicenseAgreement', window );">License agreement</a></td>
<td class="nump">$ 1,670,675<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaNonCompeteProvision', window );">Non-compete provision</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaNonSolicitationProvision', window );">Non-solicitation provision</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaIntangibleAssetsCustomerRelationships', window );">Intangible assets-Customer relationships</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaGoodwill', window );">Goodwill</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaAccountsPayable', window );">Accounts Payable</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaRoyaltyPayable', window );">Royalty payable</a></td>
<td class="num">$ (258,897)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaAccruedExpenses', window );">Accrued Expenses</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaOthers', window );">Others</a></td>
<td class="num">$ (11,778)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaTotalLiabilities', window );">Total Liabilities</a></td>
<td class="nump">1,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_BreakthroughProductsIncMember', window );">Breakthrough Products, Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaCash', window );">Cash</a></td>
<td class="nump">2,298,619<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaAccountsReceivable', window );">Accounts Receivable</a></td>
<td class="num">(68,976)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaInventory', window );">Inventory</a></td>
<td class="nump">234,709<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaPrepaidExpenses', window );">Prepaid expenses</a></td>
<td class="nump">57,569<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaIntellectualProperty', window );">Intellectual Property</a></td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaLicenseAgreement', window );">License agreement</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaNonCompeteProvision', window );">Non-compete provision</a></td>
<td class="nump">$ 50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaNonSolicitationProvision', window );">Non-solicitation provision</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaIntangibleAssetsCustomerRelationships', window );">Intangible assets-Customer relationships</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaGoodwill', window );">Goodwill</a></td>
<td class="nump">$ 3,253,160<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaAccountsPayable', window );">Accounts Payable</a></td>
<td class="num">$ (741,822)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaRoyaltyPayable', window );">Royalty payable</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaAccruedExpenses', window );">Accrued Expenses</a></td>
<td class="num">$ (2,202,848)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaOthers', window );">Others</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaTotalLiabilities', window );">Total Liabilities</a></td>
<td class="nump">$ 2,980,411<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_TprInvestmentsPtyLtdMember', window );">TPR Investments Pty Ltd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaCash', window );">Cash</a></td>
<td class="nump">1,584,642<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaAccountsReceivable', window );">Accounts Receivable</a></td>
<td class="nump">30,684<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaInventory', window );">Inventory</a></td>
<td class="nump">134,212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaPrepaidExpenses', window );">Prepaid expenses</a></td>
<td class="nump">141,070<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaFixedAssetsNet', window );">Fixed Assets, net</a></td>
<td class="nump">5,698<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaIntangibleAssetsNet', window );">Intangible assets, Net</a></td>
<td class="nump">3,493<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaBloggerDatabase', window );">Blogger Database</a></td>
<td class="nump">200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaCustomerDatabase', window );">Customer Database</a></td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaIntellectualProperty', window );">Intellectual Property</a></td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaLicenseAgreement', window );">License agreement</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaNonCompeteProvision', window );">Non-compete provision</a></td>
<td class="nump">$ 50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaNonSolicitationProvision', window );">Non-solicitation provision</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaIntangibleAssetsCustomerRelationships', window );">Intangible assets-Customer relationships</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaGoodwill', window );">Goodwill</a></td>
<td class="nump">$ 6,174,899<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaAccountsPayable', window );">Accounts Payable</a></td>
<td class="num">$ (77,064)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaRoyaltyPayable', window );">Royalty payable</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaAccruedExpenses', window );">Accrued Expenses</a></td>
<td class="num">$ (56,224)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaDividendsPayable', window );">Dividends Payable</a></td>
<td class="num">(1,177,152)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaProvisionForIncomeTax', window );">Provision for Income Tax</a></td>
<td class="num">$ (518,558)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaOthers', window );">Others</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsProFormaTotalLiabilities', window );">Total Liabilities</a></td>
<td class="nump">$ 7,095,700<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_BusinessAcquisitionsProFormaAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business acquisitions pro forma accounts payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_BusinessAcquisitionsProFormaAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_BusinessAcquisitionsProFormaAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business acquisitions Pro forma accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_BusinessAcquisitionsProFormaAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_BusinessAcquisitionsProFormaAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business acquisitions pro forma accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_BusinessAcquisitionsProFormaAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_BusinessAcquisitionsProFormaBloggerDatabase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisitions Pro Forma Blogger Database.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_BusinessAcquisitionsProFormaBloggerDatabase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_BusinessAcquisitionsProFormaCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisitions Pro Forma Cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_BusinessAcquisitionsProFormaCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_BusinessAcquisitionsProFormaCustomerDatabase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisitions Pro Forma Customer Database.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_BusinessAcquisitionsProFormaCustomerDatabase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_BusinessAcquisitionsProFormaDividendsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisitions Pro Forma Dividends Payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_BusinessAcquisitionsProFormaDividendsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_BusinessAcquisitionsProFormaFixedAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisitions Pro Forma Fixed Assets Net.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_BusinessAcquisitionsProFormaFixedAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_BusinessAcquisitionsProFormaGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business acquisitions pro forma goodwil.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_BusinessAcquisitionsProFormaGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_BusinessAcquisitionsProFormaIntangibleAssetsCustomerRelationships">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business acquisitions pro forma Intangible assets-Customer relationships.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_BusinessAcquisitionsProFormaIntangibleAssetsCustomerRelationships</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_BusinessAcquisitionsProFormaIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisitions Pro Forma Intangible Assets Net.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_BusinessAcquisitionsProFormaIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_BusinessAcquisitionsProFormaIntellectualProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business acquisitions pro forma intellectual property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_BusinessAcquisitionsProFormaIntellectualProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_BusinessAcquisitionsProFormaInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business acquisitions pro forma inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_BusinessAcquisitionsProFormaInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_BusinessAcquisitionsProFormaLicenseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisitions Pro Forma License Agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_BusinessAcquisitionsProFormaLicenseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_BusinessAcquisitionsProFormaNonCompeteProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business acquisitions pro forma non compete provision.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_BusinessAcquisitionsProFormaNonCompeteProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_BusinessAcquisitionsProFormaNonSolicitationProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business acquisitions pro forma non-solicitation provision.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_BusinessAcquisitionsProFormaNonSolicitationProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_BusinessAcquisitionsProFormaOthers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisitions Pro Forma Others.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_BusinessAcquisitionsProFormaOthers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_BusinessAcquisitionsProFormaPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisitions Pro Forma Prepaid Expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_BusinessAcquisitionsProFormaPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_BusinessAcquisitionsProFormaProvisionForIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisitions Pro Forma Provision For Income Tax.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_BusinessAcquisitionsProFormaProvisionForIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_BusinessAcquisitionsProFormaRoyaltyPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisitions Pro Forma Royalty Payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_BusinessAcquisitionsProFormaRoyaltyPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_BusinessAcquisitionsProFormaTotalLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business acquisitions pro forma total liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_BusinessAcquisitionsProFormaTotalLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_FactorNutritionLabsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_FactorNutritionLabsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_KnightTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_KnightTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_HandMDLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_HandMDLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_BreakthroughProductsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_BreakthroughProductsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_TprInvestmentsPtyLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_TprInvestmentsPtyLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6783357248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Acquisitions - Purchase Price Allocated to Acquisition of Assets (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=SNYR_FactorNutritionLabsLLCMember', window );">Factor Nutrition Labs, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationAsset', window );">Total assets acquired</a></td>
<td class="nump">$ 6,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=SNYR_FactorNutritionLabsLLCMember', window );">Factor Nutrition Labs, LLC [Member] | January 22, 2015 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionCashPayment', window );">Cash payment</a></td>
<td class="nump">4,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=SNYR_FactorNutritionLabsLLCMember', window );">Factor Nutrition Labs, LLC [Member] | January 20, 2016 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionCashPayment', window );">Cash payment</a></td>
<td class="nump">750,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=SNYR_FactorNutritionLabsLLCMember', window );">Factor Nutrition Labs, LLC [Member] | January 20, 2017 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionCashPayment', window );">Cash payment</a></td>
<td class="nump">750,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=SNYR_BreakthroughProductsIncMember', window );">Breakthrough Products, Inc [Member] | UrgentRx [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionsStockPayment', window );">Stock payment</a></td>
<td class="nump">2,550,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionStockWarrantsIssued', window );">Stock warrants issued</a></td>
<td class="nump">430,411<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationAsset', window );">Total assets acquired</a></td>
<td class="nump">2,980,411<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=SNYR_TprInvestmentsPtyLtdMember', window );">TPR Investments Pty Ltd [Member] | Nomad Choice [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionCashPayment', window );">Cash payment</a></td>
<td class="nump">2,848,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionStockIssued', window );">Stock issued</a></td>
<td class="nump">1,750,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BusinessAcquisitionEarnoutPayment', window );">Earn-out payment</a></td>
<td class="nump">2,496,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationAsset', window );">Total assets acquired</a></td>
<td class="nump">$ 7,095,700<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_BusinessAcquisitionCashPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition Cash Payment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_BusinessAcquisitionCashPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_BusinessAcquisitionEarnoutPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition Earnout Payment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_BusinessAcquisitionEarnoutPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_BusinessAcquisitionStockIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition Stock Issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_BusinessAcquisitionStockIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_BusinessAcquisitionStockWarrantsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition Stock Warrants Issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_BusinessAcquisitionStockWarrantsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_BusinessAcquisitionsStockPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>BusinessAcquisitionsStockPayment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_BusinessAcquisitionsStockPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=6911338&amp;loc=d3e6819-128478<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6411-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=SNYR_FactorNutritionLabsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=SNYR_FactorNutritionLabsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementScenarioAxis=SNYR_JanuaryTwentyTwoTwoThousandFifteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementScenarioAxis=SNYR_JanuaryTwentyTwoTwoThousandFifteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementScenarioAxis=SNYR_JanuaryTwentyTwoThousandSixteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementScenarioAxis=SNYR_JanuaryTwentyTwoThousandSixteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementScenarioAxis=SNYR_JanuaryTwentyTwoThousandSaventeenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementScenarioAxis=SNYR_JanuaryTwentyTwoThousandSaventeenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=SNYR_BreakthroughProductsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=SNYR_BreakthroughProductsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_UrgentRxMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_UrgentRxMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=SNYR_TprInvestmentsPtyLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=SNYR_TprInvestmentsPtyLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_NomadChoiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_NomadChoiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6783064496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions - Pro forma Results of Acquisition (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2013</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_BreakthroughProductsIncMember', window );">Breakthrough Products, Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Revenue</a></td>
<td class="nump">$ 2,722,288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(10,621,330)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_TprInvestmentsPtyLtdMember', window );">TPR Investments Pty Ltd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Revenue</a></td>
<td class="nump">2,494,812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">(909,280)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=SNYR_FocusFactorBusinessMember', window );">Focus Factor Business [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Revenue</a></td>
<td class="nump">12,695,295<span></span>
</td>
<td class="nump">$ 10,629,171<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (183,471)<span></span>
</td>
<td class="nump">$ 932,209<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)-(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=56956515&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)-(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=56956515&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_BreakthroughProductsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_BreakthroughProductsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_TprInvestmentsPtyLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_TprInvestmentsPtyLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=SNYR_FocusFactorBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=SNYR_FocusFactorBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6793852992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 389,945<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Percentage of deferred tax asset</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">5.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_BreakthroughProductsIncMember', window );">Breakthrough Products, Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_ValuationAllowancePercentage', window );">Valuation allowance percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,137,583<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_BreakthroughProductsIncMember', window );">Breakthrough Products, Inc [Member] | US Tax Authority [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_ValuationAllowancePercentage', window );">Valuation allowance percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,707,458<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_ValuationAllowancePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Valuation allowance percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_ValuationAllowancePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Income Tax Expense (or Benefit)<br> -URI http://asc.fasb.org/extlink&amp;oid=6515339<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_BreakthroughProductsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_BreakthroughProductsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6781916704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Effective Income Tax Rate (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">U.S. Statutory Rate</a></td>
<td class="nump">34.00%<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">U.S. effective rate in excess of AU rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">U.S. valuation allowance</a></td>
<td class="num">(34.00%)<span></span>
</td>
<td class="num">(34.00%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings', window );">Foreign Tax - Australia</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">6.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Total provision for income taxes</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">5.80%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to the repatriation of foreign earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32698-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=34349781&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6781948960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Schedule of Deferred Income Tax Assets (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Deferred tax assets</a></td>
<td class="nump">$ 11,460,536<span></span>
</td>
<td class="nump">$ 241,245<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance for deferred tax assets</a></td>
<td class="num">$ (11,460,536)<span></span>
</td>
<td class="num">$ (241,245)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred tax assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Deferred Tax Asset<br> -URI http://asc.fasb.org/extlink&amp;oid=6510090<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6786170368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accounts Receivable (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Bad debt expense</a></td>
<td class="num">$ (121,291)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an unclassified balance sheet, a valuation allowance for receivables due a company that are expected to be uncollectible.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=49124121&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6782204096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accounts Receivable - Accounts Receivable, Net of Allowances (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableGross', window );">Trade accounts receivable</a></td>
<td class="nump">$ 4,101,148<span></span>
</td>
<td class="nump">$ 2,898<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Less allowances</a></td>
<td class="num">(121,291)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Total accounts receivable, net</a></td>
<td class="nump">$ 3,979,857<span></span>
</td>
<td class="nump">$ 2,898<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For unclassified balance sheet, amounts due from customers or clients for goods or services that have been delivered or sold in the normal course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 3<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an unclassified balance sheet, the amount due from customers or clients for goods or services that have been delivered or sold in the normal course of business, reduced to their estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.5)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 3<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an unclassified balance sheet, a valuation allowance for receivables due a company that are expected to be uncollectible.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=49124121&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6783053184">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Prepaid Expenses - Summary of Prepaid Expenses (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsAbstract', window );"><strong>Prepaid Expense and Other Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_PrepaidExpensesAdvancesForInventory', window );">Advances for inventory</a></td>
<td class="nump">$ 171,494<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_PrepaidExpencesMediaProduction', window );">Media production</a></td>
<td class="nump">55,849<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidInsurance', window );">Insurance</a></td>
<td class="nump">54,519<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidAdvertising', window );">Trade shows</a></td>
<td class="nump">45,700<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_PrepaidExpensesDeposits', window );">Deposits</a></td>
<td class="nump">41,228<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Supplies', window );">Consultants</a></td>
<td class="nump">24,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidRent', window );">Rent</a></td>
<td class="nump">16,216<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsMiscellaneousCurrent', window );">Miscellaneous</a></td>
<td class="nump">13,428<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrentAndNoncurrent', window );">Total</a></td>
<td class="nump">$ 422,434<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_PrepaidExpencesMediaProduction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid Expences Media Production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_PrepaidExpencesMediaProduction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_PrepaidExpensesAdvancesForInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid Expenses Advances For Inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_PrepaidExpensesAdvancesForInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_PrepaidExpensesDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid Expenses Deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_PrepaidExpensesDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsMiscellaneousCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other miscellaneous assets expected to be realized or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsMiscellaneousCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidAdvertising">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration paid in advance for advertising that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(6)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=51662920&amp;loc=d3e8275-108329<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=51662447&amp;loc=d3e5865-108316<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6787-107765<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Assets<br> -URI http://asc.fasb.org/extlink&amp;oid=6509628<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=51662447&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidAdvertising</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of expenditures made in advance of when the economic benefit of the cost will be realized, and which will be expensed in future periods with the passage of time or when a triggering event occurs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6787-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=51662447&amp;loc=d3e5865-108316<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=51662447&amp;loc=d3e5879-108316<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Assets<br> -URI http://asc.fasb.org/extlink&amp;oid=6509628<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for rent that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=51662447&amp;loc=d3e5865-108316<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6787-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=51662447&amp;loc=d3e5879-108316<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Assets<br> -URI http://asc.fasb.org/extlink&amp;oid=6509628<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Supplies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration paid in advance for supplies that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6787-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Supplies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6782340864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Concentration of Credit Risk (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2015 </div>
<div>USD ($) </div>
<div>Customer</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFDICInsuredAmount', window );">Cash frderally insured limit per bank | $</a></td>
<td class="nump">$ 250,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashUninsuredAmount', window );">Cash uninsured amount | $</a></td>
<td class="nump">$ 3,453,290<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Accounts Receivable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">78.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_NumberOfCustomerAccountedForAccountsReceivable', window );">Number of customer accounted for accounts receivable | Customer</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member] | Sales Revenue, Net [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">71.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_NumberOfCustomerAccountedForAccountsReceivable', window );">Number of customer accounted for accounts receivable | Customer</a></td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_NumberOfCustomerAccountedForAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of customer accounted for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_NumberOfCustomerAccountedForAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFDICInsuredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFDICInsuredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashUninsuredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashUninsuredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=51801978&amp;loc=d3e6351-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13531-108611<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=51801978&amp;loc=d3e6404-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13537-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6783274864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Concentration of Credit Risk - Summary of Major Suppliers (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2015</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_SuppliersOneMember', window );">Suppliers One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_NameOfProduct', window );">Name of the Product</a></td>
<td class="text">FOCUSfactor<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_AddressOfSuppliers', window );">Address of the suppliers</a></td>
<td class="text">Pittsburgh, PA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_CityOfSuppliers', window );">City of suppliers</a></td>
<td class="text">Tustin, CA<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_SuppliersTwoMember', window );">Suppliers Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_NameOfProduct', window );">Name of the Product</a></td>
<td class="text">Flat Tummy Tea<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_AddressOfSuppliers', window );">Address of the suppliers</a></td>
<td class="text">Highland, NY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_CityOfSuppliers', window );">City of suppliers</a></td>
<td class="text">-<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_SuppliersThreeMember', window );">Suppliers Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_NameOfProduct', window );">Name of the Product</a></td>
<td class="text">Neuragen<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_AddressOfSuppliers', window );">Address of the suppliers</a></td>
<td class="text">Linthicum Heights, MD<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_CityOfSuppliers', window );">City of suppliers</a></td>
<td class="text">-<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_SuppliersFourMember', window );">Suppliers Four [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_NameOfProduct', window );">Name of the Product</a></td>
<td class="text">UrgentRx<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_AddressOfSuppliers', window );">Address of the suppliers</a></td>
<td class="text">Ogden, UT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_CityOfSuppliers', window );">City of suppliers</a></td>
<td class="text">-<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_AddressOfSuppliers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address of the suppliers .</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_AddressOfSuppliers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_CityOfSuppliers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>City of suppliers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_CityOfSuppliers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_NameOfProduct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Product.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_NameOfProduct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_SuppliersOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_SuppliersOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_SuppliersTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_SuppliersTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_SuppliersThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_SuppliersThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_SuppliersFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_SuppliersFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6781775952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventory - Schedule of Carrying Value of Inventory (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">$ 535,908<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_InventoryComponents', window );">Components</a></td>
<td class="nump">115,340<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw Materials</a></td>
<td class="nump">$ 35,406<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_InventoryEnergyProduct', window );">Energy product</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 26,064<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventory</a></td>
<td class="nump">$ 686,655<span></span>
</td>
<td class="nump">$ 26,064<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_InventoryComponents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Inventory components.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_InventoryComponents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_InventoryEnergyProduct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Inventory energy product.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_InventoryEnergyProduct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=51655945&amp;loc=d3e3927-108312<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 5<br> -Section BB<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6782359264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fixed Assets and Intangible Assets (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expenes</a></td>
<td class="nump">$ 1,513<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization expense</a></td>
<td class="nump">$ 606,489<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6793853184">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fixed Assets and Intangible Assets - Summary of Fixed and Intangible Assets (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment</a></td>
<td class="nump">$ 18,187<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation</a></td>
<td class="num">(6,170)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Fixed assets, net</a></td>
<td class="nump">12,017<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_IntellectualProperty', window );">FOCUSfactor intellectual property</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible assets subject to amortization</a></td>
<td class="nump">5,521,751<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less accumulated amortization</a></td>
<td class="num">(606,489)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="nump">$ 5,915,262<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_IntellectualProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intellectual property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_IntellectualProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 13<br> -Subparagraph a<br> -Article 5<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 03<br> -Paragraph 8<br> -Article 7<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6783335776">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fixed Assets and Intangible Assets - Summary of Estimated Aggregate Amortization Expense (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2016</a></td>
<td class="nump">$ 1,111,229<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2017</a></td>
<td class="nump">1,111,229<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2018</a></td>
<td class="nump">1,109,070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2019</a></td>
<td class="nump">1,094,329<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2020</a></td>
<td class="nump">$ 489,405<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=26713463&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6783860624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 02, 2014</div></th>
<th class="th"><div>Apr. 02, 2014</div></th>
<th class="th"><div>Oct. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Nov. 12, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,500,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Promissory note converted into number of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_AccruedConsultingFeesPerMonth', window );">Accrued consulting fees per month</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 180,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_BonusPaid', window );">Bonus paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">486,958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_OutstandingBalanceOfConsultingFees', window );">Outstanding balance of consulting fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueFromRelatedPartiesCurrent', window );">Due from related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,077<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent', window );">Due to related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,162,060<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Payroll expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 128,237<span></span>
</td>
<td class="nump">$ 10,867<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=SNYR_HandMDLLCMember', window );">Hand MD LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Percentage of ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Payroll expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_KnightTherapeuticsIncMember', window );">Knight Therapeutics Inc [Member] | Loan Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueFromRelatedParties', window );">Amount owed to related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,267,268<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,571,314<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_KnightTherapeuticsIncMember', window );">Knight Therapeutics Inc [Member] | Security Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueFromRelatedParties', window );">Amount owed to related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">925,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_KnightTherapeuticsIncMember', window );">Knight Therapeutics Inc [Member] | Royalty Distribution Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueFromRelatedParties', window );">Amount owed to related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=us-gaap_ChiefExecutiveOfficerMember', window );">Mr. Jack Ross [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options Outstanding, Granted</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation', window );">Value of granted options</a></td>
<td class="nump">$ 282,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instruments interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instruments maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Oct. 31,  2015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_AccruedConsultingFeesPerMonth', window );">Accrued consulting fees per month</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=SNYR_MsHarshbargerMember', window );">Ms. Harshbarger [Member] | Consulting Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent', window );">Due to related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_AccruedConsultingFeesPerMonth">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Consulting Fees Per Month.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_AccruedConsultingFeesPerMonth</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_BonusPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Bonus paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_BonusPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_OutstandingBalanceOfConsultingFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Outstanding balance of consulting fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_OutstandingBalanceOfConsultingFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an unclassified balance sheet, amounts due from related parties including affiliates, employees, joint ventures, officers and stockholders, immediate families thereof, and pension funds.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueFromRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 08<br> -Paragraph k<br> -Subparagraph 2<br> -Article 4<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueFromRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(3),(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeitures, of stock or other type of equity granted of any equity-based compensation plan other than an employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 30<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=51830203&amp;loc=d3e3913-113898<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6418191&amp;loc=d3e15009-113911<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=SNYR_HandMDLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=SNYR_HandMDLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_KnightTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_KnightTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SNYR_LoanAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SNYR_LoanAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SNYR_SecurityAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SNYR_SecurityAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SNYR_RoyaltyDistributionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SNYR_RoyaltyDistributionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=us-gaap_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=us-gaap_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=SNYR_MsHarshbargerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=SNYR_MsHarshbargerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SNYR_ConsultingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SNYR_ConsultingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6782053712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Payroll</a></td>
<td class="nump">$ 128,237<span></span>
</td>
<td class="nump">$ 10,867<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Legal fees</a></td>
<td class="nump">38,752<span></span>
</td>
<td class="nump">$ 10,867<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_ManufacturersLiabilitiesCurrent', window );">Manufacturers</a></td>
<td class="nump">1,527,333<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_PromotionsLiabilitiesCurrent', window );">Promotions</a></td>
<td class="nump">1,213,021<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_ReturnsAllowanceAccruedLiabilities', window );">Returns allowance</a></td>
<td class="nump">1,128,133<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_CustomersAccruedLiabilities', window );">Customers</a></td>
<td class="nump">411,033<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_InterestAccruedLiabilities', window );">Interest</a></td>
<td class="nump">110,754<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_RoyaltiesAccruedLiabilities', window );">Royalties</a></td>
<td class="nump">71,573<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_WarehousingAccruedLiabilities', window );">Warehousing</a></td>
<td class="nump">31,748<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccountsPayableAndAccruedLiabilities', window );">Other</a></td>
<td class="nump">371,518<span></span>
</td>
<td class="nump">$ 15,859<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">$ 5,032,102<span></span>
</td>
<td class="nump">$ 74,642<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_CustomersAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Customers Accrued Liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_CustomersAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_InterestAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest Accrued Liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_InterestAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_ManufacturersLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Manufactures liabilities current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_ManufacturersLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_PromotionsLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Promotions liabilities current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_PromotionsLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_ReturnsAllowanceAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Returns Allowance Accrued Liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_ReturnsAllowanceAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_RoyaltiesAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Royalties Accrued Liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_RoyaltiesAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_WarehousingAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warehousing Accrued Liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_WarehousingAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(1),(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Current Liabilities<br> -URI http://asc.fasb.org/extlink&amp;oid=6509677<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6935-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations, including trade payables, incurred through that date and due within one year (or in the operating cycle if longer) arising from transactions not otherwise specified in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6797352000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes Payable (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 12, 2015</div></th>
<th class="th"><div>Jun. 26, 2015</div></th>
<th class="th"><div>Jan. 22, 2015</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansPayable', window );">Amount of loan obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,870,170<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Common stock price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td>
<td class="nump">$ 2,067,258<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,499,640<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,536,419)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(958,740)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Note payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Fair value of derivative liability</a></td>
<td class="nump">2,067,258<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,096,179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=SNYR_STWarrantMember', window );">StWarrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Common stock price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SNYR_LoanAgreementMember', window );">Loan Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Common stock price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SNYR_AssetPurchaseAgreementMember', window );">Asset Purchase Agreement [Member] | January 22, 2015 Loan Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument interest rate percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesIssued1', window );">Note issued as part of asset purchase agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Note maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jan. 20,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Note payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SNYR_AssetPurchaseAgreementMember', window );">Asset Purchase Agreement [Member] | January 22, 2015 Loan Two [Member] | January 20, 2016 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Note payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SNYR_AssetPurchaseAgreementMember', window );">Asset Purchase Agreement [Member] | January 22, 2015 Loan Two [Member] | January 20, 2017 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Note payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SNYR_SecurityAgreementMember', window );">Security Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Recognized amortization of deferred financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">925,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SNYR_SecurityAgreementMember', window );">Security Agreement [Member] | June 26, 2015 Security Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,486<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Recognized amortization of deferred financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,643<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SNYR_SecurityAgreementMember', window );">Security Agreement [Member] | June 26, 2015 Security Agreement [Member] | U.S [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_PercentageOfSaleRevenueNet', window );">Percentage of sale revenue net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SNYR_SecurityAgreementMember', window );">Security Agreement [Member] | June 26, 2015 Security Agreement [Member] | Quarter Ending September 30, 2015 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Note payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SNYR_SecurityAgreementMember', window );">Security Agreement [Member] | June 26, 2015 Security Agreement [Member] | June 30, 2016 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Note payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SNYR_SecurityAgreementMember', window );">Security Agreement [Member] | June 26, 2015 Security Agreement [Member] | June 30, 2016 [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Note payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=SNYR_KnightTherapeuticsIncMember', window );">Knight Therapeutics Inc [Member] | Loan Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Loan amount</a></td>
<td class="nump">5,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtIssuanceCosts', window );">Expences associated with loan</a></td>
<td class="nump">$ 24,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument interest rate percentage</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent', window );">Convertible equity offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateIncreaseDecrease', window );">Change in loan interest rate</a></td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net income (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansPayable', window );">Amount of loan obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,875,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Number of warrants to purchase common stock</a></td>
<td class="nump">5,550,625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Common stock price per share</a></td>
<td class="nump">$ 0.49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_PercentageOfSharesPurchaseableUnderWarrants', window );">Percentage of shares purchaseable under warrants</a></td>
<td class="nump">6.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">289,045<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Recognized amortization of deferred financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136,207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">805,686<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositLiabilitiesAccruedInterest', window );">Accrued interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Note maturity date</a></td>
<td class="text">Nov. 11,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=SNYR_KnightTherapeuticsIncMember', window );">Knight Therapeutics Inc [Member] | Loan Agreement [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Number of warrants to purchase common stock</a></td>
<td class="nump">4,547,243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=SNYR_KnightTherapeuticsIncMember', window );">Knight Therapeutics Inc [Member] | Loan Agreement [Member] | StWarrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Number of warrants to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,595,187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature', window );">Beneficial conversion feature of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,952,953<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,952,953<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">607,732<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=SNYR_KnightTherapeuticsIncMember', window );">Knight Therapeutics Inc [Member] | Loan Agreement [Member] | LT Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Number of warrants to purchase common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,584,759<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrants exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Common stock price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_PercentageOfSharesPurchaseableUnderWarrants', window );">Percentage of shares purchaseable under warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature', window );">Beneficial conversion feature of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,462,560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">854,828<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 607,732<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=SNYR_KnightTherapeuticsIncMember', window );">Knight Therapeutics Inc [Member] | Loan Agreement [Member] | January 22, 2015 Loan One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument interest rate percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansPayable', window );">Amount of loan obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Aggregate consideration to be paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Capital expenditures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=SNYR_KnightTherapeuticsIncMember', window );">Knight Therapeutics Inc [Member] | Loan Agreement [Member] | Knight Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature', window );">Beneficial conversion feature of warrants</a></td>
<td class="nump">$ 2,553,287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding</a></td>
<td class="nump">5,550,625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,550,625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,553,287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,928,686<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">233,847<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Recognized amortization of deferred financing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,675<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,753<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositLiabilitiesAccruedInterest', window );">Accrued interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110,753<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Fair value of derivative liability</a></td>
<td class="nump">$ 4,547,243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=SNYR_KnightTherapeuticsIncMember', window );">Knight Therapeutics Inc [Member] | Loan Agreement [Member] | Knight Warrants One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature', window );">Beneficial conversion feature of warrants</a></td>
<td class="nump">$ 2,067,258<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding</a></td>
<td class="nump">4,547,243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,547,243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 138,571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,928,686<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositLiabilitiesAccruedInterest', window );">Accrued interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=SNYR_KnightTherapeuticsIncMember', window );">Knight Therapeutics Inc [Member] | Loan Agreement [Member] | Origination Fee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtIssuanceCosts', window );">Expences associated with loan</a></td>
<td class="nump">$ 110,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=SNYR_KnightTherapeuticsIncMember', window );">Knight Therapeutics Inc [Member] | Loan Agreement [Member] | Work Fee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtIssuanceCosts', window );">Expences associated with loan</a></td>
<td class="nump">$ 55,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=SNYR_NeuragenCorpMember', window );">Neuragen Corp [Member] | Security Agreement [Member] | June 26, 2015 Security Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument interest rate percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesIssued1', window );">Note issued as part of asset purchase agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 950,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Total payments of acquire assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=SNYR_NeuragenCorpMember', window );">Neuragen Corp [Member] | Security Agreement [Member] | June 26, 2015 Security Agreement [Member] | U.S [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_PercentageOfSaleRevenueNet', window );">Percentage of sale revenue net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_PercentageOfSaleRevenueNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of sale revenue net.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_PercentageOfSaleRevenueNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_PercentageOfSharesPurchaseableUnderWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of shares purchaseable under warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_PercentageOfSharesPurchaseableUnderWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28541-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to issue debt and obtain financing associated with the related debt instruments. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 04<br> -Paragraph 8<br> -Article 9<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)-(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=56956515&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)-(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=56956515&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4313-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4313-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of a favorable spread to a debt holder between the amount of debt being converted and the value of the securities received upon conversion. This is an embedded conversion feature of convertible debt issued that is in-the-money at the commitment date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21538-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Beneficial Conversion Feature<br> -URI http://asc.fasb.org/extlink&amp;oid=6505963<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6928298&amp;loc=SL6031897-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Incremental percentage increase (decrease) in the stated rate on a debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of debt discount that was originally recognized at the issuance of the instrument that has yet to be amortized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28541-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=34725769&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of debt issuance costs (for example, but not limited to, legal, accounting, broker, and regulatory fees).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an unclassified balance sheet, the carrying amount (net of accumulated amortization) as of the balance sheet date of capitalized costs associated with the issuance of debt instruments (for example, legal, accounting, underwriting, printing, and registration costs) that will be charged against earnings over the life of the debt instruments to which such costs pertain.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28555-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositLiabilitiesAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accrued but unpaid interest on deposit liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositLiabilitiesAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=51825145&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13495-108611<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13433-108611<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41271-113958<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41228-113958<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 225<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879574&amp;loc=d3e536633-122882<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 19, 20, 22<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of notes issued in noncash investing and financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 03<br> -Paragraph 13, 16<br> -Article 9<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 19, 20, 22<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=SNYR_STWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=SNYR_STWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SNYR_LoanAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SNYR_LoanAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SNYR_AssetPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SNYR_AssetPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=SNYR_JanuaryTwentyTwoTwoThousandFifteenLoanTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=SNYR_JanuaryTwentyTwoTwoThousandFifteenLoanTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementScenarioAxis=SNYR_JanuaryTwentyTwoThousandSixteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementScenarioAxis=SNYR_JanuaryTwentyTwoThousandSixteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementScenarioAxis=SNYR_JanuaryTwentyTwoThousandSaventeenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementScenarioAxis=SNYR_JanuaryTwentyTwoThousandSaventeenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SNYR_SecurityAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SNYR_SecurityAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=SNYR_JuneTwentySixTwoThousandFifteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=SNYR_JuneTwentySixTwoThousandFifteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementGeographicalAxis=SNYR_USMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementGeographicalAxis=SNYR_USMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementScenarioAxis=SNYR_QuarterEndingSeptemberThirtyTwoThousandSaventeenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementScenarioAxis=SNYR_QuarterEndingSeptemberThirtyTwoThousandSaventeenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementScenarioAxis=SNYR_JuneThirtyTwoThousandSixteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementScenarioAxis=SNYR_JuneThirtyTwoThousandSixteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=SNYR_KnightTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=SNYR_KnightTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=SNYR_LTWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=SNYR_LTWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=SNYR_JanuaryTwentyTwoThousandFifteenLoanOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=SNYR_JanuaryTwentyTwoThousandFifteenLoanOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=SNYR_KnightWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=SNYR_KnightWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=SNYR_KnightWarrantsOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=SNYR_KnightWarrantsOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfExpenseAxis=SNYR_OriginationFeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfExpenseAxis=SNYR_OriginationFeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfExpenseAxis=SNYR_WorkFeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfExpenseAxis=SNYR_WorkFeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=SNYR_NeuragenCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=SNYR_NeuragenCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6779209600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Notes Payable - Schedule of Loan Payable (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_LoansPayableGross', window );">Loans payable</a></td>
<td class="nump">$ 12,406,589<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized debt discount</a></td>
<td class="num">(2,536,419)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansPayable', window );">Total</a></td>
<td class="nump">9,870,170<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansPayableCurrent', window );">Less: Current portion</a></td>
<td class="num">(3,912,060)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermLoansPayable', window );">Long-term portion</a></td>
<td class="nump">$ 5,958,110<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_LoansPayableGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loans Payable Gross.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_LoansPayableGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of debt discount that was originally recognized at the issuance of the instrument that has yet to be amortized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28541-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=34725769&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 19, 20, 22<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermLoansPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermLoansPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6798879520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Deficit (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Nov. 12, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">300,000,000<span></span>
</td>
<td class="nump">75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Forward stock split</a></td>
<td class="text">30 for 1 forward stock split <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">81,692,954<span></span>
</td>
<td class="nump">62,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Common stock purchase price per share</a></td>
<td class="nump">$ 0.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock value</a></td>
<td class="nump">$ 817<span></span>
</td>
<td class="nump">$ 621<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Common stock issued for cash shares</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Number of shares cancelled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_PrestockSplitShares', window );">Pre-Stock Split shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,530,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockHeldInTrust', window );">Value of stock held for future issuance</a></td>
<td class="nump">$ 28,000<span></span>
</td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">81,692,954<span></span>
</td>
<td class="nump">62,100,000<span></span>
</td>
<td class="nump">4,547,243<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfExpenseAxis=us-gaap_AccountsPayableMember', window );">Accounts Payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Common stock purchase price per share</a></td>
<td class="nump">$ 0.70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Common stock issued for cash shares</a></td>
<td class="nump">292,857<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_NoteHolderMember', window );">Note Holder [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Common stock purchase price per share</a></td>
<td class="nump">$ 0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock value</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SNYR_LoanAgreementMember', window );">Loan Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">5,550,625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Common stock purchase price per share</a></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SNYR_ContributionAgreementMember', window );">Contribution Agreement [Member] | Hand Md Corp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">2,142,857<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Common stock purchase price per share</a></td>
<td class="nump">$ 0.70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_PercentageOfOutstandingCapital', window );">Percentage of outstanding capital</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SNYR_StockPurchaseAgreementMember', window );">Stock Purchase Agreement [Member] | Nomad Choice [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">3,571,428<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Common stock purchase price per share</a></td>
<td class="nump">$ 0.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_PercentageOfOutstandingCapital', window );">Percentage of outstanding capital</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SNYR_StockPurchaseAgreementMember', window );">Stock Purchase Agreement [Member] | Breakthrough Products, Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Common stock purchase price per share</a></td>
<td class="nump">$ 0.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_PercentageOfOutstandingCapital', window );">Percentage of outstanding capital</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SNYR_MergerAgreementMember', window );">Merger Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=SNYR_STWarrantMember', window );">ST Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">4,595,187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Common stock purchase price per share</a></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=us-gaap_BoardOfDirectorsChairmanMember', window );">Board of Directors [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=us-gaap_BoardOfDirectorsChairmanMember', window );">Board of Directors [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=us-gaap_InvestorMember', window );">Investor [Member] | Stock Purchase Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Common stock purchase price per share</a></td>
<td class="nump">$ 0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock value</a></td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_PercentageOfOutstandingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of outstanding capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_PercentageOfOutstandingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_PrestockSplitShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Pre-Stock Split shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_PrestockSplitShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockHeldInTrust">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of common stock held in trust.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockHeldInTrust</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB TOPIC 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 4<br> -Section C<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfExpenseAxis=us-gaap_AccountsPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfExpenseAxis=us-gaap_AccountsPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_NoteHolderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_NoteHolderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SNYR_LoanAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SNYR_LoanAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SNYR_ContributionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SNYR_ContributionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=SNYR_HandMDCorpMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=SNYR_HandMDCorpMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SNYR_StockPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SNYR_StockPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=SNYR_NomadChoiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=SNYR_NomadChoiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=SNYR_BreakthroughProductsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=SNYR_BreakthroughProductsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SNYR_MergerAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SNYR_MergerAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=SNYR_STWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=SNYR_STWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=us-gaap_BoardOfDirectorsChairmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=us-gaap_BoardOfDirectorsChairmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=us-gaap_InvestorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=us-gaap_InvestorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6796089712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 08, 2014 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2014 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>AUD</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsExpirationDate', window );">Operating lease expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Mar. 31,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Rent expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleLeasebackTransactionRentExpense', window );">Sublease rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,010<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_SubsidiaryMember', window );">Subsidiary [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Rent expense</a></td>
<td class="nump">$ 894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementScenarioAxis=SNYR_NovemberTwoThousandSixteenMember', window );">November 2016 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Rent expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementScenarioAxis=SNYR_NovemberTwoThousandSixteenMember', window );">November 2016 [Member] | AUD [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Rent expense | AUD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">AUD 5,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementScenarioAxis=SNYR_DecemberTwoThousandSixteenMember', window );">December 2016 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Rent expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementScenarioAxis=SNYR_DecemberTwoThousandSixteenMember', window );">December 2016 [Member] | AUD [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Rent expense | AUD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">AUD 5,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41499-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiration date of each operating loss carryforward included in operating loss carryforward, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6907707&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleLeasebackTransactionRentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the current period expense recorded for use of the property in connection with the transaction involving the sale of property to another party and the lease of the property back to the seller.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41499-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleLeasebackTransactionRentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_SubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_SubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementScenarioAxis=SNYR_NovemberTwoThousandSixteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementScenarioAxis=SNYR_NovemberTwoThousandSixteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrencyAxis=SNYR_AustralianDollerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrencyAxis=SNYR_AustralianDollerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementScenarioAxis=SNYR_DecemberTwoThousandSixteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementScenarioAxis=SNYR_DecemberTwoThousandSixteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6781817680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Schedule of Future Minimum Rental Payments For Operating Leases (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent', window );">2016</a></td>
<td class="nump">$ 220,676<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">2017</a></td>
<td class="nump">27,294<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Total</a></td>
<td class="nump">247,970<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_SubsidiaryMember', window );">Subsidiary [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent', window );">2016</a></td>
<td class="nump">10,728<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">2017</a></td>
<td class="nump">9,834<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Total</a></td>
<td class="nump">$ 20,562<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6584154&amp;loc=d3e38371-112697<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6453985&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_SubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=SNYR_SubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6797455344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Options (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 14, 2015</div></th>
<th class="th"><div>Nov. 12, 2015</div></th>
<th class="th"><div>Apr. 02, 2014</div></th>
<th class="th"><div>Apr. 02, 2014</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Jul. 30, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 523,714<span></span>
</td>
<td class="nump">$ 282,247<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExercisePrice', window );">Estimated fair value of Company's common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.74<span></span>
</td>
<td class="nump">$ 0.33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.32%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.27%<span></span>
</td>
<td class="nump">1.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExpectedVolatilityRate', window );">Volatility rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">154.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15207.00%<span></span>
</td>
<td class="nump">125.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExpectedTerm', window );">Expected lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding', window );">Stock options outstanding intrinsic value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=us-gaap_ChiefExecutiveOfficerMember', window );">Mr. Jack Ross [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options Outstanding, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Stock options exercise price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=SNYR_TwoBoardMembersMember', window );">Two Board Members [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options Outstanding, Granted</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Stock options exercise price per share</a></td>
<td class="nump">$ 0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TitleOfIndividualAxis=SNYR_TwoEmployeeMembersMember', window );">Two Employees Members [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options Outstanding, Granted</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Stock options exercise price per share</a></td>
<td class="nump">$ 0.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SNYR_EquityIncentivePlanTwoThousandsAndFourteenMember', window );">Equity Incentive Plan 2014 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock shares reserved for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,525,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Staff Accounting Bulletin (SAB)<br> -Number Topic 14<br> -Section F<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Agreed upon price for the exchange of the underlying asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssumptionsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected dividends to be paid to holders of the underlying shares or financial instruments (expressed as a percentage of the share or instrument's price).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsExpectedTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period the instrument, asset or liability is expected to be outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssumptionsExpectedTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Measure of dispersion, in percentage terms (for instance, the standard deviation or variance), for a given stock price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Risk-free interest rate assumption used in valuing an instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of equity-based compensation awards outstanding. Excludes stock and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=us-gaap_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=us-gaap_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=SNYR_TwoBoardMembersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=SNYR_TwoBoardMembersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TitleOfIndividualAxis=SNYR_TwoEmployeeMembersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TitleOfIndividualAxis=SNYR_TwoEmployeeMembersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SNYR_EquityIncentivePlanTwoThousandsAndFourteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SNYR_EquityIncentivePlanTwoThousandsAndFourteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6782310320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Options - Summary of Options Outstanding by Price Range (Details) - Stock Option Plan [Member]<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2015 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Options Outstanding, Number Outstanding | shares</a></td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Options Outstanding, Remaining Average Contractual Life</a></td>
<td class="text">8 years 7 months 13 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Options Outstanding, Weighted Average Exercise Price</a></td>
<td class="nump">$ 0.41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Options Exercisable, Number Exercisable | shares</a></td>
<td class="nump">3,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Options Exercisable, Weighted Average Exercise Price</a></td>
<td class="nump">$ 0.25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SNYR_StockOptionPlanMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Options Outstanding, exercise price</a></td>
<td class="nump">0.25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=SNYR_StockOptionPlanMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Options Outstanding, exercise price</a></td>
<td class="nump">$ 65<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SNYR_StockOptionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SNYR_StockOptionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6781695824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Options - Summary of Stock Options Activity (Details) - Stock Option Plan [Member]<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2015 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options Outstanding, Outstanding at Beginning balance | shares</a></td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options Outstanding, Granted | shares</a></td>
<td class="nump">4,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options Outstanding, Exercised | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Options Outstanding, Expired or canceled | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options Outstanding, Outstanding at Ending balance | shares</a></td>
<td class="nump">5,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Outstanding at Beginning balance | $ / shares</a></td>
<td class="nump">$ 0.25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Granted | $ / shares</a></td>
<td class="nump">$ 0.45<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercised | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Expired or canceled | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Outstanding at Ending balance | $ / shares</a></td>
<td class="nump">$ 0.41<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.28,29)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 02<br> -Paragraph 29, 30<br> -Article 5<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=SNYR_StockOptionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=SNYR_StockOptionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6782807120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Warrants - Summary of Warrants Outstanding by Price Range (Details) - Warrant [Member]<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2015 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=us-gaap_WarrantMember', window );">Exercise Price Range One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Warrants Outstanding, exercise prices</a></td>
<td class="nump">$ 0.34<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Warrants Outstanding, Number Outstanding | shares</a></td>
<td class="nump">3,584,759<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Warrants Outstanding, Remaining Average Contractual Life</a></td>
<td class="text">9 years 1 month 6 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Warrants Outstanding, Weighted Average Exercise Price</a></td>
<td class="nump">$ 0.34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Warrants Exercisable, Number Exercisable | shares</a></td>
<td class="nump">3,584,759<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Warrants Exercisable, Weighted Average Exercise Price</a></td>
<td class="nump">$ 0.34<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=us-gaap_WarrantMember', window );">Exercise Price Range Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Warrants Outstanding, exercise prices</a></td>
<td class="nump">$ 0.49<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Warrants Outstanding, Number Outstanding | shares</a></td>
<td class="nump">4,547,243<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Warrants Outstanding, Remaining Average Contractual Life</a></td>
<td class="text">9 years 10 months 24 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Warrants Outstanding, Weighted Average Exercise Price</a></td>
<td class="nump">$ 0.49<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Warrants Exercisable, Number Exercisable | shares</a></td>
<td class="nump">4,547,243<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Warrants Exercisable, Weighted Average Exercise Price</a></td>
<td class="nump">$ 0.49<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=us-gaap_WarrantMember', window );">Exercise Price Range Three [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Warrants Outstanding, exercise prices</a></td>
<td class="nump">$ 5.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Warrants Outstanding, Number Outstanding | shares</a></td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Warrants Outstanding, Remaining Average Contractual Life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1', window );">Warrants Outstanding, Weighted Average Exercise Price</a></td>
<td class="nump">$ 5.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Warrants Exercisable, Number Exercisable | shares</a></td>
<td class="nump">1,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1', window );">Warrants Exercisable, Weighted Average Exercise Price</a></td>
<td class="nump">$ 5.00<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=SNYR_ExercisePriceRangeOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=SNYR_ExercisePriceRangeOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=SNYR_ExercisePriceRangeTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=SNYR_ExercisePriceRangeTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=SNYR_ExercisePriceRangeThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=SNYR_ExercisePriceRangeThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6785183904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Warrants - Summary of Stock Warrants Activity (Details) - Warrant [Member]<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2015 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Warrants Outstanding, Beginning balance | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Warrants, Granted | shares</a></td>
<td class="nump">19,277,814<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Warrants, Exercised | shares</a></td>
<td class="num">(10,145,812)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Warrants, Expired or canceled | shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Warrants Outstanding, Ending balance | shares</a></td>
<td class="nump">9,132,002<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePriceEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Warrants Outstanding, Weighted Average Exercise Price, Beginning balance | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Granted | $ / shares</a></td>
<td class="nump">$ 0.44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_ShareBasedCompensationArrangementsByShareBasedPaymentAwardWarrantsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Exercised | $ / shares</a></td>
<td class="nump">$ 0.00000020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Expired or canceled | $ / shares</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePriceEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Warrants Outstanding, Weighted Average Exercise Price, Ending balance | $ / shares</a></td>
<td class="nump">$ 0.92<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Exercise Price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Exercise Price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePriceEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award Warrants Outstanding Weighted Average Exercise Price Equity Instruments Other Than Options Nonvested Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_ShareBasedCompensationArrangementByShareBasedPaymentAwardWarrantsOutstandingWeightedAverageExercisePriceEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_SNYR_ShareBasedCompensationArrangementsByShareBasedPaymentAwardWarrantsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangements By Share Based Payment Award Warrants Exercises In Period Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">SNYR_ShareBasedCompensationArrangementsByShareBasedPaymentAwardWarrantsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>SNYR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6783332992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 12, 2015</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Fair value of derivative liability</a></td>
<td class="nump">$ 2,067,258<span></span>
</td>
<td class="nump">$ 3,096,179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td>
<td class="nump">$ 2,067,258<span></span>
</td>
<td class="nump">5,499,640<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Fair value of derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,028,921<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=56944662&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=6451184&amp;loc=d3e28541-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=51825145&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13495-108611<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13433-108611<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41271-113958<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6945355&amp;loc=d3e41228-113958<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6781948960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives - Schedule of Assumptions Used For Fair Value of Derivative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 12, 2015</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">2.32%<span></span>
</td>
<td class="nump">2.27%<span></span>
</td>
<td class="nump">1.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExpectedTerm', window );">Expected remaining term</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years 6 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">154.00%<span></span>
</td>
<td class="nump">15207.00%<span></span>
</td>
<td class="nump">125.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected dividends to be paid to holders of the underlying shares or financial instruments (expressed as a percentage of the share or instrument's price).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsExpectedTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period the instrument, asset or liability is expected to be outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssumptionsExpectedTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Measure of dispersion, in percentage terms (for instance, the standard deviation or variance), for a given stock price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Risk-free interest rate assumption used in valuing an instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=36462937&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6781684496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments - Summary of Net Sales Attributed to Customers Geographical Segment (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 13,456,377<span></span>
</td>
<td class="nump">$ 9,158<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementGeographicalAxis=SNYR_UnitedStatesMember', window );">United States [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">13,129,753<span></span>
</td>
<td class="nump">$ 9,158<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementGeographicalAxis=SNYR_ForeignCountriesMember', window );">Foreign Countries [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 326,624<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementGeographicalAxis=SNYR_UnitedStatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementGeographicalAxis=SNYR_UnitedStatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementGeographicalAxis=SNYR_ForeignCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementGeographicalAxis=SNYR_ForeignCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6781614624">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Segments - Summary of Net Sales Attributed to Customers Product Group (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 13,456,377<span></span>
</td>
<td class="nump">$ 9,158<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SNYR_FocusFactorBusinessMember', window );">Focus Factor Business [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,482,367<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SNYR_FlatTummyTeaMember', window );">Flat Tummy Tea [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,513,990<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SNYR_OtherMember', window );">Other [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 460,020<span></span>
</td>
<td class="nump">$ 9,158<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Net sales for any other product group of similar products are less than 10% of consolidated net sales.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=26872669&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SNYR_FocusFactorBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SNYR_FocusFactorBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SNYR_FlatTummyTeaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SNYR_FlatTummyTeaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SNYR_OtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SNYR_OtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6785549472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments - Summary of Net Sales Attributed to Customers Product Group (Details) (Parenthetical)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=SNYR_OtherMember', window );">Other [Member] | Sales Revenue, Net [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=51801978&amp;loc=d3e6351-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13531-108611<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=51801978&amp;loc=d3e6404-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=49121117&amp;loc=d3e13537-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=SNYR_OtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=SNYR_OtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.3.1.900</span><table class="report" border="0" cellspacing="2" id="idp6784955264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Segments - Summary of Long-lived Assets (Net) Attributable to Operations Geographical Segment (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets net</a></td>
<td class="nump">$ 17,423,679<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementGeographicalAxis=SNYR_UnitedStatesMember', window );">United States [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets net</a></td>
<td class="nump">17,411,598<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementGeographicalAxis=SNYR_ForeignCountriesMember', window );">Foreign Countries [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets net</a></td>
<td class="nump">$ 12,081<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=51669610&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementGeographicalAxis=SNYR_UnitedStatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementGeographicalAxis=SNYR_UnitedStatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementGeographicalAxis=SNYR_ForeignCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementGeographicalAxis=SNYR_ForeignCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>97
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M"7I:#GJB!/D6R-ARDA#6'*T]X-ISO/8 ;,\1VP.R/<=L#]#V'+4]8-MSW/8
M;L^1VP.Z/<=N#_#V'+T%Z"T<O07H+:1W;?2RS=%;@-["T5N WL+16X#>PM%;
M@-["T5N WL+16X#>PM%;@-["T5N!WLK16X'>RM%;@=Y*.BM!AR4<O17HK1R]
M%>BM'+T5Z*T<O17HK1R]%>BM'+T5Z*T<O0/0.W#T#D#OP-$[ +T#1^\ ] ZD
MLVYTV,W1.P"] T?O /0.'+T#T#MP] Y [\#1.P"] T?O"/2.'+TCT#MR](Y
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M0=5 Y3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%
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MA010"J#T%="RIP_?2"?,2GS9* N@#$#9[X(\9]F;ZCN <@#E?U2C(^G6 "H
M5#P'G<E^L,J7Z]=*?!R<[I3#/BZA?/F\_')H6VGOQB;HJT[3BRZI18=5908:
M?P"]!=#;YZ##ZL= NHV1 *7>0:EWSTN==I5IE;B0MPI+Q3/4:\8];:R?$^>J
M4OI:>LNA>& GH^?"JHW4I/@MQ9,+'XU2QKR5%8V5'=^(<<"LHAP2Y]JA #$Z
M&3-2GG;7A#'V#@NA?S$CX"=]2\(<.N?? ?^2GE)L=%?^+?=7$84&QHR"YS[
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M.6/[R_N T53<BJ+MQ93MW%1;Q(A"VPO&]IVI=C<:$(6V%XSM(2H4XK/!=[!
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M971S+W-H965T,2YX;6R-5LN.FS 4_17$!PS8O"."-$E4M8M*HUFT:R=Q AK
MU';"].]K&\(8CSN01?S@G'O\.M?.>T+?6(DQ=]Z;NF5;M^2\VW@>.Y6X0>R)
M=+@57RZ$-HB+)KUZK*,8G16IJ3WH^['7H*IUBUSUO= B)S=>5RU^H0Z[-0VB
M?W>X)OW6!>ZCX[6ZEEQV>$7N3;QSU>"65:1U*+YLW6>P.8!40A3B5X5[IM4=
M.?@C(6^R\>.\=7TY!ESC$Y<AD"CN>(_K6D82RG_&H!^:DJC7']&_J>F*X1\1
MPWM2_Z[.O!2C]5WGC"_H5O-7TG_'XQPB&?!$:J;^G=.-<=(\**[3H/>AK%I5
M]L.7,!AI=@(<"7 BP/A+0C 2@HD PB\)X4@(#8(W3$4MQ %Q5.24] [KD#P>
M8"/@5 81D1TQ>Z:::GV'WGOAY]Y=AIDA=@,"*@28$)Z(;16 <X$=U.C0)K#7
M$8$-<= 1X?(0 F..@:('BAXMTT.#'BIZJ.BQ=8ET1+(L$!D"D49/YP+M(# @
MXF$/HA@F0; L$QLRL2:36>>A(X"_K) 8"HG.!U:)&00N2Z2&1*KSK:=E-X.L
M."Z9(9'I_,@J,8/$RQ+ -VWGZQ$2N_%FF'2%RB=S SV"?<_GF#4JT%2!6@3X
MGR0RPZQ((\ T,0CT"-9,LIMC5E@$F%X'NI5A:#/C8<0DXXIEOORMT#)M#W3?
MP\BFM0>Z\U,09S"+5AQI8'H?Z-:&]BPVQZS(8\#T/]#=#5.[R@R3K5 Q4P#0
M#1[XUH0Y8N+Q3 (S[7O:+=E@>E7/#>:<R*WEPW4X]4Y/FF>H;MD/>)%WZ(I_
M(GJM6N8<"1=WM;JF+X1P+(;A/XGM*\6C:VK4^,)E-1%U.CQ#A@8GW>-5-3WM
MBG]02P,$%     @ D6%^2*<#AC!R!   (Q4  !@   !X;"]W;W)K<VAE971S
M+W-H965T,BYX;6R5F-MNXS80AE_%\'U7G.%!9. 8J+58M!<%%GO17BLQ'1LK
M6:ZDQ-NW+W5P=L2,UW(NHH/_(7^>/@ZU.E?U]V;O?;OX41;'YG&Y;]O30Y(T
MSWM?YLVGZN2/X9==59=Y&Q[KEZ0YU3[?]D%ED: 0)BGSPW&Y7O7OOM;K5?7:
M%H>C_UHOFM>RS.O_-KZHSH]+6%Y>?#N\[-ON1;)>)>]QVT/IC\VA.BYJOWM<
M_@X/F32=I%?\??#GAMPO.O-/5?6]>_AS^[@4G0=?^.>V*R(/ES>?^:+H2@HU
M_SL6^K/.+I#>7TK_TC<WV'_*&Y]5Q3^';;L/;L5RL?6[_+5HOU7G/_S8!MT5
M^%P53?]_\?S:M%5Y"5DNROS'<#T<^^MY^,6*,8P/P#$ WP- _3) C@$R"D@&
M9WV[/N=MOE[5U7G1G/)NM.$AR.NND%#R(C2FZ1_[[AK>OJTEK)*WKIR)9#-(
ML)<@I\BH0OZ4)*%^U@1&)K"/ET.\O!TOHWC9QZLA7DTM'H=&#))TD!@EK).<
M+IOHI+WM145>%/6B62^#Q/02(U)A%=NKDY+,;2<Z<J)I?,HZT<2)=*FSFM5E
MFO0*6C>C6TQDQE SEJW$$#,0^B6]74L:U9+26AS;Y)34HA 5/U\R*@,1_FZ;
ML9$92\PHP9JQ="988S0[83(J0R.,NFW&168<-0.L&4=J<5(:A_P2<60R:"W3
M&5,31(P=0?T@ZV?4C&.  E(>/N+.=0(?& C4#-OHS:@9S8!R@2%78 CW^HEQ
M"$C]\#P;-8,?[4"CN6('[[43TQ4H7A6/M%$SDB2U5E]Q(^]U$_,5*!:5X=U0
MPF(*TBG-*K-1>=]DCD$+FNQ?:@:V(*8C4#PJ%H\;H'S40B+$$_#2)D/:E"JC
M9NS($),4*$H5CU*@D'00]E1^(YN4-6O08Y0"9:GF60H32FH-6@C>CKW73@Q3
MH#35/$V!XE2"06%8WQE0GO9;S8R]!F.@(J5@O/A&2TB!FNI)3=31J!L<!<[-
M\1,S%2D%-<]4I$R5PAE('3MB>"]2\4.&22FH>:0B12IH+3#E$[AL5(Y#9D',
M66(8<Q4EP0;9^:^7$+,0*0MYPFU0W1CT2Q_?FVYBC$&D"2>?2&Y03Q:IM8[?
MU"=ES7(3(Q4I4C6/5)P@%84%8(] V:2P679BGB)EH.9YBI2G!B$5PO)V[@4J
MQD!%RD >3)M1,V;]D()+^>0HFRAGKX>8JDBI:OBSZ$0C#=\[5S37CY,Q3*4@
M*]/,:(N,\2<IL0R/OU$S])J-L]O+>92*PIR8X25FGZ3L,U>.QY1]QE[;&28R
M-6^KDA].ZS0'-'P^*6D^&?(W%-=8/%%:$];,C-.1C$DJ*?T,3U))2?J;U<99
M_B25394@I$0W9^1BHDI*0<,355*B:A46*5SYLJ$GIE ;,V=MQ%R5%(6&YZJD
M&>@O\^^)DLN_$_(YZY2_^+_R^N5P;!9/5=M69?]1;%=5K0^%B4^AA7N?;]\?
M"K]KN]LTW-?#-[SAH:U.ET^2[]]%U_\#4$L#!!0    ( )%A?D@S-J )WP$
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M=*7GPET$+E!\N%QKU[NU^ ]02P,$%     @ D6%^2.&>&D2\ P  _@\  !@
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M[>JZL\XB>W1=.[AA_'I1V%W7GZ;NO/'CJ;_HZM/;M'T=^5=_ %!+ P04
M" "187Y(V/_[E9L%  " '@  &    'AL+W=O<FMS:&5E=',O<VAE970U+GAM
M;(V937.C.!"&_XK+]XQ1"PF4<ERUX%"[AZV:FL/.F<0D=HUMO$#BV7^_? A'
M+3="<QA_Y)5:;R/KZ8;UM:Q^U?NB:!:_3\=S_;3<-\WE<;6J7_?%*:^_E9?B
MW/[EK:Q.>=-^K-Y7]:4J\ET_Z'1<01#(U2D_G)>;=?_=]VJS+C^:X^%<?*\6
M]<?IE%?_)<6QO#XMV7+\XL?A?=]T7ZPVZ]5MW.YP*L[UH3POJN+M:?D'>\QX
MU$EZQ3^'XEH;[Q?=XE_*\E?WX:_=TS+HUE <B]>FFR)O7SZ+M#@>NYG:R/_J
M2;]B=@/-]^/L66^W7?Y+7A=I>?QYV#7[=K7!<K$KWO*/8_.CO/Y9: ^BF_"U
M/-;]_XO7C[HI3^.0Y>*4_QY>#^?^]3K\)0[T,'H Z %P&P#@',#U 'X;P*5S
M0*@'A%\#A'. T /$UY*4<X#4 ^1M .L]K(9D]:G>YDV^65?E=5%?\FX#LL=6
M7G63M#,OVOS6_<?^"@[??FY8$*Q7G]U$2),,&M :1FE2K %*L\4:3FF>L2:D
M-!G6B)MFU?HE38-E&OH)0CV!Q$'.@^E!$PV:V,[,($I-D8A%%).^S7"<C/9L
M3O00<:84)<N0C$$,;-X\M\QS9#XBS0\:>3/?_YL/%5JA0A0J)D.%R!(7I/$T
M-!=T)])Y#AUYUMMK7I)-2"9-"\NT0*9).XDP[/2F/1,LK5C2C,7(/9I(<R-+
M>A]+8ST0QB%Y#FSE?'Y=$KV'S?6 \+(=6;8C9)N1MB-SQTC?'1Q;D6(4"<A(
ML6F(SF]L+"942L5T@N/Y!+LD.L%F,.'I6UF^%?+-2=_*W#2^"6:!#:  A2)/
M_ 2):-NIUNCK$ .$$9EDYUPCA>;C95HCJ7C3]N_XRY!]0=MGLTM.G9JSMLZ,
M%(7H@B'W\U-ECJFFS=L<9@C$C#Z/V00^I\/8Q&,(>8S<%AD2>86Q:<<0[AB)
MNV>&>*?:@TF1ITKF%$XORJ810SAB-(ZT:(@E@3Q04R2*9138U=FXR81[DXV)
M,&4/;3G(09&!,X9I"4)*G\MCLY(A6-('=<),$K:9\#W5;$(QC"@:'%JDT4PG
MW92 4'9=.)YID<>9YM*,J3:I"=+/N\U,AJ%)PX,A)'IFV:844SZ'I_(X/%V:
M<5\KQ)?)PW-^JHPA=,9>YL$&)P2NPW/L8A 4Z3V&-*PK3Z;Z& ]R.C5C%V.2
MD_F6*&"C$Q Z:7.)%NE4LQ#:+LTCUEW'B$@%].\9S/:,3W2,8*Y'M-F.Z%H0
M7%WCF.SYSC*S @K/9-L,!<10H'_48/:-W+<D!!ND@$ *)&82,/DX41(":ANC
M-MF2K"^WX-$Z.C5CLG% WV3;T 8$;1!T DPL<A%U>]LCEHU%P%B<.$;,IHV\
M]BF@'C+H-C:=:H\NTJD94XWC^3628',:$*>!OAL"B(K*\PBQL0@(BT#?#0&S
MF20W?@HF.=O#6I$YW()',^G4C'DVP_G60V"3&A"I@2Y#P<1BZ!F*VUSDB(OT
M,9QPQ#S[GJ;.-#<Y]3!1>G$/*#HU.L\HF$>ESVT<<H1#3N.0,W0U62ABYA/,
MYB%'/.3D_=Z$S^,IY2:>A))Q3-]@WCHG&_/LP4-GP.D$W-U%Q3TE?=L"B:82
M8#)3 (_HN;;.N4;_\_$R5[QI^S:B.>YUR:,^X?/$3+F)\9 'H7T[;[3O06B/
M>!DW"6W%F[9O YKCKIHLEQ,DFF@\G!K=*7/4*4>"2Q&2],@XZI1MY;0]NR;@
MJ";@=+''S9H@MK? >'G1W6>N((@X6<YLD5+>MU=C,DS90RRDBCG]K 0I1<A4
M9+2BT[FP*P2.*@1.%Z/<K!!B)A4H8?^L5L:#N4O^7OR=5^^'<[UX*9NF//6/
M]][*LBG:^8)O[87<%_GN]N%8O#7=VZA]7PT/2(</37D9G_?>'CIO_@=02P,$
M%     @ D6%^2)X.\WA8!@  ?B(  !@   !X;"]W;W)K<VAE971S+W-H965T
M-BYX;6R5FDUOXS80AO^*X7O6Y R'I +'P-I%T1X*+/;0GK6)DAAK6ZFE;+;_
MOK(^$LYDM)$NL:0,A^_PX^&0TOJE/'^O'HNB7OP\'D[5S?*QKI^N5ZOJ]K$X
MYM6G\JDX-?^Y+\_'O&YNSP^KZNE<Y'=MH>-A!<;XU3'?GY:;=?OLRWFS+I_K
MP_Y4?#DOJN?C,3__MRT.Y<O-TBZ'!U_W#X_UY<%JLUZ]EKO;'XM3M2]/BW-Q
M?[/\;*]WOC5I+?[>%R]5<KVXB/]6EM\O-W_>W2S-14-Q*&[KBXN\^?E1[(K#
MX>*IJ?G?WNE;G9>"Z?7@_?<VW$;^M[PJ=N7AG_U=_=BH-<O%77&?/Q_JK^7+
M'T4? UT<WI:'JOV[N'VNZO(X%%DNCOG/[G=_:G]?NO]$TQ?3"T!? %X+6/_+
M M@7P+<"KHVT4];&]5M>YYOUN7Q95$_YI;?M=6-^OCAI/"^:8*KVMFVN[NF/
MC45:KWY<'#&;;6<#G<VKQ:KQKE8!O(HM),5!JV"76B!\7 .*(+ MCWT0_F,'
M3CAPK0/7.;"1BSQU870VH;6Y"H2>G&JX8X:9-R:;$!()1<1""A\[\,*!3T+*
M0(VH,_%='>0(U.[?I9ZF-&X02D)2/J*J)"1*O(G&Z.,DS%02A9*8=C/JW1R3
MWB.RP3JUDU,S!  WH8LR(2=C<C)U[F5ZR*F4+)%B36:<^5B*-9(#)ATO5FV:
MWJ9O&Y=E/JDJ[2?F;$I'V7=8LFG;R&H&/389-N2:F::KL7/5@%0#3,U(ZT Z
MG0S$#*RN!^;JD;RSF$ZI3)>#B9RK$,:Z"N>*D>RT#)Y.1TUOU'>5,6-=Y>:J
MD=RT#)P.)[B0Y+2>!:3._ZU-X7EET09#ZBC=]9;]>M ,BSA!DV2H3=$W-AT"
MDY1Y5/MBQ^W &^\F*)(LM0RFCG1)D4MR41^M.V9HV?@8ER1Y:E-8ZHOSMK?Q
MO8T;F<T[9D>1LBF)CX0J&-9&*KZWO5'?1MXYM#KG(<7OE8N9#31!E$0K6#9#
M)JQ;('D(G(=Z2P,P $5$=<K#7!J"I"$PA.D#$1@-O0DF.EW.7!Z"Y"%P'NIT
MAI2'5ZXEHHY$F(M$D$@$2@7IE-KV1@,4QA'-O$W2(_D*C*^DKZ; ^ J9C3 F
M:&Y^"A*N$)@@?06#E)H8(X+7EW>8FZ6"1"LPM)*>,@-#J\,LB^1U07&N( E6
MR%)DT(3E B4*D:&0]%F**0IM,TN#"D)D(.1VXXHD!Y&EF++M!D5IBFFM-D\'
M4<S23%O"4)(5&5E)C7^+C*R]*ET4L+UH\%/V!OAN>XU,E(Y[9(0E1)2]UP]'
MG$M8E(1%1EC2"8N.-U+ +.C[6YQ+6)2$1498KQ,64\+J^UN<RU:4;$7&5DFH
M04G*UB;_&QL\:>)*4T>TA"LRN'H=KIC"-?KH HQ,_=3010]Q0H:/$K#( .MU
MP&(*6&QF#I%^%, ,+PG^E!,LB5ADAP%>WW1@FI2B?H"QXT: $SK-25H[1FNO
MT]H9T4 Q4UMRQPUQPO['25@[EK3Z*4=\$JV.H=7K:'4I6J/Q[[;-0T@I6!L]
M$Q8@)['J&%;]R*ECBE4+/D:5'&XN5-V[(U#'6CB;X$)BT#$,PDA *0;M>-[K
MYK+0218ZQL*@4]FE+*2L:5^CIW5N;IKI) D=(V'0V>Q2P$$S $&NMX.>N6FF
MDQ1TC()!)[-C&_.LZ55)YD'/W"S3200ZAL"@4]FE=,M\1O*08Y S<G Z?@ O
M&4B,@4$G,K&,]1?;.)I[)$H2@<3R59G+#'KL5#US#T5)\I083X.>/U/*4Z#Q
M;27-/08@B5-B.-6W#EMB. V_T#,7J"2!2BQ+#3H-*<U2'1IG=?K0W!R5WKU0
M8G .>M),*9P=0)#'%X.<N7 F"6=B<(XZG"F%<S!C:*:Y:":)9F)HCCJ:>Z/0
MHYE&A\Y<,I,D,S$R1Y5P6QH!;IJF4/J:RB)-6-5)8ID8EN4+O$',A/=4E*(;
MIFTGO*2R9U36#_&V?@2VJ1J?DCNZ26_-O&2R9TR.^NMS/X):IL:F8XO>M\TJ
M>:U_+,X/[><.U>*V?#[5W:OSUZ>OGU1\ALMG >+YUE[ON@\CWMQLUD_Y0_%7
M?G[8GZK%M[*NRV/[O<%]6=9%H\]\:B;\8Y'?O=X<BOOZ<AF:ZW/W>41W4Y=/
MP]<>KY^<;/X'4$L#!!0    ( )%A?DBYR/=0G0$  +$#   8    >&PO=V]R
M:W-H965T<R]S:&5E=#<N>&ULA5/;3N,P$/T5RQ^ T[1 5:61* C! Q+B8??9
M32:)A>T)MM.P?[^^I*&M$+S$,Y-SSISQI1C1O-L.P)%/);7=TLZY?L.8K3I0
MW%YA#]K_:= H[GQJ6F9[ [R.)"59GF4W3'&A:5G$VJLI"QR<%!I>#;&#4MS\
MVX'$<4L7]%AX$VWG0H&5!9MYM5"@K4!-##1;>K?8[%8!$0%_!(SV)";!^Q[Q
M/23/]99FP0)(J%Q0X'XYP#U(&81\XX])\ZME()[&1_7'.*UWO^<6[E'^%;7K
MO-F,DAH:/DCWAN,33"-<!\$*I8U?4@W6H3I2*%'\,ZU"QW5,?];91/N>D$^$
M_(+ 4J-H\X$[7A8&1V)['LYNL?%P$T2\,O'>;$SC]*EZ*!?KFX(=@M 99I<P
M><+,".;5OVV1G[?8Y2?T_'?Z\L+A,M*7D\/;WP56%P*K*+#Z<<1SS/JB"3O9
M4P6FC5?'D@H'[=+FS=7Y=M[E\4R^X&71\Q9>N&F%MF2/SI]L/-0&T8$WD5U=
M4]+Y]S,G$AH7PEL?FW2E4N*P/SZ0^966_P%02P,$%     @ D6%^2$N><(Z@
M 0  L0,  !@   !X;"]W;W)K<VAE971S+W-H965T."YX;6R%4]M.XS 0_17+
M'X#3-+"T2B-1$(*'E1 /N\]N,DDL;$^PG8;]^_6E#6V%X"6>F9QSYHPOY83F
MS?8 CGPHJ>V&]LX-:\9LW8/B]@H'T/Y/BT9QYU/3,3L8X$TD*<GR++MAB@M-
MJS+67DQ5XNBDT/!BB!V5XN;?%B1.&[J@Q\*KZ'H7"JPJV<QKA )M!6IBH-W0
MN\5Z6P1$!/P1,-F3F 3O.\2WD#PW&YH%"R"A=D&!^V4/]R!E$/*-WP^:GRT#
M\30^JC_&:;W[';=PC_*O:%SOS6:4--#R4;I7G)[@,,)U$*Q1VO@E]6@=JB.%
M$L4_TBIT7*?TIU@>:%\3\@,AGPFW632>&D6;#]SQJC0X$3OP<':+M8>;(.*5
MB?=F8QJG3]5]M;A=E6P?A,XPVX3)$V9&,*_^98O\O,4V/Z'G/].7%PZ7D;Y,
MW5?9SP+%A4 1!8IO1SS#K"Z'9"=[JL!T\>I84N.H7=J\N3K?SKL\GLDGO"H'
MWL%O;CJA+=FA\R<;#[5%=.!-9%?7E/3^_<R)A-:%\)>/3;I2*7$X'!_(_$JK
M_U!+ P04    " "187Y(ZXVO"* !  "Q P  &    'AL+W=O<FMS:&5E=',O
M<VAE970Y+GAM;(53VVZC,!#]%<L?4!-#]Q(1I*;5:O=AI:H/N\\.#&#5]E#;
MA.[?KVT(3:*J?<$SPSEGSOA23FB?70_@R:M6QNUH[_VP9<S5/6CA;G  $_ZT
M:+7P(;4=<X,%T2225HQGV1>FA32T*E/MT58ECEY) X^6N%%K8?_M0>&THQMZ
M*CS)KO>QP*J2K;Q&:C!.HB$6VAV]VVSW140DP!\)DSN+2?1^0'R.R:]F1[-H
M 134/BJ(L!SA'I2*0J'QRZ+YUC(2S^.3^H\T;7!_$ [N4?V5C>^#V8R2!EHQ
M*O^$TT]81KB-@C4JE[ZD'IU'?:)0HL7KO$J3UFG^D^<+[7T"7PA\)7S+DO&Y
M4;+Y(+RH2HL3<8.(9[?9!KB-(D&9!&\NI6GZN7JL-M]YR8Y1Z *SGS%\QJP(
M%M3?;<$O6^SY&9U_3L^O'.:)GB\.\\\%BBN!(@D4'XYXB2FNFK"S/=5@NW1U
M'*EQ-'[>O+6ZWLX[GL[D#5Z5@^C@M["=-(X<T(>338?:(GH()K*;6TKZ\'[6
M1$'K8_@UQ':^4G/B<3@]D/655O\!4$L#!!0    ( )%A?DB:O6Z%H $  +$#
M   9    >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;(53RV[;,!#\%8(?$,J2
MG;2&+"!.4+2' D$.[9F65A(1DJN0E)7^??F0%=L(DHNXNYJ9G>6CG-"\V![
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MB83.A?#.QR9=J)0X'"_/8WFC]3]02P,$%     @ D6%^2&!A/JB< 0  L0,
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MV5WAYY6S71 ZPFQ&3!HQBQG!O/J/)=+C$IOT@)[^35^>.%Q&^G)R^(_ZV8E
M%@6R7UL\QIRZ9 =GJL T\>I84F*OW7AX<W:^G==IG,DWO,@[WL C-XW0EFS1
M^<G&H=:(#KR)Y.R<DM:_GSF04+NPO?1[,UZI,7#8[1_(_$J++U!+ P04
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MEE82$9*KD)25_GU)2E9L(T@NXNYJ9G:6CV)$^^(Z $_>M#)N1SOO^RUCKNI
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MA?>S) H:'\,?(;;3E9H2C_WI@2ROM/P'4$L#!!0    ( )%A?D@%PIE&H0$
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MDP:&+"!.422' D$.R9F65A(1DJN2E)7^?4E*EA\(VE[$W=7,["P?Q8CVPW4
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M-#Z&=R&VTY6:$H_]Z8$LK[1\!U!+ P04    " "187Y(2@/H4* !  "Q P
M&0   'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6R%4]M.XS 0_17+'X!3MRQ0
MI9$H:+4\("$>X-E-)HF%[<G:3@-_C^VDH:T0O,0SDW/.G/$E']"^N1; DW>M
MC-O0UOMNS9@K6]#"76 ')ORIT6KA0VH;YCH+HDHDK1C/LC],"VEHD:?:DRUR
M[+V2!IXL<;W6PGYL0>&PH0MZ*#S+IO6QP(J<S;Q*:C!.HB$6Z@V]7:RWJXA(
M@!<)@SN*2?2^0WR+R4.UH5FT  I*'Q5$6/9P!TI%H=#X_Z3YU3(2C^.#^M\T
M;7"_$P[N4+W*RK?!;$9)!;7HE7_&X1],(UQ&P1*52U]2]LZC/E HT>)]7*5)
MZS#^X3<3[7L"GPA\)EQGR?C8*-F\%UX4N<6!N$[$LUNL ]Q&D:!,@C>7TC3]
M6-T7?'F5LWT4.L%L1PQ/F,6,8$']VQ;\M,66']'Y[_3EF<-EHB\GA]>_"ZS.
M!%9)8/7CB*>8F[,F[&A/-=@F71U'2NR-'S=OKLZW\Y:G,_F"%WDG&G@4MI'&
MD1WZ<++I4&M$#\%$=G%)21O>SYPHJ'T,KT)LQRLU)AZ[PP.97VGQ"5!+ P04
M    " "187Y(H(OFM" #  #_#@  &0   'AL+W=O<FMS:&5E=',O<VAE970R
M-BYX;6R-5UUSFS 0_"L,/R"@XSN#F8G3Z;0/G<GDH7TFMFPS >0B.4[_?86P
M*7>5QWH)"._M2N%V[2O/8GB7!\Z5]]FUO5SY!Z6.CT$@-P?>U?)!''FO/]F)
MH:N57@[[0!X'7F]-4=<&$(9IT-5-[U>E>?8R5*4XJ;;I^<O@R5/7U<.?-6_%
M>>4S__K@M=D?U/@@J,I@KMLV'>]E(WIOX+N5_\0>UQ&,$(/XV?"S7-Q[X^;?
MA'@?%]^W*S\<]\!;OE$C1:TO'_R9M^W(I)5_7TC_:8Z%R_LK^U=S7+W]MUKR
M9]'^:K;JH'<;^MZ6[^I3JU[%^1N_G"$9"3>BE>:OMSE));IKB>]U]>=T;7IS
M/4^?)/&ES%X EP*8"_+0;'P2,MO\4JNZ*@=Q]N2Q'E\>>]3P8231S)[>FS1+
M<_KIZ4<%<5@&'R,1PJPG#!@,FQ&!9K=* )98PZ(<[I='9(>1*8\F]2*\3Q 3
M@M@0Q)<C,NL1,<9AEPD121!!9!7!F/B^2$I$4D206$4P)KTODA&1#!%D5A&,
MR>^+Y$0D1P2%501A$H<77Q"18D$0V0]2( V'YF8A-5"(*,#N( R*''3^,RI#
M%+%=!X,2!QV@.K"@8(6]R1 ($H<N8]36+$(4]M=#0 Z-QJC[&;)V8F\U#$H=
M>HW1 &#(W:D]9@C((6<8S0"V-/BMP$8AD+JT&TT!ABR>WF@W#')I-QH$#+D\
M3>TZ&)0YZ- L8$NGW\AGA('4H=N I@$@HZ?V;L.@S*';@*8!(*-G]FXC((=N
M YH&@(R>V?]O!.3PQ08T#0 9/;.G#@$YI [0- !D],R>.@3DT@<T#6!I] 4#
MDD%AD!4.,C0, !D]MZ<! ;G\@J-I ,CHN?U+#H-<7 HT#0 9/;_1;ACDTFXT
M#0 Y/;_1;ACDT&X1C8,(.3VWMQL!.;1;1.,@0D[/[;&#02Z_I",:!Q%R>F&/
M'0*BL1,L!I2.#WLSATEO(TZ]FB:1^>D\ZSV942_X!Z_*8[WG/^IAW_32>Q-*
MCTEF0MH)H;C>1?B@W770T^B\:/E.C;>9OA^F^6Q:*'&\CIOSS%O]!5!+ P04
M    " "187Y(]"4 $:0!  "Q P  &0   'AL+W=O<FMS:&5E=',O<VAE970R
M-RYX;6R%4\MNVS 0_!6"'Q#*LMPDABP@3E"TAP)!#NV9EE82$9*KDI25_GWY
MD!7;,)"+N+N:F9WEHYS0O-L>P)$/);7=T=ZY8<N8K7M0W-[A -K_:=$H[GQJ
M.F8' [R))"59GF7?F.)"TZJ,M5=3E3@Z*32\&F)'I;CYMP>)TXZNZ*GP)KK>
MA0*K2K;P&J% 6X&:&&AW]&FUW1<!$0&_!4SV+";!^P'Q/20_FQW-@@604+N@
MP/URA&>0,@CYQG]GS<^6@7@>G]2_QVF]^P.W\(SRCVA<[\UFE#30\E&Z-YQ^
MP#S")@C6*&W\DGJT#M6)0HGB'VD5.JY3^G/_,--N$_*9D"^$ARP:3XVBS1?N
M>%4:G(@=>#B[U=;#31#QRL1[LS&-TZ?JL<H?UR4[!J$+S#YA\HA9+0CFU6^V
MR"];[/,S>OXU?7WE<!WIZ]3],?M:H+@2**) ,8]8W!SQ$K.Y:L+.]E2!Z>+5
ML:3&4;NT>4MUN9U/>3R33WA5#KR#7]QT0EMR0.=/-AYJB^C F\CN-I3T_OTL
MB836A?#>QR9=J90X'$X/9'FEU7]02P,$%     @ D6%^2*=8\ZI2 @  Z0@
M !D   !X;"]W;W)K<VAE971S+W-H965T,C@N>&ULC5;;CILP$/T5Q <LOB00
M5@1I0U6U#Y56^] ^.XD3T *FMA.V?U_;$!9[D?!+; ]GSIEQ/!YG/>/OHJ14
M!A]-W8I]6$K9/4>1.)6T(>*)=;157RZ,-T2J);]&HN.4G(U34T<(@#AJ2-6&
M>69LKSS/V$W654M?>2!N34/XOP.M6;\/8?@PO%774FI#E&?1Y'>N&MJ*BK4!
MIY=]^ *?"YAHB$'\KF@O9O- !W]D[%TO?I[W(= QT)J>I*8@:KC3@M:U9E+*
M?T?23TWM.)\_V+^;=%7X1R)HP>H_U5F6*EH0!F=Z(;=:OK'^!QUSV&K"$ZN%
M^0U.-R%9\W )@X9\#&/5FK$?ONS Z+;L@$8'Y.N 1P?L.$1#9":O;T22/..L
M#T1']+\-GQ6<:Q+%'*ADA%F:[1JL]QRE<1;=-9&%.0P89#!P0D2*?5$"V1('
M-'-'2P+%'('1N@)VDL#&?S,FD2PF86-VZR(;1V1C$:2+(G,,!F!=9.N(;"T"
MN"AB8SRV*W9$8HL KQ,D#D'BL=^));)9%]DY(CN+8+M.D#H$J4>4J242KXM
MX!80L"@2#XHO-0C7(RTL$ 8>!Q@B5P>M'^'" F&0>NBXY0CQ^BDN;!#TJ!7H
M5B2TR@UZ7$W0K3>X]3@D%@A#CXJ#;LG!V./VL$ 8>A0F="L3)AX7B V";FU&
MLP[24'XUG54$)W9KY7!+3]:I>[\@W8$<^T%W==.9/FGRK"-7^HOP:]6*X,BD
MZF^FM5T8DU1%!Y[4;I?JW3$M:GJ1>IJH.1\Z\;"0K'L\+*;73?X?4$L#!!0
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M\5 [1 ?>1/:PI63P[V=-)'0NA)]];-*52HG#\?Q UE=:_P-02P,$%     @
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MZ/S)QD/M$!UX$]G-+26#?S]+(J%S(;SWL4E7*B4.Q^,#65YI_0E02P,$%
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M 97UX;V+]7!OA\1B>WJ%TZ\@_P902P,$%     @ D6%^2#^V+_:Q 0  %@0
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MP_2Q>BQ7^4.!CUYH@=E'# F8;$9@IWZU!5FVV),S.KE-7UTX7 7Z*M+)YK9
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MRG!/"=>_WO[,!6VO$M]KT:>Y-YV^#^9)'HXRMP", G 31/!;03P*XF<%<!3
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M/.'#5>&5YS34+@RR"\T:@]J P380[.F#$TGWI)5]V#+4, PR#/H ZY!-^=F
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MH)0*FF-!1YY7 H)I[GI-TT3N:CH_>A7 X6,A[GOMIY&L?603FX 3*''KZT2
M91V97W@"@'L?U!B8.ZFNJ#_9Z)S@1 'W/N@Q/G>S-RJ2S%ZX6N%AC,^]S%S?
M _<]F#$^]S)FK@RW/-@1-O<J<QT/W/'@!%B&T/(W%?\3P=P&[GC :2K#W"0
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MK6\ET=\FGUAL'+>_&XW^G2>C(HDG';>^&XW]_3VF\))?>,/$<?<[2?)W<_.
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M,/XF*DIE\-XVG=B%E93]-HK$L:(M$4^LIYVZ<V:\)5)U^242/:?D9(K:)D(
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MN]J9,4D5'7A22U*I$\2]T]"SU)=J1PRXW5-M1[)^.B+<SRGE'U!+ P04
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M=0'+->DQ-E:(HB1$23B'S'ND/5)ZHQ.(5^P3_'*)X8H*]B#<'ZO8#_ L,'\
M)CY"()G$Y(UZ3$WYV?1>X1S8I9'V&@_6H;\_(]VC)O:=[ONF=]UILK0E9_J3
M\'/9"&?/I.J IOF=&)-4!0B>U 4IU,LT+"IZDGJ*U9S;7FT7DK6WIV=X_[)_
M4$L#!!0    ( )%A?D@#-FR.. (  "<'   9    >&PO=V]R:W-H965T<R]S
M:&5E=#0X+GAM;)55R8Z;,!A^%8L'&+,O$4&:$%7MH=)H#NW929R QL;4=L+T
M[>N%$$!DDEZ"[7R;?\/OO&/\0U082_!)22/63B5ENX)0["M,D7AA+6[4/T?&
M*9)JRD]0M!RC@R%1 GW7C2%%=>,4N5E[XT7.SI+4#7[C0)PI1?SO!A/6K1W/
MN2Z\UZ=*Z@58Y'#@'6J*&U&S!G!\7#NOWFKKN1IB$+]JW(G1&.CP.\8^].3'
M8>VX.@,F>"^U!%*/"RXQ(5I).?_I16^>FC@>7]6_F>VJ^#LD<,G([_H@*Y76
M=< !']&9R'?6?<?]'B(MN&=$F%^P/PO)Z)7B (H^[;-NS+.S_\1A3ULF^#W!
M'PB#SS(AZ G!C1!_20A[0G@CF$C0;L448HLD*G+..B!:I%\/;Z7@7(LH9:!V
M+\S4U->N7HHP]7-XT4(3S,9B?(,)XFP)4XXQWH" *L%B#'\:8^./+193E&/(
M(F)[1^1NB&!6B\#PP[X6P=2CL2DL)K$>:9:%T6*4L500/XX2SJ*$DRCAXK&,
M,4&VF*.<ZD2/@T2S(-'8Q$T>"\0S@7B2(%Y,.<4\89+,3)*)0+IX<LGHY/S(
M"Y)H=,1WG=*94SIQRAX+9#.![(EZ9/];#\^=?];N$Q7I0?W+'"1N$D;IS R.
MV@G%_&3ZL@![=FZD_=:&U:'WO_JZ'<W62WTGF#9UDRGR%IWP3\1/=2/ CDG5
M[$R?.S(FL8KHOJCWKU*WUC A^"CU,%%C;ONXG4C67J^EX6XL_@%02P,$%
M  @ D6%^2'DN];$) @  <08  !D   !X;"]W;W)K<VAE971S+W-H965T-#DN
M>&ULC97=CILP$(5?Q>(!EK\$2$20-JFJ]J+2:B_::X=, EH;4]N$[=O7-H1@
MY"A[$WO,F3/?.&&2]XQ_B I HD]*&K'S*BG;K>^+L@**Q0MKH5%/SHQ3+%7(
M+[YH.>"32:+$CX(@\2FN&Z_(S=D;+W+625(W\,:1Z"C%_-\>".MW7NC=#M[K
M2R7U@5_D_I1WJBDTHF8-XG#>>:_A]I!IA1'\KJ$7LSW2[$?&/G3P\[3S HT
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M$2V A(V/"CPL>UB!E%$H'/P^:GX=&8G3^*#^D+H-[M?<P<K(?Z+Q73!;8-1
MRW?2OYCA$<86YE%P8Z1+7[39.6_4@8*1XA]Y%3JM0]Z9%R/M/(&.!'HDE+,?
M"6PDL!,"R<Y27_?<\[JR9D"NY_&QRT6 VR@2E%%HQJ4T75>N[NMYP2JRCT+?
M,'<90Q.&GD.LI@CV!2'!P%D7],0%37R6^.7-]>\"[$2 )8'9V,;LNTF=V\B8
MJX3Y4]*2WI1GFYEJL<L3+V1RO3W?PA.W6Z$=6AL?7BH]4FN,AR!47,PQZL(
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M3+6YO;%L1[+Q<@%?_P54?P!02P,$%     @ D6%^2)J##-'] 0  ] 4  !D
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M-34N>&ULE59=;]L@%/TKR#^@-H0X3N58:CI-V\.DJ@_;,TE(;!6,!R3N_OT
M)ZZAT<Q>PH?//>=R[9-+V0OYIFI*-7CGK%6;I-:Z>TQ3M:\I)^I!=+0U3XY"
M<J+-4IY2U4E*#BZ(LQ1E69YRTK1)5;J]%UF5XJQ9T](7"=29<R+_;"D3_2:!
MR6WCM3G5VFZD59F.<8>&TU8UH@62'C?)$WS<PL)"'.)G0WLUF0.;_$Z(-[OX
M?M@DF<V!,KK7EH*8X4*?*6.6R2C_OI)^:-K Z?S&_M4=UZ2_(XH^"_:K.>C:
M9)LEX$"/Y,STJ^B_T>L9EI9P+YAROV!_5EKP6T@".'D?QJ9U8S\\R8MKV/T
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M-]-]X>X?-U!\N-ZFMRN]^ =02P,$%     @ D6%^2&:P^2C; 0  R@0  !D
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MO[,IAT(;KGDGS#%9'X7D_24D37KZ:L_M8,YG>Z4"4U@\ $T!Z!H \_\&X"D
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M;*=2']I-?BJ+^[</V_*AZ7[M2K;#\'7,X4-3/1^_7?KV%=>;_P%02P,$%
M  @ D6%^2+M;)+W\ 0  Y04  !D   !X;"]W;W)K<VAE971S+W-H965T-C,N
M>&ULE91;;YLP',6_"N)]]05L0D20UE35]C"IZL/V["1.0#68V4[HOOU\25*"
MK%9YP1?..?[]#78U2O6F&\Y-\MZ)7J_2QIAA"8#>-KQC^D$.O+=O]E)US-BA
M.@ ]*,YVWM0)@"&DH&-MG]:5GWM1=26/1K0]?U&)/G8=4_\>N9#C*D7I9>*U
M/33&38"Z E??KNUXKUO9)XKO5^EWM%P73N$%OUL^ZDD_<>P;*=_<X.=NE4*'
MP 7?&I? ;'/B:RZ$"[(+_SUG?BSIC-/^)?W95VOI-TSSM11_VIUI+"Q,DQW?
MLZ,PKW+\P<\E$!>XE4+[9[(]:B.[BR5-.O8>VK;W[1C>4'2VQ0WX;,!7 \H_
M-61G0S8S@$#FZWIBAM65DF.B!^8^-EI:N7(A-CFQQ6@_]-L59D\US<L*G%S0
MC>8Q:+#7X)AB/55D'Q)@ :(4>$:!O3\+*Z#%UP'9+"#S 7DH@\!;R#Z4$32%
MUR"<0TH6T7K7T[",?@V3SV#RB9^4910F:*C7?,,DHSF*P^1WPI 9#)GX$211
M&#*!*1<%1 6,LI [6>B,A=Y\)11EH=.-R4J$(8W#T#MABAE,<0.#HS#%Y)<A
M)5D@%&<I/F,!DQ,YL /_Q=2A[76RD<8>;G^N]U(:;H/@@]WBQMZYUX'@>^.Z
MA>VK< V%@9'#Y5*]WNSU?U!+ P04    " "187Y(8:%M]28$   *%@  &0
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M/6O^F-52&F:]T(O] (V]T:: L]JX*;%S%0YY"(SLQRMKNC?+?U!+ P04
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MY"YF,622/'8Q=T,F0]#%W'LPRR'C)%:&&R>R-@=57)E()LV9.6AE#G8!TCY
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MQWG'Q8<L*57!)ZL;N0E+I=HU ')?4D;D@K>TT6^.7#"B]%2<@&P%)0<;Q&J
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M2C=0VSM/G"NJPX K?;HJ?4^-BX:>E)FF>BY<YW8+Q;OK133>AN5?4$L#!!0
M   ( )%A?DA*#YR<W@$  "@%   9    >&PO=V]R:W-H965T<R]S:&5E=#<R
M+GAM;(U4VXZ;,!#]%<0'K(TQ$"*"U"6JVH=*JWUHGYU@ EH;4]L)V[^O+R1+
M$-KL"YX9SCESQA@7HY!OJJ54!^^<]6H7MEH/6P#4L:6<J"<QT-Z\:83D1)M4
MGH :)"6U(W$&$(0IX*3KP[)PM1=9%N*L6=?3%QFH,^=$_GNF3(R[, JOA=?N
MU&I; &4!;KRZX[17G>@#29M=^"W:[A.+<(#?'1W5+ ZL]X,0;S;Y6>]":"U0
M1H_:*A"S7&A%&;-"IO'?2?.CI27.XZOZ=S>M<7\@BE:"_>EJW1JS, QJVI S
MTZ]B_$&G$9S#HV#*/8/C66G!KY0PX.3=KUWOUM&_P6BBK1/01$ W0H0_)<03
M(?XJ 4\$O"  /XK;B#W1I"RD& ,U$'LZHJV!2RMBE ,SO7*IVU]?O909Q@6X
M6*$[S+/'((>)-W -4\TQ: VQOU/Y@ !C<M4I6CA%CH\=/X71?8_>._68S+N
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M276BS6&N&9-8)?DOJNY&W<RW <&UU-U4]?EX68T#R?KKU7N[__._4$L#!!0
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MS#33<^$:B%LHWE_;X=23B[]02P,$%     @ D6%^2"[F Y!, @  D <  !D
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M*'HD@C4MSE+O>U59*GO#FQ9>%=*]$$S].0"7PQ['^.)X:ZK:. ?)4C+QBD9
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MMG%\SY12&K#)10]KC&H[SY/!H31NN[%[%5H\&$9VEX&=_AK97U!+ P04
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ML@:.O$ G^H*?,-4=2DNRC?!S.]3,2C)9;_;9FG)W$HKVKX#V<OH["/[3#/2
M-? 5-_B.V5!T U2_+'MZS%_^LXPHYI3>TG1@VK<%*"VP#N.&O<EA7CF1.VP_
M[#:2-VIW^X*B$=ZULB/3:#!EN!1 NO?P-R9@D#XN<(.*B'F3[C$(L.4MB@][
M#>'#;3R0?L#/P9W;K^$0[A+0.6Y2&'7AF_V\C\"]2GL%&_SS:K_98&X8!A/
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MM2P*5C(*L1U:?O#B0C(]Z9MHDRY1$I''BQ@S:TYTI5;HNP ^21$:.'8L;7O
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M99_%D^D\/AL/:"@3# 7;7'RDM4G^@(Z&+T[CP702GPV&>#YMI E7FY6/H-1
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MA78TSO-/A&JY]S)_]2^I_-O&A]88$<P*03<R]_8Y\D&O4BV );^,"R;2(*Q
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M3$*7$E7XW&7IRB.K9;K@RDZ4C41/H@:E/J<7[O0QM<^7@@ DL6*N4D#7YT*
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MC<T/DPB%BCZ1-J>L6EJ2/OQ9KR3;.N/0?03J=)%)(87ZZ+AR!B3R'U^^(*A
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M'BORP3=-YXG\]N4]S8+#MO*>>3^>@ 9)46B@P^%X7J_K.>Q4O'[WGO@GV\7
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MX4[S^P%DA)K /TW0;S%!QW.X],##6DS0>7\.UJG:GQY6IL,T8+*BFN>DWM(
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MW'D6_"P$2']'V1^JP[?I%B\CA8W] :31D69N((=P H%:N2^2HG@X!<+#QH)
M"\\<],3KH,NET^]CKD=O+!B.%)2X'\C81&)$0PKV*2OO2*VVV[[?BK%>V2($
MC]7R @,=6].1EMA+5@/\3UC+<]T)8;.$10V'BC%C-D'2#>;-%2Y]=4&=AC0C
MFAZ2EPG?4W0=ZIPM1"GVM-=OSC48(E*&8P1="&MLB-*<%23DY^9I=((8&.?
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M"+_<32166]?P5O(IR=:BUCK+5912(BC+-HP05$A/=;88DA%YJ2P=H8&*L_U
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MV'O)P9SM;0UF$!-#N682'2=J%;:W4ST.@?1("LAGPDTFFTYT/+1NBNQ6$P"
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M%7>E)<>H=!G1:;O<D4V*0_('C6P3P17B+DGW%U<I$FL$1V+UZN?#=#?> &)
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MS, Z\\(V'0BKHA<R 7.VX@RKTC*(1AMIJ3&FQ5BU10A#KG4O^A/MB_*T-?T
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MT=)($VB2E> =,@%%$M'BA@(NN/1&<9!#(R-5OUYFT@OXQQ)=O,CA W\E'<^
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M HW#.QJ;I[JC=GH,OVW 4'DMZ4A'T&C/')SCY$4ZL*3(S783B:TSG< ]C^.
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MCZ"'O/C]=KO[P_\ 4$L! A0#%     @ D6%^2)C7(XPZ @  CBT  !,
M         ( !     %M#;VYT96YT7U1Y<&5S72YX;6Q02P$"% ,4    " "1
M87Y(2'4%[L4    K @  "P              @ %K @  7W)E;',O+G)E;'-0
M2P$"% ,4    " "187Y(7V2C&7 "   T+@  &@              @ %9 P
M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " "187Y(E:0U
M@-X#  "_$0  $               @ $!!@  9&]C4')O<',O87!P+GAM;%!+
M 0(4 Q0    ( )%A?D@ZH21F/0$  &D#   1              "  0T*  !D
M;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( )%A?DB97)PC$ 8  )PG   3
M              "  7D+  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%
M  @ D6%^2!8P#O]T @  9 T   T              ( !NA$  'AL+W-T>6QE
M<RYX;6Q02P$"% ,4    " "187Y(JA4KZ; %  "R%P  #P
M@ %9%   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ D6%^2,5V8XR7 @
MY@D  !@              ( !-AH  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;%!+ 0(4 Q0    ( )%A?DBG X8P<@0  ",5   8              "  0,=
M  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    " "187Y(,S:@
M"=\!  !G!0  &               @ &K(0  >&PO=V]R:W-H965T<R]S:&5E
M=#,N>&UL4$L! A0#%     @ D6%^2.&>&D2\ P  _@\  !@
M ( !P",  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( )%A
M?DC8__N5FP4  ( >   8              "  ;(G  !X;"]W;W)K<VAE971S
M+W-H965T-2YX;6Q02P$"% ,4    " "187Y(G@[S>%@&  !^(@  &
M        @ &#+0  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%
M  @ D6%^2+G(]U"= 0  L0,  !@              ( !$30  'AL+W=O<FMS
M:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( )%A?DA+GG".H $  +$#   8
M              "  >0U  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"
M% ,4    " "187Y(ZXVO"* !  "Q P  &               @ &Z-P  >&PO
M=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ D6%^2)J];H6@ 0
ML0,  !D              ( !D#D  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX
M;6Q02P$"% ,4    " "187Y("Q=A3Z(!  "O P  &0              @ %G
M.P  >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( )%A?DA@
M83ZHG $  +$#   9              "  4 ]  !X;"]W;W)K<VAE971S+W-H
M965T,3(N>&UL4$L! A0#%     @ D6%^2#Y6D]F? 0  L0,  !D
M     ( !$S\  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( )%A?DA@0=NUH0$  +$#   9              "
M 49(  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @ D6%^
M2">R<TZ> 0  L0,  !D              ( !'DH  'AL+W=O<FMS:&5E=',O
M<VAE970Q.2YX;6Q02P$"% ,4    " "187Y(Z]F_X: !  "Q P  &0
M        @ 'S2P  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0
M   ( )%A?D@%PIE&H0$  +$#   9              "  <I-  !X;"]W;W)K
M<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @ D6%^2)WA/]R? 0  L0,
M !D              ( !HD\  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q0
M2P$"% ,4    " "187Y(G)3# : !  "Q P  &0              @ %X40
M>&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( )%A?DBW;+C<
MH0$  +$#   9              "  4]3  !X;"]W;W)K<VAE971S+W-H965T
M,C0N>&UL4$L! A0#%     @ D6%^2$H#Z%"@ 0  L0,  !D
M ( !)U4  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4    " "1
M87Y(H(OFM" #  #_#@  &0              @ '^5@  >&PO=V]R:W-H965T
M<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( )%A?DCT)0 1I $  +$#   9
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M970S,2YX;6Q02P$"% ,4    " "187Y(,6G",J,!  "Q P  &0
M    @ %59   >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    (
M )%A?DC,DAW8HP$  +$#   9              "  2]F  !X;"]W;W)K<VAE
M971S+W-H965T,S,N>&UL4$L! A0#%     @ D6%^2*D/!Q^P 0  %@0  !D
M             ( !"6@  'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"
M% ,4    " "187Y(CR/SU*0!  "Q P  &0              @ 'P:0  >&PO
M=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( )%A?D@]3GUWH@$
M +$#   9              "  <MK  !X;"]W;W)K<VAE971S+W-H965T,S8N
M>&UL4$L! A0#%     @ D6%^2!B2,W.K 0  %@0  !D              ( !
MI&T  'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"% ,4    " "187Y(
M/[8O]K$!   6!   &0              @ &&;P  >&PO=V]R:W-H965T<R]S
M:&5E=#,X+GAM;%!+ 0(4 Q0    ( )%A?DCD^4P#KP$  !8$   9
M      "  6YQ  !X;"]W;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%
M  @ D6%^2.<FVPJE 0  L0,  !D              ( !5',  'AL+W=O<FMS
M:&5E=',O<VAE970T,"YX;6Q02P$"% ,4    " "187Y(AH!WJ[H!  ![!
M&0              @ $P=0  >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+
M 0(4 Q0    ( )%A?DCB+!J@.@(  .H&   9              "  2%W  !X
M;"]W;W)K<VAE971S+W-H965T-#(N>&UL4$L! A0#%     @ D6%^2&5X-;U$
M @  #P@  !D              ( !DGD  'AL+W=O<FMS:&5E=',O<VAE970T
M,RYX;6Q02P$"% ,4    " "187Y(,V?+YJ4%  !H(   &0
M@ $-?   >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( )%A
M?DCKMA+8K@4  *DB   9              "  >F!  !X;"]W;W)K<VAE971S
M+W-H965T-#4N>&UL4$L! A0#%     @ D6%^2-AJVM9* @  LP@  !D
M         ( !SH<  'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q02P$"% ,4
M    " "187Y(NC,XN$<"   +!P  &0              @ %/B@  >&PO=V]R
M:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    ( )%A?D@#-FR.. (  "<'
M   9              "  <V,  !X;"]W;W)K<VAE971S+W-H965T-#@N>&UL
M4$L! A0#%     @ D6%^2'DN];$) @  <08  !D              ( !/(\
M 'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6Q02P$"% ,4    " "187Y(WMDX
M6,H!  #1!   &0              @ %\D0  >&PO=V]R:W-H965T<R]S:&5E
M=#4P+GAM;%!+ 0(4 Q0    ( )%A?D@3/BWZG@$  +(#   9
M  "  7V3  !X;"]W;W)K<VAE971S+W-H965T-3$N>&UL4$L! A0#%     @
MD6%^2/3=73W3 0  S@0  !D              ( !4I4  'AL+W=O<FMS:&5E
M=',O<VAE970U,BYX;6Q02P$"% ,4    " "187Y(7SO-#DT"   1"   &0
M            @ %<EP  >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4
M Q0    ( )%A?DB:@PS1_0$  /0%   9              "  >"9  !X;"]W
M;W)K<VAE971S+W-H965T-30N>&UL4$L! A0#%     @ D6%^2*LL@<!" @
MY0@  !D              ( !%)P  'AL+W=O<FMS:&5E=',O<VAE970U-2YX
M;6Q02P$"% ,4    " "187Y(O]F9 _<!  #>!0  &0              @ &-
MG@  >&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+ 0(4 Q0    ( )%A?DAF
ML/DHVP$  ,H$   9              "  ;N@  !X;"]W;W)K<VAE971S+W-H
M965T-3<N>&UL4$L! A0#%     @ D6%^2.[G&50= @  \@8  !D
M     ( !S:(  'AL+W=O<FMS:&5E=',O<VAE970U."YX;6Q02P$"% ,4
M" "187Y(Q[W")]$!  #E!   &0              @ $AI0  >&PO=V]R:W-H
M965T<R]S:&5E=#4Y+GAM;%!+ 0(4 Q0    ( )%A?DA.4;T-.P,  ,@.   9
M              "  2FG  !X;"]W;W)K<VAE971S+W-H965T-C N>&UL4$L!
M A0#%     @ D6%^2)O6"NZ$ @  / D  !D              ( !FZH  'AL
M+W=O<FMS:&5E=',O<VAE970V,2YX;6Q02P$"% ,4    " "187Y(9<4\</,&
M  #N*@  &0              @ %6K0  >&PO=V]R:W-H965T<R]S:&5E=#8R
M+GAM;%!+ 0(4 Q0    ( )%A?DB[6R2]_ $  .4%   9              "
M 8"T  !X;"]W;W)K<VAE971S+W-H965T-C,N>&UL4$L! A0#%     @ D6%^
M2&&A;?4F!   "A8  !D              ( !L[8  'AL+W=O<FMS:&5E=',O
M<VAE970V-"YX;6Q02P$"% ,4    " "187Y(*!V<2S<"   5"   &0
M        @ $0NP  >&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+ 0(4 Q0
M   ( )%A?DA3#@BYW0$  $,%   9              "  7Z]  !X;"]W;W)K
M<VAE971S+W-H965T-C8N>&UL4$L! A0#%     @ D6%^2/<M 3'K @  Y@P
M !D              ( !DK\  'AL+W=O<FMS:&5E=',O<VAE970V-RYX;6Q0
M2P$"% ,4    " "187Y(9X>MXA "  !C!@  &0              @ &TP@
M>&PO=V]R:W-H965T<R]S:&5E=#8X+GAM;%!+ 0(4 Q0    ( )%A?DA?3S/_
M) (  !0'   9              "  ?O$  !X;"]W;W)K<VAE971S+W-H965T
M-CDN>&UL4$L! A0#%     @ D6%^2+J.5]F9 @  *PL  !D
M ( !5L<  'AL+W=O<FMS:&5E=',O<VAE970W,"YX;6Q02P$"% ,4    " "1
M87Y(\(YRKCD"   9!P  &0              @ $FR@  >&PO=V]R:W-H965T
M<R]S:&5E=#<Q+GAM;%!+ 0(4 Q0    ( )%A?DA*#YR<W@$  "@%   9
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M970W-BYX;6Q02P$"% ,4    " "187Y(W\3:6<X!   +!0  &0
M    @ %ZUP  >&PO=V]R:W-H965T<R]S:&5E=#<W+GAM;%!+ 0(4 Q0    (
M )%A?DC)-..Q_:   #IV @ 4              "  7_9  !X;"]S:&%R9613
@=')I;F=S+GAM;%!+!08     5@!6 (P7  "N>@$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='UTF-8'?>
<FilingSummary>
  <Version>3.3.1.900</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>190</ContextCount>
  <ElementCount>387</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>86</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/BalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/StatementsOfOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Consolidated Statement of Stockholders' Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/StatementOfStockholdersEquityDeficit</Role>
      <ShortName>Consolidated Statement of Stockholders' Equity (Deficit)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/StatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - Nature of the Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/NatureOfBusiness</Role>
      <ShortName>Nature of the Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - Acquisitions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/Acquisitions</Role>
      <ShortName>Acquisitions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - Accounts Receivable</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/AccountsReceivable</Role>
      <ShortName>Accounts Receivable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - Prepaid Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/PrepaidExpenses</Role>
      <ShortName>Prepaid Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - Concentration of Credit Risk</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/ConcentrationOfCreditRisk</Role>
      <ShortName>Concentration of Credit Risk</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - Inventory</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/Inventory</Role>
      <ShortName>Inventory</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - Fixed Assets and Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssets</Role>
      <ShortName>Fixed Assets and Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - Accounts Payable and Accrued Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/AccountsPayableAndAccruedLiabilities</Role>
      <ShortName>Accounts Payable and Accrued Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - Notes Payable</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://synergystripscorp.com/role/NotesPayable</Role>
      <ShortName>Notes Payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - Stockholders' Deficit</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/StockholdersDeficit</Role>
      <ShortName>Stockholders' Deficit</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - Stock Options</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/StockOptions</Role>
      <ShortName>Stock Options</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - Stock Warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/StockWarrants</Role>
      <ShortName>Stock Warrants</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - Derivatives</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/Derivatives</Role>
      <ShortName>Derivatives</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - Segments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/Segments</Role>
      <ShortName>Segments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://synergystripscorp.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://synergystripscorp.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - Acquisitions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/AcquisitionsTables</Role>
      <ShortName>Acquisitions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://synergystripscorp.com/role/Acquisitions</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://synergystripscorp.com/role/IncomeTaxes</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - Accounts Receivable (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/AccountsReceivableTables</Role>
      <ShortName>Accounts Receivable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://synergystripscorp.com/role/AccountsReceivable</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - Prepaid Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/PrepaidExpensesTables</Role>
      <ShortName>Prepaid Expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://synergystripscorp.com/role/PrepaidExpenses</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - Concentration of Credit Risk (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/ConcentrationOfCreditRiskTables</Role>
      <ShortName>Concentration of Credit Risk (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://synergystripscorp.com/role/ConcentrationOfCreditRisk</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - Inventory (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/InventoryTables</Role>
      <ShortName>Inventory (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://synergystripscorp.com/role/Inventory</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - Fixed Assets and Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssetsTables</Role>
      <ShortName>Fixed Assets and Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssets</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - Accounts Payable and Accrued Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/AccountsPayableAndAccruedLiabilitiesTables</Role>
      <ShortName>Accounts Payable and Accrued Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://synergystripscorp.com/role/AccountsPayableAndAccruedLiabilities</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - Notes Payable (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://synergystripscorp.com/role/NotesPayableTables</Role>
      <ShortName>Notes Payable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://synergystripscorp.com/role/NotesPayable</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/CommitmentsAndContingenciesTables</Role>
      <ShortName>Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://synergystripscorp.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - Stock Options (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/StockOptionsTables</Role>
      <ShortName>Stock Options (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://synergystripscorp.com/role/StockOptions</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - Stock Warrants (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/StockWarrantsTables</Role>
      <ShortName>Stock Warrants (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://synergystripscorp.com/role/StockWarrants</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - Derivatives (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/DerivativesTables</Role>
      <ShortName>Derivatives (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://synergystripscorp.com/role/Derivatives</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - Segments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/SegmentsTables</Role>
      <ShortName>Segments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://synergystripscorp.com/role/Segments</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>Summary of Significant Accounting Policies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://synergystripscorp.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - Summary of Significant Accounting Policies - Schedule of Assumptions Used for Fair Value of Warrant Derivative Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfAssumptionsUsedForFairValueOfWarrantDerivativeLiabilitiesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Assumptions Used for Fair Value of Warrant Derivative Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - Acquisitions (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/AcquisitionsDetailsNarrative</Role>
      <ShortName>Acquisitions (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://synergystripscorp.com/role/AcquisitionsTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00000045 - Disclosure - Acquisitions - Purchase Price Allocation Assets Acquired and Liabilities Assumed on Estimated Fair Values (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/Acquisitions-PurchasePriceAllocationAssetsAcquiredAndLiabilitiesAssumedOnEstimatedFairValuesDetails</Role>
      <ShortName>Acquisitions - Purchase Price Allocation Assets Acquired and Liabilities Assumed on Estimated Fair Values (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00000046 - Disclosure - Acquisitions - Purchase Price Allocated to Acquisition of Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/Acquisitions-PurchasePriceAllocatedToAcquisitionOfAssetsDetails</Role>
      <ShortName>Acquisitions - Purchase Price Allocated to Acquisition of Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00000047 - Disclosure - Acquisitions - Pro forma Results of Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/Acquisitions-ProFormaResultsOfAcquisitionDetails</Role>
      <ShortName>Acquisitions - Pro forma Results of Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>00000048 - Disclosure - Income Taxes (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/IncomeTaxesDetailsNarrative</Role>
      <ShortName>Income Taxes (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://synergystripscorp.com/role/IncomeTaxesTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>00000049 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/IncomeTaxes-ScheduleOfEffectiveIncomeTaxRateDetails</Role>
      <ShortName>Income Taxes - Schedule of Effective Income Tax Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>00000050 - Disclosure - Income Taxes - Schedule of Deferred Income Tax Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/IncomeTaxes-ScheduleOfDeferredIncomeTaxAssetsDetails</Role>
      <ShortName>Income Taxes - Schedule of Deferred Income Tax Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>00000051 - Disclosure - Accounts Receivable (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/AccountsReceivableDetailsNarrative</Role>
      <ShortName>Accounts Receivable (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://synergystripscorp.com/role/AccountsReceivableTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>00000052 - Disclosure - Accounts Receivable - Accounts Receivable, Net of Allowances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/AccountsReceivable-AccountsReceivableNetOfAllowancesDetails</Role>
      <ShortName>Accounts Receivable - Accounts Receivable, Net of Allowances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>00000053 - Disclosure - Prepaid Expenses - Summary of Prepaid Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/PrepaidExpenses-SummaryOfPrepaidExpensesDetails</Role>
      <ShortName>Prepaid Expenses - Summary of Prepaid Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>00000054 - Disclosure - Concentration of Credit Risk (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/ConcentrationOfCreditRiskDetailsNarrative</Role>
      <ShortName>Concentration of Credit Risk (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://synergystripscorp.com/role/ConcentrationOfCreditRiskTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>00000055 - Disclosure - Concentration of Credit Risk - Summary of Major Suppliers (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/ConcentrationOfCreditRisk-SummaryOfMajorSuppliersDetails</Role>
      <ShortName>Concentration of Credit Risk - Summary of Major Suppliers (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>00000056 - Disclosure - Inventory - Schedule of Carrying Value of Inventory (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/Inventory-ScheduleOfCarryingValueOfInventoryDetails</Role>
      <ShortName>Inventory - Schedule of Carrying Value of Inventory (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>00000057 - Disclosure - Fixed Assets and Intangible Assets (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssetsDetailsNarrative</Role>
      <ShortName>Fixed Assets and Intangible Assets (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssetsTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>00000058 - Disclosure - Fixed Assets and Intangible Assets - Summary of Fixed and Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssets-SummaryOfFixedAndIntangibleAssetsDetails</Role>
      <ShortName>Fixed Assets and Intangible Assets - Summary of Fixed and Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>00000059 - Disclosure - Fixed Assets and Intangible Assets - Summary of Estimated Aggregate Amortization Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/FixedAssetsAndIntangibleAssets-SummaryOfEstimatedAggregateAmortizationExpenseDetails</Role>
      <ShortName>Fixed Assets and Intangible Assets - Summary of Estimated Aggregate Amortization Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>00000060 - Disclosure - Related Party Transactions (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/RelatedPartyTransactionsDetailsNarrative</Role>
      <ShortName>Related Party Transactions (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://synergystripscorp.com/role/RelatedPartyTransactions</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>00000061 - Disclosure - Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/AccountsPayableAndAccruedLiabilities-ScheduleOfAccountsPayableAndAccruedLiabilitiesDetails</Role>
      <ShortName>Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>00000062 - Disclosure - Notes Payable (Details Narrative)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://synergystripscorp.com/role/NotesPayableDetailsNarrative</Role>
      <ShortName>Notes Payable (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://synergystripscorp.com/role/NotesPayableTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>00000063 - Disclosure - Notes Payable - Schedule of Loan Payable (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://synergystripscorp.com/role/NotesPayable-ScheduleOfLoanPayableDetails</Role>
      <ShortName>Notes Payable - Schedule of Loan Payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>00000064 - Disclosure - Stockholders' Deficit (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/StockholdersDeficitDetailsNarrative</Role>
      <ShortName>Stockholders' Deficit (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://synergystripscorp.com/role/StockholdersDeficit</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>00000065 - Disclosure - Commitments and Contingencies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/CommitmentsAndContingenciesDetailsNarrative</Role>
      <ShortName>Commitments and Contingencies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://synergystripscorp.com/role/CommitmentsAndContingenciesTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>00000066 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Rental Payments For Operating Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/CommitmentsAndContingencies-ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails</Role>
      <ShortName>Commitments and Contingencies - Schedule of Future Minimum Rental Payments For Operating Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>00000067 - Disclosure - Stock Options (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/StockOptionsDetailsNarrative</Role>
      <ShortName>Stock Options (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://synergystripscorp.com/role/StockOptionsTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>00000068 - Disclosure - Stock Options - Summary of Options Outstanding by Price Range (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/StockOptions-SummaryOfOptionsOutstandingByPriceRangeDetails</Role>
      <ShortName>Stock Options - Summary of Options Outstanding by Price Range (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>00000069 - Disclosure - Stock Options - Summary of Stock Options Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/StockOptions-SummaryOfStockOptionsActivityDetails</Role>
      <ShortName>Stock Options - Summary of Stock Options Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>00000070 - Disclosure - Stock Warrants - Summary of Warrants Outstanding by Price Range (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/StockWarrants-SummaryOfWarrantsOutstandingByPriceRangeDetails</Role>
      <ShortName>Stock Warrants - Summary of Warrants Outstanding by Price Range (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>00000071 - Disclosure - Stock Warrants - Summary of Stock Warrants Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/StockWarrants-SummaryOfStockWarrantsActivityDetails</Role>
      <ShortName>Stock Warrants - Summary of Stock Warrants Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>00000072 - Disclosure - Derivatives (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/DerivativesDetailsNarrative</Role>
      <ShortName>Derivatives (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://synergystripscorp.com/role/DerivativesTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>00000073 - Disclosure - Derivatives - Schedule of Assumptions Used For Fair Value of Derivative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/Derivatives-ScheduleOfAssumptionsUsedForFairValueOfDerivativeDetails</Role>
      <ShortName>Derivatives - Schedule of Assumptions Used For Fair Value of Derivative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>00000074 - Disclosure - Segments - Summary of Net Sales Attributed to Customers Geographical Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/Segments-SummaryOfNetSalesAttributedToCustomersGeographicalSegmentDetails</Role>
      <ShortName>Segments - Summary of Net Sales Attributed to Customers Geographical Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>00000075 - Disclosure - Segments - Summary of Net Sales Attributed to Customers Product Group (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/Segments-SummaryOfNetSalesAttributedToCustomersProductGroupDetails</Role>
      <ShortName>Segments - Summary of Net Sales Attributed to Customers Product Group (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>00000076 - Disclosure - Segments - Summary of Net Sales Attributed to Customers Product Group (Details) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/Segments-SummaryOfNetSalesAttributedToCustomersProductGroupDetailsParenthetical</Role>
      <ShortName>Segments - Summary of Net Sales Attributed to Customers Product Group (Details) (Parenthetical)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="snyr-20151231.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>00000077 - Disclosure - Segments - Summary of Long-lived Assets (Net) Attributable to Operations Geographical Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://synergystripscorp.com/role/Segments-SummaryOfLong-livedAssetsNetAttributableToOperationsGeographicalSegmentDetails</Role>
      <ShortName>Segments - Summary of Long-lived Assets (Net) Attributable to Operations Geographical Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>snyr-20151231.xml</File>
    <File>snyr-20151231.xsd</File>
    <File>snyr-20151231_cal.xml</File>
    <File>snyr-20151231_def.xml</File>
    <File>snyr-20151231_lab.xml</File>
    <File>snyr-20151231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies/>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>103
<FILENAME>0001493152-16-008381-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-16-008381-xbrl.zip
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M UA,5<VT8=5,V\5:*O39,/39 )92U31M3$W3=C&3"G$V!G&>G8TTF_!_FHW
MWZTM<S!-41H=9VE*PW.OFM*V$+9%9'2!M#J9UM+(B'^WJB3KC4NR5K>T=)04
MKW/U4=(ET4<_\#<1Y2*97-\"8"9.@_*KX-?NM&=?$:XMLX6S1 KT N#M.V]?
M"/P5UC\;ULL;^*3"^_7A??$"*LR?H[NVZHV6-8$;A_.S8CZ(I"O\>/NS8^8G
M#2QPZ#4C$MW7 \S@QN'J6>BBZ54S,,5!BB>'G>/U1>9?,$9MFF/E40E[IJ9
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M=3C-EV";L>$I:Y,4FT0?BL6"2 \E6*QI1239^PNCY)*"*ZS4G'BP1<!A%&5
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M5'J $2$K%CTUZPZ+5=#CA8YQ%D&*$)3SB/TWK(_TU2HD[PP8"C_6[2WHO5B
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M#-1"O0=JGI,A'.+DGCXH5ZA T'P-^V;LPVH5@#C$*9]FQU:1Q8)"5'8R4XE
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M,$B^)1*L)BIZQ+V3_*GQV+'2F]6-!IWV0+SC:;1(57,WW5:<-':G+5R=>K*
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M[E;!3%K[TZIA5H]2/H9PPLR CX@C6CCAZ5;2.'@LA5)39^#FI^%4[)SJ#@C
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M,=]F(0H^;Y>>VB6:I$C<,9E_@+%!,IV3\=(4NY+&6(7^9"[$W:P9CN':II1
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MGVF+BMXTJD+=:=B^31K4B(_W!AK[^&T2:4=D''YM9 [@U]0%P$]*R#E4(NO
M53:T&!#%55(0R-W(#^Q1H-1&C]@;8LBAS;!R,$DV>N(9'BG&,=E':D' 9DOS
M- 40B<W0A@3MDNNBHE/W9&//QY!-FB*S\9>*F<05I<"6CY2$^IBY5AYME]UD
M@2;YG@S,M>4;BAMML,*@KGM6 +*J/BML<@<%$9U+6%8+*,J_,5D*(75B2H=G
M>/\8R.6O1RR.N^!UJ@(\/.W:$=G31X]*@Z9^$-C3!-N.O;PE=SL7V\%85%R$
M>B$%2K#=B<@@3K.H$L !D=6=0;0NW!@X@BG/$BS#7?5Q#?!66?LZP;R,G/ZD
MQ4)U*WT*>'6TB]B=\Z2+;Z_H51+?-1A+RC^Q6]P'6,>#5]\>0;EZXOL9S/GK
MKP1VGO@BL(%@_%1[@1V 8,^PAGD6?_]-4XX+0TB6&:.=[*[RM]A]5GJ4T"*A
M1B2% #D/40)AD!2T4&#.2R"_SI.2]"OV%'2/[\TGC;MP+Q>X)*6$3AYV $_?
M%!I][B/(.GRC#H#5P0Z9B#51 ;\C7%(^\%_>:&_HWTO,:^;_SM)K;*;WR9E%
MC[\2Q/QOH,X(67=.&>++T/Y5$3^]2>E!4@(Q#V&Y@L8)-B=^!#?;]-.H@/2-
M60F3_)?;?0Y) T%X?WEC)%QS\AD10 R6&RLZFA.%<H2S2\(:ER7*BB*3Q7<>
M.O^QV9K39PKH+40;?C)1]YT8.AG&^SLS3C\&M50*=!-X>@C@P)ZA?F)?T_^Z
MNOKPX?JZ3-O$8%R[S?Y/E=G-PH!4Y#4WG_Y3V::N\\T*A+[=CC8#-[JL#@%B
M/E>>U>R9ZIC?Q0\@EQ<HT?,69-G0#H,[1&2OM.85>$NO\(>REIRX[9='AYMP
MKZ\=B/[]\5E5#0]IUJOR<FL]*9\%LM3):AY8VKXVZ!1O7XJWL[7[X-G!P[-H
M/-OPPE7U]6J?D_6<QWVO[2L2EC%0M<$I>-=5&<+/3/"'>S^BG%$9$W&2$+NG
M/6)<&+A,F/7FVI47)>'A;6VJJU.SB]8D! Y& W5@]EL3;K<(%0B4]G S:U"R
MFW]AS8GD7^TQ4.46HXY5(XN%=F'B12OI+W8+3ALVU?:FCNM0:)]%JC]Z[WF#
M,_C0);V6_4/@"5PFK1)+ I?]<UT3@<L^#UPJL>>P#]W$@?U&F=E39P&.XE_>
M?/QR_>;W<^VBUY=:VC1+Y %D4!:\/0H9W'WYY^VO'_ACT0?6C+XB _]B.33_
MND;<B6L+P^ZBANXS1:LD#K_=O9<9U-[\KFO]D=$;#/_[ES(2ZI,').F#E#Q]
M*,A[%]C6G[P5Z US"T.0(2-1?.C.CB*77J$N'P*;?LA^X%OP +^[_7&'*'Q!
M%0;'FCG6FN)NI?#OE\%'*A5A+VC1\Z=HEF,-,TIO>/.K''=K&3!,O3?>Q()0
M3Y%\>N]?LEI!H0IV^$= O4SK;HHR@C3X3[HE-LW9!(U]B<:B\2(:?X3.KY[C
MPOTKB&$;_]*0: ;G1I^+!G\>B/7\NX?'(CY)6TL[!D\RU>;U&\[0]B\^6F)#
M+#'^;.QF-@;:EER0$E\2[AI\!<]$ZHQ=V!A[X:)O<BZJ4G4H+L0'..[#_1.,
M#?_MWS_Z<6AYLSOG1V3;7@66A^8+X9AJAX^99UT_UX7EP)_-9LX*\9E+3#D!
M3]7RWOMX%A;D</DM+X?>MNJ> +@OEI83X%^^!B(_[>O\D^\]?,(68<S).>W>
M!1NB8:YH:I!( E_740+G) )6R<!2CMT#Y(^L(/Z88-W72YB*9N8L+QO!K9Q@
M&B\P+5@T*.+HWW8*4)[-=@@9#!@LB$MMZUA"H8P!-7=^2+_G?;T<6E#,&K,R
M"&T$]37U$2Z+E0#R##-1R<( .PE<*VE+6TR_2-HEA3Q9^G\Y/'9,N65IKA_5
M8DO8;"P'_=\QUBE&%L-[YREF\$LW_1TB]B&VV[>E[PF$=!JC7$J$A,_P]X@J
ME +FJ_'6=\2NF^MU)S48Y\ 93KH+"'B-2GS A("3KE@/B&R1U%A+&6H7;+_(
MR\,S3ED6*J6F<.0[3)XM:6$A,\3R[3B2:Y#IU$?I_BEH.P-<Q<P]N#UD(3T1
MZBQ,VL5GX&@S>.9Q:,]C5W&I%#^C:&DR+=-<1 M)JT81VAY!!A%VGP/((D&9
M=<<6-6&89X^#U(;Y%>-@(MCKB"/'$@6@C'.+I5X)?$7"!O%8D>K"(B1'NA]+
M<'L+D5J<*JK*\[48:6#$_84SS4'XRQ_AZ\O7(]LA,,SH$8X?\LZE"6&)A"69
M,,3UHAA0M"4[/*+VP)Q[HH*5K$TMQ+"3*9#6(Y>-R;69Z7!Y$Y,MSL#\.?J'
M[\\0*H]0V2.$[X/-QKXI_O0"VIH(5@YR$![/><=J-T2_U*3]-2+E9* R6*]W
M49N3?(ZU]2:+F*(=*=_XA[$Q)7U 7=7EE&_JB8!52C"$F(%E;4ZY@<5^X<):
MLOSAQ)B2<>=CR=4\-)Q(2.:@2L]Y4\;SL'.?5_"86==7(TE/Q);;8IN(!/_D
MGYQMP5;*4DAY2ZB!*_N:4VI^\2!UZ-/BVT2&2.]/W \"@DYL0:FIJ+S-\_;A
M%@P9=J2#+[['CF,^U99\8$TR7H!E$/RQNI>4P\Y28)Y02)#OY#>Q+C2^Y[$2
MA;07T4P2&L^YQKHZ_M[.K #\ W<A'?MD(UAQ#SO;R+5YL#V"@:7"FQDBUN*=
MDC8"[\@2LC[!C)A2):^@JWGU%C=]">$M+7YZM;U%Z)'L"R*$]&0D@LO48(:Y
MQ[2C* D2E.?VRT&HS%H9LK2*"&HH:;B&=A$+.A%)7^(H8"?2)VL"<WWZ=/7K
M5J;H15=??95@9PU^?)ZA+9+0-& +BQO >S@D,UC5L@-.:==DW1A*X,JERDU0
M_(3<^D1:5R594R(F65=PD^# <;'EDUT*,<_HRTW+7ILRW/P#/ ;EAH-A\Z%O
M;V[SOT++>O\(] "'_M3!6C4&:_;1FUXH9U3"8F5*4D4'^:]/7F;*"Q0/=@Y)
M6LT6A9$5LG AP;:[;BX*P?Y%E&29PSH<%ZPS?B+U&=EIPHX6Q :',:^_7GV[
M$](^X_WQ\!/*THW#K,^9NTV+#SHA554(A%NB)N!OIJRMI))=!XH6BSG%*2)K
M *\@C1>\2R!WF4-ER<*<[$K):_01%4E"^Q<2HDF(EMQ$')1)L1Y W@_H R9.
M.FNR!P.\'5QHR@(<N]0??MN_,,6O@ YGEM3[L=VBX$YAFO)V:&JJIFDL',+N
M ?P+,/6$>N5)V,^LSI^#/"5A(^ J.XZR<8QA5V(J'1X._O >72%G$K.&&(FU
M09J<[E18>RIDK9 (5[+WTISE5V0Q@\F$781M *FG9DP@MBN/@A4+)-OHI60P
MTY[.,G&\S1]^@--G41P.&R=02VA&#R&.+!;8"9!%C<CX,?.@RO]0_N[,F+F\
M>V89L'= Y))M4=?-A-L$,8$-PY]%_D,*SYERR25"L -D?@O6;KGT'>)!,!#R
MB*5@8B8$Q7KU^G."YV!!4-Y%A=]Q\7N%"?$&<@77XIFELJZ=5L2GDH\,@=ZK
M$FP'MA)&,X.-QL+ PH:JMS'<1-@0L+23\SL+KB%X\L^Q12,+QLI+RAY2DL5/
M\  IY,%9Q:!U&$_$*F%8D'+5J 8:8W[PQW.)_3"-L2CEZD.FF="ZTMY?1$ER
M\8H$EM?J02Z4]W'R%D"M1==^7$U6#G]#\6D&"YTV+)/[HI,:14EW6!:Y%2@X
MQ=5C\%W2=DPF">,$<[[D:Q$+8(L>6OS(%@M#$1TZYRVXBH9@%>A\7\(.04"-
M!YL?2@FX(#6'MG[8'9B!!%U"^_0[?T.T**3-] 4NQ=)C$V\()P6O^=)QO4ET
ML[",B6HA9@:^(+FB'1KICHI!=42^(,.#NC1S[%#-S48TD*$$&MEXY]*:1X].
MP-K"P&(C]-)YJ?W$[8BJ"ZZ@_=TB//3()M^/P"DYJ I']HPQB(\/8V2>B%GY
M#%G-L.ATDYAJ2S1[X3A\<"?P ][^=_/65((8>T2#Y%Q%-XD$@@U)=Z8<"IT[
M :$JB]D)NX0M;9[0G%%=1P*UU+' ?"VLB/7EX7XRQGL((26>4I@'Y*V;YU0\
M+W!/.. 5@^+B:R194INO/,GS*4#03P^#G-R7=2+>]XLHPN GJ0[.>V:Q39*<
M4U]@W6_Q3\#V%QHA<W6Y+[% :,@=>1,X'&0:C4IQO*Q:DE3 J1?Z*4PH*6#
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MW7_*.,C<9'XL'9:H0DU.N+;-?!B; 3JQ?O#)SA%=5P38K]0D=@[#*Q):I0!
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M!&?R.;P%:S9%D10.PXQ!^E\"F^,P\ZX*E)#B@V<8$-J*:"Z([?M\1/#CS1O
MXV585W/;YOT)": TM DBAP"%NGP3*=]$:C>8K!-(#1%DN?%'4D3,3.Z%D<3,
MX'^F=B&@1 &S?(@L$P!+ %1R42XYJ,5B6D1#L:D9A:26R\#_01E-[K/R%H[Y
M_LA0>X,A:S2AJX8^4,?&2,60VE*TX.A4H%X3(0Z$CR3=2YW@%>SNTK40*FT6
M$7NV8@RVZ!_TQ8X#Z\'VE"L_6%YD&OE,X3>\_$4YDT"I^3?R/1.PZ=_3HX]
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MJRO(V?/=*PO23'[.7;ZR@)L&+"#8M6I 654QP(CHJ@:ZJH&N:N %Y D=8]7
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MKRZ?K&#V=4EM;NDY,/SHW=B!X\_^"/PPK*E$M.QLM!O7*CJ0*^[N?2WG0+?
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M-,LQMZ8__(:;UV PK+K5Q>J+XO1W5NA,\1AUW#BJ#&98$5K@7+N0TY(WS-T
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MO(!OD6.<<XJ('MFO^W9Q=R$Y7'-[1LT@\<P5_ES9H663+X4](H6+EE&!D.F
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MQMG)^/F%%X2L/([)[BB<>SXM;L@<_;3>=%L5::Z*.9$L5[&S(AT;+EAN6K8
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MG6AMC%93J@36JQ50(1("QZAKR5][0"KR3IW)80,V,;SJ\H=$0RA\H_0T53D
M(I_).,01<7A[77M!N#F$IL4^5?RYH@T4_^G.MV>\;.2&",V\T_+)?FO@-PN_
M?WK^GV*(]5N!UW8]X3 HH,F=N/.KF]_[LY[:*OS$6<\PVH!7F13LG2C<>N[L
MB?@+?/#&M'TL;]K@Y3WTJ5D;%UP(6P4$:J"]IO7 QE7T_FX^*HT)W2LW &40
MUXNU;BQ\ LA\8@;D,V'_/;:$V^ 6R@=+18&O&^W#G:Z#HHU+QSI+C7D6NSXK
MHF*-A@-%'>38-_UH^05KU"(VC8N_L:<X+![?3+/%MFKQ:P>T"H8U!"0T31D9
M6E]7=H31!H8PW"4F<>.H9];H('C G^ZF=U&(E9<!E528$=F>O57WGSHO0(=5
M*L,'<$H;O'TWI6.F'^=@6/.QV>I1=>S')SZT>XU(#*8U6:8;([!E,\[S[<@T
M&/7;LJCWC*$^R'H<#H_ZX2ZJ#3@:H(?T-:/%.";Q\6_F3WL1+<096Q]H>F]O
MS''8X]V4L]2=_X"P?_E)_(D=D'O?QF@V_V/ _QJH!Q>0FX\WR,![XE.4-K0N
MJ(19.\BS601L(X]RF:U*K(4\>9V0<5Z(^2V?:#,OG+J:LN,-,>GT[6;<$P67
M*6@E(V.CQBN&7>LHM)675BFD@XSMK]K<C:'0@9PJ[.WX+(@X)@RCIV5UC3=(
M)C']55/Z RW;#:4*I5A<.DG-@-N/7GQ@VD[F8)6BW? #VV/%()Y03&\PMU&!
M*8M%O=@?R&^TJ1%.OP+"Q2SSPS594B6QL)<4;3Y6G\MAK[6$FM]H1J^O9WM]
M[%RJ3MB.?]GVE<&@I[4:W3(WYQF@6_H:5$?:L#_LGQ'2@DZ9&O!F33QO;#>)
M9FRO,SJ&1TX;CA3=R*)5"&5]R&S(!4Z\:)%+F OMT?ZY[D7+/_S_(M,/B?^%
MYFD_DF5(__HTM_V<!^[1Q!*LY.T=SC<]O\L')L>QM=A>;Z@/2N.7K6FXF[*'
M@>3;P]7%E;H'"+RIO;ZF9%-HMT![0,P:SMD@"GIG0:-290,GPO/8M[+1'QC[
M(<U;^V22C7CZ41P,//$%E:\LW0YJ<W#;?R<Q<[5W1CB+J5=K&0>E\?[NA?N&
M;FC=7FR:BD;W"@-\::^-G45O662SL.^!5Q\,S1@O^+E_B LI[NIS[?E+$3%L
MB&-8Z+3.%. =S*DA>$B%HU,[\&@XWD4'53@\=1S4CR:7&[;EQY3-=6\Y]01F
MTSS*=F[>6F4@]&&Q0BA=Z1O#N,GCVG>W)=74W_=5\.M"3LC>2-64_H:<FPUE
MA7&^W\&2O,0^+Y1//S*&H#2MYRIN2RVB(?2YYUC$#[[\;P1W)'8>] /"8NM+
MT#A$.Y+\K:?0T8JJQ,>N2 %^0PKH1S+-A'<ON08E'L5/.$(#FR 1-UA-\OGT
MFCX"F.*OKA"$NR4MXKOQ_"FQ,9H",N*>^+9GE>]HLD$>J-B%*G_''P#<U7:G
M04(K!E9MZ.A&+],XH6"E]>22Q<)SZ=[]01S02I_\J%BW%JEM64FX+_[X_B (
M];X>[@%",E0)9RKE1BI]P5E&E $^X[R0XGW2TWV"GWLT=J@.+I0> )NI4!)<
M9#-PF+\:8//7I%5-X?$N@F@;R88CK5<$9L%RE6';XFOX[CTS[U#&+V3_%/27
MZ%IVUT^&0SRS>B\<T'AL  Z[]B$Q-^$_ONG8IOO9<YR"-BE7/QJ*X:Y=:@F&
M5"(K@_2&4(:)R1R- ]NRS8+!.D7G7]\39&QV3)_#B;1/<$$&)NT>GGFK#@'5
M4[**D<"B.TA[$^'M_,UV,9>1W^#!YZBJBJIAQDA_(REWK'HPF/?B"549Y$8K
M' .5K^AWPAY3^P^^&&A;>'GWNH<$?*]M& U[)\!G;_+K@]%@L_C;M%S]4.Y%
M:TTQ^EIEX*F:/=YM/8Q7K0=F3*6A^(!6M#_-39?;%5=\ZB;L;^C;;F!/:#&$
MF-ME1^IDD0ET(B36'<=QI3CK2U>C_2[R:;%Y(KK6ZP]&63]Q_LL55HYY^0=V
MZK/H:$2A ,Q 5U4C.Q;K #"!J4OLF<MF^-EB<&G*4*T7*+TLH>K@"WT?2H@,
ML9M@([)B'\06E:ILDUE#ZPVR7=W$5JX/WK+M9[6AIF43/LK!2[TACY,YL2*'
MW$W1I<8]:D_T_Q$^SE/8698;F)K,/UV&[Y)Y]&(35JM.>T45>.8#TUD7$\_Q
M_(\X@CDDJS-7,_-P*30.^A2E)?=8FJ$46T123Y4E1)0.2L6]D8"\.-MVZF%+
MJ>#C 9'+3:W=CMON<;9LX#D. 0N6)F8-(!O1?R]-RXK_O3:%=Q?,+[85SC_2
M2=( H>=;Q$?H'',9D(]2_-.[%!X$Q8_7H0GC$].)]W'LA2 \TJ>16>D;5@&2
M_)?[/8>@ 2'<O[[3$JPY^ P( ,8!@DOJI0%4"#S'MO(\ARG0(-%B!D>29<EW
M$=C_)6S?Z3-K'$5APR>3(U()H=8@KE=&G/[H-YJEZO[V:6#8@]!%8NI_KJ^_
M?+FY*=J#^&-<C/2U7X7YZC8KLP5Y:F4Y]5=A(FUX4P#.7_:$K?]K_MCY&(@5
M7E759%WIR\9P="K2G"%1+PY RYK.6$85*#C= KAE,MU!TQR'DL7SW6N^IT3O
MG-),5.X2*[?Q[S79Z/5E714]3:(?_JVCKOBQ.N5%)8K+DQ>:SJE4.P[7_CLQ
MDH<#158'RHDP.!ZFC>&YRH+[E@3!1RD.>RQ1AGMN)U9 :/?D$:A!2K\4-W="
MNV4'J :AC:EE%V#3+DYQ?+1+#3?$\B*P8PZF .]>N@HS&/+(&,JJ>JI[X^P)
M?)#3]H'Z!'._.H!+=MV5N>(4YLEY N[H?!_]-).-%2#<>/ZU&<SKB 9H_31I
M<-,Z>P-3UM4?5Y4<#9IT^E/Z':%X\2E@O+(L.Z2S2^Y-V_KJ7IM+&U1PD12Y
MT6@T/"K,/#:6^<R3]XFP3Y4+D-5*P@<2FK9+K"^F[]KNK&2LKH[#N"?'J8?:
MO&T@[L]PF@$<=TR03\AOVRAX0'XKE3XNQ'4;$LLU140JYW/,]X1\W_.R*26^
M--S9W'&;SCD-KEPKZ54ZJ6>ZR)ZK[#F!.#O-%D<SU#ZS=J@HN18R&Y>K")F
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M)2?()E*FQ2W.09G,X]]3WN6GPW:E&7'IV"WV%9QS%= VS' P^-IQN0ZVVZ1
ML452KJ=09$Z@-\TXW JY?P=3KYX!;EY<(S8N/.>;;F#22CXL$J7_=-AJ9W(Z
MLGK(5G,M/DF<0DR\<C))&<*L'*N<!O,FSU@9*C_Q>VL:N1/>W'@2TSANW;KY
MQHI]RG@#V99M4K<R;]7^X_+Q4OJ,3EI_8QED\EYFS![S8H=Q339OM(HUHAG0
MWE]%>)0=VW3Y&K]=2E=P*R\\EX3X/>XSQZ,?UV?SJ[H0:.KJ#CE3\6-/K\$,
M&ECT![=@@)!@^N4%]CH@/WF5.':6@6W"!LT'!R),I00H%:\K0%Q*7UE?:)/"
MQP4=2#"D:=+U. <H^^O*^K 2!2'_=1#1H @!*EA+FA;NYT$*V>*LWS[K4AUD
MP5E?BVTSZ"PX8R./$&-0GO<*PM?V+,91K$J5]4A.Q$%6KY%I)(E6\%*"A.9/
MW".Z=E+R#U? )@&/-\T#_,%$M6@1UU-CE^ZX23<M+LXL7K2UO"_ NF!*+XV]
M;X&=(U_9_%/\Z<U<&#D:,'E2, BVD3=&&73SM\O1D2@-\%<WL9)<;!/@H$O5
M#ZA%% ^HR]?5)UW\)VSOL&M3@+*+SB2-2ZY_E^;>"Q@^OLQB@B'5^;"K!ZN>
MI]8.2 R<I$E[#SBO,H4BMQ3K79"NE;;=IS(AMR+O;L N+&8.>B]HX;%X^!+D
M@HT14=[%'T@PF8/4F1-LYV_B;!&+04 %$78NX&JH3V5>;KA)]KHDM$<2USTE
M/,)T,"SM80__E253FMLS%+F3U3'('"LZW)7\Q)X)V!>!G8THQ$&"M"M#P0!,
M%N+G#28D-Z(Q-?QB0@TKHB  .V,#H B(/XZH(KTT0VR<$.R6?UO$5BSAZ.3K
M?X**/_>BL[08,[@Q>Z:S%U.B$&[B<?..>F#@V(!^N#3]\!7[_;#G*#P^^D*F
MA.L<>+XSPSO8AZ@F1%4'CZIIB['SBI=Z $?,IB,^)G]>X-%847_S:2R@I?@S
MID]EC$UFNA8:G'GC-7L41/A[\YB@<SL)M'E3BIYTFZK/W;$(?[]ZO):&JA$S
MG9/<E6A[8</+B6_3WCG4\<<N&WN*+6WDQ/^7SG_%[K+V-/*Q:Z^4&4G"9N[
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MFE)F"5[#%S@$2,2N,IBGETH1RWONF>K>1_[H8H0PVUO+/:1W6KI1HM@6O?N
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MFV8T&37%_A_T'>6P1GY52SMKPNR%? TSX\V%M2V5)MJ"2!W X#!CWU#/3U*
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M)_(&ZFYPH5SC:#D)Z8C,$WU*=4$PWR^#M^?V^APFO7:K$Q(%\M*08[JF_ZY
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M,MMJAB/QR@J5A,66IBL$8/'*[%D7U)6TSMWG;VZ"2."&,2_?SU&,R),N!X+
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MG?0\81 )$GOK,U:9:]7=M&)8J<3*,"M" > EXKD"/J- [=%ZD:G&$$! <ZW
ME!5U&2I"@1,5!B!P3M[T'IWI<04/N@#:**V'[H6'(I@P"8'XUBR(_+6)!(DN
M\#F[S4$ EII.M6-7O%8"N(A7"9'3;.=F-_*\1&[\(0][U\&YN\:1Z\M0$79K
M87EIATC. (A74\ JC&BW?][GU\*$G*'K,(R1!\J?=Q'TF%;MSK:(7H5V\-0Q
MNTSNN7DR0-ZE2P,<+$+9^JAN/ZW:=FU!1TXY>)B8Q:9\5Q5IT_MMI^_-8%+C
MSE-)LIW'R</2I2C_5"V 8K^I_4A44@SN6.87Q3U:9^%0WD5,>7P@HIAXR=.M
M9(V(NMH/E!('X'9F+7#I!&R&7-JWU]#E6("P.S6/7:K2E*;<+?J6_$4&GZQ[
M/Q!4X@("\9V-(*:3KSF*>_W["F,5&Q".[UN[**5T71'*,^3*;TF%YO9*7DHU
M).@/W0@:/'Y$A-M^[BC2#HG^9[VB'WG_C,/4#7M" !M%SOON=Q1&R*M*:+B'
MSL'CV@V@'O8@C#_:>!XEK&QGZP.B3WC65+DH#6,OVHVY$3T5MKIYCKAS0S2>
M\YB*Q!N."W!!$<H_ \@V4^$@]J+5D!<#IE<%TNH=?PI#?4^X*1R5QTTM(C74
ME*I<^@J*2KY;SU"IHAY$H*EIHR$"M17&<N=^HZ&R*IJ:+!IB,@ZJ3'\JS+">
M_49CPP (15/#0W,H#EHAV_Z]AT5EG;1M39B0!Q1%/MJ+@U?%!NC>,VA$7(#(
MM&U^ (BJMW:$@WP?**FLHJ;VBO;OLDRMS&HV)BHF^W?$,Y,\H!EKF:\)4N]N
M*QW67NRU<0?.!BLM&^DTUC\=%,?MZWRHPQ[X9FW6+5 TT\?14N1P(^W:5UCW
M. "1L\ '!YJ3S:#+]>TK=OLL@."9]1796L9W9O1=V@D8-V$WZR&34P^B9=A!
MA$\J7OO7XPY]* C3S,^<\$7"^=G+KDF6G6?TS:5>]M21/GY<!^D4W8KA6.*I
MU<(7K9\CK3(.3B][?5@DUE6%@ZP?AM8FC(!PFO5FN451FK;YAH0"S K-K >F
M3"TH_9S5Z.^O]QAAG_G:95QPN9QS(8CVO7I8,!_)R89J/2P8K/I<H/X#CX+'
M(0^W9*W9_TB[<6J9_N/L.K<?QERO\'.!BY_WN<@&2T*7=\,YN_&<W8"M<U99
M*;I _\=]^HM=6J>PJGITGL#C-_L$ICV<K$L'(@1+21?H/"X+,NWHY'NV3BY4
M8;I Z\D^K5DO9]>M=4+EM:8+)+_=)[G0/]GBDA&<=(@.YNU^1>H"N:?E6;MM
MWSIMBO6H"P2_VR<X&<1)NR1)2G;C.)N!6N=$6JRZP,/[?1ZR[D[2WRD.T-G&
MH52UNL!'Z63<;B796 D>V6A.8;CVS_:J(M<%ZDLG8M+%V?;I("L)7/&Z0&GI
M["OF&MGV[6 OE)>_SE-^4CH4<R,DDV-OC&YDOE\BNT!RZ7Q,NCC;/MV06*J:
M7:"Q="ZF-.XZM9]7JJ*6=H'$TCE8Z-&^$/<K;!>(*YUZN^8=*/% L>T"A:5C
M;M?-V?2SY+XAO'><E,XZ]7N'\[?-OSK)<]6D_':!U=)Q6(?5=. N&!64["ZP
M4SH?\QUW!%N0=ZAD51D26PV)K72B=.Z[89CECE-,:E7NTI.$5A"OM@7DY^F4
MY4JJ:FLXC14H9B*E'#0)&TY]=! @O<A<U1BT=E)6 6Z&5^Z,-;V-(YHJ#NYC
M>'-S+DR\(^HR?6?FT40P]4D-RB&IOS.==Z?:8G3VDO^+^+"I,X;=IT]]:=B6
MEB1/IVSWJVIKYCAJ('<8.,O/I\,0LOE\:@'%3@^L_PSP8AE-EHBZ:Q1'>!9>
M!S/A>27H82I'GV E$'7"05U;<X#H;V[@?;Z0J05[K4SEX%,3;16QX%:D69QG
M%+E?HR4E\6*9E4N1SF%A'U,)]=1$+2<=W#HT"WZRIOS%,DN1<!>]W$3B%)-P
MA^FIS2*7T W)^]2P]_2VUM8]FI%%@/]"WK7'.,!SO'WZY69%FI0ISCT1)K6Y
MD)<HC1-V&)XQ*K_"![;F#TT_6.XHU@:_=MIY-OY5YV3UB(/$B^(!K5W*!.6_
M[)C/ZSVJD^;@H:V?)GHXM//&M>$M]RS!SJ(K7IDF5Z"FQC10'*@WH-?A!SRO
M#7N9YMSN1&]5)0^)O/-=MX]K^UYX K+?EMPC*GSQNJ1^SRE/1'K)36+?-:]+
MND$?/1$')2<*D:=>E]QL7?!$U)?\*[:]NB15[,$GHK_D@B'WXS.QCD5.<2+V
M2OX;JJYQ73*9]Y$3,5/RX2AXRG6[T$$'-!$#)<\,H1O:X-LP^#9\][X-P_N3
M[O<G>]X3A_>GZNOJ\/XTO#]5&9&Y;RWVL$M?A*;C_69VOS154JO]>4FWF?@J
MYK&5GYD(5_'JGDTZGNLX"3\/KPC-BL8&BQOD;NZGM8S#!PQOZD6F@4GX4"ZA
M6?+&L#$H'[PA4O?+L:[Y$(XN[RN%6 X1R=4A/MN(CBYIS@5J""@^+=FN<OTZ
M%7$6NB&BM1S3DW7JE%"E (,+7J7,#V\Y\%R6U0R5 X!JA!IDGW"VW["'^Z/=
M)I:\4Z4K]DN8I-;,Y;G/UL5NRN4L*!E[U8(KF<UJ"(XUSJCCK7/T.9Q 9TZH
MPTET$AIYDXS*W,HH6GHR2KL.^E";8B4#73'\HV(266!R&*PE@[6D#90F?&F,
MY]>!AY^P%[N^V# "-+?;!B+DT39S1XG8/W"T3"Y&?'M:XO6$7++M6W[3KCV0
M&4.)&!P)D&JRL<Y@8@ICFTTM+<Z#;F-4R"P.T]B-C;N".$ %:F^H:'K3-484
M6;)SUSVG*&'P@ATGXA.PW-+NPP_BS#:GIXMT_[C"@1O,L.OOLJ=QRF7%N]5Z
MFSGA0 1( Q8L/=':1\_FLTLCPIV>5?]P@]BE+Y-OC ;V7S)9DCAT ^\!L\LX
M"H3GEE)?4P\)M=82:<(4>(QIKI@%4H2X4U1CD(J]386_:(>I@BUPP]0-5!R@
MR1+3^@M)VM&47VYC>-0X@I#YH!F9![2.DJ^6:+K"<RD\BKVG/_<+HSIL04#]
MK$-C#-'LIP5Y>NTAS-6-4_X/#N)I3LM@/TUOT,+UTYL'H*"S5J5&ENKF5:2"
MAWZ'0I98'5@3HR8C@=@(0&&K^G([8K52TZTM>L-QUF<N?70]TB#>NM2S<_\(
M:!(+HZVKR08!T!RM^H4NV+2Y?WY OH^HV.)5V79ZTK62HR!E :7@OO+!;*F1
MP?M5M_>KV=H>@_>K[8\Y@_>KK=ZO>K.O&*JP<GCV%5&QE?=69%\YMCI!126U
MH/VO<5Z*SA*PG/0X \N)2*D]L3D'RXDA ]'!25A.1":@DY]-%[',M,!/B"S8
MWK?$,YD+DZ"+W<JLE->*5)!FP4GUBSRY,@5)T,5P6EM0Z$25 4OU5YTHV:S-
M:D.R4QWVRX/8EI+]>?K14 R/=+H3@%A(@!\-VT]XG5")>637Q.X#H\1+A?YO
M7M@RYY!"(T/FC)(@*P1MN8=.75G;O)77P*.=S5H/))_=9Q['* .ET,S41E\U
MQ8F$3'"+-VM2G; /C.>YDM"2D(?JYG9O_4(>*UPNC *2(Y,GO[DE@;O[)6]X
ME*V4V@,9"GD0@D,.8\G2X\<4QC8?8RW.@VZS3*!93+E7P(*BA!Z)0U5EZ^FQ
M(;-DTQ5&%%D"+<5O-?NYW> 9ST^HAD)UX^FQ(5=##2"(. (QT.UKR O LRT!
M!PLU&,#VTQ-#KM,:D) P!9Y0NGVGDTP3=S&=+5W592'J8NSA1,<.)>4+?E31
M[HX;1>D)J7I> .VG)X:>#;6<&$*F0#!.S09I;>\>#VRO=2DFBD\MQ>9V7YV$
M/%8X01O.+Y72^"4(UVB6I,B7&N_A+H:?6"H%OI\*2L*O=1<?G0C9?)G1@F+7
MUQ82>'\BE\KN*X5FTV-3;RW2N4]D5(-Z<.-7%\AS8LGK<TAEN]]L>O*F![*M
MIAK>?S3+END;,[):HPC=4?*$^>H5"AEL/STQY--62]H2\D&QOS?[D'@>4XJ"
MF<35NMC*;L6HBJ,*X[[>R3[R_>R[/ $:='#RII4M#47\5TF*2$C5KK^T(5&;
M-9 &4N]4WQC%841='[O!!>'Q),)-N[KQ]*1KW4,V78D:R>#D-NSNL<D>.R%9
M3;%-PAH4?J(D%.S<LI[3M[:GU57C $).]^)8\:R46>&-+P'[1,E:!:T4>4^+
ML:C% :B^F]5T\M6%>$FA.Z9WL!_<!3H6:#Z"7A;CI4P]N.,9QBJ,QO-/A'C<
M<OF Z!.>H?"!^!Z;A#3"?R4,B5!3Z=\'_-3Y /4#O3L@+R\VBY!W^82"&%6=
M/+S97BN+)0U2"\G3K%?0+8K2TGHWPF._T,QBZ</D0N(W'"O@^BB\1\D\840+
MC*/%AO9#4$DP!$)3?UQ@3]F=2N,YIT,H8-X#[F"QH%4(AP1NUO.MI(+G@K!J
M7#URO2R&29EZW4]MT.*@*&0?S1+OIZ5%-L1!RT/0Q6+)JY&NVZ*G9XE<!Q%B
MI$=9]55X5>PUM!@.$<'@%<]T?L]'IDB$$8TY9QO*[QFG";O>;ON% 5(?PW[L
MZO("PFKVZG[%!8IN\!/:+W'[)43SV+_!<P&@*KWMAU*="Q!$PTXY+D_8G7AX
MW<9<)NQ_+%TV'Z_#,.9,Y5R2Q'JUZBCV@UJ?&Q!<LP;JA.I'-T3>.7\$932G
M M[ZFYV][)IDY_GHFTN]C0GQCN(9$P6O"TR"U TPW9L$4Z&U;_9@XK3,.SC-
MS%H_<NLE88#1G+"IM%\4>O0 8B'E($!F[2.;MQDVKQYQD)J=T8PL OP7V\X\
MQC:>8W=;H#Z[6GFC(%_7/:GLQ7<_GB:9T!<8W58^9__4:)%M<%X9#L$F+ZX?
MO4AO5\5V]B-912\(05,CD(+5+7W;8Y,(/6'D73%^'N)'/PU5J;0S[QNSQ -8
M#$031D"$-)M^=A$J5PC=N=@#@"BULUS> +V@6,V:=K9E+W,5)R^?V93!F1HE
MN'K*NEH,5#T6P'=DTS6+\U4SCPK:[\A/)@V7LOR8' >78817W&BRE8BXTND[
M8?W.(V=#BY,0X^RH<5)RG T]CAMXA;JE&4D.:[HE*E?Y-%_8U((8G-($&TJ"
M#B5!AQ32%J:0-FOD'5)(#RFD&X/T@Z>03JM8WL9,_TF4)_<QE"4W%G4Q5--3
M+0>LC'#=NULG6;L-95$X/&NWL,B<%5F[#16-:Y:T6U@*SOJ4W3W.V-UE%1J=
M^;JM3DDOH1N2M_;<])FY/'\!9S/@BM"5>^Z&2VBN2[J9*K6@9F-3HAY"0+-Z
M(J)E-)MQ@VO(+:[X";APRQ@J#])?< !>.E)K1)2)'N1D7.V>F7H+3)$%\)3N
M#H\[BM8N]K+'(^B5IL8(_<6FBA'P..\.H2O\C+S4G L[LZL/T%]\*O@ 3_\N
M-[2"(UU#C"I&Z2]0$#,06DW=31J@=>:3Q0+1"S=RN5M3 Z3V1N@O2E6,0 AI
MCM41ZI5Q&)'501#M#]%?C"HY@4#2[-HA6>&\3N@LBEV?_;9&[ K7;-<K#=-?
ML$!N(, T>WJ(:-O/&-L K/TA^@M4)2<02)J3_(CHNB7!^5[ZIP8X58S27Z@@
M9L";;(=6!T;; _'Q#$>)R\6!F%4.U6O@8(ZZ,O;745(W1VUBE>0-EWC=Y#JL
M-&Y_<55G#P2Y0^L&SWKQ#2=>,'5QW'3M+U0%#D T.K1D;*R26?J? VRTV0C]
MQ::*$1"B#JT9F2]Y<X2* _07H H^0'PZM%^P>4-C=(BY=F^$_B)4Q0@(48<&
MC O\A#T4> =L<_M#]!>D2DY E#JT8&P54O:_TK1!$_>YT>M'Q3C]Q0MF!P2M
M0RO&.%HBVF332SOV%Y8<_2 .'1HJ)B1R_5PT00-$]H?H+S:5G( ON]:'LB O
MRU:4-AK/TWN>,$SE?:,P%>0Y$<DW=<A\$[<R1)\,T2<]B3X)T>RG!7EZ[2',
M 3KE_^"XG.9P83]-;]#"]2^#"(,!):Q5J9&E$2-5I(*B[U#(*3U@8 %K4FS1
M<<"'0&P$H%#E)+%,K%9&:=06_1!\H:Y,0;/6OI +_0[K77M/*\A:3C D;=UN
MTSK=U-_9)V@)M9"4WYF-DAQ*&UJ6JGXH;3B4-K0CB+5_I0W_X0:Q2U\FWQC1
M[+^$__\EB4,W\*[P/$)(7#%.M;NA<-9:Y>/J\*)[(U1%)Z/G 3_7AZ:JKZFH
MU\.  3D!M>"N<'%Y?$IC9(J]387-ZL&F@A=PT9A5'X8L)DTY 0\I:_ <LIC8
MJ X.64QLS6+RA2X8>_?/PO.KV,CN^/<*6D'CC68EX981Y9TO"9XA2=7EO7:=
MFVIJ2;2:7-!6T[Z[*@^ES_)KJ[^DYSI-/_3L[7R?]JYLOQ6O^&EN[+K"+W3K
MG?C+U'=T&ZR@)2'E#Y<GG8^RB@7J,%1T[AT8$ ^Z5=.:D#2"HL\0*(B^?3_L
M2Y<&)(YJ[T?%?KT#H()\\#BVK33!.5.P<<!U-)Z1&C,B=^F X4M!S8'L1?0
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M"B\98LO4$% ]!%37?HDP'5 ]N(YTD!QS<!T97$>^9]<1O5$Y]CF42*C5O75
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M/<5=Y$O@IMP@;\.$ZK9:T=5^[!19 +$S:RBZ0'/$[[%7.-B^SMXB(6*5'?J
MDX!P$!VS1ICBOI!2SG9RB8> J)?].,FI!\$R:V'9O)UE>4QA?/8:V@]))<'@
M.[]I3YHU"7&4JZR7%=O;,"':VB1=[4=*D040.\,YQ7E-0:E%,M_*?D3*U(+"
MM\E#YC._Z_$21HQ-5?4MW\=^8&2T@S"9-6OD2W=*UDAO7E7+U(+";VI>4#'\
MN3[*/"6J->"2=:S0P6(QJQ .2MRL78#-BN0)=4(27PB*KH,G=HPEO\'37]3+
M8IR4J0?!,IP7ALVK4+B$<E;_L!=+1T0PB(+I*SW%3TD-YIP:*#K#*YK;CXB
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MMA:.7Y>$[]<?O9$D?K0)68R#,C$?BQ3\P-.Q0A 6F[E;$<'OR7(T.1N+%/S
ML[%"$'TR/>L001;)9'9"EHCX@>=DM2QTFZ&AI%A-V:H(#Q-9)#7HD$FF*TO)
MM7?Z6B\U:*(WS8V@>Z+7U'!J!N\>!(]&TK[3":Q;0M!D;9HQH>ED!6/M-ROV
MT!P(2E+72T7/IV +PH!F6]/\!YUOC;FH>:OV146Z>CXC.Q&/Z!7,Z"OS!5MC
M3TPD3.'(7GAO^4+D/U2_)I_LOR;G1MB^$CO;08;WXN&]>'@O'MZ+C;];#N_%
MPWOQ\%Z\_PQ;1;.=#\9O19(WNR'M-* ;[#YBG\D."<Z#RN;65S^"J890,;L<
M1BM"(_Q7HNV/YQ?H,>):*XF#Z(ZB%8Y7,$#2KM:#I<:!PO%N^DYR]#!;(B_V
MT7@^"L-XE=Z\OC#UC]V^KEQ,?W?]&'$6-UV$KK!O19>7(V?S,>X(F_N<P[_G
ML \Z_(M.\DG>9-<YYQZ[$UU;XGE(3[6<3_ MBAY<'X6CB#5_C-E%=$+.XS B
M*T3#3X@LJ+M>XIGK9UV%,CHMN0MGWRLZ"K-O.LE'G=U7G8@XV^\Z^0]O!AG\
MB(=[X?=_+]S2GE\"XDNBH(O=-T8IK[9='[.=*$^N[$8CZ&+F4BD7.E%EP-++
MIDZ4;+Z":D.RTQ1*7P+NB9'0'@I3S)0;&G)1EJ\ (J-:]W8&R);IF0@O@G.N
MK5,LD6]UXQ8FO'XA"T@')6TXZR!Z0D$LNMIO6E@?=5D@5.$";R8"LMY%YXX2
M+YY%GRB)U\(;SCM=-YSLBT[RR>%J,UQMOO^KS81]8#S//9^+KS5 <[NO-$(>
M;;O.Y'UK1H%W2P)W]\N$_2MT9XD52_8P4'L@,U<?,3CD,)8LO0R9PMCFBU.+
M\Z#3J]05F<7A%?L^H6=QR$Z.4*;Q ^T-7:R:KC&BR%)7MR[?C29,]WN9(%<L
M_U)#4[<M'9*O9D;[_0L0>N)1)Y1VKH4I-T,-8M[G CQF>G.__=B7^^W'[_I^
M>^=2-L 21=S44GW9?=_R9=?Y6X&(X?([7'Z'R^]P^?V^+T;#Y??[QWBX_+9_
M^:UW ?@N]']K\\R<DV"&>+IMSLP]#K^>O?!I)C[BA)WL/N@4^+4M^4J)9$ZP
MS"U"V,G,,:8B>@E89<ZM.[ATHV7S@:0549NC+)([<F9=8'=FF<Y1V=S00::R
MAH@:]3W9'N_8B<%^<!>B[-RB7J;B8Y1OTU+B^V/[NB'!XLC'3\@;A2&*0C;A
M-J8H?HI/R)@I &DU^;HN[1_4;& ["IR4!.=OC(A_<_)D<)O8CI#!QWVPA?V@
MMK#!Q]UBN]C@XS[XN-MS.1A\W#O2&@<?=\N$W#\?]UMVH8@I?]!-56!X*]IO
M:;W/>R7!!]R/LM_Y?WC](O;+_P=02P,$%     @ DF%^2-M[N57V?0  O$\'
M !4   !S;GER+3(P,34Q,C,Q7VQA8BYX;6SDO7MS',F1)_C_F=UWB.NYO9',
MR&Z2K9&F>V9V#0^"C1$(8 %0?3K9F"Q1&55(,2NSE \ -9_^XI'O>&=517A1
M:[8C-LH]\A?AOWA[N/_[_WI=I^@9%V629__QW?OOWWV'<+;(XR1;_<=W7^[?
MGMR?75Y^A\HJRN(HS3/\']]E^7?_ZW_^G_\'(O_OW_^OMV_118+3^&=TGB_>
M7F;+_-_0=;3&/Z-/.,-%5.7%OZ$_16E-_Y)?)"DNT%F^WJ2XPN0'_N&?T>^^
M?__^$;U]:U'NGW 6Y\67N\NNW*>JVOS\PP\O+R_?9_ES])(77\OO%[E=<?=Y
M72QP5];]]9_OT/_X<(X^O'O_+^\__/@>O7_W1W3Q9W1^<?W]ZY)4YCRJB!SY
M^?=$[-V/Y/_\^.[A_>]^_MU//W_XW?]G^=$JJNJR^^B[UW]]]_['=^_>_<C5
M_SU-LJ\_T__S&)48$1-EY<^O9?(?WPVJ^O+C]WFQ^N'#NW?O?_A_/U_=+Y[P
M.GJ;9-14"_Q=JT5+D>F]_^FGGWY@O[:B@N3K8Y&VW_CQAQ9.5S+Y-='(#Y"4
MR<\E@W>5+Z**,<WX&:24H/_UMA5[2__T]OV'MS^^__ZUC+]K&Y^U8)&G^ XO
M$:OFS]5V0]A;)I1\WS5_>RKP4@XF+8H?J/X/&5X1B\?T0S_1#[W_/?W0/S5_
MOHH><?H=HI*$DLIZ_30JJU'ZP3?86UPD>?PQFX=ZJAT(/ND[1;5#!8;ZWJOP
MD%=1.@O\4-,[[&L\K\5[/?\M3:86/*^E!YH'@5V)D)V;5]ZN*?WC%?G7"")^
MK<B<B>,6)"U",P*S+[")H2F[*SU?C,I-Z6B>%^.ZE]FV>-M.GJQV=$K]Z_V6
MK 96V\_D_^#BOGZ\S!:?\?H1=]H,^G]\9Q+^88J)JIT4+;"H6!AJUTC\L,C)
MW+2IWJ:\';GZLLC79@Q-&^0FR;^FCUW)O,7(QQ55&(D5N&2K$B>##>MAU9@-
MO'5*Q.EJ#V=OO]Q_]S\;><05$-% 1 7]A2O]U[__T']A#C^:6K :+*/RD56C
M+M^NHFCS ^7-#SBMRO8OC$EOW[UOIO=_:O[\U].Z3#)<EB>+O]=)F= UQ<EK
M4D[J;Y3VP29+R)1.!M'@?++#-R54*XT&XN@O5 $(F<A^9)UG]U6^^"H=DS1R
M/@FDA#FDCB $AC0J9%.Z<#G$!(&-.G3;AM<XJ\[2J"QOE@RC9MS1R/LDCA'V
MD$!*83!$,B$4"$7%4+YL*05HY+E?X"PBFY); E@[],@$O5)("73$'4$*#FE4
MT(3E3R/X!E%1J -0B])F\!G+!AEX9'"E@\Y0$ YW-.A4]-G3,*/:3=&1[&9#
M5U+*H4,GZ&\7I0/:[Z!D4L'-;X0FV)[-+UP8XNA!(='S9\V@,1;Q.5;(P V'
MB.'OP:FA 34E!>,!E0&U\/BXWJ3Y%N,!O;7K#XV\3Y(880\9HQ0&0Q\3PBF7
M6GDT&FE@#3(G+U$1/Y"O:$:9B8Q/!DGA#5DS$@##%!FJ*3N8#*)"AUU\?/Q[
MG53;2]+4694\8SK /;SD#T]Y74997)YD\06I>X6Q9EWB7H:W)<O<ZG6K&=<"
M@I-L%]3"$,6*05TY?!U$2/0[8./4:4YZR\WR/"GP@GRB/'N*DF)MV(:;E+R>
M)UM58'2LK-4(3D,GF,(A,U6BASR=&C"^/215BF^6EUF</"=Q':6:^5$AZY-=
M6KA#4DD%P7!)AVY*(29+*=1+@UJS?XY>DW6]U@Y0$QF?C)'"&S)E) "&(3)4
M4V8T,L!&E#L"4;?*'OSNDP<"K"$'NA_!V'^*:&I[]CNL<2#)S./ 6,;K.""#
M-QH'A@)@>"!#)8P#7 ;8.'"9/>.2E*TEQ%3()R/D (>4&$N X804UI04K1 P
M5MSAE/D\1D6U?2BBK(P6]+2H/-T.?]%-'PX%>)U?G"LVFH"LM<&PT!FR,(5Q
M,<3D#GLVQ)W&3E8%9A=FZ@,@A:"W4QXMT.XH1RH5G!A&:,*\Q5WY.F%@0Q4]
MLKQ9GA0%76I1?+JML5S6Z]98!W>T-98)!F>/#3IA:TP/E<G.>""-HBQ&UWGV
M-AK\;3@\@5HS=U?X_'R2OD#*,_*?I8T#A5PGB".%#K[4H4*F (:"-B@5!\R]
M+"B>G<0Q\V^-TMLHB2^SLVB35%&J79H;=+S>CMG ']V6Z13 \,P&I7";UND@
MJO3V,D.-&K#9\PY749+A^&-49$FV*K5<4PG[7<#K (\7ZS)),+32PA/XM%C4
MZYHOQ,_Q,EDD^UN&J;S$GI+-.LK.DVB=9_%MD?\-+S1+<JVX/X\Q,^C>;TPM
M&YPDE@ %'S*N@1H5U.@<FBK=K9F:'H*(-THHP'4TF/P.P_1R4%-S[_^V4F'@
M6U*Y)*:K_"QN/ZJVM4[:F]G-D#L&J$5AD,&(3_ :;!40T>CNM ]-DL$3G8?\
M%%^698UC-4NTXMYH8@&ZXXE&%@91S "USZ4><G2*$=<Z^)119T])FIXG954D
MCS5=*W\J\GJCF4$,&OXF%"OH_?RB%8=!'"N,PNS#E=!0"S$U8'N<LZ<$+S^^
MXD5-?<INEF3YC/7W75H-KZ\VS=!'[S?5XL&)9H]1.( NOD?_&9$!ZBXO#[[4
MN7KXE9U):K8Z@HBWH4<!KAMK)K\'M[D&U-3(5P^H$3NTA2_R15U>1'1)U#XN
M5]M:(^S-ZD; G?V5DC"88((WY0231UP!=8$ #DR/_XRR.BJV#R]D_;P=.#'?
M)Z]ZKW1+16^T<:I(1R$K+1AT<H$ZI5:CBSZ\>\.BL4%;LA28A3JCX>(TETRB
MF-?%B0+D:$4RD0G.' ,PT?MADQ<5"]MW6-\')9GQ,_G+O(%GJAI^Z)%7QCSX
MC/6"DV@&6,, ] =@ Y!N$:R0\3GT*)?!4H'@?-&AFA+#TRKXCUFR>JH>GG 1
M;3#9BBW*TZAXC.*\U 97LU+S-LXX5*(;8RQT@O/%$>B40ESSX/LHMBZ_KJN"
M775?18_EU=699BNEE?>WF[* W6^H-,(P6&*!4-A6\0U5IX.HTAM$U Y^IVP^
M7!%$_-T=&PY7[B$>KLA!"??"W@Y7Q$'+<3J!,8VX3!_@IPW+Z6*HLM>@G:H=
M3YWAAZ>D<#QEL=#RM\^QKD*_Q3&JP*"1-4YA8T,4T8_[/E9132C$.NP# M2+
M9*DGDK6JOPG(K3+]Q&2G!X-7;F"%B:S5;AGV+X=FV)=[-87ZW[QQ9 JG(T'[
M PPK3]!,S?CE^WM@YQV=,_DGG*_(-/B4++1!%C3R05S[5;"E;OU3X>"<L44X
MY=%0[+#'LV=I7B;9BIX#:UR:1"%_CDPJ@+W[TE0BN-FUL,1 O$RN.8H_M"M;
MUKFT6#Q'U(I[=&4S@AZXLBEE@;#""%!T9>LU#O!84<&47\C"Y?/Y65YH/-=$
M&6^<4,'KB# 5@&%]!:JIR:D8^APC*GB0]42)%]^O\N<?8IS0I<3OZ#\H"7XW
M6$&0/_WU"J^B]&-6)=(W\5()'Q300*,$D/P<W/QJ3(+#$)5"7.RP<_]5LL!9
MB2TF I6D/P<Q+=3>3TPJ%MSX9FP"";BPO_&>S#)EG59D(6*W+E )^UP5Z $/
MUP1R21B\,,&3K <:>=^K >TMF"#B>2V@ONN:_ [#ZG)0\H7 N?45U@%WY'M^
M!/W!JQF><?&8=^GKI%MT.[B&]] H<7L/?;C!<3^O?\!8R1JI]B%0E:-'7P^!
M[O&B+NA*SSR=*D4]GM!KP0Y.Y*5R,(94/3CQQ)U+^YM$R1?S+/XSCC1/3$49
MGQR0PAL:?R0 QNHR5!)STX?C5.[0=J870-A@9U'&FYU5\#H[3P5@V%F!2HC)
MQ,2\V/FTP-'7ZJG(Z]73;9'']:+2.X48%+PQP IX1P>M- QNV$ 40J,/=%"K
M],:'?PA;B]R2RC]%5H<O>GF_2:L,L,>YJQ3",#AC@5">R:K5\;EPJ*J4!Z.S
M64PJA3TN)0R !VL*A200DAC@B:N,5MX?.ZZ),?+U!E>8C&+/2:E*6F42]L8.
M(^".'4I)&.PPP9NR@\:%;!10IW%P/Y]B14AX]WJ/TQ3K(ADI!/UY .F ]NY
M,BD8=-!!$QR%&EG4"!]\3[(I>$1N.B*5M]7VJM*$L-%)^]NG&"'W.Q:E* QF
M&/$)NYC;.S300$0%$9U#L^2D+JLB2I,H.\\I+=4,44EZ8X<>:L<,N1@,5FBQ
M"0?-7\Z!>1:>U46!LX4N6/Y8Q.L3;@FXT?/MP>_!V: !)1QG-R*>WVP[N)_;
MZX9[M6WK@&ZK&)Q!<] J'VY_\.. KGQF'LT/##!5#1\80%X9<V" *%Q@ -,U
MG!MF;_$!#/L?\\8GV(['L-6!-,9(,2DW-P<_^5A'\=E3GBPTONL2(8\G'0J
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M76;+O%BS]\ GCS0!QJ*27MU8Z?F[('.H1G])9J$4G$>N2(7+LD85$5W$E=%
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M-AUX60 WF3P8=EF 5(9SZW5@L.N\QA?$8G<X);N*^#8JJ@27>G;I5;P^AK(
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M(E0I;7HQH,01 "I._7Z3$I'?\CQ$#8_R# I_:-0MCI/F)K#<\!F4O$= ,U9
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M3;B8FR5]ZW.1YB^F=&UZE2!1?33@I?%])/)@!DT+D.J8/V2^HDJ(::&_M'I
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M8K1>-(QJCF7XO0N?4;WQI;A# 6 (.P>U+&174P9/,3PL!?)"SJKR9K<.MT+
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M)CJX65ZT$'7>6'H5KQZH%N!'7J8:>3#LL@ IO@%<Y*N,#5;#W)ET HUGL.^
M%FMOPYN<&C(C340\>V99'&"H *K>6;7!00!=(IWC35XFU< MN7%4;C$K1SZC
MGM\YQ;(:X]G%H 1F)+!%JHK FDP("(-[+/:^_DYH+.*343)P0_(,?P?#$PDH
M84=%HSDG3 1%)8OJ1F<'EOBVO]*)5@5FE^<@O'UWB"$/[M#; JO49"!#R!?)
M,UE?/&/S0SN%K-\Y0@-W3">)()@^KD,W90Y]!X*>VYPR<:?9O1G:.:"CXMID
MZ,0FRQNF$O)V!:($V%UT"!+!&:"%)7OBT[T7"S2*._E?^AVIC2_XI-BFC?Q
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MS)*ZC\2E!]20<C\-_ID5'L/)8RRQOEQYE.7[YG3V&TGX89>/=;JJ);5I0#-
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MVYU?KW'^MBF<1^4--A-T4AF_%K&9ZU<QX^+R"0GR*I9E?<26O/1;!;@CYR&
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M5+;^8O95U-GT5C3U0MER:S0"0H2@7%[7Z#$MIMM,N =.9UOGL(UU4[Z&%"1
M7/"4R-.R/[[[]$DE_&U7]^M+0H*KF&UM\]-9N>?O[/>5F+CRPMQ]%6\EP3"X
MBO/&Y>A$Z\KX)F* DUG,)F*(DWR,HDDYRLK[6CW^M!SI\4(_4&EHOLKR=WK%
M T*EC>OX?O,"STW^<.S"VV5961$UMPDY' #2T1E8P.+ C-Z*WT#YK9*PI2EX
M5<K1F6&@PL /W6\Q5Z'%0;,6QH-^(#;[&)TEQ5Q >($5R<RN&"'744JXW%-S
M6+M[&(^QQ9@U[)!NIN(%?:8!5ZK[K]1Z#^,QWQBSA@G2BHVI<">=9FF2>E'
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M0.C:_: W-&"AV(K2(:LT_TYK%%=TIH4&3 W$YV=L^!B*9TC-+2'^]_/X^4U
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MS:08SF0SGHD7!;5:F.60)KSI=E"5:IK[%LN4N<2(46T%:$60BA(JN3_*(4>
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MQ$\S+]PP(#4#=#5U;0309_!1L8AC5Q:VT93<\%M;2Q/2G)]Z2M?6 =#2@0H
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MG@-=E??<EA4K/>)AKIL_==83FY1]('/5W UT.JN&"92'?QZ6GGO</E6B!!)
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M>7(M,C Q-3$R,S$N>'-D4$L! A0#%     @ DF%^2!CE._\M&@  OU0! !4
M             ( !Y#$! '-N>7(M,C Q-3$R,S%?8V%L+GAM;%!+ 0(4 Q0
M   ( ))A?D@DJKD&03L  %$7!  5              "  41, 0!S;GER+3(P
M,34Q,C,Q7V1E9BYX;6Q02P$"% ,4    " "287Y(VWNY5?9]  "\3P< %0
M            @ &XAP$ <VYY<BTR,#$U,3(S,5]L86(N>&UL4$L! A0#%
M  @ DF%^2)D=CR]760  @0L& !4              ( !X04" '-N>7(M,C Q
C-3$R,S%?<')E+GAM;%!+!08     !@ & (H!  !K7P(    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
